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Published: 24 March 2020Fig. 1 (abstract P001). (1) Representative images from ADtg mouse
showing markedly increased distribution of Aβ1-40 in a “banding”
pattern within a region of acute vascular disruption. Graph showing
significant increase in Aβ1-40 bands/% area of FITC in ADtg mice
subjected to MV compared to SB ADtg mice. (2) Increased cleaved
caspase-3 in the entorhinal cortices of WT mice subjected to MV
compared to SB controls. (3) Significantly decreased activation of
cleaved caspase-3 in the entorhinal cortices of ADtg mice subjected
to MV compared to SB ADtg controlsP001
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Introduction:
A long-term cognitive impairment that resembles Alzheimer’s disease
(AD) is a known complication of acute critical illnesses that affects up
to 2 million individuals annually in the US. Mechanical ventilation
(MV) is a hallmark critical care intervention that is strongly associated
with cognitive decline.
Methods:
We subjected double transgenic Alzheimer’s disease (Adtg)
(APP/PSEN1) and wild-type (WT) mice to MV for 4 hours and
compared to spontaneously breathing (SB) controls. Cerebral
soluble/insoluble amyloid-β (Aβ) and neurological and systemic
markers of inflammation were quantified. Hippocampal blood-
brain barrier permeability was quantified using a novel meth-
odology that enabled assessment of small and large molecule
permeability across the blood-brain barrier. Immunohistochem-
istry was used to assess the regional relationship between
amyloid-β1–40 and acute vascular disruption and neuronal
injury.
Results:
See image
Conclusions:
Short-term MV resulted in increased cerebral soluble Aβ1-40
and increased cerebral TNF-α and IL-6 concentrations. BBB per-
meability and neuronal injury were decreased in mechanically
ventilated ADtg mice, whereas BBB permeability and neuronal
injury were increased in mechanically ventilated WT mice com-
pared to their respective SB controls. There was increased distri-
bution of Aβ1-40 in regions of acute vascular disruption,
resulting in lower BBB permeability. Overall, these results sup-
port a possible physiological role for Aβ1-40 to decrease BBB
permeability and neuronal injury during the acute stress of MV,
however it is expected that long-term sustained of this putative
protective pathway will contribute to neurodegeneration and
cognitive impairment.© The Author(s). 2020 Open Access This artic
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Fig. 1 (abstract P004). Box-plots of WBC (panel A), CRP (panel B),
and PCT (panel C) in the groups
Critical Care 2020, 24(Suppl 1):87 Page 2 of 213Introduction:
The aim of the study was to investigate into the molecular mecha-
nisms of neuroprotection with 50 vol% xenon in an in vivo model
experiments.
Methods:
Eight rats were anesthestized (Combi-Vet machine; induction chloral-
hydrate 300 mg/kg intraabdominally; then 30 mins of 50 vol% xenon
inhalation (95% O2 0.5 l/min, 100% xenon 0.5 l/min; O2 50%, Xe
50%); 8 rats were in the control group (Combi-Vet anesthesia ma-
chine; induction chloralhydrate 300 mg/kg intraabdominally; then 30
mins of 95% O2 0.5 l/min). Rats were euthanized and brain homoge-
nates were made. Content of the phosphorylated (inactivated form)
of the GSK-3 beta enzyme and key antioxidant enzymes (hemoxy-
genase, superoxide dismutase, catalase) in rat brain homogenates
was assessed by western - immunoblotting. Statistica 6.0, parametric
methods were used for data analysis.
Results:
The research results showed that xenon inhalation anesthesia re-
sulted in a 2-fold increase of the phosphorylated (inactivated form)
of the GSK-3 beta enzyme (р<0.05); increased the content of the key
antioxidant enzymes (hemoxygenase (by 50%, р<0.05), superoxide
dismutase (by 60%, р<0.05), catalase (by 20%, р>0.05) in rat brain
homogenates compared to the controls.
Conclusions:
An increase of the phosphorylated GSK-3 beta enzyme and pool of
antioxidant enzymes (hemoxigenase, superoxide dismutase, cata-
lase) in the brain under the xenon anesthesia was proved which sug-
gests a new molecular mechanism for the realization of its
neuroprotective properties and has a great clinical outlook.
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Introduction:
Ventriculostomy-related infection (VRI) is a serious complication in
patients with hemorrhagic stroke. In such patients, diagnosis of VRIs
is complicated by blood contamination of CSF following ventricular
hemorrhage. We aimed to evaluate the diagnostic potential of white
blood cells count (WBC), C-reactive protein (CRP), and procalcitonin
(PCT) to identify VRIs in patients with hemorrhagic stroke during the
time of external ventricular drain (EDV) in situ.
Methods:
This retrospective study was conducted at the Neurosurgical-ICU, University
Hospital of Zurich. A total of 347 patients with hemorrhagic stroke and an
external ventricular drain (EVD) were admitted over a 6 years period at the
ICU. Of those, 14 patients with VRIs (“VRI”), defined by positive CSF bacterial
culture and increased WBC in CSF (>250/ul), and 115 patients without VRIs
and with serial CSF sampling (“no-VRI”) were analyzed. Patients with CSF-
contamination or suspected VRI (negative CSF cultures but antibiotic treat-
ments) were excluded. WBC, CRP, and PCT were measured daily. CSF was
sampled routinely twice a week or by T>38°C. For the analysis, mean peak
values of WBC, CRP, PCT during the time of EVD in situ were compared be-
tween groups (t test). Data are expressed as mean with CI 95%.
Results:
Between groups, WBC and CRP were similar (WBC: 15.13 G/L and 14.55 G/
L, p=0.68 and CRP: 115.93 mg/l and 129.44 mg/l, p=0.56 in the group VRI
and no-VRI, respectively) (Figure 1, panel A and B). In the group VRI, PCTwas low and significantly lower than in the group no-VRI (0.16 ug/l and
2.61ug/l, p=0.03 in the group VRI and no-VRI, respectively) (panel C). WBC
in CSF were similar between groups (710.14/ul and 675.16/ul p=0.93 in the
group VRI and no-VRI, respectively).
Conclusions:
In this study, serum-inflammatory markers were not able to screen
patients with VRIs. Their routine measurement should be carefully
evaluated.P005
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Introduction:
Central nervous system (CNS) infections constitute a potentially life-
threatening neurological emergency. Patients admitted to the inten-
sive care unit (ICU) usually present with a severe disease and organ
failure, leading to high mortality and morbidity.
Methods:
We have performed a retrospective analysis during a 5-year period of
patients admitted to a polyvalent ICU. Clinical, demographic and out-
come data were collected to evaluate its clinical impact on the out-
come of patients with CNS infections.
Results:
We identified 30 patients with the diagnosis of meningitis, meningo-
encephalitis and ventriculitis, where the median age was 57,6 years (range
24-80). Upon clinical presentation, their most frequent signs were fever
(70%), meningeal signs (40%), seizures (30%), and a Glasgow Coma Scale
score <8 (66%). All needed ventilation support and 66% needed cardiovas-
cular support. A definitive microbiological diagnosis was achieved on 22
patients and antibiotic therapy was adjusted on 18 of them. Most common
microorganisms were Streptococcus pneumoniae (n=7), Listeria (n=5) and
Pseudomonas aeruginosa (n=4) (Figure 1). Other gram negative microorgan-
isms were detected and lead to more adverse outcomes. Meningitis was
the cause of admission on 26 patients and on a minority (n=4) meningitis
was considered to be a secondary diagnosis on patients admitted for other
causes (traumatic brain injury, subarachnoid or intraparenchymal
hemorrhage, postoperatively of neurosurgical tumor). Patients that
Critical Care 2020, 24(Suppl 1):87 Page 3 of 213eventually died had at least one risk factor (age>65, immunocompromised
due to diabetes, corticotherapy, HIV or heart transplantation).
Conclusions:
Patients admitted to the ICU were not so aged, but had some comor-
bidities and risk factors leading to more uncommon microorganisms,
increasing the risk of adverse outcomes. This lead to an increase of
mortality: 23% in the ICU and an overall of 43%.Fig. 1 (abstract P005). Isolated microorganismsP006
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Introduction:
Patients in UWS are characterized by a persistent systemic inflamma-
tory response syndrome that can lead to selenium deficiency
Methods:
Ànalysis of selenium level was investigated in 54 UWS patients with
signs of SIRS: 31patients with TBI and 23 patients with hypoxia. Dur-
ation of UWS was 2-4 month. Selenium blood level was performed
once every 10 days for 30 days (three times on the whole). After first
blood level measurement, 46 patients (27 TBI and 19 hypoxia) re-
ceived sodium selenite pentahydrate (Selenase) at a dose of 6 mkg /
kg / day for 7 days; In 8 patients (4 TBI and% hypoxia, selenase was
not administrated (control group).
Results:
In patients who were treated with selenase, maximum concentration
of selenium was observed on the 20th day and was on 34.74%
higher on average than in the initial study. In the initial study, the
average value in patients with hypoxia was 24.24 ± 10.90 mkg/l, the
maximum value was 61.30 mkg/l, between 2-9 days 28.83 ± 15.46
mkg/l (max 70.00 mkg/l), from 10-19 day - 30.22 ± 8.54 mkg/l (max
50.70 mkg/l), from 20-30 days 34.76 ± 16.75 mkg/ l (57.10 mkg/l). At
the first measurement the average value in patients with a conse-
quence of TBI was 24.81 ± 8.83 mkg/l, maximum value was 53.00
mkg/l, between 2-9 days 39.26 ± 12.39 mkg/l (max 64.50 mkg/l),
from 10-19 day - 37.41 ± 12.88 mkg/l (max 59.50 mcg/l), from 20-30
days 37.35 ± 12.75 mcg/l (max 64.30 mcg/l). Original selenium blood
level are 23-190 mkg/l. The average value of the initial values in thecontrol group was 21.4 ± 1.6, mkg/l on day 30 in the control group
17.8 ± 3.8 mkg/l.
Conclusions:
Therapy with selenase showed a statistically significant increase of
selenium blood concentration (p = 0.00) compared with the control
group. Selenase administration did not show a statistically significant
value on severity of SIRS process. Average values of selenium levels
did not depend on the etiology of brain damage in UWS patients.
Funding :
The study was funded by RFBR project number 19-29-01066/2019
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Introduction:
The objective of this study was to evaluate the pharmacokinetics
(PK) of levetiracetam (LEV) in critically ill patients with normal and
augmented renal clearance (ARC), and determine if the recom-
mended dosage regimen provides concentrations in the therapeutic
range (12-46 mg/L) [1].
Methods:
A prospective observational study was conducted in a tertiary hos-
pital. Six blood samples were taken during a dose interval at steady
state and LEV was quantified by HPLC. A population PK study was
carried out. Statistical analysis was conducted to evaluate the differ-
ences in PK between patients with and without ARC. The suitability
of drug concentrations was also assessed.
Results:
Seventeen patients were included, 13 with normal creatinine clear-
ance (CrCL) (80-129 mL/min) and 4 with CrCl≥130 mL/min (ARC). Ten
patients received 500mg q12h, one 1000mg q12h and two 1500mg
q12h. The data were best fitted to a two-compartment model. Figure
1 shows LEV concentrations during the dosing interval. Mean clear-
ance (CL) was 4 L/h and mean volume of distribution of central com-
partment (V) was 44 L. Interindividual variability was 38 and 61% for
CL and V, respectively. No differences were identified between both
groups (p>0.05) in PK parameters. No correlation was found between
LEV CL and CrCL. Trough levels were below the minimum concentra-
tion (Cmin) 12 mg/L of the therapeutic range in all patients except 1.
Furthermore, between 3-5 h 50% of samples were below the Cmin.
Conclusions:
Administered doses were not able to maintain LEV concentrations in
the recommended therapeutic range. Other dosage strategies, such
the extension of infusion time with higher doses, could be evaluated
in order to obtain a more favourable profile. No correlation between
LEV CL and CrCL was found.
Acknowledgements
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Fig. 1 (abstract P007). LEV concentrations during the dosing interval
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Introduction:
The mechanical properties of muscles such as tone, elasticity, and
stiffness are often affected in chronic critical ill (CCI) patients. A
hand-held device known as the MyotonPRO demonstrated accept-
able relative and absolute reliability in a ward setting for patients
with acute stroke [1]. The technology works on the principle of ap-
plying multiple short impulses over the muscle bulk via the testing
probe. The aim of our study is to assess the feasibility of objective
measurement of muscle tone in CCI patients with neurological dy-
namics and serum biomarkers.
Methods:
The study included 23 CCI patients with neurological disorders
(stroke, traumatic brain injury, neurosurgical intervention for brain
tumors) with more than a 3-weeks stay in ICU. Dynamic measure-
ments of the muscle properties were taken on the deltoideus,
brachioradialis, quadriceps femoris, gastrocnemius using the Myo-
tonPRO. To identify the leading factor in impaired muscle tone
also were measured neurological (S100, NSE), inflammatory (IL-6),
bacterial load (PCT) biomarkers using Elecsys immunoassay and
the serum level of microbial metabolites using GC-MS (Thermo
Scientific).
Results:
All patients were divided into groups depending on positive and
negative clinical dynamics. Significant differences were obtained in
parameters characterizing changes in muscle tone of lower limbs -
Fgastrocnemius(tone) -15.5 vs 18.5 Hz, Rquadriceps femoris(the mechanical
stress relaxation time) - 16.5 vs 13.6 ms (p < 0.01, respectively). Some
significant correlations between five parameters of muscle tone bio-
markers and microbial metabolites were revealed.
Conclusions:
The results of a quantitative measurement of muscle tone objectively
reflect the dynamics of neurological status, which in the future may
be promising technique for the personalized approach CCI in
patients.
References:
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Changes in hormonal status in patients with unresponsive wakeful-
ness syndrome (UWS) remains poorly understood.
Methods:
275 patients in UWS were examined at the period from 2007 to
2017. 152 patients (115 men) with TBI and 123 patients (63 men) after
hypoxia. ACTH, cortisol, TSH, free T3 and T4, STH, prolactin and natri-
uretic peptide were studied in the period from 2 to 4 months UWS.
In men, the level of total testosterone, LH and FSH was additionally
studied. The obtained data was compared with the UWS outcome in
6-12 months (CRS-R scale assessment).
Results:
None of the studied hormones of the hypothalamic-pituitary-adrenal axis
were a reliable criterion for predicting the outcome of UWS. Most often
and consistently was revealed a tendency of disrupt the rhythm of cortisol
secretion, with higher rates in the evening hours. The average value of
STH was higher in men with the consequences of head injury who had re-
covered consciousness than in those who remained in UWS. Significant de-
crease in testosterone levels, regardless of age, was found in patients with
a consequence of TBI. Mean levels of LH were higher in patients with TBI
and hypoxia who remained unconscious than in patients who later restored
consciousness. The average level of FSH was higher in patients who had re-
covered consciousness . The increase of natriuretic peptide level was ob-
served both in patients who remained in chronic UWS and in those who
restored consciousness.
Conclusions:
No certain endocrine background, characterising this category of pa-
tients was found. Violations of some hormones secretion rhythms, in
particular, cortisol can be considered usual for UWS patients, espe-
cially in patients with TBI.
Acknowledgement: The study was funded by the Russian Foundation For
Basic Research (RFBR) project number 19-29-01066/2019
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Introduction:
Therapeutic hypothermia has not been used before our research in
chronically critically ill (CCI) patients. Temperature decrease in neur-
onal cells is a strong signal that triggers endogenic cytoprotection
programs using early response genes expression. Our goal is to de-
termine influences of craniocerebral hypothermia (CCH) on level of
consciousness in CCI patients.
Methods:
We examined 98 patients with different types of brain injuries. 54
males and 44 females, mean age 45.56 ±16.03. Patients were divided
into 2 groups: main group - 47 patients (Vegetative State (VS) – 28,
minimally conscious state (MCS) – 19), comparison group – 51 pa-
tient (VS – 32, MCS –19), groups were equal on main parameters (se-
verity, functional state, comorbidity). Patients from main group
received courses of CCH, duration -180 minutes, scalp temperature 5-
8 °С, cerebral cortex cooling up to 32-34 oC, session end was without
slow reheating period, and session’s amount was set - until signs of
consciousness recovery. Cortex temperature check done noninva-
sively by using detection of brain tissue EMI in SHF- range. Con-
sciousness recovery in VS and MCS patients controlled using CRS-R
scale.
Results:
CCH sessions significantly increased level of consciousness in VS and
MCS patient groups. In VS patients vegetative state increased until
minimally conscious state and MCS +, and in MCS group until lucid
consciousness (p <0.05) (Figure 1).
Conclusions:
Craniocerebral Hypothermia is used in chronically critically ill patients
for the first time. Our research results demonstrated effectiveness of
Critical Care 2020, 24(Suppl 1):87 Page 5 of 213CCH as an additive treatment tool in such patients. This let us opti-
mistically determine the perspective of inclusion of CCH method in
chronically critically ill patient’s rehabilitation to increase level of
consciousness.Fig. 1 (abstract P010). Consciousness change after CCH sessions
using CRS-R scaleP011
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Introduction:
Sepsis associated encephalopathy (SAE) may manifest in up to 70%
of adult septic patients. [1] Transcranial Doppler (TCD) may provide
important information about cerebral hemodynamics in various dis-
orders. [2] Two indices reflecting cerebro-vascular resistance (CVR)
can be calculated; the pulsatility index (PI), and the resistive index
(RI). [3] In this study, we aimed to assess the cerebrovascular resist-
ance in septic shock paediatric cases with encephalopathy admitted
to the PICU and compare them to a group of critically ill conscious
non septic patients.
Methods:
This case-control study included 45 critically ill children with sepsis
associated encephalopathy and 30 critically ill non-septic and non-
encephalopathic children admitted to a tertiary care paediatric hos-
pital. PRISM III score and neurological assessment, including level of
consciousness assessed using the Full Outline of Unresponsiveness
(FOUR) score were determined. PI and RI of the middle meningeal ar-
tery were done on both sides using TCD to all included patients.
Results:
The study showed that mean PI and RI values of the septic critical
cases were significantly higher than those of the control group, CVR
increases with the more deepening of coma (the decline in FOUR
score). Cerebral CO2 reactivity in septic patients were found dis-
turbed. There were positive correlations between both PI and RI and
PaCO2 with high significance.
Conclusions:
Cerebrovascular resistance is increased in cases of sepsis - associated
encephalopathy. Carbon Dioxide vasoreactivity is impaired in cases
of septic shock.
References:
1. Pytel P et al. Curr Opin Neurol 22: 283-287, 2009.
2. Purkayastha S et al. Semin Neurol 32:411-20, 2013
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Introduction:
Despite the clinical benefit of endovascular treatment (EVT) for large
vessel occlusion (LVO) in ischemic stroke, space-occupying brain
edema (BE) represents a common complication during the course of
disease. Routinely, CT imaging is used for monitoring of these pa-
tients, notably in the critical care setting, yet novel and easy bed-side
techniques with the potential to reliably predict BE without repetitive
imaging would be valuable for a time and cost effective patient care.
We assessed the significance of automated pupillometry for the iden-
tification of BE patients after LVO-EVT.
Methods:
We enrolled 40 patients admitted to our neurocritical-care unit who
received EVT after anterior circulation large vessel occlusion. We
monitored parameters of pupillary reactivity [light-reflex latency (Lat;
s), constriction and re-dilation velocities (CV, DV; mm/s), and percent-
age change of apertures (per-change; %)] using a portable pupil-
ometer (NeurOptics®) up to every 60 minutes during the first 72
hours of ICU stay. BE was defined as midline-shift ≥5mm on follow-
up imaging within 3-5 days after EVT. We assessed differences in
pupillary reactivity between patients with and without BE (U-test)
and evaluated prognostic performance of pupillometry for develop-
ment of BE (ROC analysis).
Results:
In 32 patients (19 women, 74.3±12.0 years) without BE, 1,224 assess-
ments were compared to 207 assessments in 6 patients (3 women,
71.7±11.8 years) with BE. On day 1, day 2, and day 3 after EVT, pa-
tients with BE had significantly lower CVs and DVs, and smaller per-
changes than patients without BE, whereas Lat did not differ be-
tween both groups. ROC-analyses revealed a significant negative as-
sociation of CV, DV, and per-change with development of BE.
Conclusions:
Automated pupillometry seems to identify patients at risk for BE after
EVT. A prospective study should validate whether automated pupillo-
metry harbors the potential to reduce unnecessary follow-up CT
imaging.
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Introduction:
The aim of this preliminary analysis is to detect differences between
the qualitative and quantitative evaluation of the pupillary function
carried out by doctors and nurses of an intensive care unit (ICU) of a
tertiary level hospital. Secondary purpose is to investigate new indi-
cations for the use of pupillometry in a population admitted in ICU
Methods:
The study has been conducted (currently in progress) at the intensive
care unit and ECMO Referral Center at Careggi Teaching Hospital
(Florence; Italy). The enrolled patients are adult subjects (> 18 years)
with alteration of consciousness defined by a Glasgow Coma Scale
(GCS) < 9, following a primary brain injury and/or the use of seda-
tive drugs. The studied parameters, obtained with NeuroLight pupill-
ometer ® (ID-Med, Marseille, France) are analyzed, integrated and
Fig. 1 (abstract P014). Circle of Willis and Pulsed-wave Doppler
mode of middle cerebral artery
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neurophysiological investigations according to internal protocols.
Results:
Visual/qualitative evaluation of the pupil function shows a lower reli-
ability if compared to automated pupillometry. The estimated error
in the proper determination of photomotor reflex is 34.9% (p< 0.01).
No significant difference is reported between quantitative and quali-
tative pupillometry in the detection of anisocoria.
Conclusions:
Our preliminary results are compatible with previously reported data
[1-3], even if there was no difference in anisocoria determination.
Interestingly, a longer latency period among patients treated with
opioids has been observed. Other results are still in progress.
References:
1. Morelli P et al. Minerva Anestesiol 85:995-1002, 2019
2. Oddo M et al. Intensive Care Med 44:2102-2111, 2018
3. Couret D et al. Crit Care 13;20:99, 2016
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Introduction:
Due to the dynamic of critical care disease, a rapid bedside, non-
invasive and highly sensitive and specific method is required for
diagnosis. In this study we set out our experience with trancranial
color-coded duplex ultrasound (DXT) [1]. The DXT study identifies
cerebral arteries as well as hemorrhagic phenomenon, hydroceph-
alus, mass-occupying lesions and midline shift. This is the main differ-
ence between DXT and conventional Transcranial Doppler (DTC)
which is a blind study and do not provide any image.
Methods:
Descriptive, cross-sectional and observational study from December
2018 to June 2019. 21 patients were included. Inclusion criteria: Neuro-
critical patients. Exclusion criteria: No acoustic window, presence of
ultrasound artifacts. Data collection was performed. It was used a low-
frequency transducer from 1.5-3.5 MHz with trancranial duplex preset
(Figure). The patterns were defined as normal, vasospasm, high resist-
ance, hypermedia and cerebral circulatory arrest, depending on the
cerebral flow velocity, Lindegaard Ratio (LR) and Pulsatility Index (IP).
Results:
12 men (57.1%) and 9 women (42.9%). Average age 55.6(20-79). Pa-
tients diseases: Subarachnoid hemorrhage 6, traumatic brain injury 5,
AV malformation 4, stroke 2, hemorrhagic cerebrovascular accident
2 and mass occupying lesions 2. Normal Pattern: 10 patients (rel. freq
0.47). Vasospasm: 5 patients (rel. freq 0.23). High resistance: 4 pa-
tients (rel. freq 0.19). Hyperemia: 1 patient (real. freq 0.04). Cerebral
circulatory arrest: 1 patient (rel. freq 0.04)
Conclusions:
DXT should be part of the routine of neuromonitoring, it allows real
time images especially useful in unstable conditions. Although it will
be needed a large amount of patients to be statistical significant,
DXT is useful considering a non invasive study, bedside and it allows
early identification of different clinic conditions.
References:
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Introduction:
Embolization of the draining vein during endovascular treatment of arterio-
venous malformation (AVM) may result in venous outflow obstruction and
hemorrhage. Anaesthesiologist can use deliberate hypotension to reduce
blood flow through AVM which may be somehow helpful to prevent this
scenario. Adenosine-induced cardiac arrest may facilitate the embolization
too. The goal of our study was to improve the results of endovascular treat-
ment of AVM using adenosine-induced cardiac arrest.
Methods:
After obtaining informed consent 13 patients (8 male, 5 female) were
selected for adenosine-induced cardiac arrest during endovascular
AVM embolization. Main age was 40,8±6 years old. 9 of them were
evaluated as III class ASA, 4 as IV. Endovascular treatment in all cases
was performed under general anaesthesia. Propofol, fentanyl, rocuro-
nium were used to induce anaesthesia, then all the patients were
intubated and ventilated with parameters to keep EtCO2 32-35 mm
Hg. Sevoflurane 2,1-2,6 vol% (12 cases) or desflurane 6 vol% (1 case)
were used to maintain anaesthesia. Hemodynamic monitoring con-
sisted of ECG, pulsoximetry, non-invasive blood pressure measure-
ment. Onyx or/and Squid were used as embolic agents. CT was
performed to every patient just after procedure as well as neuro-
logical examination.
Results:
Adenosine dosage was 0.875-1.26 mg/kg. Time of consequent car-
diac arrest was 10-40 sec. There were 10 cases we administered ad-
enosine for 1 time, in one case we had to administer it twice, in one
Critical Care 2020, 24(Suppl 1):87 Page 7 of 213- 3 times and 4 times in one more case as well. Hemodynamic pa-
rameters recovered without any particular treatment in all the pa-
tients. Embolization has been performed in all the cases
uneventfully. Postoperative CT showed no hemorrhage. Nobody from
investigated group had neurological deterioration in postoperative
period.
Conclusions:
Our study shows that adenosine-indused cardiac arrest is not very
difficult to perform method and it can be useful during AVM
embolization.
P018
Incidence of postoperative major adverse cardiac events in
patients undergoing carotid endarterectomy: a single-center
retrospective study
A Suphathamwit, C Leewatchararoongjaroen
Faculty of Medicine Siriraj Hospital, Mahidol University, Department of
Anesthesiology, Bangkok, Thailand
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Introduction:
Major adverse cardiac events (MACE) is an important causes of mor-
bidity and mortality after carotid endarterctomy (CEA)[1,2,3]. The in-
vestigators aim to determine the incidence of MACE in patients
undergoing CEA in the tertiary university hospital.
Methods:
This retrospective study recruited 175 patients between January
1999 – June 2018. The patients received CEA with coronary artery by-
pass graft surgery were excluded. Primary outcome was the inci-
dence of MACE at 7 days, 30 days and 1 year postoperatively. MACE
was defined as myocardial infarction, congestive heart failure, signifi-
cant arrythmia and cardiac arrest. Secondary outcome was the inci-
dence of postoperative stroke. The patients’ chart was reviewed and
direct contact was performed for patient’s information.
Results:
The incidences of MACE were 7.5%, 1.1% and 1.1% at 7 days, 30 days
and 1 year, respectively. MACE at 7 days were 1.1% of myocardial in-
farction, 2.9% arrhythmia, 1.1% congestive heart failure and 2.3% car-
diac arrest. There were no significant differences in age, BMI,
baseline hemoglobin level, creatinine level and severity of carotid ar-
tery stenosis between those with and without MACE. The incidence
of stroke at 7 days postoperatively was 4.6%. There was no new
stroke occurred at 30 days and 1 year after surgery.
Conclusions:
The patients with carotid artery stenosis were at high risk from major
cardiac disease. The overall incidence was 7.5% within 7 days after
surgery. Significant arrythmia was the most common adverse cardiac
event.
References:
1. Mutirangura P et al. J Med Assoc Thai 99:785-93, 2016.
2. Go C et al. Ann Vasc Surg 29:1265-71, 2015.
3. Boulanger M et al. Stroke 46:2843-8, 2015
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Introduction:
A major risk factor for stroke is atrial fibrillation (AF). To treat AF
anticoagulation is needed. There are now several anticoagulants
available. However, a lack of head to head data as well as the ab-
sence of accurate techniques makes it difficult to compare them andmeasure determine there efficacy. Stroke is known to produce an ab-
normal clot microstructure which is a common factor in many throm-
botic diseases. This pilot study aims to use a functional biomarker of
clot microstructure (df) and clotting time (TGP) to investigate the thera-
peutic effects of different anticoagulants in stroke and AF.
Methods:
We recruited 114 patients (59 AF and 55 stroke & AF). Two samples
of blood were taken: before anticoagulation (baseline) and post
anticoagulation (6-10weeks). Patients were either given warfarin
(31%) or axipaban (69%). df and TGP were measured and compared
before and after anticoagulation.
Results:
Warfarin increased TGP (267±56 secs to 332±78 secs (p<0.05)), and
decreased df (1.71±0.05 to 1.65±0.06 (p<0.05)). Apixaban increased
TGP (235±66 sec to 410±105 sec (p<0.05)) but did not change df
(1.72±0.04 & 1.72±0.05). Interestingly we found that in the apixaban
group TGP significantly correlated (p=0.05) with blood drug concen-
tration levels.
Conclusions:
In this study we show that df and TGP can quantify and differentiate
between the therapeutic effects of two different oral anticoagulants.
Showing that warfarin prolongs clotting and weakens the ability of
the blood to form stable clots. Conversely apixaban prolongs clotting
time but does not affect the bloods ability to form stable clots. This
shows the utility of the df and TGP biomarkers in comparing two dif-
ferent treatment options, something no other current marker has
proven able to do. Where df and TGP may prove useful tools in a
personalized approach to anticoagulation treatment and monitoring
in an acute setting.P020
HAIR-score optimalisation in subarachnoidal bleeding
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Introduction:
The HAIR-score stratifies the risk for in-hospital mortality after spon-
taneous subarachnoid hemorrhage (SAH) [1]. Maximal early lactate is
associated with increased risk for poor outcome [2]. We investigated
whether the combination of both HAIR-score and early abnormal lac-
tate (<24h), gives a better association with mortality after spontan-
eous SAH.
Methods:
In this retrospective cohort study at a tertiary university hospital, data
was collected for all patients with spontaneous SAH during a period of
eleven years (2007-2017). Multiple binary logistic regression models
were fitted for each outcome (ICU mortality and hospital mortality). The
first one included the individual components of the HAIR-score, the
second model also included an indicator for abnormal (>18 mg/dl) lac-
tate within the first 24h (La-HAIR-score). In addition, two simple binary
logistic regression models were fitted as continuous covariates: The
HAIR-score (theoretical range 0-8) and the La-HAIR-score, with one extra
point to patients with abnormal lactate concentration (theoretical
range 0-9). These models were compared with a likelihood ratio test
and Nagelkerke’s R² test.
Results:
A total of 470 patients were included. In our sample, not all original
HAIR components were associated with ICU or hospital mortality. The
multiple logistic regression model of the La-HAIR-score had a signifi-
cantly better fit to the data, compared to the original HAIR-score. The
p-value of the likelihood ratio test was 0.01 for ICU mortality and
0.025 for hospital mortality. A score of 8 on the La-HAIR-score had a
100% specificity for both ICU and in-hospital mortality.
Conclusions:
Combination of HAIR-score and abnormal lactate within the first 24h,
the La-HAIR-score, significantly improved the model fit for ICU and
Critical Care 2020, 24(Suppl 1):87 Page 8 of 213hospital mortality compared to the model with the original HAIR-
score.
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Introduction:
Urapidil is an antihypertensive, vasodilatory drug with no tachycardia
or increased ICP effect. Recommended for neurocritical patients in
European and Asian guidelines. OBJECTIVE: To evaluate the efficacy
and tolerance of injectable urapidil for the treatment of hypertensive
emergencies in neurocritical patients.
Methods:
We carried out a prospective study of 175 cases in 2 South American
Neuro ICU (Chile and Argentina), with clinical and biological monitor-
ing. Treatment was initiated if the blood pressure was higher than
180/110mmHg with organ disfunction. Efficacy was defined as a low-
ering of blood pressure to 150/100 mmHg or below. The drug was
administered according to protocol by IV bolus (by PVC) followed by
continuous infusion. Sex, age, SAP, MAP, DAP and CR were evaluated
at the beginning and end of bolus therapy, as well as response to
the drug at 5, 10, 15 minutes, and maintenance dose. Statistical ana-
lysis: Wilcoxon test for paired samples.
Results:
175 patients (average age : 63). Ischemic stroke (86), ICH (59), SAH (16),
HELLP / PEE (5), ACS (3), HE (2). Changes in SAP (198 to 130), DAP (116 to
78) and MAP (155 to 94) (p two tails <0.001) (Figure 1). No significant
changes in CR (median 76 to 72). 9 deaths, none attributable to administra-
tion of urapidil. 124 (71%) responded to 1st dose at 5 min, 50 (28%) to 2nd
dose at 10 min and 1 (1%) required a 3rd dose at 15 min. All responded
favourably. Urapidil was effective in all cases, with a significant decrease in
BP. 99% within 10 minutes. There was no lack of response or complications.
Conclusions:
Injectable urapidil seems to be an antihypertensive agent that is easy
to use and effective in all the cases of this first South-American ex-
perience. Further comparative studies are required.Fig. 1 (abstract P021). Hemodynamic effects of urapidilP022
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Introduction:
Patients with poor-grade aneurysm subarachnoid hemorrhage (aSAH)
World Federation of Neurological Surgeons (WFNS) Grades IV and V,
have commonly been considered to have a poor prognosis (70-100%
mortality). Though early intervention and aggressive treatment in
NeuroICU has improved outcome in the past years, it is controversial
because most of the patients left hospital severely disabled. The
objective of this study was to investigate the clinical and social out-
comes in intracranial aneurysm patients with poor-grade aSAH
underwent different intervention therapies.
Methods:
A single center observational registry of 25 poor-grade aSAH con-
secutive patients, defined as WFNS Grades IV and V, treated at ter-
tiary chilean referral center from December 2013 to March 2019 were
enrolled in this study. The clinical data including patient characteris-
tics on admission and during treatment course, treatment modality,
aneurysm size and location, radiologic features, signs of cerebral
herniation (dilated pupils), and functional neurologic outcome were
collected. Clinical outcomes were assessed via GOSE and and socio-
occupational outcome, both at discharge and at 6 months.
Results:
883 admissions, 190 were SAH. 84 patients Fisher III and IV. 25 pa-
tients WFNS 4 or 5: 20% mortality (5/25). Every death was de-
clared out of therapeutic reach during admission by neurosurgeons.
Mortality per year (3/3 2014, 0/4 2015, 1/3 2016, 0/4 2017, 0/6 2018,
1/5 2019), suggesting reduction of mortality rates while expertise in-
creased. Of the 20 survivors, 3 were released in poor neurological
conditions (GOSE ≥4) at the neuro ICU discharge. After 6 months,
all patients (20/20) achieved GOSE ≤ 3, with adequate family, social
and labor reintegration (Figure 1). 20% mortality is less than previ-
ously reported, and survivors had a favorable recovery, confirmed
with neuro psychological test.
Conclusions:
Poor-grade aSAH patients in our study shows a more positive out-
come than previously considered.Fig. 1 (abstract P022). GOSE WFNS 4 - 5 SAH patientsP023
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Pre-hospital management of acute ischemic strokes focuses on fac-
tors associated with success in intravenous thorombolysis (IVT)with
alteplase [1]. Distance of patient’s residence from stroke ready hospi-
tals could be one such factor.
Methods:
Retrospective study from our department’s thrombolysis data-
base with 157 patients (mean age 66 years). Demographic data,
thrombolysis time (from symptoms onset to drug administra-
tion, thombolysis within 3 hours or between 3-4.5 hours),
complications during hospital stay (symptomatic intracranial
hemorrhage or death or new embolic episode or other major
hemorrhage), functional outcome at 3 months (modified Rankin
Scale-mRS), mortality at 3 months were retrieved and analyzed
in association with distance of patient’s home from our hospital.
Distance was calculated with the use of an international web
mapping service. Those factors were also compared at patients
according to residence in a rural, medium urban or large urban
area.
Results:
Shorter distance was associated with less time spent for thromb-
olysis, fewer in-hospital complications and better functional out-
come (mRS ≤ 2) at 3 months time (Table 1). Living in a rural
area was associated with worse functional and neurologic out-
come (p< 0.05, Mann-Whitney U test for both comparisons).
Conclusions:
Unlike previous studies [2] our study showed association of
thrombolysis time with distance from stoke centre and further-
more better results with less complications when distance is
short. Long distance from stroke centres and residence in rural
areas probably play a negative role in thrombolysis outcome and
should be taken into consideration when national health systems
organize pre-hospital and hospital network for strokes.References:
1) Kobayashi A et al. Eur J Neurol 25:425-433, 2018
2) Acharya AB et al. J Stroke Cerebrovasc Dis 20:295-301, 2011Table 1 (abstract P023). Correlation of safety and efficacy markers of
thrombolysis and thrombolysis time with distance from stroke centre
Distance p Value
Thrombolysis time (Spearman´s rho: 0.41) <
0.001a
b
Thrombolysis time: 3 hours (n= 121) / 3-
4.5 (n=36)
16400 (400 - 72600) / 37500
(1400 – 88600)
<
0.001c
b
Complications: NO (n= 148) / YES (n= 9) 20300 (400 - 88600) / 37000
(2700 - 72600)
0.04c b
Death (3 months): NO (n= 136) / YES (n=
21)
20200 (400 - 88600) / 27700
(450 - 72600)
0.24 c d
Functional outcome: mRS≤2 (n= 103) /
mRS>2 (n= 54)
18800 (400 - 88600) / 25900
(450 - 77100)
0.03c b
Results are expressed as mean (range). a: Spearman Correlation Coefficient. b:
Statistically significant. c: Mann-Whitney U test. d: not statistically significant.
Complications (during hospital stay): symptomatic intracranial hemorrhage,
death or new embolic episode or other major hemorrhage. mRS: modified
Rankin ScaleP024
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Introduction:
Prognosis of subarachnoid hemorrhage (SAH) is scarce, indeed almost
half patients die or become severely disable after SAH. Outcome is re-
lated to the severity of the initial bleeding and delayed cerebral infarc-
tion (DCI). Infection and more precisely pneumonia have been
associated with poor outcome in SAH. However, the interaction be-
tween the two pathologic events remains unclear. Therefore, we hy-
pothesized that DCI may be associated to pneumonia in SAH patients.
Thus the aim of our study was to analyze the association between de-
layed cerebral infarction and pneumonia in patients with SAH.
Methods:
In this retrospective, observational, monocentric cohort study, patients
included in the analysis were admitted in Neurosurgical Intensive Care
Unit or Surgical Intensive Care Unit in the University Hospital of Brest
(France) for non-traumatic SAH. Primary outcome was diagnosis of DCI
on CT scan or MRI 3 months after SAH. Multivariate analysis was used
to identify factors independently associated with DCI.
Results:
A total of 224 patients were included in the analysis (female male ra-
tio 141/83, median age 57 [47-65] years). Multivariate analysis was
adjusted on sedation, intracranial surgery, Fisher classification of SAH
severity, pneumonia occurrence and non-pneumonia infectious event
occurrence (Figure 1). Pneumonia occurred in 66 patients (29.5%)
and other causes of infections in 45 patients (20.1%). DCI was found
in 108 patients (48.2%). Factors independently associated with DCI
were pneumonia (OR 3.10 [1.41-7.06]; p=0.006) and non-pneumonia
infectious events (OR 2.50 [1.20-5.39]; p=0.016). Interestingly severityFig. 1 (abstract P024). Forest plot representation of results of
multivariate analysis for occurrence of delayed cerebral infarction.
Results expressed as odds ratio with 95% confidence interval
Table 1 (abstract P026). Prescription frequencies in patients
categorized by GOS score and age group
GOS, 5-11 years Any prescription Antidepressant Stimulant Antipsychotic
3, n= 5 2 (40%) 0 (0%) 1 (20%) 1 (20%)
4, n= 10 3 (30%) 1 (10%) 3 (30%) 0 (0%)
5, n= 63 3 (5%) 1 (2%) 1 (2%) 1 (2%)
GOS, 12-17 years
3, n= 16 5 (31%) 4 (25%) 0 (0%) 2 (13%)
4, n= 42 19 (45%) 15 (36%) 1 (2%) 10 (24%)
Critical Care 2020, 24(Suppl 1):87 Page 10 of 213of initial bleeding evaluated by Fisher scale was not independently
associated with DCI.
Conclusions:
DCI is independently associated with the occurrence of pneumonia
or other cause of sepsis. Those results may highlight the need for
rigorous approach for prevention protocol, early diagnosis and treat-
ment of hospital acquired infectious diseases in SAH patients.
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Introduction:
Hypocarbia and hypercarbia alter cerebral blood flow and intracranial
pressure. Both might cause secondary brain injury after traumatic
brain injury (TBI).
Methods:
We performed a retrospective observational study from Jan 2012 to
Dec 2017 including adult blunt trauma patients with initial Glasgow
Coma Scale (GCS) ≤ 14, clinical suspicion for TBI, endotracheal intub-
ation and continuous capnography. We excluded interfacility trans-
fers, penetrating TBI and cases treated for herniation (management
includes hyperventilation). All patients were treated by a single air
medical transport service in southwest Pennsylvania. Our primary ex-
posure was depth-duration of EtCO2 <35mmHg (hypocarbia). Second-
ary outcomes were depth-duration of hypercarbia >45mmHg, and
maximum depths of hypocarbia and hypercarbia. Our primary out-
come was survival to discharge. Covariates were age, sex, initial GCS,
shock index and first prehospital serum lactate. We performed un-
adjusted and adjusted logistic regression testing relationships be-
tween EtCO2 and outcome.
Results:
Overall, 148 patients were included and 113 (76%) survived. Overall,
104 (70%) were hypocarbic at least once. Median hypocarbia depth
was 26 [IQR 18-30] mmHg, median hypocarbia duration was 15 [4 –
28] min, and median depth-duration was 60 [14 – 141]
mmHg*min. Hypercarbia occurred in 56 (38%) patients. Median dur-
ation of hypercarbia short (0.5 [0 – 5] min) and median depth dur-
ation was only 2 [IQR 0 – 18] mmHg*min. Neither hypocarbia nor
hypercarbia (maximum, duration or depth-duration) were associated
with outcome in unadjusted or adjusted models. Age [OR; 0.96, 95%
CI 0.94-0.98], initial GCS scores [OR; 1.12, 95% CI 1.01 to 1.25] and
shock index [OR; 0.41 95% CI 0.19 to 0.88] were independent predic-
tors of mortality.
Conclusions:
Among intubated blunt TBI patients, prehospital hyper- and
hypoventilation do not appear to worsen outcomes.
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Introduction:
Traumatic brain injury (TBI) can have devastating neurological, psycho-
logical and social sequelae. Increased psychiatric morbidity after TBI
has been shown in both adult and the pediatric population. Also, crit-
ical illness as such is a risk factor for psychiatric problems in youth. Our
aim was to assess risk factors for later being prescribed psychiatric
medication in survivors of intensive care unit (ICU)-treated pediatric TBI.Methods:
We used the Finnish Intensive Care Consortium (FICC) database to
identify patients 5-17 years of age, treated for TBI in four ICU in
Finland during the years 2003-2013. We examined electronic health
records and CT scans and collected data on drug prescription after
discharge. We used multivariable logistic regression models to find
statistically significant risk factors for psychiatric drug
reimbursement.
Results:
We identified 248 patients of which 46 patients received psychiatric
drug prescription (19%) during follow up. The median time to prescrip-
tion was 14 months after TBI (interquartile range [IQR] 5-31 months). 33
patients received antidepressants, 9 received stimulants and 18 re-
ceived antipsychotics. Increasing age showed a positive association
with all drug prescriptions except for stimulants, where an inverse rela-
tionship was observed (Table 1). Using multivariable analyses, we could
not find any admission or treatment related factors that significantly as-
sociated with being prescribed psychiatric medications. Teenage survi-
vors with moderate disability (Glasgow outcome scale [GOS] 4) showed
high numbers of psychotropic drug utilization (45% received any medi-
cation, 36% received antidepressants, 24% received antipsychotics).
Conclusions:
Our data suggests, that the risk of psychotropic drug prescription
after TBI depends on factors other than those related to injury sever-
ity or treatment measures. The incidence of drug prescription is es-
pecially high in patients with moderate disability.P027
The effects of 1-adamantylethyloxy-3-morpholino-2-propanol
hydrochloride on the formation of steroid neurotoxicity in rats
with brain injury
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Introduction:
Depending on the nature of the brain injury and the severity of the vic-
tims, mortality in traumatic brain injury (TBI) ranges from 5 to 65% [1].
One of the targets for pathogenetic influence on the course of TBI is
the use of pharmacological agents that are able to counteract the
negative effects of excess concentrations of glucocorticoids on brain.
Methods:
The therapeutic effect of new pharmacological derivative 1-
adamantylethyloxy-3-morpholino-2-propanol hydrochloride (ademol)
in rats with TBI was evaluated for 8 days. The pseudoperated animals
and control group received 0.9% NaCl solution and the comparison
group received amantadine sulfate. Cortisol levels were used to de-
termine the efficacy of the test drugs in TBI.
Results:
In rats treated with ademol, the level of cortisol in the blood ranged
from 179 to 188 ng/ml (P5-P95) and was 2.58-fold lower (p<0.05)
compared to control pathology group on the 8 day of therapy.
5, n= 107 14 (13%) 12 (11%) 3 (3%) 3 (3%)
Critical Care 2020, 24(Suppl 1):87 Page 11 of 213Instead, the effect of amantadine sulfate on the level of cortisol in
the blood was significantly less than that of ademol. The concentra-
tion of cortisol in rats with amantadine sulfate in the blood ranged
from 271-280 ng/ml (P5-P95), was 1.73 times lower (p<0.05), com-
pared with the control pathology group, and by 49.2% (p<0.05)
exceeded the corresponding value in animals treated with ademol.
Conclusions:
Therapeutic treatment of rats with severe TBI with a solution of ade-
mol, preferably better than rats in the group with 0.9% NaCl and
amantadine sulfate protect the brain from the formation of steroid
neurotoxicity by cortisol (p<0.05).
References:
1. Rickels E. Eur J Trauma Emerg Surg 43:729–730, 2017.Table 1 (abstract P029). Odds ratio and significance level for each
variable
Variable Odds ratio 95%CI P
CPC 0.0029 0.0000 to 0.8336 0.0431
ICP 1.0614 0.9300 to 1.2115 0.3768
CPP 1.0128 0.8519 to 1.2041 0.8854
PaCO2 1.1137 0.8738 to 1.4195 0.3843
Glucose 1.0322 0.9905 to 1.0757 0.1319
Lactate 0.2381 0.0237 to 2.3900 0.2227
Internal body temperature 7.2637 0.4385 to 120.3210 0.1662P028
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Introduction:
Severe traumatic brain injury (TBI) is the leading cause of morbidity
and mortality among young people [1]. The aim of the study is to as-
sess how plasma and cerebrospinal levels of YKL-40 [2], independ-
ently or in combination with NSE, IL-6, TNF-α and CRP affect the
clinical models and the outcome in TBI.
Methods:
30 patients with isolated severe TBI admitted to the Intensive Care Unit at
the University Hospital “St. George”- Plovdiv from 2017 to 2018 were in-
cluded. Cerebrospinal fluid (CSF) and plasma were collected on the 24th and
96th hour after the injury. CSF samples were also collected from 15 adult ca-
davers and served as an age-matched and gender-matched control group.
Levels of YKL-40, NSE, IL-6 and TNF-α were analyzed with ELISA. GCS, APA-
CHE III and Marshall Classification were determined prior to randomization
and at the 96th hour after admission. Outcome was assessed as in-hospital
mortality and at six months mortality.
Results:
The CSF level of YKL-40 in the TBI group was significantly higher compared
to the control group (p=0.005). CSF levels of NSE are significantly higher
compared to plasma concentrations on 24-th hour in TBI patients. Mean
plasma levels of YKL-40 and TNF-α were higher compared to CSF, but the
difference was feeble. We found statistically significant difference in plasma
levels of YKL-40 (p<0.001) and NSE (p<0.001) in patients with short survival.
A significant correlation between plasma concentrations of YKL-40, TNF-α
and NSE was determined.
Conclusions:
Plasma NSE concentration is the major independent variable which
influenced the survival of TBI patients. Plasma and CSF YKL-40 levels
along with NSE, reflect the inflammatory process and would provide
new information about its dynamics in TBI patients.
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Introduction:
Although cerebrovascular pressure reactivity (PRx) well correlate
to patient’s outcome [1], it requires continuous monitoring and
mobile average calculation for its determination. We therefore hy-
pothesized that a simplified model of variation between mean ar-
terial pressure (MAP) and intracranial pressure ICP over the first
three days of admission would have been able to predict patient
outcome: we call this new parameter Cerebrovascular Pressure
Correlation index (CPC).
Methods:
We performed a retrospective observational study of all adult pa-
tients with severe TBI admitted to ICU from January 2017 to April
2018 inclusive. All consecutive patients with a clinical need for ICP
monitoring were included for analysis. Both for ICP and MAP data
were mean value over 2-hours registration, for a total of 12 observa-
tions/day, CPC was therefore calculated as the Pearson Correlation
Coefficient between ICP values (x axis) and MAP values (y axis),
obtaining one single value every 24 hours. Variables included in the
model (i.e. CPC, CPP, ICP, systemic glucose, arterial lactate, PaCO2,
ICP, and internal body temperature) were collected for the first 3
days since trauma.
Results:
For the main outcome only the minimum value of CPC fit the regres-
sion analysis (P = 0.004). The correspondent ROC curve showed an
AUC of 0.80. The associated Youden criterion was ≤0.26 (Sensitivity =
0.90; Specificity = 0.68). Of all the variables considered for the sec-
ondary outcome only CPCmin fit the regression model (P =0.03).
Table 1 reports the median and IQR range for SG and NSG of all the
variables considered in the model.
Conclusions:
This observational study suggests that CPC could be a simplified
model of variation between MAP and intracranial pressure ICP over
the first three days of admission predicting patient outcome.
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Introduction:
In severe traumatic brain injury (TBI) the heart rate variability (HRV)
could inform about severity and predict outcome. In this study we
depicted the dynamic response of HRV to iatrogenic interventions.
Methods:
Prospectively collected high resolution data of patients from multiple
centers with severe TBI from the Intensive Care Unit (ICU) cohort of
the CENTER-TBI study were analyzed. Bad outcome was defined
as having a Glasgow-Outcome-Scale GOSE between 1-3 at 6 months.
HRV parameters were calculated according to international guide-
lines using a 5-minute sliding window, updated every 10s. Hourly
and daily medians were further analyzed
Results:
We included 273 patients (11403 h analyzed).80% were male, 46±19 years
old and had an initial GCS of 6 (IQR 3-10). 72 had at least one unresponsive
pupil. Outcome data was available for 90.1% of patients with 50.8% (N=125/
246) having a bad outcome. The ratio of LF (low frequency) to HF (high fre-
quency) power (LF/HF ratio) was lower in patients with at least one unreact-
ive pupil (1.2±1.1 vs.1.5±1.3, p=0.03) and who had a bad outcome (1.1±
0.9)vs. good outcome (1.8±1.4) (mean difference 0.69; 95%CI 0.38-0.99, p<
0.001) suggesting parasympathetic dominance. During deep sedation we
found a lower LF/HF Ratio (0.9±1.1 vs.1.6±1.7, p<0.001), a lower heart rate
standard deviation(HR-SD)(p<0.001) and root mean square of successive dif-
ferences heartbeats(RMSSD) (p=0.006), compared to patients that were not
suppressed. During 151 sedation boli the HR-SD increased (mean diff.0.71
95%CI 0.9-0.4, p<0.002) compared to baseline (30min before bolus). During
days with induced hypothermia (63d-mild hypothermia; 23d≤35°C, N=42)
the LF/HF Ratio was lower (1.6±1.7 vs 1.1±1.1, p=0.02), as were the HR-
SD(p=0.01)&RMSSD (p=0.01).Patients with a good outcome but not those
with poor outcome showed increased RMSSD during suctioning(reflecting
better vagal response) (Figure 1).
Conclusions:
HRV reflects severity and ICU interventions. A dynamic analysis dur-
ing interventions may offer prognostic information.Fig. 1 (abstract P030). The patients with a good 6-month outcome
(GOSE>3) after severe traumatic brain injury showed an increase in
root mean square of successive differences between normal
heartbeats (RMSSD) (compared to baseline 30 -minutes before
tracheal succtioning)P031
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Introduction:
Impaired cerebrovascular reactivity (CAR) after traumatic brain injury
(TBI) is a marker for disease severity and poor outcome. It is unclear
how dynamic changes in body temperature and fever impact CAR
and outcome.
Methods:
We calculated the pressure reactivity index (PRx) using the CENTER-
TBI high-resolution intensive care unit cohort, as a moving correl-
ation coefficient between intracranial pressure (ICP) and mean arter-
ial pressure (MAP). Minute and hourly values of PRx and temperature
were averaged in patients with simultaneous recording of ICP and
ABP. Demographic data was based the Core Registry (V2.0). Linear
mixed models were calculated based on minute-by-minute data
using R with lme4 V1.1-21 and ggeffects V0.9.0. Generalized estimat-
ing equation models were used to analyze changes during efferves-
cence (increase of temperature of >1°C within 3 hours).
Results:
We assessed high frequency physiological data during 567 days of
102 patients admitted to the ICU with predominantly a closed injury
type (N=94/102). Median age was 46 years (IQR 29-62), baseline GCS
was 6 (IQR 3-9), and 27% had at least one unreactive pupil. The main
measurement site for temperature was the urinary bladder 55/
102(54%). Half of the patients (49/102) developed fever(>1h with
mean T ≥ 38.3°C) with a total of 834h fever and a median of 9h
fever(IQR 4-24) per patient. Of 110 effervescence episodes 30(27%)
reached the febrile threshold of 38.3°C which was associated with an
increase in PRx from 0.09 (±SD 0.25) at baseline (2h before) to 0.26
(±SD 0.3) during the febrile peak (p=0.014) (Figure 1-A). Linear mixed
models showed a quadratic relationship between PRx and
temperature (p<0.001) with an increase in predicted PRx with febrile
and hypothermic temperatures (Figure 1B).
Conclusions:
The association of increasing body temperature with worsening of
CAR supports prevention of fever in severe TBI. Prospective studies
are needed to further differentiate between mechanisms involved
(i.e. inflammation) and central autonomic dysregulation.Fig. 1 (abstract P031). A) Changes in mean PRx during episodes of
effervescence (1°C within 3 hours); B) Predicted relationship between
PRx and temperature based on mixed linear models
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Introduction:
After traumatic brain injury (TBI) fever is common and may cause
secondary brain damage. In this study we investigated the associ-
ation between changes in brain temperature (BT), intracranial pres-
sure (ICP), and cerebral perfusion pressure (CPP).
Methods:
CENTER-TBI is a co-operative effort of several neurotrauma centers in
Europe and includes a repository of monitored data sampled at high-
frequency (from 200 Hz to 500 Hz). Simultaneous BT, ICP and CPP re-
cordings were studied, focusing on episodes of BT changes (delta BT
≥0.5 °C, lasting 15 minutes - 3 hours) up or down-ward. Using the lin-
ear correlation coefficient episodes were coded as responding (R),
when there was a clear association between ICP and BT (Pearson’s R
value ≥0.5) or non-responding (NR) when the correlation coefficient
was <0.5.
Results:
Twenty-one patients were selected for the study for a total of 2435
monitoring hours. The mean duration of monitoring was 86 hours.
All patients reached a BT above 38° and experienced at least one epi-
sode of ICP above 20 mmHg. A CPP lower than 60 mmHg (often of
very short duration) has been recorded in all patients. 149 episodes
(79 for BT elevation and 70 for BT reduction) were identified. During
BT elevations, the increase in temperature was accompanied by ICP
increases in slightly more than half episodes (43 R (54%) vs 37 NR
(46%)). During BT reduction there were 32 R (46%) and 38 NR (54%)
episodes.
Conclusions:
Patients after TBI usually develop BT> 38° soon after the injury. The
BT may influence brain physiology, as reflected by ICP, through vas-
cular responses (respectively vasodilation/vasoconstriction). Our ana-
lysis identified potential ICP and CPP variations connected to BT
changes in approximately half of episodes. However, it has to be
noted that both ICP and CPP have been actively manipulated in the
ICU, potentially blunting the biological responses due to BT.
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Introduction:
Acute kidney injury (AKI) is relatively common in patients with severe
traumatic brain injury (sTBI) and it can contribute to morbidity and
mortality [1]. NephroCheck is a point-of-care urine test that flags two
biomarkers that indicate if a critically ill patient is at risk for AKI. We
investigated the incidence of subclinical AKI in patients with sTBI.
Methods:
We performed a prospective observational study of all adult pa-
tients with severe TBI admitted to ICU from January 2017 to April
2018 inclusive. All consecutive patients with a clinical need for
ICP monitoring were included for analysis. Urine samples ofsevere TBI patients was collected at ICU admission from 33 pa-
tients to measure NephroCheck (NC) test [IGFBP7]x[TIMP-2] was
performed using the NephroCheck® Astute1 40 ™ meter. Serum
creatinine was collected at admission, during the first three days,
at ICU dismission and 60-days follow up to assess renal recovery.
The diagnosis of AKI was based on KDIGO criteria.
Hemodynamics, electrolytes, PEEP, P/F, kind of fluid administered,
Fluid Balance, % Fluid overload, length of stay, The Sequential
Organ Failure Assessment score, injury severity scores and mortal-
ity were collected.
Results:
A total of 15 patients (45%) presented a median NC higher values at
ICU admission. One patient with positive NC value experienced AKI at
24 hrs. The positive NC group had more plasma transfusion (p-value
0.03) and a lower median hematocrit at 24 hrs (p-value 0.013), but simi-
lar hospital length of stay (p=0.17) and mortality rate (p=0.80)
Conclusions:
NC at ICU admission identifies subclinical AKI in TBI patients and it
maight be used to predictclinical AKI. Hemodilution (but not fluid
overload) seems to be associated with development of subclinical
AKI. Higher NC at ICU admission is not associated with worst long-
term outcome in TBI patients.
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Introduction:
Severe traumatic brain injury (TBI) is considered a serious public
health problem in Europe. Partly because of the heterogeneity of TBI,
considerable uncertainty may exist in the expected outcome of pa-
tients. The International Mission for Prognosis and Analysis of Clinical
Trials in TBI (IMPACT) and the Corticosteroid Randomization After Sig-
nificant Head Injury (CRASH) prediction models are considered the
most widely validated prognostic models [1,2]. However, studies
using these prediction models for benchmarking of outcomes have
been scarce. We aimed to compare actual outcomes in a TBI cohort
of critically ill TBI patients with predicted outcomes in a quality of
care initiative in an Academic Hospital.
Methods:
In this retrospective cohort study, we included consecutively admit-
ted TBI patients to the ICU Adults of Erasmus MC, University Medical
Center, Rotterdam, The Netherlands between January 2018 and Feb-
ruary 2019.
Results:
We included 87 patients with TBI. 14-day mortality was 25%, six-
month mortality was 36% and six-month unfavourable outcome was
50%. The IMPACT core+CT+lab model predicted 34% 6-month mor-
tality (vs 35% actual, p=0.89) and 51% unfavourable outcome (vs
50% actual, p=0.9). The 14-day mortality prediction by CRASH prog-
nosis calculator was 43% versus actual 14-day mortality of only 25%
(p=0.01), whereas 6-month unfavourable outcome prediction by
CRASH was 67% (vs. 50% actual, p=0.02) (Figure 1).
Conclusions:
The IMPACT model, although developed more than a decade ago,
seemed appropriate for benchmarking purposes in this single center
cohort in the Netherlands, while CRASH predictions were less applic-
able to our setting.
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Table 1 (abstract P035). Survival to discharge based on presenting
rhythm
Presenting rhythm Total patients Survival to discharge
VF/VT 62 65%
PEA/asystole 33 24%P035
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Introduction:
Out of hospital cardiac arrest (OHCA) continues to be associated with
significant mortality and morbidity. Centralisation of care has consid-
erably improved patient survival but has resulted in increased mor-
bidity in the form of neurological deficit. Accurate neurological
prognostication remains challenging incorporating repeated clinical
examination and ancillary investigations [1, 2].
Methods:
Data was collected retrospectively and analysed for 96 patients ad-
mitted post OHCA from October 2018 to October 2019. Patient arrest
demographics were collected in conjunction with extensive inpatient
investigation findings including CT, traditional pupil assessment,
pupillometry and EEG.
Results:
50% of patients survived to hospital discharge. Patients presenting in
a shockable rhythm continue to have higher survival rates (Table 1).
53% of patients who received immediate CPR survived to hospital
discharge in comparison to 41% of patients who did not receive im-
mediate CPR. 73% of patients underwent non-contrast CT head. 74%of patients had traditional pupillary examination performed on ar-
rival. Pupillometry was introduced in December 2018; 31 out of a
possible 85 patients had pupillometry during their inpatient stay.
EEG was undertaken in 11% of cases.
Conclusions:
Our data shows receiving immediate CPR and presenting with a
shockable rhythm remain positive prognostic factors. CT head as a
stand-alone prognostic modality is unreliable with 14% of patients
who survived to discharge, with intact neurology, had an admission
CT head reported as hypoxic brain injury. A new neuroprognostic
strategy is required in our unit that adds further certainty to likely
clinical outcome. This includes increased use of tests such as EEG
and pupillometry and the introduction of biomarkers such as neuron
specific enolase, somatosensory evoked potential testing and mag-
netic resonance imaging.
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Introduction:
Post-resuscitation care of patients following an out-of-hospital car-
diac arrest (OOHCA) is set out by the UK Resuscitation Council [1].
This is in line with the European Resuscitation Council guideline [2].
The aim of this audit was to review compliancy to this guideline at
the Intensive care unit at the Bristol Royal Infirmary .
Methods:
A retrospective audit was performed over a six-month period
in adults who were admitted to the intensive care unit at the BRI fol-
lowing an OOHCA whom later died during that admission (41 pa-
tients). The focus was on whether the Neuroprognostication and
End-of-life (EOL) care received was as per the standards set by the
UK Resuscitation Council.
Results:
The main neuroloical examinations documented were pupillary reflex
(100%), corneal reflex (75%) and motor response to pain (100%).
61.5% of patients received an SSEP analysis >72 hours post-ROSC,
81.5% underwent an EEG and 66.7% had >2 serum neuron-specific
enolase measurements recorded. All patients (100%) underwent a CT
Head during their admission. 5.6% of patients were referred to Pallia-
tive Care during their admission. 22% of patients were prescribed all
EOL medications. Most common prescriptions included Alfentanil
(90.2%) and Midazolam (58.5%). Finally, 100% of appropriate patients
were referred to be potential organ donors.
Conclusions:
The audit reflected our local practice and that some parameters were
not being maintained as set by UK Resuscitation guideline. Multiple
Fig. 1 (abstract P039). A-C, Receiver-operating characteristic
analyses for prediction of Cerebral Performance Category (CPC) Scale
1-2 vs CPC 3-5 at 6-months follow-up for serum samples collected at
24, 48 and 72 hours. The enlarged sections in B and C show the
overlap of GFAP, UCH-L1 and NSE at high specificities at 48 and
72 hours
Critical Care 2020, 24(Suppl 1):87 Page 15 of 213modalities of documentation posed a problem in analysing the care
that these patients received.
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Introduction:
Targeted temperature management (TTM) and fever avoidance im-
proves mortality and neurological outcome post out of hospital cardiac
arrest (OHCA) [1]. Patients follow a protocol from admission: TTM for 72
hours (36°C for 24h and then normothermia for 48h). We looked at the
rationale for commencing TTM, temperature control devices, if we met
temperature guidelines and the reasons for TTM failure.
Methods:
We retrospectively analysed patients who had been coded OHCA on
iCLIP (our electronic patient record) between 30/06/2018 to 30/06/
19. We analysed ICU charts for recorded temperatures (< 72hrs)
for TTM patients. We then accessed notes through iCLIP and
assessed rationale for TTM commencement and reasons for failure.
We compared our results to our ICU standards, based on current con-
sensus and the TTM1 results [1]. We also looked at the effectiveness
of a clerking proforma (Feb 2019) on documentation.
Results:
95 patients were admitted post OHCA. 76 were initiated on TTM; of
the 19 not: 10 patients were critically unstable, while 9 patients had
good GCS on ROSC. Of recorded arrest rhythms 57/71 (80%) of TTM
patients were shockable while 9/15 (60%) of non TTM patients were
shockable. Of the TTM patients: 6 had surface cooling devices and 70
had intravascular cooling devices. 21/73 (29%) of TTM patients failed
TTM adherence by either having a mean of >0.5°C OR a spike of
>1°C above target temperature. 13/ 21 (62%) had predictable med-
ical causes of TTM failure: Aspiration pneumonia or myoclonic
jerks. The other 8 patients had process-based failures: going for PCI
or being warmed early. The proforma has had a marked improve-
ment on documentation.
Conclusions:
These results highlight that raised temperatures in TTM are predict-
able. To improve this we will focus on recognition of these risk fac-
tors and establish means to minimise their impact. We have also
shown the benefit of an established clerking proforma.
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The prognostication of neurological outcome in comatose out-of-
hospital cardiac arrest (OHCA) patients is an integral part of post car-
diac arrest care. Biochemical biomarkers released from cerebral cells
after hypoxic-ischemic injury represent potential tools to increase ac-
curacy in predicting outcome after OHCA. Currently, only neuron-
specific enolase (NSE) is recommended in European prognostication
guidelines. In this study, we present the release dynamics of GFAP
and UCH-L1 after OHCA and evaluate their prognostic performance
for long-term neurological outcome in OHCA patients.
Methods:
Serum GFAP and UCH-L1 were collected at 24, 48 and 72 h after
OHCA. The primary outcome was neurological function at 6-month
follow-up assessed by cerebral performance category scale (CPC), di-
chotomized into good (CPC 1-2) and poor (CPC 3-5). Outcome prog-
nostic performance was investigated with receiver operating
characteristics (ROC) by calculating the area under the receiver oper-
ating curve (AUROC) and compared to NSE.
Results:
717 of 819 included patients had at least one serum GFAP or UCH-L1
value at 24, 48 or 72 h after OHCA. GFAP and UCH-L1 levels were sig-
nificantly elevated in patients with poor outcome. GFAP and UCH-L1
discriminated excellently between good and poor neurological out-
come at all time-points (AUROC GFAP 0.88-0.89; UCH-L1 0.86-0.87)
and overall predictive performance measured by AUROC of GFAP
and UCH-L1 was superior to NSE (AUROC 0.76-0.85) (Figure 1). How-
ever, the ROC at the highest specificities of UCH-L1 and GFAP over-
lap those of NSE and comparing the sensitivities for UCH-L1 and
GFAP with those of NSE for the highest specificities (>95%) revealed
higher sensitivities for NSE than for UCH-L1 and GFAP at 48 and 72
h.
Conclusions:
GFAP and UCH-L1 predict poor neurological outcome in patients
after OHCA excellently and with a higher overall accuracy than NSE,
but both biomarkers perform inferior to NSE at specificities over 95%
at 48 and 72 h limiting their clinical use to guide decisions on
prognosis.P040
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Introduction:
Blood pressure management in post cardiac arrest (CA) patients en-
sures sufficient cerebral perfusion to avoid secondary brain injury. In
Critical Care 2020, 24(Suppl 1):87 Page 16 of 213previous studies, lower mean arterial pressure (MAP) was associated
with poor clinical outcome. However, the relationship between
hypotension and severity of hypoxic-ischemic encephalopathy (HIE)
remains uncertain.
Methods:
We retrospectively analyzed MAP during the first week in three CA
patient groups: (1) Patients surviving with no/mild HIE – cerebral per-
formance category (CPC) 1. (2) Patients surviving with severe HIE –
unresponsive wakefulness syndrome (CPC 4). (3) Deceased patients
with post-mortem brain autopsy. In these autopsy patients, we used
the Selective Eosinophilic Neuronal Death (SEND) classification to
quantify the histopathological severity of HIE.
Results:
We included 354 autopsy patients, 118 had histopathological severe
and 236 patients no/mild HIE. Between autopsy patients with no/
mild HIE and severe HIE, there was no difference in mean MAP dur-
ing the first week. However, no/mild HIE autopsy patients with post-
CA regain of consciousness had a mean MAP of 75 mmHg compared
to 65 mmHg in those never conscious before death. We found no
difference in MAP between 216 patients with full neurological recov-
ery (CPC 1) and 57 surviving with unresponsive wakefulness syn-
drome (CPC 4). Hypothermia induced small reversible hypotension in
all groups.
Conclusions:
Contradicting previous studies, we found no difference in post-CA
MAP of patients with histopathological and clinical evidence of pres-
ence and absence of HIE. No/mild HIE patients with post-CA regain
of consciousness before death showed high-normal blood pressure
stability. This may indicate a blood pressure effect on neuronal func-
tion rather than structural integrity. Importantly, extracerebral causes
for loss of consciousness and mortality need to be considered.
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Introduction:
The objective of the study is to analyse the 20-30msec complex of
the somatosensory evoked potentials [SSEP] in comatose survivors of
out of hospital cardiac arrest [OHCA], to identify the patterns of this
complex and to test whether the addition of P25/30 in analysis could
improve N20’s positive predictive value for favourable outcome. Pre-
viously it was suggested that P25/30 have a role in the prognosis of
neurological outcome after OHCA [1].
Methods:
Single-centre, prospective, observational study. Patients: Adult coma-
tose survivors of OHCA treated with organ support, neuroprotection
and targeted temperature [T] management for normothermia. SSEP
recorded at 24-36h post ROSC and interpreted by two interpreters
for P25/30 and N20 in different amplitude thresholds. Neurological
outcome at hospital discharge was assessed by the cerebral perform-
ance category [CPC] score.
Results:
First 30 patients: 18 male, 12 female, mean age 62.3 years. OHCA
rhythm VF in 17, asystole in 13. Cause of OHCA: cardiac in 20 and
non-cardiac in 10. Mean anoxic time 30min. Mean T in the first 24-36
hours 35.9. Among survivors with unfavourable outcome [CPC 3-5] 14 had bilaterally absent P25/30 and N20, 2 bilaterally present
P25/30 and bilaterally absent N20, 1 bilaterally present P25/30 and
N20, 1 bilaterally present 25/30 and unilaterally present N20 and 1
unilaterally present P25/30 and N20. All 11 survivors with favourable
outcome [CPC 1-2] had bilaterally present P25/30 and N20.
Conclusions:
Early results suggest the presence of variable patterns of 20-30msec
SSEP complex in comatose survivors of OHCA. As the number of en-
rolled participants increase, it is yet to be determined whether the
presence of P25/30 could potentially increase the positive predictive
value of N20 for the favourable neurological outcome.
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Introduction:
Local chain-of-survival improvements affect P-OHCA survival [1-5]. Also
initial rhythm in P-OHCA is an important predictor of survival [1,4]. Little
is known about the relationship between initial rhythm in P-OHCA and
long-term outcome [6-8]. Our aim was to establish the relation between
shockable rhythm and favorable long-term outcome in POHCA.
Methods:
All children aged 1 day-18 years who experienced non-traumatic
OHCA between 2002-2017 and were admitted to the Sophia Chil-
dren’s Hospital in Rotterdam were included. Long-term outcome was
determined using a Pediatric Cerebral Performance Category score at
the longest available follow-up interval. The primary outcome meas-
ure was survival with favorable neurologic outcome, defined as PCPC
1-2 or no difference between pre- and postarrest PCPC. The associ-
ation between shockable rhythm and the primary outcome measure
was calculated in a multivariable regression model, adjusted for the
pre-defined variables.
Results:
From the 329 patients included in the 16 year study period 126 (38%)
patients survived to hospital discharge of which 99 patients (30%) had
favorable neurologic outcome (median follow-up duration of 24
months). The rate of favorable neurologic outcome rose from
17% in 2002 to 52% in 2017 (p < 0.001 for trend) (Fig. 1). In ad-
justed analysis initial shockable rhythm (OR 7.2 [95%CI 2.2-23.7]),
initial unknown rhythm (OR 10.2 [95%CI 3.5-29.2]) and the year
of event (OR 1.2 [95%CI 1.2-1.4]) were associated with favorable
long-term neurologic outcome.
Conclusions:
The odds of favorable neurologic outcome at the longest follow-up
duration were significantly higher after a shockable initial and un-
known rhythm. Secondly, trend analysis showed an increase in AED
defibrillation and shorter CPR duration. This was followed, finally, by
a rise in ROSC, survival to hospital discharge and favorable neuro-
logic outcome rate.
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Fig. 1 (abstract P044). Patient and arrest characteristics over time.
A. The total amount of mortality as a stacked bar: in light-red the
number of patients who deceased at scene, in green the number of
patients deceased during admission, in red patients who died after
discharge. The grey line is the total number of inclusions. B. The rate
of bystander AED use, rate of initial shockable rhythm, rate of less than
15 minutes of CPR and rate of favorable neurologic outcome over
time. P for trend significant for bystander AED use, less than 15
minutes of CPR and favorable neurologic outcome. Trend analysis
performed using binary logistic regression for dichotomous data (and
a Kruskal-Wallis test for non-normally distributed continuous data)
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Introduction:
Cardiac arrest (CA) is a global ischemia-reperfusion injury syndrome
[1]. The aim of the study is to evaluate the incidence of AKI in coma-
tose patients resuscitated from CA.
Methods:
We performed retrospective study of consecutive comatose patients
resuscitated from CA and admitted to our ICU from January 2013 to
May 2019 inclusive. Data obtained at baseline, 24 hrs, 48 hrs, and 72
hrs included: temperature trend and rate, serum creatinine,MAP,
VIS, PEEP, diuretic use, urine output, fluid balance (FB). AKI was de-
fined according to KDIGO criteria.
Results:
Thirty-six patients were treated with TH 33°C out of 46 ICU admis-
sions (78%). Fifty-four patients were treated with TTM 35°C out of
106 ICU admission (51%) while fifty-two were not treated with
temperature management (49%). The incidence of AKI was 17.35 at
24h for NO TTM group, 13.9% for TH group and 14.9% for TTM
group. At 48h the incidence of AKI increased at 41.7% for TH, 37.1%
for TTM while in NO TTM group increased less (18.8%). At 72h the in-
cidence of AKI was 33.3% for TH group, 27.8% for TTM group and
32.7% for NO TTM group.SCr at baseline, at admission at 24 and 48h
was not significant different in the three groups. Median cumulativeFB was significant different in the TH group at 48h 1522 (488 – 2236)
compared to 382 (- 397 – 1553) in TTM group and 228 ( -393 – 1530)
in NO TTM group (p< 0.003). Twenty-four patients (16.9%) required
RRT in the overall population. Urinary TIMP-2 e IGFBP7 was 1.54 (0.8
– 3.46) in TTM group and 1 (0.19 – 2.18) in TH group (p = 0.105).
Conclusions:
AKI occurred in more then 30% of patient after CA even if there are
no clear impairment of serum creatinine, AKI can show in a subclin-
ical way and determine an alteration of FB, hemodynamic function,
and chronic renal loss of function
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Introduction:
Low socioeconomic status is associated with worse outcome after
cardiac arrest. This study aims to investigate if patients´ socioeco-
nomic status impacts the chance to receive early coronary angiog-
raphy after cardiac arrest.
Methods:
In this nationwide retrospective cohort study, 4011 patients admitted
alive after out-of-hospital cardiac arrest (OHCA) and registered in the
Swedish Registry for Cardiopulmonary Resuscitation were included.
Individual data on income and educational level, prehospital parame-
ters, coronary angiography results and comorbidity were linked from
other national registers.
Results:
In the unadjusted model there was a strong correlation between in-
come level and rate of early coronary angiography where 35% of pa-
tients in the highest income quartile received early angiography
compared to 15% in the lowest income quartile. When adjusting for
confounders (educational level, sex, age, comorbidity and hospital
type) there were still higher chance of receiving early coronary angi-
ography with increasing income, OR 1.31 (CI 1.01-1.68) and 1.67 (CI
1.29-2.16) for the two highest income quartiles respectively com-
pared to the lowest income quartile. When adding potential media-
tors to the model (initial rhythm, location, response time, bystander
cardiopulmonary resuscitation and if the arrest was witnessed) no
difference in early angiography related to income level where found.
The main mediator was initial rhythm (Figure 1).
Conclusions:
Higher income is strongly related to the rate of early coronary angi-
ography after OHCA. This finding is consistent when adjusting for
known confounders. However, the association between income and
early angiography seems to be mediated by initial rhythm. Patients
with low income more often presents with non-shockable rhythms
which lowers the likelihood to undergo early coronary angiography.
Fig. 1 (abstract P046). Correlation between disposable income and
rate of early coronary angiography. Confidence interval in gray.
Values above 0 on y-axis indicate increased rate of early coronary
angiography. Second figure adjusted for confounders. Third and
fourth figure adjusted for increasing numbers of potential mediators
as stated in Figure
Table 1 (abstract P049). Changes in blood gases during intraoperative
cardiac arrest
Blood gases Before CA
(n[%])
During CA
(n[%])
During CA ROSC
(n[%])
During CA
(n[%])
pH <7.35 18 [62] 29 [78] 19 [73] 10 [91]
pH >7.45 4 [14] 2 [5] 1 [4] 1 [1]
PaCO2 <
35mmHg
9 [31] 7 [19] 6 [23] 1 [1]
PaCO2
>45mmHg
6 [21] 21 [57] 15 [58] 6 [55]
PaO2 <
100mmHg
5 [17] 12 [32] 9 [34] 3 [27]
PaO2 100-
200mmHg
28 [28] 8 [22] 6 [23] 2 [18]
PaO2
>200mmHg
16 [55] 17 [46] 11 [42] 6 [55]
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Introduction:
Simulation teaching is a modern type of critical care (CC) education.
The aim of this study was to assess the effect of simulation teaching
of CC on a comparison of final examination in different model levels
of cardiopulmonary resuscitation (CPR) after the first (CC1) and third,
final CC3.
Methods:
The success rate of CPR was tested in prospective study (2017-2018)
on two groups with a total of 66 students in CC1 and CC3 at the Fac-
ulty of Health Studies. Three semester of undergraduate nursing
simulation education (lectures and training) used the Laerdal SimMan
3G. Quality of CPR was evaluated according to 4 parameters: com-
pression depth, compression rate, chest release and time of correct
frequency. We tested if CPR quality differed between the two groups.
For the compression depth and compression rate parameters, first
the conformity of variance was verified and then two-sample t-test.
As the chest release and time of correct frequency are recorded as
percentages, the Wilcoxon rank-sum test was conducted for these
parameters. To ensure good resuscitation, all recorded parameters
must be properly performed during resuscitation. Thus, pivot tables
were used to generate statistics and test if the number of correctly
performed resuscitation parameters for CC1 and CC3 differ.
Results:
The compression depth parameter was statistically significantly
higher for the CC3 than for the CC1 (p=0.016). There were no differ-
ences in compression rate (p=0.210), chest release (p=0.514) and
time of correct frequency (p=0.586). It was also tested how many of
the parameters were performed correctly by students at CPR. The
chi-square test shows the relative frequency of CPR success is higher
for the CC3 group than for the CC1 group. At least 3 out of 4 param-
eters were correctly performed by 13% of CC1 students compared to
28% of CC3 students.
Conclusions:
The study showed a significant improvement of CPR in the final CC3
and supported the three semester simulation education.
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Introduction:
Blood gas analysis (BGA) is a common approach for monitoring the
homeostasis during surgery. While it is well known that cardiac arrest
(CA) leads to circulatory collapse and disturbances in homeostasis, lit-
tle is known about changes of blood gas during peri-operative CA.
Methods:
We retrospectively analysed patients ≥18 years who suffered from
peri-operative CA during non-cardiac surgery from 01/2014 to 12/
2018. Peri-operative CA was defined as need for cardiac compression
during anaesthesia care. Collected data included pH, PaCO2, PaO2,
return of spontaneous circulation (ROSC) and 30-day mortality after
CA.
Results:
Within the study period, we observed 56 peri-operative CA (m=35, f=
21; age 69±16) during 62742 anaesthesia procedures (ROSC occurred
in 38 patients (68%). 30 days after CA, the mortality was 45% (n=17),
23% (n=13) were discharged, and 14% (n=8) still in hospital. 87% (n=
49) of CA patients had an invasive blood pressure monitoring, 52%
(n=29) had BGA before and 66% (n=37) during peri-operative CA.
Prior to CA, the average values were: pH 7.3±0.1, PaCO2 39±8 and
PaO2 225±107. During CA, the average values were pH 7.2±0.2,
PaCO2 50±17 and PaO2 215±138. Table 1 shows the distributions of
blood gas before and during CA. There were no statistical differences
between the groups (pH: p=0.4; PaCO2: p=0.19; PaO2: p=0.21).
Conclusions:
Hypercapnia and respiratory acidosis is common in peri-operative
CA. These data suggests inadequate ventilation during peri-operative
resuscitation. Further studies should focus on its impact on the
outcome.P050
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Table 1 (abstract P051). Association between monitored cardiac arrest
and patient survival
Survival Illness
category
Monitored
n(%)
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
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Cardiac arrest on ICU (ICU-CA) is usually monitored. Beside-
diagnostics and trained healthcare professionals are immediately
available. This offers exceptional opportunities and poses the ques-
tion which diagnostic strategies are carried out in ICU-CA.
Methods:
Retrospective analysis of adult ICU-CA from 2016-2018 at a maximum
care hospital in Germany with five ICU (two perioperative, two med-
ical, one interdisciplinary) summarizing 71 ICU beds. ICU-CA was de-
fined as requirement for chest compressions and/or defibrillation
according to Utstein criteria. Diagnostics during ICU-CA were col-
lected and analysed. Subgroup analyses included patients with and
without ROSC. Primary endpoint was the performance rate of add-
itional diagnostics during ICU-CA. Secondary endpoints were the
type of diagnostics (i.e. blood gas analysis [BGA], echocardiography
[EC] or chest-x-ray [XR]) and its therapeutic consequences.
Results:
There were 114 ICU-CA out of 14.264 ICU patients in total (incidence
79.9 per 10.000 ICU patients [CI95 65.3-94.5). All patients were moni-
tored (electrocardiogram, pulsoxymetry, invasive blood pressure). Dur-
ing ICU-CA 50 (44%) patients received at least one additional
diagnostic [i.e. BGA 41 (36%), EC 22 (19%) or XR 7 (6%)]. In 27 (54%) of
these cases a therapeutic consequence was documented. These were
application of HCO3- [n=12 (11%)], thoracic drainage [n=5 (4%)], trans-
fusion or pericardiocentesis [each n=3 (3%)], lysis and bronchoscopy
[each n=2 (2%)]. Comparing cases with and without ROSC, there were
significant more diagnostics done in the group without ROSC but more
therapeutic consequences seen in the ROSC-group (Table 1).
Conclusions:
ICU-CA is frequent. Diagnostics to detect reversible causes of CA
were used rarely in ICU-CA (44%), even in patients without ROSC.
Notably, diagnostics often had therapeutic consequences particularly
in ROSC. Further studies are required to define standardized diagnos-
tic algorithms during ICU-CA.Table 1 (abstract P050). ICU-CA characteristics
Overall No-ROSC ROSC p-value
ICU-CA 114 37 77 -
Age [years] 72 ± 12 74 ± 9 72 ± 13 0.2
Male [n(%)] 78 (68) 25 (68) 53 (69) 0.89
Diagnostic done [n(%)] 50 (44) 25 (68) 25 (32) 0.0004
Therapeutic consequence [n(%)] 27 (54) 8 (32) 19 (76) 0.001
ROSC Cardiac 73 (83.0) 2.79 (1.37-5.68) 2.86 (1.02-8.08)
ROSC Noncardiac 329 (72.0) 1.24 (0.92-1.67) 0.68 (0.44-1.05)
72-hour survival Cardiac 59 (67.0) 2.08 (1.13-3.85) 2.40 (1.04-5.51)
72-hour survival Noncardiac 215 (47.0) 1.13 (0.86-1.49) 0.80 (0.52-1.23)
Survival to hospital
discharge
Cardiac 35 (39.8) 1.50 (0.80-2.81) 1.36 (0.58-3.20)
Survival to hospital
discharge
Noncardiac 109 (23.9) 0.95 (0.69-1.30) 0.69 (0.45-1.06)P051
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Introduction:
The importance of early detection in the in-hospital cardiac arrest
(IHCA) is emphasized. Previous studies have reported that clinical out-
comes are improved if IHCA is witnessed, or if a patient admitted to a
monitored location [1, 2]. This study aimed to evaluate the association
between continuous monitoring and survival of IHCA on general ward.
Methods:
A retrospective cohort study of IHCA in patients admitted to ward at
an academic tertiary care hospital between January 2009 and De-
cember 2018 was performed. The primary outcome was return of
spontaneous circulation (ROSC). The secondary outcomes were 72-
hour survival and survival to hospital discharge.Results:
Of the 996 enrolled patients, 54.7% patients had monitored. Among
monitored group, 63.5% patients were pulse oximetry and electrocar-
diogram monitored. There were many witnessed events in the moni-
tored group (93.8% vs. 57.4%, p<0.0001). By univariate analysis, there
was difference of ROSC in the monitored group (73.8% vs. 66.7%,
odds ratio [95% confidence interval] = 1.40 [1.07-1.84]; p=0.016).
There were no significant difference 72-hour survival (1.00 [0.68-
1.47]; p=0.993) and survival to hospital discharge (1.03 [0.77-1.36]; p=
0.864). In subgroup multivariate analyses, the groups were divided
according to illness category. In patients with cardiac illness, ROSC
(83.0% vs, 63.5%, 2.86 [1.02-8.09]; p=0.047) and 72-hour survival
(67.0% vs. 49.4%, 2.40 [1.04-5.51]; p =0.039) were higher in the moni-
tored group (Table 1).
Conclusions:
Cardiac patients with continuous monitoring on general ward
showed improving ROSC and 72-hour survival but not survival to
hospital discharge in IHCA.
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Introduction:
In-hospital cardiac arrest is associated with poor outcomes. Although
steroids are frequently used in patients with septic shock, it is un-
clear whether they are beneficial during cardiac arrest and after re-
turn of spontaneous circulation (ROSC).
Methods:
Of 369 cardiac arrest patients evaluated, 100 were enrolled. Ad-
vanced life support was conducted according to the2015 resuscita-
tion guidelines. Forty-six patients were randomly assigned to receive
methylprednisolone 40 mg during resuscitation, and 54 to receive sa-
line (placebo). After resuscitation, steroid-treated patients received
hydrocortisone 240 mg daily for up to 7 days, followed by tapering
Critical Care 2020, 24(Suppl 1):87 Page 20 of 213over the next 2 days. Primary outcomes were mean arterial blood
pressure and central venous oxygen saturation (ScvO2) at 20 minutes,
4, 24, 48 and 72 hours after ROSC. Secondary end-points included
left ventricular ejection fraction and eccentricity index at 12 and 72
hours, cardiac output and serum cytokine levels at 4, 24, 48 and 72
hours, cerebral blood flow index at 4 and 72 hours after ROSC, organ
failure–free days from follow-up day 1 through 60,neurological status
at dischargeand steroid-associated complications.
Results:
Post-resuscitation MAP did not differ significantly between steroid-
and placebo-group at any time point (20 min: 85.2±21.3 vs. 84.7±
21.4; 4h: 83.9±18.1 vs. 78.9±15.9; 24h: 79.9±16.0 vs. 81.9±15.2; 48h:
80.2±10.0 vs. 84.2±13.6; 72h: 85.2±11.6 vs. 84.7±14.5 (p>0.05 for all
comparisons). There was no significant difference between the two
groups in ScvO2 andall the secondary outcomes (p>0.05 for all
comparisons).
Conclusions:
The present study found no significant physiologic benefit of cortico-
steroid administration during and after resuscitation in hospitalized
patients with cardiac arrest.Table 1 (abstract P054). Medical care associated causes of ICUCA
Total
[n(%)]
ROSC
[n(%)]
no
ROSC
[n(%)]
No vasopressors
before ICUCA [n(%)]
induction of anaesthesia 11(39) 8(73) 3(27) 8(72)
bedding procedures 7(25) 4(57) 3(43) 3(43)
other medication 4(14) 3(75) 1(25) 1(25)
injuries (pneumo-/
hematothorax, tracheotomy
injury)
3(11) 2(67) 1(3) 3(100)
switching syringes for
continuous infusions
2(7) 2(100) 0(0) 0(0)
no pacemaker in AV-block III 1(4) 0(0) 1(100) 1(100)
28(100) 19(68) 9(32) 16(57)P053
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Introduction:
The aim is to explore EMS experiences of participating in a large trial
of airway management during out-of-hospital cardiac arrest (AIR-
WAYS-2), specifically to explore:
1. Any changes in views and practice as a result of trial
participation.
2. Experiences of trial training.
3. Experiences of enrolling critically unwell patients without
consent.
4. Barriers and facilitators for out-of-hospital trial participation.
Methods:
An online questionnaire was distributed to 1523 EMS providers who
participated in the trial. In-depth telephone interviews explored the
responses to the online questionnaire. Quantitative data were col-
lated and presented using simple descriptive statistics. Qualitative
data collected during the online survey were analysed using content
analysis. An Interpretive Phenomenological Analysis approach was
used for analysis of qualitative interview data
Results:
Responses to the online questionnaire were received from 33% of
AIRWAYS-2 study paramedics and 19 study paramedics were inter-
viewed. Paramedics described barriers and facilitators to trial partici-
pation and changes in their views and practice. The results are
presented in five distinct themes: research process; changes in views
and practice regardingairway management; engagement with re-
search; professional identity; professional competence.
Conclusions:
Participation in the AIRWAYS-2 trial was enjoyable and EMS providers
valued the training and study support. There was enhanced confi-
dence in airway management as a result of taking part in the
trial. Study paramedics expressed preference for the method of air-
way management to which they had been randomized. There was
support for the stepwise approach to airway management, but alsoconcern regarding the potential to lose tracheal intubation from
‘standard’ paramedic practice.P054
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Introduction:
Cardiac arrest on intensive care unit (ICUCA) following therapeutic in-
terventions is of imminent importance, because the interventions are
comparatively predictable and precautions can potentially be taken.
This study investigates medical care associated complications that
led to ICUCA.
Methods:
Intensive care database was screened for patients ≥18 years who ex-
perienced ICUCA in a tertiary hospital with five ICU (two medical,
two surgical, one interdisciplinary, with a sum of 71 ICU beds) in
Germany from 2016-2018. ICUCA was defined as receiving chest
compression and/or defibrillation after admission on ICU and classi-
fied as “medical care associated” if it was preceded by a therapeutic
intervention (i.e. induced by medication, bedding procedures, iatro-
genic injuries, procedure associated). Subgroups included patients
with recurrence of spontaneous circulation (ROSC) vs. no-ROSC and
patients with vs. without vasopressor therapy before intervention.
Results:
There were 125 ICUCA in 114 patients of totally 14,264 ICU patients.
Medical care associated complications leading to ICUCA were de-
tected in 28 cases (22%) [Incidence 19.6/10,000(CI95 12.3 -26.9)].
ICUCA following therapeutic interventions occurred because of circu-
latory insufficiency [n=20(70%)], respiratory failure [n=5(17%)] and
airway associated problems [n=3(10%)]. Nine of the 28 patients
(32%) with care-associated ICUCA died. Table 1 demonstrates thera-
peutic interventions followed by ICUCA.
Conclusions:
Care-associated complications were common reasons for ICUCA.
Most of events were induced by circulatory insufficiency due to in-
duction of anaesthesia and bedding procedures. Further investiga-
tions should focus on preventive strategies, such as vasopressor
infusion before therapeutic interventions.
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Introduction:
The low-flow duration (LFD) in extracorporeal cardiopulmonary resus-
citation (ECPR) is considered to be related to the neurological out-
come. Nevertheless, there are a few reports on how the LFD and the
prognosis had changed over time with continuous efforts. In this in-
vestigation, we aimed to clarify the temporal change in the LFD and
outcomes of patients with ECPR at a single center between January
2003 and December 2017.
Methods:
This retrospective observational study was performed at Chiba
University Hospital, a tertiary-care hospital in Japan. We reviewed
medical records of all patients who received ECPR from January
2003 to December 2017. Over time changes in LFD were investi-
gated, and then, the association of LFD with a 90-day outcome
was analyzed.
Results:
Records from 175 patients were utilized in this study. Of them, 117
patients were in-hospital cardiac arrest (IHCA), and 58 patients were
out-of-hospital cardiac arrest (OHCA). We found the significant short-
ening of LFD during the study period (IHCA, slope -5.39 [min/3-year],
P<0.0001; OHCA, slope -5.49 [min/3-year], P=0.0084). In the multivari-
able regression, the shorter LFD was significantly associated with bet-
ter 90-day survival and a favorable neurological outcome only in the
IHCA group (LFD per minute, 90-day favorable neurological outcome:
odds ratio=1.03, 95% confidence interval=1.00-1.06, P=0.046).
Conclusions:
The LFD was significantly shortened over time in both groups of
IHCA and OHCA. The shorter LFD was associated with a better 90-
day outcome.
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Introduction:
In-hospital cardiac arrest (IHCA) is a lethal event. However, IHCA has
received less attention than out-of-hospital cardiac arrest (OHCA).
There have been some studies on IHCA; however, there is a lack of
information on the evidence and clinical features of IHCA compared
with information for OHCA. We therefore conducted this study to
clarify important aspects of the epidemiology and prognosis of IHCA
in patients with code blue activation.
Methods:
We carried out a retrospective observational study of patients with
code blue events in our hospital during the period from January
2010 to October 2019. We obtained information on the characteris-
tics of patients including age and gender, IHCA characteristicsincluding the time of cardiac arrest, event being witnessed, presence
of bystander cardiopulmonary resuscitation (CPR), initial shockable
rhythm, vital signs 1 h or 6 h before cardiac arrest, survival to
hospital discharge (SHD), and the cardiac arrest survival postre-
suscitation in-hospital (CASPRI) score. The primary endpoint was
SHD. We performed univariate and multivariate logistic regression
analyses.
Results:
A total of 293 code blue events were activated during the study
period. Finally, 81 patients were included in this study. Overall, the
SHD rate was 28.4%. The median time of CPR was 14 min (interquar-
tile range, 6-28 min). The rate of initial shockable rhythm was 19.8%.
There were significant differences in CPR duration, shockable rhythm,
and CASPRI score between the SHD group and non-SHD group by
univariate-logistic regression analysis. CASPRI score was found to be
the most effective predictive factor for SHD (OR=0.98, p=0.006) by
multivariate-logistic regression analysis.
Conclusions:
Our results demonstrated that CASPRI score is associated with SHD
in CPA patients with in-hospital code blue events. CASPRI score in
IHCA patients would be a simple and useful adjunctive tool for man-
agement of post-cardiac arrest syndrome (PCAS).P058
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Introduction:
The peri-operative care of premature pediatric patients requires spe-
cial expertise and is therefore reserved for specialized centers. Al-
though premature birth is described as a risk factor for peri-operative
complications and cardiac arrest (POCA) there are no data on its inci-
dence and causality in this particular population [1]. The present
study investigates the incidence and causality of pediatric POCA at a
tertiary care hospital and level I perinatal center in Germany.
Methods:
In the anesthesia database of the study center, all anaesthesiological
procedures in patients <16 years of age were examined for POCA in
preterm infants (gestational age <40th week of gestational age) be-
tween 2008 and 2018. The peri-operative period was defined be-
tween the beginning of anesthesiological care up to 60 minutes after
anesthesia and/or sedation. We defined cardiac arrest as the neces-
sity of chest compressions. The perioperative phase and the cause of
the POCA, gestational age and birth weight were recorded.
Results:
Between 2008 and 2018, 308 (1.3%) of the 22,650 pediatric anesthe-
siological procedures were performed on 301 premature infants. In
total, 10 POCA occurred in 9 of these patients (f=6, M=3; average
gestional age 208±27 days; average birth weight 1510±747g (inci-
dence 3.2%, CI 96 1.3-5.2%). The time of occurrence and the causes
of POCA are shown in Table 1.
Conclusions:
POCA in premature babies is rare and has an incidence of 1.3%,
which is significantly higher than the non-premature babies. The
main causes are problems or complications associated with the re-
spiratory tract and its management, as well as massive hemorrhage.
References:
1. Habre W et al. Lancet Respir Med 5:412-25, 2017
Table 1 (abstract P058). Perioperative phase and causes of peri-
operative cardiac arrest
Peri-operative Phase n Cause n
Induction 1 Difficult airway 1
Maintenance 8 Hemorrhagic shock 4
Mucus obstructed endotracheal tube 2
Dislocated endotracheal tube 1
Septic Shock 1
Awakening 1 Hypoxaemic attack in case of fallot-pentalogy 1
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Introduction:
Peri-operative cardiac arrest (POCA) in children's anesthesia care
is a dreaded event. Depending on the country and population,
studies describe incidences between 2.9-20.6 per 10,000 children's
anesthetics. There are no data on the current incidence of
pediatric POCA in Germany. The present study investigates the
incidence of POCA at a tertiary hospital and level I perinatal cen-
ter in Germany.
Methods:
In the anesthesia database of the study center, all anaesthesiological
procedures in patients <16 years were examined for POCA. The
peri-operative period was defined between the beginning of
anesthesia care up to 60 minutes after anesthesia or sedation.
Cardiac arrest was defined as the necessity of chest compres-
sions. Age, weight, ASA status, cause of death and survival after
30 days were recorded.
Results:
18 POCA (median weight was 2525g [Q1 7151;Q75(14748)]) were ob-
served in 22,650 anaesthesiological procedures (incidence 7.9±4.2 per
10,000 [CI95 4.3-11.6]). Table 1 shows the distribution of the individual
age groups, incidences and mortalities of POCA. Peri-operative 30-day
mortality was 3 per 10,000 [CI 95 1-5]. Three children died intraopera-
tively as a result of hemorrhagic shock, one on the PICU as a result of
malignant hyperthermia. 30 days after POCA, 4 more children had died
on the ICU due to their underlying disease.
Conclusions:
POCA is a rare event. Risk factors are an age <28 days and an ASA
status ≥ III. The main cause of peri-operative death in patients <16
years of age is massive hemorrhage, the 30-day mortality is deter-
mined by the underlying disease.Table 1 (abstract P059). Distribution of age groups
Age n Anesthesias Incidence (per 10.000) Mortality (per 10.000)
< 28 days 10 642 155.8 62.3
28 days-<1 year 5 2922 17.1 6.8
1- ≤5 years 2 8096 2.5 1.3
6- ≤12 years 1 7882 1.3 1.2
13-≤15 years ´0 3108 - -P060
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Introduction:
Cardiac arrest occurs in 1.2 per 1000 hospital admissions in the UK.
Return of spontaneous circulation (ROSC) is achieved in approxi-
mately half of resuscitation attempts, but rate of survival to hospital
discharge is substantially lower [1]. In our centre, post-arrest care ac-
counts for 6.4% of ICU admissions. Premorbid social function is pur-
ported to affect outcomes, but comorbidity scores are more often
used for risk stratification. Using a novel Social Function Score along-
side an existing comorbidity scale, we aimed to identify trends to in-
form management of patients at risk of deterioration.
Methods:
A six-month prospective observational study was conducted in a
major UK hospital from October 2017 to April 2018. For all adult in-
patient cardiac arrests, medical notes were reviewed and data col-
lected on the following domains:
Patient demographics
 Comorbidities and functional status
 Admission details
 Post-arrest events
Statistical analysis was performed using Student’s unpaired t-test.
Results:
54 cardiac arrests occurred. 85% were in medical patients, with the
majority male (63%) and aged over 75 (63%). 89% were emergency
admissions, with mean duration of hospital stay pre-arrest 9 days. In
17 cases (31%) sustained ROSC was achieved. However, seven of
these (41%) were not subsequently admitted to the ICU. Only six pa-
tients (11%) survived to hospital discharge. Pre-admission function
and comorbidity were worse in patients who did not survive to dis-
charge (Fig. 1), but these were not statistically significant in view of
small survivor group size.
Conclusions:
In an increasingly frail inpatient population, a substantial proportion
of patients in whom circulation is restored after cardiac arrest are
subsequently considered unsuitable for ICU admission. Given our un-
derstanding of inferior outcomes in patients with poor physiological
reserve, we encourage early discussion regarding the appropriate-
ness of CPR in selected patients, guided by social function and
comorbidity.
References:
1. National Cardiac Arrest Audit 2017/18Fig. 1 (abstract P060). Box and whisker plots displaying a) Modified
Charlson Comorbidity Index and b) Social Function Score at time of
admission, in patients alive at hospital discharge (blue) vs. dead (orange)
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Introduction:
There are studies that determine events related to poor outcome in cardiac
arrest [1]. In our study, following parametres were determined OHCA pa-
tients; age median years, Asian/Europe/Syrian, Bystander CPR, Bystander
AED, EMS defibrillation, initial cardiac rhythm, prehospital ROSC, corneal
and pupillary light reflex and day survival. We determineted poor prognos-
tic sign with post-cardiac arrest patients. In this study, we identified the
causes of poor outcome in patients with OHCA.
Methods:
This was a single-centre, retrospective study. We determined inci-
dence and epidemiological factors including: demographics, initial
cardiac rhythm. Our study population were non-traumatic OHCA. Our
ICU, All OHCA patient were evaluated wtih ECHO, and fluid, inotrope
and vazopressor were added according to cardiac performance.
Results:
During our study, 5970 patients who were admitted to intensive care
unit between 2012-2019 were screened. 133 of these patients were
out-of-hospital arrest and 41 of them were in-hospital arrest. Devel-
opment of cerebral oedema during treatment in hospital remains a
poor prognostic sign. The evaluation of initial cardiac ritm is useful to
predict neurological outcome in post-cardiac arrest patients.
Conclusions:
Survival after OHCA remains low. The evaluation of initial cardiac ritm
is useful to predict mortality and neurological outcome in post-
cardiac arrest patients.
References:
1. Ørbo M et al. Resuscitation 85 :1462-1468, 2014
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Introduction:
Basic life support (BLS) education and training for school children is
active in Japan. However, the BLS action by schoolchildren may be
limited by school rules. This study aimed to analyse the time factors
for basic life support performance and outcome in classmate-
witnessed out-of-hospital cardiac arrest (OHCA) and to investigate
how schoolchildren act when they detect OHCA.
Methods:
Nation-wide database for 1,068 school children cases with OHCA and
local extended database for 5,478 EMS-unwitnessed OHCA, both of
which were prospectively collected during the period of 2011–2016,
were retrospectively analysed.
Results:
Proportion of schoolchildren-detected OHCA was low in classmate
cases (16.8%, 179/889) in nationwide database and extremely low in
all EMS-unwitnessed OHCAs (1.6%, 88/5,478) in local database. Na-
tionwide database analyses revealed that both emergency call and
bystander CPR were delayed when a classmate witnessed the OHCA
case: median, 1 vs. 0 min and 3 vs. 2 min, respectively. Classmate-wit-
nessed cases were associated with higher incidences of shockable
initial rhythm, AED use and traumatic causes. The rate of neurologic-
ally favourable outcome was 19.6% and 12.3%, respectively inclassmate-witnessed and other cases: adjusted OR; 99% CI, 1.24;
0.63–2.47. Of 88 cases detected by schoolchildren in our prefecture,
8 (34%) cases had presumed cardiac aertiology and 12(13.8%) cases
were caused by suicide attempts (hanging and fall). School children
placed emergency 119 calls as the first action only in 32 (36.4%)
cases. Emergency calls were largely delayed when school children
dialled other numbers or left the scene to seek adult help. School
children were rarely involved in bystander CPR (21%) and AED place-
ment (1%).
Conclusions:
School children are rarely involved in entire BLS. Emergency calls and
bystander CPR are delayed when schoolchildren act to seek help. Be-
cause schoolchildren detect suicide-related OHCAs, psychological
care to schoolchildren involved in BLS may be necessary.
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Introduction:
To investigate the predictive value of peripheral blood neutrophil-to-
lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) on in-
hospital mortality in patients with spontaneous circulation recovery
after cardiac arrest.
Methods:
A retrospective analysis was made of 30 patients who recovered
from cardiac arrest in our hospital from April 2012 to November
2018 and were admitted to the intensive care unit for more than 24
hours. They were divided into survival group and death group ac-
cording to the outcome of discharge.The dynamic changes and dif-
ferences of NLR and PLR in 24 hours and 48-72 hours after admission
to ICU between the two groups were analyzed and compared. Multi-
variate analysis and ROC curve were used to explore the predictive
value of NLR and PLR for in-patient mortality.
Results:
Compared with the survival group, PLR in the dead group was sig-
nificantly lower within 24 hours of admission to the intensive care
department (P < 0.05), while NLR in 48-72 hours was significantly
higher (P < 0.05). The NLR of surviving group was significantly lower
than that of 24 hours (P < 0.05), while the NLR and PLR of death
group were not significantly different (P < 0.05) from that of 24 hours
(P < 0.05). Multivariate logistic regression analysis and ROC curve
showed that NLR of 48-72 h in ICU was an independent risk factor
for predicting in-patient mortality, and had high sensitivity and speci-
ficity in predicting death outcomes.
Conclusions:
Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio can help
to judge the outcome of patients with cardiac arrest and recovery of
autonomic circulation after cardiopulmonary resuscitation.
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Introduction:
High concentrations of neurofilament light chain (NFL) in serum pre-
dicted poor outcome in patients resuscitated from cardiac arrest [1].
We aimed to evaluate the prognostic value of NFL in COMACARE trial
Fig. 1 (abstract P065). Comparison of serum free iron level at admission,
24 hours and 48 hours according to SOFA score at 48 hours
Critical Care 2020, 24(Suppl 1):87 Page 24 of 213[2,3] patients who were resuscitated from cardiogenic out-of-hospital
cardiac arrest (OHCA) with a shockable initial rhythm.
Methods:
Using the commercially available Single Molecule Array (Simoa) NF-
light immunoassay (Quanterix, Lexington, MA), we measured NFL
levels from plasma taken 48 h after OHCA. We assessed neurological
outcome six months after OHCA and defined good outcome as Cere-
bral Performance Category (CPC) 1-2 and poor outcome as CPC 3-5.
Results:
Overall, six-month outcome was good for 73 of 112 (65.2%) patients.
The median (interquartile range) NFL concentration at 48 h was 19
pg/ml (11-31) in the patients with good outcome and 2343 pg/ml
(587-5829) in those with poor outcome, p<0.001. NFL at 48 h pre-
dicted poor outcome with an area under the receiver operating char-
acteristic curve (ROC) of 0.98 (95% CI, 0.97-1.00). With the cutoff 263
pg/ml, the sensitivity was 0.83 (95% CI, 0.71-0.96), specificity was 0.99
(95% CI, 0.96-1.00), and the positive likelihood ratio was 60.8 (95% CI,
8.6-428.4)
Conclusions:
In patients resuscitated from OHCA with a shockable rhythm, the
plasma NFL concentration at 48 h after cardiac arrest had an excel-
lent ability to predict 6-month outcome.
References:
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Introduction:
Out-of-hospital cardiac arrest (OHCA) remains associated with a very
high mortality and poor long-term prognosis. Ischemia reperfusion
through lesions due to oxidative stress is responsible for cell dam-
ages and free iron may play a key role in these phenomenons. Little
is known about magnitude of changes in iron metabolism parame-
ters after cardiac arrest and its association to patient’s prognosis.
Methods:
This is a single centre cohort study. Adults admitted for OHCA and
receiving targeted temperature management were eligible. Free iron,
transferrin saturation coefficient, ferritin, hepcidin and soluble trans-
ferrin receptor were measured in plasma at ICU admission (H0), at 24
hours (H24) and 48 hours (H48). SOFA score changes were calculated
between H0, H24 and H48. Demographic data and neurological sta-
tus at 6 months with Cerebral Performance Category score (CPC
score) were also assessed. (NCT number:NCT03491670)
Results:
Between May 2018 and March 2019,31 patients were hospitalized for
OHCA and 25 patients have been included. The reasons for cardiac arrest
were asystole in 13 patients (52%) and shockable rhythm in 10 patients
(40%). Hospital mortality was 68% (17 patients) and 19 patients had a poor
neurological outcome (CPC score 3-5 or death) at 6 months. Mean SOFA
score at H0 was 11.40 ± 3.14. Mean free iron level at ICU admission
was 22.46± 12.41 μmol/l and significantly decreased between H0 and H48
(mean: 22.46± 12.41 μmol/l vs 5.27±6.10μmol/l; p = 0.0003). At H48,patients with SOFA score > 12 (vs SOFA score ≤ 12) had a higher free iron
level (35.5 μmol/l vs 16 μmol/l, p = 0.0333) (Figure 1). We found a positive
correlation between free iron level at H0 and changes of SOFA score be-
tween H0 and H48 (r= 0.56 IC95[0.08;0.76]).
Conclusions:
Out-of-hospital cardiac arrest is associated with a significant change
of plasma free iron level. Free iron level at admission is associated
with short term outcome. Further research is warranted to better de-
termine the significance of such changes.P066
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Introduction:
The optimal level of arterial oxygen in the post-resuscitation period
is unknown. Recent studies show conflicting results in regard to
hyperoxia and its association with survival after out-of-hospital car-
diac arrest (OHCA) [1]. The aim of this trial is to study the association
between early hyperoxia after OHCA with return of spontaneous cir-
culation (ROSC) and 30-day survival.
Methods:
Observational study using data from three Swedish national registers
(i.e. intensive care, cardiac arrest and national patient registries). Re-
suscitated OHCA patients, who are unconscious (Glascow Coma
Scale ≤8) and admitted to an ICU between January 2010-March 2016
were included. Patients were divided into 4 groups based on lowest
PaO2 within 1 hour from ICU arrival. Hypoxia was defined as PaO2<60
mmHg, normoxia as PaO2 60-100 mmHg, hyperoxia as PaO2 100-400
mmHg and severe hyperoxia as PaO2 > 400 mmHg. Multivariate logis-
tic regression was performed. The primary endpoint was 30-day
survival.
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In total, 3496 patients were included in the analysis of which 284 pa-
tients had hypoxia, 1490 had normoxia, 1448 had hyperoxia and 274
had hyperoxia. The crude 30-day survival rates were 27.1% in the
hypoxia group, 38.1% in the normoxia group, 34.9% in the hyperoxia
group and 25.9% in the severe hyperoxia group (Figure 1). The
hyperoxia group had significantly lower 30-day survival compared to
the normoxia group, adjusted odds ratio 0.62 (95% confidence inter-
val 0.44-0.89, p=0.01). The difference in survival between the other
groups compared to the normoxia group did not meet statistical
significance.
Conclusions:
In this Swedish observational cohort study of resuscitated OHCA pa-
tients, early severe hyperoxia, compared to normoxia, was associated
with significantly lower 30-day survival. This is in accordance with
several previous reports and warrant further studies.
References:
1. Wang CH et al. Resuscitation 85:1142-1148, 2014Fig. 1 (abstract P066). Comparison in 30-day survival between
different groups according to lowest PaO2 (mmHg) within 1 hour
from ICU arrival. Adjusted odds ratios (OR) are used and the
normoxia group is used as a reference groupP067
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Introduction:
After a successful resuscitation, a systemic inflammatory response oc-
curs, and the C-reactive protein (CRP) level represents the degree of
inflammation [1-3]. This study examined the association between in-
creased inflammation and early-onset pneumonia (EOP) in patients
treated with extracorporeal cardiopulmonary resuscitation (ECPR)
after out-of-hospital cardiac arrest (OHCA).
Methods:
This retrospective study included data of patients with OHCA treated
with ECPR admitted to St. Luke’s International Hospital between April
2006 and April 2019. The exclusion criteria were as follows: age < 18
years, therapeutic hypothermia withdrawal due to death or circulatory
failure, or sepsis as a suspected cause of cardiac arrest. Patients werediagnosed with EOP according to clinical signs and symptoms acquired
after a hospitalization period of >48 h and within 7 days of admission.
The CRP levels were measured daily from admission to day 3.
Results:
We studied 55 patients with a median age of 55 years (interquartile
range: 42-65 years). Furthermore, 52 (95%) patients were males, and
the median time interval from collapse to adequate flow was 51 (42-
63) min. All patients received prophylactic antibiotics, and 18 (33%)
of them had favorable neurological outcomes (CPC, 1-2). EOP oc-
curred in 32 (58%) patients, with a significantly higher CRP level on
day 3 than that in those without EOP (13.9 [11.2-19.0] mg/dL vs. 10.9
[7.3-13.6] mg/dL, p = 0.006). Multivariable analysis revealed that the
CRP level on day 3 (odds ratio, 1.28; 95% confidence interval, 1.06-
1.56; p = 0.002) was significantly associated with EOP development.
Conclusions:
Increased inflammation correlated with EOP development in patients
with OHCA treated with ECPR.
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Introduction:
Categorizing reasons for death after eCPR is important for comparing
outcomes to other studies, assessing benefits of interventions, and
better define this heterogeneous patient collective. A categorizing
for death after cardiac arrest in both in-hospital (IHCA) and out-
of-hospital (OHCA) arrests has been proposed in non-eCPR pa-
tients by Witten et al. Here, we adopt this categorization to eCPR
patients.
Methods:
Single-center, retrospective, cohort study of patients without ROSC
after IHCA or OHCA and eCPR between 2010 and 2017. Patients with
survival below 24 hours were excluded. Patients were allocated to
one of five predefined reasons for death.
Results:
231 va-ECMO patients were included (age 58.6±14.3, 29.9% female,
58% eCPR, 30 day survival 42.9%). Reasons for death for patients
with va-ECMO for shock (survival 53%) and eCPR (36%) were: neuro-
logical withdrawal of care (10% vs 25%), comorbid withdrawal of
care (18% vs 4%), refractory hemodynamic shock (16% vs 33%), re-
spiratory failure (3% vs 2%), and withdrawal due to presumed patient
will (0% vs 1%) (Figure 1). The differences in reasons for death
among the two groups were significant (p <0.001), driven by with-
drawal due to neuroprognostication, comorbidity and hemodynamic
instability.
Conclusions:
Categorizing death after va-ECMO into five categories is feasible.
There are significant difference between patients with va-ECMO for
shock and eCPR. Interestingly, only a quarter of patients after eCPR
died due to brain damage.
Fig. 1 (abstract P068). Mode of death in VA-ECMO patients and
patients after ECPR
Critical Care 2020, 24(Suppl 1):87 Page 26 of 213Fig. 1 (abstract P069). WLST, withdrawal of life sustaining therapy;
ICU, intensive care unit; M, male; F, female; TBI, traumatic brain injury;
L, liver; RL, right lung; LL, left lung; RK, right kidney; LK, left kidneyP069
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Introduction:
Scarcity of potential dead brain donors and the persistent mismatch
between supply and demand of organs for transplantation has led
the transplant community to reconsider donation after circulatory
death (DCD) as a strategy to increase the donor pool. Normothermic
regional perfusion (nRP) by extracorporeal membrane oxygenation
(ECMO) may be the most effective method for preserving abdominal
organs in DCD, especially in liver transplantation [1, 2]. A pitfall of
this method is its complexity and the unavailability of this resource
in some hospitals, especially in regional hospitals, where potential
DCD donors may exist. Aim of this study is to report the use of Mo-
bile ECMO team in controlled DCD.
Methods:
From June 2018 to November 2019 our group has worked as a mo-
bile ECMO team for cDCD outside our center. Portable equipment in-
cluded cannulation material and the ECMO device. The transplant
team consisted of 1 transplant coordinator (anesthesiologist-intensi-
vist, ECMO operator and organ extraction supervisor), 1 cardiac sur-
geon (cannulation), 1 interventional radiologist (cannulation) and one
cardiovascular perfusionist (ECMO operator).
Results:
Twenty-five cDCD donations were performed. Characteristics of do-
nors and organs retrieved are summarized in Figure 1. From 25
cDCD, 17 livers, 4 lungs, 45 kidneys were obtained. The evolution of
grafts and receptors was favorable at day 30 post-transplant.
Conclusions:
Mobile ECMO teams may enable cDCD in hospitals without these re-
sources, thereby increasing the pool of donors and optimizing graft
outcomes.
References:
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Introduction:
The demand for donor lungs is still considerably greater than supply.
17% of patients listed for a lung transplant die within one year [1].
Veno-venous (VV) ECMO is an effective bridging strategy for patients
listed for transplant, with end stage respiratory failure, who acutely
deteriorate.
Methods:
A retrospective observational study of patients supported by VV
ECMO whilst awaiting lung transplantation, over a 67-month period
(March 2014- October 2019) at Harefield Hospital, in the UK.
Results:
32 patients with an acute deterioration of their end-stage lung dis-
ease required VV ECMO support as a bridge to transplantation
(BTT). The mean age was 34.8 years (range 19-57), 62% were male
patients. Aetiology included; end stage cystic fibrosis (n=24, 75%),
pulmonary fibrosis (n=4, 12.5%), previous lung transplant failure (n=
2, 6.3%), bronchiectasis (n=1, 3.1%) and pulmonary hypertension (n=
1, 3.1%). Average duration of ECMO support pre-lung transplant was
11.1 days (range 1-39 days). Cannulation was femoral-femoral (n=
20), Avalon Elite® (n = 6) and femoral – jugular (n= 6). 19 patients
(59.4%) underwent lung transplant on VV ECMO support, the others
required conversion to veno-arterial (VA) ECMO or cardiopulmonary
bypass, most commonly due to hemodynamic compromise. Average
duration of invasive ventilation post-transplant was 19.8 days, with
18 patients (56.3%) requiring a tracheostomy. The mean ICU stay was
Fig. 1 (abstract P072). Variations in terms of HU, Vair and elastance
in the correspondent lung regions at the two different levels of CPAP
Critical Care 2020, 24(Suppl 1):87 Page 27 of 21325.6 days, with an ICU mortality of 21.9% (n =7); in keeping with the
literature [2]. However, patients requiring intubation despite VV
ECMO (n=7), pre-transplant had a far higher mortality (n=5, 71.4%).
Conclusions:
VV-ECMO is a recognized support therapy for patients awaiting lung
transplant. Our overall survival to discharge of 78.1%, suggests
favourable outcomes are achievable.
References:
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Introduction:
A thrombus formation is one of the most frequent and adverse com-
plications during extracorporeal membrane oxygenation (ECMO) sup-
port. Previous studies have reported that increased D-dimer is a
useful predictor of thrombus formation within the ECMO circuit. The
purpose of this study was to identify coagulation/fibrinolysis markers
for predicting the replacement of ECMO circuit due to intra-circuit
thrombus during ECMO support.
Methods:
Fourteen patients who underwent veno-venous ECMO for acute re-
spiratory failure between January 2014 and December 2018 were en-
rolled. These patients received a total of 125 days of ECMO support.
Of these, 9 days (times) on which the ECMO circuits were replaced
was regarded as the replacement group, while the remaining 116
days were considered as the non-replacement group. The several co-
agulation/fibrinolysis markers were routinely measured every day
during ECMO support. we compared with the levels of these markers
between two group to identify the most relevant marker for ECMO
circuit replacement due to thrombus.
Results:
The mean duration of ECMO support was 9±11 days, and the mean
number of ECMO circuit replacement was 0.6±1.0 times per patient. D-
dimer, Thrombin-antithrombin complex (TAT), Plasmin-α2 plasmin in-
hibitor complex (PIC), and soluble fibrin (SF) were significantly higher in
the replacement group rather than in the non-replacement group (P <
0.01, respectively). According to a multivariate analysis, SF was the only
independent predictor of ECMO circuit replacement due to thrombus.
The odds ratio (95% confidence intervals) for SF (10 μg/mL) was 1.2
(1.1-1.3). The area under the curve and optimal cut-off value were 0.94
and 85 ng/mL for SF, respectively (sensitivity, 100%; specificity, 85%).
Conclusions:
From these results, we concluded that SF may be the useful marker
rather than D-dimer for predicting the replacement of ECMO circuit
due to intra-circuit thrombosis.
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In patients with acute respiratory distress syndrome (ARDS), nonaer-
ated, poorly aerated, and normally aerated regions coexist to variable
degrees in lung parenchyma. The recruitment maneuvers aim to re-
open collapsed lung tissue. In a theoretical point view, this strategy
may also prevent the normal aerated lung tissue hyperinflation [1].
The objective of our study was to evaluate lung characteristics in
terms of Hounsfield Units (HU), volume and elastance before and
after a recruitment maneuver.
Methods:
In 37 patients with severe ARDS who underwent V-V ECMO, com-
puted tomography scans (CT-scans) at 5 cmH2O of continuous posi-
tive airway pressure (CPAP) and 45 cmH2O were performed. The
same CT image was selected at the two different levels of pressure.
The distribution of lung opacities, in terms of HU, was classified using
the “UCLA” colour coding table (OsiriX image processing software,
Geneva, Switzerland). Correspondent lung regions of about 1020 vox-
els were selected. The quantitative analysis, in terms of Volume air
(Vair) was performed with Maluna software (Version 3.17; Maluna,
Goettingen, Germany). Elastance was calculated as the pressur-
e(cmH2O)/ Vair (ml) ratio.
Results:
See Figure 1.
Conclusions:
Lung inhomogeneity occurs also after recruiting maneuvers. Our data
confirm that the elastance of recruited lung regions is higher than
the elastance of the normal aerated lung regions at low positive
end-expiratory pressure (PEEP) (baby lung). On the contrary the
“baby lung” frequently develops hyperinflation. The unpredictable
pattern of distribution of volume after recruitment maneuverers may
explain the controversial role of PEEP during the ARDS treatment.
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Introduction:
Supplementation of antithrombin (AT) might decrease heparin re-
quirement to achieve an adequate level of anticoagulation during
Fig. 1 (abstract P074). A) Survival of ECMO patients with vs. without
prone positioning while ECMO. Initial survival differences equalized in
Kaplan-Meier survival curve after 30 days (Log rank=0.109). B) Survival
depending on early prone positioning after initiation of ECMO support.
Patients treated with early PP while ECMO showed a superior survival
to patients treated with late PP or without PP while ECMO. Optimal cut
off value for duration of ECMO initiation to first PP was calculated
using ROC-analysis (AUC = 0.789) and the Youden-Index. Highest
sensitivity and specificity for beneficial survival were achieved for a
beginning of PP in <0.71 days. (Log rank=0.018). PP: Prone positioning
Critical Care 2020, 24(Suppl 1):87 Page 28 of 213extracorporeal membrane oxygenation (ECMO). Formal recommenda-
tions on target, timing, and rate of AT supplementation are lacking. We
conceived this study to evaluate the effect of prolonged AT supple-
mentation in adult patients requiring veno-venous ECMO for respira-
tory failure on heparin dose, adequacy of anticoagulation and safety
Methods:
Before ECMO start patients were randomized to either receive AT
supplementation to maintain a functional AT level between 80 and
120% (AT supplementation group) or not (control group) for the en-
tire ECMO course. Anticoagulation was provided with unfractionated
heparin following a standardized protocol [1]. The primary outcome
was the dose of heparin required to maintain the ratio of activated
partial thromboplastin time between 1.5 and 2. Secondary outcomes
were the adequacy of anticoagulation measured with anti-Factor Xa
and the incidence of hemorrhagic and thrombotic complications and
amount of blood products transfused
Results:
From August 2017 to March 2019, 72 patients were screened and 49
enrolled in the study. Forty-eight patients underwent final analysis (1
patient was excluded for erroneous randomization). Patients did not
differ with regards to baseline characteristics. AT (%) was 82.6±23.3
% in the control group and 106.2±22.3 %, p=0.001 in the treatment
group. Supplementation of AT did not decrease heparin dose (14.9±
6.2 vs 13.8±6.6 IU/Kg/h in the control and treatment group respect-
ively, mean difference: -1.2 (95% CI: -3.7; - 1.2), p=0.33) and anti-
Factor Xa levels. Bleeding, blood product transfusions and throm-
bosis were comparable in the two groups
Conclusions:
AT supplementation did not decrease heparin requirement in pa-
tients on veno-venous ECMO for respiratory failure
References:
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Introduction:
Prone positioning (PP) improves survival in patients with severe
ARDS. However, there is little evidence if PP is able to improve out-
come in veno-venous extracorporeal membrane oxygenation (ECMO)
patients. Therefore, we performed a retrospective analysis of patients
treated with PP while ECMO support.
Methods:
We report retrospective data of a single-center registry of all patients
treated with veno-venous ECMO for severe ARDS between October
2010 and Mai 2018 at the Interdisciplinary Medical Intensive Care
Unit at the Medical Center, University of Freiburg, Germany. ECMO
weaning success and survival were analysed before and after pro-
pensity score matching. Moreover, predictive factors for survival in
patients with PP while ECMO were analysed.
Results:
A total of 158 patients with complete medical data could be ana-
lysed (age 52.2 years, 67% male). 38 patients (24.1%) received PP
while ECMO therapy. There was no difference in ECMO weaning rate
(47.4% vs. 46.7%, p=0.940) or ICU and hospital survival (36.8% vs.
36.7%, p=0.984, Fig. 1 A) between patients with and without PP
while ECMO therapy. Propensity score matching confirmed this find-
ing (survival: 36.8% vs. 42.1%, p=0.639). However, early initiation of
PP while ECMO support (cut off via Youden-Index <0.71 days) was as-
sociated with superior survival in univariate and multivariate analysis
(Odds ratio 20.6 [95%-CI 1.4-312.9], p=0.029, Fig. 1 B).
Conclusions:
This retrospective analysis was not able to show a survival benefit for
additive PP to ECMO support in general. Early initiation of PP couldbe an important factor for improving survival in this setting and
should be considered in a randomized controlled trial for further
evaluation.P075
Cause-specific mortality during extracorporeal membrane
oxygenation, a single center review of medical records
M Panigada, D Tubiolo, P Properzi, G Grasselli, A Pesenti
Fondazione IRCCS Ca´ Granda Ospedale Maggiore Policlinico, Intensive
Care Unit, Milano, Italy
Critical Care 2020, 24(Suppl 1):P075
Introduction:
Mortality during Extracorporeal Membrane Oxygenation (ECMO) settles
around 35% and the occurrence of bleeding during ECMO is associated
with a high mortality rate. However, cause-specific mortality is rarely re-
ported, probably due to the difficulty of its classification. The purpose
of the study was to evaluate the agreement between two expert ICU
physician in the classification of the cause of death of patients sup-
ported with ECMO for either respiratory or cardiac support.
Methods:
Two Intensive Care Unit (ICU) expert staff physicians independently
reviewed the entire medical records of all ECMO patients who died
before ICU discharge from January 2011 to September 2019 at Fon-
dazione IRCCS Ca’ Granda, Milan. They were asked to choose the
cause of patient’s death among six categories. In case of disagree-
ment, a third expert adjudicated the case. The two reviewers were
also asked whether, in their opinion, bleeding during the last 24
hours contributed to death. ELSO definition of major bleeding [1]
during the last 24 hours was also recorded for each patient.
Results:
Two-hundred and two patients were supported with ECMO of whom
70 (34.6%) died. Most of these patients (N=53, 75.7%) died during
ECMO. Interrater agreement for cause-specific mortality between the
two expert physicians was substantial (k 0.71, SE 0.07, p<0.01) Of the
14 discordant cases 6 were categorized as refractory respiratory fail-
ure and 4 as multiorgan failure and septic shock respectively. The
distribution of cause-specific mortality is shown in Figure 1. Major
bleeding (ELSO) was present in 27 (38.6%) patients, only in 9 (33.3%)
of them bleeding contributed to death according to the reviewers.
Critical Care 2020, 24(Suppl 1):87 Page 29 of 213Conclusions:
The most common cause of death during ECMO in our cohort was
multiorgan failure with substantial agreement between the two re-
viewers. Apparently, major bleeding contributed to death only in a
small proportion of patients.
References:
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table-contents.pdfFig. 1 (abstract P075). Causes of death during ECMO
Fig. 1 (abstract P076). Underlying pulmonary disease or status of
immunosuppression in ECMO patients without invasive mechanical
ventilationP076
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Introduction:
Veno-venous extracorporeal membrane oxygenation (ECMO) support can
be combined with a variety of different non-invasive ways to deliver oxy-
gen to the patient’s lung. Several positive effects might be linked to this so
called “awake ECMO”. So far there is little evidence about indications and
outcome of this approach.
Methods:
We report retrospective registry data on all ARDS patients treated
with ECMO support at a university hospital between 10/2010 and 04/
2019. In a systematic review of medical records, we distinguished be-
tween patients with invasive mechanical ventilation (IMV) from the
initiation of ECMO therapy (IMV group) and patients that received
any kind of non-invasive oxygen supply (non-IMV group).
Results:
A total of 276 patients could be analysed. 16 (5.8%) patients received non-
IMV ECMO support. Patients receiving non-IMV ECMO therapy showed se-
vere underlying pulmonary disease and immunosuppression (Fig. 1). These
patients had higher rates of lung fibrosis, long-term oxygen therapy, pul-
monary hypertension, renal insufficiency and immunosuppression (p<0.05).
12 of 16 patients (75%) required IMV during the hospital stay in average
5.3±5.0 [0.8-17.1] days after ECMO initiation. Reasons were hypoxia despite
of ECMO, insufficient ECMO-flow, insufficient protective reflexes or patient
agitation. Patients with initially non-IMV ECMO support showed a numerical
but not significant lower ICU and hospital survival (25.0% vs. 45.4%, p=
0.111).Conclusions:
Non-IMV ECMO support was applied in patients with severe under-
lying pulmonary disease and/or immunosuppression. In a high pro-
portion of patients the ventilation regime had to be switched from
non-invasive to invasive. Survival in this very selected cohort was
low. In this retrospective analysis no evident benefit for a non-
invasive ventilation strategy could be found. The high proportion of
patients who switched from non-IMV to IMV therapy underlines the
need for rigorous patient selection.P077
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Introduction:
The objective of this study is to evaluate intra-hospital transportation
of patients on extracorporeal membrane oxygenation (ECMO). It is a
retrospective analysis of prospectively collected database, performed
as part of ongoing quality improvement initiatives.
Methods:
The setting of this study is an 18-bed, combined surgical and medical
adult Intensive Care Unit (ICU) located in a 570-bed hospital that
serves as the national referral centre for Cardiothoracic Surgery, Heart
& Lung transplantation and ECMO in Ireland. We reviewed 33
months of data (from 2017 to 2019) regarding patients admitted to
our critical care unit who required intra-hospital transfer for diagnos-
tic and/or therapeutic interventions. We also compared the data to
available local guidelines.
Results:
23 patients were transported on ECMO on a total of 28 occasions; the
most common indication being CT brain (Table 1). ECMO cannulation
sites were peripheral in 20 patients, 3 patients were centrally cannu-
lated. Median time from start of the transfer until the patient was
returned to ICU was 50 minutes (range: 35-195). The ECMO console
was placed on a dedicated ECMO trolley apart from two occasions
where it was placed on the patient's bed. Number of staff required for
transport was between 4 to 10; with an ICU Consultant as team leader.
ECMO specialist nurses were always present on the transport team. 27
transfers were during normal working hours with 1 happening on a
weekend. A total of 12 complications occurred during the transports, of
Critical Care 2020, 24(Suppl 1):87 Page 30 of 213which 1 was significant and 11 were not. The significant complication
encountered was Ventricular Tachycardia in a V-A ECMO patient which
required electrical defibrillation. No adverse events related to transport
were seen following return to ICU.
Conclusions:
In this single-centre study, we have demonstrated safe intra-hospital
transport of ECMO patients. The use of local guidelines, appropriate
personnel and performance during normal working hours is
recommended.Table 1 (abstract P077). Summary of results
Total number of transfers 28
Most common indication for transfer CT brain
Sites of cannulation Peripheral > central
Staff members involved in transport 4 to 10
Time of transportation 35 to 195 minutesComplications arising during transport 12Fig. 1 (abstract P078). Visualization of fluid velocity (in m/s) within
the rotary pump (cross-section)P078
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Introduction:
Extracorporeal membrane oxygenation (ECMO) is used increasingly
in critically ill patients suffering from acute respiratory failure, cardio-
genic shock or cardiac arrest. However, this therapy can have dele-
terious side effects such as bleeding or clotting complications and
hemolysis. These complications are particularly caused by physical
stress acting upon the blood components while passing through the
ECMO system, especially within the rotary pump. We here present a
novel approach to simulate blood flows through rotary blood pumps
used in current ECMO systems in order to better understand the
genesis of these complications.
Methods:
Geometries of the Xenios DP3 (Xenios AG, Heilbronn, Germany) ro-
tary pump were reconstructed by CT-scans and manual measure-
ments using computer-aided design (CAD). The Computational Fluid
Dynamics (CFD) simulation was performed using the software Preon-
Lab (FIFTY2 Technology GmbH, Freiburg, Germany), which imple-
ments a mesh-free Lagrangian method requiring minimal
preprocessing of the CAD data. The geometries are introduced to the
simulation model as tessellated surfaces. Five operating points have
been specified by the rotation of the centrifugal fan and the corre-
sponding inflow and outflow of blood. The blood is approximatively
modelled as a Newtonian fluid with a density of 1040 kg/m3.
Results:
PreonLab allows detailed assessment of the blood flow while passing
through the rotary pump including analysis of local flow rates, pres-
sure gradients and shear stress acting upon the blood. Dead zones in
the fluid flow can be detected which gives reference points for opti-
mizations of the pump design.
Conclusions:
For the first time, we demonstrate a novel approach for flow simula-
tion in an ECMO rotary pump (Figure 1). This approach may help bet-
ter understand hemodynamics within the extracorporeal system to
define optimal operating points or re-design components aiming to
limit hemolysis, coagulation disorders and bleeding in seriously ill
patients.P079
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Introduction:
When veno-arterial extra-corporeal membrane oxygenation (VA-
ECMO) support can be terminated, arteriotomy wounds of the pa-
tients of are traditionally closed by open repair in the operation the-
aters. Lots of manpower are involved and timeslots in operating
theaters are scarce. Transport of the critically-ill is risky. Successful
VA-ECMO decannulation using percutaneous device called ProGlide
has been reported and our group had adopted and modified this ap-
proach [1].
Methods:
This is a retrospective study analyzing the one-year experience of
bedside VA-ECMO decannulation. Our institution is a 23-bed tertiary
ECMO referral center in Hong Kong. Our first bedside decannulation
was performed in November 2018, and since then, this practice had
replaced the traditional open repair, unless contraindicated. Data
from November 2018 to October 2019 were analyzed.
Results:
In the study period, 39 patients received VA-ECMO. 28 survived to
decannulation and 25 received bedside percutaneous decannulation.
Their median age was 59 (52-67). The default arterial catheter size was
17Fr, with 15 Fr in 3 cases and 19Fr in one. Five (20%) failed percutan-
eous closure and they were subsequently surgically repaired without
Critical Care 2020, 24(Suppl 1):87 Page 31 of 213additional complications. Among the 20 successful cases, 2 ProGlides
were used in 15 cases and 3 used in 5 cases. The procedure time was
27 minutes (15-45), which was faster than 2.5 hours by open repair. Me-
dian blood loss was 300mL (250-400). Post procedural clinical and ultra-
sound Doppler examination revealed minor complications in 4 patients,
including 2 arterial clots and one pseudoaneurysm who were managed
conservatively and one wound infection requiring exploration. There
were no other major vascular complications.
Conclusions:
Bedside percutaneous VA-ECMO decannulation is safe and effective.
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Introduction:
Extra corporeal life support (ECLS) continues to be associated with
high mortality rates. Our ability to predict outcome prior to initiation
ECLS remains limited. Here we take a single cell RNASeq approach in
an effort to identify novel immune cell types that are associated
with—and may contribute to—survival on ECLS.
Methods:
Whole genome transcriptomic profiles were generated from ~40,000
peripheral blood monocytes obtained from 38 patients at the time of
cannulation for veno-arterial ECLS (VA-ECLS). Within each subpopula-
tion, differential gene expression analysis was performed to identify
new markers associated with survival. Findings were validated in a
additional cohorts by flow cytometry.
Results:
Surviving patients had significantly higher proportions of CD8+ NKT
cells (CD3+/CD8+/CD19-/CD56+) that were CD52+ (p = 0.001, FDR <
0.05) (Figure 1). To validate this observation, we performed FC ana-
lysis of a second cohort of 20 patients. For each patient, we quanti-
fied the proportion of CD8+ NKT cells that were CD52+. Using the
median proportion as the cutoff, we again found that a high propor-
tion of CD52+ cells among CD8+ NKT cells was predictive of 48 hour
survival (p=0.024). We noted that while high levels of CD52+ cells
among the CD8+ NKT cells was protective in this cohort of VA-ECLS
patients, this relationship did not hold for patients with sepsis. As
only a few the VA-ECLS patients were septic, we analyzed a third co-
hort of septic ECLS patients. We observed that high levels of CD52+
cells among the CD8+ NKT populations was not protective in this
population.
Conclusions:
The proportion of CD8+ NKT cells that are positive for CD52 is pre-
dictive of survival among patients undergoing VA-ECLS for non-
infection related indications.P081
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shock patients receiving venoarterial extracorporeal membrane
oxygenation: a cohort study
H Wang, D Hou
Beijing Anzhen Hospital, Capital Medical University, Center for Cardiac
Intensive Care, Beijing, China
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Introduction:
This study aims to describe the prevalence of neurologic complica-
tions and hospital outcome in adult post-cardiotomy cardiogenic
shock (PCS) patients receiving veno-arterial extracorporeal mem-
brane oxygenation (V-A ECMO) support and factors associated with
such adverse events.
Methods:
415 adult patients underwent cardiac surgery and received V-A ECMO for
more than 24h because of PCS. Patients were divided into two groups:
those who developed a neurological complication and those who did not
(the control group). Multivariable logistic regression was performed to iden-
tify factors independently associated with neurologic complications.
Results:
Neurologic complications occurred in 87 patients (21.0%), including
cerebral infarction in 33 patients (8.0%), brain death in 30 patients
(7.2%), seizures in 14 patients (3.4%), and intracranial hemorrhage in
11 (2.7%) patients. In-hospital mortality in patients with neurologic
complications was 90.8%, compared to 52.1% in control patients (p <
0.001). In a multivariable model, the lowest systolic blood pressure
(SBP) level pre-ECMO (OR, 1.12; 95% CI: 1.08–1.17) and aortic surgery
combined with coronary artery bypass grafting (OR, 9.22; 95% CI:
2.10–40.55) were associated with overall neurologic complications
(Figur 1). Lowest SBP (OR, 1.22; 95% CI: 1.15–1.31) was the only risk
factor of brain death as well. Coagulation disorders (OR, 9.75; 95% CI:
1.83–51.89) and atrial fibrillation (OR, 12.19; 95% CI: 1.22–121.61)
were shown to be associated independently with intracranial
hemorrhage, whereas atrial fibrillation (OR, 8.15; 95% CI: 1.31–50.62)
was also associated with cerebral infarction.
Conclusions:
Neurologic complications in adult PCS patients undergoing VA ECMO
support are frequent and associated with higher in-hospital mortality.
Identified risk factors of neurologic complications might help to im-
prove ECMO management and might reduce their occurrence.
Fig. 1 (abstract P080). 72 h survival
Fig. 1 (abstract P081). Risk factors of neurologic complications
during extracorporeal membrane oxygenation. SBP, systolic blood
pressure; CABG, coronary artery bypass grafting
Table 1 (abstract P082). Patient demographics and mortality
Discharge
Home
Deceased Total
On ECLS or within 24h After weaning
All 7 (31,8%) 5 (22.7%) 10 (45.4%) 22
Male 7 (41.2%) 4 (23.5%) 5 (29.4%) 17
Female 0 (0%) 1 (20%) 4 (80%) 5
<60y 5 (45,5%) 2 (18.2%) 4 (36.4%) 11
>60y 3 (27.2%) 3 (27.2%) 5 (45.5%) 11
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Use of levosimendan during weaning of mechanical circulatory
support
S Hendrickx, J Verbeke, N De Neve, K De Decker
OLV Aalst, Intensive Care, Aalst, Belgium
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Introduction:
The use of calcium sensitizers has grown enormously in the last dec-
ade, probably due to their interesting pharmacodynamic proper-
ties. Levosimendan (LS) is frequently administered in patients under
mechanical circulatory support. We performed a retrospective evalu-
ation of patients treated with LS prior to weaning from mechanical sup-
port. This evaluation was combined with a review of the literature.
Methods:
A query of our ICU patient data management system revealed 22 pa-
tients receiving LS prior to or during VAD/ECLS support. Outcome
data were obtained from the patients medical records.
Results:
Of our 22 patients, 78% was successfully weaned off ECLS. Fourteen
patients (63 %) died before being discharged of whom 5 while on
ECLS support. Of the weaned patients, 9 died afterwards. 4 of the
converted patients needed subsequent veno-venous ECLS support
for right ventricular support after the implantation. Survival to dis-
charge ratio for the whole group was 31 %. More detailed demo-
graphic results can be found in Table 1.
Literature review
A pubmed search using the terms “(ECMO OR ECLS) AND LS AND
weaning” resulted in 7 publications which dealt specifically with wean-
ing of ECLS support. Several weaning approaches are available, how-
ever poor outcome has remains a problem. Some recent studies show
a possible beneficial effect of LS infusion prior to weaning from ECLS.
However most of these studies are retrospective or observational at
best. Because LS is primarily reserved for the most severe cases, out-
come interpretation is difficult. Overall weaning success ranges from
82%-92% and variation is very dependant of inclusion criteria.
Conclusions:
The calcium sensitizer LS can be used when weaning off patients from
ECLS, certainly given its low incidence of complications. Future, large
randomized trials are however needed in order to confirm this strategy.P083
A series of two hemorrhage-associated pheochromocytoma crises
precipitating cardiogenic shock requiring extracorporeal life
support.
P O´Connor, C Costello, S Egan, M Afrasenei, S O´Brien, E Carton, I
Conrick-Martin
Mater Misericordiae University Hospital, Critical Care Medicine, Dublin 1,
Ireland
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Introduction:
Cardiogenic shock induced by catecholamine excess in pheochromo-
cytoma affects 2.9-7.1% of new presentations, in whom 1.5-5.7% re-
quire mechanical circulatory support [1, 2]. Of patients in crises
requiring veno-arterial extracorporeal membrane oxygenation (V-A
ECMO) mortality is 7% [3]. Hemorrhagic pheochromocytoma is a
known but rare precipitant of crisis [3].
Methods:
We included patients presenting to MMUH Jan 2016 – Dec 2019 in
cardiogenic shock requiring V-A ECMO with new diagnosis of
pheochromocytoma.
Results:
Case 1 – 30 year old female presented with abdominal pain & flash
pulmonary oedema. Transthoracic echocardiography (TTE) demon-
strated inverse Takotsubo’s cardiomyopathy. CT abdomen revealed a
hemorrhagic left adrenal mass. Phentolamine precipitated cardiac ar-
rest and following successful resuscitation peripheral V-A ECMO com-
menced for worsening cardiogenic shock. Decannulated from ECMO
after four days, she subsequently underwent uneventful robotic
adrenalectomy.
Case 2 – 58 year old female with chest pain and ischemic ECG. TTE
revealed Takotsubo’s cardiomyopathy. CT revealed hemorrhage into
right adrenal mass. Peripheral V-A ECMO commenced for cardiogenic
shock. She awaits surgery following 6 day uncomplicated ECMO
course with successful decannulation, extubation, and uptitration of
alpha blockade.
Conclusions:
Cardiogenic shock is well described in newly diagnosed pheochro-
mocytoma, and crisis may be precipitated by hemorrhage into
tumour. V-A ECMO represents a rescue therapy in a subset of these
patients refractory to medical management, facilitating cardiac recov-
ery and subsequent definitive surgery.
Consent to publish: written informed consent for publication was ob-
tained from the 2 patients.References:
1. Riester A et al Eur J Endocrinol 173:757–764, 2015
2. Giavarini A et al. Heart 99:1438–1444, 2013
3. Hekimian et al. Ann Intensive Care 6:117, 2016
Fig. 1 (abstract P085). From the left to the right: esophageal
pressure (i) during pressure support ventilation (PSV); (ii) during
spontaneous breathing trial (SBT); (iii) during SBT + ECCO2R
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Cardiac tamponade complicating extracorporeal membrane
oxygenation: a single center experience
A Fontoura1, R Roncon-Albuquerque Jr.2, JA Paiva2, C Basílio2
1Unidade Local de Saúde da Guarda, Intensive Care Medicine
Department, Guarda, Portugal; 2Centro Hospitalar Universitário de São
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Introduction:
Although cardiac tamponade (CT) complicating extracorporeal mem-
brane oxygenation (ECMO) support is seldom reported, risk factors
such as vascular cannulation, systemic anticoagulation and recent
heart surgery are frequently present. The goal of this study is to as-
sess the prevalence, diagnostic challenges, therapeutic and outcome
implications of CT complicating ECMO.
Methods:
Retrospective analysis of the Centro Hospitalar Universitário São João
ECMO Referral Center (Porto, Portugal) database (10 year period). Of
the 466 ECMO cases, CT complicating ECMO support occurred in 5
patients (1.07%): 3 veno-venous (VV) and 2 veno-arterial (VA).
Results:
Of the 5 patients, 2 were women and 3 men, with a mean age of
56,4 years. ECMO support was performed during 26,6±22,3 days: 3
for refractory respiratory failure (1 community-acquired pneumonia,
1 pneumocystosis and 1 status asthmaticus), and in 2 for severe car-
diogenic shock (1 arrhythmic storm and 1 acute myocardial infarc-
tion). CT occurred after 19,6±24,6 days of ECMO support. CT was
suspected during VA-ECMO due to sudden hemodynamic deterior-
ation with decreased pulse pressure. In VV-ECMO, CT was suspected
due to circulatory collapse, with cardiopulmonary arrest in 2 patients.
A large pericardial effusion with collapsed right chambers by trans-
thoracic echocardiography established the diagnosis, in all cases. Pa-
tients with VV-ECMO and cardiopulmonary arrest required ECMO-
assisted cardiopulmonary resuscitation (E-CPR). Emergent surgical
drainage of hemopericardium was required in all cases, with cardiac
perforation repair in 2 cases. All patients survived to ICU (42,6±25,6
days) and hospital (55,6±28,9 days) discharge without significant
complications.
Conclusions:
CT is a rare but life-threatening complication during both VV- and
VA-ECMO. A high index of suspicion is needed and bedside transtho-
racic echocardiography plays a major role for timely diagnosis and
treatment. Excellent prognosis is possible with E-CPR and emergent
surgical drainage and repair.
P085
Extracorporeal CO2 removal reduces inspiratory muscle effort
during renal replacement therapy in a difficult to wean patient
after orthotopic liver transplantation: a case report
I Cavalli
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Introduction:
During a spontaneous breathing trial respiratory mechanics can
worsen, and respiratory muscle effort can increase, leading to respira-
tory muscle fatigue, pump failure, hypercapnia and an unsuccessful
weaning from mechanical ventilation. This case report discusses the
possibility of applying extracorporeal CO2 removal (ECCO2R) to re-
duce respiratory muscle effort in a liver transplant recipient who
already failed three weaning attempts from mechanical ventilation.
Methods:
The ECCO2R membrane lung was integrated into a conventional
renal replacement therapy circuit and blood flow was increased from
150 to 300 ml/min. Measurements of respiratory mechanics (includ-
ing esophageal pressure, as shown in Fig. 1) were used to assess the
reduction of respiratory effort before and during the application of
ECCO2R.Results:
After 5 minutes of spontaneous breathing (SB), respiratory rate in-
creased from 12 to 24 breaths/min, PaCO2 increased from 39 to 54
mmHg, pressure time product per minute (PTP/b) and pressure time
product per liter (PTP/L) increased to 142.9±26.9 cmH2O
.s/min (from
78.9±15.3 cmH2O
.s/min in PSV), and 13.4±2.5 cmH2O
.s/L (from 7.1±
1.1 cmH2O
.s/L in PSV), respectively. ECCO2R was subsequently started
with a sweep gas flow of 10 L/min. After 1 hour of ECCO2R, respira-
tory rate decreased to 18 breath/min, PaCO2 decreased to 44 mmHg;
and PTP/b and PTP/L decreased to 83.9±19.3 cmH2O
.s/min and 9.5±
1.8 cmH2O
.s/L, respectively. The patient was successfully extubated
and ECCO2R was discontinued after 36 hours.
Conclusions:
In a difficult-to-wean patient recovering from orthotopic liver trans-
plantation (OLT), ECCO2R can be added to a renal replacement circuit
and may reduce the ventilatory demand and prevent severe hyper-
capnia and respiratory distress (Figure 1), thus facilitating the recov-
ery of adequate spontaneous ventilation and allowing effective
weaning from mechanical ventilation.
Consent to publish: written informed consent for publication was ob-
tained from the patient.P086
AKI during aeCOPD: the potential role of combined renal-
respiratory extracorporeal support
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Introduction:
We describe the use of a low-flow platform (PrismaLung®-Prisma-
flex®) for combined extracorporeal CO2 removal-renal support
(ECCO2R-CRRT) in patients affected by acute exacerbation of chronic
obstructive pulmonary disease (aeCOPD) associated to acute renal
failure (AKI).
Methods:
We evaluated aeCOPD patients submitted to PrismaLung-Prismaflex due
to AKI (AKIN >2) associated to hypercapnic acidosis (pH<7.25, pCO2>60
mmHg) during the period May 2016-July 2019 at Prato Hospital ICU.
Physiologic data were collected (T0, 24h, 48h, 72h). Complications and
outcome were recorded. Data were presented as mean±DS; Anova Test
was used to compare changes over time (significance P<0.05).
Results:
14 aeCOPD patients with AKI and hypercapnic acidosis were identi-
fied (75±9yr SOFA 13±2). Rationale for ECCO2R-CRRT was to treat AKI
and to facilitate extubation in invasively ventilated patients (IMV 9pa-
tients) or to avoid intubation (4patients at risk of non-invasive
ventilation-NIV- failure). Hemo-diafiltration (effluent-flow 35 ml/kg/h)
Critical Care 2020, 24(Suppl 1):87 Page 34 of 213was delivered through a 13fr-double-lumen-cannula; 350 ml/min
blood-flow with 10lt oxygen sweep-gas-flow and aPTT 1.5-2 baseline
were maintained (iv-heparin). In all cases respiratory and metabolic
parameters improved without complications (Figure 1). ECCO2R-CRRT
facilitated extubation (4 out 9 IMV pts). In 4 out of 5 pts at risk of NIV
failure, it avoided IMV. Treatment mean duration was 73±31 hours,
mean lenght of ICU stay was 6±4 days. All patients survived to the
treatment, nevertheless 2 patients died due to irreversible multiple
MOF.
Conclusions:
In our aeCOPD series PrismaLung®-Prismaflex® facilitated weaning
from IMV and avoided intubation in patients at risk of NIV failure
without complications. These positive results may be related to min-
imal invasiveness of the low–flow device used and may constitute
the rationale for a larger randomized controlled trial.
Consent: Written informed consent for data publication has been
obtained.Fig. 1 (abstract P086). Mean CO2 and pH during ECCO2R-CRRT
treatment
Table 1 (abstract P087). Model predicted extracorporeal carbon
dioxide removal rates
Hemolung Hemolung iLA/
Cardiohelp
iLA/
Cardiohelp
Time After TV = 4.1 mL/kg
PBW
8 hours 24 hours 8 hours 24 hours
ECCO2R Rate (mL/min) 44 71 131 141P087
Extracorporeal carbon dioxide removal rates during the
SUPERNOVA trial: estimates from a mathematical model
JK Leypoldt1, J Kurz2, J Goldstein3, D Pouchoulin4, JG Laffey5, K Harenski2
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Warsaw, Poland; 2Baxter Deutschland GmbH, Medical Affairs,
Unterscheissheim, Germany; 3Baxter World Trade SPRL, Acute Therapies
Global, Braine-l´Alleud, Belgium; 4Baxter, Gambro Industries, Research
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Critical Care 2020, 24(Suppl 1):P087
Introduction:
The primary outcome findings from the SUPERNOVA trial [1] demon-
strated that the use of extracorporeal carbon dioxide reamoval
(ECCO2R) allows a reduction in tidal volume (TV) to ultraprotective
levels (≈4 mL/kg predicted body weight or PBW) during mechanical
ventilation in ARDS patients without significant increases in the arter-
ial partial pressure of carbon dioxide (PaCO2). Unfortunately, it was
not feasible to directly measure ECCO2R rates during the trial.
Methods:
We used a mathematical model of whole-body oxygen (O2) and car-
bon dioxide (CO2) transport and biochemistry [2] to calculate ECCO2Rrates that permit a fit to the data reported for Hemolung (ALung
Technologies) and iLA (Novalung)/Cardiohelp (Getinge) devices in
the SUPERNOVA trial [3]. The mathematical model was calibrated
under baseline conditions where patients were mechanically venti-
lated at a TV of 6 mL/kg PBW in the absence of an ECCO2R device;
the O2 consumption rate, CO2 production rate and pulmonary shunt
fraction were adjusted to match the measured baseline arterial par-
tial pressure of O2 and PaCO2. Assuming all baseline parameters were
fixed, TV was then reduced to 4.1 mL/kg PBW and the mathematical
model predicted the ECCO2R rate to the change in the PaCO2 level.
Results:
Model predictions for the devices are shown in Table 1.
Conclusions:
These predictions suggest that ECCO2R rates for iLA/Cardiohelp de-
vices were approximately twice those for Hemolung devices during
the SUPERNOVA trial. These results may be useful to evaluate the ex-
pected performance of novel ECCO2R devices.
References:
1. Combes et al. Intensive Care Med 45:592-600, 2019
2. Leypoldt et al. Artif Organs doi: 10.1111/aor.13601, 2019
3. Combes et al. Thorax 74:1179-1181, 2019P088
Efficiency and safety of a system CRRT plus ECCO2R to allow ultra-
protective ventilation protocol in patients with acute renal failure
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Introduction:
Despite renal function replacement techniques (CRRT), a patient who
develops acute renal failure(AKI) in intensive care unit (ICU) has a
mortality rate of 5-80%. This risk is partly due to the adverse effect of
AKI on other organs than the kidney. Respiratory complications are
frequently associated with the development of AKI. New machines
combining CRRT with a carbon dioxide removal membrane (ECCO2R)
allows the setting up of an ultra-protective ventilation (4 ml/kg of
predicted boby weight (PBW)) to reduce any lung damage from
mechanical ventilation (MV). The reduction in tidal volume (Vt) is as-
sociated with a decrease in lung damage partly triggered by AKI. We
evaluated the efficacy of a combined system CRRT+ECCO2R to re-
duce the Vt to ultraprotective values in patients with acute respira-
tory failure and AKI.
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Five patients with acute respiratory failure invasively mechanically ventilated
for at least 48 that develop AKI needing CRRT were recruited in our ICU.
CRRT + ECCO2R was performed with OMNI system® (B.Braun Avitum,
Melsungen, Germany). The Vt was progressively reduced to 4 ml/kg/PBW
according to a predefined ventilation protocol and therapy was set as fol-
lows: CVVHDF, blood flow up to 400 ml/min, dialysis dose 25-35 ml/kg/h,
sweep gas:10 L/min. Hemodynamic, respiratory and biochemical clinical pa-
rameters were recorded: before the start of treatment (T0) and at the end of
each 12-hour interval. Adverse events during treatment have been reported.
Results:
Within an hour, patients treated with CRRT+ECCO2R have achieved
and maintained an ultra-protective ventilation protocol. The pH and
PaCO2 values did not show statistically significant differences from
T0 throughout the treatment. In treated patients no complications
were recorded.
Conclusions:
The combined system CRRT+ECCO2R was safe and effective in allow-
ing a reduction of the Vt up to 4 ml/kg of PBW. Further studies are
needed to extend the result of our pilot study.P089
WithdrawnFig. 1 (abstract P090). Mechanical power as a function of RR and
VT for varying ECCO2R and deadspaceP090
Calculating the optimal ventilator strategy to reduce mechanical
power in patients with extracorporeal carbon dioxide removal
(ECCO2R)
KF Bachmann, M Haenggi, D Berger
Inselspital Bern, University Hospital, Bern, Switzerland, Department of
Intensive Care Medicine, Bern, Switzerland
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Introduction:
ARDS is a syndrome with high morbidity and mortality. An emerging
treatment option is ECCO2R, but the benefit its remains unclear. We
assess different degrees of ECCO2R and varying dead space (DS) on
ventilator settings in order to minimize mechanical power.
Methods:
We calculated mechanical power as
(1) Power=RR*{Δ〖Vt〗^2*[1/2*EL+RR*(1+I:E)/(60*I:E)*R]+ ΔVt*PEEP}
(EL: system elastance, R: airway resistance, PEEP: positive end expira-
tory pressure, I:E: Inspiratory to expiratory ratio).
We calculated the combination of respiratory rate (RR) and tidal vol-
ume (VT) (“optimal RR” and *optimal VT*) leading to minimal applied
power for a stable carbon dioxide elimination of 300 ml/min (VCO2)
for two scenarios: 1) variation of physiological DS from 10 to 40 % of
VT at a fixed rate of ECCOR2. 2) variation of ECCO2R of either 80, 120,
160 or 200 ml/min at a fixed physiological DS of 20%. The alveolar ventila-
tion (VA) necessary to eliminate the VCO2 was calculated as (2) VA= (-
VCO2*σ_CO2*R*T*(1+K_c ))/(VCO2/Q-P_vCO2*σ_CO2*R*T*((1+K_c ))/760)
σCO2: CO2 solubility in blood, R: gas constant, T: temperature.
PvCO2: venous partial pressure, Kc: function of pH (12.5 for a pH of
7.2), Q: blood flow [5 l/min]).
Results:
Increasing DS from 10 to 40% increases the minimal mechanical
power from 5.9 to 10.8 J/min, primarily caused by an increase of opti-
mal Vt (495 – 672 ml). Optimal RR was only slightly increased (6.4 –
7.5 /min, Figure 1 Panel A). For varying ECCO2R removal, necessary
ventilation ranges from 1.6 to 3.6 L/min. This predicts a minimal
power between 5.6 and 10.4 J/min with an unchanged optimal Vt
(540 - 543 ml) and an increasing optimal RR (5.4 to 12.3 /min (Figure
1 Panel B)).
Conclusions:
In order to minimize mechanical power, increasing shunt or CO2 pro-
duction should be met with increases in RR while increases in DS
should be met with increases in VT. Our results indicate that during
ECCO2R, mechanical power and thus risk for lung injury can be mini-
mized with higher VT compared to conservative ventilation strategies.P091
Validity of empirical estimates of physiological dead space in acute
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Introduction:
Increased physiological dead space fraction (VD/VT) is a hallmark of the acute
respiratory distress syndrome (ARDS) and has been shown to predict ARDS
mortality. VD/VT is also important in estimating the reduction in tidal volume
(VT) and driving pressure (ΔP) with extracorporeal CO2 removal (ECCO2R).
VD/VT can be measured with volumetric capnography but empirical formu-
lae using the patient’s age, weight, height, gender and PaCO2 have been
proposed to estimate VD/VT based on estimates of CO2 production (VCO2).
The accuracy of this approach in critically ill patients, however, is not clear.
Methods:
Secondary analysis of a previously published trial [1] in which VD/VT
and VCO2 were measured in ARDS patients. Estimated dead space
fraction (VD,est/VT) was calculated using standard formulae. Agree-
ment between methods was evaluated by Bland-Altman analysis.
The predicted change in ΔP with ECCO2R was evaluated using both
measured and estimated alveolar dead space fraction (VDalv/VT).
Results:
VD,est/VT was higher than measured VD/VT, with a low correlation
between the 2 (R2= 0.21). VCO2 was underestimated by the pre-
dicted approach (Table 1), accounting for 57% of the error in estimat-
ing VD/VT. The expected reduction in ΔP with ECCO2R using VDalv/
VT was in reasonable agreement with the expected reduction using
Critical Care 2020, 24(Suppl 1):87 Page 36 of 213VDalv,est /VT (Bias= -0.7, Level of agreement (LOA) = -1.87 to 0.47).
Measured VD/VT was the only variable associated with increased risk
of mortality in univariate and multivariate logistic regressions, after
adjusting for, age, SOFA score, respiratory system compliance and
PaO2/FiO2 (OR 1.9, [95%CI 1.08-3.3], p= 0.02).
Conclusions:
VD/VT and VD,est/VT showed low LOA and should not be used inter-
changeably. The predicted decrease in ΔP from ECCO2R was similar
when using both approaches.
References:
1. Matthay MA et al. Am J Respir Crit Care 184:561–568, 2011Table 1 (abstract P091). Correlation and agreement between
measured and estimated dead space values
Measured Estimated R2 Bias and limits of
agreement
VD/VT 0.56 (±
0.11)
0.61 (±
0.14)
0.21 Bias= 0.05 (LOA=
0.21 – 0.31)
VDalv/VT 0.14 (±
0.08)
0.3 (±
0.12)
0.11 Bias= 0.17 ( LOA=
-0.07 – 0.41)
Anatomical dead space
fraction (VDanat/VT)
0.45 (±
0.11)
0.34 (±
0.06)
0.12 Bias= -0.11 (LOA=
-0.33 – 0.11)VCO2 208 (±66) 178 (±49) 0.39 Bias= -29.7 (LOA=
-132 – 73)P092
Efficacy of PEEP on cyclic recruitment/derecruitment (R/D) in ARDS
patients with different percentage of potentially recruitable lung
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Introduction:
Individualized mechanical ventilation (MV) in patients with ARDS may
potentially reduce ventilator induced lung injury (VILI). We explore
bedside approach of Electronic Impedance tomography (EIT) to
evaluate the percentage of potentially recruitable lung in ARDS pa-
tients, and assess the efficacy of PEEPon cyclic R/D in ARDS patients
with different recruitability.
Methods:
This is a prospective observational study. Patients with moderate and
severe ARDS (PaO2/FiO2<200 mmHg) are enrolled. PEEP detrimental
titration method (from 24 to 6 cmH2O) is used to estimate percent-
age of potentially recruitable lung, calculated by electrical impedance
algorithm.ARDS patients are divided to non-recruitable and recruit-
able group with the median. According to ARDS net FiO2/PEEP table,
PEEP is set to routine and high PEEP(PEEPR/PEEPH). Electrical imped-
ance is recorded by EIT. Ventilation distribution is evaluated by ΔZ%,
GI, alveolar collapse and hyperinflation percentage, RVDI. Respiratory
mechanics parameters and gas exchange parameters are recorded.
Results:
20 patients are enrolled and 10 patients are divided to non-recruit-
able and recruitable group separately. When PEEP is set at PEEPR or
PEEPH, there is no significant difference in ventilation distribution in
dependent lung and independent lung, recruit-able alveolar collapse
and hyperinflation percentage between non-recruitable (NR)
and recruitable(R) group (P>0.05). Compared with PEEPR, ventilation
distribution (ΔZ%) increase in dependent lung and decrease in inde-
pendent lung, recruitable alveolar collapse decrease significantly and
hyperinflation significantly increase in NR and R group at PEEPH. At
PEEPH, cyclic R/D in ROI4 is significantly higher in NR group than R
group. Compared with PEEPR, cyclic R/D doesn’t change globally and
in ROI1-4 in NR and R group at PEEPH.
Conclusions:
High PEEP strategy can improve ventilation distribution, but it can
only decrease cyclic recruitment/ derecruitment in the dorsal part of
ARDS patients in recruitable group.P093
Early neuromuscular blockers in acute respiratory distress
syndrome: a systematic review and meta-analysis
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Introduction:
Acute Respiratory Distress Syndrome (ARDS) is a common condition
in critically ill patient. However neuromuscular blockers (NMB) result
controvertial in early treatment of ARDS [1]. We ought to search sys-
tematically and realize a meta-analysis on the matter.
Methods:
An electronic search of randomized clinical trials in adult patient
treated with early neuromuscular blockers compared without neuro-
muscular blockers in ARDS. The primary objective of the analysis was
the mortality at 21 to 28 days. Secondary endpoints included mech-
anical ventilation free days, ICU acquired weakness and barotrauma.
Results:
The search obtained 6 studies for the analysis [1-6]. A total of 1557 patients,
785 patients in the NMB group and 772 patients in the control group were
included. Comparing those treated with NMB vs. control, the analysis showed
relative risk (RR) 0.87 for mortality at 21 to 28 days (95% CI [0.75-0.99], p=
0.04), RR. 0.55 for Barotrauma (95% CI[0.35-0.85], p=0.008), RR.1.19 for ICU ac-
quired weakness (95% CI[0.99-1.42],p=0.07) and mean difference 0.56 for
Mechanical ventilation free days (95% CI[-0.46-1.59],p=0.28) (Figure 1).
Conclusions:
The early use of neuromuscular blockers in ARDS showed no increase in mor-
tality, but the results should be taken with caution. There was no differences
in mechanical ventilation free days. Barotrauma is less with the use of NMB.
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Introduction:
Acute respiratory failure (ARF) is one of the major reason for admis-
sion of the patients with hematologic malignancies to the intensice
care unit (ICU) and pneumonia is among the leading causes of lung
infiltrates in these patients. Lung CT is the golden standard in the de-
tection and characterization of pulmonary infiltrates, but it requires
the transportation to the radiology units and radiation exposure.
Ultrasound can be performed at the bedside without the need for
transportation and without irradiation [1, 2]. The aim of this study
was to compare the diagnostic accuracy of ultraound in the detec-
tion of lung infiltrates, compared to CT scan.
Methods:
Patients admitted to the ICU for ARF and suspected pulmonary infec-
tion, who required CT for detection and characterization of lung infil-
trates, were examind by ultrasound. The assessment of six regions
per hemithorax was used; each region was classified for the presence
of normal aeration, B lines, indicating interstitial fluid and consolida-
tion +/-air bronchogram. Diagnostic variables were assessed for lung
ultrasound, using CT as a reference point.
Results:
PUlmonary infiltrates conssitent with pneumonia were confirmed by
CT in 24/25 patinets. Ultrasound detected either inhomogenous B
lines or onsolidation in 23/24 patients (total sensitivity 96%, specifi-
city 100%, 95% CI 79.65% to 99.90% and 2.50% to 100.00%, PPV. Ac-
curacy of ultrasound was 96.1% (80.36% to 99.90%).
Conclusions:
Ultrasound is fairly sensitive in the detection of lung infiltrates in pa-
tients with hematologic malignancies.
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Introduction:
In patients with pneumonia requiring intensive care (ICU) admission,
we hypothesise that abnormal right ventricular (RV) function is asso-
ciated with an increased 90-day mortality. RV dysfunction in critically
ill patients has a well-known association with adverse outcomes [1].
However, its impact on mortality in patients with pneumonia has not
been directly studied.
Methods:
Patients admitted to the Queen Elizabeth Hospital Birmingham ICU be-
tween April 2016 and July 2019 with a diagnosis of pneumonia who
had a formal cardiologist TTE were included. Abnormal RV function was
defined by either depressed function, dilated size or moderate to se-
vere risk of pulmonary hypertension (pHTN). Abnormal LV function was
defined by an LV ejection fraction £ 45% or grade II or more diastolic
dysfunction. Patients with a clinical suspicion of pulmonary embolism
were excluded. The primary outcome was 90-day mortality. Continuous
data is presented as median (IQR). Categorical data is presented as %
and analysed using a chi-squared test.Results:
942 patients were admitted to ICU with pneumonia, of which 347
(37%) had a TTE. Patients were 59% male, had a median age of 67 (46-
88) and 90-day mortality of 31%. Abnormal RV function was present in
30% (n=103), with 15% depressed, 15% dilated and 14% with moder-
ate to severe risk of pHTN. RV dysfunction was associated with an in-
creased 90-day mortality compared to normal RV patients (62% vs.
18%, p<0.0001). LV function was abnormal in 25% (n=88) and was not
associated with a higher 90-day mortality compared to normal LV pa-
tients (38% vs 29%, p = 0.20). RV dysfunction was associated with a
higher 90-day mortality than LV dysfunction (62% vs 38%, p = 0.001).
Conclusions:
This is one of the first studies to demonstrate that abnormal RV func-
tion is associated with an increased mortality in ICU patients with
pneumonia. Interestingly, abnormal LV function was not associated
with an increased mortality.
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Introduction:
We previously reported a simple correction method of estimating
pleural pressure (Ppl) by using central venous pressure (CVP) and that it
can be used to estimate Ppl and transpulmonary pressure in pediatric
patients with respiratory failure. However, it remains unknown that this
method can be applied to patients with various levels of chest wall
elastance and/or intravascular volume. The objective of this study is to
investigate whether our method is accurate in various conditions of
chest wall elastance and intravascular volume.
Methods:
The study was approved by the Animal Care and Use Committee of
Rakuno Gakuen University. Ten anesthetized and paralyzed pigs (43.2
± 1.8kg) were mechanically ventilated and subjected to lung injury
by saline lung lavage. Each pig was subjected to 3 different intravas-
cular volume and 2 different intraabdominal pressures; in each condi-
tion, the accuracy of our method was tested. Specifically, airway flow,
airway pressure (Paw), esophageal pressure (Pes), and CVP were re-
corded in each condition, then changes in Pes (ΔPes) and ΔPpl calcu-
lated using a corrected ΔCVP (cΔCVP-derived ΔPpl) were compared.
cΔCVP-derived ΔPpl was calculated as κ × ΔCVP, where κ was the ra-
tio of the ΔPaw to ΔCVP during the occlusion test.
Results:
Means and standard deviations of the two variables that reflect ΔPpl
(ΔPes and cΔCVP-derived ΔPpl) in all pigs with all conditions were
6.1 ± 4.1 and 6.4 ± 5.3 cmH2O. The Bland-Altman analysis for the
agreement between ΔPes and ΔCVP showed a bias of -0.3 cmH2O
and a precision of 2.9 cmH2O in all pigs with all conditions; a bias of
0.1, -0.7, -0.2 cmH2O and a precision of 2.2, 3.6, 2.8 cmH2O in low,
normal and high intravascular volume, respectively; a bias of -0.3,
-0.2 cmH2O and a precision of 2.8, 3.1 cmH2O in low and high
intraabdominal pressure, respectively.
Conclusions:
Our method can estimate pleural pressure from CVP with a reasonable
accuracy regardless of intravascular volume and intraabdominal pressure
(Fig. 1).
Fig. 1 (abstract P097). The Bland–Altman analysis for the agreement
between ΔPes and cΔCVP-derived ΔPpl in various conditions. low: low
intravascular volume, normal: normal intravascular volume, high: high
intravascular volume, abd-: without an abdominal compression band,
abd+: with an abdominal compression band
Table 1 (abstract P099). Extubation/reintubation rates plus use of nasal
high flow in patients ventilated for >48 hours
Number Percentage
Ventilated >48 hours 1076 76.2%
Extubated 718 66.7%
Reintubated within 24 hours 126 17.6%
Reintubated overall 184 25.6%
Reintubated HFNO used 100 54.3%
Remained extubated 534 74.4%
Remained extubated HFNO used 221 41.4%
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Introduction:
The activity and functionality of the diaphragm are difficult to meas-
ure in patients ventilated in intensive care. Ultrasound can be a use-
ful tool for monitoring diaphragm muscle activity during different
ventilation modes. Few data currently exist on diaphragm muscle ac-
tivity in critically ventilated patients [1]. Our goal is to evaluate the
respiratory muscular work of the diaphragm with different settings of
the respirator by means of an ultrasound scan.
Methods:
The ultrasound assessments of the diaphragm were performed with
a 10MHz linear probe at the apposition zone. We measured the
thickening of the diaphragm with the respiratory acts, through the
thickening fraction (Thickening Fraction, TF), defined as:TF = (Tdimax
- Tdimin / Tdi min)% Tdimax: Diaphragm thickness at the end of in-
spiration (maximum thickness) Tdimin: Diaphragm thickness at the
end of expiration (minimum thickness). Ventilatory support was di-
vided into 4 classes: 1 - spontaneous breathing (SB) or Continous
Positive Airway Pressure (CPAP); 2 - Pressure Support Ventilation
(PSV) with low pressure support (5-12cmH2O); 3- PSV with high pres-
sure support (> 12 cmH2O); 4 - Controlled Mechanical Ventilation
(CMV).
Results:
A total of 223 assessments were performed in 70 patients. The evalu-
ations were all possible at the right hemidiaphragm, while on the left
they were not possible in 7% of the cases. The median TF (IQ range)
of the 4 ventilation classes was respectively: 42% (25-62%) in SB /
CPAP; 26% (17-31%) in low-PSV; 17% (9-22%) in high PSV; and 5% (2-
13%) in CMV. The Kruskal-Wallis test confirms a significant difference
between the groups (p <0.0001).Conclusions:
The ultrasound of the diaphragm can be a valid tool for monitoring
respiratory muscle activity during mechanical ventilation.
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Introduction:
Extubation failure is defined as reintubation after 48 hours of extuba-
tion in mechanically ventilated critically ill patients. It is associated with
morbidity and mortality. The aim of our study was to assess reintuba-
tion rates in a busy district general hospital and evaluate the impact of
high flow nasal oxygen therapy (HFNO) on reintubation rates.
Methods:
We performed a retrospective observational study looking at patients
admitted to our 7 bedded Level 3 critical care unit (370 patients a
year) for a period of 5 years between 1stNovember 2014 and 31stOc-
tober 2019. We included patients over 16 years of age who were
mechanically ventilated and length of stay was greater than 48
hours. Exclusions were age < 16 years, tracheostomy and patients re-
quiring ventilation for < 48 hours. Data was collected from Ward
Watcher, a SICSAG database and electronic patient records.
Results:
There was 1735 patients and 1413 patients were included (802 male
611 female). 1076 (76.2%) of patients required ventilation for over 48
hours, 66.7% (718/1065) of those were extubated (Table 1). 25.6%
(184/718) of patients required reintubation, despite 54.3% (100/184)
receiving HFNO. Of the patients successfully extubated 41.4% (221/
534) received HFNO.
Conclusions:
Our study failed to show any impact of HFNO on reducing extuba-
tion failure. Further work is needed to develop a standardized ap-
proach to weaning and to consider routine application of non-
invasive ventilation to reduce reintubation rates [1].
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Introduction:
Oral endotracheal intubation is common to critically ill patients in inten-
sive care unit. Oral care for an intubated patient is important to maintain
the moisture of oral mucosa. Also, the securement method of oral endo-
tracheal tube developed from cloth tape to commercial tube holder.
Methods:
Training PowerPoint and video for microteaching was prepared to
train up 30 ICU nurses to perform the new practice. Demonstration
and re-demonstration was arranged to assess skills of every nurse.
Afterwards, each nurse answered a quiz to evaluate the understand-
ing of OETTH and its special techniques in application. Questionnaire
was designed to collect the feedback from all nurses too.
Results:
The result showed there was 21 nurses (72%) out of 30 nurses
achieved full marks in the post-quiz which demonstrated their full
understanding of the use of oral ETT holder and its nursing care.
About the feedback from nurse, 72% of nurses claimed that they
were confident in using the new OETTH in clinical setting after train-
ing. 96% of nurses agreed in time-saving of nursing care routine with
the use of an OETTH. However, only 56% of nurses agreed that the
OETTH is effective in prevention of oral mucosa injuries and another
24% of nursing staff disagreed on its function in improving the pa-
tient’s oral care.
Conclusions:
In conclusion, some of the nurses did not agree the prevention of
oral mucosa injuries by the new securement method with OETTH
while some nurses welcomed the new OETTH as more easy and ef-
fective in oral care to intubated patients.
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Introduction:
We fulfilled a survey study dealing with bronchoscope-guided percu-
taneous dilatational tracheostomies (PDT), using the classic laryngeal
mask airway (LMA) for the airway management [1]. The aim was to
verify the safety and the effectiveness of the aforementioned
procedure
Methods:
We performed an observational prospective survey study enrolling 150
patients hospitalized in the Intensive Care Unit. Before performing the
tracheostomy, the endotracheal tube has been replaced by the laryn-
geal mask airway. Arterial blood gases, ventilation pressures and tidal
volumes have been monitored, registered and compared.Results:
The median peak inspiratory pressure has been detected stable in all
patients. Furthermore, during the ventilation with the laryngeal
mask, the tidal inspiratory and expiratory volume difference observed
between before and after the bronchoscope positioning, has shown a
statistically significant variation. Finally, in all cases ETCO2, SpO2.,
PaO2, and blood pH values persisted within the normal range.
Conclusions:
The standard LMA provides for a reliable airway management and al-
lows an effective ventilation while performing the PDT. Once posi-
tioned in the supraglottic zone, the LMA does not need to be moved
throughout all the PDT performance, avoiding risks of displacement,
glottic harm and airway device damage, and permitting an easy hand-
ling of the bronchoscope, which gives an appropriated visualization
of the trachea and a more efficient aspiration. In consequence to the
large internal diameter of the LMA tube, Ppeak has continued to be
stable in all patients, providing for minor resistance and inspiratory
work. Eventually, no late complications, such as tracheal stenosis and
infections, have occurred.
References:
1. Strametz R et al. Cochrane Database of Systematic Reviews 11:
CD009901, 2018
P102
Dilatative percutaneous tracheostomy vs surgical tracheostomy:
what late complications?
F Righetti1, E Colombaroli2
1Intensive Care Unit, Fracastoro Hospital, Emergency Department, San
Bonifacio, Verona, Italy; 2Intensive Care Unit, Fracastoro Hospital, San
Bonifacio, Verona, Italy
Critical Care 2020, 24(Suppl 1):P102
Introduction:
There are many possible post-tracheostomy late complications with
both percutaneous and surgical techniques (peristomal bleeding,
granulomas, tracheomalacia, tracheal stenosis) [1]. The purpose of
our retrospective study is to define the prevalence of these complica-
tions by comparing the two techniques.
Methods:
60 tracheostomized adult patients (pcs) were divided into 2 groups:
group A (percutaneous dilatation technique according to Ciaglia)
group B (surgical technique), followed for 4 years (2016-2019), cuffed
cannulae, cannula change every 60 days at home, tracheofibroscopic
control in Intensive Care Unit (ICU). The results were expressed as a
percentage of prevalence and subsequently comparing the two
groups.
Results:
30 pcs in group A and 30 pcs in group B. 1440 home tracheostomy
cannula replacements, 240 tracheofibroscopy performed in ICU. In
group A: 56% had peristomal bleeding, 36% external peristomal
granulomas, 16% intra tracheal granulomas, 6% tracheomalacia. In
group B: 23% had peristomal bleeding, 16% external peristomal
granulomas, 33% intra tracheal granulomas, 13% tracheomalacia, 3%
tracheal stenosis.
Conclusions:
Peristomal bleeding resolved independently. The external granu-
lomas were treated with silver nitrate for a month. Intra-tracheal
granulomas were treated with laser therapy. Tracheomalacia and tra-
cheal stenosis resolved by placing a reinforced cannula with variable
flange under bronchoscopic guidance. Comparing the two groups it
Critical Care 2020, 24(Suppl 1):87 Page 40 of 213emerged that the percutaneous dilatative technique has fewer ser-
ious late complications (intra tracheal granulomas, tracheomalacia,
tracheal stenosis) than the surgical technique.
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Introduction:
Tracheostomies are the most common surgical procedure performed
on critically ill patients. Randomized control trials comparing tracheos-
tomy timing in intensive care patients have been equivocal. In order to
perform non-urgent tracheostomy in our ICU, consent is required from
the patient or a formal guardian appointed ad hoc by the courts. Since
tracheostomies are practically the only elective surgery performed in
the critically ill, ICU requested guardianship almost always indicates a
clinical decision to perform tracheostomy. As appointing a guardian
and arranging a tracheostomy takes about a week, the decision to ap-
point a guardian offers a unique "intention to treat" opportunity to
evaluate outcomes in patients for whom tracheostomy is planned.
Methods:
We performed a retrospective analysis over 3 years on patients for
whom guardianship was sought excluding those requiring urgent
tracheostomy and those with a do-not-resuscitate order. Patients
were divided according to outcome (tracheostomy, extubation or
death prior to tracheostomy) and compared.
Results:
Guardianship was sought for 233 ventilated patients. A decision to
withhold tracheostomy was made for 13 patients, who were ex-
cluded, leaving 220 patients for analysis. Tracheostomy was per-
formed for 131/220 (60%) patients, 62/220 (28%) were extubated
and 27/220 (12%) died while waiting for tracheostomy (from non-
airway related reasons). Tracheostomy was performed on mean ven-
tilation day 16±1. Comparing extubated patients to those who had
tracheostomy (Table) shows similar demographics, but significantly
lower mortality and hospital length of stay.
Conclusions:
A significant proportion of patients initially planned for tracheostomy
were successfully extubated. Despite demographic similarities, mor-
tality in this group was significantly lower than for patients undergo-
ing tracheostomy. For a selected subgroup of possibly difficult to
characterize patients, delaying tracheostomy may be beneficial.Table 1 (abstract P103). Tracheostomy demographics and outcomes
Variable extubated n=
62 (%)
tracheostomy n=
131 (%)
p-
value
Demographics Male 45 (72.6) 78 (59.5) 0.108
Age - years ± CI 63±8 63±6 0.915
Surgical patient 28 (45.2) 50 (38.2) 0.432
APACHE II score ± CI 22±1 21±1 0.425
Outcomes In-hospital mortality 9 (14.5) 37 (28.2) 0.046
ICU LOS, h, median
(IQR)
422 (288-518) 383 (204-601) 0.152
hospital LOS, h,
median (IQR)
857 (628-
1180)
1236 (857-1633) 0.001
Fig. 1 (abstract P105). Ventilator Settings prior to PTIP104
WithdrawnP105
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Introduction:
Percutaneous tracheostomy insertion (PTI) is a core competency for
ICU trainees. Standards for insertion are available from Intensive Care
Societies and eminence-based groups [1]. Standard of PTI has not
previously been analyzed in Singaporean public ICUs.
Methods:
Retrospective analysis was performed of PTIs from September 2015
to 2018. Audit proforma was based on best practice guidelines. PTIs
for acute airway scenarios were excluded. Ethical approval was
granted via local processes for audit and quality improvement work.
Results:
151 tracheostomized patients were admitted in the study period. After ex-
clusion, 109 patients were audited. 91 patients had a PTI as a bedside pro-
cedure by the ICU team, 17 patients had a tracheostomy performed in
theatre; data was missing for 1 case. PTI was performed at a mean of 11
days from admission. Trial of extubation occurred in 44% of cases. Ventila-
tor settings were mostly appropriate (Figure 1). PTIs were analysed by spe-
ciality and by outcome. Complications occurred in 6 cases (incidence
6.5%). There were 3 cases of subcutaenous emphysema, 1 pneumothorax
(occuring D6 post procedure) and 1 case each of stoma and suture site in-
fection. There was 1 unplanned cannula change within 7 days of inser-
tion. 24% of cases had cuff inflated on discharge from ICU. Handover of
care was suboptimal; follow up care plans were documented in 18% of
cases. A supervising consultant was present for all PTIs. There was a trend
of increased insertion by consultant and increased reliance on theatre,
with corresponding decrease in the number inserted by trainees.
Conclusions:
PTI in our training ICU appears safe with low incidence of complica-
tions and good senior support for tracheostomy insertion. Emphasis
must continue on training junior intensivists in PTI. Transition of care
beyond ICU requires further work where currently there is subopti-
mal handover of care and safety netting for non-ICU colleagues.
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Introduction:
Burns inhalation injury (BI) is suggested to significantly impact burns mortal-
ity. Yet, there is inconsistent evidence of how this is influenced by its
bronchoscopically graded severity. This study evaluated the effect of differ-
ent bronchoscopic BI grades on mortality.
Methods:
A retrospective, single-centre cohort study of all patients admitted to
the London Burns centre intensive care unit (BICU) over 12 years.
Demographic data, burn and BI characteristics, and ICU-related pa-
rameters were collected. A bronchoscopy expert retrospectively
graded BI using bronchoscopy images and reports. The primary out-
come was mortality. Secondary outcomes were hospital and ICU
length of stay measures. The impact of pneumonia after 48 hours
was determined. Univariate and multivariable Cox’s proportional haz-
ards regression analyses informed factors predicting mortality.
Results:
BI was diagnosed in 84 of 231 (36.4%) critically ill burns patients. Me-
dian (IQR) total body surface area burned (TBSA) was 20% (10 to 40).
Overall, mortality risk was significantly increased by BI (45.2% vs
23.8%, p<0.001) and pneumonia (27.2% vs 11.3%, p<0.001). Median
survival time with BI was significantly lower than without BI (94 vs
131 days, Log-rank test p=0.002). More severe grades of BI (2/3) had
significantly increased risk of mortality (adjusted HR=2.14, 95%CI:
1.12-4.09, p=0.022) compared with lower grades (1) (adjusted HR=
0.58, 95%CI: 0.18-1.86, p=0.363) (Fig. 1). Facial burns (adjusted HR=
3.13, 95%CI: 1.69-5.79, p<0.001), higher TBSA (adjusted HR=1.05,
95%CI: 1.04-1.06, p<0.001) and older age (adjusted HR=1.04, 95%CI:
1.02-1.07, p<0.001) also independently predicted mortality; though,
pneumonia did not.
Conclusions:
Moderate to severe bronchoscopically graded BI significantly in-
creased mortality in critically ill burns patients. Facial burns, higher
TBSA and age also independently predicted mortality. Further studies
on the diagnostic accuracy, reliability and impact of bronchoscopi-
cally grading BI are recommended.Fig. 1 (abstract P106). Kaplan-Meier log survival plots of the
different grades of Burns Inhalation injury (BI)P107
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Introduction:
Supplemental oxygen administration is ubiquitous in the critical care
environment, yet evidence is mounting for the deleterious effects of
hyperoxia [1]. Concerns over the adverse effects from hypoxaemia
often exceed those of hyperoxaemia in developing world settings,
and inconsistent availability of blood gas monitoring may limit judi-
cious oxygen titration. The aim of this project was to audit oxygen
delivery practice and introduce QI measures to avoid excess oxygen
delivery in a tertiary ICU in Lusaka, Zambia.
Methods:
A prospective snapshot of ventilatory parameters were recorded for
critically ill patients over a 5-week period, including positive end ex-
piratory pressure (PEEP), FiO2, and time-course SpO2. Systematic edu-
cation was provided through group and one to one tutorials to
empower nursing and medical staff to titrate oxygen safely and ap-
propriately. Repeat data collection was then performed over 4 weeks.
Results:
Initially 18/30 patients (60%) were over-oxygenated, as defined by
FiO2 >0.5 and SpO2 consistently >95%. 12/18 patients with an FiO2
of >0.5 had PEEP ≤ 5cm (67%). No patient had a PaO2 recorded in
the past 24 hours. Education was provided as well as implementation
of unit protocols above all patient beds documenting a stepwise ap-
proach to titration PEEP and FiO2. Post intervention fewer patients
were over-oxygenated: 7/21 (33%) had FiO2 >0.5 and SpO2 consist-
ently >95%, and 7/18 with an FiO2 >0.5 (39%) had a PEEP ≤ 5cm. In
addition, 7/21 (33.3%) had a PaO2 recorded within 24 hours.
Conclusions:
This QI project has shown that nurse engagement and systematic
education to titrate FiO2 and PEEP can be achieved in a resource
poor setting and may decrease the incidence of hyperoxia in critic-
ally ill patients. Availability of blood gas monitoring and knowledge
of interpretation was a major barrier to oxygen titration
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Introduction:
Tracheal intubation (TI) in adult burn patients might be unnecessary
in 30 to 40% of cases [1, 2]. In pediatric burn patients, there is little
data on both the rate of TI and the rate of early extubation [3]. It has
been common practice for a child with a facial burn and/or a sus-
pected airway injury to be intubated early due to the risk of losing
airway patency. However this risk should be mitigated against the
potential risks of TI and mechanical ventilation in children. Therefore
the aim of this study was to describe the airway status of child burn
victims taken in charge of in our pediatric burn intensive care unit.
Focused on patients arriving with TI, we investigated the rate of early
extubation. In addition we compared non intubated patients with
those with prolonged TI.
Methods:
This retrospective study described a cohort of 1520 patients hospital-
ized between 2010 and 2018. Data was retrospectively recorded from
the patient’s paper clinical chart.
Results:
The mean age of our patients was 2.8 ±3.1 years [mean±sd] with an
average burn area of 14±11%. 86% had scald burns and 45% had fa-
cial burns. 4% of the children were admitted in the burn ICU with TI.
Critical Care 2020, 24(Suppl 1):87 Page 42 of 213For 36% of them, tracheal tube was removed within the first 48
hours after admission. The probability of prolonged TI increased in-
dependently with the burned skin area (BSA) (p <0.0001), the pres-
ence of facial burns (p = 0.001), and in case of flame burns (p =
0.007) (Figure 1). Among patients with more than 70% BSA, 85%
were intubated more than 48h. Among patients with less than 20%
BSA, 0.5% were intubated more than 48h.
Conclusions:
According to our retrospective data, it seems appropriate to intubate
children with 70% and more BSA, while for patient with less than
70% BSA, it might be relevant to seek guidance from physician of
the nearest Burn Center. Under 20% BSA, TI seems rarely required.
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3. Mosier MJ et al. J Burn Care Res 37:e1-6, 2016Fig. 1 (abstract P108). Probability of tracheal intubation depending
on burn skin area, facial burns and flame burns (multivariate analysis)
Table 1 (abstract P109). AUC for initial blood gas parameters in
predicting the need for intubation for more than 48 hours and the
presence of inhalation injury
Need for intubation for more than 48
hours
Presence of inhalation
injury
pH 0.203 0.241
PaCO2 0.715 0.691
PaO2 0.458 0.408
PF
ratio
0.437 0.467
COHb 0.536 0.604P109
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Introduction:
We hypothesise that initial blood gas parameters have a good predict-
ive applicability in detecting the need for intubation and the pres-
ence of inhalation injury in patients with suspected inhalation injury.
To the best of our knowledge, this has not been directly studied in
the literature.
Methods:
Patients with suspected inhalation injury admitted to the ICU at
Queen Elizabeth Hospital, Birmingham between April 2016 and May
2019 were included. The initial blood gas parameters analysed
were PaO2 (kPa), PaCO2 (kPa), pH, carbon monoxide level (COHb; %)
and PaO2/FiO2 (PF) ratio. Receiver operator characteristics (ROC) for
these parameters were plotted against the need for intubation for
more than 48 hours and the presence of inhalation injury as de-
tected by bronchoscopy and laryngoscopy. Area under the curve
(AUC) for each parameter was calculated.
Results:
85 patients were admitted with suspected inhalation injury to the
ICU. 68% were intubated for more than 48 hours. Of patientswho were intubated, 69% had inhalation injury as indicated by
bronchoscopy or laryngoscopy. Table 1 outlines the AUC for ini-
tial blood gas parameters in detecting the need for intubation
for more than 48 hours and the presence of inhalation injury. pH
was the parameter with the most prominent AUC, with reverse
correlation indicating fair accuracy. No clear inflection point was
identified, although all patients with pH < 7.25 required intub-
ation and had inhalation injury. PaCO2 had a fair predictive ap-
plicability in detecting the need for intubation. PF ratio,
PaO2 and COHb had poor accuracy.
Conclusions:
Initial blood gas parameters had a broadly poor predictive applicabil-
ity for the need for intubation and the presence of inhalation injury
in patients with suspected inhalation injury. Severe acidosis (pH <
7.25) was the most useful blood gas parameter. Clinicians should be
cautious in using blood gas parameters alone to inform intubation
decisions.P110
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Introduction:
Lung cancer surgery is associated with a high rate of pulmonary complica-
tions including ARDS and mandates lung protective ventilation strategies
[1,2]. Such strategies include non-intubated video assisted thoracic surgery
(NiVATS) with spontaneous breathing [3]. Currently neither data on respir-
ator settings nor on gas exchange have been reported for applying the
latter. This data constitutes a prerequisite for meaningful evaluating the re-
spiratory consequences of non-intubated spontaneous breathing during
lung cancer surgery. The aim of this case series was for the first time pro-
viding such data from lung cancer surgery including pneumonectomy.
Methods:
During a 12 month period 32 patients without contraindications [3] sched-
uled for video assisted thoracic surgery (VATS) for non-anatomical and ana-
tomical lung resection including one pneumonectomy (Px) were offered
non-intubated spontaneous breathing. All patients gave informed written
consent to the procedure as well as for analysis and publication of data.
Anaesthetic management included target controlled infusion of propofol
and remifentanil, laryngeal mask airway, and pressure support ventilation.
Critical Care 2020, 24(Suppl 1):87 Page 43 of 213Data from 2 patients were excluded due to change of procedure for rea-
sons of surgical access. Data are given as median and range (Figure 1).
Results:
All patients breathed spontaneously during the operation. It allowed for
low driving pressures, lung protective tidal volumes, as well as adequate
oxygenation also in pneumonectomy. It may result in hypercapnia. Car-
diorespiratory complications were not observed.
Conclusions:
Spontaneous breathing during lung cancer surgery is feasible and it
may be applied during pneumonectomy. Whether it decreases the
rate of pulmonary complications in patients undergoing lung cancer
surgery deserves further study.
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length of hospital stay (LoS), respirator settings, results of intraoperative blood
gas analysis, and duration of surgery. Px = PneumonectomyP111
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Introduction:
Prolonged cuff inflation in tracheostomized patients inhibits phon-
ation, contributes to dysphagia, causes psycho-emotional distress
and results in diaphragmatic weakness. It also increases the risk of
ventilation acquired pneumonia and ventilator induced lung injury.
The aims of this study were to determine whether cuff deflation trials
had an effect on the length of the weaning period, length of ITU stay
and total tracheostomy days.
Methods:
A retrospective audit of all tracheostomized patients admitted
to ITU at Liverpool University Hospitals NHS Foundation Trust
from 8 January 2017 – 30 August 2019 were reviewed. The ex-
clusion criteria included long term tracheostomies, patients who
had a tracheostomy at the point of admission, patients who
died or were transferred prior to decannulation and patientswith insufficient clinical documentation. Trials of early cuff de-
flation were introduced to ITU on 26 April 2018. Patients were
divided into two groups: the ‘pre-trial group’, consisting of pa-
tients who received a tracheostomy prior to 26 April 2018, and
the ‘post-trial group’ who received a tracheostomy after 26 April
2018.
Results:
183 tracheostomized patients were identified with 70 patients
meeting the inclusion criteria. There were 27 patients in the pre-
trial group and 43 in the post-trial group. The mean length of
ITU stay (43.33 pre-trial vs 39.21 post-trial, p=0.242), the number
of total tracheostomy days (31.99 vs 27, p=0.313) and the mean
number of days between first cuff deflation and decannula-
tion (21.77 vs 19.11, p=0.385) was not significantly different be-
tween groups. The protocol allowed significantly earlier cuff
deflation (12.1 vs 4.8 days).
Conclusions:
We present early data that early trials of cuff deflation within 48
hours of tracheostomy insertion can be achieved using a standard-
ized protocol. Its impact on length of stay, duration of ventilation
and patient-centered outcomes needs to be investigated in larger
multi-centre trials.P112
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Introduction:
The management of the endotracheal tube cuff pressure (Pcuff) is
routine practice for critical care nursing staff. Underinflation could
lead to ventilator-associated pneumonia [1] whereas overinflation ex-
poses to tracheal damage [2]. Multi-daily check and adjustment is
recommended to ensure that Pcuff lies between 20 and 30 cmH2O
[3]. To automate this task some devices exist but may be inconveni-
ent, bulky and/or ineffective. Their use is not supported by guide-
lines. A portable elastomeric device could be appealing for Pcuff
automated regulation. This prospective randomized controlled study
tested whether the Tracoe Smart Cuff ManagerTM reduced the rate of
patients undergoing ≥1 episode of underinflation (Pcuff<20 cmH2O),
as compared with routine manual Pcuff adjustment.
Methods:
Monocentric, randomized controlled study. Patients with acute brain
injury and receiving mechanical ventilation were prospectively allo-
cated to one of the two arms: manual reading and adjustment of
Pcuff at least every 8h (routine care) or adjunction of the Smart Cuff
ManagerTM (intervention). This study was approuved by an institu-
tional review board.
Results:
Among 60 randomized patients (routine care in 32, Smart Cuff Man-
agerTM in 28), 506 measurements were performed in 48h. With rou-
tine care, a higher rate of patients experienced at least one episode
of underinflation (62.5 vs. 17.8%;p<0.001). Episodes of underinflation
episodes (15% vs. 2%;p<0.001) and manual adjustments (77% vs.
56%;p<0.001) were more frequent with routine care. For overinfla-
tion, there was no between-arms difference (p>0.99).
Conclusions:
The adjunction of continuous Pcuff control with the Tracoe Smart Cuff
ManagerTM reduced the incidence of Pcuff underinflation as com-
pared with manual intermittent adjustments. Overinflation was not
promoted by this device.
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Introduction:
Percutaneous tracheotomy (PT) in patients at the ICU is an inva-
sive method of airway providing. It is requiring prolonged mech-
anical ventilation. PT as a method has proven to be simpler than
surgical tracheosomy (ST), because it is performed in hospital bed
without transporting the patient to the operating room, which is
important in cases of hemodynamically unstable patients. Original
kits, quick training and ability to perform in patient's bed, have
imposed PT as the method of choice for ICU patients.
Methods:
In a one-year retrospective study, we have followed 161 patients in 2
groups, at ICU II, Clinical for Anesthesia and ICU and Pain Therapy, Clin-
ical Centre of Vojvodina. Patients in ICU underwent PT with assistance
of fiberoptic bronchosce, or ST in the operating room, due to the need
for prolonged mechanical ventilation. Ultrasound Doppler examination
of the blood vessels in the neek and their relationship with trachea de-
termined the indication for PT or ST. In PT group were 110 patients, in
ST 51. We have observed early and late complications and lenght of
mechanical ventilation after the tracheostomy was performed.
Results:
On most patients (110) we have made PT assisted by fiberoptic bron-
choscope. 51 patients underwent ST. Early complications in PT in
terms of minor bleeding (<100ml) from the smaller vein blood ves-
sels of the skin and subcutaneous tissue of the neek were 3,6% dur-
ing the performance. Serious complication, false route, subcutaneous
cannula placement, with subcutaneous emphysema was 0,9%. The
late complications of PT in the form of tracheal stenosis are still be-
ing monitored, and no reports have been reported so far. Early com-
plications in ST( bleeding, twisting cannula as well as malposition)
were 20%.
Conclusions:
PT with assistance of fiberoptic bronchoscop has proven to be a safe
and rapid invasive method, with no more complication than ST, in
the ICU performed by ICU doctors on patients, in bed without trans-
port to the operating room and as a safe alternative to ST.
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Introduction:
Direct laryngoscopy as a technique for tracheal intubation is a poten-
tially lifesaving procedure that healthcare professionals in a variety of
fields are taught. However, this skill is challenging to acquire and dif-
ficult to maintain. Poorly performed intubation technique can lead to
potentially serious complications [1]. The Intersurgical iView video la-
ryngoscope is a new intubation tool which may have advantages
over direct laryngoscopes, such as the Macintosh, in the hands of
novice personnel.
Methods:
A prospective randomized counterbalanced trial of 30 medical stu-
dents, who did not have previous airway management experience,was conducted. Each student received brief didactic teaching,follow-
ing this, participants were directly supervised performing laryngos-
copy and intubation using the Macintosh and iView devices in an
alternating pattern. Students were permitted up to three attempts to
successfully intubate under four conditions, three laryngoscopy con-
ditions using aLaerdal Intubation Trainer and one using a Laerdal
SimMan Manikin.
Results:
There was no significant difference in the success rate of intubation or
time to intubation between the two devices. The iView outperformed
the Macintosh in time to intubation in the normal airway in the final
scenario, once students gained experience with both devices. No sig-
nificant difference was found in the number of optimisation manoeu-
vres, or intubation attempts between groups. Areas where the iView
outperformed the Macintosh included severity of dental trauma and
participants’ perception regarding ease of use ofthe device.
Conclusions:
The iView may prove to be a useful teaching tool for novice
personnel who are acquiring the skills of tracheal intubation.
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Introduction:
Airway pressure release ventilation (APRV) is a mechanical ventilatory
mode where elevated continuous positive airway pressure (CPAP) is
applied with periodic releases to facilitate CO2 clearance [1]. To date,
there are no clear parameters that predict a positive response to
APRV. The purpose of our study was to identify these.
Methods:
This was a retrospective cohort study in a single, large tertiary adult
ICU from 2015-2018. Demographic, pathological and physiological
data were extracted from the clinical information system CareVue ©.
APRV responders were defined as patients remaining on APRV at four
hours post initiation with a positive change in PF ratio. The cohort
was stratified by responder status; univariate and multivariate ana-
lyses were used to identify factors associated with APRV response.
Figures are mean (SD). Anonymized data was stored in a password-
protected, securely stored computer file.
Results:
103 patients mean age 53.4 (15.5) were ventilated using APRV and 96
fulfilled inclusion criteria. 55% were male, 61% had a primary pul-
monary pathology. Total ventilated days were 12.1 (9.6). Prior to
APRV, 6% had evidence of left ventricular systolic dysfunction, PaO2
was 9.7 (3.0), PF ratio was 15.1 (9.3), PaCO2 was 7.1 (2.2), H+ was 52
(19), PPeak was 25.9 (5.4), PEEP was 10.5 (3.2), Vt/kg was 7.4 (2.6),
CRP was 186 (123). APRV settings were: Phigh 27.5 (4.2), Plow 0 (0.4),
Thigh 4.5 (1.1), Tlow 0.5 (0.3). 1% were ventilated prone, 4% had a
neuromuscular blocker infused and 11% had a neuroprotective strat-
egy employed at time of APRV. 48 patients responded to APRV (table
1). Hospital mortality was 31.2% in responders vs 54.2% in non-
responders (p=0.037).
Conclusions:
Patients with a primary pulmonary pathology were more likely to re-
spond to APRV. This association has not been described before and
warrants further multi-centre exploration in a larger patient group.
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Table 1 (abstract P115). Comparison of APRV responder variables
(physiology pre-APRV)
Variable Responder (n=
48)
Non-responder (n=
48)
P
value
APACHE II score 21.5 (8.4) 23.6 (10.5) 0.311
Fluid balance (ml) +3258 (4107) +4172 (5508) 0.382
Hours ventilated prior to
APRV
53.3 (65) 87 (213) 0.3
PaCO2 6.7 (1.8) 7.6 (2.5) 0.047
PEEP 11.0 (3.2) 10.0 (3.1) 0.12
PF Ratio 13.9 (6.8) 16.7 0.189
Primary pulmonary pathology 70.8% 50% 0.037
Fig. 1 (abstract P116). Representative image showing the ventilation
maps before and after closed endotracheal suctioning (CES). A) The drop in
Critical Care 2020, 24(Suppl 1):87 Page 45 of 213the EIT plethysmogram during suctioning, when no Inline Suction App was
used – associated with a significant drop of lung compliance. B) A minor
change in EIT ventilation map and in the plethysmogram when the Inline
Suction APP was ONP116
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Introduction:
Airway suctioning is common during mechanical ventilation, using ei-
ther an open endotraqueal suctioning or closed endotracheal suc-
tioning (CES). Closed circuits were developed to prevent arterial
desaturation and atelectasis associated to ventilator disconnection.
However, CES may cause substantial loss of lung volume. The pur-
pose of this study was to investigate the effects of a compensation
method to prevent the loss in aeration during CES.
Methods:
The suctioning technique was performed for 15 seconds, negative
pressures limited at 150 mmHg. Closed suction catheters with 14Fr
(Halyard Health, Georgia, EUA) were used. Electrical impedance tom-
ography (EIT) monitoring and arterial blood gas were collected. A
NihonKoden Mechanical Ventilator (NKV550, California, EUA) was ap-
plied, having a newly developed algorithm for suctioning which
overcomes any pressure loss during suctioning (InlineSuction-APP).
When activated, the APP delivers PCV ventilation, adding 2 cmH2O of
end-expiratory pressure above PEEP, and delivering driving pressures
of 15 cmH2O.
Results:
Pigs (30±5.4kg) with injured lungs and mechanically ventilated. We
tested the aspiration procedures using low PEEP=5cmH2O, or high
PEEP=±12.3cmH2O with VT2O), whereas maintenance of compliance
was observed when the APP was ON (from12.2±1.4 ml/cmH2O to
12.5±4.5 ml/cmH2O. Blood gas in a representative animal showed a
drop in PaO2 when APP was off (from 247, to 149 mmHg after 2 min,
and to 176 mmHg after 10 min) (Figure 1). With APP ON the PaO2
changed from 259 (pre-suction), to 223 (2 min), to 253 mmHg (10
min).
Conclusions:
The new NKsoftware, delivering PCV ventilation during suctioning,
could prevent atelectasis and functional loss associated to the
procedure.P117
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Introduction:
Patients with advanced-stage non-small-cell lung cancer have high
mortality rates in the intensive care unit (ICU). In the last two de-
cades, targeted therapies have changed the prognostic of patients
with lung cancer outside the ICU. The fast efficacy of targeted ther-
apies led some intensivists to use them as rescue therapy for ICU
patients.
Methods:
We performed a national multicentric retrospective study with the
participation of the GRRROH (Groupe de Recherche en Réanimation
Respiratoire en Onco-Hématologie). All patients with non-small-cell
lung cancer admitted to the ICU for acute respiratory failure between
2009 and 2019 were included in the study if a Tyrosine Kinase Inhibi-
tor was initiated during ICU stay. Cases were identified using
hospital-pharmacies records. The primary outcome was overall sur-
vival 90 days after ICU admission.
Results:
Thirty patients (age: 60+/-14 years old) admitted to a total of 14 ICUs
throughout France were included. Seventeen patients (59%) were
Critical Care 2020, 24(Suppl 1):87 Page 46 of 213nonsmoker. Adenocarcinoma was the most frequent histological type
(n=21, 70%). Most patients had metastatic cancer (n=21, 70%). Epi-
thelial Growth Factor Receptor mutation was the most common on-
cologic driver identified (n=16, 53%). During the ICU stay, 17 (57%)
patients required invasive mechanical ventilation, 13 (43%) catechol-
amine infusion, 3 (10%) renal replacement therapy and one (3%)
extracorporeal membrane oxygenation. Eighteen patients (60%) were
discharged alive from ICU and 11 (37%) were still alive after 90 days
(see Figure). Moreover, 6 patients (20%) were alive one year after ICU
discharge.
Conclusions:
Despite a small sample size this study showed that, in the context of
lung cancer involvement responsible for acute respiratory failure, the
use of Tyrosine Kinase Inhibitor should not be refrained in patients
with severe condition in ICU.Fig. 1 (abstract P117). Probability of survival after ICU admissionP118
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Introduction:
Community-acquired pneumonia (CAP) is the most common infec-
tious disease requiring admission to intensive care units (ICUs). The
aim of this study was to investigate factors predicting poor outcome:
the composite of in-hospital mortality and/or mechanical ventilation,
in patients admitted to hospital because CAP.Methods:
Between june 1, 2014 and september 30, 2018; 312 patients with
CAP were prospectively registered. On admission data including pa-
tient characteristics, clinical findings, radiologic features and need for
mechanical ventilation were assessed and further analyzed. Mechan-
ical ventilation was defined as the requirement of invasive and/or
non-invasive ventilation at any time during hospitalization. A multi-
variate analysis was performed to identify predictors of poor
outcome.
Results:
Three hundred and twelve patients were included in the study and
26% of them had a poor outcome. In multivariate analysis, patients
with a history of chronic obstructive pulmonary disease (COPD) (p=
0.002), and those with elevated values of heart (p=0.001) and respira-
tory rates (p=0.01), and increased urea levels (p=0.01) had a worse
outcome. (AUC ROC 0.83; 95% IC: 0.78-0.87).
Conclusions:
A history of COPD, elevated heart and respiratory rates and increased
urea levels at admission were independent variables of poor out-
come in patients with CAP.
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Introduction:
The burned patient is one of the most complex patients whith a very
high mortality. Those patients with inhalation injury have a worst
prognosis, typically associated with respiratory complications. The
aim of our study is to evaluate the mortality of burn patientes with
inalation injury in a critical burn unit.
Methods:
A prospective, observational and descriptive study was conducted
over a period of 3 years. Inhalation injury was defined with these cri-
teria (≥ 2): history of injury in an enclosed space, facial burns with
singed nasal hair, carbonaceus sputum and stridor. If they were intu-
bated it was diagnosed by bronchoscopy. Demographic data, TBSA,
ABSI, Baux score, APACHE II, SOFA, mechanical ventilation (MV), com-
plications, length of stay, hospital course and mortality data were
collected.
Results:
362 burns patients were admitted. 24% (84 patients) had inhalation
injury. Mortality among patients with inhalation injury was 28,6% (24
patients). Most patients were men and those who died were older
and with higher severity scores (Fig. 1). We found no significant dif-
ferences between groups in the need for MV (95% vs. 85%) or in the
percentage of tracheostomy performed (33.3 vs. 28.3). However, pa-
tients who died had more respiratory complications like ARDS, and
also shock, renal failure and need of renal replancement therapies
Critical Care 2020, 24(Suppl 1):87 Page 47 of 213although infectious complications were similar in both groups. There
was no statistically significant difference in volume used during initial
resuscitation in the different groups.
Conclusions:
Patients with inhalation injury who died had higher severity scores at
the begining. Although there were no differences in the need for
MV patients who died had more respiratory complications as well as
shock, renal failure and need of RRT, but no infectious complica-
tions.The volume used during inicial resuscitation, that was always re-
lated to the prognosis, was similar in both groups. Further studies
are needed to see if this greater initial severity corresponds to the
degree of inhalation.Fig. 1 (abstract P120). Illustration of lung dose for each
patient intervention
Fig. 1 (abstract P119). Demographic characteristics and severity
scoresP120
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Introduction:
Patients with acute exacerbations such as asthma are prescribed
aerosol therapy from presentation in the Emergency Department to
progression through to the Intensive Care Unit. However, the variabil-
ity in dose delivery to the lung across the possible patient interven-
tions is not well characterized. Here, we assess the predicted lung
dose of a bronchodilator in a simulated spontaneously breathing
adult patient via both facemask and nasal cannula, and via tracheos-
tomy during mechanical ventilation.
Methods:
A standard dose of 2.5 mg in 2.5 mL salbutamol was aerosolized
using the Aerogen Solo nebulizer (Aerogen, Ireland). For facemask
testing, the nebulizer was used in combination with the Aerogen
Ultra with 2LPM supplemental oxygen flow. For nasal cannula
testing, the nebulizer was used in combination with the Airvo 2
system (Fisher and Paykel, NZ) system at both 10 and 50LPM gas
flow rate. Tracheostomy-mediated ventilation was assessed in
combination with a HME, with the nebulizer placed between the
HME and the tracheostomy tube. International Standard ISO27427
adult breath settings (Vt 500mL, BPM 15, I:E 1:1) were used
across all tests, and generated using a breathing simulator
(ASL5000, Ingmar Medical, USA) or mechanical ventilator (Servo-U,
Maquet, Sweden). The dose delivered to the lung was assessed
using a capture filter at the level of the trachea, with drug massdetermined using UV Spectrophotometry at 276nm and
interpolation on a standard curve.
Results:
The results of testing are illustrated in Figure 1.
Conclusions:
The bronchodilator dose delivered to the simulated patient was seen
to be relatively consistent between progressive interventions, except
during high flow therapy, with the more clinically relevant 50LPM
gas flow rate having a profound effect on the dose. These results
may go some way towards explaining how different patient interven-
tions can affect aerosol dose.P121
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Introduction:
COPD patients are known to have marked underlying lung parenchy-
mal damage and associated microvascular changes [1]. They have
two to four times increased mortality from ischemic heart disease
and one fourth of patients develop pulmonary embolism particularly
during acute exacerbations. The aim of the study was to demonstrate
whether these patients’ underlying inflammatory response promotes
thrombotic risk using the functional biomarker (fractal dimension-df).
The stable COPD patients were divided into four groups based on
their Forced Expiratory Volume at one second (FEV1); mild (>80%),
moderate (50-80%), severe (30-50%) and very severe (<30%).
Methods:
30 stable ambulatory COPD patients with no evidence of infection or any
underlying disease process that affect their coagulation system where re-
cruited from the chest clinic of a tertiary teaching hospital. Blood samples
were taken to perform fractal dimension (df), full blood count, platelet
aggregometry, PT, aPTT, fibrinogen, d-dimer, CRP and Factor XIII.
Results:
The mean df in stable COPD patients was 1.690 (normal df 1.73 ±
0.04). The very severe group had highest df (1.712 ± 0.023, p=0.103),
had significantly low FEV1 (24.20 ± 3.70, p<0.001) and significantly
low BMI (21.57 ± 1.49, p<0.001). There were no significant rise in in-
flammatory markers, standard markers of coagulation and d-dimer.
Conclusions:
Ambulatory COPD patients who has a well-controlled disease have a
normal coagulation profile despite having known parenchymal and
vasculo-inflammatory disease. The clot microstructure (df) in these
Fig. 1 (abstract P123). Demographic and clinical characteristics of
the patients (left panel); RRI values in AKI and not-AKI patients at
each level of PEEP (right panel)
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bulatory COPD patients are less prone to develop thromboembolism
and an increased risk occurs due to an exacerbation, sepsis or in-
creased immobilisation.
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Introduction:
The mechanical ventilation (MV) have been identified as an inde-
pendent factor indicating a worse prognosis for lung cancer patients
[1]. This study was conducted in order to assess the results of non-
invasive mechanical ventilation (NIV) and/or invasive mechanical ven-
tilation (IMV) modalities in lung cancer patients admitted to the ICU
with acute respiratory failure (ARF).
Methods:
In this study, lung cancer patients with respiratory failure who were
admitted to the ICU between January 2017 and December 2018 were
evaluated retrospectively.
Results:
93 patients were included in the study. The mortality rate was 18.3%.
83 patients had NIV. IMV was applied to 10 patients. In the first 24
hours, 39 of the 83 patients who were initially treated with NIV were
administered IMV. The duration of hospital stay, diagnosis of pneu-
monia and mortality rate were found to be significantly lower in pa-
tients treated with NIV alone (p≤0.001, p=0.004, p=0.025), but
Glaskow Coma Score (GCS) was significantly higher in this group
(p≤0.001). The mortality rate was similar between the patients who
were initially treated with IMV and those who were treated with IMV
in the first 24 hours. Charlson Comorbidity Index (CCI) and MV dur-
ation were significantly higher in patients who died (p=0.01, p=
0.021), but GCS was significantly lower in this group (p=0.032). In the
linear regression model for the likelihood of mortality, CCl≥9 and un-
successful NIV increased the mortality rate by 3.4 (1.1-10.5) and 5.2
times (12-23.6) respectively (p=0.036, p=0.032).
Conclusions:
NIV has been an effective modality for respiratory support in most
lung cancer patients presenting with ARF. However, failed NIV seems
to be a factor for increased mortality. Therefore, the choice of re-
spiratory support modality to be applied in this patient group should
be decided by considering the GCS, CCI and etiology of ARF.
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Introduction:
The interaction between ventilator settings and the occurrence of
acute kidney injury is not fully elucidated. This study aimed atinvestigating the effect of stepwise increase in PEEP level on the risk
of acute kidney injury as evaluated with the renal resistivity index
(RRI).The primary outcome is to investigate whether increased levels
of PEEP could lead to increase RRI and whether RRI could predict the
occurrence of AKI.
Methods:
Patients mechanically ventilated for at least 48 hours and without
AKI at admission were included in the study. RRI was calculated at
ICU admission. Posterolateral approach was used for kidney ultra-
sound. The peak systolic velocity (Vmax) and the minimal diastolic vel-
ocity (Vmin) were determined by pulse wave Doppler, and the RRI
was calculated as (Vmax -Vmin)/Vmax. The exam was performed modify-
ing the PEEP levels: 5, 10 and 15 cm H2O in random order for 15 mi-
nutes. Occurrence of AKI was defined within 7 days according to
KDIGO criteria.
Results:
Sixty-four patients were enrolled in the study and incidence of AKI
was 14/64 (22%). Demographical and clinical characteristics are re-
ported in Table 1. Increase in PEEP showed a significant increase in
RRI from PEEP 5 to PEEP 10 (p<0.001) and from PEEP 10 to PEEP 15
(p=0.001) (Figure 1). The area under the ROC curve of RRI to predict
AKI was 0.845 at PEEP 5, 0.898 at PEEP 10 and 0.894 at PEEP 15 (all
p<0.001). The Youden index analysis showed an RRI>0.70 as the best
cut off for AKI with a sensibility of 65% and a specificity of 96%. Pa-
tients with RRI>0.70 were 11/64 (17%), 13/64 (20%) and 22/64 (34%)
at PEEP 5,PEEP 10 and PEEP 15 respectively. Patients ventilated with
a PEEP value associated with RRI>0.70 had higher incidence of AKI
(11/14 vs 6/50, p<0.001).
Conclusions:
The application of PEEP can increase intrarenal vascular resistance,-
which is associated occurrence of AKI; PEEP level should therefore be
balanced taking into account the RRI. The RRI seems able to predict
occurrence of AKI in mechanically ventilated patients.P124
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Introduction:
High oxygen can damage tissues [1]. In this study, we analyze the
histological and pulmonary mechanics modifications that can occur
Critical Care 2020, 24(Suppl 1):87 Page 49 of 213when identifying different inspiratory oxygen fractions (FiO2) in lungs
of healthy rats during protective mechanical ventilation.
Methods:
We use Sprague-Dawley rat. 4 groups were designed, each with 6 an-
imals, the tidal volume (6 ml/kg), PEEP (3 cmH2O) and respiratory
rate (90 rpm) were kept constant, changing the FiO2 between the
groups. Four groups were established: FiO2 0.21, 0.4, 0.6 and 1. After
4 hours, the lungs were removed for histological study and obtaining
the wet/dry index. The histological modifications studied were: alveo-
lar septa (AS), alveolar hemorrhages (AH), intraalvelolar fibrin (IF) and
inflammatory infiltrates (II). Each parameter was rated from 0 to 3 [2].
Peak pressure (Pp) and pulmonary compliance were monitored every
60 minutes. Different statistical tests will be used to analyze the data.
Results: References to the damage produced in the AS, AH, IF, II and
the global histological pattern were identified in the groups with the
highest FiO2 and there was more damage (p <0.00001) (Figure 1).
The wet/dry index rose significantly as the oxygen concentration in-
creased (p = 0.001). In the groups to which a FiO2 of 0.6 and 1 was
administered, the Pp selected specific values with respect to the
baseline intake from the first 60 minutes, an aspect that was not ap-
preciated in the other groups (p <0.0001). Regarding pulmonary
compliance, it will be seen that, in the FiO2 0.6 and 1 groups, it de-
creased from the first 60 minutes, finding differences with respect to
the other groups (p <0.0001).
Conclusions: Mechanical ventilation applied for 4 hours in healthy
animals produces disorders that are more pronounced as oxygen
concentration increase. FiO2 greater than or equal to 0.6 should be
avoided without clinical justification.
References:
1. Hedenstierna G et al. Intensive Care Med Oct:1-4, 2019
2. Matute-Bello G et al. Am J Respir Cell Mol Biol. 44: 725-38, 2011Fig. 1 (abstract P124). Distribution of the percentage of global
histological involvement among the groups (median and P25-75)
Fig. 1 (abstract P125). PAMV = prolonged acute mechanical
ventilation; STMV = short-term mechanical ventilationP125
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Introduction:
Patients requiring prolonged acute mechanical ventilation (PAMV,
defined as 4+ days on MV) are sicker and incur disproportionate
morbidity and costs relative to patients on short-term MV (STMV, <4days of MV). We quantified specific clinical outcomes among patients
requiring PAMV vs. STMV in a contemporary database.
Methods:
We conducted a multicenter retrospective cohort study within ~700
hospitals in the Premier database, 2014-2018. Using ICD-9-CM and
ICD-10 codes we identified PAMV and STMV patients, and compared
their baseline characteristics and hospital events. Because of the
large sample size, we omitted hypothesis testing.
Results:
A total of 691,961 patients met the enrollment criteria, of whom
266,374 (38.5%) received PAMV. At baseline, patients on PAMV were
similar to STMV with regard to age (years: 62.0 ± 15.8 PAMV vs. 61.7
± 17.2 STMV), gender (males: 55.6% PAMV vs. 53.9% STMV), and race
(white: 69.1% PAMV vs. 72.4% STMV). PAMV group had a higher co-
morbidity burden than STMV (mean Charlson score 3.5 + 2.7 vs. 3.1
+ 2.7). The prevalence of each of the indicators of acute illness sever-
ity – vasopressors (50.3% vs. 36.9%), dialysis (19.4% vs. 10.3%), severe
sepsis (20.3% vs. 10.3%), and septic shock (33.5% vs. 15.9%) – was
higher in PAMV than STMV, as were hospital mortality and combined
mortality or discharge to hospice (Figure 1), extubation failure (12.3%
vs. 6.1%), tracheostomy (21.6% vs. 4.5%), development of C. difficile
(4.5% vs. 1.7%), and incidence density of ventilator-associated pneu-
monia (2.4/1,000 patient-days vs. 0.6/1,000 patient-days).
Conclusions:
Over 1/3 of all hospitalized patients on MV require it for 4 days or
longer. PAMV patients exhibit a higher burden of both chronic and
acute illness than those on STMV. Commensurately, all clinical out-
comes examined are substantially worse in association with PAMV
than STMV.P126
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Introduction:
Identifying the readiness of patients recovering from critical illness
for liberation from invasive mechanical ventilation (IMV) is not always
straightforward [1]. The Scottish Intensive Care Society (SICS) trainee
audit 2018 conducted a Scotland-wide study to understand current
practices relating to liberation from IMV.
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Data were prospectively collected on patient demographics, indica-
tion for intubation, spontaneous breathing trial (SBT) practices,
physiological markers, ICU outcome and ICU LOS. All patients >18
years ventilated with IMV for > 24hrs from the 1stNov. 2018 –
30thNov. 2018 were eligible for inclusion. Exclusion criteria included
extubation for end-of-life, death whilst intubated and presence of
tracheostomy. Logistic regression was performed to detect factors as-
sociated with extubation failure (EF). Results were analysed via Excel
2010 and Stata v.14.1. Patient Benefit and Privacy Panel approval was
granted.
Results:
Total population of 172 patients were included: 108 (63%) male and
median APACHE2 score 19 (IQR 13-23). EF at first attempt occurred
on 27 occasions (15.7%), median ICU LOS of 10 days (IQR 7–12), mor-
tality rate 22.2%. The cohort successfully extubated first time had a
median ICU length of stay of 5 days (IQR 3–9) and mortality rate of
1.4%. Methods of SBT and extubation outcomes detailed in Table 1.
No SBT prior to extubation had higher odds of EF (OR 2.52, CI 1.09-
5.84, p=0.03); patient ventilation for < 3 days had a three times
higher odds of EF (OR 3.31, CI 1.09-10.1, p=0.03). These were inde-
pendently associated with EF on multivariate analysis
Conclusions:
We found a reintubation rate of 15.7% in Scottish ICUs. Type of SBT
most commonly used is divergent from the methods advocated in
the literature. The lack of SBT and early extubation attempt was asso-
ciated with failure, which in turn was associated with longer ICU LOS
and higher mortality.
References:
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days and SBT performed
Total
population
(n=172)
Successful first
extubation
attempt (n=145)
Failed first
extubation
attempt (n=
27)
Univariate
analysis (p-
value)
Time from
intubation to first
extubation <3days
–
115 (66.9) 92 (63.4) 23 (85.2) 0.02
SBT not performed
– no. (%)
69 (40.1) 53 (36.6) 16 (59.3) 0.03
Total SBT
population
(n=103)
Successful first
extubation (n=
92)
Failed first
extubation (n=
11)
T-piece - no. (%) 9 (8.7) 8 (8.7) 1 (9.1) -
CPAP only - no. (%) 64 (62.1) 58 (63.0) 6 (54.6) -
PS 5-8 ≥ PEEP - no.
(%)
28 (27.2) 24 (26.1) 4 (36.4) -P127
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Introduction:
In patients undergoing prolonged invasive ventilation we hypothe-
sise that abnormal right ventricular (RV) and left ventricular (LV)function are associated with increased 90-day mortality. Whether
changes in LV or RV function could aid in the prognostication of
these patients has not been directly studied.
Methods:
Patients admitted to the Queen Elizabeth Hospital Birmingham ICU
between April 2016 and July 2019 who were intubated and venti-
lated for more than 7 days and had a formal transthoracic echocar-
diogram (TTE) whilst in ICU were included. Abnormal RV function
was defined by the presence of depressed function, dilated size or
moderate to severe risk of pulmonary hypertension. Abnormal LV
function was defined by the presence of LV depression (LV ejection
fraction £ 45% or grade II or more diastolic dysfunction) or a hyper-
dynamic LV (formally mentioned in TTE report). Patients who had a
neurological cause for prolonged ventilation were excluded. The pri-
mary outcome was 90-day mortality. Categorical data is presented as
% and analysed using a chi-squared test. Continuous data is pre-
sented as median (IQR).
Results:
871 patients required prolonged ventilation, of which 350 (40%) had
a TTE. Patients were aged 62 (49-75), were 61% male and had a 36%
90-day mortality. The median ventilator days were 13 (6-20) and 77%
required a tracheostomy. Abnormal RV function was present in 26%
(n=90) and was associated with an increased 90-day mortality com-
pared to normal RV function (68% vs. 25%, RR 2.71 [2.10-3.50], p<
0.0001). LV function was abnormal in 27% (n=95) and was associated
with an increased 90-day mortality compared to normal LV function
(54% vs 28%, RR 1.91 [1.47 – 2.49], p < 0.0001). Abnormal RV function
had a trend towards an increased mortality compared to abnormal
LV function (68% vs 54%, RR 1.26 [1.00 – 1.60], p = 0.07).
Conclusions:
In this study, abnormal RV and LV function were present in a quarter
of patients undergoing prolonged ventilation and were associated
with an increased mortality.
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Introduction:
Tidal volume delivered by mechanical ventilation (MV) in sedated pa-
tients is distributed preferentially to ventral alveoli, causing overdis-
tention and associated collapse in dorsal alveoli, driving volutrauma,
atelectrauma and ventilator-induced lung injury [1]. Temporary trans-
venous diaphragm neurostimulation (TTDN) stimulates diaphragm
contraction [2]. When used in synchrony with MV, TTDN encourages
increased dorsal ventilation due to the change in pressure gradients
with diaphragm contraction, mimicking a more normal physiological
pattern. This may improve gas exchange and reduce injury.
Methods:
A pilot study was conducted using 50 kg pigs undergoing MV in a
mock ICU. Deeply sedated subjects were provided lung-protective
volume-control ventilation at 8 ml/kg. TTDN diaphragm contractions
were delivered in synchrony with inspiration on every second breath,
reducing the ventilator pressure-time-product by 15-20% during
MV+TTDN breaths. Tidal volume distribution was recorded in each
condition using electrical impedance tomography, and compared to
never-ventilated, spontaneously breathing subjects (NV).
Results:
Dorsal ventilation changed from 49% during MV breaths to 54% dur-
ing MV+TTDN breaths, compared to 60% in the NV group (p=0.035).
Ventral ventilation changed from 51% during MV breaths to 46%
during MV+TTDN breaths, compared to 40% in the NV group (p=
0.042, Figure 1).
Conclusions:
TTDN diaphragm contraction used as an adjunct to MV yields a more
physiological pattern of volume distribution. This translates into less
overdistension in the ventral areas and less atelectrauma in the dor-
sal areas and reduces ventilator-induced lung injury. This technology
Critical Care 2020, 24(Suppl 1):87 Page 51 of 213has the potential to provide a novel method of lung-protective
ventilation.References:
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2. Reynolds SC et al. Am J Respir Crit Care Med 195:339-348, 2017Fig. 1 (abstract P128). TTDN redistributes tidal volume during
mechanical ventilation toward a more physiological pattern
Table 1 (abstract P129). Quotient DTV/DPS for patients who were
successful and who failed, (DTV/DPS)/100
DVT DPS DVT/DPS * 100
SUCCESS 4.56 0.24 18.75
FAILURE 112.3 2.45 45.8
P value 0.036 0.063 0.082 / Or = 1.2P129
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Introduction:
By measuring the Pes and its derivatives, we can measure the rela-
tionship that exist between the diaphragmatic excursion and the os-
cillation of the esophageal pressure curve: Pswing (PS) so we infer
that, just as with the Pes, the variations of it might be related to a
weaning failure [1, 2]. However, no nominal value exists in the bibli-
ography to predict the test result.
Methods:
Patients who meet with the inclusion criteria start the weaning
process through a test of 30 minutes of spontaneous ventilation, T-
Tube (TT). And also the respiratory rate (RR) and the tidal volume
(TV). From this analysis, an average PS (APS) is determined for each
moment of the test (APS1, initial and APS2, final.).A quotient was ob-
tained in relation to these variables using the value previously ob-
tained (quotient DTV/DPS x100.Results:
A total of 13 patients were included (n=13).Regarding the evolution
during TT, 9 (n=9) (69%) were successful, while 4 (n=4) (30.76%)
failed When analyzing a rate that relates the variables TV and PS, a
quotient was obtained in relation to these variables using the value
previously obtained (quotient DTV/DPS) for patients who were suc-
cessful and who failed, (DTV/DPS)/100 Successful patients presented
a value of 18.75 while those of the failure group presented a value of
45.83, (OR 1,2 – 3 p=0.082) (Table 1).
Conclusions:
When presenting the relationship between TV and PS through the
quotient (DVT/DPS)/100, it is observed a tendency to have a higher
quotient among patients who failed versus those who did not fail.
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Introduction:
The process of weaning from mechanical ventilation imposes an add-
itional workload on the cardiovascular system, which may result in
impaired myocardial function, increase in left ventricular filling pres-
sure and respiratory distress. Among surgical patients, those under-
going heart surgery are particularly susceptible to cardiac
dysfunction induced by weaning because of inadequate cardiovascu-
lar reserve. The aim of our study was to depict the pathophysio-
logical changes assessed by echocardiography during the steps of
weaning and to identify possible predictors of weaning failure (WF).
Methods:
We enrolled 34 consecutive patients undergoing isolated coronary
artery bypass grafting in our institution. Data were obtained by intra-
operative transesophageal echocardiography before sternotomy (T0)
and by transthoracic echocardiography at the beginning of weaning
(T1) and at the time of extubation (T2). WF was defined as deferral of
planned extubation or respiratory failure needing reintubation or
non-invasive mechanical ventilation within 48 hours.
Results:
WF occurred in 7 patients (20.6%) and involved manifestations of re-
spiratory distress in 5 (14.7%). We found a significant association be-
tween left ventricle outflow tract-velocity time integral (LVOT-VTI)
and ventricular-arterial coupling measured at T1 and WF, with LVOT-
VTI emerging as the best predictor of WF with an area under ROC
curve of 0.8669 (Figure 1); an optimal cutoff value of 15 cm provided
100% sensitivity and 71% specificity. Significant increase in E/e’ mea-
sured at T2 (13.44 vs 9.96, P 0.02) suggested a cardiac etiology of re-
spiratory distress in patients who failed the weaning trial.
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Our study showed that serial assessment of hemodynamic parame-
ters by means of echocardiography is feasible in cardiac surgical pa-
tients and can provide insight into pathophysiological changes
during weaning. Although these preliminary data need to be con-
firmed in a larger population sample, LVOT-VTI emerged as a promis-
ing predictor of subsequent WF.Fig. 1 (abstract P130). ROC curve of LVOT-VTI measured at the
beginning of spontaneous breathing trial for weaning failure
Table 1 (abstract P131). Guideline-compliance of ventilation parameters
Trainee Consultants
Compliant with guidelines [n(%)] Compliant with guidelines [n(%)]
RR 39(97) 116(97)
Vt 35(87) 103(86)
Pmax 37(92) 117(98)
PEEP 24(60) 56(47)
RR=respiratory rate; Vt = tidal volume; Pmax=maximum pressure; PEEP =
Positive end-expiratory pressureP131
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Introduction:
Current guidelines on pre-hospital emergency ventilation are based
on the guidelines for lung protective ventilation in the intensive care
unit. The present survey was designed to determine the accordance
of actual pre-hospital emergency ventilation by German emergency
physicians (GEP) with these recommendations.
Methods:
Recommendations include a respiratory rate (RR) between 10-16/min,
a tidal volume (vt) between 6-8 ml/kg, a maximum pressure (Pmax)
<30 mbar and a positive end-expiratory pressure (PEEP) of 5 mbar.
An anonymous web-based questionnaire encompassing 7 questions
was sent to GEP from September to December of 2018. GEP were
asked to specify their level of education, their preferred ventilation
settings and the usually chosen parameters employed to guide
mechanical ventilation. Statistical analysis was performed using the
Ch²-test with a significance level ≤0.05.Results:
60% of the questionnaires were completed (159/261). 25% of the
participants were trainees (Tr), 75% consultants (Co). As target pa-
rameters for guidance of ventilation, 87% of the Tr and 91% of the
Co use capnometry. The Vt controlled 62% of the Tr and 54% of the
Co on the basis of body weight. 81% of the Tr and 81% of the Co re-
ported to control oxygenation using SpO2. Table 1 shows our ana-
lysis of the given answers. There were no statistically significant
differences between the groups.
Conclusions:
Deviations from the guidelines of pre-hospital emergency ventilation
settings are common and mainly concern the use of a guideline-
compliant PEEP. In addition, recommended target parameters for guid-
ance of ventilation were not applied in a significant proportion of GEP.P132
Analysis of inflammatory hippocampal cells after 50 hours of lung-
protective mechanical ventilation in a preclinical pig model
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Introduction:
We hypothesize that hippocampal inflammation occurs as a result of
mechanical ventilation (MV). Preclinical studies evaluating neuroin-
flammation in normal-lung MV models have not been reported.
Microglia and reactive astrocytes take part in neuroinflammation and
are important targets of investigation. They are responsible for
modulating neuronal connections, assisting in establishing stronger
synaptic connections and maintaining tissue homeostasis.
Methods:
Our study investigated the percentage of iba-1-positive cells (micro-
glia), and the percentage of GFAP-positive cells (astrocytes) in the
total number of cells counted (positive and negative cells per
marker) in the hippocampal tissue of human-size pigs with non-
injured lungs after 50 hours of lung-protective MV (MV group), com-
pared with never-ventilated (NV) pigs. The cells were counted by ma-
chine learning software IMAGEJ. Lung-protective MV was defined as:
driving pressure less than 15 cmH2O, tidal volume of 6ml/kg and peak
pressure less than 30 cmH2O.
Results:
Six NV and six MV pigs were used in this study. The percentages of
iba-1-positive cells in the hippocampus were 7% (42705 iba-1-
positive cells/589888 total cells) and 32% (65655 iba-1-positive cells/
205006 total cells) respectively in the NV and MV groups (p<0.01).
The percentages of GFAP-positive cells were 9% (35941 GFAP-
positive cells/406235 total cells) and 18% (91156 GFAP-positive cells/
Table 1 (abstract P133). Clinical and ultrasound variables
Extubation success
(N=63)
Extubation failure
(N=6)
P-
value
Pre-SBT RR 17 (15 - 20) 16 (15 - 16) 0.27
PaO2/FIO2 235 (218-278) 218 (218-220) 0.06
PaCO2
(mmHg)
40 (38 - 41) 38 (37 - 39) 0.56
20 min T-
piece
RR 18 (15 - 23) 23 (16 - 23) 0.43
PaO2/FIO2 233 (219-265) 188 (188-188) <
0.001
PaCO2
(mmHg)
40 (38 - 43) 42 (40 - 43) 0.33
DE<10mm 10 (15.87%) 3 (50%) 0.08
DTF<0.3 48 (76.2%) 5 (83.3%) 1
SBT: spontaneous breathing trial; RR: respiratory rate; PaO2/FIO2: ratio of partial
pressure of arterial oxygen and fraction of inspired oxygen; PaCO2: partial
pressure of arterial carbon dioxide; DE: diaphragmatic excursion; DTF:
diaphragmatic thickening fraction
Critical Care 2020, 24(Suppl 1):87 Page 53 of 213502195 total cells) respectively in the NV and MV groups (p<0.01).
When comparing the percentage of iba-1-positive cells to that of
GFAP-positive cells we calculated the ratios of approximately 0.78 (7/
9) and 1.78 (32/18) in the NV and MV groups respectively (p<0.01).
Conclusions:
Our study demonstrated neuroinflammation in pigs after lung-
protective MV. A higher presence of microglia and astrocytes in the
MV group indicate an inflammatory hippocampal process as a conse-
quence of lung-protective MV.
P133
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Introduction:
Weaning from mechanical ventilation (MV) is an important issue in
the immediate postoperative period following lung transplantation.
No predictor of weaning success has been validated in this group of
patients. The aim of the study was to establish whether clinical vari-
ables and/or the presence of DD may predict extubation failure in
LTx patients.
Methods:
Prospective observational study including LTx recipients admitted to
our ICU from February2017 to January2019, who underwent a spon-
taneous breathing trial (SBT) using a T-piece for 30 minutes. Clinical
variables and arterial blood gas samples were recorded before start-
ing SBT and after 20 minutes on the T-piece. Diaphragmatic excur-
sion (DE) and thickening fraction (DTF) were also assessed using
ultrasound(US) after 20 minutes on the Tpiece. US-DD was defined as
DE<10 mm or DTF<0.3 of at least one hemidiaphragm. Patients who
successfully completed a SBT, defined according to clinical criteria,-
were extubated. Extubation failure was defined as the need for rein-
tubation within 48h. Results are expressed as medians (IQR) or
frequencies (%).
Results:
193 LTx recipients were admitted to the ICU, 79 of whom underwent
an SBT. 51 were male, and the median age was 58y. Main indications
for LTx were interstitial lung disease (43.0%), COPD and cystic fibro-
sis. 59 were bilateral LTx, and 13 and 7 were left and right unilateral
LTx respectively. 69 patients were extubated after SBT and 6 required
reintubation within 48h. 53 presented US-DD, though there were no
differences between patients who succeeded and those needing
reintubation. In contrast, patients who succeeded showed higher
PaO2/FIO2 after 20 minutes on the T-piece (Table 1). Similarly, higher
reductions in deltaPaO2/FIO2 after 20 minutes on the T-piece were
observed in patients who failed.
Conclusions:
Oxygenation after SBT performed using a T-piece may predict extu-
bation failure in LTx recipients with successful SBT. US-DD was not
associated with the need of reintubation.P134
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Introduction:
To evaluate the relationship between self-extubation and patient-
ventilator interaction, among other physiological variables, in order
to predict and to prevent these events. Self-extubation (SE) are qual-
ity indicators in patients under invasive mechanical ventilations (IMV)
and are related with mortality [1].
Methods:
Planned secondary analysis of a prospective data base of clinical and
physiologic signals of patients receiving IMV. We included SE epi-
sodes (2012-2018) with continuous record of ventilator and monitor
signals (BCLink BetterCare®). We analysed demographic data, physio-
logical parameters (peripheral oxygen saturation SpO2, heart rate HR,
respiratory rate RR and media arterial pressure MAP) and patient-
ventilator interaction (asynchrony index AI, ineffective efforts during
expiration IEE and double cycling DC). We studied a period of 12
hours prior to the SE episode. We used the Wilcoxon non-parametric
test and for a proper analysis a Linear Mixed Effects Model.
Results:
We included 21 episodes of SE, mean age 62±13years, 76%men,
APACHE II at admission 17±10, 4,6±3,8days under IMV until the epi-
sode, reintubation rate 47.6%, ICU stay 20,9±17,6days, ICU mortality
14%. At the time of the SE, 65% were under sedation, 65% with
physical restraint. The 67% were in weaning. We observed a trend to
increase in SpO2, RR, HR, MAP and asynchronies in the 2-hour period
prior to SE episode. We compared these variables from this period
with a 2-hour period before and we observed a statistically
Critical Care 2020, 24(Suppl 1):87 Page 54 of 213significant difference in RR, HR, MAP and AI. Clusters of IEE and DC
increased its power in the 2-hour period before SE.
Conclusions:
In this preliminary study, patient-ventilator interaction, as well other
physiological variables, are related with self-extubation episodes. Fur-
ther analysis will be needed to analyze the value of these variables
as a predictive model.
References:
1. Danielis M et al. Intensive Crit Care Nurs 47:69-77, 2018
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Introduction:
The purpose of this study was to review the mortality and early post-
operative complication rates after TAVI (transcatheter aortic valve im-
plantation) for severe aortic stenosis in an interventional cardiology
center in Antwerp, Belgium with more than 10 years of experience.
All patients were postoperatively admitted to the ICU for judicious
monitoring. Results were compared to large international registries.
Methods:
A retrospective data analysis by medical record review of 242 pa-
tients who underwent a TAVI procedure between april 2008 - april
2019 was carried out. A literature search was executed to compare
the results with current published data. Endpoints were mortality (72
hours, 1 week, 30 days, 1 year), bleeding, vascular complications, de-
finitive pacemaker implantation, stroke, conversion and cardiac tam-
ponade. Standardized criteria according to the Valve Academic
Research Consortium II recommendations for studies evaluating TAVI
were used [1].
Results:
Vascular access was predominantly transfemoral (90.1%), compared
to subclavian (7%), carotic (1.7%) and direct aortic (1.2%) approaches.
Mean age was 82.6 (range 61-98) years old, with 51.2% female pa-
tients. Mortality rates were 1.2, 2, 4.8 and 15.9% at 72 hours, 1 week,
30 days and 1 year respectively. Life-threatening bleeding occurred
in 2.9%, major in 10.7% and minor bleeding in 3.3%. The major and
minor vascular complication rates were 12.4% and 5.8%. 97.7% was
access site related. There were no patients with aortic dissection. The
need for definitive pacemaker implantation was 18%. Incidence of
stroke and cardiac tamponade was 1.7 and 3.3% respectively. Con-
version to open sternotomy was necessary in 0.8%.
Conclusions:
The data presented in this study show that our results are in accord-
ance with the literature with favorable mortality and early postopera-
tive complication rates and support that this procedure is an
excellent alternative for surgery in the elderly patients.
References:
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It is reported that patients with pulmonary hypertension (PH; systolic
pulmonary arterial pressure (sPAP)≥35 mmHg)) have frequent cardiac
complications after transcatheter aortic valve implantation (TAVI). PH
often gets worse in some patients despite the normal cardiac func-
tion after TAVI. No studies have ever examined prognosis after TAVI
in patients with or without worsening of PH. Therefore, we retro-
spectively examined the frequency of mid- to long-term heart failure
and cardiac death in patients with and without deterioration of PH
after TAVI.
Methods:
Among 113 patients who underwent TAVI at our hospital between
February 2014 and March 2016, we analysed 27 patients with PH
(sPAP≥35 mmHg) before surgery. sPAP was measured in transtho-
racic echocardiography before and within 1 week after TAVI. Patients
were divided into two groups according to whether sPAP worsened/
did not change or improved after TAVI. We examined the frequency
of admission due to heart failure or cardiac death (death caused by
heart failure, angina, or myocardial infarction) during the period of 3
years after TAVI.
Results:
PH worsened or did not change after TAVI in 9 patients, while it im-
proved in 18 patients. The left ventricular ejection fraction measured
within 1 week after TAVI showed no difference between the two
groups (56.6±11.9% vs 58.4±10.0%, p=0.71). The worsened/ no
change group was higher in frequency of admission due to heart fail-
ure (logrank; p<0.05) and cardiac death (logrank; p<0.04).
Conclusions:
Despite successful treatment for AS by TAVI, the frequency of heart
failure and cardiac death was higher in patients who did not show
improvement of PH after TAVI, even in the absence of cardiac func-
tion decrease. Vigorous intervention for PH worsening after TAVI may
be helpful to improve prognosis.P137
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Introduction:
There are several different anti platelet drugs that can be used to
treat acute cardiac events. Currently there are no effective markers
that can assess how these drugs modify coagulation profile and qual-
ity. A new functional biomarker that measures Fractal dimension (df )
and clot formation time (TGP) has been developed [1]. df quantifies
clot microstructure whereas TGP is a real-time measure of clotting
time. We aimed to validate df and TGP in ST elevation myocardial in-
farction (STEMI) and assess the effect of two P2Y12 inhibitors which
have different pharmacological mechanisms: clopidogrel and
ticagrelor.
Methods:
We prospectively recruited 72 STEMI patients in the emergency set-
ting. Venous blood samples were collected 12 hours after admission,
following treatment with either ticagrelor or clopidogrel, in accord-
ance with the local guidelines at the time. The blood samples were
tested using the df and TGP biomarker, platelet aggregometry, clot
contraction and standard markers of coagulation.
Results:
36 patients received clopidogrel and 36 received ticagrelor. The df
for clopidogrel was higher than ticagrelor (1.75±0.05 vs 1.73±0.06,
p=0.18 which corresponds to a decrease in clot mass of 20% Figure
Critical Care 2020, 24(Suppl 1):87 Page 55 of 2131) and the TGP was reduced (205±91sec vs 257±89 sec, p=0.06 a
20% reduction in time).
Conclusions:
The results of the study suggest that clopidogrel is less powerful in
its effects on clotting characteristics compared to ticagrelor. Blood
from patients receiving clopidogrel formed quicker and denser clots.
This would suggest the risk of secondary events or stent occlusion is
lower in those patients on ticagrelor, highlighting that df and TGP
may be important in identifying patients at risk of future thrombotic
events, the study is ongoing and will investigate the long term out-
come in these patients.
References:
1. Knowles RB et al. Platelets 29:162-170, 2018Fig. 1 (abstract P137). Visual representation of the relationship
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Introduction:
New onset atrial fibrillation (NOAF) during critical illness frequently
resolves prior to discharge. However long-term risks of NOAF (i.e.
heart failure, ischemic stroke and death)remains high [1]. Previous
studies noted that nearly half of NOAF cases did not have diagnosis
recorded [2]. Addressing this may reduce post critical illness mortality
by increasing AF surveillance post intensive care (ICU) discharge.
Methods:
Retrospective data was collected from an electronic health record for
ICU admissions over a 10 month period from 1st of January to 31st of
October 2019 at Medway Maritime Hospital. Data collected included;
demographics, onset, rate, possible precipitants, attempted electrical or
chemical cardioversion, rate control, anticoagulation, rhythm on dis-
charge from ICU and hospital discharge medication. It was recorded if
NOAF was documented in ICU and Hospital discharge summaries.
Results:
Over 10 months 429 patients were admitted to ICU. 37 patients de-
veloped new onset AF with an average age of 69.2 (±10.3) and
59.4% male. Patients with NOAF had an in-hospital mortality of
43.2% compared to 29.8% . Beta blockers were used in 38% and ami-
odarone in 59%. 23 patient’s with NOAF survived ICU admission
(62%). 13.5% remained in AF on discharge of which 1 patient was
discharged from ICU on therapeutic anticoagulation (2 total, 11%). Of
those not anticoagulated 19 had a Cha2ds2-VASc of >= 2. On ICU
discharge, 23 patients had NOAF. 35% episodes documented on ICU
discharge summaries. Thirty three per cent patient had documenta-
tion about the reason for choosing rate control approach. Onhospital discharge only 28% had documentation of NOAF episode on
their hospital discharge summaries.
Conclusions:
Need to implement an automated referral to cardiology to assess
long term anticoagulation for patients with NOAF with CHA2DS2-
VASc score >=2. For clear documentation of NOAF episode in ICU
discharge summaries.
References:
1. Walkey AJ et al. Chest 146: 1187-1195, 2014
2. Moss et al. Critical Care Medicine 45: 790-797,2017
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Introduction:
A biomarker is defined as a measurable indicator of some biological
state or condition. Combined with a good clinical evaluation, they
can enable an early and safe diagnostic, thus a faster management
for the patient. Cardiac biomarker testing is not indicated in routine
in the emergency department (ED) because of low utility and high
possibility of false-positive results. However, current rates of testing
are unknown. The aim of our study was to evaluate the importance of
measuring cardiac biomarkers especially Troponins, D-dimer, and B-
type natriuretic peptide in our daily practice, and to identify the lat-
est recommendations for a better use of these biomarkers in the
diagnostic and therapeutic approaches.
Methods:
We conducted a prospective observational study, over a 13 months
periods performed in the ED of the university hospital center Ibn
Rochd, Casablanca, Morocco, including all patients admitted during
our study period and having a blood test for at least one biological
marker. The dataset was analyzed by SPSS statistics 21.0.
Results:
A total of 182 patients was enrolled. Troponins were tested in 85.3%
patients (High sensitive in 49.5% and troponin I TnI in 35.8%), D-
dimer in 30.9%, BNP 19% and NT pro BNP in 9.5% of cases. The diag-
nostic impact was significant in 94.4% of cases for troponins, 84.6%
of cases for D-dimer and 87.5% for BNP. The therapeutic impact was
considered important in 80.6% cases for troponins, 69.2% for D-
dimer and 87.5% for BNP.
Conclusions:
Cardiac biomarkers have an important role in the ED, not only do
they confirm the diagnosis (including the role of troponins in ACS)
but also eliminate others (with a strong negative predictive value of
D-dimer for thromboembolic disease) and prove the cardiopulmo-
nary origin of acute dyspnea (the significant place of BNP in confirm-
ing the diagnosis of acute heart failure).P140
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The HEART (based on History,ECG,Age,Risk Factors,Troponin) score is
a valid tool to stratify the ACS in chest pain. But some reports sug-
gest that its reliability could be low for heterogeneity in the assign-
ment due to the subjective interpretation of the History. We used
the Chest Pain Score for the “History”. In this study we compare the
reliability of the new HEARTCPS and original HEART.
Methods:
This is a multicenter retrospective study conducted in 3 Italian ED be-
tween July and October 2019 using clinical scenarios. Ten physicians
were included after a course on HEART and HEARTCPS score. We
used 53 scenarios which included clinical and demographic data.
Each participant independently assigned scores to the scenarios
using the HEART and HEARTCPS. We tested the interrater agree-
ment using the kappa-statistic (k), the confidence intervals are bias
corrected ; we used Stata/SE 14.2 statistical software . A p-value of <
0.05 defines statistical significance.
Results:
The overall inter-rater reliability was good for HEART and HEARTCPS:
Kappa =0.63 (CI 95%;0.57–0.72)and 0,65(CI95%;0.63 - 0.67); with good
agreement among all the class of risk for HEARTCPS but moderate in
the medium class for HEART .
We found significant differences of inter-rater reliability among the se-
nior and junior physicians who used the HEARTCPS:K=0.56(CI95%;0.52–
0.57)and 0.75(CI95%;0.70-0.79). HEARTCPS score increased its History
inter-rater reliability specially among the junior physicians from K=0.35
(CI 95%; 0.27-0.43) to k=0.69(CI 95%;0.62-0.71).The Junior physicians
seem to be more reliable than senior with the HEARTCPS:k=0.75 (0.71-
0.79) vs K=0.56 (CI95%;0.52-0.57).
Conclusions:
The HEARTCPS showed inter-rater reliability better than original
HEART among the medium class of risk and the junior group. It could
be proposed to young doctors to stratify the ACS risk of chest pain.
Limit: we used scenarios rather than real patients.P141
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Introduction:
The aim of this study is to discuss the short-term results of a hybrid
approach combining minimally invasive endoscopic CABG (Endo-
CABG) with a percutaneous coronary intervention (PCI). To bypass
the disadvantages and potential complications of conventional CABG
via median sternotomy, we developed the EndoCABG technique to
treat patients with single- and multi-vessel coronary artery disease
(CAD). This procedure is performed with three 5-mm thoracic ports
and a mini-thoracotomy utility port (3 cm) through the intercostal
space. This technique can be combined with PCI: the hybrid ap-
proach. The sequence of the 2 procedures (EndoCABG followed by
PCI or vice versa) may result in different outcomes.
Methods:
From 02/2016 to 12/2017 data from 81 consecutive patients sched-
uled for a hybrid technique at Jessa, Belgium, were prospectively en-
tered into a customized database. This database was retrospectively
reviewed. Subgroup analysis was performed to compare outcomes of
patients who first received EndoCABG with patients who first re-
ceived PCI. A p-value < 0.05 is considered significant, a p-value < 0.1
is considered as a trend toward significance.
Results:
Four patients underwent revision surgery and 2 patients died within
the first 30 days. In 79 patients the left anterior descendens artery
(LAD) was grafted with the left internal mammary artery (LIMA), theright coronary artery (RCA) was the most stented vessel using PCI.
Patients first treated with PCI received more units of fresh frozen
plasma after EndoCABG compared to those who were first treated
with EndoCABG (p=0.03). There was also a trend toward significant
more transfusion of packed cells in this small subgroup (p=0.07).
Conclusions:
The hybrid approach is a feasible technique as a treatment option
for patients with multi-vessel CAD. If CABG follows the PCI, patients
are more likely to receive transfusion. A possible explanation could
be the need for dual antiplatelet therapy prior to surgery in this
group, but this needs further investigation.
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Introduction:
Troponin T (cTnT) elevation in critically ill patients is common and is
associated with poor outcome. Using common assays, 40-50% of pa-
tients in the ICU will have elevated troponin level. Our aim was to
determine whether there is any prognostic difference between
troponin elevation meeting the MI criteria (rise and fall more than
20% together with Echo and ECG new abnormalities) and troponin
elevation due to myocardial injury in septic patients.
Methods:
We enrolled 101 patients with sepsis and mean SOFA score 5,2 re-
spectively in which cTnT level was measured more than once and
analyzed there ECG and Echo findings. Patients were classified into
three groups:definite MI (rise and fall cTnT ≥ 20% and contemporan-
eous changes on ECG and/or Echo),possible MI (rise and fall cTnT ≥
20% and no other findings),myocardial injury (cTnT rise less than
20%)
Results:
Data from 101 patients were analyzed (49% female; mean age 61.9
(SD 16.9)). A total of 101 patients had at least one elevated cTnT
more than 0.03 mkg/l. In 71 (70%) of patients cTnT level rised more
than 20% from the first elevated measurement.64 (63%) of patients
met MI criteria considering new ECG and Echo findings. The overall
mortality rate in all patients was 53.9%.The mortality rate didn’t differ
significantly in three groups: in the definite MI group 62.4%, in the
suspected MI group 52%, in the non MI cTnT elevation group 56,4%,
p=0,6. Coronary angiography was performed in 46 (73%) of patients
from the definite MI group,PCI was performed in 18 (39%) of pa-
tients. The mortality rate in the invasive group was not significantly
lower comparing to the nonivasive group 29% vs 37,8%, p=0,06.
Bleeding complications were significantly more frequent in the defin-
ite MI group 13% vs 7% and 8% respectively
Conclusions:
cTnT level elevation is associated with poor outcome regardless cor-
onary or non coronary injury. Myocardial revascularization may be
beneficial in patients with sepsis and definite MI, but it is also associ-
ated with increased bleeding risk.
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Chest pain is a common reason for emergency department visits, al-
though this primarily refers to Acute Coronary Syndrome (ACS), this
symptom may be frequently related to other non-ischemic etiologies.
The aim was to validate the Marburg Heart Score as a tool to exclude
coronary artery disease in emergency department patients with non-
traumatic acute chest pain.
Methods:
a prospective, observational, descriptive and analytic cohort study
conducted in the emergency department, from February 1st to
March 31st, 2019, collecting patients consulting for nontraumatic
acute chest pain, the "Marburg Heart" score was calculated for all
these patients. Telephone contact was made after 6 weeks to look
for an ischemic cardiovascular event.
Results:
We included 171 patients. The mean age was 57 +/- 13 years, the
sex ratio was 0.86. The majority of the patients (78.9%) consulted dir-
ectly to the emergency department, 21.1% were referred by a pri-
mary care physician. The median time to consultation after the onset
of chest pain was 24 hours. High blood pressure was the most com-
mon risk factor (43.9%), followed by smoking (31%), diabetes (24.8%)
and dyslipidemia (23.4%). Thirty-five patients (20.5%) had already
coronary heart disease, ECG was pathological in 19.3% of patients, 8
patients had an ACS with ST segment elevation. At six weeks, 20.6%
of the patients had an acute coronary event. According to the pa-
tients' answers on the 5 questions of the Marburg Heart score. The
area under the ROC curve of this score was 0.78 with a negative pre-
dictive value of 87.2%;
Conclusions:
The "Marburg Heart Score" is a simple, valid and reproducible clinical
score with a discriminatory power to rule out the diagnosis of coron-
ary artery disease from the first contact with the patient presenting
for chest pain in emergencies.
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Introduction:
The abdominal aortic aneurysm (AAA) surgery is a complex proced-
ure in elderly patients with high cardiovascular risk. Anesthesiological
techniques should play special attention to the volume status during
cross-clamping as well as to the blood loss. Goal directed fluid ther-
apies (GDT) in AAA surgery in elderly patients decrease the peri-
operative morbidity and mortality [1]. Aim of this study is to
investigate administration of fluid-based on either a GDT approach
or a control method (fluid administered based on static preload pa-
rameters and traditional hemodynamic) in all phases of AAA surgery
and especially in the phase of clamping and de-clamping.
Methods:
A total of 30 patients ASA III, randomly scheduled for elective, open
AAA surgery were included in this clinical trial. They were randomly
assigned to two groups I – GDT with targeting stroke volume vari-
ation (SVV) and II - Control group where fluids were administered at
the discretion of the attending anaesthesiologist. In both these
groups hemodynamic parameters, central venous pressure (CVP),
temperature, blood loss and diuresis were registered during the op-
eration and 48 hours postoperatively. Each group was assessed for
postoperative complications.
Results:
GDT group received less fluids and had a higher cardiac index (CI)
(3.9± 0.6 vs. 2.9± 0.8 l/minute per m2, p < 0.01) and stroke volume
index (55.1 ± 5.4 vs. 35.1 ± 5.8 ml/m2, p < 0.01) than the control
group. There were significantly fewer complications in the interven-
tion than control group (3 vs. 9, p = 0.02).Conclusions:
GDT fluid administration enables less use of fluids, improved
hemodynamic and fewer postoperative complications in elderly pa-
tients undergoing AAA surgery.
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Introduction:
With the benefit of neuraxial block in major noncardiac surgery, but
serious cardiac events’re reported in high risk pts receiving preop
beta-adrenergic blocking agent. The aim of this study was to study
predictors of intraoperative cardiac complications in pts underwent
major noncardiac surgery with neuraxial block.
Methods:
This prospective observational study was done in 360 high risk for car-
diac complication pts, underwent elective major noncardiac surgery
with neuraxial block [spinal, thoracic (TE) or lumbar epidural (LE)
anesthesia] alone or combined with GA & admitted to the SICU during
Jan 2017-Sep 2019. Pts with ESRD or underwent arterial vas surgery
were excluded. Study data included: pts demographic,comorbiditie-
s,ASA class, preop hypertensive med (beta adrenergic blocking agent,
ACEI/ARB, vasodilator), intraoperative cardiac complications [significant
hypotension (SBP<90 mmHg or MAP<65 mmHg>10 mins) requiring
fluid resuscitation or inotropic agent, serious cardiac arrhythmias
needed medication or intervention, PMI, cardiac failure, cardiac arrest,
cardiac death), within 72 hours postoperative organ dysfunction (AKI,
stroke) & 30days mortality.
Results:
Among the studied pts (age 65+16yrs), 72% was ASA III, 54% had hx
of HTN. 64% underwent major abdominal surgery, 21%, 8% & 72%
received spinal, spinal plus GA and TE or LE plus GA subsequently.
79% had serious intraop cardiac complications (80%, 15% & 4% had
significant hypotension, PMI & cardiac arrest subsequently), 39%, 3%
& 11% had AKI, ischemia stroke&delirium subsequently. 30 days mor-
tality was 13%. From multivariate variate analysis showed age>75
yrs, hx of HTN, preop beta-adrenergic blocking agent, vasodilator,
combined beta-adrenergic blocking agent & vasodilator or ACEI/ARB,
high dose local anesthetic agent were significant predictors of
intraop serious cardiac complications.
Conclusions:
Further study about decrease or withhold preop antihypertensive
med in high risk patient undergoing major noncardiac surgery with
central neuraxial block is warranted.P146
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Introduction:
Ultrasonography is a valid diagnostic tool, used to measure changes
of muscle mass. The aim of this study was to investigate the clinical
Table 1 (abstract P148). Data are shown as Mean±SD, TTQ-Time spent
on the Target Quadrant, TAC- Target Area Crossings
Minor surgery (n=20) Major surgery (n=20) p
Surgery duration, min 22.6 ± 6.3 20.1 ± 3.7 0.134
Anesthesia duration, min 41.2 ± 8.5 36.3 ± 8.2 0.071
TTQ-1, sec 59.5 ± 12.1 51.2 ± 13.7 0.049
TTQ-2, sec 57.8 ± 9.7 52.4 ± 12.5 0.135
TAC-1 4.9 ± 2.7 3.3 ± 1.9 0.036
TAC-2 4.6 ± 2.1 3.4 ± 2.3 0.093
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cardiothoracic surgery that present muscle weakness postoperatively.
Methods:
For this study, 221 consecutive patients were enrolled, following their
admission in the Cardiac Surgery Intensive Care Unit (ICU) within 24
hours of cardiac surgery. Ultrasound scans, for the assessment of
quadriceps muscle thickness, were performed every 48 hours for
7 days. Muscle strength was also evaluated in parallel, using the
Medical Research Council (MRC) scale.
Results:
Of the 221 patients enrolled, ultrasound scans and muscle strength
assessment were performed in 165 patients. The muscle thickness of
rectus femoris (RF), was slightly decreased by 2.18% ([95%CI: -0.21;
0.15], n=9; p=0.729) and the combined muscle thickness of the vas-
tus intermedius (VI) and RF decreased by 3.5% ([95% CI: -0.4; 0.22],
n=9; p=0.530). Patients whose combined VI and RF muscle thickness
was below the recorded median values (2.5cm) on day 1 (n=78),
stayed longer in the ICU (47 ± 74 vs 28 ± 45 hours, p = 0.015). Pa-
tients with MRC score ≤ 48 on day 3 (n=7), required prolonged
mechanical ventilation support compared to patients with MRC score
≥ 49 (n=33), (44 ± 14 vs 19 ± 9 hours, p = 0.006).
Conclusions:
The use of muscle ultrasound seems to be a valuable tool in asses-
sing skeletal muscle mass in critically ill patients after cardiothoracic
surgery. Moreover, the results of this pilot study showed that muscle
wasting of patients after cardiothoracic surgery is of clinical import-
ance, affecting their stay in ICU.
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Introduction:
The aim is to assess the incidence of cardiovascular incidents in
major abdominal surgery [1] using the revised Lee index.
Methods:
A study was conducted of 144 elderly patients who underwent major
abdominal surgery in the Krasnodar Regional Clinical Hospital No.
2 under combined anesthesia. In the preoperative period, the risk of
cardiovascular incidents was assessed using the revised Lee index
and the functional status was assessed by MET. Depending on the
Lee index, 3 groups were identified: group 1 (n = 69) - low risk (index
value - 1), group 2 (n = 52) - intermediate risk (index value -2); group
3 (n = 23) - high risk (index value> 3). We estimated the incidence of
critical incidents in groups: hypo-, hypertension, arrhythmias, and
bradycardia.
Results:
In the general population, cardiac risk was 2.2 ± 0.7 points; functional
status - 7.7 ± 1 MET. The greatest number of critical incidents was re-
corded in patients with high risk (58.4%), the smallest - in patients
with low risk (9.1%), in patients with intermediate risk - 26.5% (n <0,
05 between groups according to Chi-square criterion). In the struc-
ture of critical incidents, hypotension was most often encountered -
in 62 (43%) patients, while some patients revealed several incidents
from the circulatory system (n = 116). Overall, the Lee scale showed
good prognostic ability (AUROC = 0.81) in predicting hemodynamic
incidents.
Conclusions:
The revised Lee index is a useful tool to help assess the risk of car-
diovascular incidents and determine patient management tactics in
the perioperative period.
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Introduction:
Postoperative cognitive dysfunction (POCD) remains an unresolved
problem due to lack of consensus on its etiology and pathogenesis.
Some believe that POCD is the result of the direct toxic effect of general an-
esthetics on the nervous system. Others claim that surgical trauma activates
proinflammatory factors that induce neuroinflammation.
Methods:
Wistar rats were allocated into 2 groups: 1-minor surgery (n=20), 2-
major surgery group (n=20). After 5 days of handling and habituation
rats undergone surgery under isoflurane general anesthesia (2 vol.%).
Group 1 rats underwent laparotomy with gentle gut massage
followed by wound closure. Rats in group 2 undergone left side
nephrectomy. Starting from the 4th postoperative day spatial mem-
ory in rats was studied in Morris Water Maze which is a cylinder
metal pool with a diameter of 1.5 and a height of 0.5 m filled with
water (temp.26±1oC) up to half. It has a platform with a diameter of
12 cm and a height of 1 cm below the water level. Testing was pre-
ceded by a training stage, which included 8 sessions daily for 4 days.
Thus, rats developed spatial memory to the location of the platform.
On the 5th day of the study test stage was conducted to assess
spatial memory: rats were launched from 3 points into maze without
platform and data were recorded for 60 seconds at each session.
Time spent on the target quadrant (TTQ) and the number of target
area crossings (TAC) were registered. A second test was conducted
14 days after the first test to evaluate long-term spatial memory.
Results:
The duration of surgery and anesthesia did not differ significantly be-
tween groups. There was a significant difference between groups in
average TTQ and TAC in test 1 (Table 1). In test 2 minor surgery
group showed better results but they were less significant.
Conclusions:
Major surgery is associated with a more pronounced deterioration of
spatial memory in rats in early postoperative period compared to
minor surgery.P149
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Table 1 (abstract P150). Association between type of surgery and
airway complication
Laryngeal
edema
Pearson´s
criteria
Recurrent nerve
injury
Pearson´s
criteria
Euthyroid goiter (170
pts)
4 0.116 weak 2 0.082 NaN
Polynodos goiter (125
pts)
7 0.194 weak 4 0.147 weak
Thyroid gland cancer
(105 pts)
11 0.271
moderate
6 0.203 weak
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Patients with known coronary artery disease have higher periopera-
tive risk for myocardial ischemia [1, 2]. Mortality is frequent following
cardiac ischemia in the intensive care unit (ICU) after non-cardiac
surgery.
Methods:
The first group includes patients admitted to the Intensive Care Unit
for post-operative follow-up without myocardiac ischemia in the first
24 hours. The second group includes patients with myocardiac ische-
mia postoperatively and needs intensive care monitoring. Cardiac risk
assessment was made with the Lee Index,hemorrhagic risk assess-
ment with the HAS-BLED bleeding score and thrombotic risk assess-
ment with CHA2DS2-VASc score. Postoperatively, pathological test
values such as BNP, troponin, CRP, calcitonin were estimated. The Se-
quential Organ Failure Assessment (SOFA) systeme was used to as-
sess sepsis. The Nursing Activity Score (NAS) scale was used to
measure the workload of various nursing activities in the ICU.
Results:
According to the pilot study, the sample consists of 35 patients.
31.4% had myocardial ischemia. The Lee index was significantly
higher in patients with myocardial ischemia. The duration of
hospitalization, the high dose of vasoconstrictive drugs, the length of
stay in the ICU, the duration of mechanical stay and the nursing
workload were higher in patients with myocardial ischemia. CK-MB
and troponin levels differed significantly between the two groups.
Creatinine, bilirubin and BNP during the 24 hours were significantly
higher. Patients with myocardial ischemia had significantly higher
mortality.
Conclusions:
Cardiac risk assessment, HAS- BLED score and CHA2DS2-VASc score
in combination with cardiac enzymes such as troponin could predict
myocardiac ischemia in severely ill ICU patients.
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Introduction:
According to the literature an airway complication followed thyroid
gland surgery are: difficult trachea intubation, tracheomalacia, post-
extubation stridor and bleeding [1,2]. Most common cause of death
was problem with respiration and airway obstruction [3]. Subsequent
hypoxia could require emergency airway and even tracheostomy [3].
Aim of our study was to determine the most common of airway
complications and their association with type of surgery in our
region.
Methods:
The retrospective cohort study included 400 pts., (369 women, 31
men) was performed in Odessa regional Hospital, Oncology Centre
Odessa. There were three types of patients: with euthyroid goiter -
170 (43%), polynodos goiter - 125(31%) and thyroid cancer - 105
(26%) (Table 1). Airway complications were diagnosed after trachea
extubation based on indirect laryngoscope, presence of stridor, de-
saturation. The Pearson’s criteria was calculated.
Results:
The ratio of airway complications after thyroid surgery was 9.7% (39
pts). The main reasons of airway complications in thyroid surgery in-
cluded: laryngeal edema - 22 pts (5.5%); recurrent laryngeal nerve
injury - 12 pts (3.0%) and postoperative bleeding 5 pts (1.2%).
Conclusions:
Thyroid gland cancer and polynodosal goiter associated with laryn-
geal edema and recurrent laryngeal nerve injury (Pearsen criteria
were 0.271 -moderate and 0.203 consequentially). It's may requiremore attention from the anesthetists after extubation and readiness
for an urgent airway.
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Introduction:
Recently there has been attention of researchers to the problem of
perioperative anemia. It was found that it increases the risk of death
and postoperative complications. Threatening complication is mul-
tiple organ dysfunction syndrome (MODS). The objective was to de-
termine the level of serum iron in the perioperative period in
patients with endoprosthetics of large joints, and with the presence
of MODS in abdominal surgery.
Methods:
A prospective cohort study was conducted in 77 patients, including 18
men and 59 women, age 61.9 ± 15.1 years. Two groups were identified:
1st (control) - patients after endoprosthetics of large joints (n = 40),
2nd (main) - patients in abdominal surgery with the presence of MODS
(n = 37). The presence of MODS was established based on the criteria
for the 2016 SCCM / ACCP Conference. Serum iron was monitored
using an AU 680 analyzer (USA). The study identified several stages: 1st
- before surgery, 2nd - 1st day after surgery, 3rd - 3rd day, 4th - 7th
day, 5th - 10th day.
Results:
When studying the indicators of serum iron, its significant decrease
(p <0.05) in the postoperative period was established. In the 1st
group: 1st stage - 15.2 (10-19.4) mmol / L, 2nd stage - 5.2 (3.9-7.6)
mmol / L, 3rd stage - 6.6 (5-8.7) μmol / L, stage 4 - 9.7 (8.6-12.1) μmol
/ L, stage 5 - 9.4 (7.8-11 9) μmol / L. In the 2nd group: 1st stage -
11.9 (10-15) mmol / L, 2nd stage - 3.7 (1.7-4.1) mmol / L, 3rd stage -
3, 6 (2.4-4.5) μmol / L, stage 4 - 6.5 (4.4-8.2) μmol / L, stage 5 - 7.6
(6.5-9 4) μmol / L. Moreover, in both groups, iron increased at the
4th stage against the 2nd stage (p <0.05). When comparing the level
of iron between the groups, significant differences were found (p <
0.05) at the 2nd, 3rd and 4th stages.
Conclusions:
In patients in the postoperative period, a decrease in serum iron is
observed, the level of which rises by the 7th day, but does not reach
the initial values. This decrease is more pronounced in patients with
the presence of MODS after abdominal surgery.
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Introduction:
Outcomes of simultaneous pancreas-kidney (SPK) transplantation
have been improved over the decades. The increasing success is a
result of improved surgical technique, better organ preservation, po-
tent immunosuppression therapy and effective use of antibiotics.
Nevertheless, morbidity and mortality following SPK transplantation
remain high, mainly owing to infection [1].
Methods:
Retrospective analysis of patients admitted for SPK transplantation
from 2013-2018 in an Intensive Care Unit (ICU). Immunosuppression
was done with thymoglobulin, tacrolimus, mycophenolic acid and
corticosteroids. Ceftazidime and fluconazole prophylaxis were given
for 7 days as well as valganciclovir and trimethoprim/sulfamethoxa-
zole. Infections were diagnosed by the presence of fever with clin-
ical findings that could not be attributed to other cause.
Microbiological samples were collected at admission and when suspi-
cion of infection was present.
Results:
Total of 90 patients were admitted to ICU after SPK transplant-
ation. Mean age 37.4±6.4 years. Donor’s mean age 34.6±11.6 years.
Kidney and pancreatic graft thrombosis happened in 5.6% and
18.9%, respectively, and bleeding in 21.1%. Forty-one (45.6%) devel-
oped at least one infection during hospital stay. Infection during ICU
was found in 13.3% and main pathogens were gram negative bacilli
sensible to beta-lactam. After ICU, the incidence of multi-drug resist-
ant pathogen was 13.5%, predominantly gram negative bacilli. Fun-
gal infection was lower 4%. All-cause hospital mortality rate was
5.6%.
Conclusions:
Infectious complications are the main cause of morbidity and mortal-
ity following SPK transplantation. The administration of broad-
spectrum prophylactic antibiotics are leading to the appearance
of multi-drug resistant pathogens. Knowing local microbiological
flora may be helpful, allowing more adequate antibiotic prophylaxis.
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Introduction:
Cardiopulmonary bypass (CPB) is associated with thrombotic compli-
cations. Occurrence of thrombosis after CPB is 12% which takes the
third place between CPB-associated complications. Our study deter-
mined preoperative predictors of thrombosis in children with con-
genital heart defects.
Methods:
138 patients with congenital heart diseases in age up to 11 months
29 days (median age - 4,7 months, youngest age – 2 days after birth,
oldest – 11 months 29 days), underwent cardiac surgery with CPB,
were enrolled in this study. All patients were divided into two
groups: 1st-without thrombosis, 2nd-with thrombosis. Protein C, D-
dimer, von Willebrand factor and Plasminogen plasma levels wereassessed directly before surgery. Thrombotic cases were proven by
performing doppler ultrasound or MRI.
Results:
Thrombotic complications were diagnosed in 30 children (21%). Be-
tween all thrombotic complications ischemic strokes were diagnosed
in 73% (22 cases), arterial thrombosis in 17 % (5 cases), intracardiac
thrombus in 7% (2 cases) and mechanical mitral prosthetic valve
thrombosis 3%(1). Receiver operating characteristic (ROC) curves are
created for the listed indicators. Area under the Curve (AUC) for Pro-
tein C 0,64 (Sensitivity(Sn)- 65%, Specificity(Sp) - 50%), D-dimer is
0,65 (Sn – 65%, Sp 50%), for Plasminogen activity - 0,62 (Sn 60%, Sp
40%) and for von Willebrand factor level - 0,64 (Sn 80%, Sp 55%). An
ROC curve was created for all three indicators, the AUC was 0.7 (Sn –
80%, Sp – 40%). These parameters can be recommended as predic-
tors of thrombosis in children after cardiac surgery.
Conclusions:
CPB is related with a large number of life-threatening complications.
In our work, preoperative predictors of thrombosis were identified.
Based on this data, it is possible to create thrombosis risk scale
change the tactics of the anaesthetic approach, the prevention of
thrombosis in the postoperative period. Further studies are needed
to identify other possible predictors of thrombosis.P154
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Introduction:
Abdominal ischemia occurs in 9% of patients submitted to aortic
aneurysm repair. Its early diagnosis requires an elevated index of sus-
piction, particularly in more severe patients. We hypothesized that
earlier increase and higher levels of C-reactive protein (CRP) may
help to predict intra-abdominal ischemia.
Methods:
We performed a retrospective study of patients admitted to the in-
tensive care department (ICD) after abdominal aorta aneurism sur-
gery. We included all patients admitted during a two-year period,
that survived for more than 48 hours. Primary outcome was splanch-
nic ischemia assessed by abdominal CT-scan. We also evaluated the
presence of bacteremia, abdominal compartment syndrome and ICD
mortality. Association between inflammatory parameters and ische-
mia was evaluated by multivariate logistic regression.
Results:
We included 88 patients (47 elective and 41 emergent) admitted to
the ICD after major abdominal vascular surgery. Mean age was 71.0
± 8.6 and 90% were male. Mean SAPS II value was 44.4 ± 20.6 and
admission SOFA 6.7 ± 4.5. CRP levels increased after surgery with
peak level at day 3 (26.01 ± 11.3 mg/dL). Suspicion of systemic infec-
tion occurred in 19 patients, but none of them had positive blood
cultures. Mesenteric ischemia was confirmed in 20 patients (23%); at
day 1, there was a higher CRP value in patients that developed ische-
mia (13.5±8.8mg/dL in ischemia group vs 8.1 ±5.1 mg/dL in non is-
chemia; p=0.004), as well as in day 3 (p=0.003). These differences
remained after adjustment for patient severity, with an OR=1.1 (1.0-
1.1; p=0.04). Of note, there were no association of CRP levels with
ICD mortality.
Conclusions:
In this retrospective study, patients submitted to abdominal aortic
surgery who developed mesenteric ischemia had an earlier and a
higher increase in CRP levels. Defining an algorithm for systemic in-
flammatory biomarkers levels could be useful for early identification
of ischemic complications, allowing for earlier diagnosis and
treatment.
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Introduction:
CRP (c-reactive protein) has been shown to be a useful biomarker in
identifying complications after major abdominal surgery. Gastrec-
tomy is a high-risk surgical procedure that requires post-operative
critical care support to monitor for complications which are predom-
inantly infective in nature. The aims of this study were to determine
whether there is a relationship between post-operative CRP levels
and patients who developed post-operative infective complications.
Methods:
A retrospective analysis was performed on patients undergoing elect-
ive gastrectomy for gastric cancer at a single centre between Sep-
tember 2011 and July 2016. Post-operative CRP levels for each day
following resection were analysed for all patients. ROC curve analysis
was used to determine which post-operative day (POD) gave the op-
timal cut-off.
Results:
Of 144 patients included, the majority were male (61.8%), mean age
was 68.5 years and 53.5% had node-negative disease. A total of 84
patients (58.3%) had an infective complication, which includes those
who experienced an anastomotic leak. CRP levels on post-operative
day 3 gave the greatest AUC for the gastrectomy group (0.765). CRP
cut-off of 220mg/L was significantly associated with infective compli-
cations (OR7.29, 95% CI 3.42-15.58, p= <0.001) and gave a sensitivity
of 70% and specificity 76% (PPV 67%, NPV 78%). More patients with
a CRP >220 on post-operative day 3 experienced an infective compli-
cation (67% vs 21%, p = <0.001) or a leak in particular (17% vs 6%, p
= 0.059).
Conclusions:
A CRP level of less than 220 mg/L on POD3 may be useful to predict
the development or exclude the likelihood of such infective compli-
cations in this group of patients prior to clinical signs (PPV 67%, NPV
78%). This may prompt and facilitate decision-making regarding early
investigation and intervention or prevent inappropriate early dis-
charge from critical care, whilst providing more assurance in identify-
ing those who could be stepped down to ward level care.P156
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Introduction:
Vasoplegia is commonly observed after cardiopulmonary bypass sur-
gery (CPB) and associated with high mortality. Chronic use of renin-
angiotensin aldosterone system inhibitors (RAASi) is associated with
its incidence and ensuing need for vasopressor support after CPB.
Renin serves as marker of tissue perfusion [1]. We examined the role
of renin in the setting of RAASi exposure and vasopressor needs in
the peri-CPB period.Methods:
Prospective observational study of 31 adult patients undergoing CPB,
aged 66.0±10.5 years (22 men, 9 women). Blood was collected 1)
post induction, pre-CPB; 2) 30 min post cardioplegia, and 3) immedi-
ately post bypass. Vital signs and perioperative medications were re-
corded. As control, blood was collected from 5 men and 4 women
aged 53.5 ±10.7, not diagnosed with lung disease and not prescribed
any RAASi.
Results:
Baseline plasma renin in CPB patients tended to be higher than in
control subjects (mean=38.5pg/ml±9.2 vs. 17.1 pg/ml ± 3.5, respect-
ively, p=0.670). 30 minutes into CPB, mean renin was increased from
baseline (77.6 pg/ml±17.5, p=0.211), and remained elevated immedi-
ately post CPB (74.6 pg/ml±19.1). Patients using RAASi prior to CPB
tended to have a larger increase in renin post CPB (delta=55.3 pg/
ml±30.9) vs. those not previously on RAASi (26.9 pg/ml±9.5, p=
0.092). Renin was elevated in patients requiring vasopressor support
in the 24 hours post CPB vs. those not requiring pressors (41.4 pg/
ml±15.7 vs. 25.1 pg/ml±16.1 p=0.0246). In those prescribed RAASi
and requiring pressors post CPB, there was a tendency toward
greater renin increase than those not requiring pressors postopera-
tively (49.9 pg/ml±49.7 vs. 8.5 pg/ml±3.9, p=0.036).
Conclusions:
This study suggests a trend toward higher renin levels, particularly
during CPB, in patients prescribed RAASi, and a positive association
between renin and postoperative vasopressor needs. We speculate
that increased renin levels may predict postoperative vasoplegia.
References:
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Introduction:
Cardiac surgery is associated with perioperative blood loss and a
high risk of allogenic blood transfusion. It has been recognized that
high blood product transfusion requirement is associated with ad-
verse clinical outcomes.1 Guidelines on patient blood management
therefor aim at reducing blood loss and blood transfusion require-
ments in cardiac surgery.2 As there remains controversy about the
advantage of minimal invasive techniques on blood loss an transfu-
sion requirements,2 we wanted to investigate if the average blood
loss and transfusion requirement in minimal invasive endoscopic cor-
onary artery bypass graft surgery (endo-CABG) differ from conven-
tional technique. We assessed the influence of pre-operative
anticoagulant medication for blood loss. Estimated average blood
loss after conventional CABG3 is 400ml (+/-200) and transfusion re-
quirement 3,4 units packed red blood cells4.
Methods:
We performed a retrospective cohort study of our cardiac surgical
database. From 01/01/2016 to 31/12/2017, we collected data from
423 patients undergoing endo-CABG. We analyzed blood loss, trans-
fusion as well as pre-operative use of anti-coagulants as a risk factor
for blood loss.
Results:
We found that mean total blood loss in endo-CABG does not differ
from conventional CABG, nonetheless mean transfusion requirement
was lower in our cohort. Use of direct oral anticoagulant is aossciated
with increased blood loss and transfusion requirements (Table 1).
Conclusions:
Total blood loss is not influenced by minimal invasive technique for
CABG (endo-CABG). An explanation for the lower transfusion require-
ments is the use of a minimal extracorporeal circulation, which is
known to reduce the risk of transfusion. Another important factor is
Critical Care 2020, 24(Suppl 1):87 Page 62 of 213the implementation of a standardized transfusion-protocol based on
available evidence. Reducing transfusion requirements is an import-
ant component in improving patient outcome after cardiac surgery
and is related to multiple factors in perioperative care of our
patients.Table 1 (abstract P157). Use of pre-operative anti-coagulant
medication
Total transfusion
(blood) (units)
Total blood loss
(ml)
Total group (n=
423)
0.7 ± 3.07 0 (0, 0) 428.2 ± 343.3 314.5
(247.8, 499.3)
Use of pre-
operative
medication
Number of
patients (%)
Blood loss (ml) Total transfusion
blood (units)
No pre-operative
treatment
46 (10.8%) 480.8 ± 449.9 354
(257.5, 540)
1.62 ± 7.8 0 (0, 0)
NOAC 24 (5.6%) 542 ±435.6 343.5
(250, 671.5)
2.62 ± 5.64 0 (0,
3)
ASA 346 (81.7%) 424.8 ±336.8 306.5
(247, 492.8)
0.60 ± 1.85 0 (0,
0)
API 107 (25.9%) 411.6 ± 309.6 295
(244, 523)
0.89 ± 1.58 0 (0,
1.25)
ASA + API 89 (21 %) 426.2 ± 334.1 300
(244.5, 530.5)
0.97 ± 1.56 0 (0,
2)P158
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Introduction:
Retinal perfusion corresponds to cerebral perfusion and it is very sen-
sitive to hemodynamic disturbances [1, 2]. We investigated the asso-
ciation between retinal microvascular damage and hemodynamic
characteristics in patients undergoing coronary artery bypass grafting
surgery (CABG) with cardiopulmonary bypass (CPB).
Methods:
10 patients with coronary artery disease and systemic hypertension
were examined. Ophthalmoscopy and optical coherence tomography
were performed before and 10-14 days after CABG. The hemodynamic
parameters during CPB were analyzed.
Results:
4 (40%) patients had changes in the retinal vessels and in the gangli-
onic fiber structure on 10-14 day after surgery: in 30% of patients the
foci of ischemic retinal oedema appeared, in 10% the decrease of
the thickness of ganglionic fiber were observed. These changes may
be associated with intraoperative ischemia of the central retinal ar-
tery. In 6 (60%) patients the mean arterial pressure (MAP) during CPB
was increased up to 90 mmHg. In 4 (67%) of them the association
between MAP and foci of ischemic retinal oedema were revealed.
The ischemic retinal changes were observed significantly more often
if the delta of MAP during CPB was over then 20 mm Hg compared
with the patients where the delta of MAP was less than 20 mm Hg
(p=0.035). This is probably due to an intraoperative disorders of themyogenic mechanism of blood flow autoregulation in the retinal mi-
crovasculature in patients with coronary artery disease [3].
Conclusions:
The level of MAP up to 90 mm Hg during CPB is associated with retinal
blood flow impairment and the foci of ischemic retinal oedema. Delta of
MAP more than 20 mmHg was associated with the foci of ischemic retinal
oedema and decreased ganglionic fiber thickness in 67% of cases.
References:
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Introduction:
Atrial fibrillation after cardiac surgery (AFACS) is a very frequent com-
plication affecting 30-50% of all patients. It is associated with an in-
crease in morbidity, mortality and hospital and intensive care unit
(ICU) length of stay. We aimed to implement an AFACS prevention
care bundle based on a recently published practice advisory [1], fo-
cusing on early postoperative (re)introduction of β-blockers.
Methods:
Baseline AFACS incidence and β-blocker administration practices in
our centre were audited for all patients undergoing valve surgery or
coronary artery bypass graft (CABG) during a 6 weeks period. The
AFACS prevention care bundle – an easy to follow graphical tool –
was subsequently introduced to the cardiac ICU by a multidisciplin-
ary team and audited following a model of improvement approach.
After exclusion of patients with preoperative AF, differences between
pre- and post-implementation groups were compared with Chi-
square and Fisher’s exact tests for categorical, and One-way ANOVA
for continuous variables, using SPSS.
Results:
A total of 384 patients were analysed. Patient and surgery character-
istics did not differ between groups. Significantly more patients re-
ceived postoperative β-blockers after bundle implementation (82.7%
pre- vs 91.3% post-bundle, p=0.019) with a higher proportion on day
1 (36.7% pre- vs 67% post-bundle, p<0.001, Figure 1). The incidence
of AFACS was significantly reduced from 35.4% to 23.3% (p=0.009),
with a particularly marked reduction in the age group 65-75 years
and for isolated aortic valve and CABG surgery. There was no signifi-
cant reduction in hospital length of stay for this cohort.
Conclusions:
Introduction of an AFACS prevention care bundle using a graphical
tool improved adherence to current guidelines with regards to early
β-blocker administration and significantly reduced AFACS incidence.
Future care bundles should include preoperative interventions and
might reduce hospital length of stay.
References:
1. O'Brien B et al. J Cardiothorac Vasc Anesth 33:12-26, 2019
Fig. 1 (abstract P159). Timing of beta-blocker (re)initiation versus
incidence of AFACS before and after prevention care bundle
implementation, per post-operative day and for postoperative days
1-5 (insets)
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Introduction:
In neonates with univentricular physiology, there is a delicate bal-
ance between pulmonary and systemic circulations, with a tendency
towards generous pulmonary blood flow, and a risk of systemic
underperfusion. Preoperatively, the use of hypoxic gas mixture
(HM) has been advocated as a therapy to increase PVR, with the aim
of improving systemic oxygen delivery. It is a therapy which has
been routinely initiated in our institution in the setting of signs of
pulmonary overcirculation.
Methods:
We performed a retrospective analysis of all patients in our institu-
tion who underwent a Norwood procedure and who received HM
preoperatively. We compared peripheral saturations, arterial blood
gas analysis, serum lactate, regional cerebral and renal saturations
and invasive blood pressure, prior to, and then 4,8 and 24 hours after
HM was commenced.
Results:
Between 2014 and 2018 (inclusive), 49 patients underwent the Nor-
wood procedure. 18 patients received preoperative HM. Average
FiO2 was 17% during administration of HM. Average peripheral satu-
rations were 96.1% prior to HM, and dropped to 87.4% at 4 hours,
and 88% at 8 and 24 hours after initiation (p < 0.05). There was no
change in any of the measured markers of systemic oxygen delivery,
including regional cerebral and renal saturations, lactate, urine out-
put or blood pressure. There was an association between an ex-
tended period of HM (> 48 hours) and the need for pulmonary
vasodilator therapy post Norwood procedure.
Conclusions:
Hypoxic gas mixture in patients with parallel systemic and pulmonary
cicrculations causes desaturation and hypoxia. It does not lead toan increase in systemic perfusion and thus an improvement in sys-
temic oxygen delivery. Its ongoing use in this fragile population
should be considered.
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Introduction:
Analgesia in the critical patient, and especially in the neurocritical pa-
tient, is a basic goal in all therapeutic practices. Patients in the ICU
are frequently administered prolonged and/or high doses of opioids.
Multiple serious complications due to the use of infusion of opioids
at large doses has been described. To reduce high doses of intraven-
ous opioids, multimodal forms of analgesia can be used.
Methods:
Prospective observational study of the use of tapentadol enteral and
buprenorphine in transdermal patches, at low doses, for the control of
pain and its effect on reducing the use of fentanyl infusion in high
doses on 84 patients admitted to Neuro ICU of INDISA Clinic during 2
consecutive years (2018-19). Enteral tapentadol (through NG tube) 50
mg/6 hours, was considered in patients who required intravenous fen-
tanyl in continuous administration. Buprenorphine was also added at
low doses (5 ug/hr) in a weekly transdermal patch, in cases of neurosur-
gical spine patients, fractures and long-term neuropathic pain. Pain was
controlled on Behavioral Pain Scale (BPS) and Visual Analogical Scale
(VAS) scores, according to the conditions of each patient. Their
hemodynamic, gastrointestinal complications and the appearance of
delirium episodes according to CAM-ICU scale were recorded.
Results:
84 patients received tapentadol. 32 of them also received transder-
mal buprenorphine. All managed to maintain adequate level of anal-
gesia, not requiring fentanyl at doses greater than 0.5 ug / kg / hr.
Distribution by diagnoses: neurotrauma 21 patients, Guillain Barre 12,
spine surgery 15, HSA 18, HICE 10, malignant ischemic ACV 8. Com-
plications: gastric retention 12 patients (7%), hypotension 1 (1%),
acute hypoactive delirium 3 (3.5%), acute hyperactive delirium 8
(9%). No drug interactions were found.
Conclusions:
The introduction of enteral tapentadol and buprenorphine patches in
neurocritical patients was safe and resulted in a decrease in the use
of endovenous opioids and its adverse effects.
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Introduction:
We hypothesized that changing the pain management for our post car-
diac surgical patients to an assessment-driven, protocol-based ap-
proach using fast acting and easily titratable agents will significantly
improve patient satisfaction by reducing pain intensity in the first 24h
after surgery as suggested by Society of Critical Care [1] guideline.
Methods:
We prospectively assessed 101 and 99 (05.2018 vs 06.2019) consecu-
tive patients before and after introducing our pain management
protocol. The nursing and medical team received rigorous training
on the guideline as well as the correct assessment using appropriate
pain scores measured at least hourly (Numeric Pain Score, ≥ 2 is
Critical Care 2020, 24(Suppl 1):87 Page 64 of 213moderate to severe or Critical Care Observation Tool, > 2 is moderate
to severe). We introduced a multimodal approach with a combin-
ation of fast acting iv, long acting oral opiates, regular paracetamol
and rescue iv boluses for difficult to control situations and we cre-
ated a prescription bundle on our electronic prescribing record.
Among other variables we assessed hours spent in moderate to se-
vere pain in the first 24h after surgery and compared to the data col-
lected before the guideline was introduced.
Results:
We analysed 101 patients from 2018 and 99 from 2019. Baseline
characteristics were similar between the two groups. In 2018 only
41.6% of the patients spent less than 5 hours and 29.4% spend more
than 10 hours in moderate to severe pain. The 2019 data showed
significant improvement in that 79.5% of patients spent less than 5
hours and only 5% patients who spent more than 10 hours in mod-
erate or severe pain. (p <0.0001, Chi Square) (Figure 1). Only 9% of
the patient needed rescue medications. 3% of time was the protocol
inadequate necessitating other approach.
Conclusions:
Introducing an assessment driven, stepwise, protocolized pain man-
agement significantly improved patient satisfaction by reducing pain
intensity in the first 24h on our Cardiothoracic Intensive Care Unit.
References:
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Introduction:
Proximal femur fractures are most common fractures in the elderly
and associated with significant mortality and morbidity, with high
economic and social impact. Perioperative pain management influ-
ence outcomes and mortality after surgery with early mobilizationbeing possible [1, 2]. The goal of the study was to compare the effi-
cacy and safety of the compartment psoas block for perioperative
analgesia in elderly patients with proximal femur fractures.
Methods:
The randomized controlled study was held in medical center "Into-
Sana" (Odesa, Ukraine) from January 2018 till July 2019. Patients with
proximal femur fractures and older than 60 years were included in
the study. They were randomly allocated to 2 groups – compartment
psoas block group (bupivacaine analgesia was started as soon as
possible before surgery and prolonged during and after surgery with
additional ischiadicus block before surgery) and general (inhalational)
anesthesia with systemic analgesia perioperatively.
Results:
60 patients were included in this study. Perioperative compartment
psoas block was associated better pain control, decreased opioid
consumption, better sleep quality, earlier mobilization after surgery,
decreased incidence of opioid-associated vomiting/nausea and myo-
cardial injury. There were no difference in the incidence of hospital
acquired pneumonia and delirium.
Conclusions:
Perioperative compartment psoas block is effective and safe for peri-
operative analgesia in elderly patients with proximal femur fractures,
and is associated with better pain control and decreased complica-
tions incidence.
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Introduction:
Parenteral olanzapine is frequently used in combination with paren-
teral benzodiazepines for hospitalized patients with severe agitation.
The FDA issued a warning for increased risk of excessive sedation
and cardiorespiratory depression with this combination based on
post-marketing case reports with overall limited quality of evidence
[1]. The purpose of this study is to evaluate the safety and efficacy of
concomitant parenteral olanzapine and benzodiazepine for agitation.
Methods:
This retrospective chart review evaluated agitated patients who re-
ceived concomitant parenteral olanzapine and benzodiazepine
within 60 minutes from 1/31/2016 to 9/1/2019 . The primary end
points were rate of respiratory depression requiring mechanical ven-
tilation and hypotension requiring vasopressors. The secondary end
points were percentage of patients requiring additional sedatives for
agitation during the same time frame, cumulative dose of olanzapine
and benzodiazepine (midazolam equivalent) received, and rate of
cardiac arrest and death.
Results:
A total of 208 patients were included with notable baseline charac-
teristics: median age of 35 years old, 59% with a history of substance
abuse, and 40% with a history of psychiatric illness. For the primary
outcomes, 2.9% of patients required mechanical ventilation and 0%
required vasopressors. Additionally, 27.9% patients received
Critical Care 2020, 24(Suppl 1):87 Page 65 of 213additional sedating agents to control agitation. Refer to Table 1 for
more details. No cardiac arrests or deaths were observed.
Conclusions:
Concomitant use of parenteral olanzapine and benzodiazepine
within 60 minutes for the treatment of agitation appears to have a
small risk of respiratory depression without significant hypotension.
References:
1. Marder SR et al. J Clin Psychiatry 71:433-41, 2015Table 1 (abstract P164). Results
Primary Outcomes Initial Post Difference
SBP, median (IQR), mm Hg 130 (119-
145)
125 (109-
136)
-5
Vasopressor support – 0/208 (0%) –
Mechanical ventilation for respiratory
depression
– 6/208 (2.9%) –
Secondary Outcomes
Olanzapine, mean, mg – 11.8 –
Midazolam equivalent, median (IQR), mg – 5 (4-5) – Fig. 1 (abstract P165). ResultsP165
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Introduction:
Hip fracture is very common in the elderly,it causes moderate to se-
vere pain often undertreated. FICB is a simple safe method, easy to
learn and use. The aim of our study is to assess the efficacy and
safety of preoperative FICB compared with intravenous analgesia for
elderly patients with femoral fracture and hip surgery in terms of opi-
oid consumption and perioperative morbidity
Methods:
After informed consent obtained,54 patients 50-98 yo ASA I-III with hip frac-
ture were randomized to receive either an US guided FICB(40 ml of ropiva-
caine 0,35%) or a sham injection with normal saline 30' before surgery.
Both groups were operated under general anesthesia. Postoperative anal-
gesia was done according to VAS: VAS 0-30 mm, paracetamol 1g iv at 8 h,
VAS 30-60 mm, ketoprofen 100 mg iv at 8 h, VAS>60, morphine 0,1mg/
kgBW iv. The primary outcome was the comparison of VAS score at rest
over the first 30'following the procedure, at the end of the surgery and at
6h intervals for 24h. The secondary outcome were the incidence of the car-
diovascular events, of the PONV and of the confusion episodes, the amount
of morphine consumption for 24h
Results:
At baseline, FICB group (A) had a lower mean pain score than the sham in-
jection group (B). The same difference was observed over 24 h of follow-up
(p<0.05). There was a significant difference between the two groups in total
cumulative iv morphine consumption at 24 h and in the incidence of PONV
and confusion episodes (Figure 1).Conclusions:
FICB provides effective analgesia for elderly patients suffering from hip frac-
tures, with lower morbidity and lower opioid consumption compared with
intravenous analgesia.P166
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Introduction:
Pain and suffering controversies in DOC to be debated by the scien-
tific, legal and medical ethics communities.
Methods:
ANI (anti nociception index) monitor was used to assess pain in pa-
tients with chronic disordersof consciousness (DOC) age range 22 to
56 years - 9 in vegetative state/ unresponsive wakefulness syndrome
(VS/UWS) and 20 minimal consciousness state (MCS). Average age:
in MCS group 31,8±11,29 and 42,1±8,46 in VS/UWS group. Neuro-
logical status was assessed using CRS-R scale. The average score on
the CRS-R scale was 5±1.4 in VS/UWS and 10.45±4.5 in MCS. Pressure
on the nail phalanx was used as a pain impulse. ANI and Nociception
coma scale was evaluated before the application of pain stimulus,
immediately after and past 30 minutes. Prolactin level was measured
before the pain stimulus application and 10 minutes after. ANI less
than 50 indicates pain, 70-100 hypoalgesia, 30 severe pain.
Results:
The mean value of the ANI in MCS patients: before the pain stimulus
66.25±14.11, after the pain stimulus application 45±16.12 and 30 mi-
nutes later 66.55±18.13. Prolactin level in MCS patients before pain
13.01±9.06 ng/ml; after pain 13.75±8.73 ng/ml (p>0.05). Prolactin in
VS/UWS patients before pain 10.79±7.2 ng /ml, after pain 14.5 ±8.88
ng / ml (p> 0.05).
Conclusions:
ANI monitor revealed that VS/UWS and MCS patients react equally to
the pain impulse. Prolactin dynamics showed poor statistical mean
and can not be consider as a marker of nociception in this group of
patients. It is possible that the level of pain impulse was insufficient
neuroendocrine response activation or the increase of prolactin level
occurs in the long term (more than 10 minutes). In all patients the
Critical Care 2020, 24(Suppl 1):87 Page 66 of 213basal level of the ANI index was above 66.25, which indicates ab-
sence of pronounced pain sensations at rest, but medical manipula-
tions, physical therapy, can deliver pain.
Acknowledgement: The reported study was funded by RFBR project num-
ber 19-29-01066/2019Fig. 1 (abstract P167). Mean arterial pressure in the first 48 hours
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Introduction:
Septic shock can result in catecholamine hyposensitivity, leading to
hemodynamic instability and death. Experimental data suggest that
central alpha2-agonists like dexmedetomidine (DEX) increase vaso-
pressor responsiveness and reduce catecholamine requirements in
septic shock [1]. However, because it can cause hypotension and
bradycardia, clinicians may be reluctant to use DEX in such patients.
Methods:
In this cohort study of the Sedation Practices in Intensive Care Evalu-
ation (SPICE III) trial, an international randomized trial comparing sed-
ation with DEX to usual care, we studied critically ill patients with
septic shock admitted to the Austin Hospital, Melbourne, Australia,
and the University Hospital of Bern, Switzerland. The primary out-
come was mean noradrenaline requirements in the first 48 hours.
Results:
Between November 2013 and February 2018, 417 patients were re-
cruited into the SPICE III trial at both sites. Eighty-three patients with
septic shock were included in this sub-study, of whom 44 (53%) re-
ceived DEX and 39 (47%) usual care. Mean noradrenaline dose dur-
ing the first 48 hours was 0.03 [0.01, 0.07] μg/kg/min in the DEX
group and 0.05 [0.01, 0.15] μg/kg/min in the usual care group (p=
0.08). Over the first 48 hours, patients in the DEX group had higher
mean arterial pressures (MAP) (Figure 1) and lower vasopressor re-
quirements to maintain the target MAP (expressed by the noradren-
aline equivalents to MAP ratio: NEq/MAP) compared to the usual
care group (ratio of adjusted difference in geometric means 1.4 [1.1,
1.9], p=0.02).
Conclusions:
In critically ill patients with septic shock, sedation with DEX does not
increase noradrenaline requirements in the first 48 hours as com-
pared to usual care. In contrast, DEX appears to be associated with
lower vasopressor requirements to maintain the target MAP.
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Introduction:
Total hip arthroplasty THA is one of the most common major surgical
procedures associated with significant postoperative pain that can
adversely affect patient recovery and could increase morbidity. Ef-
fective perioperative pain management allows an accelerated re-
habilitation and improve the functional status of these patients.
Multimodal analgesia MMA combines analgesics with different mech-
anism of action which by synergistic and additive effects enhance
postoperative pain management and reduce complications. The aim
of our study is to assess if perioperative association of very low dose
of ketamine, a potent NMDA antagonist and dexamethasone, by anti-
emetic and antiinflammatory properties could decrease opioid con-
sumption and postoperative morbidity of patients with THA.
Methods:
After informed consent, 58 patients scheduled for primary hip joint
replacement surgery aged 55-91 yo ASA I-III were prospective ran-
domized in two groups. Both groups were operated under general
anesthesia fentanyl/sevoflurane. Supplementary, patients in group A
received 12 mg iv dexamethasone and 8mg at 12 h and ketamine 10
mg iv bolus at induction and 10mg/h iv during surgery. Postopera-
tive analgesia was done according to VAS, 0-30 mm paracetamol 1 g
iv at 8 h, 30-60 mm ketoprofen 100 mg iv at 12h, VAS>60 mm mor-
hine 0,1 mg/kgBW iv. We recorded perioperative opioid consump-
tion, the number of intraoperative cardiac events, VAS score at the
end of surgery and at 24 h, the incidence of PONV and persistance
of chronic pain at 3 months.
Results:
We obtain a significant less pain score at the end of surgery p<0.05
in group A, no significant difference at 24 h, a significant less chronic
pain at 3 months, a fewer NPVO and cardiovascular events in group
A, p<0.05 (Figure 1).
Critical Care 2020, 24(Suppl 1):87 Page 67 of 213Conclusions:
A multimodal approach with very low doses of ketamine and dexa-
methasone could be efficent in the treatment of pain for elderly pa-
tients with hip arthroplasty, decreasing postoperative side-effects
and reducing chronic pain persistance.Fig. 1 (abstract P168). ResultsP169
Analgesia usage in ICU survivors
P Mactavish1, C Pudrie2, M Shaw3, P Henderson2, H Devine4, T Quasim5,
J Iwashyna6, J McPeake4
1Glasgow Royal Infirmary, Pharmacy, Glasgow, United Kingdom;
2University of Glasgow, School of Medicine, Dentistry and Nursing,
Glasgow, United Kingdom; 3NHS Greater Glasgow and Clyde, Clinicial
Physics, Glasgow, United Kingdom; 4Glasgow Royal Infirmary, Intensive
Care Unit, Glasgow, United Kingdom; 5University of Glasgow, School of
Dentistry and Nursing, University of Glasgow, Glasgow, United Kingdom;
6VA Ann Arbor Health System, Centre for Clinical Management Research,
Ann Arbor Michigan, United States
Critical Care 2020, 24(Suppl 1):P169
Introduction:
Treatment in an Intensive Care Unit (ICU) often necessitates uncom-
fortable and painful procedures for patients. Chronic pain is becom-
ing increasingly recognized as a long term problem for patients
following an ICU admission [1]. Throughout their admission patients
are often exposed to high levels of opioids, however there is limited
information available regarding analgesic prescribing in the post-ICU
period. This study sought to examine the analgesic usage of ICU sur-
vivors pre and post ICU admission.
Methods:
183 patients enrolled in a post-intensive care programme between
September 2016 and June 2018. Intensive Care Syndrome: Promoting
Independence and Return to Employment (InS:PIRE), is a 5-week mul-
ticentre, multidisciplinary rehabilitation programme for ICU survivors
and their caregivers. Patients’ level of analgesia was recorded pre-admission and upon attending InS:PIRE, their level of prescribed anal-
gesia was categorized using the Word Health Organisation (WHO) an-
algesic ladder [2].
Results:
33.3% of patients (n=61) were prescribed regular analgesia pre-
admission; this increased to 60.7% (n=111) post-admission, repre-
senting a significant absolute increase of 27.4% (95% CI: 20.2% -
34.4%, p<0.001) in the proportion of patients who were prescribed
regular analgesia pre and post ICU. In addition, pre-admission, 22.4%
(n=41) of patients were prescribed a regular opioid (step 2 and 3 of
the WHO ladder) compared to 38.7% (n=71) post-admission, repre-
senting an absolute increase of 16.3% (95% CI: 9.8% -22.8%, p<
0.001).
Conclusions:
This study found a significant increase in analgesic usage including
opioids in ICU survivors. Follow-up of this patient group is essential
to review analgesic prescribing and to ensure a long term plan for
pain management is in place.
References:
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P170
Impact of a multifaceted and multidisciplinary intervention on
pain, agitation, and delirium management in a Canadian
community ICU: a quality improvement study
Z Ma1, M Carmargo Penuela2, M Law2, HO Chung3, J Tsang3
1McMaster University, NIagara Regional Campus, Michael G. DeGroote
School of Medicine, St. Catharines, Canada; 2Brock University,
Department of Health Science, St. Catharines, Canada; 3McMaster
University, Division of Critical Care, Hamilton, Canada
Critical Care 2020, 24(Suppl 1):P170
Introduction:
Pain, agitation, and delirium (PAD) are commonly encountered b pa-
tients in the Intensive Care Unit (ICU). Delirium is associated with ad-
verse outcomes, including increased mortality and morbidity. Clinical
guidelines suggest that routine assessment, treatment and preven-
tion of PAD is essential to improving patient outcomes. Despite the
well-established improvements on patient outcomes, adherence to
clinical guidelines is poor in community hospitals. The aim of this
quality improvement project is to evaluate the impact of a multifa-
ceted and multidisciplinary intervention on PAD management in a
Canadian community ICU.
Methods:
A PAD advisory committee was formed and involved in the develop-
ment and implementation of the intervention. The 4-week intervention
targeted nurses (educational modules, visual reminders), family mem-
bers (interviews, educational pamphlet, educational video), physicians
(multidisciplinary round script), and the multidisciplinary team (poster).
An uncontrolled, before-and-after study methodology was used. Adher-
ence to PAD guidelines in the assessment of PAD by nurses was mea-
sured 6 weeks pre-intervention and 6 weeks post-intervention.
Results:
Data on 430 patient-days (PD) and 406 PD were available for analysis
during the pre- and post-intervention, respectively. The intervention
significantly improved the proportion of PD with assessment of pain
and agitation at least 4 times per 12-hour shift from 68.0% to 87.5%
and from 69.7% to 82.2%, respectively (Figure 1). Proportion of PD
with delirium assessment at least once per 12-hour shift did not sig-
nificantly improve.
Critical Care 2020, 24(Suppl 1):87 Page 68 of 213Conclusions:
A multifaceted and multidisciplinary PAD intervention is feasible and
can improve adherence to PAD assessment guidelines in community
ICUs. Quality improvement methods that involve front-line staff can
be an effective way to engage staff with PAD.Fig. 1 (abstract P170). Pre-intervention and post-intervention PAD
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Introduction:
Sedation is a significant part of medical treatment in ICU patients. A
too deep sedation is associated with a longer time of mechanical
ventilation, lung injury, infections, neuromuscular disease and delir-
ium, which can lead to a longer duration of ICU hospitalization, as
well as an increase of morbility and mortality. Many patients spend a
considerable amount of time in a non-optimal sedation level. A con-
tinuous monitoring system of the sedation level is therefore neces-
sary to improve clinical evaluation.
Methods:
Our goal was to evaluate the incidence of non-optimal sedation (under and
over sedation) comparing the parameters expressed from NGSedLine with
clinical evaluations and to correlate oversedation and the incidence of delir-
ium. We have studied a cohort of patients admitted to the ICU of Spedali
Civili of Brescia University Hospital requiring continuous sedation for more
than 12 hours. In addition to standard monitoring, the patients have been
studied using Next Generation Sedline (Masimo). Sedation depth was evalu-
ated through RASS scale and the presence of delirium was evaluated with
CAM-ICU scale.
Results:
We collected data from 50 adult patients. Our data showed high inci-
dence of oversedation. 45 of our 50 patients had a SR>2 and 48 had
a PSI level<30. A logistic regression analysis was performed and it
showed statistically significant association between incidence of de-
lirium and the age of the patients (p 0.009). The association between
delirium incidence and Suppression Rate time was at the limits of
statistics significance (p 0.059) and was statistically significant for non
neurocritical patients (p 0.049). Our study didn’t show an association
between delirium and the total time of sedation.
Conclusions:
Non-optimal sedation is an unsolved problem in ICU, affecting lot of
patients, with a major incidence of over-sedation compared to
under-sedation. Our study shows an association between SR levels
and the incidence of delirium.P172
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Introduction:
Delirium is a common complication on intensive care units. Data on inci-
dence and especially on predictors of delirium in patients after acute myo-
cardial infarction (MI) are rare. By analyzing all patients after acute MI, we
aim to identify incidence and potential risk factors for delirium.
Methods:
In this retrospective study, all patients hospitalized for acute MI treated with
coronary angiography in an university hospital in 2018 were included and
analyzed. Incidence of Delirium within the first 5 days of care attributed to
the MI and was defined by a NuDesc Score ≥2, which is taken as part of
daily care three times a day by especially trained nurses. This research is au-
thorized by ethics committee file number 387/19.
Results:
626 patients with acute MI (age 68.5±13.3 years, 260 STEMI, mortality
3.4%) were analyzed. Delirium occurred in 70 (11.2%) patients and
was associated with a longer hospital stay (12±15.9d vs 5.5±4.3d, p<
0.001). Patients with delirium were significantly older than patients
without (76.3±11.14 vs. 67.5±13.10 years, p<0.001) and had more
often preexisting neurological diseases (24.3% vs. 10.8%, p<0.001)
and dementia (11.4% vs. 1.4%, p<0,001). Multivariate logistic regres-
sion analysis suggested that odds ratio for delirium was higher in pa-
tients after resuscitation OR 7.5 (95% CI 2.1-26.7), preexisting
dementia OR 28.9 (CI 3.1-268) and in patients with alcohol abuse OR
18 (CI 2.7-120). While maximum lactate was also connected to delir-
ium OR 1.4 (CI 1.1-1.9), infarct size or type had no effect on the inci-
dence of delirium.
Conclusions:
In patients with MI, delirium is frequent. Incidence is associated with
clinical instability and preexisting neurological diseases rather than
infarct size.
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Introduction:
Delirium in the critically ill patients is common and distressing. The
incidence of delirium in the ICU ranges from 45% to 87%. Although
delirium is highly common among intensive care patients, it is mostly
underreported. To date, there have been limited data available re-
lated to prevalence of delirium in surgical patients. In a study pub-
lished in 2008, the risk was observed 73% in surgical and trauma
patients [1]. The purpose of this study was to find out the incidence
and associated risk factors of delirium in surgical ICU (SICU) of a ter-
tiary care hospital.
Methods:
We conducted prospective observational study in patients with age
more than 18 years and who were admitted to the surgical ICU for
more than 24 hours in Aga Khan University Hospital from January
2016 to December 2016. Patients who had preexisting cognitive dys-
function or admitted to ICU for less than 24 hours were excluded.
Delirium was assessed by Intensive Care Delirium Screening Checklist
ICDSC. Incidence of delirium was computed and univariate and multi-
variable analyses were performed to observe the relationship be-
tween outcome and associated factors.
Results:
Delirium was observed in 19 of 87 patients with an incidence rate of
21.8%. Multivariable analysis showed that COPD, pain >4 and
Critical Care 2020, 24(Suppl 1):87 Page 69 of 213hypernatremia were strong predictors of delirium. Midazolam [aOR=
7.37; 95%CI: 2.04-26.61] and Propofol exposure [aOR=7.02; 95%CI:
1.92-25.76] were also the strongest independent predictors of delir-
ium while analgesics exposures was not statistically significant to pre-
dict delirium in multivariable analysis.
Conclusions:
Delirium is significant risk factor of poor outcome in surgical inten-
sive care unit. . There was an independent association between pain,
sedation, COPD, hypernatremia and fever in developing delirium
References:
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Introduction:
Delirium is an acute mental syndrome which may cause negative
consequences if it is misdiagnosed [1,2]. The aim of this study was to
determine the incidence of delirium in different intensive care units
and reveal the risk factors.
Methods:
The study was performed with 212 patients hospitalized in intensive
care units of anesthesia, neurology and general surgery departments.
Written informed consent was obstained from patients or relatives.
Delirium screening test was performed twice daily with CAMICU
(Confusion Assessment Method for the ICU). Patients who met the
study criterias, were evaluated for the possible risk factors of delirium
and the data was recorded daily. Patients were reevaluated after the
treatment.
Results:
The incidence of delirium was 32.5%. Delirium was found to increase
with the length of stay (p <0.001). The mean age of the patients with
delirium was 67.46. this was higher than the patients without delir-
ium (52.48) (p<0.001). Visual impairment (p<0.001), hearing impair-
ment (p=0.001), educational status (p=0.024), hypertension (p=0.002),
mechanical ventilation (p = 0.001), oxygen demand (p=0.002), mid-
azolam infusion (p=0.025), propofol infusion (p=0.042), infection (p <
0.001), SOFA (p = 0.001), APACHE II (p <0.001), nasogastric catheter
(p=0.012), aspiration (p <0.001), number of aspirations (p<0.001), en-
teral nutrition (p<0.025), albumin (p=0.025), steroid (p=0.024), hyper-
carbia (p=0.039) hypoxia (p=0.039), sleep disturbance (p<0.001) were
found risk factors for delirium. Oral nutrition (p<0.001) and
mobilization (p=0.003) were found to prevent delirium development.
Conclusions:
Various factors are important in the development of delirium. These
risk factors should be considered in reducing the incidence of delir-
ium in intensive care units.References:
1. Salluh JI et al. BMJ 350:2538, 2015
2. Kotfis K et al. Anaesthesiol Intensive Ther 50:160-67, 2018
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Introduction:
Alcohol use disorders (AUDs) is very common in ICU patients (up to
20%). An unplanned and brutal stop of alcohol consumption, as it can
occur during ICU admission, may lead to an alcohol withdrawal syn-
drome (AWS). The most severe clinical manifestation of AWS is described
as delirium tremens (DT). There are no current guidelines available for
AWS treatment in ICU. The study’s aim was to describe the clinician’s
practices for DT treatment and the outcome of DT in ICU patients.
Methods:
Observational retrospective cohort study in two ICUs of a university-
affiliated, community hospital in France. Patient diagnosed for DT
during their ICU stay, as defined by DSM-V classification, were en-
rolled in the study.
Results:
61 patients with DT were included between 2014 and 2017. Benzodi-
azepines was administered to 23% of the patients in order to prevent
an AWS. As associated measures, vitamin therapy was administered
to 83% of the patients and 59% had an increased fluid intake (mean
2.5L+/-0.7). Concerning the curative approach of AWS, the treat-
ment’s heterogeneity was notable. There was a high frequency of
treatment’s association (66% of the patients), every patient had ben-
zodiazepines and the use of second line treatments such as neuro-
leptic, alpha-2 agonist, propofol was variable (Figure 1).
Complications of DT were the following:
 Need for mechanical ventilation due to unmanageable
agitation or acute respiratory distress (33% of the patients)
 Self inflicted injuries such as pulling out of central lines, tubes,
surgical drain (46%)
 Falls (7%).
 Seizures (33%).
Conclusions:
Delirium tremens is a severe complication of an untreated AWS, which
can lead to serious adverse events in ICU. The current lack of evidence
concerning the management of AWS in ICU probably explains the het-
erogeneity of treatments. Given the potential severity of AWS in ICU,
further evidences are required to optimize care of AWS in ICU patients.
Fig. 1 (abstract P176). DT treatment in ICU from D0 to D5. Most of
the patients presenting a DT during their ICU stay were treated with
benzodiazepine. A significant number of them received association
of different molecules regardless the absence of evidence in
the literature
Critical Care 2020, 24(Suppl 1):87 Page 70 of 213P177
The incidence and related risk factor of delirium in surgical
stepdown unit
S Yoon1, S Yang2, G Cho2, H Park2, K Park2, J Ok2, Y Jung2
1Asan medical center, Nursing department, Seoul, South Korea; 2Asan
Medical Center, Seoul, South Korea
Critical Care 2020, 24(Suppl 1):P177
Introduction:
Step Down Units (SDUs) provide an intermediate level of care be-
tween the ICU and the general medical-surgical wards. The Critically
ill patients who are in recovery after long-term intensive care or who
require monitoring after acute abdominal surgery are admitted to
SDUs. Delirium in critically ill patient is common and leads to poor
clinical outcomes. It is, however, preventable if its risk factors are
identified and modified accordingly.
Methods:
To determine risk factors associated with delirium in critically ill pa-
tients to admitted surgical SDU at Asan Medical Center. This is retro-
spective study conducted on critically ill patients who were admitted
to the SDU from September 2018 to April 2019 and able to express
themselves verbally. Delirium status was determined using the Short-
CAM tool. Data were analyzed by SPSS 13.0 software, using t-test,
Fisher's exact test and logistic regression.
Results:
The incidence of delirium was 32.1%(25 of 78 patients) and hypoac-
tive delirium(12case, 48.0%) was the most commonly assessed,
followed by hyperactive delirium(9case, 36.0%), mixed type(4case,
5.1%). Risk factors associated with developing delirium identified
from univariate analysis were age(P=0.048), admission via ICU (P=
0.041), tracheostomy (P=0.037), chronic heart failure (CHF) (P=0.017),
invasive hemodynamic monitoring (P=0.041), heart rate (P=
0.037). After adjusted in multivariate analysis; factors those remained
statistically significant were old age (RR 1.16, 95% Confidence Interval
[CI]=1.07-1.25, P=0.041), having a tracheostomy (RR 2.99, 95% CI=
1.48-2.08, P=0.028), CHF (RR 4.01, 95% CI=1.98-5.23, P<0.001), andchronic renal failure (RR 4.45, 95% CI=1.12-3.23, P<0.001). Those were
significant risk factors of delirium in SDU.
Conclusions:
We identified risk factors consistently associated with incidence of
delirium following admitted to surgical SDU. These factors help to
focus on patients at risk of developing delirium, and to develop pre-
ventive interventions that are suitable for those patients.
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Introduction:
Patients with sepsis frequently develop delirium during their inten-
sive care unit (ICU) stay, which is associated with increased morbidity
and mortality. The prediction model for delirium in ICU patients
(PRE-DELIRIC model) was developed to facilitate the effective pre-
ventive strategy of delirium [1]. However, the PRE-DELIRIC model has
not yet been validated enough outside Europe and Australia. The
aim of this study is to examine the external validity of the PRE-
DELIRIC model to predict delirium using Japanese cohort.
Methods:
This study is a post hoc subanalysis using the dataset from previous
study in nine Japanese ICUs, which have evaluated the sedative strat-
egy with and without dexmedetomidine in adult mechanically venti-
lated patients with sepsis [2]. These patients were assessed daily
throughout ICU stay using Confusion Assessment Method-ICU. We
excluded patients who were delirious at the first day of ICU, were
under sustained coma throughout ICU stay and stayed ICU less than
24 h. We evaluated the predictive ability of the PRE-DELIRIC model to
measure the area under the operating characteristic curve. Calibra-
tion was assessed graphically.
Results:
Of the 201 patients enrolled in the original study, we analyzed 158
patients in this study. The mean age was 69.4 ± 14.0 years and 99
patients (63%) were male. Delirium occurred at least once during
their ICU stay in 63 patients (40%). To predict delirium, the area
under the receiver operating characteristics curve of the PRE-DELIRIC
model was 0.60 (0.50 to 0.69). Graphically, the prediction model was
not well-calibrated (Figure 1).
Conclusions:
To predict delirium in Japanese ICUs, we could not show the well dis-
crimination and calibration of the PRE-DELIRIC model in mechanically
ventilated patients with sepsis.References:
1. van den Boogaard M et al. Intensive Care Med 40:361-9, 2014
2. Kawazoe Y et al. JAMA 317:1321-8, 2017
Fig. 1 (abstract P180). Live performance of music therapy in ICU
Fig. 1 (abstract P178). Observed and expected incidence of delirium
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Introduction:
Delirium is a serious and common complication and in some cases it
treatment is difficult. Aim of the study was an evaluation of the
prevalence, structure of delirium and efficacy of dexmedetomidine
and haloperidol sedation in geriatric patients after femur fracture.
Methods:
After local ethic committee approval 207 case-records of geriatric pa-
tients with femur fracture in the period from 2017 to 2018 in the In-
stitute of traumatology and orthopedics in Astana were analyzed.
Patients was divided for 2 groups: in D – patients with delirium
treated by i/v dexmedetomidine (0.2-1.4 mkg/kg per hour), in G
group patients with delirium treated by i/v galoperidol (0.10-0.15
mkg/kg). Delirium was assessed by RASS at day of permission and
every day at 8 a.m. The prevalence, structure of delirium and efficacy
of sedation were analysed.
Results:
By anthropometric and gender characteristics of the group did not
differ. The average age in the D-group with delirium was 81.8±0.9
years old, which was comparable to the G-group — 79.7±0.7 years
old (p = 0.06). All study participants had similar comorbidities. Delir-
ium in all patients debuted at 2.0±1.4 days, with an average duration
of 2.2±1.2 days. The effect of dexmedetomidine was better and
expressed in 52% decrease in the duration of delirium in compare to
haloperidol (p <0.05). Dexmedetomidine provided a more controlled
and safe sedation compared with haloperidol. The average consump-
tion of narcotic analgesics in the subgroup with dexmedetomidine
was two times less than in the subgroup with haloperidol. Thus, the
average consumption of trimeperidine hydrochloride in patients of
group D was 6.9 mg versus 14.1 mg in group G (p = 0.004).
Conclusions:
In gerontological patients with femur fracture treatment delirium by
dexmedetomidine was more effective in compare with haloperidol.When using dexmedetomidine, the consumption of narcotic
analgesics in postoperative period was 50% less than with
haloperidol.P180
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Introduction:
Intensive care units (ICU) are not comfortable for patients, relatives
or next of kin. In the last years many news approaches were de-
scribed to implement the humanization of medical treatments. The
positive effect of music therapy in ICU is well described, especially re-
ducing delirium risk [1]. The aim of this paper is describing the effect
in patients and their family of a music live performance in ICU.
Methods:
After Ethical Committee approval (Procedure AOU 0018356/18, Italy)
for three months (November 2018-January 2019) patients in ICU
were treated twice a week with live music therapy performed by
Coral Vecchi-Tonelli of Modena, Italy (Fig. 1). Data were collected all
awake and conscious patients. Vitals parameters, GCS, RAAS and
CAM ICU were collected before, during and after the treatment, at
every performance. After the treatment a feedback questionnaire
were given to patients and to next of kin.
Results:
18 subjects were enrolled in the research with mean age of 66.66
years old, delirium rate before the treatment was 16.38% later
15.38%, RAAS does not show any difference. Over 85% of patients
were satisfied, and relatives felt less anxiety. We recorded also a satis-
faction also in relatives not enrolled.
Conclusions:
The study does not demonstrate a delirium risk reduction for the
small sample and the length treatment, anyway it was recorded a
low delirium rate. The safety and the potential effect of music ther-
apy are well known, surely the research underlines the feeling of pa-
tients and their next of kin: ICU is the most stressful setting for
admitted patients and its humanization is a current topic for medical
literature. Live performances could be an entertainment moment
and probably create a moment of an interaction among patients,
their family and medical and nurse: ICU become more Human. The
high level of satisfaction push us to continue this experience.
References:
1. Mofredj A et al. J Crit Care 35:195–199, 2016
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Introduction:
Patients undergoing medical procedures benefit from distraction tech-
niques to reduce the need for drugs alleviating pain and anxiety. This
study investigates if medical hypnosis or virtual reality glasses
(VRglasses) as adjuvant method reduces the need for additional drugs.
Methods:
In a prospective, randomized, interventional trial, patients undergo-
ing procedures were stratified in four age groups, and randomly
assigned into three arms by means of a closed envelope system. All
patients received standard care for pain before the procedure; the
control group received further drugs for pain and stress as indicated
by the Visual Analog Scale (VAS; threshold 3/10) and ComfortScore
(threshold 14/30), two index groups received either medical hypnosis
or VR glasses as a plus before and during the procedure. VAS and
Comfort were scored continuously and analysed with the Kruskal-
Wallis Test. Patients, parents and healthcare providers scored their
satisfaction at the end.
Results:
Of 104 included patients 6 to 86 years old, 47% were female. Regard-
less of age, pain and comfort scores were similar before and at the
start of the procedure (VAS 3.7-4.2; Comfort 16-16.7), but as of one
minute after starting the procedure, both VAS and Comfort reduced
significantly more in both index groups compared to the control (p<
0.001), remaining far below the threshold for both pain and stress
(Figure 1). There was no advantage of one index group over the
other (p=0.43). There were no adverse effects. Patients in the VR
group were more satisfied than in the standard group (p=0.02) or in
the hypnosis group (p=0.04). There was no significant difference in
satisfaction of parents or healthcare providers.
Conclusions:
From the very start of the intervention, the application of either med-
ical hypnosis or VR glasses significantly reduces pain and anxiety in
patients undergoing medical procedures. More studies are needed
but both are promising safe adjuvant tools to standard pharmaco-
logical treatment.Fig. 1 (abstract P181). Evolution of VAS and COMFORT scores
during proceduresP182
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Introduction:
Recent clinical studies have confirmed the benefits of music therapy
in managing pain and improving quality of care in the emergency
department. The aim wasTo evaluate the impact of receptive music
therapy on pain and anxiety induced by emergency care
Methods:
A randomized controlled study in patients consulting the emergency
department. Two groups: the music therapy group; Patients needed
venous sampling, peripheral venous catheter or arterial catheter. Will
bless ten minutes music therapy by headphones and a second con-
trol group of patients with the same care without music therapy.
Consent was requested from all participants. The level of pain caused
by the act of care was assessed by visual analogic scale. Heart
rate, blood pressure and the mood of the patient were assessed be-
fore and after emergency care. We assessed patient satisfaction, ad-
verse events. Patients admitted to the emergency room, patients
with communication difficulties and non-consenting patients were
not included
Results:
Two hundred and forty patients were included randomized in both
groups, 123 with music therapy and 117 without music therapy, the
results showed comparable characteristics between the two groups:
demographic data, pathological history, and initial clinical presenta-
tion. After the session of music therapy a difference was noted in the
evaluation of the mean VAS who was in the group with Music of
2.87 ± 1.82 versus 3.60 ± 2.06 in the control group p< 0.004 CI 95%
[-1.23; -0.23], and the mean of diastolic blood pressure which was 71,
07 mmHg in the first group against 74.27 mmHg for the control
group p = 0.048 CI 95% [-6.37; -0.25]. As for the mood, the patients
were more smiling after the act of care in the group music therapy.
All patients were satisfied with their experience and 93% recommend
this therapy to their relatives .
Conclusions:
Music therapy may reduce pain and anxiety in patients during emer-
gency care.
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Introduction:
The music therapy is the intervention of music and/or its elements to
achieve individual goals within a therapeutic.the music has proved to
have positive physiological and psychological effects on patients [1].
Patients admitted to the Intensive Care Unit (ICU) experience anxiety
and stress even when sedated, negatively influencing recovery [2].
Methods:
Two groups are established, a music therapy group (MG) and a con-
trol group (CG). The first one undergoes music therapy interventions,
Critical Care 2020, 24(Suppl 1):87 Page 73 of 213it consists of 10-minutes sessions of live music. Patients of the GC
will receive the usual treatment established by the service protocol
for weaning management and the data are collected during the
same time interval. Data collection includes Mean arterial pressure
(MAP), heart rate (HR), respiratory rate (RR), oxygen saturation (SaO2)
and temperature (T).
Results:
A total of 28 patients were recruited, of which 6 patients had to be
excluded for meeting any of the exclusion criteria (n=22). Of which
13 (n=13) were randomized in the GM and the rest to the GC (n=9)
IC95%. Regarding delirium in GM 9 (40.9%) presented a POSITIVE
CAM-ICU, while in the CG were 13 (59.9%) (P=0.09). When analyzing
the variables in the CG and GM, it was observed that there were no
differences with respect to HR, RR and MAP variable (Figure 1).
Conclusions:
According to the results, we can say that music therapy as a non-
pharmacological strategy for management of anxiety and delirium in
patients of critical care units, might be an useful tool for the manage-
ment of patients in weaning of mechanical ventilation
References:
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Critical Care 2020, 24(Suppl 1):P184Introduction:
Coagulopathy and basopenia are common features of anaphylaxis,
but the role of coagulopathy in anaphylaxis remains uncertain. The
aim of this study is to evaluate the association between coagulopa-
thy and clinical severity or basopenia in patients with anaphylaxis.
Methods:
We conducted a single-center, retrospective study of patients with
anaphylaxis about their coagulopathy. Levels of fibrin degradation
products (FDP) and D-dimer were analyzed with the cause of ana-
phylaxis, clinical symptoms, medications and outcomes. We also
studied the levels of intracellular histamine as a biomarker of baso-
phil degranulation in the peripheral blood in relation to FDP and D-
dimer.
Results:
In total, sixty-nine patients were enrolled to the study, and the levels
of intracellular histamine were analyzed in 14 patients. The symp-
toms included respiratory failure (n=47), shock (n=56), abdominal im-
pairment (n=20), and consciousness disturbance (n=37). Thirty-two
patients needed continuous intravenous vasopressors for refractory
shock. The increase of FDP was significantly associated with con-
sciousness disturbance (p=0.029) and refractory shock (p<0.0001).
The increase of D-dimer was also significantly associated with refrac-
tory shock (p=0.0066). There was no correlation between the levels
of intracellular histamine and either of FDP or D-dimer (p=0.13 and
p=0.16, respectively).
Conclusions:
The increase of FDP and D-dimer were associated with severe symp-
toms of anaphylaxis, while they were not correlated with intracellular
histamine. These results suggest that anaphylaxis is closely associ-
ated with coagulopathy in a mechanism which is different from ba-
sophile degranulation in anaphylaxis.P185
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Introduction:
Cardiovascular involvement in influenza infection occurs through direct
effects on the myocardium or through exacerbation of pre-existing car-
diovascular disease [1]. The aim was to study cardiac manifestations in
all pts admitted to the ICU with severe influenza’s attack.
Methods:
Clinical, laboratory, electrocardiographic, echocardiographic and
hemodynamic data were retrospectively recorded in all pts admitted to the
ICU due to influenza infection (winter 2018-spring 2019). Diagnosis was
established by PCR on bronchial aspirates the next 7 days after admission.
Myocardial injury was defined by troponin levels >116 pg/ml (10 fold ULN).
Left ventricular systolic dysfunction was defined as EF <50% and was char-
acterized as either global or regional. Hemodynamic monitoring by
Critical Care 2020, 24(Suppl 1):87 Page 74 of 213transpulmonary thermodilution method (PICCO) was recorded in pts with
shock (norepinephrine >0.1 μg/kg/min). Values are expressed as mean±SD
or as median (IR).
Results:
Nine pts (5 males) with a mean age 49.78±17.01 years, APACHE II
19±5.29 and SOFA score 10.50±2.93 were assessed. ICU admission
was due to ARDS (7) and COPD exacerbation (2). ICU LOS was 24.44±
14.19 days and mortality rate was 18%. No history of vaccination or
coronary heart disease was referred. Results are shown in table 1.
Levosimendan was administered in 2 pts with severe cardiogenic
shock. In all survivors, shock and indices of myocardial dysfunction
subsided till discharge. Coronary angiography was performed in 1 pt
showing no abnormalities. Mortality was attributed to septic shock
and multi-organ failure.
Conclusions:
Myocardial involvement, though common in influenza pts admitted
to the ICU, didn’t contribute to a dismal prognosis.
References:
1. Fagnoul D et al. J Crit Care 28: 321–327, 2013Table 1 (abstract P185). Hemodynamic indices in H1N1 patients
Elevated troponin N=7 (77.78%)
Systolic dysfunction N=4 (36%)
ECG abnormalities N=7 (77.78%)
CI (l/min/m2) 2.86±0.13
GEF (%) 20.50±4.95
GEDI (ml/m2) 824±64.1
SVRI (dyn/sec/cm/m2) 2179±339
EVLWI (ml/kg) 11.33±5.13
Fig. 1 (abstract P186). Effects of levosimendan on cardiac output (CO),
cardiac index (CI), glutathione (GSH) and malonyldialdeide (MDA, which is
representative of thiobarbituric acid reactive substances (TBARS). * p<0.05
vs T0. Square brackets indicate significance between groups (p<0.05)P186
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Introduction:
The cardioprotective effects of levosimendan could be related to the
modulation of oxidative balance. We aimed to examine the effects of
levosimendan in patients with cardiogenic shock or with ejection
fraction (EF) lower than 30% on cardiac systo-diastolic function and
plasma oxidants/antioxidants (glutathione, GSH; thiobarbituric acid
reactive substances, TBARS).Methods:
In 4 patients undergone coronary artery bypass grafting or angioplasty,
cardiovascular parameters were measured at T0 (before the beginning
of levosimendan, 0.1mcg/Kg/min), T1(1 h after the achievement of the
therapeutic dosage of levosimendan), T2 (at the end of levosimendan
infusion), T3 (at 72 h after the end of levosimendan infusion), T4 (at the
end of cardiogenic shock). The same time-course was followed for
plasma GSH and TBARS measurements.
Results:
We found an improvement in cardiac output, cardiac index and systolic
arterial blood pressure. EF increased from mean 25% to 45%. A reduc-
tion of central venous pressure and wedge pressure was also observed.
Moreover, indices of diastolic function were improved by levosimendan
administration (E/E’ from 14 to 6; E/A from >1 to <1) at early T2. It is to
note that an improvement of GSH and TBARS was observed early after
levosimendan administration (T1), as well (Figure 1).
Conclusions:
The results obtained have shown that levosimendan administration
can regulate oxidant/antioxidant balance as an early effect in low
cardiac output patients. The modulation of oxidative condition could
be speculated to play a role in exerting the cardio-protection exerted
by levosimendan in those patients.
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Introduction:
This study analyses the prognostic ability of noradrenaline dose in
the first four days following the onset of septic shock.
Methods:
Patients with a diagnosis of septic shock (Sepsis 3.0) admitted to the ICU
at Queen Elizbeth Hospital, Birmingham between April 2016 and July
2019 were included. The primary outcome was 90-day mortality. Continu-
ous data is presented as mean (SEM). Categorical data is presented as %
and analysed using a chi-squared test. A p value of <0.05 was used to de-
termined significance. To allow for multiple comparison between data, a
Bonferroni calculation was used to determine significance at a p value of
<0.01. Receiver operator characteristic (ROC) curves were generated for
noradrenaline dose and area under the curve (AUC) was calculated.
Results:
847 patients were admitted with septic shock. The majority (61%) were
male, with a mean age of 62 (±0.6) and a 90-day mortality of 43%. Median
noradrenaline dose had a fair prognostic ability on day 1 (AUC =
0.754 [0.714 – 0.794]) and good prognostic ability on day 2 (AUC = 0.844
[0.810 – 0.878]) (Figure 1). A noradrenaline dose of 0.25μg/kg/min on day
1 and 0.15 μg/kg/min on day 2 had a 70% sensitivity and 70% specificity
for mortality. Median noradrenaline dose was an excellent prognostic indi-
cator on day 3 (AUC =0.911 [0.878 – 0.943]) and day 4 (AUC = 0.908 [0.879
– 0.948]). A noradrenaline dose of 0.1μg/kg/min on day 3 and 0.05 μg/kg/
min on day 4 had a 90% sensitivity and 90% specificity for mortality. In pa-
tients who survived, vasopressors were weaned off within 4 days in 90%
of cases. In those who died, death occurred within 4 days 88% of the time.
Conclusions:
Noradrenaline dose has a good prognostic ability in septic shock. In
this septic shock cohort, the majority of patients that died did so
within 4 days. Furthermore, the majority of survivors were weaned
off vasopressors within 4 days. Therefore, by day 3 and 4, small doses
of noradrenaline had an excellent prognostic ability for septic shock.Fig. 1 (abstract P187). Maximum noradrenaline dose (micrograms/kg/
minute) from onset to day 4 of septic shock and % 90-day mortality. (**: p
= 0.005; ***: p <0.0001; ns = non-significant)P188
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Introduction:
This study evaluates whether vasopressor use in the emergency
department (ED) and vasopressor use within four hours of
arrival to ED is associated with survival in patients with septic
shock. The optimal timing of vasopressor administration in
septic shock is unknown. Emerging evidence suggests early
administration in non-intensive care settings may improve out-
comes [1].
Methods:
Patients with a diagnosis of septic shock (Sepsis 3) who were ad-
mitted to intensive care directly from the emergency department
(ED) between April 2016 and July 2019 at Queen Elizabeth
Hospital, Birmingham were included. The primary outcome was
90-day mortality. Early vasopressor use was defined as the admin-
istration of metaraminol or noradrenaline within 4 hours from ar-
rival in ED. Continuous data is presented as mean (SEM) and
analysed using an unpaired t-test. Categorical data was analysed
using Fishers exact test.
Results:
87 patients had septic shock and were admitted to intensive care
directly from ED. Patients were 61% male, aged 64.7±1.9 years,
and had a 44% 90-day mortality. Seventy-nine percent of patients
had vasopressors in ED; 56% within 4 hours. The first vasopressor
was metaraminol in 60% of cases. Early vasopressor use was as-
sociated with a lower mortality than late vasopressor use (33%
vs. 58%; RR 0.56 [0.35-0.92]; p = 0.029). Vasopressor use in the
ED was associated with a lower mortality than no vasopressor
use in the ED (38% vs 67%; RR 0.56 [0.36-0.88]; p = 0.035). There
was no difference in the median MAP in ED between early or
late vasopressor use (64.3 [1.2] mmHg vs 63.8 [2.7] mmHg; p =
0.56). A comparison between patients who survived and died is
outlined in Table 1.
Conclusions:
Early administration of vasopressors and their use in the
emergency department was associated with survival in septic
shock. This seemed to be independent of median MAP recorded
in the ED.
References:
1. Permpikul C et al. Am J Respir Crit Care Med 199:1097-105, 2019.Table 1 (abstract P188). A comparison of early vasopressor use in
septic shock patients who survived and died
Survived (n = 49) Died (n=38) p value
Age (years) 63.7 (2.6) 66.0 (2.8) 0.55
Median MAP in ED (mmHg) 64.5 (1.1) 63.9 (1.9) 0.77
Fluid given (mls) 3372 (179) 3394 (158) 0.93
Vasopressor use in ED (%) 88.9% (43/49) 68.4% (26/38) 0.035
Early vasopressor use (%) 67.3% (33/49) 42.1% (16/38) 0.029
Time spent in ED (mins) 401 (27.5) 427 (38.3) 0.57
Time to ITU review (mins) 201 (19.4) 199 (24.1) 0.94
Fig. 1 (abstract P190). Perception of adequacy of training. Red: to
be improved, orange: sufficient, green: adequate
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Introduction:
Cardiac tamponade is a life-threatening clinical syndrome caused by
an increase in intrapericardial pressure that requires early diagnosis
and management. In our Moroccan endemic context, tuberculosis
(TB) still remains a real public health issue and its pericardial
localization is a serious form of extrapulmonary TB associated with
substantial morbidity. However, pericardial effusions causing pericar-
dial tamponade are rare in patients with TB. The aim of our study
was to evaluate the prevalence of tuberculous cardiac tamponade,
its clinical presentation and evolutive particularities in our cardiac
care unit
Methods:
We conducted a cross-sectional prospective study from May 2016 to April
2019 including all the patients admitted in our unit for cardiac tamponade.
We excluded all the traumatic or post-myocardial infarction forms.
Results:
Out of 83 patients, the tuberculous etiology was identified in 15 cases
(18,1%), mean age was 34 years, 57,8% were men. 9 patients reported a TB
contact in their environment, 5 had a medical history of pulmonary TB.
After pericardiocentesis, the liquid was citrine yellow in 6 cases and hematic
in 5 patients, no patient underwent surgical drainage in our serie. Mycobac-
terium tuberculosis was found in the expectorations in 4 cases and ADA
was positive in 4 patients. HIV serology was negative in all our patients. A 6
months anti bacillary therapy with isoniazid, rifampin, pyrazinamide, and
ethambutol was initiated in all our patients with a good evolution in 7
cases, 2 deaths, 1 chronic constrictive pericarditis, 2 small pericardial effu-
sion and 3 lost to follow-up.
Conclusions:
Althought cardiac tamponade is rarely caused by tuberculosis, this
condition remains common in endemic countries such as Morocco
and affect younger population, hence the importance of a better
knowledge of its prevalence and and multidisciplinary management
and more importantly the treatment of the underlying cause using
Combined antibacillary medication that has shown satisfying results.
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Introduction:
Point-of-care ultrasound (PoCUS) became an invaluable tool in anaes-
thesia and critical care (ACC) [1]; appropriate training should inte-
grate ACC residency programs [2].
Methods:
On-line surveys sent to 3 groups (ACC schools directors, residents and con-
sultants), as approved by CPAR (Collegio Professori Anestesia Rianimazione),
on teaching in vascular accesses-VA, lung ultrasound-LUS, transthoracic
echocardiography-TTE, focused-assessment sonography for trauma-FAST,
transcranial Doppler- TCD, regional anaesthesia-RA, diaphragm ultrasound-
DUS.
Results:
In 270 survey days the form was filled by 568 residents (30/40 uni-
versities) 22 directors, 216 consultants (24/40 universities). For all the
groups bedside teaching, followed by frontal lectures, is the most fre-
quent tool for all techniques. LUS and DUS more frequently include
research activities; AR e VA usually include simulations. Overall, themost neglected technique is FAST. According to directors and consul-
tants, residents are mentored by consultants (96.2%/ 95.4%) and
older residents (46.2%/ 26.9%), while according to residents, consul-
tants/older residents mentor in 72%/ 39.6% of cases, while 48,6% of
the training is performed with no mentoring. Ultrasound compe-
tences evaluation is performed mostly in everyday bedside activity
(>55%) for all groups; however, residents report no evaluation in a
higher percentage (37.5 vs.7.7%). Perception on adequacy of the
training is displayed in Fig 1. The main perceived limiting factor is
the absence of a standardized didactic program, followed by men-
tor’s availability in residents’ perception and by mentor’s experience
in consultants’ one.
Conclusions:
PoCUS teaching is present although not optimal and not
homogenous in Italian ACC residency schools. Standardisation of resi-
dents’ ultrasound curriculum is suggested to improve ultrasound
teaching.
References:
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Introduction:
Ultrasound (US) guidance during Central Venous Catheter (CVC) place-
ment is recommended by guidelines and radiographic confirmation of
the position is considered as the golden standard. Nevertheless, there
is little literature regarding the feasibility of ultrasonic evaluation of the
CVC tip position. The main objective was to examine the accuracy of
bedside ultrasound for confirmation of the CVC position and exclusion
of pneumothorax compared with chest radiography (CXR).
Methods:
The study included a convenience sample of critically ill patients with
supradiaphragmatic CVCs and a CXR for confirmation. US is used for
direct confirmation of the guidewire in the Internal Jugular (IJV) or
Subclavian (SCV) vein and visualizing the guidewire in the right
atrium. To evaluate for pneumothorax, “sliding sign” of the pleura
was noted on US of the anterior chest.
Results:
34 patients have been included, 35% of the catheters have been
placed in the SCV and 65% in the IJV. It was possible to confirm the
position of the CVC tip for 70.6% (23 correct, 1 incorrect CXR) of 34
Critical Care 2020, 24(Suppl 1):87 Page 77 of 213cases by transthoracic echocardiography (TTE) (Figure 1). Overall, it
was not possible to identify the guide in the right atrium 11 cases
(10 false negatives, 2 of them due to the presence of defibrillator
leads). Regarding the 1 case where an incorrect position was seen on
CXR it was also detected on ultrasound: US of the inserted vein and
a negative TTE confirmation. In all cases it was possible to exclude a
pneumothorax by US.
Conclusions:
These results show that bedside ultrasound might be a feasible tech-
nique to confirm the CVC positioning. It is important to note that the
level of the operator’s expertise is significant when assessing the
feasibility of this method. We only had a limited sample size and the
occurrence of only one misplaced catheter. These preliminary results
need to be confirmed on a larger scale.Fig. 1 (abstract P191). TTE confirmationP192
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Introduction:
Recent reports suggested to use internal jugular vein (IJV), inferior
vena cava (IVC) and carotid ultrasound measures to confirm conges-
tion and to predict prognosis in heart failure (HF) patients. Our aims
were to check the validity of the previous US measures in predicting
HF diagnosis and prognosis.
Methods:
This review was based on the PRISMA guideline . The systematic
search of the literature published from 1941 through 30 October
2019 explored the PubMed and Cochrane Library databases. Inclusion
criteria: studies who investigated the reliability, the accuracy in pre-
dicting HF diagnosis and death or re-hospitalization of the IJV, IVC
diameter, IVC collapsibility index (IVC-c = IVC max – IVC min / IVC
max X 100) and Common Carotid US measures in adult (>18 yrs) with
HF. Five researchers selected studies using inclusion criteria and then
assessed their quality using the QUADAS-2 guidelines. The key words
for literature search were: common carotid, internal jugular veins, in-
ferior vena cava, ultrasonography and heart failure.
Results:
We collected 744 studies: 727 excluded with reasons, 18 studies were
included for the final analysis: 4 on IJV, 13 on IVC, 1 on Carotid US. A
IJV ratio < 4 predicts death and readmission : HR=2.7-10. A IVC ≥2 cm
and IVC-c ≤15% showed an high accuracy in HF diagnosis and a mod-
erate validity in predicting death and re-admission : AUC=0.63-0.78;HR=1.1-5.8 for IVC; AUC=0.63-0.74, HR=0.7-6.8 for IVC-c. The LVET ( time
interval between end diastole and the dicrotic notch of Common ca-
rotid artery Doppler waveform showed a good validity in predicting HF
diagnosis: AUC=0.81 (95% CI, 0.72–0.87).The studies collected showed a
moderate quality according to QUADAS-2 guidelines.
Conclusions:
Because few reports have been published on this topic the conclu-
sions of this review should be confirmed. The IJV and IVC ultrasound
measures seem to have a moderate accuracy in predicting diagnosis,
death and hospitalization in patients with Heart Failure.P193
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Introduction:
More than 7-million transthoracic echocardiograms are performed
annually in the US. These studies may reveal structural and functional
cardiac abnormalities that inform clinical care in the intensive care
unit. And yet, little is known about the epidemiology of baseline
echocardiography, specifically among patients admitted to intensive
care with sepsis.
Methods:
We studied electronic health records of 1,076,925 adult patients from 12
hospitals at UPMC from 2013 to 2014. Eligible patients were those with
Sepsis-3 at presentation who required intensive care during hospitalization.
Demographics, comorbidities, illness acuity, and baseline echo parameters
(within 1-year prior to incident sepsis hospitalization) were abstracted. An
abnormal echocardiogram was defined as LVEF<50%, LV diastolic dimen-
sion >6 cm, moderate/severe RV dysfunction, or moderate/severe valvular
stenosis/regurgitation. We compared characteristics of patients who did
and did not receive an echo, those with normal and abnormal studies, and
patients stratified by in-hospital mortality.
Results:
Among 43,086 adults with sepsis, 8,077 (18%) had baseline echocar-
diographic data within 1-year of admission, on average 131 (SD 103)
days prior to presentation (Figure 1). Most septic patients had abnor-
mal echo studies (N=5782, 72%). Of those who died (2,666 (6.2%)),
1,821(68.3%) had no echo data,192(7.2%) had normal and 653
(24.5%) had abnormal studies, compared to 40,420 (93.8%) survivors
of which 7,232 (17.9%) had baseline echo, 2,298 (5.7%) had normal,
and 5,779(14.3%) had abnormal echocardiograms. Comparing deaths
to survivors, reduced EF<39% (15.7% vs 12.6%, p=0.01), severe RV
dysfunction (11.1% vs 8.4%, p=0.52), RV dilation (21% vs 17.2%, p<
0.01) and severe tricuspid regurgitation (19.4% vs 13.1%, p<0.001)
were more common among deaths.
Conclusions:
Most septic patients admitted to intensive care have abnormal base-
line echocardiography. A reduced LV ejection fraction and severe
right sided heart disease were more common among deaths than
survivors.
Table 1 (abstract P194). Minimal guidewire length = 105 mm (95th
percentile of the vessel length) + 30 mm (to ensure that the guidewire
J-tip passes the junction of the right and left brachiocephalic veins and
the azygos arch into the lower part of the superior vena cava) + steel
cannula length (the maximum length that can be inserted into the
patient) + CVC full length + 10 mm (the part of the guidewire that must
extend from the CVC before CVC-insertion)
Manufacturer Model Actual guide-
wire length
(mm)b
Calculated minimal
guidewire length
(mm)c
Discrepancy
(mm)
Arrow, 2-
lumen
Blue
FlexTip 16
cm
590 506 84
Bactiguard, 3-
lumen
BIP CVC
16 cm
440 513 -73
B Braun, 3-
lumen
Certofix
15 cm
495 528 -33
Meritmedical,
3-lumen
Careflow
15 cm
445 535 -90
Fig. 1 (abstract P193). Panel A. Patient baseline characteristics. Panel B.
Chord diagram showing abnormal echocardiographic parameters by
mortality. The ribbons connect from mortality status to individual
echocardiographic abnormalities if the group mean is greater or lesser than
the overall mean for the entire cohort. For example, patients who died
(light blue) are more likely to have RV dysfunction, LV dysfunction, and
tricuspid regurgitation but not aortic stenosis or mitral regurgitation
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Most guidewires used for central venous catheterization of the
right subclavian vein in adults are too short; a CT-based
observational study
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Introduction:
Central venous catheter (CVC) misplacement occurs more frequently
after cannulation of the right subclavian vein compared to the other
sites for central venous access. Misplacement can be avoided with
ultrasound guidance by using the right supraclavicular fossa view to
confirm correct guidewire J-tip position in the lower part of the su-
perior vena cava. However, retraction of the guidewire prior to the
CVC insertion may dislocate the J-tip from its desired position,
thereby increasing the risk of CVC misplacement. The aim of this
study was to determine the minimal guidewire length needed to
maintain correct guidewire J-tip position throughout an US-guided
infraclavicular CVC placement in the right subclavian vein.
Methods:
100 adult intensive care patients with a computed tomography scan
of the chest were retrospectively and consecutively included in the
study. The distance from the most plausible distal puncture site of
the right subclavian/axillary vein to the junction of the right and left
brachiocephalic veins (= vessel length) was measured using multipla-
nar reconstructions. In addition, measurements of the equipment
provided in commonly used 15-16 cm CVC kits were performed. The
minimal guidewire length was calculated for each CVC kit.
Results:
The guidewires were up to 90 mm too short to maintain correct J-tip
position throughout the CVC insertion procedure in seven of nine
commercial CVC kits. Four of these are shown in Table 1.
Conclusions:
When US guidance is used to confirm a correct guidewire J-tip pos-
ition, retraction of the guidewire prior to the CVC insertion must beavoided to ensure correct CVC-tip positioning. This study shows that
most of the commonly used 15-16 cm CVC kits contain guidewires
that are too short for CVC placement in the right subclavian vein.P195
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1University Hospital Habib Bouguiba Sfax, Intensive Care Unit, Sfax,
Tunisia; 2university hospital habib bouguiba sfax, intensive care unit, sfax,
Tunisia; 3S.B.U Bozyaka Egitim ve Arastirma hastanesi, emergency
department, izmir, Turkey
Critical Care 2020, 24(Suppl 1):P195
Introduction:
In critically ill patients, due to long period of supine position, lung
water accumulation in posterior areas,outside of lung or heart
diseases, can be induced and B-lines can be observed. The aim of
our study is to find, by transthoracic ultrasound, the correlation be-
tween B_lines and fluid status in patients with long period of supine
position.
Methods:
This prospective study included 924 assessments performed in 154
patients with length of stay of 10 days or more . Each patient’s fluid
status was evaluated in admission and each 48 hours,using B-lines
number assessment by lung ultrasound,measurement of inferior vena
cava (IVC) diameters, and central venous pressure (CVP) analysis .Pa-
tients were stratified into three subgroups according to their B-lines
number : mild ≤14, moderate (14–30) and severe (>30).
Results:
There were 530 separate assessments with mild,294 with moderate
and 100 with severe B-lines occurrence. There was a significant posi-
tive correlation between the log B-lines number and both IVC diam-
eter and CVP values.The correlation between log B-lines number and
IVC diameters decreases but not significantly during hopitalization ( r
Fig. 1 (abstract P196). Ultrasound image showing the needle path
and vessels in the oblique approach
Critical Care 2020, 24(Suppl 1):87 Page 79 of 213in admission= 0.55, p=0.001 ; r in day 10 =0.43,p=0.035). Correlations
between the log B-lines number and CVP during hospitalization
yielded similar results (r in admission= 0.75, p=0.001 ; r in day10 =
0.63, p=0.0026).
Conclusions:
B-lines number assessment keeps a significant reliability to reflect hy-
dration status in patients with long period of supine position.
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Introduction:
Ultrasound-guided cannulation is usually done using either longitu-
dinal or transverse approach. The oblique approach utilizes advan-
tages of both these approaches allowing visualization of the entire
course of needle including tip and lateral discrimination of artery
from vein [1]. The reported incidence of the complete overlap of
femoral vein by the femoral artery is 8-10 percent [2,3]. We describe
the use of the oblique approach for successful cannulation of such a
femoral vein which is not possible by usual approaches (Figure 1).
Methods:
Case 1: A 36-year male, a diagnosed case of carcinoma right buccal
mucosa was operated for wide local excision, right-sided neck dissec-
tion, and reconstruction. In immediate perioperative period, he sus-
tained cardiac arrest due to exsanguinating bleeding from maxillary
artery and pterygoid plexus needing external carotid artery ligation.
Later in the course, hemodialysis was planed for acute kidney injury.
Case 2: A 25-year male was under evaluation for multiple cervical
lymphadenopathies and superior vena cava obstruction (SVCO). He
presented to ICU with tumour lysis syndrome and life-threatening
hyperkalemia requiring urgent hemodialysis.
Results:
In both the patients, neck vein cannulation was risky and screening
ultrasound revealed a complete overlap of the femoral vein by fem-
oral artery precluding its cannulation by traditional longitudinal or
transverse approach. However, due to unavailability of safer alterna-
tives, femoral vein cannulation was done under ultrasound guidance
using oblique approach technique by the operator experienced in
the oblique approach
Conclusions:
Oblique approach allowed successful cannulation of the femoral vein
completely overlapped by the femoral artery as it offers both the
visualization of the entire course of the needle and lateral discrimin-
ation of artery from the vein.
(Written informed consent was obtained)
References:
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Introduction:
Previous studies have demonstrated the potential of P wave charac-
teristics to predict atrial fibrillation (AF). However, data on p-wave
measurements in critically unwell patients are lacking. This study
aimed to determine whether P wave indices in our sample diverged
from previously established reference values in healthy subjects.
Methods:
Digital ECG recordings of 49 critically ill patients admitted to the
Royal Liverpool University Hospital were collected from the Clinical
Information System. 19 patients were excluded due to absent or in-
adequate data. ECGs of 30 patients were converted to images and
analysed with a new technique in ImageJ to allow measurement of P
wave indices. P wave indices included P wave axis, PR interval, mean,
maximum and minimum durations, dispersion, and P wave terminal
force in V1 (PTFV1). Results were compared to reference values de-
scribed in previous studies [1 - 3].
Results:
Maximum P wave duration (137.4ms ± 19.6) and dispersion (79.5ms
± 16.5) were increased compared to reported values in the literature
(103ms and 34ms, respectively) [1]. Mean PR interval (155.4ms ±
26.4) was also decreased [1]. Mean P wave duration (100.6ms ± 17.3)
Critical Care 2020, 24(Suppl 1):87 Page 80 of 213was greatly lower than values recorded in previous studies (66 (59,
72), 123 ± 12, 111.4 ± 14.7) [1,2,3]. Measurements in 6 patients dem-
onstrated abnormal PTFV1 values of ≥4000μVms. Abnormal P wave
axis was found in 5 patients. 1 patient displayed both abnormal
PTFV1 and P wave axis.
Conclusions:
Our preliminary results demonstrate that mean maximum P wave
duration, dispersion, and PR interval were altered in patients with
NOAF compared to healthy subjects. 37% of patients had abnormal-
ities in PTFV1 or P wave axis. Further research is warranted to investi-
gate differences of p-wave characteristics in critically ill patients who
do and those who do not develop NOAF.
References:
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Introduction:
Endothelial cells play a pivotal role in the atherogenic process. Endo-
thelial cell dysfunction (ED) is the main risk factor for cardiovascular
diseases such as hypertension, coronary heart disease (CHD) and per-
ipheral occlusive disease (POD). These diseases significantly increase
the risk for perioperative complications. Therefore, identifying pa-
tients with ED is important and should influence our prospective
perioperative strategy. However, sensitive tools to diagnose ED are
still missing and do not belong to our standard of care. Aim of this
study was the validation of a new non-invasive method to detect ED
and a correlation with a set of established an new endothelial
biomarkers.
Methods:
The cohort includes 20 preoperative patients without anamnestic
relevant cardiovascular disease and 20 patients with known periph-
eral occlusive disease (POD). We used non-invasive EndoPAT® Tech-
nology from ITAMAR-Medical to measure ED by changes in vascular
tone before and after occlusion of the brachial artery and calculate a
reactive hyperemia index (RHI). In addition, we measured established
markers and alternative biomarkers potentially indicate vascular dis-
eases such as substrates and products from the NO-metabolism L-
Arginin, asymmetric/symmetric dimethylarginine (ADMA/SDMA), von-
Willebrand factor (vWF) and Sphingosine-1-phosphate (S1P).
Results:
RHI was able to identify patients with POD. RHI was significant lower
in patients with clinical signs and symptoms of POD (P<0.05). Among
other markers ADMA was significant higher in POD patients com-
pared to controls and correlates with RHI.
Conclusions:
The PAD technology is a helpful non-invasive functional test to
measure ED and seems able in identify patients with vascular dis-
ease. In future, a combination of anamnesis, new diagnostic toolsand biomarkers may further increase our sensitivity in identifying
risk-patients.
P199
Single-lumen 5Fr and triple-lumen 6Fr peripherally inserted central
catheters (PICCs) for cardiac output assessment by transpulmonary
thermodilution
S D´Arrigo1, C Sandroni1, S Cacciola1, AM Dell´Anna1, M Pittiruti2, MG
Annetta1, G Chiuri1, M Antonelli1
1Fondazione Policlinico Universitario A. Gemelli IRCCS, Department of
Anesthesiology, Intensive Care and Emergency Medicine, Rome, Italy;
2Fondazione Policlinico Universitario A. Gemelli IRCCS, Department od
Surgery, Rome, Italy
Critical Care 2020, 24(Suppl 1):P199
Introduction:
Trans-pulmonary thermodilution (TPTD) using single-lumen 4Fr and
double-lumen 5Fr Peripherally Inserted Central Catheters (PICCs) sig-
nificantly overestimate cardiac index and the other hemodynamic
parameters if compared to Centrally Inserted Central Catheters (CICC)
[1]. However, the reliability of PICCs of larger size is still unknown.
Methods:
Prospective method-comparison study conducted in a medical-
surgical ICU of a teaching hospital. We compared TPTD measure-
ments via single-lumen 5Fr or triple-lumen 6Fr polyurethane power
injectable PICCs vs. triple-lumen 7Fr CICC using a TPTD-calibrated
Pulse Contour hemodynamic monitoring system (VolumeView/
EV1000TM Edwards ©).
Results:
Out of 160 manual measurements in 15 patients, we did not found
any difference in CI between single-lumen 5Fr PICC compared to
CICC (3.2±1.04 vs. 3.2±1.06 L/min/m2, p=0.824; percentage of error
14.7%); we also found no differences GEDVI, EVLWI, SVI and CVP. CI
was slightly higher when using triple-lumen 6Fr PICC than when
using CICC (3.3±0.8 vs. 3.0±0.7 L/min/m2, p=0.107, percentage of
error 19.0%), although this difference did not reach the statistical sig-
nificance. We found instead a difference in GEDVI (685±133 vs. 632±
102 mL/m2, p=0.05; percentage of error 19.5%).
Conclusions:
Single-lumen 5Fr PICCs are surely accurate for TPTD use, whereas
triple-lumen 6Fr PICCs lead to a slight overestimation (ClinicalTrial.-
gov NCT03834675).
References:
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Introduction:
Spinal cord injury causes vasoplegia and bradycardia, therefore se-
verely affecting the cardiovascular system. To date, no publication
describes the applicability of advanced hemodynamic monitoring in
these patients.
Methods:
From March 2017 onwards we conducted a prospective, single cen-
ter pilot study including all patients with an acute spinal cord in-
jury. We excluded patients that had a preexisting cardiac condition
Critical Care 2020, 24(Suppl 1):87 Page 81 of 213as well as patients suffering from sepsis. Measurements were per-
formed using the PiCCO system (Pulsion, Munich, Germany) at least
3 times a day.
Results:
Until December 2019 25 Patients (mean age 56 ± 20 years, range 18-
82) with a total of 337 measurements were included. In 19 Patients
the levels of C2 to C7 were affected. Three patients had a lesion of
the thoracic level and 3 subjects suffered from lumbar paraplegia.
We observed a mean Cardiac Index (CI) of 4,2 ± 1,2 l/min/m2, a mean
Stroke Volume Index (SI) of 59 ± 15 ml/m2 and a mean Systemic Vas-
cular Resistance Index (SVRI) of 1384 ± 443 dyn*s*cm-5*m2. There
were 14 Patients requiring norepinephrine on at least one day of
measurements. With vasopressors (n=46) we observed a mean CI of
4,1 ± 1,2 l/min/m2, a mean SI of 59 ± 16 ml/m2 and a mean SVRI of
1317 ± 572 dyn*s*cm-5*m2. Without catecholamines (n=292) we
noted a mean CI of 4,2 ± 1,1 l/min/m2, a mean SI of 59 ± 15 ml/m2
and a mean SVRI of 1394 ± 418 dyn*s*cm-5*m2.
Conclusions:
Our preliminary results do show a difference of the mean SVRI in pa-
tients suffering from acute spinal cord injury when compared to the
reference range of healthy individuals. Furthermore, the SVRI is re-
duced in both subjects under vasopressor therapy and patients that
did not receive catecholamines. We assume a complex adaptation of
the cardiovascular system that can compensate for the loss of vascu-
lar resistance in the absence of vasopressors without affecting the
cardiac index.P201
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Introduction:
Achieving effective critical care in low- and middle-income countries
is a global health goal [1], which includes the provision of effective
point of care ultrasound [2]. We sought to establish Zambia’s first fo-
cused critical care echocardiography training programme in a 16-
bedded ICU at University Teaching Hospital, Lusaka.
Methods:
The programme was accredited by the UK Intensive Care Society
FICE programme, with teaching adapted for local disease patterns
such as tuberculous pericardial effusions. Parasternal, apical and sub-
costal windows were used to assess ventricular dysfunction, hypovol-
aemia, pleural effusion, alveolar interstitial syndrome and
pneumothorax. Zambian doctors working with critically ill patients
received an intensive one-day course, followed by mentored scan-
ning at the bedside. Teaching was delivered by visiting fellows from
the UK who are accredited in echocardiography and experienced
ultrasound educators.
Results:
26 Zambian doctors who work with critically ill patients (16 anaesthe-
tists, 8 paediatricians, 2 physicians) were enrolled. Two handheld ul-
trasounds (GE VScan and Phillips Lumify) were donated to the
programme. Feedback from participants indicated high satisfaction
with the course: 100% agreed that the course improved their under-
standing of critical care echocardiography and that it was pitched at
the right level. Participants believed the course was essential for de-
veloping skills in critical care, and that it was relevant to their clinical
practice. Demand for further training is high. Challenges include
maintaining sustainability, clinical governance, local accreditation,
and servicing of equipment.
Conclusions:
Establishing a training programme in focused critical care echocardi-
ography in a resource poor setting is both feasible and well received.
Clinician motivation to gain competence at critical care echocardiog-
raphy is high in an environment with limited availability of diagnostic
services.References:
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Introduction:
An increasing number of less or non-invasive devices provide esti-
mates of cardiac index CI and stroke volume index SVI with accept-
able accuracy (low bias), but low precision (high percentage error).
Nevertheless, the usefulness of more precise measurements by indi-
cator dilution techniques and strict normal ranges are questioned.
Therefore, we investigated the association of CI and SVI derived from
transpulmonary thermodilution (TPTD) as well as heart rate HR and
their distribution within and without normal ranges (3≤CI≤5L/min;
40≤SVI≤60mL/min; 60≤HR≤90/min) with hospital mortality.
Methods:
We analyzed data of a prospectively maintained database including
927 TPTD-measurements (PiCCO; Pulsion; Germany) of 55 ICU pa-
tients. Primary endpoint: hospital mortality of patients with mean
values of CI, SVI and HR within and without normal range. Statistics:
chi-square test. (SPSS 26).
Results:
Patients: 15 female, 40 male; APACHE II 23±6. Mortality was 61.5%,
30.3%, 55.6% for patients with mean CI below, within and above nor-
mal range. Mortality was higher for patients with mean CI outside
compared to mean CI inside normal range. (59.1% vs. 30.3%, p=
0.034). Mortality was 54.6%, 41,7% and 11.1% for patients with mean
SVI below, within and above normal range. Mortality was not differ-
ent for patients with abnormal mean SVI (41.9% vs. 41.7%, p=0.984).
Mortality was 0%, 22.7%, 56.3% for patients with mean HR below,
within and above normal range. Mortality was higher for patients
with abnormal mean HR (54.6% vs. 22.7%, p=0.019).
Conclusions:
Patients with abnormal mean CI or HR suffer from increased hospital
mortality. Abnormality of mean SVI was not associated with mortality.
These data support accurate measurement of CI as a hemodynamic
target and the normal range defined for CI. Since CI also carries the
HR information, CI seems to be the more important target than SVI.
Our data cannot necessarily be interpolated to less invasive and less
precise measurements of CI.P203
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Introduction:
Previous studies have shown that 0.8% of CVC attempts resulted in
arterial punctures that were not recognized by blood color. To over-
come the problem, our team has developed a concept of pressure
detecting syringe that can indicate the artery puncture [1]. Based on
previous research, different springs, the actuator of the design, have
been evaluated to optimize the proposed device and reduce the risk
of CVC procedure.
Methods:
Tested devices - The inner-spring is set between the pressure indica-
tor and plunger (Fig. 1A). Three springs are tested.
Critical Care 2020, 24(Suppl 1):87 Page 82 of 213Test condition - Blood samples were simulated by glucose solution with ab-
solute viscosities of 2 and 6 mPa-s. Different blood pressures were applied
to simulate the artery and vein (Fig. 1B). The response time (RT) is defined
as the time required to show the indicating signal (IS) which is the move-
ment of the piston from the position in Fig. 1B: A2-1 to A2-2.
Results:
The RT is strongly influenced by spring (Fig. 1B) but every design can
show the IS when pressure is higher than 50 mmHg, the assumed
minimum artery pressure. The RT of S1, the strongest spring design,
is about 10s in the 50mmHg-pressure and high viscosity condition.
During our tests we found the user can realize the IS before the pos-
ition be fully changed from Fig. IB: A2-1 to A2-2. Thus, we believe
the 10s RT, the worst case, is still acceptable. We also found the weak
spring force may lead to difficulty to empty the syringe because the
spring must to overcome the blood pressure and the friction be-
tween the piston and barrel. As a result, it was difficult for S3 to ab-
solutely empty the syringe even if the blood pressure is only 30
mmHg. The spring will be compressed as Fig. 1B: A2-2 and fail to
push the piston when pushing the plunger forwardly, which is not
acceptable in clinical use.
Conclusions:
The results indicate the feasibility of using the device to facilitate
CVC and we believe the S1 or S2 are more suitable for the future
application.
References:
1. Lin LY et al. Eur J Anaesthesiol 36, e-Supplement 57:222, 2019Fig. 1 (abstract P204). AMOC curves displaying false alarm rate as a
function of time to bleeding detection ; Features - 20 mL/min LOOCV:
model trained and tested on the 20mL/min cohort using standard
statistical features; Features - Transition from 5 to 20 mL/min model
trained on standard features on 5 mL/min cohort and tested on 20
mL/min cohort; Cross Correlations: Corresponding models trained on
cross-correlation features only
Fig. 1 (abstract P203). A The illustration of the proposed device; B.
the relationship between response time and blood pressureP204
Cross-correlation features of vital signs enable robust detection of
hemorrhage
V Jeanselme1, A Wertz1, G Clermont2, MR Pinsky2, AW Dubrawski1
1Carnegie Mellon University, Auton Lab, School of Computer Science,
Pittsburgh, United States; 2University of Pittsburgh, School of Medicine,
Pittsburgh, United States
Critical Care 2020, 24(Suppl 1):P204Introduction:
Models using standard statistical features of hemodynamic vital sign wave-
forms (VS) enable rapid detection of covert hemorrhage at a predetermined
bleed rate [1]. By featurizing interactions between VS we can train powerful
hemorrhage detectors robust to unknown bleed rates.
Methods:
Waveforms (arterial, central venous, pulmonary arterial pressures; peripheral
and mixed venous oxygen saturation; photoplethysmograph; ECG) of
healthy pigs were monitored 20 min prior and during a controlled
hemorrhage at 20 mL/min (N=38) and 5 mL/min (N=13). Two sets of VS fea-
tures were extracted: statistical features [1] and maximal pairwise cross corre-
lations between pairs of VS within a 5s lag over various time window sizes
(30s, 60s, 180s, 300s); and normalized with pre-bleed data of each given ani-
mal. For each feature set, a tree-based (ERT) model [2] was trained and
tested in a one-animal-out setting to mitigate overfitting on the 20 mL/min
cohort, and another trained on the 5 mL/min and tested on the 20 mL/min
cohort. We evaluated models with Activity Monitoring Operating Characteris-
tics curves [3] that measure false alert rate as a function of time to detect
bleeding.
Results:
Models using cross-correlations show no significant deterioration of perform-
ance when applied to detect bleeding at different rates than trained for,
while standard models require 64s longer on average to detect hemorrhage
at 1% false alert rate in the previously unknown setting (Figure 1).
Conclusions:
Correlations between VS data encode physiologic responses to
hemorrhage in a way independent of the actual bleed rates. This en-
ables training effective hemorrhage detectors using only limited ex-
perimental data, and using them in practice to detect bleeding that
occurs at rates other than used in training.
Acknowledgement: Work was partially supported by DARPA FA8750-17-2-
013 and NIH NIGMS 1R01GM117622
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Fig. 1 (abstract P205). A: Key results of the regression analysis; B:
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Introduction:
Artificial intelligence (AI) is receiving increasing interest in modern
ICU. The purpose of this project was to develop an application soft-
ware for guiding hemodynamic decision support in critically ill
patients.
Methods:
We validated a dataset of 634 data lines containing hemodynamic
variables and treatment options. We selected nine hemodynamic var-
iables as inputs. Furthermore, data were collected regarding under-
lying conditions: heart failure, septic shock, renal failure or respiratory
failure or a combination. We applied DataStories regression on the
dataset (Turnhout, Belgium, www.datastories.com). Six different inter-
ventions were analyzed as KPI: administration or removal of fluids, in-
creasing or decreasing inotropes and increasing or decreasing
vasopressors. Finally, we elaborated and challenged 63537 predictive
models to generate a decision algorithm to predict each KPI. We first
looked at how each hemodynamic parameter impacts the prediction
of each KPI individually and performed a standard correlation ana-
lysis as well as a more involved analysis of the mutual information
content between each KPI and all other hemodynamic parameters
individually. Confusion matrix and variable importance was obtained
for each KPI.
Results:
The baseline hemodynamic parameters were: GEDVi 738±218 ml/m2,
EVWLi 11.2±5.5 ml/kg PBW, SVV 14.8±8 %, MBP 77.8±16.5 mmHg, HR
94.2±23.5 bpm, CI 3.3±1.2 L/min.m2. The results of the regression
analysis identified the different variables of importance for each of
the different interventions (Fig 1A). Based on these results the
hemodynamic variables (HR, MBP, GEDVI, ELWI, CI, SVV) were used to
develop the final HemoGuide prediction model (Fig 1B).
Conclusions:
The HemoGuide app can be used to advise physicians with respect
to basic therapeutic decisions at the bedside or as an educational
tool for students. With the collection of new data, the accuracy of
the system may grow over time. The next step of the project is to
develop a more-sophisticated suite: the ICU cockpit.HemoGuide Simulator InterfaceP206
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Introduction:
Capillary Refill time (CRT) is well known as an indicator of peripheral
perfusion. However, it has been reported to have an intra-observer
variance, partly because of manual compression and naked-eye
measurement of the nailbed color change. We hypothesized that a
Critical Care 2020, 24(Suppl 1):87 Page 84 of 213feedback function on a CRT measurement device would lead to an
accurate compression.
Methods:
We developed a novel portable CRT measurement device with an
OLED display that feedbacks weather the strength of the nailbed
compression is enough and counts the time. We settled the target
strength and time as 5N and 5seconds according to the study we re-
ported before [1]. 20 examiners measured CRT with and without the
feedback function. The pressing strength and time during the meas-
urement were evaluated.
Results:
There was a significant difference among the pressing strength and
time between the CRT measurement using the device with and with-
out the feedback function (strength: P<0.001; time: P<0.001). Further-
more, intra-examiner variance was significantly reduced with the
feedback function (strength: P<0.001; time: P<0.001). In all measure-
ments without the feedback function, 41% was outside the optimal
strength while the measurements with the feedback function 100%
achieved the targeted range. Without the feedback function, 12%
could not reach the optimal time, while 100% with the feedback
function did. In total, 49% of the measurements could not achieve
the optimal pressing strength and time.
Conclusions:
The feedback function for CRT measurements, guiding examiners to
an optimal pressing strength and time, fulfilled the required meas-
urement conditions and reduced intra-examiner variance. Our novel
portable device would assist an accurate CRT measurement regard-
less of personal work experience.
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Introduction:
The aim of the study was to detect the difference of conjunctival
microcirculation between septic patients and healthy subjects and
evaluate the course of conjunctival microcirculatory changes in survi-
vors and non-survivors over a 24 hours period of time.
Methods:
This single-centre prospective observational study was performed in
mixed ICU in a tertiary teaching hospital. We included patients with
sepsis or septic shock within the first 24 hours after ICU admission.
Conjunctival imaging using IDF videomicroscope as well as systemic
hemodynamic measurements were performed at three time points:
at baseline, 6 hours and 24 hours later. Baseline conjunctival micro-
circulatory parameters were compared with healthy control.Results:
A total of 48 patients were included in the final assessment and ana-
lysis. Median APACHE II and SOFA scores were 16 (12-21) and 10 (7–
12) respectively. 44 (92%) were in septic shock, 48 (100%) required
mechanical ventilation. 19 patients were discharged alive from the
intensive care unit. We found significant reductions in all microcircu-
latory parameters in the conjunctiva when comparing septic and
healthy subjects. We found a significant lower proportion of perfused
vessels and microvascular flow index (MFI) of small vessels during all
three time points in non-survivors compared with survivors. In non-
survivors we observed no significant changes in conjunctival micro-
circulatory parameters over time. However, survivors had significantly
improved MFI of small vessels at second and third time points com-
pared to first time point.
Conclusions:
Microcirculatory perfusion in conjunctiva was altered in septic pa-
tients. Over 24 hours evaluation survivors in comparison with non-
survivors had better microcirculatory flow with incremental improve-
ment of microvascular flow index.P208
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Introduction:
Extracorporeal membrane oxygenation (ECMO) therapy is an emer-
ging treatment modality for acute respiratory and/or cardiac failure.
Cardiac output monitoring during ECMO therapy remains challen-
ging. This study aims to validate a new method of thermodilution
technique during ECMO therapy.
Methods:
16 healthy pigs were centrally cannulated for veno-arterial ECMO
and precision flow probes were placed on the pulmonary artery main
trunk for reference. 10ml boluses of iced 0.9% saline chloride solu-
tion were injected into the ECMO circuit and right atrium at different
ECMO flow settings (4, 3, 2, 1 L/min). Rapid response thermistors of
standard PA-catheters in the ECMO circuit and pulmonary artery re-
corded the temperature change. After calibration of the catheter
constants for different injection volumes in the ECMO circuit, the dis-
tribution of injection volumes passing each circuit was assessed and
enabled calculation of pulmonary blood flow. Analysis of the expo-
nential decay of the signals allowed assessment of right ventricular
function.
Results:
Calculated blood flow correlated well with true blood flow (r2 = 0.74,
p < 0.001, Figure 1 Panel A, individual measurements). The calculated
changes in blood flow tracked the true changes with 100% concord-
ance (Panel B, average of 5 measurements). Bias was -6 [95% CI -53 –
48] ml/min with clinically acceptable limits of agreement (668 [95%
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(RVEF) was 17 [14 – 20] %. ECMO flow reductions increased end-
diastolic (EDV) and end-systolic (ESV) volumes (Panel D) with reduc-
tions in pulmonary vascular resistance, but without changing central
venous pressure (CVP) and only little changes in RVEF. EDV correlated
highly with ESV (r2 = 0.98, p < 0.001, Panel D).
Conclusions:
Adapted thermodilution allows reliable measurements of cardiac out-
put and assessment of right ventricular behaviour. During ECMO
weaning, the right ventricle dilates even with stable function, pos-
sibly due to increased venous return.Fig. 1 (abstract P209). Venous Excess Ultrasound Score prototypes
combining inferior vena cava (IVC) measurements to pulse-wave
Doppler patterns in the hepatic vein, portal vein and intra-renal
veins. Portal Doppler is considered mildly abnormal when a variation
in the velocities during the cardiac cycle of 30 to <50% are
observed while is considered severely abnormal when a variation of
more than 50% is seen. Hepatic Doppler is considered mildly
abnormal when the systolic component is lower in magnitude than
the diastolic component but still toward the liver while it is
considered severely abnormal when the S component is reversed
(toward the heart). Intra-renal venous Doppler is considered mildly
abnormal when it is discontinuous with a systolic and diastolic
phase while is it considered severely abnormal when it is
discontinuous with only a diastolic phase seen during the cardiac
cycle. S: systole, D: diastole
Fig. 1 (abstract P208). Cardiac output monitoring (Panel A, B, C)
and right heart function (Panel D) during VA ECMO weaning,
assessed by modified thermodilutionP209
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Introduction:
Organ congestion is susceptible to be a mediator of adverse out-
comes in critically ill patients. Point-Of-Care ultrasound (POCUS) is
widely available and could enable clinicians to detect signs of venous
congestion at the bedside. The aim of this study was to develop pro-
totypes of congestion scores and to determine their respective ability
to predict acute kidney injury (AKI) after cardiac surgery.
Methods:
This is a post-hoc analysis of a prospective study in 145 patients for
which repeated daily measurements of hepatic, portal, intra-renalvein Doppler and inferior vena cava (IVC) ultrasound were performed
before surgery and during the first 72 hours after cardiac surgery
[1]. Five prototypes of venous excess ultrasound (VExUS) scores com-
bining multiple ultrasound markers were developed (Figure 1). The
association between each score and AKI was assessed using time-
dependant Cox models as well as conventional performance mea-
sures of diagnostic testing.
Results:
A total of 706 ultrasound assessments were analyzed. We found that
defining severe congestion as the presence of severe flow abnormal-
ities in multiple Doppler patterns with a dilated IVC (>2cm), corre-
sponding to grade 3 of the VExuS C score, showed the strongest
association with the development of subsequent AKI compared with
other combinations of ultrasonographic features (HR: 3.69 CI: 1.65-
8.24 p=0.001). The association remained after adjustment for baseline
risk and vasopressor/inotropic support (HR: 2.82 CI: 1.21-6.55 p=
0.016). Furthermore, this VExUS score offered a useful positive likeli-
hood ratio (+LR: 6.37 CI: 2.19-18.50) when detected at ICU admission,
which outperformed central venous pressure measurements.
Conclusions:
The VExUS C score combines multiple POCUS measurements and
may identify clinically significant venous congestion. Further studies
should aim to validate this score in other patient populations.
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Introduction:
To assess and compare the efficacy of Superior Vena Cava (SVC) & In-
ferior Vena Cava (IVC) diameter changes in response to passive leg
raise by Echocardiography in predicting fluid responsiveness in
mechanically ventilated hemodynamically unstable critically ill
patients.
Methods:
30 patients with hypovolemia or septic shock, mechanically venti-
lated and critically ill were prospectively enrolled over a one-year
period in our ICU. Heart rate, systolic blood pressure, diastolic blood
pressure, mean arterial blood pressure, respiratory variation in SVC
diameter measured by transesophageal echocardiography(TEE), IVC
diameter by transthoracic echocardiography(TTE) and change in car-
diac index measured by maximal doppler velocity in left ventricular
outflow tract were recorded. With formulas, predictive indices like
Collapsibility Index of SVC (cSVC) and Distensibility Index of IVC(dIVC)
were calculated and measurements were performed at baseline and
1 minute after PLR. Patients were separated into responders(R)(in-
crease in cardiac index ≥10%) and non-responders(NR) (increase in
cardiac index <10% or no increase).
Results:
Among 30 included patients, 24 (80%) patients were responders.
cSVC was significantly more accurate than dIVC in predicting fluid
responsiveness.The areas under the receiver operating characteristic
curves for cSVC and dIVC regarding assessment of fluid responsive-
ness were 1.00 (95% confidence interval(CI):1.00 to1.00) and .66 (95%
CI: 0.44 to 0.89) respectively. No significant correlation between cSVC
and dIVC was found among R (r=.02, P=0.92) and NR (r=0.46, P=
0.35)at baseline.The best threshold values for discriminating R from
NR was 35% for cSVC with sensitivity and specificity of being 100%
and 25% for dIVC with 54% sensitivity and 86.7% specificity.
Conclusions:
cSVC had the better sensitivity and specificity than dIVC in predicting
fluid responsiveness. cSVC had a greater diagnostic accuracy than
dIVC in our study.
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Introduction:
There is an increasing awareness on the consequences of fluid ad-
ministration in patients leading to the development of methods that
evaluate the effects of fluids loading on the cardiocirculatory system.
However, most of methods used in the clinical practice investigate
the effects of fluids on the cardiac function, instead of investigating
those on the determinants of venous return. Besides volume of
fluids, the determinants of fluid loading are the blood volume distri-
bution and the availability of vascular bed. In this study we aimed to
test non-invasively the effects of fluids administration on the venularcompartment in the skeletal muscle. In addition to the mean sys-
temic filling pressure (msfp), we calculated changes in the stressed
and unstressed volumes (Vs, Vu) and the venular bed availability.
Methods:
We enrolled 10 critically ill patients in our Intensive Care Unit. We
assessed volumes and pressures by the Near Infra-Red Spectroscopy
on the forearm using graded venous occlusions in steps of 5mmHg
from 50 to 0 mmHg. The msfp, Vu and Vs were measured as previ-
ously reported (Microcirculation 2014; 21:606–614). The vascular bed
availability was measured by changes in the volume recruited from
the occlusion maneuvers. All the measures were done at baseline
and after a fluid load ranging from 250 to 500 ml. Values were
expressed as median and interquartile range. Wilcoxon test was used
to compare data and a p< 0.05 was considered as significant.
Results:
Vascular bed recruited was 33.6% (22.8–42.2) at baseline and 23.9%
(19.0–33.4) after a fluid load (p=0.002). The Vs was 0.5mL (0.3 – 0.7)
at baseline and 0.6 mL (0.5–0.9) after fluids (p=0.620). The Vu was
1.9mL (1.7-2.5) at baseline and 2.3mL (2.0-2.4) after fluids (p=0.193).
Conclusions:
Following fluid administration the only variable that decreased in all
subjects was the vascular bed recruited. This was possibly related to
changes in the interstitial pressure due to fluid leakage.
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Introduction:
Hypotension is a common side effect of general anesthesia (GA) and
is associated with organ hypoperfusion and poor perioperative out-
come [1]. Post-induction hypotension (PIH) is caused by the depres-
sant cardiovascular effect of anesthetic drugs and could be amplified
by hypovolemia. The aim of this study was to assess the ability of
two echocardiographic fluid responsiveness markers to predict PIH:
the inferior vena cava collapsibility index (IVC-CI) and the velocity
time integral change (ΔVTI) after passive leg raising.
Methods:
Sixty patients > 50 years of age and scheduled for elective surgery
were included. IVC-CI and ΔVTI were measured before GA induction.
Anesthesia protocol, fluid infusion and vasopressor administration
were standardized in all patients. PIH was defined as a mean arterial
pressure (MAP) <65 mmHg or a relative decline from pre-induction
value of at least 30% within 12 minutes of GA induction. Receiver op-
erating characteristic (ROC) curve analysis was used. The optimal cut-
off was selected to maximize the Youden index (sensitivity + specifi-
city − 1).
Results:
The measurement of IVC-CI and/or ΔVTI were unsuccessful in seven
patients (11.6%). PIH occurred in 32 patients (incidence 53 %). The
areas under the ROC curves (Figure 1) were 0.84 [95% CI: 0.72 – 0.96;
p<0.0001] for ΔVTI and 0.67 [95% CI: 0.52 – 0.83; p=0.043] for IVC-CI.
The optimal cut-off values were 18% for ΔVTI (sensitivity 75%, specifi-
city 91%) and 25% for IVC-CI (sensitivity 75 %, specificity 45%).
Conclusions:
The ΔVTI after passive leg raising was able to predict PIH and per-
formed better than IVC-CI. The use of this marker could help
individualize strategies to prevent PIH (pre-induction fluid loading,
vasopressors, anesthetic technique and close hemodynamic
monitoring).
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curves of ΔVTI (continuous line) and IVC-CI (Dashed line) for
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Introduction:
Pulse pressure variation (PPV) and stroke volume variation (SVV) pre-
dict fluid responsiveness. In addition, numerous non-invasive devices
provide other dynamic indices such as „Pleth varisbility index (PVI)
which is derived from the pulse oximetry plethysmography wave-
form. Although several studies showed prediction of fluid responsive-
ness by PVI, the data are conflicting, and the cut-offs of PVI range
from 7 to 20%.
Methods:
We compared 240 measurements of PVI (Massimo; USA) with PPV
and SVV simultaneously derived with the PiCCO-device (Pulsion,
Germany) in 30 ICU-patients. Primary endpoint: Concordance of mea-
surements within the categories ‘<9%’, ‘9-13%’ and ‘>13%’. Second-
ary endpoint: Derivation of corrected thresholds for PVI. Statistics:
SPSS 26.
Results:
n=30; 15 female, 15 male; mechanical ventilation 240/240 (100%); va-
sopressors 156/240 (65%). PVI could not be derived in 1 of 240 mea-
surements (0.4%). PVI (14.8±9.3%) was higher (p<0.001) than PPV
(11.1±9.0%) and SVV (12.6±7.3%). Classifications within the categories
‘<9%’, ‘9-13%’ and ‘>13%’ agreed in 117 of 239 (49%) measurements
for PVI vs. PPV (Kendall-tau r=0.435; p<0.001) and in 131 of 239
(55%) cases for PVI vs. SVV (r=0.431; p <0.001). PVI-values of 14% and
17% had the highest sum of sensitivity and specificity (ROC-analysis;
Youden-Index) to predict the established PPV-cut-offs of 9% and
13%. PVI in the corrected categories ‘<14%’, ‘14-17%’ and ‘>17%’substantially better agreed (166/239; 65%; r=0.500) with the PPV-
categories ‘<9%’, ‘9-13%’ and ‘>13%’ compared to the uncorrected
PVI categories ‘<9%’, ‘9-13%’ and ‘>13%’ (agreement 117 of 239 mea-
surements (49%); p<0.001 vs. 166 of 239; chi-square-test).
Conclusions:
PVI was significantly higher than PPV and SVV. Only 49% and 55% of
PPV- and SVV-values are classified in the same categories ‘<9%’, ‘9-
13%’ and ‘>13%’ as PVI. Adjusting the PVI thresholds to 14% and
17% instead of 9 and 13% significantly improves the agreement PVI-
with PPV-categories.P214
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Introduction:
Preload responsiveness might be detected by the changes of cardiac
index (ΔCImini) induced by a “mini-fluid challenge” (mini-FC) of 100 mL
or even by the changes (ΔCImicro) in response to a “micro-fluid chal-
lenge” (micro-FC) of 50 mL. However, the smaller the fluid challenge,
the larger the “grey zone” of diagnostic uncertainty. We tested whether
(1) micro- and mini-FC monitored by calibrated pulse contour analysis
detect preload responsiveness and (2) adding 50 mL when the result of
a micro-FC is within the grey zone improves diagnostic accuracy.
Methods:
In 30 patients with circulatory failure, we infused 50 mL saline over
30s followed by 50 mL over 60s. We measured ΔCImicro and ΔCImini
by the pulse contour analysis (PiCCO2). Preload responsiveness was
defined by an increase in CI (ΔCIPLR) during a passive leg rais-
ing test ≥10%. Diagnostic uncertainty was described by calculating
the grey zone after bootstrapping.
Results:
ΔCImicro were larger in responders than in non-responders (5.1[2.5-
9.9]% vs. 0[0-0.7]%, respectively; p<0.0001). It was also the case for ΔCI-
mini (9.7[7.0-12.6]% vs. 0.8[0-2.9]%, respectively; p<0.0001). We found a
correlation between ΔCImicro and ΔCImini on the one side and ΔCIPLR
on the other side (r=0.71 and r=0.82, respectively; p<0.0001 for both).
For the micro-FC, the area under the receiver operating characteristic
curve was 0.975±0.03 (threshold 1%), while it was 0.955±0.03 for the
mini-FC (threshold 4%). For the micro-FC, the grey zone ranged from
0.82% to 3.47% and included 9 (30%) patients. For the mini-FC, it
ranged from 2.8% to 6.8% and included 9 (33)% patients, among which
6 were already in the grey zone of the micro-FC.
Conclusions:
When evaluated by pulse contour analysis, micro- and mini-
FC reliably detect preload responsiveness but with a large diagnostic
uncertainty. It seems that adding 50mL more fluid to a micro-FC
when its result is within the grey zone does not improve the diag-
nostic accuracy. The study is ongoing.P215
The applicability of fluid responsiveness indices in circulatory
failure (AFRIC study)
R Shi, N De Vita, F Gavelli, JL Teboul, A Pavot, S Carelli, X Monnet
Hôpital de Bicêtre, Hôpitaux universitaires Paris-Saclay, Le Kremlin-
Bicêtre, Service de médecine intensive-réanimation, Paris, France
Critical Care 2020, 24(Suppl 1):P215
Introduction:
Passive leg raising (PLR), pulse pressure variation (PPV), and the end-
expiratory occlusion (EEXPO) test are dynamic indices of fluid respon-
siveness, widely validated in critically ill patients. Our study aims to
investigate the prevalence of conditions in which their use is limited.
Methods:
From January to November 2019, patients with acute circulatory fail-
ure, defined by the need of either norepinephrine support or fluid
Critical Care 2020, 24(Suppl 1):87 Page 88 of 213administration in the previous 24h, were included. The validity cri-
teria of PLR, PPV and EEXPO were evaluated.
Results:
100 patients were enrolled. Septic shock was present in 79% of cases,
cardiogenic and hypovolemic in 8% and 7% respectively, and 6% of
shocks were vasoplegic (non-septic). At the time of enrolment, 94%
of patients had norepinephrine infusion, 66% were mechanically ven-
tilated (MV) and 28% had acute respiratory distress syndrome. PLR
results were not reliable in 34% of cases, due to either compression
stockings (14%) or intra-abdominal hypertension (IAH) (11%). In 7%
of cases, no cardiac output (CO) monitoring could be obtained.
Among MV patients, PPV was not interpretable in 83% of cases
mainly due to spontaneous breathing activity (24%) and low tidal
volume ventilation (21%). The remaining non-interpretable cases
(38%) had multiple concurrent limitations. EEXPO could not be inter-
preted in 20% of MV patients, because either a 15-s respiratory hold
could not be maintained (62%), or CO could not be monitored (38%).
PLR and EEXPO were both valid in 33% of patients, while all the 3
tests were valid in 6% of patients (50% and 9% of MV patients,
respectively).
Conclusions:
In conclusion, PLR interpretation is not reliable in 34% of shock pa-
tients. In MV patients, PPV and EEXPO test cannot be evaluated in
83% and 20% of cases, respectively.P216
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Introduction:
The Starling-SV bioreactance device (Cheetah Medical) reliably de-
tects passive leg raising (PLR)-induced changes in cardiac index (ΔCI).
We tested whether it can also track the small and short-time ΔCI in-
duced by the end-expiratory occlusion (EEXPO) test, and whether
shortening the time over which it averages cardiac output (24 s in
the commercial version) improves the detection.
Methods:
In 42 mechanically ventilated patients, during a 15-sec EEXPO, we
measured ΔCI (in absolute value and in percentage) through cali-
brated pulse contour analysis (CIpulse, PiCCO2 device) and Starling-SV.
For the latter, we considered both CIStarling-24 provided by the com-
mercial version and CIStarling-8 obtained by averaging the raw data
over 8 s. We calculated the correlation between ΔCIpulse and both
ΔCIStarling-24 and ΔCIStarling-8, and the area under the receiver operat-
ing characteristic curve (AUROC) to detect preload responsiveness,
defined by a PLR test.
Results:
When considering absolute values, the correlation coefficient r be-
tween ΔCIpulse and ΔCIStarling-24 was 0.362 (p=0.02), which was lower
than the one between ΔCIpulse and ΔCIStarling-8 (rr comparison). When
considering percentage changes, no correlation was observed be-
tween ΔCIpulse and ΔCIStarling-24. Conversely, the correlation coefficient
between ΔCIpulse and ΔCIStarling-8 was 0.402 (p=0.01), but it was lower
than the one obtained for absolute values (p=0.04 for r comparison).
EEXPO-induced ΔCIStarling-8, both in absolute values and in percent-
age, detected preload responsiveness with AUROCs of 0.90 (sensitiv-
ity 83%, specificity 87%) and 0.89 (sensitivity 83%, specificity 79%),
respectively.
Conclusions:
Shortening the averaging time of the bioreactance signal increases
the reliability of the Starling-SV device to detect EEXPO-induced ΔCI.Moreover, the accuracy of the method is increased when absolute ra-
ther than percentage changes of CI are considered.
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Introduction:
The end-expiratory occlusion (EEXPO) and end-inspiratory occlusion
(EIXPO) tests consist in interrupting mechanical ventilation for 15-sec
and observing its effects on cardiac output with direct measurements
of CI. The perfusion index (PI) is the ratio between the pulsatile and
the non-pulsatile portions of the plethysmography signal. It is in part
determined by stroke volume and can detect a positive passive leg
raising (PLR) test. We hypothesized that the changes in PI could de-
tect a positive EEXPO test and thus preload responsiveness in a to-
tally non-invasive way.
Methods:
In critically ill patients, we measured PI (Radical 7, Masimo) and CI
(PiCCO2, Pulsion Medical Systems) before and during a PLR test, a
15-sec EEXPO and EIXPO tests and, if decided, before and after vol-
ume expansion (VE) (500-mL saline).
Results:
We included 31 patients. In 19 patients with a positive PLR test (in-
crease in CI ≥ 10%), CI and PI increased during PLR by 17±7% and
49±23%, respectively, and during EEXPO test by 6±2% and 11±8%,
respectively. During EIXPO, CI and PI decreased significantly by 12±
4% and 11±9% respectively. In the 12 patients with a negative PLR
test, PI did not significantly change during PLR, EEXPO and EIXPO
tests. Only four patients received VE, causing an increase of CI and PI
by 15±3% and 32±47% respectively. The correlation between the PI
and CI PLR-induced changes was significant (r = 0.84, p<0.001). Dur-
ing the EEXPO test, if PI increased by >5%, a positive response of CI
(≥5%) to the EEXPO test was diagnosed with a sensitivity of 87 (60-
98)% and a specificity of 94 (70-100)% (AUROC curve: 0.92 (0.77-
0.99), p<0.0001). During the combination of EEXPO and EIXPO tests,
if PI increased by >9%, a positive response of CI to the EEXPO test
was diagnosed with the same sensitivity and specificity.
Conclusions:
An increase in PI >5% during an EEXPO test accurately detects a
positive response of CI to the EEXPO test.
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Introduction:
Fluids are among the most prescribed drug in intensive care, particu-
larly among patient with circulatory failure. Yet, very little is known
about their pharmacodynamic properties and this topic has been left
largely unexplored. There is a lack of strong scientific evidence in
current guidelines for fluid administration in shock. Several factors
may impact the hemodynamic efficacy of fluids among which the
Fig. 1 (abstract P219). Temporal trends and regression lines of: A)
volume of fluid given in control arms from hospital admission and
hour 6 or hour 72 post trial enrolment B) Mortality and Apache-II.
References 2, 5 and 6 report 28-day mortality; references 1, 3 and 9
report 60-day mortality; references 4, 7 and 8 report 90-day
mortality. The size of the circles is proportional to the size of
patient cohorts
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fluids administration rate on their pharmacodynamics in particular by
studying mean systemic pressure (Pms).
Methods:
We conducted a prospective observational study in 17 patients with
circulatory failure to compare two volume expansion strategies.
When a patient required a fluid bolus, 500 mL of normal saline were
administered and several hemodynamic parameters were recorded
continuously: cardiac output (CO), arterial pressure (AP), mean sys-
temic pressure (Pms). Infusion rate was let to the discretion of the at-
tending physician and a “slow” and a “fast” group were determined
based on the median of the infusion time. Fluids effect was mea-
sured by the area under the curve (AUC), maximal effect (Emax) and
time to maximal effect (tmax) for each hemodynamic variable.
Results:
Pms AUC was higher in the “fast” group compared to the “slow”
group (p=0.043). We observed a shorter tmax and a higher Emax for
Pms in the “fast” group compared to the “slow” group (p=0.039 and
0.02 respectively). Regarding CO, tmax was also shorter in the “fast”
group (p=0.041). AUC and Emax were similar between the two groups.
Fluid effect dissipated within 60 minutes following the end of fluid
infusion for every patient in both groups. The decreasing slope from
maximal effect was comparable in the groups, for Pms and CO alike.
Conclusions:
The effect of a 500 mL fluid bolus in septic shock patients vanished
within one hour. A faster infusion rate increased maximal effect and
shortened the delay to reach it. Study is ongoing.
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Introduction:
In the past, high-volume intravenous fluid resuscitation in severe sep-
sis and septic shock was common. More recently, concerns over the
harmful effects of this practice have led some clinicians to adopt less
liberal fluid strategies. We sought to analyse temporal trends in fluid
administration in the control arms of recent adult sepsis trials and as-
sess any correlation with patient severity and mortality.
Methods:
A literature search was conducted to identify relevant randomized
controlled trials that reported fluid administration published post
2000. We recorded 4 outcomes: total amount of IV fluid administered
in the control arms of these trials between hospital admission and
hour 6 and hour 72 following trial enrolment, mortality rates at the
latest reported time point and APACHE-II score at admission. We
computed the Pearson correlation coefficient and linear regression
between study dates and the 4 outcomes.
Results:
We identified 9 relevant trials [1-9], which recruited a total of 2,444
patients in their control arms, from 1997 to 2018. The temporal ana-
lysis revealed no obvious trend in the in the total volume of IV fluid
given by hour 6 following trial enrolment (Correlation p=0.94) (Figure
1). However, the total volume of fluid given by hour 72 decreased
significantly over the period of interest (R=-0.78, p=0.02). In parallel,
we observed a decrease in mortality (R=-0.6, p=0.08) but there was
no evidence of decrease in illness severity over time (p=0.84).
Conclusions:
We found that in published RCTs over the last two decades, the
amount of intravenous fluid given to patients with sepsis in the ini-
tial 6 hours did not appear to change, however less intravenous fluid
was given over the first three days. Upcoming large RCTs will test
the safety and efficacy of restrictive fluid administration approaches
in sepsis.
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Introduction:
Clinical practice guidelines recommend prompt intravenous (IV) fluid
resuscitation for pediatric sepsis, including an initial fluid bolus of 20
mL/kg [1]. However, recent evidence is conflicting as to the effective-
ness, volume, and consequences of aggressive fluid resuscitation in
septic children. Therefore, we sought to determine the epidemiology
of early IV fluid resuscitation in an integrated health system, specific-
ally at community hospital emergency departments (ED).
Methods:
We studied a retrospective cohort of pediatric patients (ages > 1
month to < 18 years) with sepsis identified in electronic health rec-
ord data at 11 community EDs in southwestern Pennsylvania from
2010 to 2014. Sepsis was defined as 1) suspected infection (combin-
ation of fluid culture collection and administration of antibiotics and
2) organ dysfunction (pediatric SOFA score ≥ 1) within 24 hours of
suspected infection. Fluid bolus therapy was defined as electronic
documentation of administration of 0.9% normal saline IV bolus
within 1 hour of the time of sepsis onset.
Results:
Among 1,247 patients with pediatric sepsis, 513 (41%) received IV
fluid bolus therapy within 1 hour of time of sepsis onset. The volume
of fluid administered ranged from 2 mL/kg to 67 mL/kg (Figure 1,
Panel A), corresponding to a median volume of 20 mL/kg (IQR 17-22
mL/kg). Patients who received ≥ 20 mL/kg of fluids (n = 258, 50%)
were younger (mean age 5 years, SD 5 vs. 9 years, SD 6; p<0.001),
more often had blood cultures collected during evaluation (86% vs.
76%, p=0.003), and were more often transferred to another facility
(48% vs. 33%, p<0.001) when compared to patients who received <
20 mL/kg of fluids (n = 255, 50%). Mean fluid bolus volume within 1
Critical Care 2020, 24(Suppl 1):87 Page 90 of 213hour of time of sepsis onset by hospital ranged from 12 mL/kg to 24
mL/kg (Figure 1, Panel B).
Conclusions:
In a cohort of community emergency departments, 41% of septic
children received intravenous fluid boluses within one hour, and of
those, only one half received volumes concordant with guidelines.Fig. 1 (abstract P221). Subjects by fluid balance sextiles with rangeFig. 1 (abstract P220). Overall distribution of fluid bolus volume
and mean fluid bolus volume by hospital. A) Frequency of fluid
bolus therapy volumes within one hour of sepsis onset. B) Mean
fluid bolus therapy volume (SD) within one hour of sepsis onset
by hospitalP221
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Introduction:
Septic shock patients are often at risk for volume overload. We ex-
plore a control patient population receiving standard of care (SOC)
resuscitation to evaluate fluid balance in patients with sepsis or sep-
tic shock.
Methods:
FRESH is a prospective randomized controlled study, evaluating the
incidence of fluid responsiveness (FR) and patient centered outcomes
in critically ill septic patients (NCT02837731). Patients initially pre-
sented to the ER with hypotension and symptoms of septic shock
and were admitted to the ICU. Patients randomized to treatment
group had a dynamic assessment of fluid responsiveness (Starling SV,
Cheetah Medical) to guide their resuscitation. Control patients re-
ceived resuscitation per Institution standard of care. Patients were
broken into sextets based on fluid balance.
Results:
48 patients received SOC treatment across 11 institutions globally.
38% were female, and the average age was 62 years. Patients exhib-
ited 2.8 SIRS criteria with a 2.0 average qsofa score. Patients received
a mean of 6.6 ± 3.4L of fluid from hospital arrival until ICU discharge
or 72 hours, whichever occurred first. Patients exhibited an average
fluid balance of 4.2 ± 3.4 L of fluid at ICU discharge/ 72 hours. Fluid
balance ranged from 14.9L to -1.5L (Figure 1).Conclusions:
A wide range of fluid balance exists in septic shock patients cared
for in ICU.P222
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Introduction:
The link between hypoalbuminaemia and poor outcomes in critical
care is well established [1]. Limited data are available on serum albu-
min trends during critical illness [2]. In this study we assessed trends
in serum albumin for up to 7 days in both septic and non-septic crit-
ically ill patients.
Methods:
We retrospectively examined the records of 1107 adult patients ad-
mitted to critical care at the Royal Liverpool University Hospital be-
tween 2008 and 2014. We then excluded patients who did not have
albumin data available for the first 7 days, leaving us with 758 pa-
tients. 506 patients (66.8%) had sepsis, and of these patients 116 had
died by day 28. Of the 252 non-septic patients (33.2%), 40 patients
had died by day 28. Albumin levels were collected for 7 days from
admission to critical care, in addition to other demographic and bio-
chemical data. Statistical analysis was performed using repeated
measures analysis.
Results:
Septic patients had lower serum albumin than non-septic patients
throughout the 7 day period (p<0.001). We observed a decrease in
albumin by day 2 in all groups, with levels increasing over the subse-
quent days. There was no difference in daily serum albumin between
non-septic patients who survived or died.
Conclusions:
This is the first study, to our knowledge, to compare albumin trends
in septic and non-septic critically ill patients over 7 days. Further re-
search is needed to elucidate the optimal recipients and timing of al-
bumin therapy.References:
1. Vincent JL et al. Crit Care 18:231, 2014
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Introduction:
Burn injury is characterized by marked inflammation, capillary leak-
age, and profound hemodynamic alterations. Early albumin resuscita-
tion is avoided fearing a paradoxical fluid escape into the
interstitium. On the other hand, administration of crystalloids in
massive amounts causes tissue edema and fluid extravasation, which
deteriorates tissue perfusion by increasing oxygen diffusion distance.
Albumin administration could reduce the amount required to main-
tain hemodynamic stability in this population. We investigated
whether albumin improves tissue perfusion and microcirculation by
reducing tissue edema.
Methods:
This is an observational study conducted in the Burn Unit of Maas-
stad Hospital, Rotterdam. Patients with burns higher than 15% of
Total Body Surface Area (TBSA) were included in the study. Sublin-
gual microcirculation was measured at admission (T0), 4(T4), and
12(T12) hours after burn injury. Total Vessel Density (TVD) and Func-
tional Capillary Density (FCD) were analyzed. Fluid Management was
calculated according to the modified Parkland formula. Albumin
(20%) infusion was started 12 hours after the burn insult.
Results:
A total of nine patients were recruited between January and Decem-
ber 2019. Patients were included in the study after 5.7±2.3 hours of
the insult with a mean TBSA of 36±22%. The amount of crystalloid
infusion was 2718±3348 ml and 8501±5230 ml at T0 and T12,re-
spectively. Within the first 12h (T12) 502±386 ml albumin was
given. TVD decreased from 23.6±2.2 at T0 to 20±1.3 at T4 (p<0.05)
(Figure 1). It increased to 22.7±3.2 at T12 (ns vs T0). FCD decreased
from 21.2±2.3 at T0 to 18.4±2.1 at T4(p<0.05). It increased to 21.5±
3.2 at T12 (ns vs T0). Focus depth increased (117±32 to 143±28) until
albumin administration (p=0.23). It decreased to 95±28 μm at T12(p<
0.05). Hematocrit decreased after albumin administration (45 to
34%)(p<0.05)
Conclusions:
Resuscitation with crystalloids impaired tissue perfusion. Microcircula-
tion was improved after albumin therapy.Fig. 1 (abstract P223). Macro- and microhemodynamic parametersAcknowledgement:
OD was funded by TUBITAK for this study.
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Introduction:
Spontaneous bacterial peritonitis (SBP) accounts for ≥24% of the bac-
terial infections that occur in patients with cirrhosis, and SBP has a
high mortality rate (20% to 50%). Albumin infusion has been shown
to improve the outcome of SBP. The aim of this study is to examine
the impact of albumin infusion on hospital length of stay (LOS) for
cirrhotic patients with SBP.
Methods:
We utilized a nationwide Electronic Health Record data set (Cerner
Health Facts®) to extract real-world data on adult patients (≥18 years
old) with cirrhosis and SBP who received antibiotics and admitted
between January 1, 2009, and April 30, 2018. International Classifica-
tion of Diseases (ICD-9/10) codes were used to identify cirrhosis and
SBP. We used laboratory data for calculation of the Model for End-
stage Liver Disease Sodium (MELD-Na) score and vital signs data for
calculation of the quick Sepsis Related Organ Failure Assessment
(qSOFA) score at baseline for each encounter. A generalized linear
model was used to assess the relationship between albumin infusion
and hospital LOS.
Results:
There were 2,131 encounters that identified patients with SBP and
cirrhosis, of which 1,661 survived hospitalization. Albumin was in-
fused within 24 hours of admission ('early albumin') in 43% (n=718),
after 24 hours in 31% ('late albumin', n=517), and not administered
in 26% ('no albumin', n=426). MELD-Na was higher at presentation in
early albumin cases versus late- or no-albumin cases (mean 24.0 and
19.5). Unadjusted LOS was lower in patients receiving early albumin
(8.7 days versus 10.4 days). Risk-adjusted analysis demonstrated that
early albumin led to a 17.5% reduction in LOS (95% CI 12.6%-22.2%,
p = <0.0001).
Conclusions:
In these real-world data, albumin infusion within 24 hours of admis-
sion in patients with cirrhosis and SBP was associated with a shorter
hospital stay despite more severe illness. Early albumin may not only
improve clinical outcomes but may also reduce the costs of
hospitalization in cirrhotic patients with SBP.P225
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Introduction:
Septic shock is among the most common critical care illnesses and
incidence is rising, with mortality in excess of 35%. Septic shock pre-
disposes patients to multiple organ failure. While albumin is effective
in management of circulatory dysfunction in septic shock, its
utilization in this population is understudied in the US. We evaluatedthe impact of albumin utilization on hospital length of stay (LOS)
among septic shock patients.
Methods:
We used a nationwide Electronic Health Record data set (Cerner
Health Facts®) to extract real-world data on adult patients (≥18 years
old) with severe sepsis or septic shock, admitted between January 1,
2013, and April 30, 2018, identified by International Classification of
Disease (ICD-9/10) codes, and receipt of antibiotics and vasopressors.
We calculated the Charlson Comorbidity Index (CCI) and the Acute
Physiology Score (APS) at baseline. A generalized linear model was
used to examine the association between albumin and hospital LOS,
especially accounting for the timing of albumin infusion.
Results:
We identified 3,156 unique visits for septic shock patients that sur-
vived to discharge. Albumin was infused within 24 hours of admis-
sion ('early albumin') in 15%, after 24 hours ('late albumin') in 20%,
and not administered in 65%. Both CCI and APS were higher, at pres-
entation, in early albumin cases than late- or no-albumin cases
(mean: 7.49 and 7.17, and 51.50 and 43.23, respectively). Unadjusted
LOS was slightly lower in patients receiving early albumin (11.81 days
versus 11.84 days). A risk-adjusted analysis demonstrated that early
albumin was associated with 4.92% shorter LOS (95% CI 0.43%-
9.22%, p = 0.0322).
Conclusions:
Albumin infusion within 24 hours of admission was associated with a
shorter length of hospital stay. Early albumin infusion may lead to
better outcomes and reduced costs in patients with septic shock.
Further research is being conducted to assess other potential bene-
fits of early albumin administration in this patient population.P226
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Introduction:
Every new septic event follows by hemodynamic instability may lead
sequentially to decreased organ perfusion, multiple organ failure.
Acute renal failure is recognized clinical feature during sepsis (up to
40-50% in all cases). Furthermore, urine output close monitoring is a
cornerstone diagnostic clinical tool in each septic critically ill patient.
In present study, we analyzed the dynamic minute-to-minute
changes in the urine flow rate (UFR) and also the changes in its
minute-to-minute variability (UFRV) during new septic event in critic-
ally ill patients.
Methods:
Demographic and clinical data were extracted from the of 50 critically
ill patients who were admitted to the ICU and developed new septic
event (followed by fever and leukocytosis) and analyzed. A Foley
catheter was inserted into the urinary bladder of each study patient.
The catheter was then connected to electronic urinometer, a collect-
ing and measurement system which employs an optical drop de-
tector to measure urine flow. The urine flow rate variability (UFRV) is
defined and calculated as the change in UFR from minute to minute.
Results:
UFR and UFRV both decreased significantly immediate after new sep-
tic episode until beginning fluid resuscitation (ppvalues <0.001) (Fig-
ure 1). Statistical analysis by the Pearson method demonstrated a
strong direct correlation between the decrease in UFR, UFRV and the
decrease in the MAP (R=0.03, p=0.003; R=0.03, p=0.004) (Figure
1), and heart rate (R=0.12,p=<0.001) since systemic pressure starts to
drop. UFRV and UFR demonstrated good clinical response to fluid
Critical Care 2020, 24(Suppl 1):87 Page 93 of 213administration despite the fact that systemic blood pressure did not
improve (Figure 1).
Conclusions:
We consider that dynamic changes in UFRV and UFR could poten-
tially serve as a more sensitive signals ofclinicaldeterioration during
the new septic event in critically ill patients.We also suggest that
those parameters mightbeable to identify the optimal end-point
of fluid resuscitative measures in septic critically ill patients.Fig. 1 (abstract P227). Thirty-day survival according to AKI
classification model 1 and model 2. Hazard Ratios (HRs) for 30-day
mortality adjusted by sex, age, type of admission, APACHE IV score,
SOFA score at day of admission (excluded renal SOFA score) for
patients with AKI classified with model 1 and model 2
Fig. 1 (abstract P226). Clinical correlation between urine flow rate
variability (UFRV) and UFR and mean arterial blood pressure over
new septic event (black arrows) and and after initial fluid
resuscitation (red arrows). Note: The UFRV and UFR decreased
progressively in parallel with the falling mean arterial blood pressure
and, than, rose again after the administration of fluidsP227
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Introduction:
Diminished urinary output (UO) is largely used as marker of acute
kidney injury (AKI) in critically ill patients. We aimed to explore the
role of urinary output on incidence and mortality of AKI developed
during ICU admission.
Methods:
The study population consists of all patients admitted between 2007
and 2018 to one of the Dutch ICUs included in the NICE database
with an ICU length of stay of at least 48 hours, having daily measure-
ment of creatinine and UO. Only patients without renal replacement
therapy that have a serum creatinine lower than 1.1 mg/dl (97.5
μmol/L) or a UO above 0.5 ml/kg/h on the day of the index ICU ad-
mission were considered at risk for AKI. Patients were followed dur-
ing their ICU stay and classified according to the highest KDIGO
criteria reached based on creatinine alone (model 1) and creatinine
plus UO (model 2) using ICU admission serum creatinine as baseline.
In both models, patients were classified as: no AKI, renal impairment
at the first day of ICU admission, AKI stage 1, AKI stage 2, and AKI
stage 3.
Results:
We identified 52,863 patients (60% male, mean age 63 years, median
ICU-LOS 4 days). Of those, 51.2% of patients had renal impairment at
the first day of ICU admission. Among the remaining patients, 44.4%
in model 1 and 29.9% in model 2 were classified as having no AKI,
2.6% and 1.4% as AKI stage 1, 0.7% and 9.3% as AKI stage 2, and1.1% and 8.2% as AKI stage 3, respectively. Survival at 30-day mark-
edly differed according to the AKI classification model used (Figure).
Similarly, adjusted HRs for 30-day mortality differed among patients
with and without AKI compared to patients with renal impairment at
the first day of ICU admission (Figure 1).
Conclusions:
Among patients admitted to the ICU 50% had renal impairment at
the first day of ICU admission. Our findings suggested that UO plays
an important role both on AKI incidence and mortality and should
be carefully interpret in the clinical setting especially in AKI stage 2
classification.P228
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Introduction:
Acute kidney injury (AKI) mostly attributed to renal tubular damage,
has a high morbidity and mortality outcome [1], so a sensitive tool to
assess the degree of tubular affection is needed for early detection
and management of this condition.
Methods:
We investigated the ability of furosemide stress test (FST) (one-time
bolus dose of 1mg/kg or 1.5 mg/kg if on prior furosemide-intake) to
predict progression to AKIN Stage-III in critically ill subjects with early
AKI.
Results:
We studied 80 subjects; 40 consecutive patients in group I receiving
FST and 40 consecutive patients in group II receiving standard med-
ical management for AKI;15 patients (37.5%) and 20 patients (50%)
met the primary endpoint of progression to AKIN-III in groups I and II
respectively. Patients with progressive AKI had significantly lower
urine output following FST in the first 6 hours (p<0.033). The area
under the ROC curves for the total urine output over the first 2 hours
following FST to predict progression to AKIN-III was 0.87 (p = 0.001).
The ideal-cutoff for predicting AKI progression during the first 2
Critical Care 2020, 24(Suppl 1):87 Page 94 of 213hours was a urine volume of less than 325 milliliters with a sensitivity
of 87.1% and specificity 84.1% group receiving FST. On the other
hand, statistically significant hypotension, hypo-(kalemia, phosphate-
mia and magnesemia) occurred in group I.
Conclusions:
The FST in patients with early AKI could predict liability for progres-
sion of AKI, however it should be performed under adequate
monitoring.
References:
1. Bellomo R et al. Lancet 380: 756-766, 2012Fig. 1 (abstract P229). Cortical and medullar oxygenation. C: Control,
C+F: C+Furosemide, IR: ischemia reperfusion, IR+F: IR + furosemide *:
p<0.05 vs BL +: p<0.05 vs T1 #: p<0.05 vs CP229
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Introduction:
Ischemia-Reperfusion (IR) causes renal dysfunction and damage. IR
induces renal tubular injury triggered by hypoxia and hyperoxia, me-
diated by oxidative stress and inflammation. Furosemide inhibits
Na+-K+-2Cl- cotransporter in the thick ascending limb of the renal
medulla to decrease Na+ reabsorption, reducing oxygen consump-
tion. We investigated if furosemide could improve renal oxygenation,
function and damage by reducing O2 consumption and oxidative
stress after IR.
Methods:
24 Wistar albino rats were divided into 4 groups, with 6 in each
group; Sham-operated Control (C), Control + Furosemide (C+F), IR
and IR+F. After anaesthesia (BL), 45 min supra-aortic occlusion was
applied to IR and IR+F groups followed by 15 min (T1) and 2 hours
of reperfusion (T2). Furosemide 50μg/kg/h infusion was simultan-
eously administered to C+F and IR+F after ischemia. Systemic
hemodynamic, renal blood flow (RBF), renal vascular resistance (RVR),
renal oxygen delivery (DO2ren), renal oxygen consumption (VO2ren),
creatinine clearance (Ccr), sodium handling, urine output (UO), cor-
tical (CμO2) and medullar (MμO2) microvascular oxygenation were
measured.
Results:
RBF was reduced in IR (2.1±1) and IR+F (2.3±1) at T1 (p<0.05) but it
was further reduced in IR+F (1.9±1) (p<0.05) at T2 compared to C
and C+F. RVR was increased in IR (5338±2860) and IR+F (5123±2517)
at T1 compared to C. RVR was normalized in IR (2198±879) but not
in IR+F (4232±2636) at T2 compared to C (p<0.05). CμO2 and MμO2 did
not differ between groups after IR insults (Figure 1). Tissue O2 was re-
duced at the medulla, but not at the cortex in IR+F group compared
to IR. DO2ren and VO2ren were reduced in IR (56±17 and 26±12 ml/
min) and IR+F (34±20 and 21±14) at T2 (p<0.05). PC was higher
in IR+F (37.33±4.27) compared to IR 29.67±3.39 (p<0.05). VO2/
TNa+ was increased in IR+F compared to IR. No change in Ccr and
UO was observed.
Conclusions:
Furosemide after IR causes further impairment of renal perfusion, en-
ergy utilization and renal oxygenation resulting in renal damage.P230
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Introduction:
Acute renal failure (ARR) is a common complication in ICUs and usu-
ally caused by hypoperfusion. ARF induced by hypoxemia is a con-
cept rarely reported in ICU. Its incidence and pathogenesis are not
well understood. We aimed to study the relationship between hypox-
emia and the occurrence of ARF.
Methods:
Retrospective cohort study including patients with hypoxemia what-
ever its etiology between January 2016 and August 2019. Patients
with chronic renal failure were excluded. ARF was defined and
ranked according to the KDIGO criteria 2012. Arterial blood gas, urea,
creatinine and clearance were reordered on the first, third and sev-
enth days of evolution.
Results:
50 patients were included and 2 groups were obtained: group of
hypoxemic patients with ARF (ARF+, n=30): versus group of hypox-
emic patients without ARF (ARF-, n= 20). The incidence of
hypoxemie-induced ARF was therefore 60%. Clinical characteristics
were comparable in both groups with a mean age of 47 ± 16 and a
sex ratio of 1.77. The comparative study showed in ARF+ group: a
lower pH (7.20 [7.8-7.33] vs.7.34 [7.27-7.41], p = 0.003) and a higher C
reactive protein (CRP) in the same group (201 [129.75-325.75] vs.
Critical Care 2020, 24(Suppl 1):87 Page 95 of 213117.5 [29.5-225.25], p = 0.023). The most significant correlation was
showed with MDRD clearance at day 3 and P/F ratio at day 1 (Rho =
0.338, p = 0.038). Multivariate analysis found that septic shock and
non invasive ventilation in hypoxemic patients were the factors re-
lated to ARF with respectively OR=11.08, 95% CI=1.56-83.84, p=0.016
and OR=6.18, 95% CI=1.16-34.07, p=0.033. Overall mortality was 68%
(n=34) and ARF was an independent factor of mortality: OR=6, and
95% CI=1.35-26.64, p = 0.017.
Conclusions:
Hypoxemia-induced ARF is a common complication associated with
excess mortality. Our study suggests that renal function is correlated
with the degree of hypoxemia and that this correlation is rather dis-
tinct 48 hours from hypoxemia.Fig. 1 (abstract P231). Survival estimates (90 days) by metformin
exposureP231
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Introduction:
In preclinical models of sepsis, we have previously demonstrated that
activation of AMP activated protein kinase (AMPK) using metformin,
improves survival and organ function. Thus, AMPK activation is a po-
tential therapeutic target in sepsis, and we hypothesize that expos-
ure to metformin during sepsis is associated with decreased AKI and
mortality
Methods:
Retrospective analysis of a 13-hospital cohort of adult ICU patients
with type 2 diabetes mellitus (T2DM) who presented sepsis. We in-
vestigated if exposure to metformin during the hospitalization was
associated with reduced 90-day mortality and AKI. We used 1:4 Pro-
pensity Score Matching (PSM), Propensity Score Stratification (PSS)
and Propensity Score Weighting (PSW) based on the probability to
be exposed to metformin using 55 covariates. For PSM an exact
match for insulin, amputation, cardiovascular diseases, retinopathy,
Charlson Index, eGFR, HbA1C, and APACHE III, were used. Sepsis was
defined using sepsis 3 criteria, and AKI as KDIGO stage 2 or 3.
Results:
From 164,910 patients, we found 673 diabetic adults exposed to
metformin during hospitalization and 14,174 who were not. PSM in-
cluded 523 treated vs 1,680 no treated patients and resulted in an
OR of 0.54 (95%CI 0.41-0.71, p<0.001) for 90-day mortality favoring
metformin exposure (Figure 1). PSS: (OR: 0.49, 95%CI 0.34-0.63, p<
0.001) and PSW (OR: 0.58, 95%CI 0.55-0.61, p<0.001) confirmed this
protective effect. Metformin exposure also had a protective effect on
stage 2-3 AKI (PSM: OR 0.82, 95%CI 0.67-0.99, p=0.04; PSS: OR 0.83,
95%CI: 0.71-0.98, p=0.02; PSW: OR 0.72, 95%CI 0.69-0.76 p<0.001).
Conclusions:
Metformin exposure during hospitalization is associated with de-
creased 90-day mortality and AKI in septic adult patients with T2DM.
These findings suggest that metformin may constitute a potential
therapeutic strategy in sepsis, and the potential role of AMPK activa-
tion as a protective mechanism. However, studies are needed to con-
firm this association and the specific mechanisms of action.P232
Development and internal validation of a model to predict acute
kidney injury recovery at hospital discharge
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Introduction:
Acute kidney injury (AKI) may occur up to 50% in the intensive care unit
(ICU). Predicting AKI recovery may allow for risk stratification of patients, pa-
tient and family counseling, and early post-discharge renal care planning.
However, predicting AKI recovery at an early stage remains a challenge.
Methods:
This is a retrospective study of the EPaNIC multicenter randomized con-
trolled trial database [1], which was split into development (n=2194) and
validation (n=2446) cohorts, and patients experiencing AKI stage 3 and/or
renal replacement therapy (RRT) in the ICU were included [2]. AKI recovery
was defined as being alive, without any stage of AKI, and without need of
RRT at hospital discharge. A logistic regression model with backward fea-
ture elimination was developed. The model performance was assessed by
discrimination, calibration, and net benefit analysis, and internally validated
with ten-fold cross validation.
Results:
Only the results in the development cohort are reported. Of the 229 pa-
tients who developed AKI3, 86 patients (37.55%) recovered from AKI. The
multivariable model selected age, bilirubin, heart rate, mean arterial blood
pressure, surgical diagnostic group on ICU admission, mechanical
hemodynamic support on ICU admission, suspected sepsis on ICU admis-
sion as AKI recovery predictors. The model had a mean area under the re-
ceiver operating characteristic curve (AUROC) of 0.75 (Standard deviation
(SD) 0.01), mean calibration slope of 1.02 (SD 0.04), and mean calibration-in-
the-large of <0.01 (SD 0.01) (Figure 1). At the classification threshold that
maximized sensitivity and specificity, mean net benefit with respect to
treat-none was 0.16 (SD 0.01) and mean net benefit with respect to treat-all
was 0.11 (SD 0.01).
Conclusions:
By using the routinely collected clinical data, the developed predic-
tion model can fairly identify patients with a higher chance of AKI re-
covery at hospital discharge.
References:
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2. Kellum JA et al. Kidney Int Suppl 2:1–138, 2012
Fig. 1 (abstract P232). Internally validated model performance:
(top row) ROC curve; (middle row) calibration curve; (bottom
row) decision curve
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Introduction:
Acute kidney injury (AKI) is a frequent complication in critically ill pa-
tients and is associated with increased morbidity and mortality. Sep-
sis is one of the most Common cause of AKI.
Methods:
A prospective study was conducted over 6 months (January 01–June
30, 2018).We included patients with septic shock at admission or at
any time during hospitalization.The AKI staging was based on KDIGO
criteria.Patients were divided into two groups, a group with AKI
(AKI+) and a group without AKI (AKI-).Then we compared the base-
line characteristics, laboratory and physiologic data. Patients with AKI
(AKI+) were subdivided according to their prognosis.
Results:
Were enrolled 75 patients. The mean (SD) age was 56.43(±18) years.Sex ra-
tio was 1.91. Fifty-two (70%) patients developed AKI.SAPSII and SOFA score
in admission were higher in patients with kidney injury [59 Vs 44 points
(p= 0.002), 6.5 Vs 4 points ;(p=0.003)] respectively.The serum lactate level
was significantly higher in (AKI +) group patients during the first day of sep-
tic shock [6.12± 1.38 mmol/l (AKI+)Vs 4.11± 0.79 mmol/l(AKI-);(p=0.002) ]
and its clearance was lower [(32±10.99% (AKI +)Vs 61±13%(AKI-);(p=0.001)].
A significant difference was observed in C reactive protein level [224±114
mg/l (AKI +) Vs 124±77 mg/l (AKI-) ; (p=0.004)].Among (AKI+) patients,
KADIGO III was observed in 59.6% of cases.Nineteen (36.5%) patients re-
ceived hemodialysis.A normal kidney function was recovered in 40.4% of
cases.AKI+ patients had a higher occurrence in Disseminated intravascular
coagulation (32 Vs 3 patients, p=0.002),acute respiratory distress syndrome
(18 Vs 2 patients; p=0.023) and cardiac dysfunction (20 Vs 1 patient, p=
0.001).Mortality was higher in AKI group (67% Vs 9%; p=0.001).
Conclusions:
The development of septic AKI was associated with poor outcomes
and prognosis.A better understanding of sepsis induced AKI pathway
will enable us to develop targeted therapeutic protocols.Newer tool-
s,permitting AKI early detection, may make these therapies more
fruitful.
P234
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Introduction:
This study aims to show that contrast procedures do not significantly
increase the risk of renal injury and should not be deferred. Trad-
itionally CIAKI is the most important cause of in-hospital renal failure
after nephrotoxic drugs and shock. Problem is also the non-uniform
definition of CIAKI proposed by three different initiatives (AKIN, ESUR
and KDIGO). AKIN, being the most rigorous, defines CIAKI as an in-
crease in serum creatinine >0.3 mg/dL or >50% of baseline within
48hours.
Methods:
A retrospective observational single-centre cohort study analyzed 82
patients who underwent a contrast procedure with Iomeron 350. The
first group underwent a CT pulmonary angiography (CTPA), and the
Fig. 1 (abstract P236). When comparing AUC in different
categories of BMI, the mCG appeared to be the only statistically
accurate formula in patients with BMI 30–34.9
Critical Care 2020, 24(Suppl 1):87 Page 97 of 213second a coronary angiography with PCI. No patient was previously
prepared (RAAS blockade removal, crystalloid administration etc). We
studied demographics, history of CKD and comorbidities and their
impact on the CIAKI by the AKIN criteria.
Results:
A total of 82 patients were divided into two groups (CTPA and PCI).
CTPA group (20M, 21F) all had acute PE and the PCI group (28M,
13F) were treated for ACS. The mean age was 69 and 65 years re-
spectively. CKD was more prevalent in the PCI group (8pt vs. 3pt)
possibly explained by the more advanced atherosclerotic disease. Ad-
vanced CHD (NYHA III/IV) was found in 3pt (PCI) vs. 2pt (CTPA) while
diabetes and shock were equally distributed (11pt and 5pt) in both
groups. The mean amount of contrast was significantly higher in the
PCI group (242.3mL vs. 60mL). The mean creatinine/eGFR measured
before and after contrast in the CTPA group was 87.3/71.7 vs. 75.1/83
and in the PCI group 91.4/75.9 vs. 105.3/76.1. None of the patients,
according to the AKIN definition, developed any significant rise in
creatinine/eGFR despite existing comorbidities and risk factors.
Conclusions:
Contrast procedures with non-ionic contrast in patients with signifi-
cant comorbidities and risk factors for secondary AKI pose minimal
risk for CIAKI and therefore should not be deferred in clinical
practice.P236
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Introduction:
The goal of this study was to determine whether changing the body
mass (BM) with fat-free mass (FFM) in Cockcroft-Gault (CG) formula
could provide a more accurate prediction of AKI in obese patients
undergoing cardiac surgery.
Methods:
In this retrospective study, we reviewed institutional data of patients
who underwent elective cardiac surgery in a tertiary referral univer-
sity hospital. Baseline patient creatinine value was collected and GFR
was estimated using the MDRD, CKD-EPI and CG formulas. CG for-
mula was further modified by replacing the BM with FFM derived
from the bioelectrical impedance analysis. Postoperative AKI was de-
fined by KDIGO creatinine change definitions. Accuracy of the eGFR
values to predict the AKI was calculated with ROC-AUC analysis. All
the calculations were performed in different categories of BMI.
Results:
476 patients were included in the study, 67.2% of them were men,
mean age was 64.5±10.8y. Median Euroscore II was 1.69 [IQR: 1.05-
2.49]; 66.4% patients underwent CABG. Total of 138 patients were di-
agnosed with postoperative AKI (28.99%). The mean measured eGFR
varied according to equation: MDRD 74.74±0.9, CKD-EPI 76.79±0.9,
CG 86.42±1.4, mCG 61.19±1.0. When comparing AUC in different cat-
egories of BMI, the mCG appeared to be the only statistically accur-
ate formula in patients with BMI 30–34.9 (Figure 1).
Conclusions:
The eGFR is a poor predictor of AKI in obese patients undergoing
cardiac surgery. The FFM modified Cauckraft-Gault formula yield
more accuracy in this specific group.P237
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Introduction:
Acute kidney injury (AKI) is a frequent condition in intensive care
units (ICU) and progressive care units (PCU), affecting 15% to 70% of
the patients, depending on the studied population and AKI defin-
ition. AKI has been identified as an independent risk factor of ICU
mortality and development of chronic kidney desease. The objective
of this study was to describe the incidence of each AKI stages as de-
fined by KDIGO definition (with evaluation of urine output, serum
creatinine and initiation of renal replacement therapy (RRT)), in a
mixed medical and surgical population of patients hospitalized in
ICU and PCU over a 10-year period (2008-2018).
Methods:
We included all patients who stayed more than 12 hours in ICU or
PCU of Edouard Herriot Hospital from May 2008 to January 2019.
Data used to classify the patients were the urine output over a six-
hour period, serum creatinine and the need for RRT, according to
KDIGO classification
Results:
18,882 hospital stays were analyzed. Median ICU/PCU length of stay
was 3 days [IQR: 1.5-6.6]. Among ICU patients, 74% had at least one
AKI episode graded 1, 2 or 3 and 49% had at least one severe epi-
sode (stage 2 or 3). Among PCU patients, 44% had at least one epi-
sode of AKI and 20% a severe episode of AKI. Patients had an
average of 1.9 episodes of AKI per stay. Table 1 represents the inci-
dence of maximal AKI stage during one stay. We found that urine
output was the more frequent criteria to make diagnosis of AKI stage
1 or 2 whereas RRT was more frequent for AKI stage 3.
Conclusions:
This retrospective study reports a more important AKI incidence in
our ICU/PCU than in previous studies. The difference could be
Critical Care 2020, 24(Suppl 1):87 Page 98 of 213explained by the difficulty to collect urine output from conventional
database. Serum creatinine and the use of RRT are often the only
two criteria used to define and classify AKI. These results confirm the
high incidence of AKI in ICU and PCU and the importance to make
an early AKI screening of patients for whom preventive nephropro-
tective actions are needed.Table 1 (abstract P237). Incidence of highest AKI stage reached during
one ICU/PCU stay. AKI = AKI stage 1, 2 or 3 ; severe AKI = AKI stage 2 or
3
ICU (n = 12356) PCU (n = 6019)
No AKI (%) 25.4 56
AKI stage 1 (%) 25.4 24.4
AKI stage 2 (%) 23.6 15
AKI stage 3 (%] 25.5 4.6
AKI (%) 74.6 44
Severe AKI (%) 49.2 19.6
Fig. 1 (abstract P238). In-hospital mortality in patients with and
without infection and different AKI stages. AKI, acute kidney injury;
Mort, mortalityP238
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Introduction:
ICU-patients with acute kidney injury (AKI) requiring renal replace-
ment therapy (RRT) are at risk for infections [1,2]. In this study we
evaluated the incidence of infection in ICU patients with and without
less severe AKI. Finally, impact on outcomes was explored.
Methods:
This is a retrospective study on the PDMS (Protection Data Manage-
ment System) of the 4 adult ICUs of a University Hospital. AKI was
assessed on KDIGO criteria (creatinine (Scr) and urine output), during
the first 7-d of ICU stay. Infection was validated in the PDMS by a
team of ICU specialists.
Results:
During a 4-year period, a total of 7485 subjects were enrolled. AKI
was diagnosed in 64.7% of patients during ICU stay. AKI patients
were older (63 vs. 59 y, p=0.001), had higher SAPS 2 (57 vs. 41, p<
0.001), and had more urgent ICU admission (64% vs. 48%, p<0.001).
More AKI patients had mechanical ventilation (55% vs. 41%, p<0.001)
and vasopressors on d-1 (47% vs. 23%, p<0.001). AKI stage 1, 2, and
3 was present in 25.5%, 28.0% and 11.1% of patients. More AKI pa-
tients had infection (57% vs. 28%, p<0.001) and increasing AKI stages
were associated with higher infection rates (AKI-0: 28%; AKI-1: 55%,
AKI-2: 55%, AKI-3: 69%, p<0.001) (Figure 1). We observed 2-3 times
higher mortality in AKI patients with infection, and a stepwise in-
crease of mortality with increasing AKI stages. After correction for in-
fection and other confounders we found that all AKI stages were
associated with in-hospital mortality (ORs AKI-1: 1.7, AKI-2: 2.0, AKI-3:
3.6, all p< 0.001).
Conclusions:
Over half of AKI patients experienced an episode of infection and in-
creasing AKI severity was associated with higher infection rate. AKI
patients with infection had marked higher mortality, suggesting thatinfection was an important driver of outcome. However, after adjust-
ment, AKI stages had strong association with hospital mortality.
References:
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Introduction:
Several new biomarkers have been introduced to improve early diag-
nosis of acute kidney injury (AKI). “NephroCheck” (NC; Astute Medical,
USA) is a bedside test calculating “AKIRisk” (product of urinary con-
centration of the cell cycle arrest-markers TIMP-2 and IGFBP7). Sev-
eral studies suggest the usefulness of NC in selected populations.
However, the value of early routine measurement of NC is unclear.
Methods:
Therefore, we compared the prediction of a combined endpoint
(CEP: death <60 days and/or requirement of renal replacement ther-
apy RRT) by NC within 12h of ICU admission (NC1) and 24h later
(NC2) with admission values of serum-creatinine, BUN, cystatin C,
urinary NGAL, APACHE II and SOFA (ROC-analysis). As a secondary
endpoint we investigated the additional value of pathological mea-
surements of NC1≥0.3 and/or NC2≥0.3 (NC+) in addition to AKI de-
fined as KDIGO≥1 in a combined model (Kaplan-Meier-analysis).
Statistics: SPSS 26.0.
Results:
106 patients of a general ICU (63±17 years; APACHE II 18±8; SOFA 6±
4). ICU-mortality was 14/106 (13,2%), mortality <60d 33/106 (31,1%).
De novo or acute on chronic (AoC) AKI according to KDIGO≥1: 65/
106 (61,3%). Requirement of RRT 21/106 (19.8%). CEP 40/106 (37.3%).
NC2 provided the largest ROC-AUC regarding the CEP (AUC=0.716;
p<0.0001). Furthermore, cystatin C (AUC=0.715; p<0.001), BUN (AUC=
0.700; p=0.001), creatinine (AUC=0.700; p=0.001), NC1 (AUC=0.659;
p=0.008) and APACHE-II (AUC=0.651; p=0.012) significantly predicted
Critical Care 2020, 24(Suppl 1):87 Page 99 of 213the combined endpoint. Kaplan-Meier-analysis (p=0.024) demon-
strated the lowest survival time for patients with both AKI and ele-
vated NC1and/orNC2 (AKI+/NC+: 36±4d) compared to AKI+/NC- (42±
8d), AKI-/NC+ (49±4d) and AKI-/NC- 54±4d).
Conclusions:
1) NC1 and NC2 were significant predictors of the combined end-
point CEP. However, their predictive capacity was not superior to
cystatin C on admission. 2) By contrast, combination of NC with AKI
according to KDIGO improves prediction of the combined endpoint
vs. KDIGO alone.Fig. 1 (abstract 240). ROCP240
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Introduction:
Objective: This study aimed to explore the diagnostic performance of
a novel Doppler index expression of renal artero-to-venous coupling
(RAVC) in the prediction of acute kidney injury (AKI-3) in post-
surgical critically ill patients compared with systolic time intervals de-
rived from electrocardiographic-gated intrarenal artery Doppler (STI),
renal venous impedence index (VII) and renal Doppler resistive index
(RDRI) [1, 2].
Methods:
Design: Prospective observational study including 45 critically ill pa-
tients. Doppler were measured within 6hours following admission to
the intensive care unit (ICU). AKI was defined according to the Kidney
Disease Improving Global Outcomes criteria (KDIGO). The new Dop-
pler index RAVC was calculated as follows: (Cardiac Cycle Time – ven-
ous flow time)/Arterial Total Ejection time – Pre-Ejection Time).
Results:
Mean RAVC was 4.7±3.4 in patients with AKI 0–2 and 0.8±2.3 in pa-
tients with AKI 3 (P<0.001). Mean STI was 0.82±0.60 in patients with
AKI 0–2 and 0.50±0.27 in patients with AKI 3 (P<0.001). Median VII
was 0.81±0.19 in patients with AKI 0–2 and 0.43±0.24 in patients
with AKI 3 (P<0.001). Mean RDRI was 0.81±0.14 in patients with AKI
0–2 and 0.71±0.08 in patients with AKI 3 (P<0.001). As assessed by
the area under the receiver operator characteristic curves (AUC),
RAVC performed best in diagnosing AKI 3 [AUC=0.95 (95% CI: 0.83–
0.99)] if compared with STI [AUC=0.90 (95% CI: 0.79–0.99)], VII [AUC=
0.92 (95% CI: 0.83–0.99)] and RDRI [AUC=0.67 (95% CI: 0.43–0.92)]
(Figure 1).
Conclusions:
In our study, artero-venous renal coupling has been shown to be the
best predictor for AKI stage 3.
References:
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Introduction:
The first days of critical illness are associated with increased protein
catabolism [1]. Urinary creatinine excretion (UCE) may be a predictor
of endogenous protein catabolism [2]. This study aimed to evaluate
the relation between UCE and creatinine clearance (CrCl), in particu-
lar, with augmented renal clearance (ARC), during intensive care unit
(ICU) admission.
Methods:
Retrospective study in adult patients admitted to a multipurpose ICU
of a tertiary center during 12 months. Urine was collected for an 8-h
period and daily UCE was calculated by extrapolation to 24h. Relative
UCE was calculated as a percentage of theoretical values obtained
with equations proposed by Walser [3].
Results:
A total of 407 patients were included, with a mean age of 62.3±17.3
years, and 35.4% were female. Mean CrCl in the first 2 days of admis-
sion was <60, 60-129 and ≥130mL/min/1.73 m2 in 35.4%, 35.9% and
28.6% of patients, respectively. Considering only patients with a CrCl
≥60mL/min/1.73 m2, an analysis by age categories (20-39, 40-64 and
65-89 years), showed significant higher incidence of trauma on ad-
mission and higher CrCl in younger patients. Relative UCE in the first
2 days of admission was 119.4±37.5%, 114.5±39.5% and 115.0±42.6%
for 20-39, 40-64 and 65-89 years groups (p=0.795) and decreased for
all groups in the 3-7 days of admission period, with lower values for
Critical Care 2020, 24(Suppl 1):87 Page 100 of 213older patients (p=0.011). Relative UCE was positively associated with
the presence of ARC in the different periods of time evaluated. In a
multivariate logistic regression, 90-day mortality was not associated
with relative UCE ≥ 100% or ARC.
Conclusions:
Critically ill patients showed increased relative UCE in the first days
of ICU admission, which may be attributed to higher protein catabol-
ism. Increased relative UCE was associated with ARC and both had
no effect on 90-day mortality.
References:
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Introduction:
This study compared epidemiology, short- and long-term outcomes
for patients with community-acquired (CA) and hospital-acquired
(HA) acute kidney injury (AKI).
Methods:
We retrospectively analyzed all episodes of AKI over a period of 3.5
years (2014–2017) on the basis of routinely obtained serum creatin-
ine measurements in 103,161 patients whose creatinine had been
measured at least twice and who had been in the hospital for at
least two days. We used the “Kidney Disease: Improving Global Out-
comes” (KDIGO) criteria for AKI and analyzed the first hospital admis-
sion. A total of 103161 were admitted in hospital and fulfilled the
inclusion criteria. Average observation period per patient was 248
days.
Results:
The incidence of CA-AKI among included hospital admissions was
9.7% compared with an incidence of 8.6% of HA-AKI, giving an over-
all AKI incidence of 18.3%. Patients with CA-AKI were younger than
patients with HA-AKI (64 vs 66.2y) and had significantly less comor-
bidities, including preexisting cardiac failure, ischemic heart disease,
hypertension, diabetes. Patients with CA-AKI were more likely to have
stage 1 AKI (69,3 vs 58,4%, p<0.001) and had significantly shorter
lengths of hospital stay than patients with HA-AKI (14 vs 24d, p<
0.001). Those with CA-AKI had better survival than patients with HA-
AKI (Figure 1; p<0.001). Patients with CA-AKI were less likely dialysis
dependent before discharge (1.9 vs 4.8% in HA-AKI; p<0.001). Pa-
tients with HA-AKI received more often administrative coding of AKI
(29.3% vs 26.5% in CA-AKI patients; p<0.001)
Conclusions:
Patients with CA-AKI sustain less severe AKI than patients with HA-
AKI, accordigly showing better short- and long-term outcomes. How-
ever, patiens with CA-AKI are at risk of inadequate clinical perception
of AKI.P243
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Introduction:
The evidence base for management of fluid removal during renal re-
placement therapy (RRT) is limited. A recent international survey re-
vealed the extent of practice variation worldwide [1]. Our aim was to
summarise the responses from Europe-based healthcare profes-
sionals who participated in the survey.
Methods:
The international self-administered, cross-sectional, internet-assisted,
open survey was disseminated between January 2018 and January
2019 via website links and emails to members of different critical
care societies.
Results:
485 participants from 31 European countries completed the survey
of whom 365 (75%) were intensivists and 306 (63%) worked in
university-based hospitals. Persistent oliguria / anuria was the most
common indication for fluid removal (51% responders). The parame-
ters which guided fluid removal included hemodynamic status (47%
responders), cumulative fluid balance since admission (23% re-
sponders), and 24-hour fluid balance (17% responders). 90% of par-
ticipants reported using CRRT with a median net ultrafiltration rate
98 mL/hr (IQR 51–108mL/hr) for hemodynamically unstable and a
rate of 300 mL/hr (IQR, 201–352mL/hr) for hemodynamically stable
patients. Only 26% of practitioners checked net fluid balance hourly
(70% nurses, 16% physicians). New hemodynamic instability, defined
as new onset or worsening tachycardia, hypotension, or need to start
or increase the dose of vasopressors was reported to occur in 20%
Critical Care 2020, 24(Suppl 1):87 Page 101 of 213patients (IQR 10.0–30.0). Different strategies to re-gain hemodynamic
stability were used. (Figure 1) Main barriers to fluid removal were pa-
tient intolerance (72% physicians, 85% nurses) and interruptions in
fluid removal (43% physicians, 64% nurses). The majority of partici-
pants agreed that guidelines and protocols would be beneficial.
Conclusions:
The practice of fluid removal during RRT is very variable across Euro-
pean countries. Nurses and doctors identified a need for evidence-
based protocols and clear guidelines.
References:
1. Murugan R et al. Crit Care Med 48:e87-e97, 2020Table 1 (abstract P244). Results
Gender (F/M) 4/7
Age (year) 57,9±20,1
SOFA score (during first CRRT) 11,3±4,9
Sepsis (n) 10
Cirrhosis (n) 2
UFH RCA p-value
Mean filter life time (hour) 40,5±38,9 67,8±29,8 <0,001
Mean ultrafiltration flow (ml/hour) 81,4±39,6 118,2±51,4 <0,001
Fig. 1 (abstract P243). Common measures to correct hemodynamic
instability during fluid removalP244
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Introduction:
Kidney Disease Improving Global Outcomes (KDIGO) guidelines suggest
the use of anticoagulation in continuous renal replacement therapy
(CRRT) [1]. The effectiveness of the anticoagulation is important be-
cause replacing the hemofilter and tube interrupts CRRT and increases
total therapy time. Regional Citrate Anticoagulation (RCA) and Unfrac-
tionated Heparin (UFH) are most commonly using methods for CRRT
anticoagulation [2]. The aim of this study was to investigate the effi-
cacy, safety and metabolic differences of the patients in ICU who
underwent CRRT and anticoagulation method changed from UFH to
RCA for different reasons.
Methods:
After ethics committee approval (2019-14/9) 100 patients who under-
went CRRT between 2018-2019 at Bursa Uludag University Hospital
ICU have been investigated and 11 patients who underwent CRRT by
both RCA and UFH included in the study. We divided patients in two
groups (RCA, UFH), demographic data (sex, age), SOFA score, creatin-
ine, urea, mean filter life time (FLT) and ultrafiltration flow (UF), plate-
lets, electrolytes (Na, K, Ca, Mg), lactate, NaHCO3 and pH of groups
at beginning and ending of first RCA and UFH hemodialysis col-
lected. We used t-test and 1000 bootstraps statistic tests.
Results:
In agreement with other studies [3,4], FLT and UF was statistically sig-
nificant lower in UFH group (Table 1). There was no statistically sig-
nificant difference in efficiency (urea and creatinine decrease), pH,
lactate, NaHCO3 level, platelets count and electrolytes between two
groups. To our knowledge, there are no studies comparing these twoanticoagulation methods in the same patients. Small number of pa-
tients and retrospective evaluation are limitations of the study.
Conclusions:
Our results suggest that the implementation of RCA method is safe
and effective as UFH method with longer FLT and UF.
References:
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Introduction:
Continuous renal replacement therapy (CRRT) with Regional citrate
anti-coagulation (RCA) is increasingly being used as a treatment mo-
dality in critically ill patients. There is limited experience of use of cit-
rate anticoagulation patients with acute liver failure and acute on
chronic liver failure who pose a tough challenge of being at a higher
risk for bleeding. An institutional protocol was formulated for use of
commercially available citrate solutions and the same was studied to
assess filter life and safety of citrate in liver disease. The primary ob-
jective was to assess safety of citrate anticoagulation in liver disease.
Methods:
This study was a single centre, prospective, non-randomized, single
arm, observational study. All adult patients, with acute liver failure
and acute on chronic liver failure requiring CRRT were included.
Blood ionized calcium levels of 0.9 to 1.1mmol/l was targeted
throughout the therapy and total to ionized calcium ratio of less than
2.4 was maintained. RCA was stopped if the ratio was more than 2.4
for 2 consecutive assessments. Incidence of citrate accumulation and
toxicity were assessed. Average filter life was also assessed. Metabolic
parameters, electrolytes and strong ion gap were followed till 24
hours after completion on CRRT.
Results:
A total of 25 patients were included in the study. Nineteen patients
of acute on chronic liver failure and 6 patients of acute liver failure
underwent CRRT with RCA. Baseline average serum bilirubin, lactate
and INR were 11.8 mg/dL, 6.4 mmoL/L and 2.1 respectively. The aver-
age filter life was 50 hours 3 minutes. Citrate accumulation took
place in (n=13) patients and RCA had to be stopped for ( n=6) pa-
tients due to the same. None of the patients had evidence of citrate
toxicity.
Conclusions:
Citrate anticoagulation was well tolerated in patients with acute liver
failure in patients with or without pre-existing chronic liver disease on
CRRT.
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Introduction:
The intention of this study is to highlight the levels of citrate load for
the general population that increases the risk of citrate complications
(insufficient trisodium citrate delivery; net citrate overload and citrate
accumulation) [1].
Methods:
This was a prospective data collection between February and March
2019 in a fourteen bedded Critical Care Unit. Eleven consecutive epi-
sodes of CRRT were collected (a new episode characterized if CRRT
was discontinued for 48 hours and above). One episode was ex-
cluded due to short duration (less than 4 hours). Patients undergoing
RCA-CRRT received either a fixed 25 or 35 ml/kg/h effluent dose
protocol.
Results:
Median patient age was 59, male 100%. Average time on CRRT was
4.1 days (2-9). 70% of the patients had complications, although 60%
were minor (Figure 1). All of the patients with net citrate overload
had citrate loads of 13.8mmol/h or above. The main risk factors were
found to be shock and liver impairment which occurred in 60% of
cases of which 40% developed complications.
Conclusions:
A fixed dose effluent protocol to standardise practice can potentially
lead to a higher risk of minor complications. In our experience this is
likely due to a lack of appropriate monitoring for RCA-CRRT compli-
cations. Despite this, our complication rate of citrate accumulation is
in line with that reported in literature. Citrate loads in our 25 ml/kg/
hr protocol were 22.6% higher than our 35 ml/kg/hr protocol and
strongly related to higher complication rate that worsened in pa-
tients with risk factors for poor citrate metabolism.
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Introduction:
There is no optimal timing of continuous renal replacement therapy
(CRRT) in acute kidney injury (AKI); however, it is based on volume
overload, azotemia, hyperkalemia and severe metabolic acidosis
[1]. An important reason for metabolic acidosis in AKI is increased un-
measured anions (UA) [2]. Delta-pH-UA (ΔpHUA) detects the degree
of metabolic acidosis caused by UA and is calculated by using ‘The
Partitioned pH Model’ [3]. In this study, we investigated whether
ΔpHUA was a predictor to start CRRT in patients with AKI.
Methods:
The study was designed as a multicentric, prospective, observational
study in 2019. Patients who were ≥18 years old and diagnosed with
AKI [1] were included. The moment AKI was diagnosed, arterial blood
gas, albumin, magnesium, inorganic phosphorus, urea, creatinine and
ΔpHUA values were recorded. All patients were divided into two
groups as CRRT(-) and CRRT(+) which consists of patients performed
CRRT due to traditional criteria.
Results:
90 of 709 patients (12.7%) were diagnosed as AKI. CRRT rates in
stage I, II and III AKI were 0.2% (1/41), 47.1% (16/34) and 100% (15/
15) respectively. When patients with stage II were evaluated, the only
parameter which was significantly different between CRRT(+) and
CRRT(-) was ΔpHUA (-0.124±0.076; -0.054±0.048) (p=0.001). Likewise,
the only parameter which had significant UAC value to predict start-
ing CRRT was also ΔpHUA (for≤-0.083; 0.82 [0.67-0.97]) (p=0.002). In
the logistic regression model, the likelihood of starting CRTT was in-
creased 25-fold (3.5-169) by only ΔpHUA≤-0.083 (p=0.001).
Conclusions:
ΔpHUA is prominently negative in patients with AKI performed
CRRT and the only decisive parameter in stage II AKI in which clini-
cians have difficulty in deciding whether to start CRRT. Hence, we
think that ΔpHUA may be a promising parameter to detect the opti-
mal timing of CRRT in AKI.
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Continuous renal replacement therapy (CRRT) is labor intensive and
requires advanced nursing knowledge and skills. However, 40% of
registered nurses (RN) are less than 2-year post-registration experi-
ences in our unit. Also there is an increasing demand of CRRT from
185 CRRT days in 2017 to 248 CRRT days in 2018. The obstacles for
CRRT in our department, includes variation of regimen, complicated
workflow and insufficient training of nurses. A continuous quality im-
provement project is carried out to standardize the regimen, en-
hance workflow and provide structured training to nurses in the
intensive care unit, to enhance nursing competence.
Methods:
1. Questionnaires was set and distributed to identify obstacles of
safe CRRT care.
2. Workgroup was set up to carry out discussion and conduct
literature review. New nurse led protocols were designed . A
standardize CRRT doctor prescription form was designed to
guide the new practice
3. Department journal club applied the evidence-based practice
to introduce the new update practice
4. A single page CRRT nursing observation form was made to
allow easy observation. The practice of safety check was
introduced. Micro-teaching was conducted.
5. Lecture, demonstration and stimulation workshop was
arranged.
Results:
1. Patient outcome showed 80% electrolyte imbalance
(Potassium) was corrected within 8 hours of the
commencement of the new CRRT regime.
2. CRRT circuit half-life is prolonged from 12 hours to 48 hours.
3. The new method of capping procedure . No catheter
associated blood-stream infection was seen after the new
method was launched.
4. Knowledge improvement from 70% in pretest to 98% passing
rate after training.
5. 90% of experienced nurse expressed the theory enhancement
session and simulation workshop were useful.
6. Majority of nurses can perform CRRT independently.
Conclusions:
By standardizing the CRRT regimen, improving workflow and provid-
ing structured training, patient safety and nursing staff competency
are achieved.P249
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Introduction:
Sepsis and septic shock is a leading cause of mortality in the inten-
sive care unit. We tried to evaluate a novel hemoperfusion cartridge
through a retrospective evaluation of patient’s data in our centre. We
used it as an adjuvant therapy in our patients with Sepsis and septic
shock due to varied causes. The aim of this study was to evaluate
the efficacy of therapeutic hemoperfusion cartridge (HC-Foshan Bio-
sun Medical ®) in the management of patients with sepsis.Methods:
We retrospectively analysed data of Group 1 (n=30 Sepsis) and
Group 2 (n=30 sepsis+Hemoperfusison; sepsis treated with Hemoper-
fusion cartridge) admitted between 2015 to 2018. Group 2 had re-
ceived Hemoperfusion cartridge as adjuvant therapy along with
standard of care. Demographic data, procalcitonin [1] and leukocyte
levels before and after therapeutic cytokine removal and duration of
HC were recorded.
Results:
While the mean duration of CVVHDF was 96.4 hours, the duration of
Hemoperfusion cartridge (application was 32.1±16.4 hours). Among 30
patients who survived 25 patients were administered hemoperfusion
cartridge within 12 hours of ICU admission. There was a significant re-
duction in scores like APACHE and SOFA score post Hemoperfusion
cartridge therapy procalcitonin and leucocyte levels after therapeutic
Hemoperfusion cartridge were found significantly lower than the pre-
treatment values (respectively p=0.001, p=0.001). Retrospective analysis
showed significant reduction of vasopressors, and improvement in
MAP in Group2.
Conclusions:
Therapeutic Hemoperfusion cartridge with cytokine removal applied
with CVVHDF in septic patients have positive contributions to pro-
vide survival advantage.
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Introduction:
Removal of activated leukocytes and endotoxin from the blood is a
complex therapeutic effect of the device for removing endotoxin.
Methods:
In the main group (16 patients with abdominal septic shock) after sur-
gery, the traditional treatment was supplemented with two sessions of
endotoxin removal (2 hours each with an interval of 24 hours) using
“Alteco LPS adsorber” (Sweden). The control group consisted of 8 pa-
tients with a similar diagnosis and only traditional treatment.
Results:
28% of white blood cells were adsorbed in LPS adsorber. Among them,
granulocytes (35%) were maximally extracted, then CD14 + monocytes
(CD14+ Mo) (33%), HLA-DR + mononuclear cells (6%), monocytes (2%). IL-6,
IL-10, procalcitonin (PCT) were not adsorbed. The 28-day mortality rate in
the main group was 50% and was lower compared to the control group -
75%. During monitoring, in the main group 24 hours after the first removal
of endotoxin, a decrease in the initially increased amount of activated
CD14+ Mo by 2.2 times, as well as functionally mature defensin+ granulo-
cytes (def+ Gran) by 1.6 times was observed. IL-6, IL-10, and PCT decreased
by 1.9; 17.8; and 1.2 times, respectively. During this period, the control
group showed an increase in CD14+ Mo and def + Gran, while IL-6, IL-10
did not change, and PCT increased 1.9 times. A day after the second re-
moval of endotoxin and then 5 days later, the main group of IL-6, IL-10,
and PCT continued to decline. In the control group, only IL-10 decreased
after 3 days, the rest continued to grow.
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The cellular adsorption of endotoxin-bound CD14 + Mo and mature
def + Gran is an important part of the mechanism of action of the
endotoxin removal device.Fig. 1 (abstract 251). LPS concentration in LPS pulse addition testP251
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Introduction:
In the EUPHRATES trial, the polymyxin B-immobilized fiber column
(PMX) hemoperfusion (HP) had no significant effect on 28-day mor-
tality. Endotoxin (LPS) burden by endotoxin activity assay >0.90 may
exceed 50 μg [1], so the dose and duration of PMX-HP could be in-
sufficient to lower the LPS burden. To confirm this issue, we experi-
mented in a closed-circuit with 24 h continuous LPS addition, and
PMX can adsorb > 50μg [2]. Further, LPS concentration became con-
stant within 2 h in the single LPS spike test for determining PMX-HP
duration [3]. To prove our hypothesis that the single LPS spike test
reflects the adsorption equilibrium, and not saturation, we added
LPS intermittently to reaction.
Methods:
LPS (10 ng/mL) was mixed with 125 mL deactivated fetal calf serum
as a reflux solution, as previously described [2]; this concentration is
much higher than that observed in septic patients. We created a
closed circuit that incorporates PMX-01R at 1/14th the amount of an
adult PMX and performed PMX-HP at 10 mL/min for 5 h. LPS was
added in two shots (post 2 h: 1250 ng, 10 ng/mL; post 4 h: 3750 ng,
30 ng/mL). LPS was measured using the Limulus Amebocyte Lysate
test at 0, 0.5, 1, 2, 3, 4 and 5 hr.
Results:
After an initial decrease between 0 and 1 h, LPS concentration did
not decrease between 1 and 2 h after PMX-HP initiation. Post LPS
pulse addition at 2 h, it increased and then decreased till 3 h. Futher,
it did not decrease between 3 and 4 h, but it increased and then de-
creased again after LPS pulse addition post 4 h (Figure 1). LPS ad-
sorption rates were 76.2, 43.4, and 40.7% at 2, 4, and 5 h,
respectively.
Conclusions:
LPS adsorption capacity of PMX-01R was maintained even after two
additional shots of LPS, suggesting that the constant LPS concentra-
tion in the previously reported LPS spike test might be indicative of
adsorption equilibrium rather than saturation.
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Introduction:
Exta-corporeal blood purification ( BF ) is used in patients with sepsis
– septic shock . However the main Critical Care Societies don’t sug-
gest it’s use, because of the negative RCT. Probably lacking of precise
clinical end points and stratification of the patients may explain
these results. The aim of this study is to evaluate whether 1- Patients
submitted to CRRT with the oXiris stratified on the basal AKIN stage
have different response. 2- This translates in a different clinical
response.
Methods:
A coohort study included 65 patients admitted to three Intensive
Care with sepsis / septic shock ( SEPSIS 3 Criteria ) and AKI ( AKIN
score). All patients were submitted to CVVHDF with the oXiris filter
(Baxter, USA) . The main clinical data, Il 6, Procalcitonin, Endotoxin (
EAA ) and SOFA score were evaluated at basal time ( T0 ) and at the
end of the treatment ( T1 ). All data are expressed as mean ± SD or
median and IQR . ANOVA TEST was used to compare the changes in
the time.
Results:
60 patients were submitted to RRT with the oXiris filter for 46 ± 12
hours . 21 patients had AKI 3 stage , 13 patients AKI 2 stage and 25
patients had AKI 1 stage. At T0 all groups had an high vasopressor
Table 1 (abstract P254). ADVOS treatment performance parameters
Parameter Before 1st ADVOS After 1st ADVOS p-value
Critical Care 2020, 24(Suppl 1):87 Page 105 of 213support to maintain MAP ≥ 70 mmHg. IL6, Procalcitonin EAA and
SOFA total were also elevated with no difference between the
groups. At T1 creatinine improved better in AKI 2 ( p< 0.001 vs. T0 )
and in AKI 1 ( p< 0.0001 vs T0) then in AKI 3 group. MAP increased
in AKI 2 ( p< 0.01 vs T0) and AKI 1 ( p < 0.01 vs T0) , but not in AKI
3 group. IL6, procalcitonin decreased more in AKI 1 ( p < 0.0001 vs
T0) then AKI 3 . At T 2 SOFA total was higher in AKI 3 then AKI 1 ( p<
0.001 ) and AKI 2 ( p< 0.01 ).
Conclusions:
AKI 2 and AKI 1 stage patients submitted to BP with the Filter oXiris
respond better then AKI 3 stage patients . 2 – This transalte in a bet-
ter clinical course. 3- CRRT with Oxiris filter is useful in septic pa-
tients with AKI, but AKI 3 stage septic patients represent an high risk
group.Bilirubin total [mg/dl] 11.2 ± 1.2 9.2 ± 0.8 <0.001
Creatinine [mg/dl] 1.9 ± 0.2 1.4 ± 0.1 <0.001
BUN [mg/dl] 32 ± 3 20 ± 2 <0.001
pH 7.33 ± 0.01 7.40 ± 0.01 <0.001
HCO3 [mmol/l] 21.3 ± 0.6 25.5 ± 0.7 <0.001
Base Excess [mmol/l] -4.5 ± 0.8 1.0 ± 0.8 <0.001
Platelets [/nl] 129 ± 15 100 ± 13 <0.001P254
A non-interventional, multicenter, non-randomized patient registry
for multiple organ dialysis with the ADVOS system: 2-year interim
analysis in 118 patients
V Fuhrmann1, A Perez2, A Faltlhauser3, B Tyczynski4, D Jarczak1, J Lutz5, J
Weinmann-Menke6, W Huber7, A Kribben4, S Kluge1
1Department of Intensive Care Medicine, University Medical Center
Hamburg-Eppendorf, Hamburg, Germany; 2ADVITOS GmbH, München,
Germany; 3First Department of Internal Medicine, Kliniken Nordoberpfalz
AG, Klinikum Weiden, Weiden, Germany; 4Klinik für Nephrologie,
Universität Duisburg-Essen and Universitätsklinikum Essen, Essen,
Germany; 5Medical Clinic, Nephrology-Infectious Diseases,
Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany; 6Division of
Nephrology, I. Department of Medicine, University Medical Center Mainz,
Mainz, Germany; 7Medizinische Klinik und Poliklinik II, Klinikum rechts der
Isar, Technische Universität München, Munich, Germany
Critical Care 2020, 24(Suppl 1):P254
Introduction:
Multiple organ failure is a challenging problem in the ICU. As an ad-
vanced dialysis system, the ADVOS procedure can eliminate water-
soluble and protein-bound substances, regulate the acid-base bal-
ance as well as fluid and temperature. In 2017, a national registry
was established to collect data under "real-life" conditions of patients
treated with ADVOS without any trial-specific interventions (DRKS ID:
DRKS00017068).
Methods:
Data from 01/2017 to 02/2019 from 4 German hospitals (university
hospitals in Hamburg-Eppendorf, Mainz, Essen, and Klinikum Weiden)
were analyzed. Clinical parameters, treatment settings and adverse
events were documented. The 28- and 90-day mortality rates were
compared with extrapolated rates based on the SOFA score.
Results:
118 patients with a median age of 60 years (IQR 45-69), of whom 70
(59%) were male, were evaluated. Patients had a median SOFA score
of 14 (IQR: 11-17) before the 1st ADVOS treatment, which is associ-
ated with an expected mortality of 80%. The number of failing or-
gans was 3 (IQR 2-4): cardiovascular (74%), lungs (57%), liver (47%),
kidneys (74%), coagulation (69%) and CNS (29%). 429 treatments
with a median duration of 16 (IQR: 10-20) hours were evaluated. 87
were discontinued, of which 25 (6%) were due to a device error. 79
adverse events were documented, 13 were related to the device (all
due to clotting and recovered without sequelae). Significant removal
of protein-bound (bilirubin: 11.2 vs 9.2 mg/dl) and water-soluble
toxins (BUN 32 vs 20 and creatinine 1.9 vs 1.4 mg/dl). In addition,improvement in acid-base balance was observed: pH (7.33 vs. 7.40),
bicarbonate (21.3 vs. 25.5 mmol/l) and base excess (-4.5 vs. 1.0
mmol/l) (Table 1). 28- and 90-day mortality rates were 60% and 65%,
respectively.
Conclusions:
In a cohort of patients with multiple organ failure, we observed an
improvement in the expected mortality rate, especially if the ADVOS
procedure was applied early. Adverse events are comparable to other
dialysis therapies in intensive care patients.P255
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Introduction:
Acute kidney injury (AKI) due to ischemia-reperfusion affects one-
third of the patients in cardiac surgery. We investigated the potential
role of Cyclosporine (CsA) to prevent postoperative AKI and mitigate
inflammatory response to extracorporeal circulation (ECC).
Methods:
Double-blind, randomized, placebo-controlled single-center study.
Patients (n=67) scheduled for elective cardiac surgery were random-
ized to 2,5 mg/kg CsA or placebo before the surgery. The primary
objective was to assess the role of CsA to reduce the incidence of
postoperative AKI. The secondary objective was to study CsA induced
changes in the inflammatory response to ECC.
Results:
All enrolled patients were analyzed. Postoperative AKI was more pro-
nounced in the Cyclosporine group compared to placebo. OR=5.03
(1.76-15.74), 95% CI. The cytokine production in response to ECC was
not affected by Cyclosporine (Figure 1).
Conclusions:
In patients undergoing cardiac surgery, a single preoperative dose of
CsA does not prevent the postoperative decrease in renal function.
CsA does not alter cytokine release in response to extracorporeal cir-
culation. Elevated post-ECC levels of pro-inflammatory cytokine IL-6
are associated with kidney dysfunction and may be predictive.
Fig. 1 (abstract P255). Differences in cytokine concentration before
and after extracorporeal circulation and AKI. AKI defined as a 30%
increase of preoperative Cystatine C
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Introduction:
New generation adsorbent such as oXirisR was introduced as novel
technique in renal support for critically ill patients [1]. Septic shock
patients require decatecholaminization strategies emphasizing blood
purification to remove catecholamine-producing mediators and
evacuate overload fluid in interstitials.
Methods:
Our 64-year-old female patient, admitted to ICU after surgery with
history of ovarium cancer. Her septic shock was worsened with ARDS,
hypercoagulable state and AKI. Vasopressors were set. Patient was
controlled with mode SIMV16,PS12,TV350 ml,PEEP7,FiO270%. Renal
support was implemented by diuretic and CVVH started on the sec-
ond day. At first,regular adsorbent was used, post-filter mode was
set, and periodic fluid removal target was 50 ml/h. But after 24hours,
no significant changes observed. OXirisR added and after 12 hours
passed, requirements of vasopressors reduced, tidal volume in-
creased, hemodynamic parameters stabilized, urine production in-
creased. It was continued for 2 days and patient was recovered.
Results:
Our patient had fallen into inadequate CARS stage in which not able
to counter septic effects on vital organs (Figure 1). Renal would be
primary target for filtration and monitoring tool. Adsorbent consisted
of AN69 and polyethyleneimine was useful to purify blood from en-
dotoxins conjoined with slower filtration. Continuous yet cautious
process in CVVH evacuate fluid and mediators while maintain steady
hemodynamics. Biomarkers could not be evaluated due to limited re-
sources, but improving parameters could be signs that showed re-
covery process had already took place.
Conclusions:
Advanced hemofiltration is a privilege. Implementing and enhancing
it with new generation adsorbent would increase survivors byextracting unnecessary fluids and eliminating catastrophic endo-
toxins and mediators.
Consent to publish: written informed consent for publication was ob-
tained from the patient.
References:
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Influence of complications of diabetic ketoacidosis treatment on
length of stay at intensive care unit
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Introduction:
Aim of study was to estimate the rate of hypokalemia and
hypoglycemia as diabetic ketoacidosis (DKA) treatment complica-
tions, relate them also insulin interruption and use of sodium bicar-
bonate (NaH2CO3
-) with length of stay (LOS) in ICU.
Fig. 1 (abstract P258). Pcv-aCO2/Ca-cvO2 variation with pH
Critical Care 2020, 24(Suppl 1):87 Page 107 of 213Methods:
Analysis of retrospective cohort study data of 120 patients (pt)
treated for DKA at ICU of Kaunas Clinics during 2014 - 2019 has been
carried out. Serum kalemia, glycemia; hypokalemia, hypoglycemia ep-
isodes; rate of insulin interruption for hypo- and normoglycemia dur-
ing ketoacidosis; use of NaH2CO3
- for ketoacidosis, and LOS in ICU
were analysed. SPSS 23.0 was used for statistic calculations. Traits
evaluated as significant at p < 0.05.
Results:
At the beginning of DKA treatment in totally hypokalemia (3.1 ± 0.3
mmol/l) was recorded in 64/120 pt (53.3 %). Due to ignoring of blood
pH (6.8 - 7.3 (7.0 ± 0.1) kalemia was falsely misinterpreted as “normo-
“ or “hyper-“ 3.5 – 7.1 (5.1 ± 0.9 mmol/l) in 49/68 pt (72.1 %), thus
disregarded so complicated by obvious hypokalemia additionally in
26/49 pt (53.1 %). In hypokalemia LOS in ICU was 52.9 ± 29.7 vs 32.8
± 18.6 h, p < 0.05. Insulin use has caused hypoglycemia (1.2 – 3.3
(2.5 ± 0.7 mmol/l)) in 22/120 pt (18.3 %), LOS in ICU 63.2 ± 38.5 vs
38.9 ± 21.2 h, p < 0.05.Insulin use was interrupted in case of normo -
and hypoglycemia with still persisting ketoacidosis in 39/120 pt (32.5
%), LOS in ICU was found to be 56.5 ± 30.7 vs 37.0 ± 22.5 hr, p <
0.05. NaH2CO3
- was given for symptomatic treatment of ketoacidosis
during first 10 h of DKA in 33/120 pt (27.5 %) with stable
hemodynamic: HCO-3 buffer has increased (4.8 ± 3.3 - 7.9 ± 3.1
mmol/l), p < 0.05, but it didn’t control ketoacidosis, and LOS in ICU
was 55.2 ± 27.5.2 vs 39.1 ± 25.6 h, p < 0.05.
Conclusions:
Hypokalemia, hypoglycemia, precocious interruption of insulin use
were recorded as complications of DKA treatment. All of them have
prolonged LOS in ICU. Symptomatic treatment of ketoacidosis with
NaH2CO3
- had no effect on it, and prolonged LOS in ICU as well.
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Introduction:
A growing interest exists about CO2 derived parameters in shock
management. Central venous-arterial PCO2 difference (Pcv-aCO2) is
strictly related to cardiac output; central venous-arterial PCO2 differ-
ence to arterial-central venous O2 content difference ratio, Pcv-aCO2/
Ca-cvO2, has been proposed as anaerobic metabolism when it’s >1.4
mmHg/ml [1].
Methods:
To evaluate Pcv-aCO2/Ca-cvO2 reliability in detecting anaerobic metab-
olism, we analyzed it in 7 consecutive patients affected by MALA ad-
mitted to our ICU, considering these patients as a prevalent
anaerobic metabolism model. We calculated, by Douglas formula,
central venous-arterial CO2 content difference to arterial-central ven-
ous O2 content difference ratio, Ccv-CaCO2/Ca-CcvO2, as a Respiratory
Quotient surrogate. We performed arterial and central venous blood
gas analysis simultaneously at admission, we calculated Pcv-aCO2,
Pcv-aCO2/Ca-cvO2 and Ccv-aCO2/Ca-cvO2 and we recorded ScvO2. We
verified relationship between Pcv-aCO2/Ca-cvO2 and ScvO2 and arterial
pH, arterial lactates, SOFA score at admission and Ccv-aCO2/Ca-cvO2 by
linear regression analysis.
Results:
Pcv-aCO2/Ca-cvO2 greatly increases in MALA (2.16 ± 0.84). Pcv-aCO2/
Ca-cvO2 (Fig.1) shows significant co-variation with pH (R2=0.618; p=
0.003) and SOFA score at admission (R2=0.628; p=0.003). Pcv-aCO2/
Ca-cvO2 has poor agreement with Ccv-aCO2/Ca-cvO2 (R2=0.008) and
disagrees with it in identifying anaerobic metabolism, in our series, in
fact, Ccv-aCO2/Ca-cvO2 is, in 3 patients, < 1 like an aerobic RQ value.
Pcv-aCO2/Ca-cvO2 shows better agreement with pH, SOFA score and
lactate level than ScvO2.Conclusions:
In our series, Pcv-aCO2/Ca-cvO2 is good illness and acidosis severity
marker, but it seems to be affected by pH value in accord with Hal-
dane effect [2]. Pcv-aCO2/Ca-cvO2, in our study, doesn’t seem to be a
reliable anaerobic metabolism marker nor a RQ surrogate.
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Introduction:
It is thought that early administration of basal insulin to patients with
diabetic ketoacidosis (DKA) may improve outcomes. Small studies
have shown trends towards decreases in time to closure of anion
gap (TCAG), rates of rebound hyperglycemia following discontinu-
ation of intravenous (IV) insulin, rates of hypoglycemia, intensive care
unit (ICU) length of stay (LOS), and hospital LOS [1-4].
Methods:
This was a single-center, retrospective chart review of our institu-
tion’s DKA protocol between January 2010 and August 2019. Patients
that received early basal insulin within 24 hours of initiation of IV in-
sulin and before closure of the anion gap (AG) were compared to
those that did not receive early basal insulin. The primary outcome
was median TCAG. Secondary efficacy outcomes include: time on IV
insulin infusion, time to de-escalation of level of care, hospital LOS,
and re-elevation of AG. Secondary safety outcomes included inci-
dences of hyperglycemia, hypoglycemia, and hypokalemia.
Results:
A total of 334 patients were identified meeting inclusion and exclu-
sion criteria. Median TCAG was longer in the experimental group (9
vs. 6 hours, p <0.01). Incidence of re-elevation of AG and incidence
of hyperglycemia were lower in the experimental group. Other out-
comes were similar (Figure 1).
Conclusions:
Early administration of basal insulin to patients with DKA resulted in
a longer TCAG with a lower incidence of re-elevation of AG and
hyperglycemia. Early administration of basal insulin appears to be
safe with respect to hypoglycemia and hypokalemia.
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Introduction:
Glycaemic control continues to be a challenge in critically ill patients.
Stress induced hyperglycaemia has been associated with increased
morbidity and mortality [1]. Conversely, patients receiving intensive glu-
cose control have a higher risk of death [2]. A quality improvement pro-
ject was designed to develop a comprehensive insulin protocol that
recognized pre-existing diabetes and reduced hypoglycaemia.
Methods:
Data was collected prospectively in all adult patients admitted to the RAH in-
tensive care unit (ICU) between October 2018 and August 2019 from the na-
tional ICU audit database and electronic patient records. Daily figures were
collected for numbers of hypoglycaemic episodes (<4mmol/l), “in range” (4-
10mmol/l) blood sugar measurements and patients with a pre-existing diag-
nosis of diabetes. Data was collected and analysed using Microsoft Excel.
Results:
307 patients were identified; 56 patients (18.2%) had pre-existing dia-
betes. A total of 6908 blood sugar measurements were reviewed;
5268 (76.3%) were “in range” and 126 hypoglycaemic episodes
(1.8%) occurred. There was no significant correlation between num-
ber of diabetic patients and measurements within range. Of note,
there was an increase in number of measurements per patient in the
second half of the time period (11 vs 32).
Conclusions:
The development of this protocol has improved glycaemic control in
our ICU. There are considerably fewer episodes of hypoglycaemia
and a large proportion of blood sugar measurements are in range.
We hope to continue data collection and interrogate the prevalence
of pre-existing diabetes further to reduce glycaemic variability.
References:
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The optimal management of blood glucose levels for critically ill pa-
tients remains unclear. Hypoglycemia, hyperglycemia and gly-
cemic variability are associated with mortality. The time in targeted
blood glucose range (TIR) has been suggested to correlate with mor-
tality depending on the status of antecedent glycemic control, but It
has not been verified optimal TIR and whether there is an optimal
disease-specific TIR.
Methods:
A retrospective observational study was performed at a single center. In
the present study, we enrolled all critically ill patients admitted in inten-
sive care unit from 1 January 2016 to 31 October. Patients with diabetic
ketoacidosis or hyperosmolar hyperglycemic syndrome and patients
who had < 10 blood glucose readings were excluded. Gathered infor-
mation included, in part, demographics, comorbidities, severity of ill-
ness scores, diagnosis at admission, length of ICU stay and hospital
discharge status. The primary outcome was 28-day mortality. We ana-
lyzed to find the optimal TIR for critically ill patients. Several TIRs were
each tested for correlation with mortality.
Results:
A total of 1,523 patients, 51.8% of whom had diabetes, were studied.
TIR 70 to 139 mg/dL (OR, 0.33; 95%CI, 0.18-0.58), TIR 70 to 179 mg/
dL (OR, 0.33; 95%CI, 0.23-0.47) and TIR 110 to 179 mg/dL (OR, 0.28;
95%CI, 0.17-0.44) > 80 % was independently associated with mortal-
ity in critically ill patients respectively. The optimal TIR did not differ
depending on diagnosis at admission.
Conclusions:
In this retrospective evaluation, TIR 110 to 179 mg/dL > 80 % was inde-
pendently associated with mortality in critically ill patients, especially those
with good antecedent glucose control. These findings have implications for
the design of future trials of intensive insulin therapy.
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Introduction:
The prevalence of chronic dysglycemia (diabetes and prediabetes) in
patients admitted to Swedish intensive care units (ICUs) is unknown.
We aimed to determine the prevalence of such chronic dysglycemia
and asses its impact on blood glucose control and patient-centred
outcomes in critically ill patients.
Methods:
In this retrospective, observational study, we obtained routine glycated
hemoglobin A1c (HbA1c) measured in patients admitted to four tertiary
ICUs in Sweden between March and August 2016. Based on previous dia-
betes history and HbA1c we determined the prevalence of chronic dysgly-
cemia (prediabetes, undiagnosed diabetes and known diabetes). We
compared indices of acute glycemic control in the ICU and explored the as-
sociation between chronic dysglycemia and ICU-associated infections,
mechanical ventilation, renal replacement therapy, vasopressor therapy,
and mortality within 90 days.
Results:
Of 943 patients, 312 (33%) had chronic dysglycemia. Of these 312
patients, 127 (41%) had prediabetes or undiagnosed diabetes and
Critical Care 2020, 24(Suppl 1):87 Page 109 of 213185 (59%) had a known diabetes diagnosis. During ICU stay, patients
with chronic dysglycemia had higher average blood glucose, spent
less time in target glucose range, had greater glucose variability, and
were more likely to develop hypoglycemia than patients without
chronic dysglycemia. Chronic dysglycemia was associated with
greater need for renal replacement therapy (odds ratio 2.10, 95% CI
1.35-3.27) and increased 90-day mortality (hazard ratio 1.33, 95% CI
1.01-1.77) after adjustment for Simplified Acute Physiology Score 3.
In contrast, chronic dysglycemia was not associated with mechanical
ventilation, vasopressor therapy, or ICU-associated infections.
Conclusions:
In four tertiary Swedish ICUs, measurement of HbA1c showed that 1/
3 of patients had chronic dysglycemia (prediabetes or diabetes).
Chronic dysglycemia was associated with marked derangements in
glycemic control during ICU stay, greater need for renal replacement
therapy and with increased mortality at 90 days.
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Introduction:
The modern antidiabetic class of SGLT2-inhibitors, that are known to re-
duce the risk for cardiac events [1], are increasingly used in the last few
years. A 68-year old male patient with diabetes mellitus suffered 10
days after colectomy surgery from abdominal pain and nausea. The pa-
tient had an antidiabetic therapy with empaglifozin that was paused
until day 5 after surgery (nutrition start on day 5, weaning on day 6).
Methods:
This is a case report of one male patient seen in the ICU setting.
Daily blood values including arterial blood gases, vital parameters
and clinical status of the patient were observed and evaluated.
Results:
The blood gases showed this metabolic acidosis: pH 7.38; PCO2 20.3
mmHg, bicarbonate 12 mmol/l, BE -11.63 mmol/l, lactate 1.6 mmol/l, glu-
cose 7 mmol/l. A ketonuria despite normal blood glucose values was no-
ticed, so that the diagnosis of ketoacidosis was clear. After analyzing the
possible causes we found out, that empaglifozin in times of catabolism and
fasting can cause this severe symptomatic. We terminated the therapie with
empaglifozin and under the treatment with insulin the symptoms disap-
peared within 3 days and the patient could be discharged from the ICU on
day 17 after surgery. After one episode of ketoacidosis the therapy with
SGLT2-inhibitors should lifelong never be started again.
Conclusions:
We recommend that intensivists should be aware of the modern
SGLT2-inhibitors because of the shown severe complications and the
increased use of this medication.
Consent to publish: written informed consent for publication was ob-
tained from the patient.
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Introduction:
While obesity confers an increased risk of death in the general popu-
lation, numerous studies have reported an association betweenobesity and improved survival among critically ill patients. This con-
trary finding has been referred to as the obesity paradox. This retro-
spective study uses two causal inference approaches to address
whether the survival of non-obese critically ill patients would have
been improved if they had been obese.
Methods:
The study cohort comprises 6,557 adult critically ill patients hospital-
ized at the Intensive Care Unit of the Ghent University Hospital be-
tween 2015 and 2017. Obesity is defined as a body mass index of
≥30 kg/m2. Two causal inference approaches are used to estimate
the average treatment effect in the untreated (ATU): a naive ap-
proach that uses traditional regression adjustment for confounding
and that assumes missingness completely at random, and a robust
approach that uses super learning within the targeted maximum like-
lihood estimation framework and that uses multivariate imputation
of missing values under the assumption of missingness at random.
Results:
Obesity is present in 18.9% of patients. The in-hospital mortality is
14.6% in non-obese patients and 13.5% in obese patients. The mar-
ginal associational risk difference for in-hospital mortality between
obese and non-obese patients is -1.06% (95% confidence interval (CI)
-3.23% to 1.11%, P=0.337). The naive approach results in an ATU of
-2.48% (95% CI -4.80% to -0.15%, P=0.037), whereas the robust ap-
proach yields an ATU of -0.59% (95% CI -2.77% to 1.60%, P=0.599).
Conclusions:
A robust causal inference approach that may handle confounding
bias due to model misspecification and selection bias due to missing
data mitigates the obesity paradox, whereas a naive approach results
in even more paradoxical findings. The robust approach does not
provide evidence that the survival of non-obese critically ill patients
would have been improved if they had been obese.
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Introduction:
Bowel management within an ICU environment is often difficult. Re-
cent data collection from an intensive care unit at the RVI identified
either loose stool or constipation on > 50% of patient days. It was
postulated this could be improved with a more tightly controlled
bowel management regimen. To test this hypothesis a step-wise
bowel protocol was created and introduced. Data was collected in
the 4 month period following its implementation with the following
aims:
1) Assess effectiveness of the protocol
2) Further observe the reasons for loose or constipated stool on an
ICU
Methods:
Bowel data recorded once a day for each patient. A single recording
was defined as ’one bowel day’. Definitions: Loose stool - type 5-7;
Constipated - type 1-2 or BNO for > 3 days; ‘Normal bowel activity’ -
type 3-4 or BNO < 3 days. In addition, the number and result of per
rectal examinations performed was recorded.
Results:
1) 512 bowel days: Constipation 17%, ‘normal bowel’ 59%, loose
stools 24%. (NOTE: Pre protocol 693 bowel days collected Constipa-
tion 30%, Normal bowel 47%, Loose stools 23%)
2) 86 PRs. 65% empty rectum, 35% stool present
3) Total number of days BO 157. Total number of days BNO 355
4) When BO type of stool as follows: Type 1-2 3 days; Type 3-4 30
days; Type 5-7 124 days
Conclusions:
Re. protocol
1) Did not cause harm
2) Decreased constipation. Increased ‘normal bowel days’
3) loose stool days unchanged - discussion required
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4) When BO predominant motion is loose stools (124 days out of 157
days - 79%) - also seen in previous studies
5*) PR results show 65% of constipation was the result of an empty
rectum
6*) Days of non-defecation (355) was significantly larger than
defecation (157) - 69% vs 31%.
7*) During the 512 days only 3 were recorded as hard stools
Conclusions from 5)6)7) Constipation in ICU more likely to be the re-
sult of non-defecation (reduced activity of the gut/empty gut) than
loaded/hard stool. If unable to PR preference should be towards oral
laxative as opposed to suppository/enema
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Introduction:
Acute colonic pseudo-obstruction (ACPO) or Ogilvie Syndrome is a
disorder characterized by acute dilatation of the colon in the absence
of mechanical obstruction. ACPO can result in colonic ischemia and
perforation, leading to increased morbidity and mortality. Reported
risk factors include trauma, major surgery, sepsis, shock, electrolyte
imbalance, renal failure and medications such as opiates, sedatives
and anti-cholinergics [1]. To date there are few reports of ACPO in
the intensive care cohort. We investigated the incidence and risk fac-
tors associated with ACPO.
Methods:
The ICU admission database was interrogated to identify all patients
diagnosed with ACPO from October 2018 to October 2019. In study
subjects, a retrospective chart review was carried out recording pa-
tient demographics, admission diagnosis and severity of illness.
Charts were examined for risk factors associated with ACPO and for
details of the management of ACPO once diagnosed.
Results:
Of 400 admissions, 7 patients (2 female) developed ACPO, (mean age
52.2 years, mean APACHE 2 score 15.6 (range 8-22). Five patients
were admitted with respiratory failure. Mean time to diagnosis of
ACPO was 7.1 days after ICU admission. All patients were mechanic-
ally ventilated at the time of diagnosis. Six patients received a ceph-
alosporin as per stewardship guidelines. All patients were on
corticosteroid therapy. One patient responded to conservative man-
agement and one patient is receiving ongoing treatment. Five pa-
tients developed a colonic perforation, 3 of these underwent
emergency surgical intervention. All patients who developed a co-
lonic perforation died.
Conclusions:
ACPO is a condition with multiple associations in critically ill patients
and substantially increases mortality risk. Further research is required
into causality to better inform prevention of ACPO in ICU patients.
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Introduction:
Diarrhea is an important problem in each critically ill pateints [1]. We
aimed to investigate the frequency and management of diarrhea in
our ICU.
Methods:
In this study 47 patient retrospectively reviewed, in our ICU between
01.01.2017-03.01.2018. Patients were divided into two group as diar-
rhea “positive” and “negative”. Patients with diarrhea had fluid orloose stools 3 or more times a day. Each diarrhea period of the pa-
tients with diarrhea was examined separately and compared with the
group without diarrhea. Nutritional status, enteral product formula-
tion, leukocyte, neutrophil, albumin values, gastric sparing, antibac-
terial and antimycotic use, LOS in hospital and in ICU were
compared. In diarrhea positive group, on the day of hospitalization,
laxative and/or enema administration, toxin A in stool, nitrogen bal-
ance before and after diarrhea, enteral product change in diarrhea,
probiotic, metronidazole or oral vancomycin use were examined.
Results:
The incidence of diarrhea was 68.3%. The most common diagnosis of
ICU admision was respiratory failure (60-85%) in both groups. Diar-
rhea occurred in two days after laxative and/or enema treatment. En-
teral nutrition was higher in both groups (≥90%). Nasogastric tube
feeding was significantly higher in the diarrhea group (p=0.041).
There was no difference between nutritional product formulation
and diarrhea development (p>0,1). Antibacterial use was high in both
groups (75%); however, Teicoplanin use was significantly higher in
the group diarrhea negative group (p=0.028). The LOS in ICU, and
hospital was higher in diarrhea group (p<0.001). No difference in
mortality rates (p>0.5).
Conclusions:
Many factors may cause diarrhea in ICU, and diarrhea may adversely
affect patient treatment and increase morbidity. We think that pre-
ventive methods are as important as the treatment of diarrhea.
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Introduction:
Prognostic value of malnutrition on postoperative complications and pro-
longed hospitalization in cardiac population, operated on under cardiopul-
monary bypass (CPB) has been previously demonstrated [1]. The impact of
malnutrition on long term follow up was the aim of this study.
Methods:
A data of 1200 patients previously enrolled in prospective observa-
tional study (NCT01366807) was used. Five nutritional screening tools
Malnutrition Universal Screening Tool (MUST), Mini Nutritional As-
sessment (MNA), Nutritional Risk Screening 2002 (NRS-2002) and
Short Nutrition Assessment Questionnaire (SNAQ) were used for nu-
tritional screening during initial hospitalization. Follow up data of
747 patients was successfully collected. Among them 8 year follow
up was reported in 397 patients and 2 year follow up – in 350 pa-
tients. In order to analyze prognostic value of preoperative variables
on survival, univariate and multivariate Cox regression analyses and
Kaplan-Meyer curve analysis was performed
Results:
Nutritional screening tools did not significantly predict mortality.
Among total patient cohort mortality was predicted by Euroscore II
(HR 1.05; 1.03-1.07 CI; p<0.0001), CPB time (HR 1.003; 1.002-1.005 CI;
p<0.0001) and albumin (HR 0.94; 0.92-0.96 CI; p<0.0001) by univariate
and multivariate (Euroscore II (HR 1.05; 1.03-1.08 CI; p<0.0001), CPB
time (HR 1.006; 1.003-1.009 CI; p=0.0001), albumin (HR 0.95; 0.92-0.98
CI; p=0.0004)) analyses. Despite lack of significance, trend for worse
outcomes, associated with malnutrition were found among patients
with heart valve diseases (Figure 1).
Conclusions:
Among cardiac patients operated on under cardiopulmonary bypass
preoperative malnutrition does not significantly affected long-term
survival.
Table 1 (abstract P269). Combinations used to diagnose sarcopenia
Muscle
mass
Muscle
strength
Physical
performance
Risk of malnutrition &
Malnutrition
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Introduction:
Sarcopenia is defined as the combination of decreased skeletal
muscle mass and muscle function. However, muscle mass is assessed
by a specific instrument which is costly and immobilization. A simple
assessment tool for screening sarcopenia without muscle mass meas-
urement might be practical. Objective: to design and validate the
diagnostic performance of a simple assessment tool for screening
sarcopenia in elderly cancer surgical patients who schedule to have
elective surgery.
Methods:
Cancer surgical patients aged > 60 years were enrolled. Nutritional
status was evaluated using Mini Nutrition Assessment-Short Form
(MNA®-SF).Sarcopenia was assessed according to Asian Working
Group for Sarcopenia criteria (AWGS). The validity of four combin-
ation formulas used for a diagnosis of sarcopenia compared to AWGS
definition was presented.
Results:
251 surgical patients were enrolled. 84 patients were diagnosed sar-
copenia according to AWGS. The combination of low muscle strength
and risk of malnutrition & malnutrition and/or abnormal physical per-
formance (C3) showed the highest sensitivity (81%), specificity (78%)
and accuracy (79%) as compared to C1, C2 and C4 combination
(table). The PPV and NPV of this combination were 65.4% and 89%
respectively. C3 showed a higher diagnostic performance in male
than female. A proposed practical algorithm for a diagnosis of sarco-
penia started with the measurement of muscle strength, physical
performance (gait speed) and assess nutrition status with MNA® -SF.
If patients demonstrated low strength & risk of malnutrition and/or
low physical performance, sarcopenia is probable. The confirmation
process was then performed by muscle mass measurement. If an ab-
normal muscle mass is presented, sarcopenia is then diagnosed.
Conclusions:
The screening of sarcopenia can be performed without the muscle
mass measurement. The combination of low muscle strength and risk
of malnutrition & malnutrition and/or abnormal physical performance
showed the highest diagnostic performance.P270
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Introduction:
The use of parenteral glutamine is studied in number of RCTs and
systemic reviews (Heyland D 2013, Wischmeyer P 2014), while there
is a lack of data about the use of enteral glutamine. The aim of our
study was to determine the effect of enteral glutamine supplementa-
tion on the incidence of hospital infections and death.
Methods:
Design: retrospective cohort study. Inclusion criteria: males and females
> 18 years of age, TBSA burned 20%-80%, nasogastric intubation.Pati-
ents were divided in two groups: glutamine group (n=25) and control
group (n=17). In the study group enteral glutamine was administered
to the patients for 5 days after admission to the ICU. Baseline character-
istics were well balanced between groups. No significant difference
was found between groups on patients’ age, sex, TBSA, need for mech-
anical ventilation and rate of inhalation injury. Primary outcome was
all-cause mortality. Secondary outcome was rate of nosocomial infec-
tions (skin and skin structure infections (SSSI), lower respiratory tract in-
fections, urinary tract infections, bacteremia, sepsis).
Results:
Mortality rate was 6 (24%) and 7 (41%) in the glutamine group and
the control group, respectively, p=0.40. Rate of nosocomial infections
was 14 (56%) in the glutamine group and 11 (65%) in the control
group, respectively, р=0.81. Rates of SSSI, lower respiratory tract in-
fections, urinary tract infections and sepsis did not differ significantly
between the groups: 11 (44%) and 6 (35%), p=0.81; 6 (24%) and 7
(41%), р=0.40; 1 (4%) and 1 (6%), р=1.00; 6(24%) and 5 (29%), р=
0.97, respectively. Rate of bacteremia was significantly different be-
tween the groups: 1 (4%) in the glutamine group and 5 (29%) in the
control group, p=0.03. Retrospective design is a significant limitation
of our study.
Conclusions:
Enteral glutamine supplementation may reduce the incidence of
bacteremia in burn patients, but has no influence on the incidence
of other nosocomial infections and mortality. Further large clinical tri-
als are needed.
Fig. 1 (abstract P273). Main causes of interruption of enteral nutrition
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Introduction:
In adults and children, accepting a macronutrient deficit early during
critical illness by withholding parenteral nutrition (PN) for 1 week
(late PN) accelerates weaning from mechanical ventilation, reduces
infections and shortens ICU stay as compared with early supplement-
ing insufficient enteral nutrition with PN (early PN). We hypothesized
that these outcome benefits are in part mediated by fasting-induced
ketogenesis.
Methods:
This is a secondary analysis of the PEPaNIC RCT. First, to identify a
potential time point of maximal effect of late vs. early PN, we quanti-
fied plasma 3-hydroxybutyrate (3HB) in a matched subset of 96 pa-
tients with a PICU stay of ≥5 days. Thereafter, we quantified plasma
3HB and insulin on that “maximal effect” day (or last day for shorter
stayers; 1142 patients with available sample). Associations of 3HB
with outcomes were assessed with multivariable logistic regression
and Cox proportional hazard analyses, adjusted for baseline risk fac-
tors and randomization. In sensitivity analyses, models were further
adjusted for key regulators of ketogenesis to assess whether any ef-
fect was direct or indirect.
Results:
Late PN increased plasma 3HB as compared with early PN, with max-
imal effect on day 2 (P<0.0001 for day 1 to 5 and for the “maximal
effect” day in the 1142 patients). Adjusted for baseline risk and
randomization, plasma 3HB associated with a higher likelihood of
earlier live weaning from mechanical ventilation (P=0.0002) and of
earlier live PICU discharge (P=0.004). As plasma 3HB replaced the ef-
fect of the randomization, the 3HB effect statistically explained these
benefits of the randomization. Further adjustment for key regulators
of ketogenesis did not alter these findings. Plasma 3HB did not inde-
pendently associate with the risk of infections and mortality.
Conclusions:
Withholding early PN increased ketogenesis in critically ill children,
an effect that statistically mediated part of its clinical benefits.
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Introduction:
Critical care patients are prone to frequent feeding interruptions for
various reasons including feeding intolerance. These interruptions can
lead to adverse outcomes. The aim of the study was to determine the
reasons for and the duration of interruptions of enteral nutrition (EN).
Methods:
Single-center observational, cross-sectional study in a 19-bed mixed
ICU of a tertiary hospital. Duration: 6 months. 50 patients, aged 65.4
years old (±14.6), that stayed in the ICU > 48 hrs and were fed withEN were included. Anthropometric data, BMI, time of initiation of pre-
scribed EN, type of EN formula, daily calories delivered were re-
corded. Energy intake was calculated according to ESPEN guidelines
(25 Kcal/ kg BW/day). The causes for and duration of interruption
were reviewed from the patient’s chart. APACHE II and mNutric score
was calculated for all patients. mNutric score ≤5 was used to diag-
nose malnutrition.
Results:
All patients included in the study were endotracheally intubated.
APACHE II was 22.4 ±5.6. 58% of patients had increased risk of mal-
nutrition. ICU stay was 24.4 (8.0±32.0) days, and the in-hospital mor-
tality was 24%. There were 318 episodes of EN interruptions over a
median ICU stay of 24.4 days. Median 2.5 interruptions/patient. The
most common reason for EN interruption was gastric residual volume
monitoring followed by diagnostic and therapeutic procedures (Fig-
ure 1). Other reasons include surgery, intolerance and/or delayed
feeding and extubation. The median lost feeding time was 5.4 hours/
day (3.7-7.4) for all causes, while the mean loss of total energy intake
was 790 kcal/day (±321)/day. Average body weight of the patients
was 78 Kg (±12). Caloric deficit was calculated at 1950 Kcal/day or
40% of the prescribed caloric goal.
Conclusions:
The results of this study showed that interruptions can lead to substan-
tial caloric deficit, malnutrition and adverse events. An interruption-
minimizing protocol could be useful in order to reduce the missing
hours and to improve the clinical outcomes.P274
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Table 1 (abstract P275). Results
Na Δ≤-5
mEq
5 >Na Δ≤ -10
mEq
Na Δ>-10
mEq
p
Patients, n(%) 138(72.3) 39(20.4) 14(7.3)
Length of stay (days), mean(SD) 4.4(2.3) 4.5(2.7) 6.3(2.9) 0.022
Autoimmune hepatitis (AIH), n(%) 6(4.3) 0 3(21.4) 0.013
Terlipressine cumulative dose
(mg), mean(SD)
33.0(17.4) 37.8(16.6) 39.3(14.7) 0.169
Terlipressine duration (days),
mean(SD)
3.3(1.6) 3.8(1.6) 3.6(1.0) 0.124
Serum Na admission (mmol/L),
mean(SD)
136.9(4.5) 140.1(4.7) 141.8(3.4) <
0.001
Mortality, n(%) 4(2.9) 0 1(7.1) 0.237
Critical Care 2020, 24(Suppl 1):87 Page 113 of 213Introduction:
There are controversies surrounding the effects of optimal nutritional
intake on clinical outcomes in critically ill patients. This study aimed
at investigating the relationship of goal-directed energy and protein
adequacy on clinical outcomes which includes mortality, intensive
care unit(ICU) and hospital length of stay (LOS), and length of mech-
anical ventilation (LOMV).
Methods:
This was a single centre prospective observational study. Nutritional
requirements were guided by Indirect Calorimetry and 24-h urinary
urea.Nutritional intake was recorded daily until death, discharge, or
until day 14 of ICU stay. Clinical outcomes were collected from pa-
tient’s hospital record. The relationship between the two groups (<
80% and ≥80% of overall nutritional requirement) with mortality out-
comes was examined by using logistic regression with adjustment
for potential confounders.
Results:
Data were collected from 314 critically ill patients (age, 53.6±18.9
years; 63.4% male; body mass index, 25.7±7.2 kg/m ; APACHE II
score,23.5±6.2). Patients in the ≥80% of nutritional requirement
group (n=207) had a higher mean energy adequacy (97.9±12.3 vs.
65.4±14.7 %,p<0.001) and protein adequacy (96.8±21.2 vs. 67.3±24.1
%, p<0.001). Overall, no significant difference between <80% or
≥80% of energy adequacy in mortality outcomes in univariate and
multivariate analysis. Energy adequacy was not associated with 60-
day mortality when adjusted for protein adequacy (Adj OR 0.668;
95% CI, 0.332 – 1.343; p=0.257). However, energy adequacy of ≥80%
signicantly increased ICU LOS (p<0.001), hospital LOS (p=0.02) and
LOMV (p<0.001).
Conclusions:
Goal-directed energy and protein adequacy of ≥80% associated with
increased ICU LOS, hospital LOS and LOMV, but not associated with
mortality outcomes. Based on this result, energy provision should be
conservative during the acute phase of critical illness. The optimal
protein dose requires further investigation.
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Introduction:
Terlipressin, despite being one of the main treatments for acute vari-
ceal bleeding, may lead to severe hyponatremia due to its antidiure-
tic activity.We aimed to identify risk factors for development of
hyponatremia during terlipressin treatment.
Methods:
Retrospective study of patients admitted to Acute Intermediate Care
Unit for hypertensive upper gastrointestinal bleeding due to chronic
liver disease who received terlipressin(december2011-decem-
ber2018).Hyponatremia was defined as a decrease in Na serum levels
≥5mEq and severe hyponatremia as >10mEq within 3 days of
treatment.
Results:
We studied 191 patients, 84.3% male, mean age of 58.6 years (SD
10.8). Alcohol-related liver disease was the most frequent etiology.
Hyponatremia occurred in 53 patients (27.7%). Serum Na Δbetween
-5 and -10mEq and serum Na Δ>-10mEq occurred in 20.4 and 7.3%,
respectively (Table 1). Severe hyponatremia occurred in 11 patients(5.8%) and symptoms were reported in two cases (status epilepticus
and altered mental status). Patients with higher baseline levels of Na
were more susceptible to terlipressin-induced hyponatremia and a
longer length of stay was observed in patients with serum NaΔ>-10
mEq (6.3 vs 4.4 days, p<0.022).
Conclusions:
The prevalence of hyponatremia in our study was lower than previ-
ously reported.Higher serum Na at admission and AIH as etiology of
cirrhosis were predictors of terlipressin-induced hyponatremia. Nei-
ther the cumulative dose of terlipressin nor the duration of treatment
appear to be related to the development of hyponatremiaP276
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Introduction:
It is unknown whether the established association of hyponatremia
with mortality is causal and whether correction of mild hyponatremia
would improve survival. Our objective was to assess the independent
association of change in serum sodium in the first 48 hours after ICU
admission with hospital mortality.
Methods:
Multicenter cohort study in ten Dutch ICUs between January 2011
and April 2017. Inclusion criteria: patients with at least one serum so-
dium measurement within 24 hours of ICU-admission [Na1] and at
least one serum sodium measurement 24-48 hours after ICU admis-
sion [Na24-48h]. A Cox proportional hazard model adjusted for age,
gender, and APACHE-IV score was used to assess the association be-
tween Δ48h-[Na] (mean-[Na24-48h]-[Na1]) and hospital mortality.
Results:
In total, 36,660 patients were included for analysis. Patients with se-
vere hyponatremia (<125 mmol/L) and hypernatremia (>145 mmol/L)
at the time of ICU admission had a higher risk of mortality. For mild
hyponatremia, normonatremia, and hypernatremia at ICU admission,
Critical Care 2020, 24(Suppl 1):87 Page 114 of 213a Δ48h-[Na] >5 mmol/L was associated with larger hazards of mortal-
ity (Figure 1).
Conclusions:
An increase in serum sodium in the first 48 hours of ICU admis-
sion is independently associated with a higher mortality in pa-
tients admitted with mild hyponatremia, normonatremia, and
hypernatremia. Based on our findings, it is possible that mild
hyponatremia may be a protective mechanism in critical illness,
which questions common practice of routinely correcting serum
sodium when it is too low.Fig. 1 (abstract P276). Association between in-hospital mortality
and Δ48h-[Na] according to first serum sodium measurement at
ICU admissionP277
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Introduction:
Variceal bleeding is one of the major causes of death in cirrhotic pa-
tients. We analyzed our database to identify factors determining poor
outcome: the composite of in-hospital death from any cause and
rebleeding after days 5 and 45.
Methods:
During the period 2007-2019, 87 patients with variceal bleeding were
treated in our institution. On admission data including patient char-
acteristics and laboratory findings were assessed and further ana-
lyzed. A multivariate analysis was performed to identify predictors of
poor outcome.
Results:
Twelve patients died (10.4%) and 24 (20.8%) patients had a poor out-
come. Integrated multivariate model: albumin (p=0.14), active alco-
holism (p=0.09), portal thrombosis (p=0.01), mechanical ventilation
assistance (p=0.24), creatinine (p=0.04), base excess (p=0.09), en-
cephalopathy (p=0.07), heart rate (p=0.99), white blood cells (p=
0.05), MELD (p=0.08), mean arterial pressure (p=0.04), platelets (p=
0.48), prothrombin time (p=0.72) and gastric varices (p=0.01). In the
multivariate model the presence of portal thrombosis, elevated cre-
atinine, diminished mean arterial pressure and gastric varices were
independent associated with poor outcome in cirrhotic patients ad-
mitted for variceal bleeding. (AUC ROC 0.90; 95% IC: 0.82-0.95).
Conclusions:
The presence of portal thrombosis, elevated creatinine, diminished
mean arterial pressure and gastric varices were independent associated
with poor outcome in cirrhotic patients admitted for variceal bleeding.P278
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Introduction:
While acute liver failure (ALF) develop coagulopathy, the risk of
bleeding in ALF is controversial [1, 2]. We aimed to evaluate the
bleeding risk of ALF among critically ill patients.
Methods:
We analyzed 200,859 critically ill patients from multi-center database
who admitted to 335 Intensive care units (ICUs) in the United States
between 2014 and 2015, which is monitored by eICU Programs. Pa-
tients without diagnosis of trauma and bleeding on admission were
included. Primary outcome was all hemorrhage occurred during ICU
stay. Logistic regression analysis was performed to evaluate the risk
of bleeding in ICU.
Results:
Of 153,691 patients included in this study, 428 were ALF. Bleeding
events were occurred in 1,817 (1.18%) patients. Intracranial
hemorrhage (ICH) were occurred in 488 (0.32%), and gastrointestinal
(GI) bleeding were in 827 (0.54%) cases. On multivariable Logistic
regression analysis, variables significantly associated with all
hemorrhage were ALF (Odds ratio[OR] 4.13; 95% confidence interval
[CI]:2.52-6.77; p<0.0001), older age, African American, Hispanic, and
Native American ethnicity, cardiac arrest, stroke, sepsis, mechanical
ventilation, and history of GI bleeding. ALF were also associated with
intracranial hemorrhage (OR:8.54; 95%CI:3.09-23.6, p<0.0001), and GI
bleeding (OR:5.25; 95%CI:3.03-9.08; p<0.0001 ). ALF significantly
strengthen magnitude of effect on all hemorrhage in mechanically
ventilated patients (p=0.003) and sepsis (p=0.08).
Conclusions:
ALF is associated with all type of hemorrhage, including ICH and GI
bleeding in critical care settings. ALF showed synergy effect on
bleeding in patient with mechanical ventilation and sepsis.
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Introduction:
Acute liver failure (ALF) represents a life-threatening organ dysfunc-
tion associated with increased mortality and liver transplantation rep-
resents the only definitive treatment. The aim of this study was to
assess the effects of renal replacement therapy in combination with
hemoadsorption in ALF patients.
Methods:
Twenty-nine patients with ALF admitted to the intensive care unit
(ICU) of Fundeni Clinical Institute were included in the study. After
ICU admission, 3 consecutive session of hemoadsorption in combin-
ation with continuous veno-venous hemodiafiltration were applied.
Number of organ dysfunctions and SIRS criteria were recorded at ICU
admission. The following data were recorded before and after the 3
hemoadsorption therapies: Glasgow coma scale, PaO2/FiO2, creatin-
ine, 24-hours urine output, bilirubin, leucocyte and platelet count,
heart rate, mean arterial pressure and vasopressor support, C-reactive
protein and procalcitonine. CLIF-SOFA score was calculated before
and after the therapy. ICU length of stay and 28-days outcome
were noted.
Fig. 1 (abstract P280). Results
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The mean age in the study group was 34±14 years. The median
number of SIRS criteria was 3 [2,4] and the median number of organ
dysfunctions was 3 [1,6]. The use of hemoadsorption was associated
with a decrease in creatinine (from 1.9±1.4 to 1.2±0.8 mg/dL, p=
0.02), bilirubin (from 14.2±12.6 to 9.2±9.1 mg/dL, p=0.05) and plate-
let count (96482±70913 / uL to 51275±24393 /uL, p=0.01). We also
observed a decrease in Clif-SOFA score from 12.0±2.1 to 10.0±2.6 (p=
0.05). Overall mortality was 37.9% (n=11). Six patients (20.7%) under-
went liver transplantation with 100% 28-days survival.
Conclusions:
The use of hemoadsorption in patients with ALF is associated with
improvement in liver and kidney functional tests and may represent
a new therapy in bridging these patients to liver transplantation.
P280
Preliminary study on the relationship between in vitro lactic acid
bacteria, intestinal microecology and sepsis
CX Wei, JY Li, XZ Wang
Fujian Medical University Union Hospital, Department of
Gastroenterology, Fuzhou, China
Critical Care 2020, 24(Suppl 1):P280
Introduction:
Impairment of intestinal mucosal barrier function is the initiating fac-
tor of sepsis. In order to explore the effect of lactic acid bacteria on
intestinal barrier function impaired by sepsis, it is necessary to estab-
lish sepsis and lactic acid bacteria ecological models. However, how
to construct these models is still unclear.
Methods:
Co-cultures with a gradient of lactic acid bacteria and Caco-2 cells
were constructed. The symbiotic state was observed under an
inverted microscope and lactate dehydrogenase (LDH) toxicity tests,
transepithelial electrical resistance(TEER) tests and Western blots were
used to determine effective concentrations of lactic acid bacteria in
monolayer cell models. Lipopolysaccharide (LPS) was used to treat
cells, and Cell Counting Kit-8, quantitative reverse transcription
PCR(RT-qPCR) and enzyme linked immunosorbent assays (ELISA)
were used to determine the appropriate concentration for sepsis
models.
Results:
The number of living cells decreased significantly when the MOI(-
number of lactic acid bacteria/cell number) reached 8 (Figure 1,
panels 1a, b). The release of LDH indicated that damage to cells
began to increase when the MOI exceeded 10 (panels 2a, b). At an
MOI of 0.5, resistance values began to increase over time, whereas
resistance values began to decrease when the MOI reached 10 (panel
3). As the number of lactobacilli increased, the expression of tight
junction protein increased and then decreased (panel 4a, b, c). In
sepsis model experiments, the cell survival rate began to decrease
once the concentration of LPS exceeded 10^4 ng/ml (panel 5). RT-
qPCR results showed that 102 ng/ml LPS significantly increased in-
flammatory cytokines (panel 6), and ELISA results consistently
showed that TNF-α and IL-6 increased significantly when LPS concen-
trations reached 102 ng/ml (panel 7a, b).
Conclusions:
It is feasible to construct a cell monolayer model of lactic acid bac-
teria and LPS. The appropriate MOI of lactic acid bacteria is 0.5 and
the optimal concentration of LPS is 102 ng/ml.P281
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Introduction:
Vitamin D is not only important for calcium and phosphate homeo-
stasis, but it also has a role in sepsis regulation. Many previous studies
reported a high prevalence of vitamin D insufficiency in critically ill
patients; however, data about vitamin D status are limited in adult
patients with sepsis who visited an emergency department
(ED). Therefore, we decided to evaluate the association of 25-
hydroxyvitamin D (25-OH vit D) level on sepsis severity and risk of
hospitalization in the adult septic patient who visited ED.
Methods:
Cross-sectional study was conducted in the ED of the Faculty of
Medicine Vajira Hospital, Navamindradhiraj University, Bangkok,
Thailand, from 1 March to 30 September 2015. Patients age ≥ 18
who diagnosed with sepsis were enrolled. 25-OH vit D level was ana-
lyzed correlated with illness severity of sepsis measured by APACHE-
II and MEDS score using linear regression analysis. And the risk of
hospitalization was analyzed using logistic regression analysis.
Results:
One hundred and one patients were enrolled. On average, there
were 67.9±18.2 years old, 56% (n=57) were female, APACHE-II score
= 14.2±6.3, MEDS score = 7.9±4.6, and 25-OH vit D level = 18.5±11.3
ng/mL. The admission rate in our cohort was 88% (n=89). Significant
correlations between 25-OH vit D level and sepsis severity scores
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-0.12; 95%CI, -0.22 to -0.006, p -0.04 and – 0.10; 95%CI, -0.17 to -0.02,
p = 0.02, respectively). However; 25-OH vit D level could not predict
hospitalization in our septic patients (OR = 0.98; 95%CI, 0.93-1.03; p=
0.33), while APACHE-II and MEDS score had an influence on patient
hospitalization (OR = 1.51; 95%CI, 1.21-1.89; p<0.001 and OR = 1.56;
95%CI, 1.23-1.97, p<0.001; respectively).
Conclusions:
25-OH vit D level had a significant negative association with sepsis
severity evaluated by APACHE-II and MEDS score. However, it cannot
predict hospitalization as the same as APACHE-II and MEDS scoring
system.
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Introduction:
Sepsis is associated with high mortality and morbidity. As the sever-
ity increases, physiological parameters such as pH changes are one
of the most notable features in metabolic acidosis secondary to high
lactate. Currently there is no point of care test other than blood gas
measurement that could detect these pH changes. This is challen-
ging especially in prehospital environment. The aim of this study is
to develop a novel rapid point of care testing using a sensor to de-
tect pH change in blood.
Methods:
Sensors were produced by screen printing graphene and silver elec-
trodes and functionalizing the graphene working electrode with an
active layer of melanin. A preclinical sensor model was produced by
adding lactic acid to a citrated plasma sample thus altering its pH
over a clinically relevant range. The pH sensors were exposed to
modified plasma, recording any changes in the voltage. The relation-
ship between the voltage potential and plasma pH was established
using weighted least squares regression.
Results:
A pH dependent change in the measured voltage, with respect to
the pH of the solution, was observed with a sensitivity of -111.27
mV/pH +/- 15.95 over a physiologically relevant pH range between
pH7.1 and pH7.6.
Conclusions:
In this first phase proof of concept study a low cost, pH sensor was
fabricated and demonstrated to be effective in measuring the pH of
the plasma. This is the first time that such a sensor has been demon-
strated and validated to work in this preclinical model of acidosis.
The technology demonstrated here is a promising candidate for a
point of care test whereby abnormal blood pH levels can be de-
tected and monitored outside of a laboratory environment in a rapid
manner. Further studies are now underway to detect this change in
whole blood.P283
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Introduction:
Many patients anaesthetized in prehospital setting are at risk of inadequate
cerebral oxygenation. New hand-held oximeter enables monitoring of near-
infrared spectroscopy (NIRS) in prehospital setting. We aimed to assess the
feasibility of the new device during prehospital anaesthesia.
Methods:
We performed a prospective, observational pilot study in two
anaesthesiologist-staffed Helicopter Emergency Medical Services (HEMS)
units. Adult patients who underwent rapid sequence intubation and pre-
hospital anaesthesia because of any reason were included by the HEMS
team. NIRS monitoring of left frontal cerebral regional oxygen saturation
(rSO2) with Nonin H500 oximeter system was performed throughout the
prehospital anaesthesia. The rSO2records were reviewed in terms to identify
potentially artefact values caused e.g. moving or transporting the patient.
Results:
Total of 97 patients were enrolled in the study. Due to technical
problems or user error adequate monitoring was not achieved in 13
(13%, 95% confidence interval 8 to 22%) patients. Software update
of the monitor was installed during the study and no monitoring fail-
ures occurred afterwards. No difference was observed in the on-
scene-time during the study period compared to eligible patients
treated in four previous years. Proportion of likely artefact values was
5.5% in total (median 0.99%, Q1-Q3 0,25%-6.18%).
Conclusions:
Monitoring cerebral oxygenation with Nonin H500 hand-held oxim-
eter system during prehospital anaesthesia is feasible. The value of
this new modality available for prehospital critical care providers
needs to be further evaluated.
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Introduction:
Risk stratification of patients with acute PE helps to determine the
most appropriate treatment. The European Society of Cardiology pro-
poses the use of PESI (Pulmonary Embolism Severity Index) class to
determine when reperfusion therapies (full/partial dose thrombolysis,
catheter directed local thrombolysis, ECMO, unfractionated heparin
or LMWH) are most appropriate [1]. Our study aimed to determine
the number of Patients eligible for reperfusion strategies and inform
the likely impact on High Dependency services.
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We performed a retrospective analysis of all patients admitted to the
Royal London Hospital from 1st April 2018 through 31st March 2019
with acute pulmonary embolism. Data was obtained on demograph-
ics, suspected cause and PESI score on day of admission.
Results:
Over 1 year 165 people were diagnosed with acute PE. The majority
(85%, n=140) were diagnosed with CTPA. The mean age was 55.6
years old (median 55). Right ventricular (RV) strain pattern was
present in 10% (n=16). The majority of PE’s were unprovoked (39%),
other causes included immobility (33%), cancer (17%), deranged clot-
ting (10%) and pregnancy (1%). 45 (27%) patients were PESI III/IV of
these 7 (4%) had both echocardiographic evidence of right ventricu-
lar strain and elevated troponin values. 13 (8%) Patients had died at
time of data collection with the majority of deaths (n=6) within the
PESI V class (Figure 1).
Conclusions:
Over one year only a small proportion of patients (n=7, 4%) were
classified as ‘Intermediate High’ risk and potential candidates for re-
perfusion therapies. The average age of PESI class 3 or 4 Patients was
74.8 years (median=78). Extremes of age skew the PESI score dispro-
portionately and a number of ‘Intermediate High’ risk patients would
likely not be clinically suitable for reperfusion therapies. Adoption of
the ESC’s proposed treatment algorithm would therefore likely place
minimal additional burden on HDU services.
References:
1. Konstantinides SV et al. Eur Heart J. 2019 Aug 31. doi: 10.1093/eurheartj/
ehz405.Fig. 1 (abstract P284). PESI scores for patients presenting to a
central London teaching hospital with acute PE over the course of
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Introduction:
Vitamin C (VC) plays an important role as anti-oxidant agent which
could not be synthesized in vivo. The lack of VC results in excessive
oxidant leading to multiple organ failure. Serum levels of VC radical/
DMSO (VCR/DMSO) could be measured using electron spinresonance apparatus. Serum VCR/DMSO is previously reported to
mean serum ascorbic acid concentrations [1]. We hypothesized that
patients with severe damage may lack in VC. The aim of this study is
to measure the serum VC concentrations from patient with severe
damage who have admitted to emergency room.
Methods:
One hundred patients who have admitted to emergency and critical
care center in Oita University Faculty of Medicine and fifteen healthy
volunteers were enrolled in this study after obtaining written in-
formed consent. Serum VCR/DMSO concentrations were measured
using electron spin resonance apparatus (JES-FR30, JEOL Ltd, Japan)
on and after admission. The results were expressed as average ±
SEM. Intergroup comparisons were done using Student’s t-test or
Mann-Whitney U Test. A p<0.05 was considered statistically
significant.
Results:
Serum levels of VCR/DMSO were significantly lower in admitted pa-
tients (n=100, 0.9345±0.0524) compared with healthy volunteers (n=
15, 0.2784±0.0143). The details of admitted patients were as follows;
trauma (n=69, 0.2979±0.0159), post cardiac arrest syndrome (n=21;
0.2151±0.0272), sepsis (n=2; 0.1229±0.0131), acute respiratory dis-
tress syndrome(n=2; 0.3575±0.3089), stroke (n=3; 0.1833±0.0952),
poisoning (n=2; 0.2312±0.0600), gastric hemorrhage (n=1; 0.12235).
Serum VCR/DMSO levels decreased after admission (day 2; 0.2180±
0.0151, day 3; 0.1777±0.0152).
Conclusions:
Serum VCR/DMSO measurements using the ESR spectrometer is clin-
ically very useful to enable real-time monitoring of serum vitamin C
concentrations. Our results showed that serum levels of VC were sig-
nificantly decreased on admission and over time in severe emer-
gency patients.
References:
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Introduction:
The National Early Warning Score (NEWS) was developed in the UKto
identify the risk of death. The previous study showed that the modi-
fied Glasgow Prognostic Score (mGPS) correlate with frailty in elderly
patients [1]. The aim of this study is to evaluate the predict value of
the revised NEWS with mGPS for in-hospital mortality (in 28 days) in
elderly emergency patients.
Methods:
This study is secondary analysis and was carried out in Jikei Univer-
sity Kashiwa Hospital, in Japan, from 1 April 2017 to 31 March 2018.
The acute medical patients aged 65 and older were included. The
NEWS was derived from seven physiological vital signs. The mGPS
was derived from C-reactive protein (CRP) and Albumin. Discrimin-
ation was assessed by plotting the receiver operating characteristics
(ROC) curve and calculating the area under the ROC curve (AUC).
Results:
The AUCs for predicting in 28 days in-hospital mortality were 0.818 for
revised NEWS with mGPS and 0.797 for the original NEWS. The AUC
of the revised NEWS with mGPS was significantly higher than that of
the original NEWS for predicting in-hospital mortality (p < 0.001) (Fig-
ure 1).
Conclusions:
Our single-centred study has demonstrated the utility of the revised
NEWS with mGPS as a high predictor of acute phase in-hospital mor-
tality in elderly emergency patients.
References:
1. Viviane L et al. J Geriatr Oncol 6:479-483, 2015.
Fig. 1 (abstract P286). Receiver operator characteristic (ROC) curves
for in-hospital mortality comparing the revised National Early
Warning Score (rNEWS) with modified Glasgow Prognostic Score
(mGPS) and the National Early Warning Score (NEWS) in the
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Introduction:
The diagnostic performance of the five main emergency department
(ED) triage systems has been shown to be poor in distinguishing acute
coronary syndromes (ACS) from mild severity diseases in chest pain pa-
tients. These ED triage systems are either clinically-based, being more
sensitive or ECG-based, more specific [1]. The goal of the study was to
evaluate if incorporation of cardiovascular risk factors (CVRF) into ECG-
based triage could increase his diagnostic performance.
Methods:
CECIDOC is a prospective, observational, single-center study in an
academic Hospital. All consecutive adult patients admitted for acute
chest pain were included. We compared the ECG-based FRENCH tri-
age system [2] to a modified system upgrading patients with a nor-
mal ECG but significant cardiovascular risk from a low acuity triage
score (waiting period before medical assessment of max. 60 min.) to
a high acuity triage score (waiting period before medical assessment
of max. 20 min.). The final diagnosis was determined after a 30-day
follow-up. We predefined as being adequate a high-acuity triage
score (level 1 or 2) for ACS and a low-acuity score (level 3, 4 or 5) for
mild severity diseases.
Results:
A total of 190 patients was enrolled over a 5-month period (age 56.8 ±
16.4; M/F ratio 1.7). Triage scores of 35 patients (18.4%) with ACS were
compared to 103 patients (54.2%) with mild severity diseases. Taking
into account CVRF, the sensitivity of the triage system increased from
60 to 80% whereas the specificity decreased from 74 to 61%. Area
Under the ROC Curve (AUC) went from 0.69 to 0.72 (Fig. 1).
Conclusions:
For chest pain triage at ED, addition of cardiovascular risk factors into
ECG-based triage increases his diagnostic performance.
References:
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Introduction:
Approximately 20% of patients presenting to hospital with an intentional
overdose require admission to an intensive care unit (ICU) [1]. There are cur-
rently no UK guidelines regarding the optimal use of CT head scans (CTH)
in this patient cohort [2, 3]. This study aims to determine whether we
should be performing CT head scans in obtunded patients with suspected
overdose requiring admission to Intensive Care.
Methods:
We performed a retrospective search of the ICNARC database for
Plymouth University Hospital Trust, looking for patients admitted to
the ICU with overdose or self-poisoning as a primary diagnosis. 146
patients were identified and 86 of these patients required intubation
due to obtundation(GCS<8).
Results:
There were 59 males and 27 females with an average age of 38 years
old. The median length of stay on the unit was 1 day. 52 of the pa-
tients has a past medical history of mental illness, and 53 overdosed
on prescribed medications. The average GCS recorded on admission
was 5. 52 of the 86 (64%) patients had a CTH on admission, of which
5 were part of a trauma scan. 11 were known overdoses and 7 were
suspected overdose as per the CTH request form. The main rationale
behind those requests were to exclude additional intracranial injury.
None of those CTH showed any signs of acute pathology (Figure 1).
Conclusions:
In this retrospective study, obtunded patients with suspected or
known overdose with no history of apparent trauma or injury do not
benefit from CTH. In the absence of a history of trauma or focal
neurological signs our conclusions are that CTH provides limited
value in the management of these patients.
References:
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Introduction:
The audit was carried out to objectively investigate the problems as-
sociated with technique of folley catheterization in emergency de-
partment and 3 indoor units of internal medicine wards [1].
Methods:
A questionnaire was designed in accordance with Northampton
Healthcare NHS foundation trust guidelines 2017 and data was col-
lected from 102 House Officers and Post-Graduate residents after
permission from Head of Departments of Internal Medicine. Personal
help was available to people while they were filling questionnaire in
case they have any questions.
Results:
45.1% participants claimed that they had no formal training before
they started practicing urinary catheterization. Not being fully aware
of protocols, 24.5% doctors did not have the habit of taking in-
formed consent from patients or their attendants before
catheterization. 74-94% do not wear disposable apron, keep dispos-
able pad under patient’s thighs or clean perineum of patient before
catheterization. Almost 60% doctors allow time for lubricant to take
its effect before they insert catheter to patients and 58.8% let urine
to drain before balloon inflation. Regarding post-catheterization, 25-
40% doctors do not guide patients or attendants about when and
how to drain catheter bag. For long term catheterization, only 24.5%
doctors give written advice about catheter maintenance and 54.9%
change catheter bag after 7 days. Similarly, 7.8% percentage didn't
know about positioning catheter bag below level of patients and
10% about importance of decontaminating hands before manipulat-
ing a patient’s catheter.
Conclusions:
Regular teaching sessions should be held for both new and old doc-
tors to improve their technique of catheterization.
References:
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Introduction:
Aim of this study is to present a single center experience with
metformin-associated lactic acidosis (MALA) along with patient char-
acteristics, type of therapies employed and outcomes. Metformin isthe first-line treatement option and one of the most prescribed drugs
for diabetes mellitus type 2. Main limitation for its use is chronic
renal failure, eGFR <30 ml/min/1,73m2 being treshold for its disconti-
nuitation. One of the serious side effects is developement of MALA,
reported to be very rare. It is defined by arterial lactate>5 mmol/l
and pH<7.35 with recent metformin exposure, blood metformin
levels unnecessary for diagnosis.
Methods:
Single-centre retrospective study was performed in a medical ICU
from Jan2017 to Nov2019. General data, pH, lactate and creatinine
levels, need for vasoactive support, dose of bicarbonate adminis-
tered, necessity and type of renal replacement therapy (RRT) and
outcome were assessed.
Results:
MALA was diagnosed in 15 of 1710 ICU admissions (incidence of
0.009%). It occured more frequently in females (73%), mean age of
73.9y, mean APACHE II score 33.6. Symptoms on addmisson were:
nausea and vomiting (73%), diarrhoea (47%), mental status change
(40%), abdominal pain (27%). Predisposing factors for MALA were: in-
fection (27%), CKD (20%), heart failure (13%). Mean pH was 6.96 with
mean serum bicarbonates of 5.78 mmol/l, lactate of 16.3 mmol/l and
serum creatinine of 648.6 μmol/l. 87% required vasoactive therapy,
33% needing triple vasoactive support. Mean dose of parenteral bi-
carbonates (8.4%) was 316.7 ml. 40% of patients underwent CPR on
admission. All reported patients required RRT, and in 87% CVVHDF
was employed. Mortality rate was 40%.
Conclusions:
Although reported rare, when occuring, MALA has a high mortality
rate. It is associated with profound acidosis, severe renal insufficiency
and in our experience high need for vasoactive support and RRT.P291
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Introduction:
Cellular and molecular mechanisms, epigenetic aspects of acute clo-
zapine poisoning are studied insufficiently. The aim of this study was
to identify morphological and epigenetic alteratons in brain neurons
during acute exposure to clozapine combined wit ethanol.
Methods:
The experiments were carried out on male Wistar rats weighting
200–250g (n=21). Group I (control) received 0.9% NaCl solution en-
terally; group II — clozapine 150 mg/kg in 0.9% NaCl solution; group
III — clozapine 150 mg/kg in 40% ethyl alcohol. After 4 hours eu-
thanasia was performed. Autopsy included withdrawal of brain sam-
ples for histological examination (n = 21) and for determination of
global DNA methylation level (n = 21). The global DNA methylation
level (5-mC%) was determinated by fluorimetric method. Inter-group
comparisons were made by Kruskal-Wallis test. Histological examin-
ation of paraffin sections of brains stained with hematoxylin and
eosin was performed by light microscopy.
Results:
Histological examination of the cerebral cortex of animals re-
ceived clozapine and clozapine with alcohol established alter-
ations in the contours of nerve cells, neuronal hyperchromatosis
and nuclear deformation, eccentric positon location of the nucle-
oli, consolidation of Nissl bodies. Increased global DNA methyla-
tion level was found in the ‘clozapine+alcohol’ group compared
to the control group and ‘clozapine’ group (2.56±0.3140 vs. 1.35±
0.1069 and 1.70±0.3295, p <0.02).
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In acute сlozapine poisoning and its combination with ethanol mor-
phological changes in neurons of the cerebral cortex were detected.
In acute сlozapine with alcohol poisoning an increase of global DNA
methylation level was observed. Probably the identified changes
have a common pathogenesis which will be clarified in
our further studies.Fig. 1 (abstract P292). Patient demographics and climate
data (n=31)P292
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Introduction:
The common European adder (Viperia berus) is the only venomous
snake indigenous to the UK. Although non-aggressive if disturbed
adders may bite, envenomation can be life threatening or even fatal.
There is limited information available regarding the prevalence of
adder bites and the complications of envenomation. NHS data sug-
gests there are 100 adder bites annually in the UK with the last fatal-
ity in 1975 [1]. We performed an audit into adder bites in South West
Wales to identify the number attending our Emergency Departments,
their management and clinical course as well as any environmental
factors that predict increased likelihood of being bitten or the sever-
ity of the bite.
Methods:
A retrospective study of adder bites attending Emergency Depart-
ments in South West Wales was undertaken (Jan 2014 to Aug 2019).
Measurements included were patient demographics, clinical presen-
tation, type of treatment (conservative vs anti-venom) and outcome.
Results:
31 patients were included, age range 2-72 years (Figure 1). The ma-
jority of bites occurred in sand dunes (41.9%) and all bites were on
extremities. Anti-venom was administered to 45.2% (14/31) of pa-
tients. There was a significant positive association between the use
of anti-venom and the length of hospital stay (r = 0.520; p=0.003)
and a significant negative correlation between the anti-venom use
and both diastolic and systolic blood pressure (p= 0.501 and 0.487
respectively p=0.01). All patients fully recovered.
Conclusions:
In this study, we demonstrated that with a full clinical assessment on
presentation it is safe to decide whether anti-venom is required. The
current guidelines are safe and effective in the treatment of adder
bites.
References:
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Introduction:
The aim was to validate or refute the known thresholds for increased
risk of 7-day mortality among acute patients, according to vital and
laboratory values. Vital- and laboratory values measured at arrival to
an emergency department (ED), are part of different risk-stratification
scores, like the Sequential Organ Failure Assessment score, that indi-
cates whether a patient is critical ill or in risk of deterioration.
Methods:
A population-based cohort study at the ED at Odense University Hos-
pital, covering all adult patients ≥18 years arriving from 1 April 2012
to 31 March 2015. Patients were included at first contact within the
study period. Variables were first recorded standard vital values and
laboratory-values included in risk-stratification scores; respiratory rate,
blood pressure, heart rate, Glasgow Coma Scale, temperature, satur-
ation, creatinine, PaO2, platelet, and bilirubin. The association be-
tween vital- and laboratory values and mortality were described
using a restricted cubic spline. A predefined 7-day mortality rate of
2.5% was chosen as a relevant threshold of increased risk.
Results:
We included 40,423 patients, 52.5% female, median age 57 (IQR 38-
74) years, and 7-day mortality 2.8%. Seven-day mortality of 2.5% had
thresholds of; respiratory rate < 12/min and > 18/min, systolic blood
pressure < 112mmHg and > 192mmHg, heart rate < 54beats/min
and > 102beats/min, temperature < 36.0°C and > 39.8°C, saturation <
97%, Glasgow Coma Scale < 15, creatinine < 41μmol/L and >
Critical Care 2020, 24(Suppl 1):87 Page 121 of 21398μmol/L, for PaO2 < 9.9kPa and > 12.3 kPa, platelets < 165*10^9/L
and > 327*10^9/L, and bilirubin > 12μmol/L.
Conclusions:
In our population of adult ED patients, the thresholds of vital values
associated with increased 7-day mortality were very close to rou-
tinely used values, and most of the thresholds were included in the
lowest urgency level in triage and risk-stratification scoring systems.
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Introduction:
The number of emergency room admissions continues to increase
each year, which increases the care workload of the emergency de-
partment staff, who should to use its theoretical and practical know-
ledge in order to provide quality care in difficult working conditions.
The aim of our study was to assess the emergency room staff work-
load its impact on health workers and patients and to suggest an im-
provement strategy to decrease this workload.
Methods:
A prospective, monocentric cohort study with descriptive and ana-
lytic approach over one month (December 2018) conducted at the
Emergency Department of an academic hospital. The workload en-
dured by the emergency room staff was evaluated by the NASA Task
Load Index and on patients by the Therapeutic Intervention Scoring
System-76.
Results:
There were 286 cumulative days of hospitalization in 67 consecutive
patients admitted to the emergency room. The average age was 61
±15 years. The average length of stay at the emergency room was
about 103 ±48h. The average TISS-76 score was 31.7 ±14.9. Factors
associated with important care workload were: age ≥ 65 years, dia-
betes, more than 3 comorbidities, the use of intravenous antibiotics;
the use of vasoactive drugs and the use of mechanical ventilation; a
high TISS score was predictive of emergency room mortality. In the
indirect assessment of the care workload, 41 medical and paramed-
ical staff were interviewed, 73% of them were under 40 years old
with a sex ratio of 0.58. A high level of mental and physical workload
was expressed by ED staff with considerable level of frustration; The
ED staff suggested mainly to improve the working conditions, com-
munication and to redefine tasks "who does what".
Conclusions:
Our study had shown a significant workload in the emergency room,
a process to reduce this workload is being implemented
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Introduction:
Medical simulation is a modern teaching tool increasingly used in
specialties such as anesthesia, emergency medicine and obstetrics.
However, it’s not widely used in specialties like cardiology, althought
cardiovascular emergencies are very frequent. The purpose of our
study was to assess the effectiveness of simulation-based medicaleducation in the management of cardiovascular emergencies among
moroccan graduate students.
Methods:
We conducted a prospective, observational, multi-centrer study in-
cluding the students of three moroccan universities from the 5th to
the 7th year of medicine who underwent 6 phases: First a pre-test,
then a theoretical and practical training on cardiovascular emergen-
cies after which the students were separated in two groups, one
undergoing the medical simulation training (group 1) and one who
didn’t (group 2), followed by a theoretical then a practical post-test
on Resusci Anne and SimMan®. At last, the students were asked to an-
swer a satisfaction survey.
Results:
57 students were enrolled in the study and divided into 2 groups
(Group 1, N= 25 and Group 2, N=27). Both groups were comparables
in terms of year of study, faculty and their previous internships as
well as a former participation in medical simulation. The pre-test re-
sults were comparable between the two groups (6, 05±2,68 for
group 1 versus 5,88±2,52 for group 2). However, both theoretical
post-test results (18,83±1,27 versus 17,13±2,01 for group 2, p<0,001)
and practical evaluation results (16,15 ± 1,72 versus 10,92 ± 1,35, p<
0,001), were in favor of group 1.
Conclusions:
This preliminary study showed the significant benefit of simulation-
based medical teaching and learning as an innovating teaching tool
in the cardiovascular emergencies in the medical students’ basic
training and suggests its generalization to the cardiology and inten-
sive care interns’ continuous training.
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Introduction:
Disaster may psychologically affect the social behaviour of citizens
[1]. However, the impact of great disaster on basic life support activ-
ities of laypersons is unknown. The East Japan Earthquake swept the
Pacific coast of Japanese mainland on Friday 11 March 2011, and
caused nuclear accidents. This study aimed to investigate whether
and how this disaster influenced bystander cardiopulmonary resusci-
tation (BCPR) in family- and friends-witnessed out-of-hospital cardiac
arrests (OHCAs).
Methods:
From nationwide OHCA registry, we extracted 74,684 family and
friend bystander-witnessed OHCA cases without prehospital
physician-performed advance life support, which were recorded be-
tween 11 March, 2010 and 10 March, 2013. The alterations in BCPR
rate after the disaster in Tsunami-affected prefectures and others
were analysed by univariate and multivariable analyses.
Results:
The BCPR rate in Tsunami-affected prefecture decreased in a biphasic
manner during 20-weeks period after the onset of disaster in disaster
year of 2011, compared to pre-disaster 2010 and post-disaster 2012:
42.5% (375/882) in 2011 and 48.2% (754/1565) in 2010&2012. This
decrease in BCPR rate in tsunami-affected prefectures was more
prominent in the subgroup receiving dispatcher-assisted CPR instruc-
tion (Figure 1). A lower rate of dispatcher-assisted CPR instruction
(49.1% vs 53.4%) and higher proportion of presumed cardiac aeti-
ology (62.8% vs 56.0%) were also observed during the same period
of 2011 in Tsunami-affected prefectures. One-month survival rate of
the family- and friends-witnessed subgroup receiving dispatcher-
assisted CPR was 8.2% in 2011 and 10.2% in 2010/2012. In Tsunami-
unaffected prefectures, the changes in BCPR rate and outcome of
family- and friends-witnessed OHCA were extremely small.
Critical Care 2020, 24(Suppl 1):87 Page 122 of 213Conclusions:
A great disaster affects the family- and friend-performance of BCPR
by diminishing the willingness of family and friend bystanders to fol-
low the instruction provided by dispatchers.
References:
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Introduction:
This study aimed to assess the prognostic value of the Injury Severity
Score (ISS) and the Trauma-Related Injury Severity Score (TRISS) for
predicting mortality in terrorism victims.
Methods:
We conducted a retrospective study from February 2012 to Decem-
ber 2017. We included all terrorism victims in Tunisia who were hos-
pitalized or autopsied at the Tunis Military Hospital. The performance
of the ISS and TRISS scores was studied using the area under the
ROC curve (AUC). We determined the best threshold using the You-
den index to predict 28-day survival.
Results:
We included 168 patients. We excluded 15 patients because the re-
cords were unusable. Forty-six victims (30%) died (43 at the scene
and 3 in hospital). We found 79 blast injuries (51.6%), 65 bullet injur-
ies (42.5%), 2 (1.3%) bullet and blast injuries, and 2 (1.3%) stab
wounds ( sticking). The area under the ROC mortality prediction
curve was 0.955 (95% confidence interval: 0.925-0.984) for the ISS
and 0.948 (95% confidence interval: 0.916-0.980) for the TRISS. The
best threshold values for predicting mortality were 23.50 for the ISS
score (Sensitivity: 100%, Specificity: 83%) and 22.38 for the TRISS
score (Sensitivity: 93%, Specificity: 89%).
Conclusions:
The ISS and TRISS scores can be used for prognostic evaluation to
predict mortality in terrorism victims.P298
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Introduction:
The large number of casualties during mega-disasters are serious glo-
bal problems. Intensivist's role is critically analyzed especially focus-
ing on the special disasters and the vulnerable
Methods:
Our actual medical experience on disaster cites was basically
researched. Tokyo Subway Sarin attack (1995), 9-11 attack (2001),
Hurricane Katrina (2005), Indian Ocean earthquake/tsunami (2004),
Chernobyl (1986) and Higashi Nihon Earthquake/Fukushima nuclear
plant catastrophe (2011), Flu pandemic (2009), etc. are analyzed.
Results:
These mega-disasters had severe negative health and mental influ-
ence of various type. Linked catastrophe forms a malignant cycle. In
these situations most of the intensivist seemed useless. However
many essential roles of intensivist/medical staff existed which were
reviewed: i.e., as reliable medical/surgical/intensive care team leader,
and/or chief triage officers, in addition to operate in the field/shelter
for safety/security as well as making up preventable life-saving sys-
tems. In order to support/help victims in shelter, who are often
abused or ignored, diseased chronically and injured by trauma, and
contaminated/damaged by NBC (nuclear, biological and chemical) or
BCRNE (biological, chemical, radiological, nuclear and explosive) haz-
ards. Especially regarding NBC hazard, intensivist should be accus-
tomed more, which were often overlooked or ignored even in Japan
DMAT( disaster medical assistant teams).
Conclusions:
We had been compiling Disaster Medicine Compendium, completed
first version with 22 volumes, 2005, although this version had three-
fourth in Japanese. Second version were four-fifth in English by add-
ing several important parts. At present third version are nearly com-
pleted with mainly focusing on the vulnerable, including ding LGBD
(lesbian, gay, bisexual and transgender), pets/animals/vegetables, reli-
gious problems and/or natural condition, etc.P299
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Introduction:
The reform procedure in the Tunisian army consists in repairing the
physical damage and deciding on the applicant's ability to continue
working. Terrorism increases the impact of the co-morbidity gener-
ated and the socio-economic consequences that result from it. The
purpose of this work was to study the epidemiological, clinical and
evolutionary profile of terrorist injuries, to specify the rates of conse-
quent Partial Permanent Disability (PPI) and the possibilities of
returning to work.
Methods:
Descriptive retrospective cross-sectional study of 177 reform files on
military personnel injured during anti-terrorist operations from
Critical Care 2020, 24(Suppl 1):87 Page 123 of 213January 2013 to September 2019. The data collection was carried out
on the basis of a collection form.
Results:
 Our 177 wounded were male, 96% of whom belonged to the
army.
 The average age was 36 years and 3 months ± 8.869.
 Half of our wounded were troopers.
 Infantry and special forces were the most exposed military
units.
 Half of the accidents were recorded in the Kasserine region (88
cases).
 Chronic post-traumatic stress disorder (CPTSS) was found in
130 injured, followed by amputations in 18 injured.
 The after-effects were psychological in 32%, physical in 26%
and mixed in 39% of our injured.
 The PPI rate ranged from 36% to 75% in 23.7% of injuries..
 More than half of the injured had returned to their professional
activity, 33% were put on reform for health reasons.
Conclusions:
Our results showed that the ESPTC was the most recorded sequel,
and that the PPI rate was significant in a quarter of our injuries. In
our series, a third of our wounded were put on reform for health rea-
sons. To state the importance of initial care and adequate and rigor-
ous follow-up to recover a greater number of war wounded.P300
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Introduction:
The rapid response system (RRS) has been shown to decrease hospital
mortality [1]. The Japanese Coalition for Patient Safety has set a major
goal for hospitals to more widely implement the RRS. However, preva-
lence and actual circumstances of use in acute care hospitals (including
small scale hospitals) in Japan are as yet not well-known.
Methods:
Web-based questionnaires were sent to acute care hospitals (of scale
75 beds-or-larger) of 17 prefectures in western Japan. Each participant
hospital selected a certain department which answered the question-
naire. The RRS included the medical emergency team (MET), the rapid
response team (RRT), and the critical care outreach team (CCOT). We in-
vestigated the presence and circumstances of in-hospital emergency
calls, RRS and other systems, and then illuminated issues to be solved.
Results:
Among the 971 hospitals which questionnaires were distributed to, a
total of 149 hospitals (15.3%) replied. The in-hospital emergency call and
RRS were operated in 117 (78.5%) and 26 (17.4%) hospitals, respectively.
Among the middle-to-small scale hospitals with ≤ 200 beds, both in-
hospital emergency calls and RRS were less frequently operated than lar-
ger hospitals with > 200 beds (69.6% vs. 83.9%, p=0.04; 5.4% vs. 24.7%,
p=0.003, respectively). Several hospitals operated non-team services
through a certified critical care nurse. Data of activities was registered to
the In-Hospital Emergency Committee in Japan in 7 (4.6%) hospitals. Sat-
isfaction rates with the effectiveness of their own RRS were 60%, and
problems to be resolved were shortage of staff and knowledge, and a
lack of flow during response.
Conclusions:
Compared to larger hospitals with > 200 beds, the prevalence of the
RRS was significantly lower in middle-to-small scale hospitals. For
them, we suggest that efficacious activities and education programs
for RRS be sought.References:
1. Lyons PG et al. Resuscitation 128: 191-197, 2018
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Introduction:
Association of hospital volume or rapid response system (RRS) call rate
with altered clinical outcomes of RRS patients was not fully investigated.
We tested a hypothesisthat hospital bed number and RRS call rates are
associated with altered clinical outcomes of patients with RRSs.
Methods:
We performed a retrospective analysis of a large RRS cohort, In-Hos-
pital Emergency Registry in Japan (IHER-J), which is a data registry of
RRSs conducted by the Japanese Society of Intensive Care Medicine
and the Japanese Society for Emergency Medicine. This study en-
rolled 4,818 patients in 24 hospitals from April 2014 to March
2018. Primary outcome variable was short-term serious outcome de-
fined as unplanned intensive care unit (ICU) admission after RRS acti-
vation, or death at the scene where RRS care was initiated.
Results:
There was no significant correlation between the number of hospital bed
and RRS call rate (R2 =0.0047,P=0.75). In the primary analysis of the pre-
sentstudy using a multivariate analysis adjusting potential confounding
factors,higher RRS call rate was significantly associated with decreased
short-term serious outcome (P=0.0010, OR 0.94, 95% CI [0.91-0.98]), but
there was no significant association of hospital volume (P=0.97).In the sec-
ondary analysis of the study, there was a non-significant trend of in-
creased cardiac arrest on arrival at the location of the RRS provider at
large-volume hospitals (P=0.084, OR 1.16, 95% CI 0.98-1.38) but there was
no significant association of the RRS call rate with the incidence of cardiac
arrest (P=0.60). Large-volume hospitals had a significantly higher 1-month
mortality rate (P=0.0040, OR 1.10, 95% CI 1.03-1.18) but there was no sig-
nificant association of RRS call rate with 1-month mortality rate (P=0.76).
Conclusions:
Hospitals with increased RRS call rates had significantly decreased ad-
verse short-term outcomesin patients who had RRS activations. Pa-
tients who had RRS activations at large-volume hospitals had an
increased 1-month mortality rate.
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Early identification of patient’s deterioration on wards and appro-
priate Rapid Response Team (RRT) response have been imple-
mented in many healthcare facilities. However, the impact of
delays in patient transfer to the Intensive Care Unit (ICU) after an
RRT assessment was poorly studied. Our aim was to assess time
from RRT activation to ICU admission (RRT-ICU time) and study
its impact on clinical evolution.
Methods:
We conducted a retrospective study between January and August
2019 including patients admitted from wards to ICU, after RRT ac-
tivation, in a University Hospital. RRT-ICU time was measured,
physiological/clinical parameters were collected and mortality was
assessed. We considered 2 hours as the cutoff time between
early and late admission.
Results:
We enrolled 119 patients, 57.1% male, median age 69 years,
APACHE II 21, SAPS 43, RRT-ICU time 4 hours, 86.1% medical
admissions, 37.8% sepsis/septic shock. ICU and hospital mortal-
ity were 22.6% and 34.0%. Comparing early (E,n=30) and late
(L,n=76) admission groups, there were no statistically significant
differences between mean SAPS II (44.53 vs 41.77, p=
0.523), APACHE II (21.00 vs 21.49, p=0.564), sepsis/septic shock
(46.7% vs 40.8%, p=0.581) or admission motive. There were no
differences between ICU length of stay (5.5 vs 6.0, p=0.332),
hospital length of stay (24.5 vs 24.5 days, p=0.997), ventilation
days (0.0 vs 0.0, p=0.881), vasopressors days (0.5 vs 0.0, p=
0.770), and ICU mortality (13.3% vs 26.3% p=0.150). There was a
clear but not statistically significant difference in hospital mor-
tality between E and L groups (20.0% vs 39.5%, p= 0.057). Re-
garding the assessment at admission and 72 hours, differences
were found between E and L groups for bilirubin (-16.6% vs
6.6%, p=0.002) and lactate (-44.8% vs -21.1%, p=0.011)
variation.
Conclusions:
Our study suggests that delays in patient transfer to the ICU after
RRT activation in the wards were associated with slower physio-
logical improvement.These findings support further and larger
studies.
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Introduction:
Blood and blood product (BP) transfusions are frequently used in in-
tensive care units (ICU) [1]. It is important to know transfusion epi-
demiology and the effect of adverse transfusion reactions and their
effect on mortality and morbidity.We aimed to investigate the blood
and BP transfusions in the ICU.
Methods:
Blood and BP transfusions in ICU, between 2013-2017 were reviewed
retrospectively. We evaluated each transfusion as a data and exam-
ined the pre- and post-transfusion laboratory values, demographic
data, cause of ICU admission and comorbidities.
Results:
284 patients who underwent transfusion in the ICU, and 2188 trans-
fusion data from these patients were included. The most frequent
cause of hospitalizations were respiratory failure and sepsis. The rateof patients transfused in the five-year period decreased from 73.9%
to 36.67%. The hemoglobin threshold before transfusion decreased
from 8.34 g / dl to 7.91 g / dl. A total of 148 transfusion reactions
were observed and the most common transfusion reaction was fe-
brile non-hemolytic reaction. The most commonly transfused product
was red blood cell suspension. Transfusion reactions were found to
be slightly higher in men than women in young age group(<65y) (p
= 0.44 and p=0.021, respectively). Transfusion reactions were found
to be more frequent in emergency transfusions (p <0.01). The num-
ber of transfusions was significantly lower in patients with APACHE II
score <20 (p <0.01). The need for transfusion was found to be higher
in patients with hematological malignancy (p <0.01). It was observed
that as the mean number of transfusions increased the mortality is
also increased (p <0.01).
Conclusions:
Transfusion therapies are the treatments that are vital but have a ser-
ious mortality and morbidity risk. In particular, intensive care patients
should be considered in detail because of their specific features. Re-
strictive transfusion practices have positive results.
References:
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Introduction:
Up to 40% of surgical oncologic patients receive red blood cells
(RBC) to treat anemia. We aim to determine the potential impact of
anemia and red blood cells (RBC) transfusion on post-operative com-
plications and mortality in oncologic surgical critically ill patients.
Methods:
Retrospective, single center study. Adults admitted to intensive care
unit (ICU) after surgery for cancer with a high risk of bleeding were
eligible. Multivariate analyses were preformed to determine whether
anemia and/or RBC transfusion were associated to post-operative
complications and/or in-hospital mortality.
Results:
From January 2017 to December 2018, 287 oncologic patients were
admitted to ICU, 49.5% of the patients had anemia based on the
World Health Organization (WHO) definition; 69 (24%) had moderate
anemia (Hb < 10 g/dL and ≥ 8g/dL) and 32 patients (12.5%) had se-
vere anemia (Hb < 8 g/dL). RBC were given to 19.6% of the patients.
Patients exposed to moderate-to-severe anemia had more post-
operative complications. Patients who received RBC transfusion had
also more post-operative complications including renal failure (0.9%
vs. 19.6% ; p < 0.001), thromboembolic events (2.2% vs. 8.9% ; p =
0.039), and infections (13.5% vs. 41.1% ; p < 0.001) compared to non-
transfused patients. Multivariate analysis found an independent asso-
ciation between moderate (OR 15.03 [2.73 – 282.3] ; p < 0.001) and
severe anemia (OR 16.65 [2.71 – 325.7] ; p = 0.011) and post-
operative complications (Figure 1A). The association between RBC
transfusion and adverse events also remained after adjustment (OR
4.3 [2.2 – 8.8] ; p < 0.001) (Figure 1B).
Conclusions:
In oncologic surgical critically ill patients, there was an independent
association between anemia (even moderate anemia) or RBC
Critical Care 2020, 24(Suppl 1):87 Page 125 of 213transfusion and patient outcomes. Our findings highlight the need
for further research to determine the optimal transfusion strategy in
surgical oncologic patients.Fig. 1 (abstract 305). Multivariate analysis analyzing the risk factors
for the primary outcome (severe post-operative complications and
/or mortality) including anemia (A) or transfusion (B). (CKD: Chronic
Kidney Disease)P306
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Introduction:
Red blood cell transfusion (RBCT) increases global oxygen delivery
(DO2) and may improve microcirculation. However, the effects on
blood flow have been found to be conflicting.
Methods:
We studied ICU patients with stable hemodynamic status (mean arterial
pressure (MAP) ≥ 65 mmHg for at least 6 hours) and without active bleed-
ing, who received a RBCT. Skin blood flow (SBF) was determined (Periflux
System 5000, Perimed, index finger; perfusion unit, PU) together with MAP,
heart rate (HR), hemoglobin (Hb), lactate levels and ScvO2 before and after
RBCT. SBF was measured before RBCT (T0) and after (T1) for each 3 min. Ac-
cording to previous data indicating the lowest SBF value found in non-
infected ICU patients was 151 PU, all patients were analyzed according tothe baseline SBF (i.e. <151 PU - low SBF vs. ≥151 PU – high SBF). The rela-
tive change of SBF (ΔSBF) was calculated after RBCT and the responders
were defined by the function of >10%.
Results:
63 ICU patients were studied. RBCT was associated with increases in MAP
and ScvO2 but no change in SBF. At baseline, ScvO2 was lower in the re-
sponders than in the non-responders (p=0.04) and lower in patients with
low SBF than in the high SBF (p=0.04). There was no difference in Hb, MAP,
and lactate, between the patients with low and high SBF. After RBCT, MAP
rose in the responders (p<0.01) and in the non-responders (p=0.03), SBF
(p<0.01) rose in patients with low SBF, and SBF (p=0.02) decreased in pa-
tients with high SBF. There was a negative correlation between baseline
ScvO2 (r= -0.363, p<0.01) or baseline SBF (r= -0.560, p<0.01) and the relative
increase in SBF after RBCT.
Conclusions:
RBCT increases skin blood flow only when it is impaired at baseline.P307
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Introduction:
Erythrocyte transfusion (ET) is a common practice in ICUs. While it
can save lives in hemorrhagic shock, its efficacy is more uncertain in
moderate anemia of inflammatory origin. There is still considerable
debate about the risks / benefits and indications of transfusion of ET
in patients with non-hemorrhagic anemia. We aimed to study the ef-
fects of ET on hemodynamic and oxygen metabolism.
Methods:
Comparative cross-sectional study on matched series before / after
ET. Patients receiving ET for non-hemorrhagic anemia (Hb <7 g / dL)
were eligible. Ultrasound Cardiac output (CO), arterial and central
venous blood gas were performed before and 2h after transfusion.
Blood Formula Count (BFC) was collected 24 hours after ET. All
hemodynamic and O2 metabolism parameter’s (using the following
formulas: arterial O2 content (CO2, ml / dl) = 1.34 (ml / g) x Hb (g /
dl) x SO2 + [(0.0031 x PO2 (mm Hg)] and Oxygen delivery (DO2, ml /
min) = CO (l / min) x CO2 x 10) and hematologic were compared be-
fore/after ET by paired samples
Results:
20 patients were included of 43 years as median age and median
SOFA = 6. The median Hb indicating ET was 6.6 [6.2-6.9]. After trans-
fusion of 1 RBC pellet: CO2 (ml / dl) increased from 8.9 [8.5-9.3] to
10.4 [9.4-11.3] with p <10-3. CO (l / min), and DO2 (ml / min) de-
creased but did not reach significance: CO: 5.6 [4.4 -7.01] vs 4.6 [3.8-
6.7] and p = 0.33, CI: 3.2 [2.4-4.1] vs 2.4 [2.3-3, 8] and p = 0.16, OD2:
522 [402-623] vs 503 [433-666] and p = 0.17. Hematological parame-
ters increased (p <10-3 for all) with a change in Hb (g / dl) from 6.6
[6.2-6.9] to 7.9 [7.02 -8.4], hematocrit (%) of [19-22] to 24 [22-25] and
GR count (106 / ml) of 2.47 [2.14-2.75] to 2, 9 [2.49 to 3.22].
Conclusions:
Our results tend to confirm that, despite the improvement of CO2
after ET, DO2 does not improve (ultimate goal of transfusion!). This
effect seems to be due to the decrease of the CO consequent to the
increase of blood viscosity.P308
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Introduction:
Critical Care 2020, 24(Suppl 1):87 Page 126 of 213This audit was carried out to objectively inspect flaws in technique of
blood transfusion in both medical emergency and internal medicine
wards.
Methods:
A questionnaire was designed with reference to NICE blood transfu-
sion guidelines 2015 and data was collected from 102 House Officers
and Post-graduate Residents after permission from Head of Depart-
ments of Internal Medicine. Personal help was available to them
while they filled the questionnaire.
Results:
Information regarding reason for transfusion and risks and benefits of blood
transfusion is conveyed by 80 (78.4%) of doctors. Transfusion process is ex-
plained by 56 (54.9%) of doctors and only 44 (43.1%) doctors talk about
any transfusion needs that are specific to patients. 29 (28.4%) of doctors
guide about any alternatives to blood transfusion if available and 20
(19.6%) tell patients that they are no longer eligible to donate blood.
21(20.6%) encouraged their patients to ask questions. Regarding documen-
tation, 37 (36.3%) doctors do not document this discussion in patient’s
notes. Also, 11(10.8%) of doctors do not monitor patient’s condition and vi-
tals before, 16 (15.7%) during and 39 (38.2%) after transfusion. 32 (31.4%)
doctors said that they had formal training for blood transfusion, 60 (58.8%)
said that they do not have that, while 10 (9.8%) said that they don’t know
if they had any formal training for this purpose or not (Figure 1).
Conclusions:
1) Documented consent, vitals before, during and after transfusion,
fresh laboratory investigations after transfusion should be made an
integral part of process.
2) Workshops, audits and brief one-to-one meetings with physicians
and installation of algorithms and guidelines should be done.Fig. 1 (abstract P308). Compares the relationship of formal training
of blood transfusion with the ability to manage acute transfusion
reactions independently among junior doctorsP309
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Severe immune dysregulation is associated with adverse outcomes and is
common in intensive care unit (ICU) patients [1]. Erythropoietin-stimulating
agents (ESAs) have both anti-apoptotic and immune-modulating properties
[2]. Despite potential benefit, both the safety and efficacy of these agents
remains unclear [3]. Here we evaluate the impact of ESAs on morality at
hospital discharge in critically unwell adult patients admitted to the ICU.
Methods:
We conducted our search strategy in accordance with a predeter-
mined protocol. We searched OVID MEDLINE, OVID EMBASE and The
Cochrane Central Register of Controlled Trials, from inception until
May 2019. Eligible publications were randomized controlled trials
(RCTs) reporting mortality, including adult patients admitted to an
ICU, with both a group receiving ESA therapy and a comparator
group not receiving ESA therapy with both groups reporting mortal-
ity. No language restrictions applied.
Results:
16 of the 21 included studies reported in-hospital mortality, with evi-
dence of a decrease in the group receiving ESA therapy (276 of 2187
patients, 12.6%) when compared with the comparator group (339
out of 2204 patients, 15.4%), [relative risk (RR) 0.82, 95% CI 0.71–0.94,
P = 0.006, I2 = 0.0%]. Of these studies only one was categorized as
being of low risk of bias.
Conclusions:
We have demonstrated that in heterogenous populations of critically
ill adults, ESA therapy may decrease mortality. The evidence used in
this trial was mainly of low or uncertain quality.
References:
1 Muszynski JA et al. Curr Opin Pediatr 28:267-273, 2016.
2 Nairz M et al. Microbes Infec 4:238-46, 2012
3 Corwin HL et al. N Engl J Med 357: 965–76, 2007
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Introduction:
The use of FFP is associated with an increased incidence of complica-
tions such as acute respiratory distress and infections, and the rate of
complications increased with the quantities of FFP transfused [1].
PCC contain several important coagulation factors and it has been
suggested that they could replace FFP. This has been shown mainly
in case reports or series in which coagulation factor deficit was de-
tected by using POC viscoelastic tests in trauma [2] or traditional
hemostatic tests in obstetric patients [3].
Methods:
Multicenter observational study of the safety and efficacy of the pro-
thrombin complex concentrate. A survey of anesthetists was con-
ducted in 19 maternity hospitals at various levels of care in the
Russian Federation. Data has been collected and processed. As a re-
sult, 251 patients were analyzed. PPH was determined as a volume of
blood loss more than 500 ml during vaginal delivery or CS.
Results:
The most significant risk factors for PPH were: preeclampsia or arter-
ial hypertension and a history of postpartum hemorrhage. 32.3% had
no risk factors for PPH. It was determined that the use of Prothrom-
plex 600 IU decreased the number of patients with transfusion
FFP 12-15 ml/kg by 27.8% and increased the number of patients
without transfusion by 25.9%, compared with patients without use of
Prothromplex 600 IU (Figure 1). No complications were detected.
Conclusions:
The use of PCC safety and efficacy reduce use of FFP during PPH.
References:
1. Watson GA et al. J Trauma 67:221–7, 2009
Critical Care 2020, 24(Suppl 1):87 Page 127 of 2132. Schöchl H, et al. Crit Care 14:R55, 2010
3. Glynn JC et al. Anaesthesia 62:202–3, 2007Fig. 1 (abstract P310). Use of Prothromplex and a decrease
transfusion of FFP
Fig. 1 (abstract P311). PT before and 24 hours after the
administration of 10 mg fytomenadion given intravenously. Box-
plots with min-max whiskers. PT= prothrombin time. ***p<0.001P311
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Introduction:
Previous studies indicate vitamin K-deficiency to be common in crit-
ically ill patients without overt bleeding. The aim of this study was to
evaluate the effect of intravenously given fytomenadion on routine
coagulation status, activities of vitamin K- dependent coagulation
factors, thrombin generation and thromboelastography.
Methods:
Critically ill patients with prolonged prothrombin time (PT) – Owren
(PT-INR) >1.2) were included during office hours. Routine coagulation
status (Owren PT, Quick PT), activity of coagulation factor (F) II, FVII,
FIX, FX, protein C, protein S, thrombin generation (TGA) and throm-
boelastography (ROTEM), were measured before and 24 hours after
10 mg fytomenadion had been given intravenously. The exclusion
criteria were on-going treatment with warfarin- or NOACs, hepatocel-
lular cancer, liver resection <6 months, known coagulopathy or treat-
ment with fytomenadion <36 hours.
Results:
27 patients were included. A significant decrease of Owren PT and
Quick PT was demonstrated 24 hours after given fytomenadion (p<
0.001), Figure 1. The activity of FII, FVII, FIX and FX was increased (p<
0.01, p<0.01, p<0.01, p<0.001). The activity of protein C, protein S
and TGA were unchanged. No changes were demonstrated in
ROTEM, except for maximal clot formation (MCF), indicating in-
creased clot strength. The sensitivity analysis demonstrated that pa-
tients with higher Owren PT>1.3 at baseline showed a stronger
response to fytomenadion, including increased TGA.
Conclusions:
PT decreases and the activity of FII, FVII, FIX and FX increases 24
hours after intravenously given fytomenadion in critically ill patients.
In patients with more pronounced PT increase at baseline, these ef-
fects were even stronger and also included increased TGA.P312
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Introduction:
The FORMA-05 study compared hemostatic efficacy and safety of hu-
man fibrinogen concentrate (HFC) vs cryoprecipitate for bleeding pa-
tients with acquired fibrinogen deficiency undergoing cytoreductive
surgery (CRS) for pseudomyxoma peritonei (PMP). Maintaining ad-
equate levels of coagulation proteins, including plasma fibrinogen
concentration, during CRS are important to help control hemostasis.
Methods:
FORMA-05 was a single-center, prospective, randomized, controlled
Phase 2 study. Patients undergoing PMP surgery with predicted intra-
operative blood loss ≥2 L received HFC (4 g) or cryoprecipitate (2
pools of 5 units, approximately 4.0–4.6g fibrinogen), repeated as
needed. Plasma fibrinogen concentration (measured using Clauss
assay) and FIBTEM A20 (measured using thromboelastometry) were
measured hourly intraoperatively, while Factor (F) XIII, FVIII, von Will-
ebrand Factor (VWF) levels, standard laboratory tests and endogen-
ous thrombin potential (ETP) were measured every two hours. Post-
surgery, all parameters were measured at 6, 12, 24, and 28 hours,
and 10 days.
Critical Care 2020, 24(Suppl 1):87 Page 128 of 213Results:
The full analysis included 45 patients on either HFC (n=22) or cryo-
precipitate (n=23). The intraoperative and postoperative changes in
ETP and fibrinogen concentration are shown in Table 1. For FIBTEM
A20 (intraoperatively) and fibrinogen concentration (intraoperatively
and postoperatively), the mean numerical values appeared higher
with HFC than cryoprecipitate. FXIII (HFC: 121.86%, 66.85%; cryopre-
cipitate: 115.55%, 68.68%, at baseline and 4hr after surgery start),
FVIII and VWF were maintained throughout surgery in both treat-
ment groups. This was also the case for laboratory tests activated
partial thromboplastin time, prothrombin time and platelet count.
Conclusions:
The FORMA-05 coagulation parameters analyses showed broad over-
laps between HFC and cryoprecipitate, with satisfactory maintenance
of the clot quality parameters, FXIII concentrations and thrombin
generation parameters.Fig. 1 (abstract P313). Comparison of ROC curves of Base excess
(AUC=0.872) vs Lactate level (AUC=0.754) for diagnosis of fibrinogen
deficiency
Table 1 (abstract P312). The intraoperative and postoperative changes
in ETP and fibrinogen concentration. HFC, human fibrinogen
concentrate; SD, standard deviation
Parameter Endogenous
thrombin
potential
(nmol/L/min)
Endogenous
thrombin
potential
(nmol/L/min)
Plasma
fibrinogen
concentration
(g/L)
Plasma
fibrinogen
concentration
(g/L)
Treatment
group
HFC Cryoprecipitate HFC Cryprecipitate
Baseline mean 1514.5 (430.6) 1639.1 (339.1) 4.79 (1.316) 4.50 (1.497)
Interoperative,
2hr after
surgery start,
mean (SD)
1673.5 (340.1) 1690.2 (320.2) 3.20 (0.722) 2.67 (0.984)
Interoperative,
6hr after
surgery start,
mean (SD)
1310.7 (171.2) 1260.7 (342.2) 2.34 (0.610) 1.91 (0.543)
Postoperative
end-of-surgery,
mean (SD)
1225.4 (220.7) 1346.4 (243.6) 2.21 (0.515) 2.08 (0.562)
2 days after
surgery end,
mean (SD)
1263.44 (176.9) 1385.6 (301.6) 5.47 (0.832) 5.24 (0.818)
10 days after
surgery end,
mean (SD)
1426.16 (260.4) 1357.0 (349.5) 6.62 (1.484) 6.48 (1.685)P313
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Introduction:
Estimation of fibrinogen level by classical laboratory methods or by
viscoelastic method-rotational thrombelastometry (ROTEM) is essen-
tial for the patient with multiple trauma as it plays a key role in
hemostasis and is the first coagulation factor to be consumed. We in-
vestigated the predictive ability of lactate level and base excess to
determine fibrinogen deficiency for the patient with multiple trauma
from admission.
Methods:
This retrospective study includes 158 patients admitted to the Emer-
gency Clinical Hospital of Bucharest which meet the Berlin criteria for
the diagnosis of multiple trauma. There were taken into account: the
level of lactate, base excess, and Maximum Clot Formation(MCF/FibTEM-ROTEM) from the admission of patients in hospital. For statis-
tical analysis we used MedCalc14.1.
Results:
The study group includes 118 men and 40 women with a mean age
of 43,008 vs. 40.32 years (p=0.639) admitted with the diagnosis of
multiple trauma. We found a directly proportional and highly signifi-
cant statistical correlation between base excess and fibrinogen level
diagnosed using the MCF/FibTEM parameter(r=0.6382, p<0.0001)and
an inverse proportional correlation between lactate level and fibrino-
gen level (r= -0.2164, p=0.0065). In the ROC analysis that uses as a
variable the level of base excess and as a criterion of classification
the fibrinogen deficit (MCF/FibTEM<12 mm) it can be observed that
at a value of BE<-7 mmol/l, we can diagnose a fibrinogen deficit with
a sensitivity of 88.2% and a specificity of 80.6% (AUC= 0.872,p<
0.0001). Lactate appears to be inferior to the excess base (Figure 1),
but still has a good diagnostic power, a value of 2.6 mmol/l has a
sensitivity of 67.1% and a specificity of 75% (AUC= 0.754,p<0.0001).
The difference between the two ROC curves (0.118) is statistically sig-
nificant (p = 0.0028).
Conclusions:
Both base excess and serum lactate can be used to diagnose fibrino-
gen deficiency with the mention that base excess appears to have a
higher sensibility and specificity ability.P314
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Introduction:
Coagulopathy is the leading cause of preventable death in patients
with severe trauma. A better understanding on the role of hypofibri-
nogenemia has lead to an increase in fibrinogen administration, lead-
ing to shift from fixed-ratio transfusion protocol to a viscoelastic-
Fig. 1 (abstract 315). Study Treatment Plan
Critical Care 2020, 24(Suppl 1):87 Page 129 of 213based goal-directed algorithm. This approach requires further clinical
validation.
Methods:
We conducted a retrospective study comparing transfusion strategies
in patients with major trauma between 2013 and 2018. We retrieved
demographic data and blood products administered from patients
with at least one red-blood cell (RBC) transfusion. Primary outcome
was a reduction of RBC administration. Secondary outcomes were
mortality, ICU length of stay and acute kidney injury.
Results:
We included 141 patients admitted in the ICU due to severe trauma
(SAPSII:41.5 ±21.9), and mainly after emergent surgery (68.8%). They
featured a mean age of 45.3±19.3y, were predominantly male
(76.6%) and 73% were in shock. In the first 24 hours of hospital ad-
mission a mean of 3.6±4.5 RBC units were administered. Most pa-
tients received a fibrinogen-based protocol (FBP) (78%), with an
average of 5±3g of fibrinogen and 1±3 fresh-frozen plasma (FFP)
units, versus 3±4 g of fibrinogen and 6±4 FFP units in the FFP group.
The FBP was associated with a decrease administration of RBCs in
the first 24 hours (R = -2.6; p < 0.004), even after adjustment for se-
verity (p=0.003) and for tranexamic acid use (p = 0.003). It was asso-
ciated also with a decrease of platelet transfusion (p=0.004).
Fibrinogen-based protocol was not associated with a decrease in
mortality, acute kidney injury or noradrenaline dose.
Conclusions:
Treatment of TIC in past years has progressively changed to a goal-
directed fibrinogen-based approach. In our population, the use of
FBP lead to a reduction of RBC administration in severe trauma
patients.
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Introduction:
The FiiRST-2 study will investigate if fibrinogen concentrate (FC) +
prothrombin complex concentrate (PCC) administered within the first
hour of hospital arrival is superior to the current standard of care:
blood component therapy via a massive hemorrhage protocol (MHP)
in trauma patients. Hemorrhaging trauma patients may develop
acute trauma coagulopathy, which has multifactorial etiology. How-
ever, acquired fibrinogen deficiency and impaired thrombin gener-
ation are becoming recognized as major drivers. Prompt and
targeted coagulation factor replacement with FC and PCC may be su-
perior to standard blood component therapy.
Methods:
FiiRST-2 is a multicenter (8 Canadian centers), pragmatic, randomized,
parallel-control, superiority trial with an adaptive two-stage design.
Trauma patients >16 years old at risk of massive hemorrhage will be
randomized to receive FC + PCC or standard of care (1:1:1 red cell
[RBC]:plasma:platelet transfusion) until after the second MHP pack
has been administered, MHP is terminated, or 24 h from admission
to the trauma bay (Figure 1). Exclusion criteria include receiving >2 U
RBCs within 1 h post-admission, ≥3 h elapsed from injury, severe
traumatic brain injury, or known congenital or acquired bleedingdisorders. The primary endpoint is to demonstrate superiority with
respect to the number of allogeneic blood product units (RBCs +
plasma + platelets) transfused from admission to 24 h after admis-
sion. Secondary endpoints include RBC units transfused from admis-
sion to 24 h after as a surrogate for hemorrhage control. Safety
endpoints include AEs and SAEs during 28 days after admission.
Results:
The study is expected to end Q1 2022.
Conclusions:
This pragmatic multicenter trial will determine if early hemostatic
therapy with FC + PCC is superior to standard MHP packs in bleeding
trauma patients. Results could have a major impact on clinical prac-
tice and improve the management and outcomes of this high-risk
group of patients.P316
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Introduction:
The objective of this study was to assess the ability of the Quantra®
QStat® System (HemoSonics) to detect coagulopathies in trauma pa-
tients. Many Level 1 trauma centers have adopted whole blood
viscoelastic testing, such as rotational thromboelastometry (ROTEM®,
Critical Care 2020, 24(Suppl 1):87 Page 130 of 213Instrumentation Lab) for directing transfusion therapy in bleeding pa-
tients. The Quantra QStat System is a cartridge-based point-of-care
(POC) device that uses ultrasound to measure viscoelastic properties
of whole blood. and provides measures of clot time, clot stiffness
and a test of fibrinolytic function.
Methods:
Adult subjects were enrolled at two Level 1 trauma centers which
use a ROTEM based protocol to guide transfusion decisions. Study
protocols were approved by the site’s Ethics Committee. For each
subject, whole blood samples were drawn upon arrival to the emer-
gency department and again, in some cases, after administration of
blood products or antifibrinolytics. Samples were analyzed on the
Quantra (at POC) in parallel to ROTEM delta (in lab).
Results:
A total of 54 patients were analyzed. Approximately 42% of samples
had a low Clot Stiffness (CS) values suggestive of an hypocoagulable
state. The low stiffness values could be attributed to either low plate-
let contribution (PCS), low fibrinogen contribution (FCS), or a combin-
ation (Figure 1). Additionally, 12% of samples showed evidence of
hyperfibrinolysis based on the Quantra Clot Stability to Lysis param-
eter. Samples analyzed on standard ROTEM assays showed a lower
prevalence of low clot stiffness and fibrinolysis based on EXTEM, FIB-
TEM results. The correlation of CS and FCS vs equivalent ROTEM pa-
rameters was strong with r-values of 0.83 and 0.78, respectively.
Conclusions:
This first clinical experience with the Quantra in trauma patients
showed that the QStat Cartridge detected coagulopathies associated
with critical bleeding and may be useful for directing blood product
transfusions in these patients. Ability to perform testing at POC may
provide additional clinical advantage.Fig. 1 (abstract P316). Summary of clot stiffness parametersP317
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Introduction:
The objective of the study was to describe the conditions of use of
FIBRYGA® 1g, a new, highly purified, human fibrinogen (HF) recently
granted a temporary import authorization for use in congenital and ac-
quired fibrinogen deficiencies in France.
Methods:
Observational, non-interventional, non-comparative, retrospective study
conducted in 5 French hospital centres using FIBRYGA®. Data from pa-
tients with fibrinogen deficiency having received FIBRYGA® fromDecember 2017 to July 2019 were retrieved from their medical files. In-
dications, modalities, efficacy and safety outcomes were recorded. Indi-
cations encompassed non-surgical bleeding (NSB) either spontaneous
or traumatic, including post-partum hemorrhage (PPH), bleeding during
surgery (SB) or administration to prevent bleeding during planned sur-
gery. Treatment success was defined as control of the bleeding or
hemoglobin loss <20% for bleeding treatment and as absence of major
perioperative hemorrhage for pre-surgical prevention.
Results:
This analysis included 110 patients aged 56,7 ± 17.7 years and 60%
were male. All presented an acquired fibrinogen deficiency requiring
administration of HF. Indications were NSB (n=45, 40.9%) including
15 (13.6%) PPH, SB (n=31, 28.2%), and prevention of SB (n=34;
30,9%). Cardiac surgeries were the main procedures associated with
treatment and prevention of SB. Mean total doses of FC were 2.95±
1.66g, 2.00±1.37g and 2.21±1.23g for NSB, SB and prevention of SB.
Success rates were 88.4% (95%CI 78.8-98.0%), 96.8% (95%CI 90.6-
100%) and 91.2% (95%CI 81.6-100%) respectively. For PPH, mean
dose of HF was 2.53±0.74g with a success rate of 86.7% (95%CI 69.5-
100%). Overall, tolerance was good.
Conclusions:
Fibrinogen concentrate FIBRYGA® is mostly used for bleeding control.
In one third of patients, HF was administered preventively to avoid
bleeding during surgery. Use of FIBRYGA® was associated with
favourable efficacy outcomes.
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Introduction:
Tranexamic acid (TXA) is the gold standard to prevent or treat hyper-
fibrinolysis [1]. Effective plasma concentrations are still under discus-
sion [2]. In this prospective, observational trial using modified
viscoelastometry we evaluated the time-course of the antifibrinolytic
activity of TXA in patients undergoing cardiac surgery.
Methods:
25 patients were included. Modified viscoelastometry (TPA-test) was
performed and TXA-plasma-concentration, plasminogen-activator-
inhibitor-1 (PAI-1) and PAI-antigen-plasma-concentrations were mea-
sured over 96h. Additionally, in vitro dose-effect-curves from blood
of healthy volunteers were performed. Data presented as median
with interquartile range (Q1/Q3).
Results:
TXA plasma-concentration was increased compared to baseline (T1:0
μg ml-1) at every time-point with a peak concentration 30min (T2)
after application (p<0.0001; see Fig.1A). Lysis was inhibited from
30min (LysisTimeTPA-test: p<0.01; LysisOnsetTimeTPA-test:p<0.0001).
MaximumLysisTPA-test was decreased at T2 (T1:97% (96/97) vs. T2: 9%
(6/11); p<0.0001). Of note, after 24h some patients (n=17) had nor-
malized lysis whereas others (n=8) had strong lysis inhibition (ML<
30%;p<0.05) up to 96h. High and low lysis groups differed regarding
kidney function (cystatin C:1.64mg l-1(1.42/2.02) vs. 1.28mg l-1(1.01/
1.52);p=0.002) and active PAI-1 (93.05ng ml-1 (33.15/9100.0) vs.
16.13ng ml-1 (6.62/79.98);p=0.047). In-vitro, TXA concentrations
>10μg ml-1 were effective to inhibit fibrinolysis.
Conclusions:
In our trial, after 24h there was still completely blocked lysis in pa-
tients with moderate renal impairment. This could be critical with re-
spect to postoperative thromboembolic events [3]. Here modified
viscoelastometry could be helpful to detect the individual fibrinolytic
capacity.
References:
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Critical Care 2020, 24(Suppl 1):87 Page 131 of 2133. Chornenki NLJ et al. Thromb Res. 179:81–6, 2019Fig. 1 (abstract P318). Viscoelastometric variables (TPA-test)
(median + IQR; n=25) over time. A) Tranexamic acid plasma
concentrations (TXA). B) Lysis Time = time span between CT and
50% lysis. C) Lysis Onset Time = time span from ClottingTime to 15%
lysis. D) Maximum Lysis = difference between MCF and lowest
amplitude in % of MCF;* p<0.05 vs. baseline (before tranexamic acid
(TXA)); ** p<0.01 vs. baseline; *** p<0.001 vs. baseline; **** p<0.0001
vs. baseline
Table 1 (abstract P319). Peri-operative transfusion and bleeding
Fibrinogen group
(n= 41)
Control group
(n= 19)
p-
value
PRBCs - patients transfused (n, %) 35 (85,4%) 18 (94,7%)
PRBCs - units per patient (median,
IQR)
4 (1-6) 5 (3-10) 0,07
FFP - patients transfused (n, %) 28 (68,3%) 19 (100%)
FFP - units per patient (median, IQR) 4 (0-6) 9 (4-18) 0,001
Cryoprecipitate - units per patient
(median, IQR)
0 6 (0-10) <
0,001
Chest tube drainage (ml/24h,
median, IQR)
640 (450-1075) 1037 (800-
1600)
0,009
Surgical re-exploration (n, %) 2 (4,9%) 6 (31,6%) 0,005P319
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Introduction:
Peri-operative coagulopathy correction based on viscoelastic
hemostatic assays (VHAs) and single-factor coagulation products has
changed the paradigm of bleeding management in cardiac surgery [1].
Methods:
In a retrospective study, we analysed patients with emergency sur-
gery for thoracic acute aortic dissection (TAAD), before and after the
introduction of fibrinogen concentrate in clinical practice. Data were
collected from paper and electronic records. The study was approved
by the institutional ethical committee. 60 patients were included in
the analysis, 19 operated in 2012, before fibrinogen concentrate was
approved for human use, and 41 in 2018-2019. Therapy was guided
by a rotational thrombo-elastometry (ROTEM) algorithm. Exclusion
criteria were non-compliance with the institutional protocol and
intra-operative death. We investigated allogeneic blood transfusion
(ABT), fibrinogen use, peri-operative bleeding (POB), surgical re-
exploration and post-operative complications (POC).
Results:
The groups were similar in gender, age, body weight, additive Euro-
Score and aortic cross-clamp time. Fresh frozen plasma, cryoprecipi-
tate and red blood cell transfusion were lower in the fibrinogen
group, but not platelet transfusion (table). 48,7% of patients in the
study group received fibrinogen concentrate and median dose was 2
g (IQR 2-3). Day 1 postoperative chest tube drainage and surgical re-
exploration were significantly lower. There were no differences in
stroke, renal replacement therapy, mechanical ventilation time and
ICU stay.Conclusions:
In patients with TAAD surgery, ROTEM-guided algorithms which in-
clude fibrinogen concentrate are associated with less (POB), surgical
re-exploration and ABT. Further research is needed to document the
role of VHAs and concentrated factors in reducing (POC).
References:
1. Meco M et al. J Cardiothorac Vasc Anesth 34:119-12, 2020P320
IFiTEM a novel modality of visco-elastic blood clotting test for
ROTEM device
J Benes1, M Peltanova2, J Zatloukal2
1Faculty of Medicne in Plzen, Department of Anesthesiology and
Intensive Care Medicine, Plzen, Czech Republic; 2Faculty of Medicne in
Plzen, Plzen, Czech Republic
Critical Care 2020, 24(Suppl 1):P320
Introduction:
Viscoelastic methods are currently an indispensable method in the
diagnosis of coagulopathy in critically ill. The analysis is carried out
using defined reagents of the external (EXTEM), internal pathways
(INTEM), fibrinogen (FIBTEM) or methods to diagnose pathological or
iatrogenic disorders. Limited channels may decrease time availability
under certain circumstances. The combination of reagents could
allow for the same information from a smaller amount of examin-
ation. We have designed the IFiTEM test, which combines internal
pathway activator with a platelet aggregation inhibitor (cytochalazin
D).
Methods:
Prospective observational study approved by the local ethical board
of the University hospital, Plzen in a cohort of 80 patients over 18
years in whom a ROTEM assessment was indicated during routine
perioperative or intensive care. Conventional coagulation (serum fi-
brinogen and platelet count) and routinely performed methods
(EXTEM, INTEM, FIBTEM) were examined. The experimental IFiTEM
test was performed using a combination of liquid reagents by adding
cytacholizin D to the INTEM test. The maximal clot firmness (MCF),
the difference of the MCF with and without the added inactivator
(dIN=MCF(INTEM)–MCF(IFiTEM); dEX=MCF(EXTEM)–MCF(FIBTEM)) and
conventional tests were examined.
Results:
Results of the ROTEM and standard laboratory tests are displayed in
the Figure 1. A close correlation was observed between the MCF of
EXTEM vs. INTEM (r = 0.97) and FIBTEM vs. IFiTEM (r = 0.89). Correl-
ation between MCF(IFiTEM) and fibrinogen serum level (r=0.82) was
comparable to the MCF(FIBTEM) (r=0.88). The platelet count showed
similar (though lower) correlation with the dIN (r=0.80) and dEX (r=
0.80) parameters.
Critical Care 2020, 24(Suppl 1):87 Page 132 of 213Conclusions:
The experimental method IFiTEM could be an alternative of FIBTEM
in cases when internal coagulation pathways assessment is priori-
tized (i.e. heparinized patients on extracorporeal supports).
Acknowledgement
Supported by the program for the Development of Scientific Fields of
Charles University (Progres Q39)Fig. 1 (abstract 322). Bland-Altman plot of POC and Lab INR data.
Red line - bias (0.01); Blue lines - limits of agreement (0.33)
Fig. 1 (abstract P320). Standard and ROTEM variablesP321
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Introduction:
Andexanet alfa (AA, Portola Pharmaceuticals, San Francisco, CA) rep-
resents a modified factor Xa agent which is approved antidote for
apixaban and rivaroxaban. Andexanet alfa may also neutralize the
anti-Xa effects of betrixaban and edoxaban. This study aims to com-
pare the relative neutralization of these four anti-Xa agents by
andexanet alfa in different matrices.
Methods:
Andexanet alfa was diluted at 10 mg/ml. Apixaban (A), betrixaban
(B), edoxaban (E) and rivaroxaban (R) were diluted in pH 8.4, 0.5 M
tris buffer (TB), blood bank plasma (BBP) and in 5% albuminated buf-
fer (AB) at 0.062 - 1.0 ug/ml. Anti-Xa activities of all four agents were
measured in three systems and the reversibility indices of AA were
profiled. The reversibility index (RI50) of anti-Xa effects by AA was de-
termined at 25 - 100 ug/ml.
Results:
Each of the four agents produced varying degrees of inhibition of
anti-Xa at 0.062 – 1.0 ug/ml, the IC50 ranged 0.61 - 1.53 ug/ml in BBP,
0.47 - 1.28 ug/ml in AB and 0.49 - 1.4 ug/ml in TB. Andexanet alfa
produced a concentration dependent reversal of all four anti-Xa
agents. In the BBP, the RI50 values for A (192 ug/ml), B (32 ug/ml), E
(152 ug/ml) and R (85 ug/ml). In the AB, the RI50 values for A (140
ug/ml), B (46 ug/ml), E (176 ug/ml) and R (58 ug/ml). In the TB, the
RI50 values for A (154 ug/ml), B (79 ug/ml), E (>400 ug/ml) and R (110
ug/ml).
Conclusions:
Each of the four anti-Xa agents exhibit varying degrees of matrix in-
dependent anti-Xa potencies in different systems, the collective order
follows edoxaban > apixaban > betrixaban > rivaroxaban. Andexanet
alfa produced matrix dependent differential neutralization of the
anti-Xa effects of these agents. Individualized dosing of andexanet
alfa may be required to obtain desirable clinical results.P322
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Introduction:
Early identification of potential participants for enrolment into the
SCARLET study [1] (evaluating ART-123 for sepsis associated coagu-
lopathy) was contingent upon identifying a threshold level of coagu-
lopathy (INR>1.40). Point of Care (PoC) devices measuring INR are
commercially available but limited validation studies have been con-
ducted for measuring INR values in intensive care patients. We there-
fore sought to determine whether INR measurements measured
using a PoC device correlate with concurrently measured laboratory
(LAB) INR values in adult intensive care patients.
Methods:
Using blood already collected for clotting profile measurements
as part of clinical management in a convenience sample of adult
ICU patients, we concurrently measured INR values using a PoC
(Roche CoaguChek Pro II) and LAB (ACLTOP750 Instrumentation
Laboratory) devices. The relationship between devices was
assessed via correlation, Bland-Altman agreement and diagnostic
predictive values.
Results:
In 72 independent paired INR measurements using PoC (range 1.0 -
2.4) and LAB (range 0.9 – 1.4) devices in 37 ICU patients (1 - 4 sam-
ples/patient) we determined a Pearson correlation coefficient r =
0.76 and Bland-Altman mean difference (bias) 0.01; 95% limits of
agreement 0.33 (Figure 1). A PoC INR ≤ 1.2 had a 0.96 negative pre-
dictive value for a LAB INR ≥ 1.4 and a PoC INR ≥ 1.3 had a 1.0 posi-
tive predictive value for a LAB INR ≥1.4.
Conclusions:
PoC device INR measurements correlate relatively well with LAB mea-
surements within this target INR range of interest in adult intensive
care patients. The likely value of PoC device INR measurements for
future sepsis associated coagulopathy studies requiring a threshold
level of coagulopathy would be as a negative predictive tool for
screening potential participants.
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Introduction:
The diagnostic and prognostic value of thromboelastogram (TEG) in
sepsis has not been determined. This study aimed to assess whether
TEG is an early predictor of coagulopathy [1, 2] and is associated with
mortality in patients with sepsis.
Methods:
In total, 518 patients with sepsis on intensive care unit admission
were prospectively evaluated. We measured TEG and conventional
coagulation tests(CCTs)on preadmission and observed for develop-
ment of 1, 3 days and 1, 3, 7days respectively. Multivariable logistic
regression was utilized to determine odds of ICU/hospital mortality.
The parameter of TEG (maximum amplitude, reaction time; MA/R ra-
tio) was calculated to evaluate sepsis-induced coagulopathy. The ad-
mission patients were divided into three groupsMA/R0 group(MA/R=
5-14mm/min); MA/R1group(MA/R>14 mm/min)and MA/R2
group(MA/R<5mm/min).
Results:
410 patients with complete TEG during follow-up were included. At
enrollment, 10.73%, 65.85%, and 23.41% of the patients had lower,
normal, and higher MA/R state respectively. Compared with MA/R0
group, patients with lower and higher MA/R both had dignificantly
increase risk of hospital mortality [HR2.83 (95%CI 1.577-5.079 ), P<
0.01]; [HR1.982 (95%CI 1.073-3.66), P=0.029] respectively (adjusted
with APACHEII score) and ICU mortality [HR 2.512 (95%CI 1.301-
4.852), P= 0.006]; [HR1.644 (95%CI 1.024-2.639), P=0.002](adjusted
with APACHEII score). Patients with higher MA/R had dignificantly in-
crease risk of hospital mortality APACHEII score [HR 1.635
(95%CI1.016-2.632), P=0.043].
Conclusions:
In our cohort of patients with severe sepsis, coagulopathy defined by
MA/R ratio was associated with increased risk of ICU/hospital
mortality.
References:
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Introduction:
Blood sampling for coagulation assessment is often carried out in ei-
ther arterial or venous samples in the Intensive Care Unit (ICU). There
is controversy as to the accuracy of this method due to the inherent
differences in physicochemical properties as well as the underlying
effects of individual diseases in arterial and venous blood. Clot micro-
structure has shown to be a new biomarker (fractal dimension- df)
which encompasses the effects of diseases in all aspects of the co-
agulation system [1, 2]. In this study, we compared the effect of all
these factors in venous and arterial blood to see if there is a differ-
ence in the clot microstructure and quality.Methods:
45 patients admitted to a tertiary intensive care unit and busy teach-
ing hospital were recruited. Arterial and venous blood was sampled
from an arterial line and central venous catheter in situ from the
same patient. Standard markers of coagulation (PT, aPTT, fibrinogen,
full blood count), rotational thromboelastometry (ROTEM), whole
blood impedance aggregometry and measured clot microstructure
(df) were measured on both arterial and venous samples.
Results:
No significant difference was observed in standard laboratory
markers, ROTEM and platelet aggregation between arterial and ven-
ous blood. There were no differences in the fractal dimension (df) be-
tween the arterial and venous blood samples (df 1.658 ± 0.10 vs
1.654 ± 0.08 respectively, p=0.830).
Conclusions:
Samples from patients with critical illness give comparable results
from either arterial or venous blood despite their underlying patho-
physiological process or treatment. This confirms blood for coagula-
tion testing can be taken from arterial or venous blood.
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Introduction:
Clinicians in the emergency setting use a wide range of hemostatic
markers to diagnose and monitor disease and treatment. Current
methods rely on the anticoagulant effect of citrate on whole blood
prior to laboratory analysis. Despite the well-recognized modulatory
effects of citrate on hemostasis, the use of anticoagulated blood has
clear analytical advantages, including repeat sampling and storage.
However by altering the physiological state of the blood reproduci-
bility and accuracy of the test is affected. Recent studies have shown
the potential of a novel functional biomarker of clot formation: Frac-
tal Dimension (df), that may give an improved diagnostic accuracy. In
this study we assessed the potential of this new biomarker in scien-
tifically measuring the effects of recalcification of citrated samples.
Methods:
35 healthy volunteers were included. Unadulterated and sodium cit-
rate samples of blood were taken from each volunteer. Citrated sam-
ples were recalcified using (1M CaCl2). In the study we compared
unadulterated whole blood df results to citrated df results and re-
peated the citrated df experiments 5 times for each sample over a 2
hour period to ascertain reproducibility.
Results:
The df of citrated blood was significantly lower than that of unadul-
terated blood (1.57±0.04 vs 1.69±0.04, p<0.001). The results of the
citrate samples when tested 5 times over 2 hrs gave a coefficient of
variation of 1.16%.
Conclusions:
For the first time we show that a functional biomarker of clot micro-
structure, df, can precisely quantify and measure accurately the direct
effect that the addition of the anticoagulant sodium citrate has on
whole blood clot microstructure. The study also shows that the test
is reproducible and has potential utility as a biomarker of acute
Fig. 1 (abstract 327). Agreement between TEG®6s and R TEG®5000
on citrated recalcified and fresh whole blood
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now needs to be evaluated in a group of acute disease states.
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Introduction:
In this study, we analyzed the hematological abnormalities of dengue
patients by thromboelastography (TEG) at initial and 1-hour of fluid
resuscitation.
Methods:
This is a cross-sectional study evaluating TEG readings of dengue pa-
tients with different severities presenting to the emergency depart-
ment. Laboratory confirmed dengue patient (positive NS1 antigen or
IgG/IgM) was consecutively sampled. TEG readings were taken at
presentation and after 1-hour of fluid resuscitation.
Results:
Twenty dengue patients with varying severity had a median Reaction
time (R), α -angle, K time, Maximum Amplitude (MA) and Lysis 30%
(Ly30) of 0.495 min, 68.74ο, 3.58 min, 44.64 mm and 0.54% respect-
ively. Mean fibrinogen was normal before and after fluid infusion.
There is a non-significant reduction in MA with prolongation of other
TEG parameters between different dengue severities. There is a sta-
tistically significant reduction of α-angle and MA between pre and
post 1-hour fluid resuscitation (p=0.019 and p=0.040).
Conclusions:
Normal fibrinogen with low MA, which signifies a weak clot strength,
may indicate either a platelet reduction, platelet dysfunction or
both. Reduction in MA and α-angle post fluid resuscitation is an
alarming finding. This is in contrast with previous TEG studies al-
though none of it used normal saline exclusively, studied initial fluid
resuscitation in emergency department settings or studied a subject
with dengue. A bigger study, especially in severe dengue is needed
to validate our findings.
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Introduction:
The R (reaction time) parameter of kaolin-activated thromboelasto-
graphy (TEG) may be used to assess the degree of heparinization of
blood during ECMO. A TEG analysis is usually performed on two
types of samples: fresh (F) or citrated-recalcified (C) whole blood.
TEG®5000 can perform the analysis on C and F whole blood, the new
TEG®6s (Haemonetics Corp., MA, USA) only on C whole blood. Aim of
the study was to compare the response of R to heparin using the
two types of samples and two TEG devices
Methods:
During a three months period at Fondazione IRCCS Ca’ Granda – Poli-
clinico of Milan, TEG was performed (using TEG5000® and TEG 6s®
with and without heparinase, an enzyme that degrades heparin) on
13 consecutive ECMO patients (as part of the GATRA study,
NCT03208270) and in 8 consecutive non-ECMO patients in whom a
TEG was requested for clinical purposes. Bland Altman analysis and
Lin's concordance correlation coefficient were used to assess
agreement
Results:
A total of 84 paired samples were taken (74 in-ECMO and 10 off-
ECMO). ECMO patients received 19.2 (12.6- 25.8) IU/kg/h of heparin.Among non-ECMO patients, 5 of them did not receive any dose of
heparin, two of them a very low prophylactic dose (1.6 and 2.9 IU/
kg/h, respectively), and one of them 13.1 IU/kg/h of heparin. Using
TEG®5000, R was -21.0 (-65.5; 23.4) min shorter on C compared to F
blood in patients receiving heparin (this difference disappeared using
heparinase) and only -1.58 (-8.70; 5.54) min shorter in patients not-
receiving heparin. R was -26.6 (-77.3; 24.2) min shorter using TEG®6s
(which performs the analysis only on C blood) than TEG®5000 on F
blood (Figure 1).
Conclusions:
When evaluating the effect of heparin using TEG, clinicians should be
aware that results obtained using citrated-recalcified or fresh whole
blood are not interchangeable. Using citrated-recalcified blood to
perform TEG might lead to underestimation of the effect of heparinP328
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Introduction:
Trauma patients are at high risk for venous thromboembolism (VTE).
The 2002 EAST guidelines recommend low molecular weight heparin
(LMWH) for VTE prevention and antiXa monitoring after initiation of
the medication or after adjusting doses in certain populations [1].
Studies have shown standard enoxaparin dosing of 30 mg every 12
hours may result in low antiXa levels [2]. This study aims to evaluate
the efficacy of a pharmacist-lead protocol for adjusting enoxaparin
dosing based on antiXa levels in trauma patients.
Methods:
This single center retrospective chart review included adult trauma
patients admitted from 3/1/2018 to 9/20/2019. Per protocol, patients
with body mass index (BMI) ≤40 kg/m2 were initiated on enoxaparin
30 mg twice daily, and patients with BMI > 40 kg/m2 were initiated
on enoxaparin 40 mg twice daily. Peak antiXa levels were drawn 4 to
6 hours after at least the third dose of enoxaparin with a goal thera-
peutic range of 0.2-0.4 IU/mL. The primary objective was time in days
to goal peak antiXa level. Secondary objectives include VTE occur-
rence, bleeding attributed to LMWH, and dosing regimens utilized.
Subgroups were analyzed based on body mass index (BMI).
Results:
Of 511 patients identified, 375 patients met inclusion criteria. Median
time to therapeutic antiXa level was 3 days (IQR 2-6). Of 337 patients
Critical Care 2020, 24(Suppl 1):87 Page 135 of 213with BMI ≤ 40 kg/m2, 319 patients (94.7%) were dosed initially per
protocol and 153/319 patients (48.0%) met goal antiXa level at first
check (Table 1). Of 38 patients with BMI > 40 kg/m2, 24 patients
(63.1%) were dosed initially per protocol and 8/24 patients (33.3%)
met goal antiXa level at first check.
Conclusions:
Our results indicate the protocol is safe due to lack of bleeding at-
tributed to enoxaparin, but less than 50% of patients achieved goal
antiXa level at first check. However, despite low rates of achieving
goal antiXa level, VTE rates also remained low.
References:
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2. Walker CK et al. Ann Pharmacother 51:323-331, 2017.Fig. 1 (abstract P329). Correlation of anti factor Xa activity with
patient CCT and weight. Anti FXa activity value below 0.2 (red line),
was considered “non-effective prevention”
Table 1 (abstract P328). Results
All Patients
(N = 375)
BMI < 40 kg/m2
(n = 337)
BMI > 40 kg/
m2 (n = 38)
Time to goal antiXa in days –
median (IQR)
3 (2-6) 3 (2-5.8) 2.5 (1.8-8)
AntiXa within goal at first
check
168/375
(44.8%)
153/337 (45.4%) 13/38 (34.2%)
Final dose (mg) to reach goal
antiXa–mean +/- SD
34.5 +/- 8.0 33.2 +/- 5.9 46.5 +/- 13.5
Number of dose changes –
mean +/- SD
0.35 +/- 0.6 0.33 +/- 0.55 0.64 +/- 0.93
Rates of VTE 8/375 (2.1%) 7/337 (2.1%) 1/38 (2.6%)
Rates of bleeding 0/375 (0.0%) 0/337 (0.0%) 0/38 (0.0%)P329
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Introduction:
Most patients in the ICU are given prophylactic anticoagulation with
a fixed dose of 40 mg once daily of Enoxaparin (clexane) if CCT is
normal and 20 mg if CCT is low. Studies on non ICU patients have
shown that AFXa is below desired range for venous thromboembol-
ism (VTE) prevention. In the ICU, many factors might influence AFXa
levels including weight, creatinine clearance (CCT), shock and other
medication. ATXa activity was not yet reported in a big mixed ICU
population with variable morbidity. Our study hypothesis is that
Enoxaparin is underdosed in most cases and routine AFXa activity
should be monitored in all ICU patients.
Methods:
Preventive enoxaparin (40 mg qd) was given to all patients unless
therapeutic dose was needed or contraindication existed. Levels of
AFXa activity were taken 4 hours after the 3rd dose. Therapeutic VTE
preventive effect was defined as AFXa activity of 0.2-0.5. Patient data
was collected from medical files.
Results:
The study is still ongoing, preliminary results were analyzed for 31
patients. 14 of 31 patients (45%) had AFXa activity below normal
(subtherapeutic). Weight and CCT were negatively correlated with
AFXa activity (Figure 1). Mean weight in the subtherapeutic AFXa
was significantly higher than the therapeutic group (83.2 vs. 72.6 re-
spectively, p=0.031). CCT in the subtherapeutic AFXa was significantly
higher than the therapeutic group (95.1 vs. 60.4 respectively, p=0.003). The normal CCT group (>50) had significantly more patients
with subtherapeutic AFXa (13 vs 8, p=0.017).
Conclusions:
In our ICU, 45% of the patients receive insufficient VTE prophylaxis.
Overweight patients and patients with normal CCT should probably
receive higher Enoxaprin dose. AFXa activity should be routinely
monitored in ICU patients.P330
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Introduction:
In this study we use a new bedside biomarker to test its ability to
measure anticoagulation effects on patients who present with acute
first time deep vein thrombosis (DVT). DVT requires oral anticoagu-
lants to prevent progression to potentially fatal pulmonary embolism
and recurrence. Therapeutic efficacy monitoring of direct oral antico-
agulants (DOAC) including rivaroxaban is problematic as no reliable
test is currently available. Advances in hemorheological techniques
have created a functional coagulation biomarker at the gel point
(GP) which allows quantitative assessment of: time to the gel point
(TGP), fractal dimension (df) and elasticity (G’) [1, 2].
Methods:
The prospective observational cohort study measured TGP, df, G’,
standard coagulation and cellular markers in first time DVT patients
at three sample points: pre-treatment and approximately 20 and 60
days following 15mg BD and 20mg OD rivaroxaban respectively.
Strict inclusion and exclusion criteria applied.
Results:
40 DVT patients (mean age 64 years [SD±14.8]; 23 male, 17 female)
and 177 non-DVT patients were well matched for age, gender and
co-morbidities. Mean TGP on admission was 267s (SD±63.3s) and
262.9s (SD±73.5s) for DVT and Non-DVT respectively. DOAC therapy
significantly increased TGP to 392.3s (SD±135.7s) after 20 days, and
subsequently increased to 395.5s (SD±194.2s) at 60 days as shown in
Table 1. df, G’ and standard hemostatic markers all remain within the
normal range.
Conclusions:
TGP demonstrates its utility in determining the anticoagulant effect of
rivaroxaban. The significant difference in TGP between males and fe-
males needs further exploration. Localized stasis as a result of transi-
ent provoking factors appears not to generate a systemic strength
Critical Care 2020, 24(Suppl 1):87 Page 136 of 213enhancement in clot microstructure. Factors linked to increased clot
strength in DVT patients include increased levels of hematocrit, fi-
brinogen, white cell count and male gender.
References:
1. Evans et al. Blood 116:3341–3346, 2010
2. Lawrence et al. BMJ 168:571–575, 2015Table 1 (abstract P330). Time to the gel point (TGP) and prothrombin
time (PT) results for DVT group at baseline and on treatment. Values
reported as mean ± Standard Deviation. Significance values assessed
using one-way ANOVA
DVT
baseline
Rivaroxaban 15mg
BD dose
Rivaroxaban 20mg
OD dose
Significance
valve
TGP (s) 267.0 ±
63.3
392.3 ± 135.7 395.5 ± 194.2 <0.001
Prothrombin
Time (s)
10.8 ±
0.58
13.6 ± 1.73 12.6 ± 1.47 <0.001P331
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Introduction:
Trauma remains the leading cause of death all over the world. To
better exploit the trauma care system, precise diagnosis of the injury
site and prompt control of bleeding are essential. Here, we created a
nursing protocol for initial medical care for trauma. The aim of this
study was to evaluate the impact of protocoled nursing care for
trauma on measures of quality performance.
Methods:
This was a retrospective historical control study, consisted of con-
secutive severe trauma patients (Injury Severity Score >16). People
were divided into two groups: protocoled group (from April 2017 to
March 2019) and control group (from April 2014 to March 2017). We
set the primary endpoint as mortality for bleeding. The secondary
endpoints included time allotted from arrival to start of CT scan and
surgery, administration rate of several drugs (sedations, painkillers,
preoperative antibiotics, and tranexamic acid). For the statistical ana-
lysis, continuous variables were expressed as median (interquartile
range) and were compared by Wilcoxon rank sum tests given a non-
normal distribution of the data.
Results:
We included 152 patients in the study: 84 in the control group be-
fore the introduction of the protocol, 68 in the protocoled group. As
a primary endpoint, the mortality for bleeding was similar between
two groups (5% in the control group and 5% in the protocoled
group). As a secondary endpoint, the time to CT initiation [Group A
11 (7-16) min vs Group B 7 (5-10) min; p <0.001], and emergency
procedure [Group A 41 (33-56) min vs group B (29-43); p <0.001]
were shortened by the protocol introduction. Furthermore, the ad-
ministration rates of sedations, painkillers, preoperative antibiotics,
and tranexamic acid were increased in the protocoled group com-
pared with the control group.Conclusions:
Although the mortality as a patient-oriented outcome was not af-
fected, improved quality of medical care by nursing protocol intro-
duction may be suggested in this analysis.
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Introduction:
Unstable pelvic ring fracture (UPRF: AO-OTA type B, C) were life-
threatening injuries, but with recent advances in acute resuscitation
have focused attention on physical function and quality of life after
discharge. We aimed to clarify the long-term physical functional and
quality of life in patients with UPRF.
Methods:
This single-institutional prospective study included 72 patients with
UPRF who were admitted to the trauma surgical intensive care unit
(TSICU) and survived until discharge to home between 2012 and
2017. We evaluated the activities of daily living after the discharge
using physical and mental component scores of SF-36® and defined
physical dysfunction (PD) as physical function (PF-N) score of 40 or
less. We divided the patients in the PD (n=34) and control (without
PD, n=38) groups and compared the groups.
Results:
The patients had experienced blunt injuries, including falls (38%) and
pedestrian injuries (33%). The mean age was 59.9 years (men: 65.3%);
the median injury severity score was 22 (interquartile range: 13–29);
and the mean length of TSICU stay was 3.3 days. The average period
from the injury until the survey was 34.1 months. There was no dif-
ference between the PD group and the control group in the patient
characteristics, fracture type, pelvic fixation, and complications. At
the time of the survey, the PD group had significantly more painful
complaints than the control group (PD: 67.6%, C: 23.6%, P <0.01),
and had more physical and mental problems. The SF-36®subscale
score showed a significant positive correlation between physical
function and body pain, mental health respectively. The percentage
of those who were able to return to work was not different in both
groups (PD:26.5%, C:47.4%). In the multivariate analysis of PD, only
age (odds ratio: 1.039, 95% CI: 1.00-1.07, P = 0.03) was relevant.
Conclusions:
Long-term PD was observed in 47% of patients with UPRF. The eld-
erly were particularly prominent, and there was an association be-
tween pain and mental health.
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Introduction:
The development of new methods for diagnosing critical states is
one of the most important tasks. Patients in critical condition are
characterized by a violation of many body functions, affecting the
morphofunctional characteristics of blood cells. In case of red blood
Critical Care 2020, 24(Suppl 1):87 Page 137 of 213cells (RBC) this can lead to inhibition of oxygen transport function
and development of hypoxia. Currently used methods for analyzing
the state of RBC either do not have sufficient accuracy or require
lengthy analysis and expensive equipment. The use of a simpler and
more informative electrochemical approach to assessing the state of
RBC is very promising.
Methods:
Electrochemical measurements in RBC suspensions (~ 5 ∙ 109 cells / l)
were carried out in a special electrochemical cell [1] in the potentio-
dynamic mode in the potential range from -0.5 to +1.2 V using the
IPC Pro MF potentiostat (Kronas, Russia); optical measurements were
performed using an Eclipse TS100 inverted microscope (Nikon,
Japan), a CFI S Plan Fluor ELWD 60x / 0.70 lens (Nikon, Japan); RBC
morphology was recorded in real time using a DS-Fi1 digital camera
(Nikon, Japan).
Results:
When examining RBC of patients with severe multiple trauma a de-
crease in the ability of RBC to change their shape during electro-
chemical exposure was observed, indicating a decrease in
deformability, which can lead to a disruption in the oxygen supply to
tissues. At the same time, with the stabilization of the patient's con-
dition a restoration of the ability of RBC to change morphology was
detected which in turn could have a positive effect on the rheo-
logical characteristics of the blood (Fig. 1).
Conclusions:
The results of the analysis of red blood cells using electrochemical
changes in their morphology can be used as an additional method
for the diagnosis of critical conditions.
References:
1. Yu TA et al. Doklady Physical Chemistry 477:201-204, 2017Fig. 1 (abstract P333). The effect of therapy on the electrochemically
induced change in the morphology of red blood cells in patients with
combined traumaP334
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Severe trauma should be treated immediately. Whole-body CT
(WBCT) is widely accepted to improve the accuracy of detecting in-
juries. However, it remains the problem of time-consuming. There-
fore, we focused on the scout image taken in advance of WBCT.
Detecting major traumatic injuries from a single scout image would
reduce the time to start treatment. A previous study suggested that
even specialists could not easily find chest and pelvic injuries using
WBCT scout image alone. In this study, we aimed to develop and val-
idate deep neural network (DNN) models detecting pneumo/hemo-
thorax and pelvic fracture from WBCT scouts.
Methods:
We retrospectively collected 2088 anonymous WBCT scouts together
with their clinical reports at the Osaka General Medical Center be-
tween January 1, 2013, and December 31, 2017. We excluded incom-
plete, younger than 7 years old, postoperative, and poorly depicted
images. The part of this dataset from January 1, 2017, until Decem-
ber 31, 2017, was used for validation and the rest for training DNN
models. Pneumo/hemothorax detection model and pelvic fracture
detection model were trained respectively. Accuracy, and Areas
under the receiver operating characteristic curves (AUCs) were used
to assess the models.
Results:
The training dataset for pneumo/hemothorax contained 984 images
(mean age 48 years; 30% female patients), and for pelvic fracture
consisted of 783 images (48 years; 28%). The validation dataset for
the former contained 258 images (54 years; 30%), and for the latter
consisted of 186 images (55 years; 24%). The models achieved 59%
accuracy and an AUC of 0.57 for detecting pneumo/hemothorax,
72% and 0.62 for pelvic fracture.
Conclusions:
Our results show that DNN models can potentially identify pneumo/
hemothorax and pelvic fracture from WBCT scouts. Increasing the
number of samples, DNN model could accurately detect severe
trauma injuries using WBCT scout image.
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Introduction:
Clinical Information System (CIS) is a computer system used in col-
lecting, processing, and presenting data for patient care. It can reduce
staff workload and errors; help in monitoring quality of care; track
staff’s compliance to care bundles; and provide data for research pur-
pose. However, the transition from paper record format to electronic
record involves changes in all kind of workflow in ICU. Therefore, an
effective, efficient and evaluative rollout plan was required to
minimize the risk that might arise from the new practice.
Methods:
1. Small groups training were provided. A working station with
different case scenarios were set up for practices.
2. Individual tutorials were conducted to clarify questions.
Emphasis on patient care was always top priority.
3. Contingency plans were available in case of server breakdown
and power failure. Downtime drills were conducted to prepare
the staff in emergency situations.
4. Step-by-step transition from paper record to electronic format
was gradually carried out. A plan was discussed among CIS
team with clear dates and goals.
5. New items in CIS were first reviewed and amended in team
meeting until consensus was made; then were promulgated
to all staffs during handover before implementation.
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review and amendment would be possible if necessary.
Results:
CIS roll-out plan was smooth. All staffs were able to integrate CIS into
the daily routine. The contingency plans were well acknowledged.
New items were followed as planned. Ongoing enhancement in CIS
was put forward on nursing orders, handover summary, and integra-
tion with Inpatient Medication Order Entry (IPMOE) system.
Conclusions:
With emerging benefits CIS brings along, our staff has more time to
devote to direct patient care. Human input in data interpretation and
clinical judgment on top of CIS play an irreplaceable role in patient
care.Table 1 (abstract P337). Drug classes initiated in ICU and continued
after ICU discharge
Drug class Drug class
initiated in
ICU
Drug class continued
after transfer to the
ward
Drug class continued
on home discharge
Antibiotics 22 16 (72.7%) 9 (40.9%)
Steroids 10 8 (80.0%) 4 (40.0%)
Analgesics 19 17 (89.5%) 11 (57.9%)P336
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Introduction:
The daily request for laboratory tests in intensive care units is a com-
mon practice. Although common, this strategy is not supported,
since more than 50% of the exams requested with this rationale may
be within the normal range [1]. Misconduct based on misleading re-
sults, anemia, delirium and unnecessary increase in costs may hap-
pen [2]. We have developed a strategy to reduce laboratory tests
without clinical rationale.
Methods:
Observational retrospective study, from July 2018 to June 2019. The
number and type of laboratory orders requested, the epidemiological
profile of hospitalized patients, the use of advanced supports, the
average length of ICU stay and the impact in outcomes such as mor-
tality and hospital discharge at a private tertiary general hospital in
the city of Rio de Janeiro / RJ - Brazil were analyzed.
Results:
A strategy was implemented to reduce the request for exams consid-
ered unnecessary. Approximately 1,300 patients underwent ICU dur-
ing this period. The epidemiological profile and severity of patients
admitted to the unit were similar to those observed historically.
There was a significant reduction (> 50%) in the request for labora-
tory tests and there was no negative impact on outcomes such as
mortality, mean length of stay and no greater use of invasive re-
sources. Over the period evaluated, the estimated savings from redu-
cing the need for unnecessary exams were approximately $ 150,000
per year.
Conclusions:
The rational use of resources in the ICU should be increasingly priori-
tized and the request for routine laboratory tests reviewed. A strat-
egy that avoids such waste, when properly implemented, enables
proper care, reducing costs and ensuring quality without compromis-
ing safety.Insomnia 7 6 (85.7%) 1 (14.3%)
Anticoagulants 2 2 (100.0%) 2 (100.0%)
Antipsychotics 4 2 (50.0%) 0 (0.0%)
Gastroprotective
drugs
23 22 (95.6%) 12 (52.1%)References:
1. Peixoto AA Jr et al. Crit Care 17(Suppl 3):P12, 2013
2. Choosing Wisely [Internet]. Philadelphia (PA), ABIM Foundation. 2018;
[cited 2018 Jan 10]. Available from: www.choosingwisely.org.P337
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Introduction:
Medication errors in Intensive Care Unit (ICU) are frequent [1] and can
arise from a number of causes including transition of care. Our aim was
to investigate the impact of an integrated Electronic Health Record Sys-
tem (EHRS) on medication reconciliation (MR) errors occurring at 2 crit-
ical steps: during the transition from an ICU to the hospital ward and
from the ward to hospital discharge. The objective was to examine the
influence of ICU admission on long-term medication.
Methods:
We performed a monocentric study in 2 ICUs of a university-affiliated
hospital using drug chart and medical notes review to identify MR er-
rors before, during and after ICU admission. Data were collected
retrospectively from EHRS for 50 consecutive patients discharged
from the ICU between 1 June-31 July 2019, and who were newly ini-
tiated on specific drugs of interest.
Results:
129 drugs of interest were initiated in ICU. Many of these were contin-
ued after hospital discharge as shown in Table 1. There was appropriate
discontinuation of all the antipsychotics newly initiated in ICU. Other
than anticoagulants, there was no reason documented for continuation
of the initiated drugs. The planned durations were documented more
often after hospital discharge than ICU discharge for the following drug
classes (% of patients with a plan after ICU discharge to the ward; %
after home discharge): antibiotics (47.6%; 52.6%), and steroids (45.4%;
57.1%), but less so for analgesics (36.3%; 14.3%), insomnia (0.0%;
20.0%), and gastroprotective drugs (0.0%; 20.0%).
Conclusions:
Our study has shown that medications initiated in the ICU can be in-
advertently continued at ICU and hospital discharge due to failure in
documenting indication or duration. Systems are required to depre-
scribe ICU only drugs at discharge or communicate a plan for on-
going treatment.
References:
1. Moyen et al. Crit Care 12: 208-215, 2008
Fig. 1 (abstract P339). Sepsis 3-6h bundle components (% of
goals achievment)
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Introduction:
The Surviving Sepsis Campaign advocates the use of care bundles to
guide the management of sepsis and septic shock [1]. Our study aim
was to assess compliance with a locally introduced sepsis pathway
and to review intensive care unit admission outcomes.
Methods:
We carried out a prospective audit of patients admitted to the ICU at
Royal Surrey County Hospital with a diagnosis of sepsis between 19/
3/19 and 19/11/19, assessing compliance with local sepsis bundle de-
livery, outcome of ICU admission and degree of associated organ
dysfunction.
Results:
119 patients were identified, 71 male (59.7%), with a mean age of
65.7 (18-96). Mean 1st 24 hour SOFA score on ICU was 6.65 (2-15).
81% of patients required vasopressors, with 67% requiring noradren-
aline >0.1mcg/kg/min, and 19% requiring an additional vasopressor/
inotrope. 36% required NIV, 32% invasive ventilation and 15% RRT.
ICU mortality was 15%, in-hospital mortality 24%, mean ICU stay 8
days (1-49), and mean length of hospital stay 28 days (1-163). In the
presence of septic shock mortality was 47% with post-resuscitation
lactate >4, versus 21% in patients with no vasopressor requirement
or lactate <2 (p<0.05). The sepsis bundle was delivered in one hour
to 61 patients (51%). Where the bundle wasn’t completed, antibiotics
were delayed in 26% of cases and blood cultures weren't taken in
66%. Where the bundle was fully delivered, unit mortality was 12%
vs. 21% where it was not (p<0.05), but there was no significant differ-
ence in hospital mortality (26% vs. 30%, p>0.5) or rates of vasopres-
sor requirement, NIV, IPPV or RRT.
Conclusions:
There is room for improvement in timely delivery of the sepsis bun-
dle in our hospital and various measures are being instituted.
Though there was no significant difference in hospital mortality, ICU
mortality was significantly lower in patients when the bundle was
fully delivered.
References:
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Introduction:
Surviving sepsis campaign recommends 3h and 6 h sepsis resuscita-
tion bundle for sepsis. The study was done to assess the feasibility of
the guideline and the compliance to sepsis-3 recommendations at
an emergency department.
Methods:
Prospective interventional study was conducted during one year.
Were involved in the study all sepsis cases with a qSOFA ≥ 2. Were
assessed a composite of six components (Measurement of serum lac-
tate, Obtaining blood culture before antibiotic Administration and
Provision of broad-spectrum antibiotic before the end of H3 and
Provision of fluid bolus in hypotension, Attainment of target central
venous pressure assessed by cardiac ultrasonography, Target lactateto normal level before the end of H6). Time base line was the first
medical contact at triage zone. Secondary outcomes of study were
the mortality rate and length of stay at Intensive care unit (ICU).
Results:
Were involved in the study, 128 patients (mean age 54±17 years, sex
ration 2,3). Pulmonary infections were the main cause of sepsis (37%)
and urinary tracts infections (22%). At H3 components were achieved
in 79% of cases [lactates (100%), blood culture (82%) and provision
of antibiotics (79%)]. At H6 components were executed in 64% of
cases (fluid provision achievement in 89%, ultrasonography assess-
ment in 64% and normal lactate target achieved in 71%) (Figure 1).
The reliability-adjusted rate for completion of the 3 hours and 6
hours Bundle was at 68%. Patients compliant to composite bundle
got the mortality benefit (odds ratios = 0.31, 95% [confidence inter-
val, 0.11-0.72]). The study, however, did not show any benefits of
mean intensive care unit (ICU) length of stay.
Conclusions:
Faisability of 3-6h Bundle ratio was at 68%. It has shown a significant
improvement in adaptation and mortality benefit without reducing
mean hospital/ICU length of stay. More adapted procedures are
needed to improve results targeting full compliance of patients to
the 3-6h Bundle sepsis management.P340
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Introduction:
Paucity of epidemiological data is a major barrier in expansion of critical
care services, especially in resource limited settings. We evaluated the pat-
terns and the outcome of critically ill patients with sepsis admitted to a
level 3 Medical Intensive Care Unit in Sri Lanka.
Methods:
A retrospective cohort study was performed to describe the charac-
teristics and outcome of patients with sepsis, admitted to a medical
intensive care unit. Sepsis is defined according to sepsis 3 definition.
Results:
We examined 360 critically ill patients admitted over a period of 6 months.
Sepsis was the commonest presentation, accounted for 63.6 % of all admis-
sions. Mean age was 49.2 ± 16.1 years. Septic shock was present in
41.4% on admission. Pneumonia (35.4%) was the commonest cause, while
Leptospirosis (17.9%) and meningoencephalitis (12.2%) accounted for
Critical Care 2020, 24(Suppl 1):87 Page 140 of 213second and third commonest causes of sepsis respectively. The SOFA score
on admission (8.8 ± 5.0 vs 7.5 ± 4.9, P< 0.025), occurrence of AKI (62% vs
49.6%, p<0.02) and the length of ICU stay (8.8 days vs 6.2 days, p <0.001),
were significantly higher in sepsis than in patients without sepsis. ICU mor-
tality in sepsis (n=92) did not show a significant difference to nortality (n=
45) in those without sepsis (40% vs 35%, p= 0.5). Patients with leptospirosis
had a mean SOFA score of 13.3, however the mortality (37.5% vs 40%, p =
0.75) was similar to others with sepsis. In contrast, mortality related to sepsis
was significantly high ( 60%, p< 0.02) in the packground of immunosuppres-
sion (n= 35).
Conclusions:
Respiratory failure secondary to pneumonia was the commonest
cause of critical care admission with sepsis. Sepsis related ICU mortal-
ity was high in the background of immunosuppression.Fig. 1 (abstract P341). Percentage of clinicians trained before and
after interventionP341
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Introduction:
Training in placement, and the subsequent safe confirmation of pos-
ition, of a nasogastric (NG) tube, relies on clinicians completing an e-
Learning module at our trust. Feeding through an incorrectly
placed NG tube is a 'Never Event,' associated with significant morbid-
ity and mortality [1]. Analysis of these incidents reveal that the misin-
terpretation of chest radiographs, by medical staff, who had not
received competency-based training, is the most frequent cause [2].
e-Learning has revolutionized the delivery of medical education [3],
however, there are barriers to its use [4]. We hypothesized that, by
taking e-Learning content, and delivering it face-to-face, we would
improve training rates, and thus patient safety.
Methods:
A questionnaire was completed by 50 critical care doctors, concern-
ing their knowledge of the existence of the e-learning module,
whether they had completed formal training in NG tube placement,
and how confident they were, on confirming correct positioning,
using a 5 point Likert scale. All clinicians underwent training in the
interpretation of NG placement, using chest radiographs. After the
session they were asked to re-appraise how confident they felt. Re-
sults were compared using paired t tests.
Results:
Confidence improved in all, rising from a pre-test average score of
3.74 (SD=0.92), to post-session 4.76 (SD=0.48), p=<0.0001. Prior to
the intervention, 63% of the doctors were aware of the trust guide-
lines, but only 17% had completed the training. After the session,
100% were aware of the guidelines, and 100% had completed the
training (Figure 1).
Conclusions:
e-Learning is a useful tool, but has its limitations. By using course
content, delivered with more traditional learning methods, we im-proved the number of appropriately trained clinicians, and thus the
safe use of NG tubes in our unit.
References:
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Introduction:
There is a paucity of data assessing the impact on clinical outcomes
of anticoagulation strategies for atrial fibrillation (AF) in the critical
care population. This review aims to assess the existing literature to
evaluate the effectiveness of anticoagulation strategies used in crit-
ical care for atrial fibrillation.
Methods:
A systematic literature search was conducted by searching MEDLINE,
EMBASE, CENTRAL and PUBMED databases. Studies of adults based
on critical care with a diagnosis of AF were eligible.
Results:
1119 studies were identified through the databases and 38 were
reviewed by full text. 4 studies were selected for data extraction. A
total of 44087 patients were identified with AF, of which 17.8-49.4 %
of patients received anticoagulation. The incidence of thrombo-
embolic events ranged from 0-1.4 % in the anticoagulated popula-
tion and 0-1.3 % in the non-anticoagulated population. Major
bleeding events were reported in 3 studies and occurred in 8.6 % of
each of the anticoagulated populations. Major bleeding events oc-
curred in 0-7.1 % in the non-anticoagulated groups. 30-day mortality
in patients treated with vitamin K antagonists (VKA) was 22.9 %
Fig. 1 (abstract P343). Each handover was scored according to the
information accurately given to ICU staff
Critical Care 2020, 24(Suppl 1):87 Page 141 of 213(21.3-24.6) and 30.6 % (28.9-32.4) for untreated patients. Annual mor-
tality was 35.4 % (33.5-37.3) with VKA treatment and 46.3 % (44.4-
48.3) without.
Conclusions:
Only 4 studies contained analysable data. Anticoagulated patients
had a lower mortality at 30 days and 365 days post admission to crit-
ical care, however there was an increased incidence of major bleed-
ing events compared to the non-anticoagulated population.
Thromboembolic events were comparable in both cohorts. Data from
current literature is scarce and inferences regarding the effectiveness
of anticoagulation in patients in critical care with AF requires further
investigation and research.
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Introduction:
Every new admission to the ICU prompts a handover from the refer-
ring department to the ICU staff. This step in the patient pathway
provides an opportunity for information to be lost and for patient
care to be compromised. Mortality rates in Intensive Care have fallen
over the last twenty years, however, 20% of patients admitted to an
ICU will die during their admission [1]. Communication errors contrib-
ute to approximately two-thirds of notable clinical incidents; over
half of these are related to a handover [2]. NICE have concluded that
structured handovers can result in reduced mortality, reduced length
of hospital stay and improvements in senior Clinical Staff and Nurse
satisfaction [3].
Methods:
A checklist was created to review the information shared and to
score the handover. This checklist was created with Doctors and
Nurses and is relevant for handovers between all staff members. In-
formation was gathered prospectively by directly observing 17 hand-
overs on the ICU.
Results:
There is a notable discrepancy in the quality of handovers of new pa-
tients (Figure 1). This is true of handovers between Doctors, Nurses
and a combination of the two. It is also true of all staff grades. Whilst
a Doctor may have reviewed the patient prior to their arrival, 41%
(n=7) of patients weren’t handed over to a doctor. The most com-
monly missed pieces of information were details of the patient’s
weight (96%, n=16), their height (100%, n=17), whether the patient
has previously been admitted to an ICU (78%, n=15) and whether
the patient has any allergies (71%, n=12).
Conclusions:
The handover of new patients to the ICU is often unstructured and
important information is missed. This can be said for all staff mem-
bers and grades, and for handovers from all hospital departments.
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Introduction:
Post intensive care syndrome–family (PICS-F) describes new or wors-
ening psychological distress in family and caregivers after critical ill-
ness but remains poorly studied within specialist groups [1]. We aim
to define the degree of PICS-F within our tertiary referral cardiothor-
acic centre and map change over the course of 12 months.
Methods:
Caregivers attended a 5-week multi-professional clinic alongside pa-
tients. Peer support was facilitated through a café area and a care-
giver group psychology session was offered with individual
appointments if required. Caregiver surveys were completed includ-
ing: caregiver strain index; hospital anxiety and depression scale
(HADS); and insomnia severity index. Patients also completed HADS
questionnaires. Repeat surveys were completed at 3 and 12 months.
Results:
Over 5 cohorts, 23 caregivers attended, of which 17 were spouses
(74%), 3 children (13%), and 3 others (13%), with 13 caregivers com-
pleting surveys at 12 months. Patients' median APACHE 2 score
was 17 (IQR 14-18.5) and median ICU length of stay was 11 days (IQR
8-23.5). Most admissions were from scheduled operations (56%). Se-
vere caregiver strain was present in 4/23 (17%) with changes to per-
sonal plans (35%) the most common sub category. HADS
demonstrated 13 caregivers (57%) with anxiety and 8 (35%) with de-
pression. Caregiver anxiety exceded that of patients', only reaching
Critical Care 2020, 24(Suppl 1):87 Page 142 of 213similar levels at 12 months, while depression remained static (Figure
1). Median number of nights with ‘bothered’ sleep was 5 (IQR 1-6.75)
and 77% of caregivers expressed problems with sleep.
Conclusions:
Significant psychological morbidity in caregivers from our tertiary
cardiothoracic centre is in keeping with the general ICU population
[2]. Caregiver strain was reduced suggesting higher levels of resili-
ence. Future work should address mental wellbeing, particularly anx-
iety, to minimise the effects of PICS-F.
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Introduction:
Burnout syndrome is an illness that has increasingly affected health
professionals. It is characterized by great emotional stress, physicaland mental exhaustion and depersonalization of the individual. More
serious cases can lead to job loss or even suicide. The described work
identifies the burnout level of the multidisciplinary team through a
specific questionnaireBurnout syndrome is an illness that has increas-
ingly affected health professionals. It is characterized by great emo-
tional stress, physical and mental exhaustion and depersonalization
of the individual. More serious cases can lead to job loss or even sui-
cide. The described work identifies the burnout level of the multidis-
ciplinary team through a specific questionnaire
Methods:
Application of a questionnaire suitable for the multidisciplinary group
in November 2019. The same was answered by 85 professionals
among physicians and nursing team. There was no identification of
employees.
Results:
After analysis of the results it is observed that 50% of the group pre-
sents initial burnout, 30% with the syndrome installed and about 5%
with characteristics of greater severity. Main factors found were: men-
tal and physical exhaustion during the work day, the level of respon-
sibility existing in the activity and the perception of disproportionate
remuneration by work performed.
Conclusions:
All interviewees presented some degree of burnout or high risk to
develop it. The most severe cases should be traced through occupa-
tional medicine and anti-stress measures with reorganization of work
performance should be discussed in order to reduce the prevalence
of this syndrome.P346
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Introduction:
Burnout affecting the psychological and physical state of healthcare
workers is recognized in the last 10 years. Burnout has been shown
to affect the quality of care. Whilst some risk factors have been iden-
tified, there are gaps within the literature related to mental health
and burnout. The aim of this study is to measure levels of burnout
across 3 ICU units in the metropolitan setting.
Methods:
To determine the level of burnout we used 2 surveys, the Maslach
Burnout Inventory human services survey (MBI-hss) and the Centre
for Epidemiologic Studies Depression Scale (CES-D). With the MBI-hss
we analysed 3 different variables of burnout; exhaustion, cynicism
and emotional exhaustion. Basic demographic data and informa-
tion regarding workout schedules were collected. We studied preva-
lence and contributing risk factors using and analysing the outcomes
of the 2 self-scoring questionnaires. Analysis was performed using
descriptive statistical analysis.
Results:
There were 90 respondents, 36% scored the threshold for depressive
symptoms on the CES-D depression scale. Interestingly, 40% (CI 25.4-
57.7%) of those meeting the score for depressive symptoms identi-
fied as having frequent restless sleep compared with 11% (4.6-21.8
%) from those not meeting. Gender did not affect depressive symp-
toms 35% of females and 37% of males met the threshold. With the
MBI-hss for exhaustion the mean was 17.16 (SD 4.6) which is a high
level of exhaustion, the second variable cynicism the mean score
was 14.08 (SD 4.2), which was considered high. The final variable was
emotional exhaustion the mean was 25.16 (SD 9.90), this is consid-
ered moderate levels of emotional exhaustion.
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There was high prevalence of burnout in ICU in all different categor-
ies as well as depressive symptoms. Age and gender had no affect
on burnout. Interestingly, we identified that sleep and shift variables
were linked to increased burnout.P347
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Introduction:
Patient and medication safety are important components of critical
care. Safety strategies include the contribution of a clinical pharma-
cist and the implementation of an Electronic Health Record System
(EHRS). The study aimed to analyse clinical pharmacists’ contributions
in Intensive Care Unit (ICU) after implementing a new hospital-wide
EHRS.
Methods:
Following the implementation of a fully integrated EHRS on 31 March
2019 at our university-affiliated hospital we conducted a prospective
study in 2 ICUs by analysing pharmacists’ contributions during 4 data
collection periods of 5 days at 10, 15, 19 and 21 weeks post imple-
mentation. A pharmacists’ contribution was defined as contacting
the physician to make a recommendation in a change of therapy/
monitoring [1]. The 3 types of contribution were: a medication error -
rectification of an error in the medication process; an optimization -
proactive contribution that sought to enhance patient care, and a
consult - reactive intervention in response to a request. A panel of
experts composed of a senior pharmacist, a consultant, a nurse, and
a pharmacy student assessed the impact of each contribution, scor-
ing low impact, moderate impact or high impact.
Results:
There were 160 pharmacist contributions recorded in the 4 periods.
Of these, 66 (41.2%) were medication errors, 93 (58.1%) were optimi-
zations, and 1 (0.6%) was a consult (Table 1). 37% of the contribu-
tions were assessed as having medium impact, 36% as high impact
and 27% as low impact. In general, the consultant assessed fewer
contributions as having high impact compared to other members of
the panel, with 7 contributions assessed as high impact by the con-
sultant versus 97 by the senior pharmacist.
Conclusions:
Implementing an EHRS in combination with contributions of clinical
pharmacists can prevent medication related issues. Interestingly the
types of incident did not change over time.
References:
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period
Type of contribution Medication error Optimization Consult Total
Period 1 21 26 0 47
Period 2 12 12 1 25
Period 3 17 21 0 38
Period 4 16 34 0 50
Total 66 93 1 160P349
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Introduction:
Most ICU’s are noisy and may adversely affect patients outcomes and
staff performance [1]. WHO reports that the noise level in hospitals
should not exceed 35 dB at daylight and 30 dB at night. The aim of
this study is to evaluate the noise levels in intensive care unit, to
apply awareness training to intensive care staff in terms of noise and
to compare the noise levels before and after education.
Methods:
Noise measurement areas are separated into 17 points including 12
patient bedsides, nurse desk, staff desk, wareroom, corridor and en-
trance of intensive care unite. Measurements were performed 14
times per day. After 10 day, awareness training were given to staff in
terms of harmful effects of noise. After the training, noise measure-
ments were repeated during 10 days. After total 20 days the mea-
surements were terminated. Noise was measured with incubator
analyzer (FLUKE model: Bio-tek serial no:6050274).
Results:
The mean noise values before and after the training were not statisti-
cally different from the mean average noise values (p>0.05). When
the time of measurement were compared, the noise levels were
higher between 10-16 hours to other measurements before and after
the training statistically (p=0.001). Seventeen different noise meas-
urement areas were compared in terms of noise level, there was no
statistically significant difference (p>0.05). The differences were ex-
amined at the same hours between before and after training. Con-
trary to expectations, noise levels were found to be higher after
training statistically (p<0.05). All of noise measurements were higher
than the threshold values that WHO recommended.
Conclusions:
Increased noise levels in critical care units may lead to harmful health
effects for both patients and staff. Our results suggest that much noise
in the ICU is largely attributable to environmental factors and behavior
modifications due to education have not a meaningful effect.
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Introduction:
Critical care medicine has focused on continuous, multidisciplinary
care for patients with organ insufficiency in the face of life-
threatening illness. Despite significant resource limitation low income
countries carry a huge burden of critical illness. Available data is in-
sufficient to clearly show the burden and outcomes of intensive care
units in these developing countries [1]. The objective of our study is
to evaluate the morbidity and outcomes of patients admitted to the
Intensive Care Unit of a tertiary university hospital in Hawassa,
Ethiopia.
Methods:
This was a prospective observational study. Data was registered and
analysed starting from patient admission to discharge during a 12
month period beginning September 2018. Data regarding demo-
graphics, sources of admission, diagnosis, length-of-stay and out-
comes were analysed.
Results:
The total number of patients admitted to the ICU was 218, with 71
patients dying over a one year period. The highest admission was
Critical Care 2020, 24(Suppl 1):87 Page 144 of 213from emergency medical unit, 36% and the lowest source was from
pediatrics department, 8%. Out of these, 69.8% were males. The
mean age was 27 years (2-62). The most frequent aetiologies of mor-
bidity in the admitted patients were traumatic brain injury (24.6%),
acute respiratory distress syndrome (22.9%) and seizure disorder
(8%). Average median length of stay was 3.0 days (interquartile
range: 1.0 - 27.0). The overall mortality rate was 32.5%. The top four
causes of death in the ICU were respiratory illness at 24% followed
by sepsis with multiorgan failure at 20%, trauma (16%) and central
nervous system infection (12%).
Conclusions:
Infection morbidity and mortality remains very high and needs institution
of aggressive preventive strategies. The increase in frequency of trauma
patients need to receive due attention. Sepsis causes a high number of
deaths, though overtaken by respiratory illnesses. Improving the overall
system of ICU may achieve better outcomes in resource limited countries.
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Introduction:
ICU mortality has been widely studied in the literature in relation to
outcome index that primarily value organic failure [1]. However, early
mortality, in the first 48 hours of admission has been little docu-
mented in the literature. The aim of this study is to analyze factors
related to early mortality in ICU.
Methods:
Retrospective study at a second-level hospital. Time of study was 12
months. Patients who died in ICU were included, patients were classified
according timing of dead, including those who died within the first 48
hours of ICU admission. The variables analyzed were age, sex, comorbidity,
Charlson index, APACHE II, need for supportive treatments, more frequent
admission diagnosis, origin and support treatment limitation decisions.
The statistical study was carried out using the SPSS statistical program.
Results:
138 patients were included during the study period, 72 (52.2%) died
within the first 48 hours of admission. No differences in the needs of
support treatments were observed, more than 90% of patients re-
ceived mechanical ventilation and vasoactive therapies. Table 1
shows characteristics of patients.
Conclusions:
Half of ICU deaths occur within the first 48 hours of admission. Sever-
ity at ICU admisison was the main factor related with early mortality.
Severe stroke and coronary disease were the most frequent causes
of early deaths in ICU.
References:
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Dead first 48 hours. n: 72 Dead after 48 hours . n: 66
Age 65.16±16.7 66.01±10.8
Charlson Index 4.1±2.28 4.8±2.19
Apache II 27.31±7.84 19.98±7.66
Gender (% male) 59.7% 74.2%
Origin: Medical
ward Surgical ward
26.4% 12.5% 48.6% 8.3% 34.8% 15.2% 33.3% 16.7%
Most frequent
admission diagnosis
Septic shock 16.7% Stroke
16.7% Cardiac arrest15%
Septic shock 25.8% Stroke
19.7% Surgery 15.2%
Limitation support
therapies
19.4% 37.9%P352
Are you ready? - an audit of the 2018 guidelines in maternal
critical care in a major obstetric centre
M Smith1, Y Metodiev2, H Lynes3, D O´Neil3
1Department of Anaesthetics and Intensive Care, Anaesthetics/ICU,
Leicester, United Kingdom; 2Department of Anaesthetics and Intensive
Care, Department of Anaesthetics, Leicester, United Kingdom;
3Department of Anaesthetics and Intensive Care, Leicester, United
Kingdom
Critical Care 2020, 24(Suppl 1):P352
Introduction:
In August 2018 The Royal College of Anaesthetists published guide-
lines on care of the critically ill woman in childbirth and enhanced
maternal care [1]. Approximately 11000 babies are born across the
area covered by Leicester University Hospitals that includes two large
maternity units and is part of the UK ECMO network. This audit sets
out to assess current practice and form a basis for future planning,
which will likely be representative to most major obstetric centres.
Methods:
A retrospective audit of all patients admitted to ‘intensive care
units’ in Leicester over a 12 month period following publication of
the guidelines. The focus was on patients admitted to general adult
intensive care and excludes all patients cared for in ‘enhanced ob-
stetric care’ units. 9 simple standards were proposed relating to ac-
cessibility, resuscitation, follow up and multi-disciplinary learning.
Results:
In total 49 women were identified with a broad range of diagnosis.
The intensive care services are split across 3 hospitals and we found
this led to a number of problems. The presence of trained staff to re-
suscitate a newborn were easily accessible, no steps to provide ne-
cessary equipment pre-emptively were present in any centre. None
of our critical care units had a plan for perimortem section. On-going
reviews by the obstetric and midwifery teams were very variable.
Contact with the infant and breastfeeding support was also poor.
Conclusions:
Despite the large number of deliveries significant work needs to be
done in order to come in line with the new national guidelines for
critically ill woman in childbirth. Clearly defined pathways around es-
calation of care, resuscitation of both the mother and baby, integrat-
ing care of the mother and the infant in the first few days of life, and
multidisciplinary learning events are being produced de novo in re-
sponse to these guidelines, some of which will be illustrated in the
associated poster.
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Introduction:
Studies suggest that, when health professionals possess communica-
tion and conflict management skills, interprofessional co-operation is
ensured. Τhis supports the proper functioning of the hospital and, by
extension, the satisfaction of the nurses from their working
environment
Methods:
Population consisted of 45 individuals. The tools used at this study
were: a)The Jefferson Scale of Attitudes towards Physician-Nurse Col-
laboration [1], b)Professional Quality of Life Scale [2] and c)
Table 1 (abstract P354). Background characteristics and outcomes
Age (years) 18-64 65-79 80+
Episodes 39,551 (46.2%) 32,928 (38.5%) 13,150 (15.4%)
Female 47.1% 42.9% 49.5%
Moderate-severe comorbidity 76.1% 93.4% 94.5%
Frailty (moderate-severe eFI) 8.7% 23.7% 36.5%
Invasive ventilation 44.9% 38.1% 31.2%
Hospital mortality 14.5% 25.0% 33.5%
1-year mortaility 25.7% 45.9% 62.7%
Critical Care 2020, 24(Suppl 1):87 Page 145 of 213Interprofessional collaboration Scale [3]. Data were analyzed with IBM
SPSS 25.0
Results:
It was found that cooperative attitudes with an average score of 49
to 75 are considered to be of average significance. Interprofessional
cooperation at an average score of 2,568 states that the level of co-
operation is high and the quality of working life averages 125 to 150,
suggesting that it is very good. As far as professional satisfaction is
concerned, nurses are happy, content and satisfied with their work,
despite workload and burnout
Conclusions:
Interprofessional cooperation at the ICU of the General Hospital of
Larissa is high, but satisfaction from wages, resources, working envir-
onment and conditions is low. In addition, the results showed that
improvements in hospital communication between staff, has a posi-
tive impact on the quality of professional life
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Introduction:
As national populations age, demands upon critical care services are
expected to increase. However, while increased admission of older
patients (>80 years) to ICU has been observed in Australia and some
European countries, decline observed elsewhere may indicate ration-
ing according to chronological age. This effect was explored for
Wales, a nation with historically low numbers of ICU beds (5.9 per
100,000), by analysing ICU admissions over a 10-year period.
Methods:
Welsh adult ICU episodes 2008-17 were examined via the Secure
Anonymised Information Linkage (SAIL) Databank, Swansea Univer-
sity. Modified Charlson’s Comorbidity Index (MCCI) was calculated
using ICD-10 codes. Electronic Frailty Index (eFI) was calculated using
an algorithm based upon primary care events. Patients categorized
according to age as follows: 18-64 (youngest), 64-79 (older) and 80
(oldest) years and over.
Results:
85, 629 ICU episodes were identified. Number and proportion of
older and oldest patients did not change significantly over the
period. However, ICU admissions per 10,000 population fell from 93.9
to 81.4 and from 90.0 to 78.4 in the oldest and older cohorts, and in-
creased from 21.7 to 22.2 in the youngest cohort. Across all age pa-
tients, there was a significant increase in admissions with moderate
comorbidity (p=0.025) and a decrease in those with high comorbidity
(p=0.022). There were no significant trends in organ support,
whether overall or within age cohorts. A significant decrease in ICU
mortality (from 23.5% to 20.5%, p=0.028) and hospital mortality (from
36.6% to 33.4%, p=0.017) were observed in the oldest cohort, though
not 1-year mortality; this trend was not observed in other age co-
horts (Table 1).Conclusions:
Contrasting with previous reports, decreased admissions per unit
population in older and oldest age groups, and those with high co-
morbidity, suggest resource constraints may have influenced admis-
sion discussion and decision-making over the 10-year study period in
Wales. Further investigation is warranted.P355
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Introduction:
Up to a third of in-hospital deaths in ICU patients occurs following ward
stepdown [1]. Discharge time seems to be associated with in-hospital
prognosis, but meta-analyses have not shown a difference in weekday
compared to weekend discharge [2,3]. However, papers that examined
discharge ‘into’ out-of-hours days, particularly on Fridays, have found
differences [3]. Our aim was to assess whether discharge from ICU ‘into’
out-of-hours (OOH - weekends and public holidays) is associated with
in-hospital mortality or re-admission to ICU, and whether these patients
were seen on the wards OOH by medical staff.
Methods:
All adults discharged from the general ICU to a ward at the Bristol
Royal Infirmary in December 2016-18 were included. In-hospital mor-
tality rates were assessed for each day, with ‘into weekdays’ defined
as Sunday to Thursday and ‘into OOH’ Friday, Saturday and the day
before a public holiday. A subset of patients with data on readmis-
sion rate to ICU was also examined. All available notes from patients
discharged into OOH in 2018 were reviewed.
Results:
The study included 1732 patients with a subset of 443 with readmission
data. 117 sets of notes were reviewed from patients discharged into
OOH (Figure 1). The in-hospital mortality was significantly higher in pa-
tients discharged into OOH (5.1% vs 7.6%, P=0.012). Within the subset,
OOH was associated with in-hospital mortality or readmission to ICU
(6.8% vs 11.9%, P=0.044), though readmission rate alone was not (1.7%
vs 2%, P=0.35). Of patients discharged into OOH, once on a ward 64%
were reviewed by a specialty doctor but 20.5% were not seen.
Conclusions:
This is the first study to examine ICU discharge 'into' OOH days in-
cluding public holidays. We found increased hospital mortality in
OOH, similar to other studies [3]. Up to a fifth of high-risk ICU step-
down patients were not reviewed by a doctor on OOH days.
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Introduction:
Exploring the experiences of potential donors’ family members (FM)
in a follow up clinic is crucial to analyze the effects of organ procure-
ment (OP) on the bereavement process, to gain insight on the rea-
sons of family refusals (FR), and to improve family care during OP.
Methods:
A mixed-method study involving FM at 3 and 12 months after pa-
tients’ death was developed and approved by Local Ethics Commit-
tee. FM of potential donors after brain (DBD) and cardiac death
(DCD) treated in Careggi Teaching Hospital, Florence (Italy) were eli-
gible if adult and consenting. Invitation letters were sent to the enti-
tled 2 months after death and those who actively responded were
involved in an encounter with a multidisciplinary group including a
clinical psychologist, two nurses and two cultural anthropologists
with expertise in OP. Psychological profile and satisfaction with care
was assessed with validated tools, while the experiences of organ do-
nation (OD) request and traumatic memories were measured with
close and open ended questions.
Results:
90 envelopes were sent to the entitled of 79 DBD and 11 DCD. Re-
sponders were 29, 31.0% were FM of DCD. Reasons not to participate
were logistical problems, linguistic barriers, dissatisfaction with care,
lack of interest, perceived excessive burden. Of all FM, 18 (62.1%)
were female, mean age 54.9 (DS 15.7). Encounters included from 1 to
4 FM; 11 were spouse (37.9%), 10 (34.5%) sons, 4 (13.8%) parents, 4
(13.8%) other relatives. 28 FM were Italian, 1 from USA; 28 consented
to OD, only one refused. Three FM completed 12 months evaluation.
Conclusions:
The study is ongoing. The enrollment of not consenting FM was a
relevant obstacle to the collection of data that could help to better
understand FR. In order to reach an adequate sample size to draw
consistent conclusions, we extended the study to all the ICUs of theTuscany Region with the aim of recruiting an appropriate number of
FM who refused OD.
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Introduction:
Organ procurement (OP) is a complex process in which clinical,
organizational and psycho-social issues are at play. Understanding
the experiences and related memories of potential donors’ family
members (FM) in a follow up clinic is crucial to identify the most rele-
vant factors affecting OP and the associated outcomes. Our aims
were to describe the effects of all phases of OP on the psycho-social
wellbeing of FM, and then to gain insight into the possible causes of
family refusals to organ donation (OD).
Methods:
Mixed-method study involving FM at 3 and 12 months after patients’
death. Psychological profile was evaluated with validated tools: PWBS
(psychological well-being scale), STAI-Y (state trait anxiety inventory
– form Y), BDI-II (Beck Depression Inventory - II), IES-R (Impact of
Event Scale – Revised), ICG (Inventory of Complicated Grief). Trau-
matic memories were assessed with a 4-point scale. Satisfaction with
care was measured with FS-ICU (family-satisfaction ICU). Content ana-
lysis was based on audio-taped semi-structured interviews.
Results:
29 FM were enrolled; 18 (62.1%) were female, mean age 54.9 (DS
15.7); 11 were spouse (37.9%), 10 (34.5%) sons, 4 (13.8%) parents, 4
(13.8%) other relatives. All FM but one were Italian, 96.5% consented
to OD. DBD and DCD processes were analyzed. Quality of Life’s more
affected dimensions were personal growth and autonomy; mean
values of BDI-II (10.2), IES-R (25.2) and ICG (21.7) were below the clin-
ical cut-off. FM showed slight symptoms of anxiety. Traumatic mem-
ories were more frequent and intense in relation with the very early
stages of the process (out-of-hospital rescuing/emergency depart-
ment) and with the communication of bad prognosis and death (Fig-
ure 1). Satisfaction with care was fair good.
Conclusions:
Preliminary data suggests that the early stages of OP and the com-
munication of bad news deserve attention. The recruitment of not
consenting FM was a relevant obstacle.
Fig. 1 (abstract 359). Graft function in the first year post-transplant
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centre retrospective observational study
HA Elgendy1, GM Elewa1, AA Korraa1, HA Ahmed1, MA El-metini2, MM
Ahmed2, IM Montasser3, HM Dabbous3, MM Salah Eldin3, MF Abdelgafar2
1Faculty of Medicine Ain Shams University, Anesthesia and Intensive
Care, Cairo, Egypt; 2Faculty of Medicine Ain Shams University, General
Surgery, Cairo, Egypt; 3Faculty of Medicine Ain Shams University, Tropical
Medicine, Cairo, Egypt
Critical Care 2020, 24(Suppl 1):P358
Introduction:
Liver transplantation being a major abdominal surgery,may have
postoperative complications which may be life threatening and re-
quire ICU readmission. We coducted this retrospective observational
single centre study to identify incidence, causes and outcomes of
ICU readmission after living donor liver transplant ( LDLT).
Methods:
This retrospective observational study was conducted in Ain Shams
University Specialized Hospital on 335 adult patients ( > 18 years old)
who underwent their initial LDLT from 2008 to 2018 after approval of
Institutional Review Board and written informed consent from pa-
tients or 1st kin. Patients demographic data, preoperative vari-
ables, intraoperative variables, postoperative stay and complications,
causes,incidence and outcomes of ICU readmission were recorded.
Readmission is defined as ICU readmission within ≤ 3 months after
initial ICU discharge.The primary endpoints were the incidence and
causes of ICU readmission and secondary endpoint was one year
survival.
Results:
A detailed review of 335 patients was made, 26 patients ( 7,76%)
were readmitted, 4 patients ( 1.19 % of total patients), ( 15.3% of re-
admitted patients) were readmitted twice due to mesothelioma, sep-
sis, CVS and graft failure.Out of 26 readmitted patients, 11 patients (
42.3 %) were discharged and 15 ( 57.7%) died and 25 % of twice re-
admitted patients discharged and 75 % died. The main causes of
death were renal failure, hematemesis, sepsis, CVS, pulmonary com-
plications, vascular complications and graft failure.
Conclusions:
Causes of ICU readmission post LDLT were variables, may be related
to preoperative comorbidities, surgical complications, immunosup-
pression, sepsis and other causes. Readmission carries a greater risk
of bad outcome. The more the times of ICU readmission the worse
the prognosis.
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Introduction:
Organ replacement procedures such as ECMO (extracorporeal mem-
brane oxygenation), LVAD (left ventricular assist device) and dialysis
are routinely used to treat multi-organ failure (MOV). Globally trans-
plantation programs struggle with increasing organ shortage. Pa-
tients (pts) with MOV are a potential source for procurement.
However, outcome data after kidney transplantation (KTX) from such
donors are sparse.
Methods:
We retrospectively studied the cadaveric KTX at the Charité Berlin in
2018 and identified donors with ongoing organ replacement proce-
dures. Donor and recipient risk factors were assessed. Overall patient
and graft outcomes were analyzed at 12 months post-transplant.Results:
A total of 220 kidneys were transplanted. We identified 11 KTX from
7 donors with MOV (6 following cardio-pulmonary resuscitation, 5
with acute renal failure - 4 on dialysis) (Figure 1). In 3 donors, a veno-
arterial ECMO was implanted during ECLS-resuscitation. One donor
needed a veno-venous ECMO due to ARDS, and 1 donor had a LVAD
implanted due to cardiac failure. The donor age was 41 ± 10.5 years
(yrs). In addition, 6 donors had at least one cardiac risk factor. The
kidney donor risk index averaged 0.94 (SD ± 0.14) and S-creatinine
prior to KTX was 2.41 (SD ± 1.27). The recipients were 49.2 (SD ± 8.2)
yrs of age and cumulated an average waiting time of 7.7 ± 2.9 yrs.
Delayed graft function (DGF - dialysis within the first 7 days after
KTX) occurred in 91% of patients (pts) (vs. 43.7% DGF in the overall
2018 cohort). All pts gained renal function at a median of 7 (IQR
5.25-9) days (100% vs. 96.3% 2018 cohort). Mean S-creatinine 12
months post-transplant was 1.30 ± 0.45 mg/dL resembling an esti-
mated GFR of 58.86 ± 17.9 mL/min/1.73m2. One pt died unexpect-
edly 44 days after KTX with a functioning graft.
Conclusions:
The results of organs from donors with MOV in the first year after
KTX were excellent. Especially the young donor age together with a
targeted benefit-risk assessment enables the usage of such organs.P360
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Introduction:
One way to expand the potential donor pool is Donation after Circu-
latory Death (DCD), and a strategy to reduce the complications re-
lated to the ischemic time is the use of Normothermic Regional
Perfusion (NRP) with extracorporeal membranous oxygenation
(ECMO) [1,2].
We compare the use of standard NRP with an effective adsorption
system inflammatory mediators (CytoSorb®) in the regional normo-
thermic reperfusion phase via regional ECMO, that involves a reduc-
tion in cellular oxidative damage, assessed as a reduction in levels of
proinflammatory substances.
Methods:
We report a case series of 9 DCD-Maastricht IIIA category donors,
treated in ECMO with NRP, to maintain circulation before organ re-
trieval, in association with CytoSorb® in 5 patients. During perfusion,
from starting NRP (T0), blood samples are collected 3 times, every 60
minutes (T1, T2, T3).
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During treatment with Cytosorb®, lactate levels progressively de-
crease, AST and ALT increase less than without Cytosorb®, as sign of
improvement in organs perfusion (Figure 1).
Conclusions:
NRP with CytoSorb® might help to successfully limit irreversible
organ damages and improve transplantation outcome [2]. Develop-
ment and implementation of uniform guidelines will be necessary to
guarantee the clinical use of these donor pools.
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Introduction:
Shock is a common complication of critical illness in patients in in-
tensive care units (ICUs), who are undergoing major surgery. This
condition is the most common cause of death in postsurgical ICUs.
Nowadays, there are different ICU scoring systems for predicting the
likelihood of mortality, such as APACHE or SOFA. Nevertheless, they
are used rarely because they also depend on the reliability and pre-
dictions of physicians. In these sense, gene expression signatures can
be used to evaluate the survival of patients with postsurgical shock.
Methods:
mRNA levels in the discovery cohort were evaluated by microarray to
select the most differentially expressed genes (DEGs) between
groups of those that survived and did not survive 30 days after their
operation. Selected DEGs were evaluated by quantitative real time
polymerase chain reactions (qPCR) for the validation cohort to deter-
mine the reliability of the expression data and compare their predict-
ive capacity to that of established risk scales.Results:
IL1R2, CD177, RETN, and OLFM4 genes were upregulated in the non-
survival group of the discovery cohort. Further confirmation of the
predictive power of these genes was found in the validation cohort.
Areas under the receiver operating characteristics curves (AUC) were
0.653 (0.535–0.771), 0.669 (0.544–0.794), 0.739 (0.628–0.850) and
0.782 (0.682–0.877) for IL1R2, CD177, RETN, and OLFM4, respectively.
These values were more instructive than the classical mortality risk
scores from the APACHE (0.647; 0.543–0.751) and SOFA (0.580;
0.456–0.705). Finally, a regression model was performed including
gene expression values and different adjust variables, improving the
AUC value up to 0.800 (0.693–0.906).
Conclusions:
This study offered new biomarkers based on transcriptional patterns
for classifying patients with postsurgical shock as either at low or
high risk of death. The results were more accurate than the other
mortality risk scores APACHE and SOFA.P362
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Introduction:
This study evaluates the prognostic ability of frailty and comor-
bidity scores in patients with septic shock. The 90-day mortality
rate of individual medical conditions are also compared. The bur-
den of comorbid illness and frailty is increasing in the critical
care patient population [1]. Outcomes from septic shock in pa-
tients with chronic ill-health is poorly understood.
Methods:
Patients admitted to the Queen Elizabeth Hospital Birmingham
ICU between April 2016 and July 2019 with a diagnosis of septic
shock (Sepsis 3.0) were included. Charlson Comorbidity Index
(CCI) and performance status (PS) were calculated. The primary
outcome was 90-day mortality. Categorical variables are pre-
sented as percentage and analysed using a chi squared test. Con-
tinuous variables are presented as median (IQR) and analysed
using a Mann-Whitney test. A multivariate binary logistic regres-
sion analysis was conducted with CCI and PS, using age, APACHE
II score, initial lactate, white blood cell count and C-reactive pro-
tein as other covariates. A Hosmer-Lemeshow test of >0.05 indi-
cated good fit.
Results:
846 patients were admitted with septic shock. Patients were 61%
male, with a median age of 60 (48-73). 35% had a hemato-
oncological malignancy and 90-day mortality was 43% (Table 1). Pa-
tients who died had a higher CCI (5 [3-7] vs. 3 [1-4]; p = 0.03) and
higher PS (2 [1-3] vs. 1 [0-2]; p = 0.02) than survivors. Multivariate lo-
gistic regression analysis identified that CCI (OR 1.46 [1.24-1.71]; p <
0.0001) and PS (OR 1.65 [1.17-2.35]; p = 0.005) were independently
associated with mortality in septic shock.
Conclusions:
Comorbid illness and frailty are both independently associated with
mortality from septic shock. Hematological and metastatic solid
organ malignancies were the medical conditions associated with the
highest mortality.
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Table 1 (abstract P362). 90-day mortality of medical conditions
compared to the remaining cohort
90-day mortality of
medical condition
90-day mortality of
the remaining cohort
Relative risk
(+95% CI)
Hematological
malignancy
66% (54/81) 40% (309/765) 1.51 (1.28-
1.80); p<
0.0001
Solid organ cancer 49% (105/213) 41% (258/633) 1.21 (1.03-
1.42); p=0.04
Metastatic solid
organ cancer
60% (34/58) 42% (329/788) 1.40 (1.11-
1.77); p=0.02
End stage renal
disease
52% (56/107) 42% (307/739) 1.26 (1.03-
1.54); p=
0.045
Chronic obstructive
pulmonary disease
54% (45/83) 42% (318/763) 1.3 (1.05-
1.61); p=0.04
No comorbidities 11% (6/53) 45% (357/793) 0.25 (0.12-
0.54); p<
0.0001
Age >80 60% (51/85) 41% (312/761) 1.46 (1.20-
1.78); p=
0.001P363
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Introduction:
Interstitial lung disease is a group of diseases associated with poor
prognosis in the intensive care unit despite major improvement in
respiratory care in the last decade. The aim of our study is to assess
factors associated with hospital mortality in interstitial lung disease
patients admitted in the intensive care unit and to investigate the
long-term outcome of these patients.
Methods:
We performed a retrospective study in an intensive care unit of
teaching hospital highly specialized in interstitial lung disease man-
agement between 2000 and 2014.
Results:
A total of 196 interstitial lung disease patients were admitted in the
intensive care unit during the study period. Overall hospital mortality
was 55%. Two years after intensive care unit admission, 70/196 pa-
tients were still alive (36%). One hundred eight patients (55%) re-
quired invasive mechanical ventilation of whom 80% died in the
hospital (Figure 1). Acute exacerbation of interstitial lung disease was
associated with hospital mortality (OR=5.4 [1.9-15.5]), especially in
case of acute exacerbation of idiopathic pulmonary fibrosis. Multior-
gan failure (invasive mechanical ventilation with vasopressor infusion
and/or renal replacement therapy) was associated with very high
hospital mortality (64/66; 97%).
Conclusions:
Survival after intensive care unit stay of patients with interstitial
lung disease is good enough for not denying them from invasive
mechanical ventilation, except in case of acute exacerbation for
idiopathic pulmonary fibrosis patients. If urgent lung transplant-
ation or extracorporeal membrane oxygenation are ruled out,multiorgan failure should lead to consider withholding or with-
drawal life support therapies.P364
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Introduction:
ΑGI is a malfunctioning of the GI tract in ICU patients associated with
prolonged mechanical ventilation, enteral feeding failure and high
mortality risk. The WGAP of ESICM proposed a grading system for
AGI. Four grades of severity were identified: AGI grade I, a self-
limiting condition; AGI grade II (GI dysfunction), interventions are re-
quired to restore GI function; AGI grade III (GI failure); AGI grade IV,
GI failure that is immediately life threatening. The aim was to evalu-
ate the feasibility of using AGI grades I and II as predictors of malnu-
trition and 1-year mortality in critically ill patients
Methods:
Single-center retrospective cohort study in a tertiary university hos-
pital (2015 – 2017). AGI Grade III and IV patients were excluded. Αn-
thropometric data, GI symptoms (vomiting,diarrhea), feeding intolerance,
gastric residual volumes and abdominal hypertension were recorded.
Daily prescribed caloric intake was calculated using a standard protocol
and daily achievement of caloric intake was recorded. mNutric score was
calculated for all patients. A score ≤5 was used to diagnose malnutrition.
Results:
200 patients (59% men, mean age 65 years) that stayed in the ICU for
>48 hours were included in the study. 52% were at high nutritional risk.
1-year mortality was 31%. The prevalence of AGI II was 14%. Age, gen-
der, BMI, mortality and energy intake did not differ significantly be-
tween patients with AGI II and those with AGI I (Table 1). Logistic
Critical Care 2020, 24(Suppl 1):87 Page 150 of 213regression corrected for gender and age revealed that AGI II (OR: 2.91;
95%CI 1.01-8.40) was independent predictor of malnutrition.
Conclusions:
The AGI grading system seems useful in identifying GI dysfunction
and could be used as a predictor of impaired outcomes. In this study,
AGI II patients were prone to develop malnutrition with a prevalence
of 14%. However association between AGI II and mortality was not
establishedFig. 1 (abstract P365). Clinical frailty score 6-month trend
Table 1 (abstract P364). Results
AGI Grade I(N-172) AGI Grade II(N=28) p
Age 65(51-75) 70(57-79) 0.11
Male Gender(%) 59 50 0.35
Malnutrition Risk(%) 53 75 0.03
BMI (kg/m2) 26.4(23.5-29.9) 24.9(22.4-31) 0.70
Patients achieved energy goal (%) 39 39 0.90
1-year mortality (%) 29 41 0.3P365
The effect of ICU admission on frailty and activities of daily living
at 6-months in patients ≥ 80 years of age
A Smith1, H Flaaten2, B Marsh1
1Mater Misercordiae University Hospital, Critical Care Medicine, Dublin,
Ireland; 2Haukeland University Hospital, Department of Anaesthesia,
Intensive Care and Clinical Medicine, Bergen, Norway
Critical Care 2020, 24(Suppl 1):P365
Introduction:
The study aimed to assess the effects of ICU admission on frailty and
activities of daily living in the ≥80’s population at 6-months.
Methods:
A prospective observational study with data used as a subset of the
VIP-2 trial [1]. Research ethics committee approval from the Mater
Misercordiae University Hospital (MMUH). Inclusion criteria - ≥ 80
years of age and acute admission to ICU from May to July 2018. Data
collected on 20 consecutive patients. Frailty and activities of daily liv-
ing (ADL) were assessed using the Clinical Frailty Score (CFS) and the
Katz Index of Independence in Activities of Daily Living (KATZ).
Results:
CSF pre-admission frailty was present in 60% of patients, increasing
to 93% at 6 months (Figure 1). 74% of survivors at 6-months had a
CFS score increase by ≥ 1 point. Pre-frail and frail CFS patients suf-
fered an average 2-point deterioration in their Instrumental Activities
of Daily Living (IADL). 60% of KATZ patients were fully functional pre-
admission, deteriorating to 13% at 6 months. 74% of patients de-
clined by 1 ADL at 6 months. 60% of the deceased were deemed
fully functional initially.
Conclusions:
We demonstrate an association between an ICU admission event and
enduring functional decline at 6 months. ICU admission resulted in
patients acquiring on average 1.5 new IADL limitations despite their
initial CFS. This is echoed in a study by Iwasyna et al. who also
showed similar deteriorations in IADL and cognitive impairment [2].
KATZ benefits may be best used in describing functional decline.
74% of patients developed at least one new limitation. However, the
CFS takes into account IADL’s and thus may be more sensitive in pre-
dicting the functional outcomes of an ICU event at 6 months.References:
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Introduction:
Frailty has attracted attention in the healthcare community in recent
years, as it is associated with worse outcomes and increased health-
care costs [1]. Our objective was to study the impact of frailty as re-
corded by clinical frailty scale(CFS) to prospectively evaluate the
effect of frailty on hospital length of stay (LOS).
Methods:
A retrospective analysis of consecutively admitted critical care (CC)
patients’ data (Jan’19-Oct’19) was performed. Electronic health re-
cords were used to collect demographics, CFS and clinical outcomes.
Statistical analysis was performed using STATA. Students T-test, sim-
ple and multiple (adjusted for age, disease severity/ICNARC score) lin-
ear regression were used for comparison between groups and to see
group effect. We excluded extreme outliers (LOS>50 days; n=13).
Frailty was defined as CFS>4.
Results:
Out of the 848 patients (male 58%), 554(66%) were emergency ad-
missions, the rest elective (Table 1). 288(40%) were non-frail. The
mean LOS were 15 days (d) ±12 and 10d±9 (P<0.0001) in the frail
and non-frail patients respectively. For emergency patients, LOS were
16d(±12) and 10d(±10) for the groups, (P<0.0001). For elective pa-
tients; LOS were 12d(±10) and LOS 8d(±7), (P=0.01) for frail and non-
frail respectively. After adjusting, LOS was significantly higher in frail
patients by 5 days (95%CI 3,7; P<0.0001), by 4 days (95%CI 1,6; P=
0.002) and by 5 days (95%CI 4,8; P<0.0001) for total cohort, elective
and emergency admissions respectively. The LOS was 6 days higher
in frail than non-frail (P<0.001) for CC survivors.
Conclusions:
Frailty was associated with significantly increased LOS in this cohort,
independent of age and illness severity. Hospital capacity planning
should take this into consideration when modelling bed allocation
Critical Care 2020, 24(Suppl 1):87 Page 151 of 213for different patient groups. Targeted resource allocation may im-
prove this and increase healthcare utilisation.
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Non-
frail
Frail P
value
Additional LOS in frail
(adjusted model)
All Patient LOS (Days) 10(±9) 15(±
12)
<
0.0001
5.5(4,7), p<<0.0001
Elective LOS (Days) 8(±7) 12(±
10)
0.001 4(1,6), p=0.002
Emergency LOS (Days) 10(±
10)
16(±
12)
<
0.0001
6(4, 8), p<0.0001
Critical Care Survivors
LOS (Days)
10 (±
9)
17 (±
12)
<
0.0001
6(4, 8), p<0.0001P367
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Introduction:
Robust clinical governance requires analysis of patient outcomes during
an ICU admission [1]. On one adult ICU weekly mortality meetings are
used for this purpose and aid multidisciplinary reflections on individual
patient deaths. However, such reviews run the risk of being subjective
and fail to acknowledge themes which may relate to preceding or sub-
sequent deaths. This paper describes a new mortality review process in
which: a) reviews are structured using the Structured Judgement Re-
view (SJR) framework [2]; and b) themes are generated over an ex-
tended period of time to create longitudinal learning from death.
Methods:
The SJR framework has been developed by NHS improvement for the new
medical examiner role, looking at inpatient deaths. We adapted this to bet-
ter suit the ICU creating a novel review structure. This involves explicit
judgement comments being recorded, and the use of a scoring system to
analyse the quality of care during the patient’s stay with a focus on ele-
ments of care delivered on the ICU. Tabulation of this information allows
analysis over time, identifying trends across all patients, and in specific
subgroups.
Results:
This framework has been rolled out at the St George's Cardiothoracic ICU
weekly mortality meetings. Themes that have emerged include parent
team ownership, delayed palliative care referrals and inadequate documen-
tation of mental capacity. This will continue as part of a three-month trial
and following review of this trial may be extended to other critical care
units in the trust.
Conclusions:
This system allows greater insight into patient deaths in a longitudinal fash-
ion and facilitates local identification of problems at an early stage in a waythat is not possible within the traditional mortality review format. The na-
ture of the process means that key areas for change can be identified as a
routine part of the clinical week.
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Introduction:
An unexpected Intensive Care Unit (ICU) admission is indicative of a
serious complication in postoperative patients. Recent studies have
shown that variables relevant for the prediction of adverse events
are present in the electronic patient records [1]. In this study, we
evaluated three distinct machine-learning methods for predicting
possible patient deterioration after surgery.
Methods:
The data was collected retrospectively from the Catharina hospital in
Eindhoven. This dataset contained all the surgeries conducted in the
hospital from 2013 up to 2017. The variables in this dataset were
tested on their ability to differentiate between patients with a normal
recovery versus patients with an unplanned ICU admission after be-
ing admitted to the ward. The dataset contained 44 variables related
to either the preoperative screening, surgery or recovery room. All
variables were tested for statistical significance using a univariate lo-
gistic regression (LR), from which a subset of 34 statistically signifi-
cant (p<0.05) variables was created. These variables were used to
train three different types of models, namely, the LR, support vector
machine (SVM) and Bayesian network (BN). The network structure of
the BN was designed using expert knowledge and the probabilities
were inferred using the data.
Results:
The three models were validated using five-fold cross-validation,
resulting in the following areas under the receiver operating charac-
teristic curve: 0.82(0.79-0.86) for LR, 0.82(0.78-0.88) for SVM and
0.65(0.63-0.68) for BN (Fig. 1).
Conclusions:
The results indicate that machine learning is a promising tool for
early prediction of patient deterioration. The BN was included be-
cause it permits incorporating clinical domain knowledge into the
learning process. However, its performance resulted inferior to the LR
and SVM. In future work, we will investigate alternative domain-
aware methods, and compare the performance with that of the clin-
ical experts.
References:
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Fig. 1 (abstract P368). Plot of the receiver operating characteristics
curves for each of the three models. The lines represents the mean
of the five folds and the shaded area is the standard deviation
Table 1 (abstract P369). ICU, hospital and 1-year mortality of all
cohorts. All p-values were highly significant with a p<0.001
Cohort 1 Hematological
malignancy (n=10,401)
Cohort 2 Solid
malignancy (n=
35,920)
Cohort 3 General ICU
population (n=
423,984)
ICU
mortality
2969 (28.6%) 4890 (13.6%) 52864 (12.5%)
Hospital
mortality
3724 (37.9%) 6916 (20%) 65026 (16.4%)
1-year
mortality
5916 (60.1%) 15606 (46.2%) 111328 (28.3%)
Mean LOS
ICU (days)
5.6 3.1 3.9
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One-year mortality of patients with a malignancy admitted
unplanned to the ICU: a large cohort study between 2008 and
2017 in the Netherlands
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Introduction:
Intensive Care Unit (ICU) admission decisions of patients with a ma-
lignancy can be difficult as clinicians have concerns about unfavour-
able outcomes, such as mortality [1]. A diagnosis of a malignancy is
associated with an almost 6-fold increased likelihood of refusal of
ICU admission [1]. Recent large long-term mortality studies of pa-
tients with a malignancy admitted to the ICU are scarce. Therefore,
our aim was to compare mortality of patients with either a
hematological or a solid malignancy to the general ICU population,
all with an unplanned ICU admission.
Methods:
All adult patients registered in a National Intensive Care Evaluation
registry with an unplanned ICU admission from 2008 to 2017 were
included. Subsequently, we divided these patients into 3 cohorts: Co-
hort 1 (all patients with a hematological malignancy), cohort 2 (all
patients with a solid malignancy), and cohort 3 (a general ICU popu-
lation without malignancy). As primary outcome, we used 1-year
mortality, and as secondary outcome, ICU and hospital mortality.
Results:
We included 10,401 (2.2 %) patients in cohort 1, 35,920 (7.6%) pa-
tients in cohort 2 and 423,984 (90.2%) in cohort 3 (Table 1). The 1-
year mortality of patients of cohort 1, 2, and 3 was 60.1%, 46.2% and
28.3%, respectively (p<0.001). Age, comorbidities, organ failure, andtype of admission (i.e. surgical or medical) were positively associated
with 1-year mortality in all cohorts (p <0.05).
Conclusions:
One-year mortality is higher in both patients with a hematological
malignancy and patients with a solid malignancy compared to the
general ICU population. In addition, several factors were positively as-
sociated with 1-year mortality, i.e., age, comorbidities, medical ICU
admission, and organ failure. Future research should focus on pre-
dictive modelling in order to identify patients with a malignancy that
may benefit from ICU admission.
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Introduction:
Drug abuse is associated with immunosuppression in multiple mech-
anisms. Despite that, the only study retrospectively reviewing drug
abusers in the ICU demonstrated less infections and better outcomes.
We compared matched patient populations in order to fully under-
stand whether drug abuse is a risk factor for infection and a pre-
dictor of poorer prognosis as is perceived by most physicians. We
hypothesized that the drug abusers admitted to the ICU will fare as
good as or better than non-abuser ICU patient populations.
Methods:
This is a prospective study done between the years 2010-2012 on
the entire patient population of the Detroit Medical Center. After the
drug abuse population was identified, controls were matched accord-
ing to age and admission ICU units. Patients charts were reviewed
and data regarding baseline demographics, infectious complication
and outcome was extracted.
Results:
Data was retrospectively collected for 323 drug abusers and 305
matched controls. Comorbidities and hospital admission diagnosis
were significantly different between the two groups. Disease severity
scores were significantly higher in the drug abuser’s patient group
(DAPG) on admission and during the ICU stay. DAPG had significantly
more organ failure: more need for ventilation (30.5% vs 46.4% in the
DAPG (p<0.001)), more ARDS (1% vs 3.7%, p=0.03), more renal failure
(33% vs 45.5%, p=0.002) and more need for renal replacement ther-
apy (6.6% vs 11.2%, p<0.05) .They had longer hospital length of stay
(LOS). There was no difference in ICU or hospital mortality.
Table 1 (abstract P372). Multivariate risk factors of late death in septic
shock survivors by Cox regression analysis
Variables Hospital Mortality Adjusted
HR (95%CI)
p-
value
HAP/VAP 3.24 (1.94, 5.43) <
0.001*
SOFA score at 72 hours after weaning off
NE
1.12 (1.04, 1.19) 0.001*
Fluid (ml) 72 hours after discontinuation
of NE
1.01 (1.01, 1.02) 0.008*
Albumin level 0.57 (0.39, 0.84) 0.004*
Critical Care 2020, 24(Suppl 1):87 Page 153 of 213Multivariable modeling did not find drug abuse to be an independ-
ent risk factor for hospital mortality, ICU mortality (Hosp: OR = 1.37, P
= 0.3397; ICU: OR=1.43, PP = 0.07), but was a risk factor for a longer
hospital LOS (ME=1.46, P < 0.0001).
Conclusions:
Drug abuse is not an independent risk factor for mortality or ICU
LOS. Drug abusers should be evaluated like other patients based on
baseline comorbidities and disease severity.
P371
Treatment escalation plans in discharged patients from neuro and
cardiac ICU
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Introduction:
Treatment escalation plans (TEPs) are vital in communicating a ceil-
ing of care in a case of deterioration [1]. Having a clear plan in place
reduces anxiety and eases decision making for both patients and cli-
nicians particularly at time when patient loses their capacity to par-
ticipate in the decision making.
Methods:
This retrospective audit looked at patients in Neuro and Cardiac ICU
with a 7 day stay or longer between 1/7/19 – 20/08/19. This specific
length of stay is due to both units having planned admissions with a
one night stay and not suitable for audit. Local database ‘Ward
Watcher’ which records patient stay in ICU was used to find suitable
patients. Electronic medical records were then accessed via ‘iCLIP’ to
view if discharge summaries included a TEP.
Results:
Between 1/7/19 to 20/08/19 in Cardiac ICU 24 patients who fitted
the audit criteria were identified. 10/24 (41.6%) had a TEP in place. In
Neuro ICU 15 patients were found and 12 (80%) had a TEP. The com-
bined result is 22 patients out of 39 (56%) had escalation plans in
place. Few TEP were specific to what treatment would be suitable in
a case of deterioration i.e fluids, non-invasive ventilation, etc.
Conclusions:
This is a small audit which although it did not include general ICU still
reflects the need for encouraging clinicians and patients to speak
freely regarding escalation plans. Medical decsions is clinician led
however this audit was carried by nursing staff as we have a duty to
be advocate for our patients involvement in medical care [2].
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Introduction:
Advances in sepsis resuscitation significantly improves hemodynamic
restoration. However, substantial number of patients die on the laterdays. We conducted a retrospective review to examine late death in
these sepsis survivors.
Methods:
Medical records from the Department of Medicine, Siriraj Hospital
during January 2012 to January 2018 were analyzed to investigate
late death in sepsis survivors who had shock reversed and vasopres-
sor weaned off more than 72 hours. Factors associated with death
were also determined.
Results:
Of 280 sepsis survivors, 45 (16.1%) died on 28 days and
80 (28.6%) died on hospital discharge. Following shock reversal;
acute kidney injury, metabolic acidosis, cardiogenic pulmonary and
hospital acquired infection were the common complications. Signifi-
cant independent risk factors for in-hospital mortality were hospital
acquired pneumonia (HR, 3.24; 95%CI, 1.94-5.43; P<0.001), higher
SOFA score after weaning off norepinephrine for 72 hours (HR, 1.12;
95%CI, 1.04-1.19; P=0.001), increased amount of fluid at stabilization
or de-escalation phase (HR, 1.01; 95%CI, 1.01-1.02; P=0.008) and
lower albumin (HR, 0.57; 95%CI, 0.39-0.84; P=0.004) (Table 1).
Conclusions:
Mortality after septic shock reversal was substantial and the main
contributing factors were hospital acquired pneumonia, higher SOFA
score after weaning off norepinephrine for 72 hours, increased
amount of fluid at stabilization or de-escalation phase and lower al-
bumin level. Measures to mitigate these events would be beneficial
for rendering better outcomes.P373
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Introduction:
The scores traditionally adopted to predict Intensive Care Unit (ICU)
mortality do not take into account the functional capacity of patients.
On the other hand, there are several scales for this purpose that are
used in other clinical situations. This study aimed to evaluate
whether the Charlson Comorbidity Index (CCI), Palliative Prognostic
Score (PaP), Karnofsky (KPS) and Daily Living Activity Independence
Scale (Katz Scale) can predict mortality in acutely ill medical patients.
Critical Care 2020, 24(Suppl 1):87 Page 154 of 213Methods:
This prospective cohort study was conducted in a Medical Intensive
Care Unit of a University Hospital. In six months, 114 patients were
included. In addition to the above, the scales used were: Sequential
Organ Failure (SOFA), Simplified Acute Physiology Scores III (SAPS III)
and Acute Physiology and Chronic Health Evaluation II (APACHE II).
Information on functional capacity prior to the acute illness that led
to hospitalization was obtained through an interview with family
members. The Research Ethics Committee of the University of Campi-
nas approved this study.
Results:
The results of multivariate logistic regression analysis showed that
for each point added in PaP, there was a greater chance of 37.8% for
mortality (OR: 1.378; CI: 1.108 - 1.714; p= .0124). As expected, the
same occurred in APACHE II, where each additional point was related
to a 14.6% higher chance of mortality. (OR: 1,146; CI: 1,056-1,242; p
<.0001). Regarding the Katz scale, each less point was associated
with a 61.8% greater chance of mortality (OR: 1.618; CI: 1.012 - 2.381;
p= .0142) (Fig. 1).
Conclusions:
The PaP and Katz scales seem to be adequate for predicting mortal-
ity of critically ill patients admitted to a medical ICU. This finding
may help in the elaboration of future ICU mortality scoring systems,
as well as in more rational use of resources. However, further multi-
center studies are needed to better elucidate these results.Fig. 1 (abstract P373). Univariate and multivariate analyses
Table 1 (abstract P374). DNAR documents for patients admitted
through the emergency department at Karolinska University Hospital 1st
January to 31st October 2015
DNAR documents total, No. 3583
Documented consent with pat, No. 600
Documented consent not achievable, No. 1432
Documentation regarding consent absent, No. 1551
Documented consent with pat and next of kin, No 114
Documented consent with next of kin, No 664
Documented consent other licensed caregiver, No 1101
Abbreviation: DNAR, do-not attempt resuscitation
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The purpose of this study was to establish the characteristics of pa-
tients with a do-not attempt resuscitation (DNAR) order in a Swedish
hospital and to evaluate adherence to the regulations regarding
DNAR orders published by the Swedish authorities. The regulations
state that to the greatest extent possible, a DNAR order should be
made in consent with the patient or next of kin (if consent with the
patient is not achievable). Further the decision should be made after
consultation with at least one other licensed caregiver.
Methods:
This was a retrospective analysis of a cohort of adult patients admit-
ted to Karolinska University Hospital through the emergency depart-
ment (ED) from 1st of January to 31st of October 2015, where at least
one DNAR order was issued during the admission. Adherence to reg-
ulations was evaluated through analysis of a mandatory DNAR form
filled out for every decision.
Results:
11% of admissions through the ED received at least one DNAR order.
In total 3583 DNAR documents were issued out of whom 47% were
male (p<0.001 contrasting female sex), mean age was 77 years, 47%
were admitted to a general ward, 45% to a high dependency unit
and the remaining to intermediate care or intensive care units. The
most prevalent comorbidities were malignancy (25%), diabetes (20%)
and heart failure (16%). Although 59% were discharged, one-year
mortality was 79%. Consent was not possible to achieve in 40%.
DNAR decisions were made without any documentation regarding
consent in 43%, see table 1. Decisions were made in consultation
with at least one other licensed care giver in 31%.
Conclusions:
Adherence to regulations by the Swedish authorities is poor and
educational efforts are called upon to ensure the integrity of the pa-
tient in regards to the ethical principles of resuscitation.P375
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Introduction:
Ethic conflicts regarding emergency medicine and life-threatening
situations. Complexity in the decision-making is a challenge. The aim
of the present study are: To describe clinical decision making in
emergency situations in different ethical scenarios that include the
end of life; to analyze the influence that has the experience and the
Table 1 (abstract 376). Primary reasons behind decisions to withhold
or withdraw
Reason N %
Unresponsive to maximal therapy 153 39
Neurological prognosis 108 27
Poor quality of life 26 7
Chronic disease 40 10
Age 9 2
Patient request 7 2
Other 53 13
Critical Care 2020, 24(Suppl 1):87 Page 155 of 213different perspectives of the healthcare professionals in the decision-
making in critical situations.
Methods:
Cross sectional study design with closed-ended questionnaire including
with four clinical cases with four answer choices describing clinical deci-
sions among those that had to choose only one at the discretion of the
participant. The health care professionals surveyed were emergency
physicians, intensive care physicians, emergency nursers, Intensive Care
nurses, medical residents, medicine students and master in Bioethics.
This last group was chosen because of its experience and specific train-
ing in the field of bioethics as a control group or reference.
Results:
A total of 444 respondents participated in the study. 22.2% were emer-
gency physicians, 14.8% intensivists, 11.2% emergency nursing,
6.2% ICU nursing, 24.9% resident doctors, 13.8% medical students and
6.9% other professions. We observed variability in the responses ob-
served not only between different groups of professionals but even
within the same group reflecting the difficulty in decision making.
Conclusions:
Variability was observed regarding decisions in end of life ethics con-
flicts. A high degree of similarity with the group of Master in Bioeth-
ics was observed in the responses issued by medicine students.
P376
The Norwegian ETHICUS II data
A Robertsen1, TA Aasmundstad1, BÅ Sjøbø2, T Legernæs3, M Flückiger4, E
Søreide5, K Dybwik6, J Røe Ballestad7, A Haavind8, P Klepstad on behalf
of the Norwegian ETHICUS II investigators9
1Oslo University Hospital, Department of Anesthesiology and Critical
Care, Oslo, Norway; 2Haukeland University Hospital, Department of
Anesthesiology and Critical Care, Bergen, Norway; 3Hamar Hospital,
Department of Anesthesiology and Critical Care, Hamar, Norway;
4Akershus University Hospital, Department of Anesthesiology and Critical
Care, Oslo, Norway; 5Stavanger University Hospital, Department of
Anesthesiology and Critical Care, Stavanger, Norway; 6Nordland
University Hospital, Department of Anesthesiology and Critical Care,
Bodø, Norway; 7Drammen Hospital, Department of Anesthesiology and
Critical Care, Drammen, Norway; 8University Hospital of Northern
Norway, Department of Anesthesiology and Critical Care, Tromsø,
Norway; 9St Olav University Hospital, Department of Anesthesiology and
Critical Care, Trondheim, Norway
Critical Care 2020, 24(Suppl 1):P376
Introduction:
End-of-life (E-o-L) practices varies between countries and regions [1].
Norway is an affluent, equality-based Northern European society with
a public health care system. Legal frames and national guidelines on
limitations of life-sustaining treatment exist. Four per cent of Norwe-
gians dies within an ICU.
Methods:
An a priori post-hoc analysis of 11 Norwegian sites participating in
ETHICUS II - a prospective, observational study including all consecu-
tive ICU patients who died or had limitations of life-sustaining treat-
ment from September 2015 to February 2016 [1].
Results:
Of 3298 admitted ICU patients 450 (14%) died or had limitations. Pa-
tients’ mean age was 69 years (16-96) and 90% had a chronic disease
in addition to the acute condition that brought them to the ICU.
Eleven per cent were assessed mentally competent. Eighty-eight per
cent had limitations, 35% in the form of a sequence - decisions at
multiple time points. Mutually exclusive E-o-L categories were; 33%
withholding, 55% withdrawing, 0% shortening of the dying process,
4 % brain deaths, 8% failed CPR. Primary reasons behind decisions
are in Table 1. E-o-L discussions were initiated in 1% by the patient,in 2% by family, in 3% by nurses and in 94% by physicians. In 57%
nurses participated in discussions. In 35% physicians asked for or re-
ceived information about patients’ preferences, only 2 patients had
Advance Directives. Time from admittance to first limitation was 38h
(25-75 percentile 6 – 133 h), from first limitation to death 21h (25-75
percentile 4-69 h). Major difficulties or disagreements occurred in
7%. Among patients with limitations the study survival (to ICU dis-
charge or end of follow-up at 2 months from decision) was 20%.
Conclusions:
The Norwegian ETHICUS II cohort describe a proactive, but still some-
how paternalistic E-o-L practice with room for improvement in nurse
involvement and more active engagement of patients and families.
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Introduction:
Barriers and facilitators to framing goals of patient care (GOPC) and
factors motivating decision making is relatively unexplored [1,2,3].
Methods:
A three part survey of physicians at an Australian hospital in a cultur-
ally and linguistically diverse suburb (Table 1). Identification of levels
of confidence and barriers and facilitators to GOPC discussion and
decision making was the main outcome measure. Factors influencing
decision-making was analysed through scenarios.
Results:
22 out of 96 eligible participants responded; 12 female, 10 male, clin-
ical experience 4-31 years. Level of confidence was ranked between
“somewhat confident and very confident.” All but one respondent
had six months of ICU experience. No differences in the level of con-
fidence among Physician groups. 14 barriers and 8 facilitators were
identified; poor prognosis and patient or family request were most
common facilitators; conflict between treating teams and the pa-
tient/surrogate and language barriers were most common bar-
riers. Factors driving GOPC decision-making included clinical, value
judgement, communication, prognostication, justice and avoidance.
Conclusions:
Numerous barriers and facilitators were identified. Factors driving de-
cision making did not just consider clinical factors; conflict and
Table 1 (abstract P378). Physician-related individual variability in end-
of-life decisions
Theme Codes Quotes
Individual
variability
Views on
acceptable
outcomes
“Will this patient really leave the hospital alive,
and in that case, in what condition will the
patient be?” (R 1)
Individual
variability
Values “I am trying to actively think about not treating
marginalized people in any other way than
Critical Care 2020, 24(Suppl 1):87 Page 156 of 213prognostication were important. A larger study could explore these
themes and confirm findings. Factors associated with confidence
could inform future training schemes.
References:
1. Sulmasy DP et al. J Med Ethics 34:96-101, 2008
2. Piggott KL et al. BMC Cancer 19:130, 2019
3. Schulman-Green D et al. J Palliat Care 33:143-8, 2018others. But I think perhaps it may be that
people like heavy drug abusers may receive
more limitations than others, based on medical
factors, like they probably have low quality of
life, small physiological reserves and may have
low compliance to any aftercare”. (R16)
Individual
variability
Fear of criticism “The fear consists of that I may misjudge the
patient’s possibilities for recovery and therefore
withdraw LST too early. That it could evoke
criticism from colleagues that were not directly
involved and might have made another
decision. Also there is this fear of liability, of
being subject to a process of some kind” (R4).
Table 1 (abstract 377). Summary of survey questions
Demographics Role, Qualifications, Gender, speciality training
Decision making and GOPC Confidence, responsibility, barriers, facilitators
Discussion of GOPC Levels of confidence, barriers, facilitatorsP378
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Introduction:
We aimed to investigate physician-related factors contributing to in-
dividual variability in end-of-life (EoL) decision-making in the inten-
sive care unit (ICU).
Methods:
Qualitative study with semi-structured interviews with 19 specialists
in critical care, (experience 2-32 years) from 5 Swedish ICUs. Data
was analyzed in accordance to principles of thematic analyses.
Results:
Most of the respondents felt that the intensivist’s personality played
a major role in EoL decisions (Table 1). Individual variability was con-
sidered inevitable.
Views on acceptable outcome: Respondents experienced that the
possible outcome for patients was interpreted very differently and
subjectively among colleagues, and what seemed an acceptable
patient-outcome for one doctor, was not acceptable for another.
Values: Most of the respondents were well aware that they might be
affected by their own values and attitudes in the decision-making
process. Interestingly, several respondents mentioned that they
thought that patients that were marginalized by society, especially
drug-abusers could be at risk for receiving decisions to limit life sus-
taining treatments (LST) more often than others. None of the respon-
dents thought that their own religious beliefs played any part in
decision making.
Fear of criticism: Among the less experienced respondents there was
a clear sense of fear of making a questionable assessment of the pa-
tient’s medical prognosis. There was a fear for criticism from col-
leagues that were not directly involved in the decision-making, and
may have made another decision. This created a wish among youn-
ger respondents to defer or avoid participating in decision-making.
Conclusions:
Physician-related, individual variability in EoL decisions primarily con-
sisted of differing views on acceptable outcome, values and fear of
criticism.P379
Can the functional capacity prior to hospitalization predict
limitation of life-sustaining therapy in medical ICU patients?
JC Garbuglio araujo da Silva1, C Coutinho1, MA Filho2, D Fernandes1, T
Giraldi1, T Santos1
1University of Campinas, School of medical sciences, Campinas, Brazil;
2University Medical Center Groningen, University Medical Center
Groningen, Holland, Netherlands
Critical Care 2020, 24(Suppl 1):P379
Introduction:
Prognostic score systems have been widely used in intensive care
units (ICU) to predict the likelihood of death [1]. However, these
scores may require several laboratory data and don’t consider func-
tional capacity. Our objective was to evaluate if the functional cap-
acity prior to the acute illness that led to hospitalization could
predict limitation of life-sustaining therapy (LLST) in critically ill med-
ical patients.
Methods:
We conducted a prospective cohort study at a Medical Intensive Care
Unit of a University Hospital. A total of 114 patients were included.
The scales used were: Charlson Comorbidity Index (CCI), Palliative
Prognostic Score (PaP), Karnofsky (KPS) and Independence Scale in
Activities of Daily Living (Katz Scale). Information on functional cap-
acity prior to hospitalization was obtained through interviews with
family members. The researchers had no access to prognostic scale
scores (Sequential Organ Failure -SOFA, Simplified Acute Physiology
Scores III- SAPS III, Acute Physiology and Chronic Health Evaluation II-
APACHE II). The LLST decisions were based on discussions during
medical rounds and/or multidisciplinary clinical-bioethical meetings,
when indicated. The Research Ethics Committee of the University of
Campinas approved this study.
Results:
Multivariate logistic regression analysis showed that there is a greater
37.7% chance for LLST every 10 points less on the Karnofsky Scale
(OR: 1.377; 95%; CI: 1.244 - 1.770; p= .0126) (Figure 1).
Critical Care 2020, 24(Suppl 1):87 Page 157 of 213Conclusions:
Patients undergoing limitation of life-sustaining therapy had lower
Karnofsky Scale scores. Therefore, this scale may be useful to guide
end-of-life decisions in the future, but further studies with larger
number of patients are needed.
References:
1. Batista CC et al. Brazilian Journal of Intensive Care, 21: 247-254, 2009.Fig. 1 (abstract P380). Mortality rate for disease specific SOFA score
Fig. 1 (abstract P379). Univariate and multivariate analysesP380
Variation in SOFA predicted mortality based on infection site
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Introduction:
In this study, we investigated whether sequential organ failure as-
sessment (SOFA) score performance differs based on disease state
amongst patients admitted to the intensive care unit (ICU) with
infection.
Methods:
This was a single center retrospective study of adult ICU patients ad-
mitted with infection between 2008 and 2018. Patients were
uniquely classified into different disease states based on ICD9/10
codes. Disease states included were pneumonia, meningitis, isolated
bacteremia, cellulitis, cholangitis/cholecystitis, intestinal and diarrheal
disease, endocarditis, urinary tract infection and peritonitis. SOFA
score performance was compared across disease states.
Results:
A total of 12,283 patients were included. Of these, 50.6% were fe-
male and the median age was 70 (IQR 57-82). The most common dis-
ease states were pneumonia (32.2%) and UTI (31.0%). Overall, 1703
(13.9%) patients died prior to hospital discharge. The mean SOFA
score for the cohort was 5.4 (95%CI: 5.3-5.4). Patients with peritonitis
had the highest mean SOFA score (6.7, 95%CI: 6.3-7.0) and patients
with cellulitis had the lowest mean SOFA score (4.7, 95%CI: 4.5-5.0).
SOFA score discrimination was highest among patients with endocar-
ditis [area under the curve (AUC) 0.79, 95%CI: 0.69-0.90] and lowest
for patients with isolated bacteremia (AUC 0.59, 95%CI: 0.49-0.70).
Within each quartile of SOFA score, mortality was highest in patients
with pneumonia and peritonitis and lowest in patients with cellulitis
(see Figure 1). The addition of disease state to SOFA for theprediction of in-hospital mortality improved model discrimination
(AUC 0.69, 95%CI: 0.68-0.70 vs. 0.71, 95%CI: 0.70-0.73, p<0.01).
Conclusions:
Site of infection is an important consideration when interpreting the
SOFA score. This is an important finding as SOFA is utilized as an im-
portant tool in the definition and prognostication of sepsis.P381
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Introduction:
The Sepsis-3 Consensus definition identified organ dysfunction as
the hallmark feature of sepsis [1]. In developing Sepsis-3, the sequen-
tial organ failure assessment (SOFA) score was chosen for its prog-
nostic value and relative ease of implementation clinically [2]. We
propose an update based on epidemiologic data from two intensive
care databases that more effectively captures organ dysfunction in
the context of Sepsis-3.
Methods:
Using the MIMIC-III (exploration) and e-ICU (validation) databases, we
extracted patients with suspicion of infection to form the study co-
hort. The predictive power of each SOFA component was assessed
using the area under the curve (AUC) for in-hospital mortality. A lo-
gistic model with the LASSO penalty was used to find an alternative
statistically optimal score.
Results:
By utilising alternate markers of organ dysfunction (e.g. lactate, pH,
urea nitrogen) we demonstrated a significant improvement in AUC
for several versions of the new score, SOFA2.0 (Figure 1).
Conclusions:
The SOFA score can be updated to reflect current advances in clinical
practice. Using epidemiologic data, we have shown that substitution
of existing components with more powerful measures of organ dys-
function may provide an improved score with greater predictive
power. Moreover, SOFA 2.0 exhibits equivalent ease of implementa-
tion, but better reflects organ dysfunction in the context of Sepsis-3.
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SOFA2.0 version B, for instance, outperforms the SOFA score using
fewer biomarkers
Table 1 (abstract P383). Mortality rates: survivors vs. non-survivors (per
patient, n=78)
Total (n=78) Survivors (n=37) Non-survivors (n=41) Mortality (%)
6-point severity-of-illness score:
<3 28 19 9 32.1%
≥3 50 18 32 64.0%
Revised 4-point severity-of-illness score:
≤2 41 29 12 29.3%P382
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Introduction:
Risk of acute organ failure (AOF) in cancer patients(pts) on systemic
cancer treatment isunknown. However, 5% of non-hematologic and
15% of hematologic cancer pts will need admission to intensive care
unit (ICU). IPOP-SCI-2017/01 is a prospective cohort study designed
to ascertain the cumulative incidence of AOF in adult cancer pts.
Methods:
Single centre prospective cohort study with consecutive sampling of
adult cancer pts admitted for unscheduled inpatient care while on,
or up to 8 weeks after, systemic cancer treatment. Primary endpoint
was AOF as defined by quick SOFA. Six months accrual expected an
accrual of 400 pts to infera population risk AOF with a standard error
of 1%.
Results:
Between 08/2018 and 02/2019 10392 pts were on systemic antican-
cer treatment, 358 had unscheduled inpatient care and were eligible
for inclusion and 285 were included. Median age was 64 years, 51%
were male, 52% had adjusted Charlson Comorbidity Index (CCI) &gt;
3 and hematologic cancers accounted for 22% of pts. The cumulative
risk of AOF on hospital admission was 35% (95%CI: 31-39); and of
AOF during hospital stay was 40% (95%CI: 35-44). AOF was associ-
ated with older age, CCI &gt; 3,hematologic malignancy, shorter me-
dian time from diagnosis and &gt; 1 prior line of therapy. On
admission, 62% of pts were considered not eligible for artificial organ
replacement therapy (noAORT) and 34% of pts who developed AOF
while inhospital were judged noAORT. Overall, 17 (15%) of AOF pts
wereadmitted to ICU, 31.5% for AORT. Median follow up 9.5 months
(min 6; max 12). Inpatient mortalitywas 18%, with ICU mortality rate
of 59%, with median cohort survival 4.5 months (95%CI: 3.5-5.4). On
multivariate analysis, AOF was an independent poor prognostic fac-
tor (HR 1.6; 95%CI 1.2-2.1).
Conclusions:
Risk of AOF in cancer pts admitted for unscheduled inpatient care
while on systemictreatment is 35%, and risk of ICU is 15%. AOF in
cancer pts was an independent poor prognostic factor.P383
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Introduction:
We previously retrospectively validated a 6-point severity-of-illness
score aimed at identifying patients at risk of dying of tuberculosis
(TB) in the intensive care unit (ICU). Parameters included septic
shock, human immunodeficiency virus with CD4<200/mm
3, renal dys-
function, ratio of partial pressure of arterial oxygen to fraction of in-
spired oxygen (PaO2:FiO2) <200mmHg, diffuse parenchymal
infiltrates and no TB treatment on admission. The aim of this study
was to validate and refine the severity-of-illness score in patients
with tuberculosis requiring intensive care.
Methods:
We performed a prospective observational study with a planned
post-hoc retrospective analysis, enrolling all adult patients with con-
firmed TB admitted to the medical intensive care unit from 1 Febru-
ary 2015 to 31 July 2018. Descriptive statistics and Chi-square or
Fisher’s exact tests were performed on dichotomous categorical vari-
ables, and t-tests on continuous data. Patients were categorized as
hospital survivors or non-survivors. The 6-point score and the refined
4-point score were calculated from data obtained on ICU admission.
Results:
Forty-one of 78 patients (52.6%) died. The 6-point scores of non-
survivors were higher (3.5+/-1.3 vs 2.7+/-1.2; p=0.01). A score ≥3 vs.
<3 was associated with increased mortality (64.0% vs. 32.1%; OR
3.75; 95%CI, 1.25-10.01; p=0.01)(Table 1). Post-hoc, a PaO2:FiO2 <
200mmHg and no TB treatment on admission failed to predict mor-
tality whereas any immunosuppression did. A revised 4-point score
(septic shock, any immunosuppression, acute kidney injury and lack
of lobar consolidation) demonstrated higher scores in non-survivors
(2.8+/-1.1 vs. 1.6+/-1.1; p<0.001). A score ≥3 vs. ≤2 was associated
with a higher mortality (78.4% vs. 29.3%; OR 8.76; 95%CI, 3.12-24.59;
p<0.001) (Table 1).
Conclusions:
The 6-point severity-of-illness score identified patients at higher risk
of death. We were able to derive and retrospectively validate a sim-
plified 4-point score with a superior predictive power.P384
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≥3 37 8 29 78.4%
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Chronic critical illness remains a scientific challenge, from its
conceptualization to its impact on patient prognosis [1]. We evalu-
ated the long-term evolution of ICU survivors by identifying the real
burden of prolonged critical illness on survival, quality of life and
hospital readmissions.
Methods:
We conducted a prospective cohort in 16 Brazilian hospitals includ-
ing 1616 ICU survivors with an ICU stay > 72h. We compared the pa-
tients diagnosed with chronic critical illness with the other patients.
Telephone Follow-up at 3 and 6 months. Quality of life was mea-
sured by the SF-12 questionnaire.
Results:
It was observed that 38% of patients had some definition of chronic
critical illness. Chronic critically ill patients had higher mortality at 6
months (p=0.012). This difference is mainly due to higher intrahospi-
tal mortality (p=0.0001). Mortality after hospital discharge was similar
between groups. There was no difference in hospital readmission
rate at 6 months. Regarding quality of life, patients had similar values
in both mental and physical domains.
Conclusions:
Chronic critically ill patients have a shorter survival when compared
to patients with ICU stay greater than 72h. However, among survi-
vors, there was no difference in hospital readmission rates and qual-
ity of life at 6-month follow-up.
References:
1: Rosa RG et al. Crit Care Med 48 :64-72, 2020P385
Simple predictive score for pulmonary complications in
mechanically ventilated patients in surgical intensive unit
A Piriyapatsom, O Chintabanyat, A Trisukhonth, O Chaiwat, S
Kongsayreepong
Faculty of Medicine Siriraj Hospital, Anesthesiology, Bangkok, Thailand
Critical Care 2020, 24(Suppl 1):P385
Introduction:
Various scores are developed to predict pulmonary complications
such as ARISCAT for patients at-risk of postoperative pulmonary com-
plication [1] and LIPS for patients at-risk of lung injury [2]. The aim of
this study was to compare these scores with ours for predicting pul-
monary complications in mechanically ventilated patients in SICU.
Methods:
This prospective observational study was conducted in SICU at a uni-
versity hospital. Adult patients admitted to SICU and required mech-
anical ventilation >24 hours were included. Primary endpoint was
the composite of pulmonary complications including pneumonia,
ARDS, atelectasis, reintubation, and tracheostomy. Multivariate ana-
lysis was performed to identify risk factors of pulmonary complica-
tions and the predictive score was developed. The ROC analysis was
performed to compare power of ARISCAT, LIPS and our newly devel-
oped score for predicting pulmonary complications.
Results:
276 patients were included in this study. Pulmonary complications
occurred in 86 (31.2%) patients. Independent risk factors for pulmon-
ary complications included age >65 years old (OR 1.80, 95% CI 1.02-
3.19), P/F ratio <300 (OR 2.32, 95% CI 1.31-4.13) and abnormal chest
radiograph (OR 2.72, 95% CI 1.48-5.01). The AUROC of ARISCAT, LIPS
and our score for predicting pulmonary complications were 0.51
(95% CI 0.44-0.59), 0.58 (95% CI 0.51-0.65) and 0.70 (95% CI 0.63-
0.77), respectively. For our predictive score, 0.6, 0.8 and 1.0 point
were assigned for presenting of age >65 years old, P/F ratio <300,
and abnormal chest radiography, respectively. The score of 0.7
yielded sensitivity and specificity of 62.8% (95% CI 51.6%-72.8%) and
64.7% (95% CI 57.4-71.4%), respectively.
Conclusions:
Compared to ARISCAT and LIPS, our simple score had better power
for predicting pulmonary complications in mechanically ventilated
patients in SICU.References:
1. Mazo V et al. Anesthesiology 121:219-231, 2014
2. Gajic O et al. Am J Respir Crit Care Med 183:462-470, 2011
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Introduction:
We assessed the independent association of ICU-acquired neuromus-
cular dysfunction with 5-year mortality and morbidity. We explored
the optimal threshold of the Medical-Research-Council (MRC) sum-
score predicting 5-year outcome.
Methods:
Prospective, 5-year follow-up study of 883 EPaNIC patients (Clinical-
trials.gov:NCT00512122), systematically screened in-ICU for strength
with MRC (‘MRC-cohort’, N=600), for electrophysiology changes with
compound muscle action potential on day 8±1 (‘CMAP-cohort’, N=
689), or both (‘MRC&CMAP-cohort’, N=415). Associations of MRC
close to ICU discharge and abnormal CMAP on day 8±1 with 5-year
mortality, hand-grip-strength (HGF, %pred), six-minute-walk-distance
(6-MWD, %pred), and physical function of the SF-36 quality-of-life
questionnaire (PF SF-36) at 5-year follow-up were assessed with ad-
justed Cox proportional hazards and linear regression. The optimal
threshold for MRC close to ICU-discharge predicting adverse 5-year
outcome was derived from Local-regrESSion lines on residual- and
scatterplots.
Results:
Lower MRC [HR, per-point-increase:0.946 (95%CI:0.928-0.968), p=
0.001] and abnormal CMAP [HR:1.568 (95%CI:1.165-2.186), p=0.004]
independently associated with 5-year mortality in respective cohorts.
In the MRC&CMAP-cohort, only lower MRC [HR:0.956 (95%CI:0.934-
0.980), p=0.001] independently associated with 5-year mortality.
Among 205 5-year survivors, only lower MRC independently associ-
ated with low HGF [0.866 (95%CI:0.237-1.527), p=0.004], low 6-MWD
[105.1 (95%CI:12.1-212.9), p=0.043], and low PF-SF-36 [-0.119 (95%CI:-
0.186 to -0.057), p=0.002]. MRC≤55 best predicted poor 5-year out-
come. Both MRC≤55 and abnormal CMAP independently associated
with 5-year mortality.
Conclusions:
ICU-acquired neuromuscular complications may impact 5-year mor-
bidity and mortality. MRC if slightly reduced, may affect long-term
mortality, strength, functional capacity and physical function,
whereas abnormal CMAP only related to long-term mortality.
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Introduction:
Outcomes in intensive care units have been reported to be better in
higher-volume units [1,2]. We compared outcomes for high-risk pa-
tients between low and higher volume units.
Methods:
Audit data from Irish ICUs is analysed and reported by the Intensive
Care National Audit & Research Centre (ICNARC) in London. ICNARC
report risk-adjusted mortality rates in all patients and in low-risk
patients(predicted mortality rate <20%) for each Unit, using the
Critical Care 2020, 24(Suppl 1):87 Page 160 of 213ICNARCH-2015 model to predict the risk of death. We used this data
to calculate the proportion of high-risk patients(predicted mortality
>20%) in each Unit, the mortality rate for high-risk patients, the risk-
adjusted mortality rate and we compared the overall risk-adjusted
mortality between low and high volume units.
Results:
The median number of annual new-patient admissions among 18
participating Units was 390; units below this were defined as low-
volume and those above as high-volume Units. The proportion of all
admissions to each Unit who were high-risk ranged from 8% to
54%(mean 34%). Unit mortality rates for high-risk patients ranged
from 33% to 69%. The ratio of observed to expected mortality(Stan-
dardized Mortality Ratio - SMR) for high risk admissions in each Unit
ranged from 0.87 to 1.34(mean 1.07). In Fig. 1 Units are ordered 1 to
18 on the x axis according to increasing volume of admissions i.e.
Unit 1 was smallest and Unit 18 largest. There was no definite rela-
tionship between volume of patients admitted to a Unit and SMR in
high risk admissions. Larger units had more variability in SMR. The
overall SMR for all high-risk patients in all low-volume Units was 1.07
versus 1.03 for all patients in all high-volume Units.
Conclusions:
There was no difference in mortality for high-risk patients between
high-volume and low-volume Units.
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Critical illness survivorship increases and patients and health care
providers have to face its long-term sequelae. Post Intensive Care
Syndrome (PICS) describes emerging or worsening physical, cognitive
or mental dysfunctions, arising after severe illness and persisting for
a long time following hospital discharge, interfering with patients’
quality of life.
Methods:
In this prospective study we evaluated cognitive ability and mental
health status in ICU survivors one year after hospital discharge. Eli-
gible patients were 18-70 years old, requiring mechanical ventilation
for more than 3 days. Patients completed the Mini-Mental State
Examination (MMSE). The maximum MMSE score is 30 points.
A score of 20-24 suggests mild dysfunction, 13-20 moderate disabil-
ity, and <12 severe dysfunction. Patients also completed the Centre
for Epidemiological Studies-Depression Scale (CES-D). Scores ≥16 in-
dicate the presence of depressive symptoms. Finally, the State-Trail
Inventory (STAI), comprised of two separate scales for measuring
state (S) or trait (T) anxiety, was also completed. A cut-off of 40 de-
tects clinically significant symptoms. Questionnaires were completed
in the presence of an experienced psychologist.
Results:
Forty-one (23 F) ICU survivors with a mean age of 43±16 years were
studied. They consisted of medical (n=17), trauma (n=15), surgical
(n=8), or burn (n=1) patients. Median ICU stay was 12 (IQR: 4-66)
days. MMSE score was 28±3; in 5 patients (12%) MMSE score was ≤
24. CES-D was 17±12; 18 patients (44%) had high scores. Mean S-
anxiety scale was 50±8; 39 patients (95%) had high scores. Mean T-
anxiety scale was 44±6.
Conclusions:
One year after hospital discharge, ICU survivors exhibit symptoms
consistent with PICS, involving primarily mental health, with anxiety
and/or depression being prominent. Cognitive ability seems to be
less commonly affected. It remains yet unclear whether interventions
can ameliorate functional capacity in ICU survivors.
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Introduction:
Phase angle, derived from bioimpedance analysis (BIA), reflects tissue
quality and quantity in which cell mass, membrane integrity and hy-
dration state are represented. Phase angle, as a measure of body
composition, changes with the physical condition of patients and is
associated with survival in several disease states and during ICU ad-
mission. We questioned whether phase angle can be used as a pre-
dictor of long term ICU outcome.
Methods:
A single-center prospective observational cohort with consecutive
patients, admitted to the ICU between June 2018 and June 2019.
Demographic data, APACHE III, comorbidity and phase angle in the
first 6 hours after ICU admission were collected and the ICU-, hos-
pital- and 6 months survival were registered.
Results:
Of 1025 patients included 8.5% (87) died within 6 months after ICU
admission. Patients who died had a higher APACHE III score (95 [71-
128] versus 56 [46-68] p<0.001), and more often sepsis or malig-
nancy. The phase angle was lower among non survivors (4.9˚ [4.0-
5.9] versus 5.4˚ [4.7-6.4] p< 0.001). The cut-off value for the phase
angle, determined with the ROC is 4.6˚. The Kaplan Meier curve
Critical Care 2020, 24(Suppl 1):87 Page 161 of 213(Figure 1) showed a significant difference (Log rank p<0.001) in mor-
tality between patients with a phase angle beneath 4.6˚.
Conclusions:
A low phase angle at time of ICU admission is a predictor of long
term survival, with an optimal cut-off value of 4.6˚.Fig. 1 (abstract P391). Baseline demographics
Fig. 1 (abstract P389). Kaplan Meier curve of 6 months survival
phase angleP390
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Introduction:
ADL weakening is often seen after intensive care and called post-
intensive-care syndrome (PICS). This is also seen in even outside ICU
and proposed to be called post-acute-care syndrome (PACS), espe-
cially in elderly patients. In patients with infection, SOFA score is fam-
ous for predicting in-hospital mortality, but there are no tools for
predicting ADL weakening during admission. To search for risk fac-
tors for ADL weakening during admission other than the age, we
conducted a retrospective observational study.
Methods:
The subjects were surviving patients with infection, aged from 16 to
89 who were admitted to our department from April 1, 2018 to May
31, 2019. Information of basic characteristics, laboratory data on ad-
mission and adjunctive therapies were extracted from our database.
We use Barthel Index (BI) as ADL evaluation, and the BI at discharge
were evaluated by nurses. We stratified patients by BI at discharge of
over 60 or not, and investigated factors that predicted it. We com-
pared each factor between 2 groups, and perform a logistic regres-
sion analysis with those that had a significant effect clinically or
statistically.
Results:
There were total 2170 patients and 515 had infection. The number
of surviving patients were 397. Average age was 73.18, female was
41.6% and median SOFA was 4. BI was over 60 in 192 patients. Fac-
tors which had significant difference between 2 groups were age, ex-
istence of DIC and laboratory data on admission such as ALB, BUN,
FDP, TAT, soluble fibrinmonomer complex and thrombomodulin.
There was no relationship between ADL weakening during admission
and ICU admission. We performed a logistic regression analysis with
age, sex, SOFA, DIC, mechanical ventilation, renal replacementtherapy, ECMO, ALB, lymphocyte count and CRP. Independent risk
factors were age, sex, and ALB.
Conclusions:
Among patients with infection, there was ADL weakening as PACS,
and its risk factor other than age was female sex and poor nutritional
status on admission.P391
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Introduction:
Unplanned readmission to acute care following hospital discharge
after critical illness has a significant impact for patients, caregivers
and the healthcare system [1]. Drivers for unplanned readmission in-
clude pre-ICU functional status as well as the social circumstances
which a patient returns to [2]. At present, there is limited under-
standing of the impact of cognitive function and whether this plays
a part in the readmission process. The aim of this study was to
undertake cognitive screening during the readmission episode to
understand if ongoing cognitive impairment was still present in this
patient group.
Methods:
Ethical approval was granted from the West of Scotland Research
Ethics Service (approval number 19/WS/0091). We used a single
centre cohort study design. Using a clinical database, we identified
those patients who had an ICU admission ≥ 3 days who were re-
admitted to acute care within 90 days of hospital discharge. The re-
searcher attended the ward and after discussion with the current
direct care team and screened patients using the Mini Mental State
Exam (MMSE) tool [3].
Results:
The cut-off scores were: 24-30- have normal cognition; 19-2- mild
cognitive impairment; 10-18- moderate impairment and ≤ 9 severe
impairment. Baseline demographics of this cohort are shown in Fig-
ure 1. 11 patients were screened during a readmission to acute
care. 8 patients were found to have normal cognition (72.7%). 23.3%
of patients had some degree of cognitive impairment: 2 (18.2%) had
mild cognitive impairment and 1(9.1%) had moderate impairment.
Conclusions:
In conclusion, patients discharged from ICU have continuing cogni-
tive impairment. Future research should examine to establish
whether cognitive dysfunction after ICU is a driver for readmission to
acute care.
References:
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Introduction:
Readmissions to acute care occur in a high number of critically ill pa-
tients within 90 days of hospital discharge [1]. Biomedical drivers
such as frailty and pre-existing co-morbidities have been identified
as drivers for readmission. However at present there is limited data
on the influence of social problems on readmission.
Methods:
This study, using a grounded theory approach, sought to understand
from a patient/caregiver perspective what the drivers for readmission
to acute care were. Ethical approval was granted from the West of
Scotland Research Ethics Service (19/WS/0091). A grounded theory
approach was used to explore from a patient and caregiver perspec-
tive what the drivers for readmission are [2]. Using a clinical data-
base, we identified those patients who had an ICU admission ≥ 3
days who were readmitted to acute care within 90 days of hospital
discharge. The researcher attended the ward and after discussion
with the direct care team conducted a semi-structured interview with
patient and/or caregiver. The interview was recorded and transcribed
verbatim. The transcripts were analysed to generate initial codes,
followed by the development categories and sub-categories. Theor-
etical sampling was undertaken.
Results:
15 participants were interviewed.10(66.6%) were patients and 5
(33.3%) were caregivers. The themes that have emerged from the
data were: Pain and polypharmacy; lack of social support and/or iso-
lation; strained relationships with primary care providers and infor-
mation provision across the patient journey. Subsequent theory
development is underway to understand how this learning could
help reduce readmissions in future.
Conclusions:
In conclusion, both social and biomedical drivers are likely to contrib-
ute to acute care readmission in this group. Future interventional
work is required in order to identify modifiable factors to reduce this
burden for patients and the healthcare service.
References:
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Introduction:
Frailty has shown to have prognostic relevance for patients with crit-
ical illness. Since a wide range of tools has been described to screen
for frailty, we aimed to describe the association of two frailty screen-
ing tools, the Clinical Frailty Scale (CFS) score and the modified Frailty
Index (mFI) in critically ill patients.Methods:
We performed a post-hoc analysis of a multicenter cohort of patients
admitted to six Canadian Intensive Care Units (ICU) between Febru-
ary 2010 and July 2011. Frailty was identified using the Clinical Frailty
Scale (CFS) and the modified Frailty Index (mFI). Concordance of the
frailty screening tools was evaluated with partial Spearman rank cor-
relation and intraclass correlation (ICC). Discrimination and predictive
ability of the tools for hospital mortality, 1-year mortality, hospital re-
admission and adverse events were compared using concordance
statistic (C-statistic) and calibration plot adjusting for age, sex, Se-
quential Organ Failure Assessment (SOFA) score and ICU admission
source, respectively.
Results:
The cohort included 421 patients. Prevalence of frailty was 32.8%
(95% confidence interval [CI] 28.3%–37.5%) with the CFS and 39.2%
(95% CI 34.5%–44.0%) with the mFI. Concordance between the two
tools was low [(ICC of 0.37; 95% CI 0.29-0.45) and partial correlation
coefficient of 0.38 (95% CI 0.29-0.47)], even after adjustment. Hospital
and 1-year mortality were greater for frail compared to non-frail pa-
tients using of both tools. Similarly, both tools found frail patients
were less likely to be living independently after hospital discharge,
and more likely to be rehospitalized when compared to non-frail
patients.
Conclusions:
While the CFS and mFI show low concordance, both showed good
discrimination and predictive validity for hospital mortality. Both
tools identify a subgroup of patients more likely to have worse clin-
ical outcomes.
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Introduction:
The Post-Intensive Care Syndrome (PICS) is a myriad of physical, psy-
chiatric and cognitive disorders secondary to critical illness, leading
to a decreased quality of life and an important socioeconomic bur-
den. This study aimed to identify if the conformity to a PICS Preven-
tion Bundle was able to reduce the incidence of the syndrome at ICU
discharge.
Methods:
All patients admitted to the ICU from January 1st to December 31st
2018 were included. The conformity to each of the ten components of
the PICS Prevention Bundle was assessed daily, and the patients were
evaluated for anxiety, depression, cognitive dysfunction, muscular
weakness, mobility impairment and nutritional risk at ICU discharge
and at a 3-to-6-months follow-up consultation. The patient cohort was
divided in terciles according to bundle conformity for the analysis.
Results:
From the 1145 enrolled patients, 352 (31%) were evaluated at ICU
discharge, and 103 (29%) attended to the follow-up consultation.
There was no difference in baseline characteristics between the co-
horts. There was no correlation between the prevalence of PICS at
discharge and Bundle conformity during ICU stay (90% vs. 87% vs
87%, p 0.834), though there was a decrease in nutritional risk and
days in mechanical ventilation (Table 1). After 3 to 6 months there
was a reduction on the prevalence of any kind of PICS, mobility im-
pairment, muscular weakness and nutritional risk. The patients that
developed PICS were older and had a higher Simplified Acute Physi-
ology Score III at ICU admission.
Conclusions:
A higher adhesion to a PICS Prevention Bundle was not able to pre-
vent the occurrence of the syndrome.
Table 1 (abstract P394). Differences in Post-Intensive Care Syndrome
(PICS) prevalence according to terciles of conformity to the PICS
Prevention Bundle
Low (n=
122)
Intermediate (n=
113)
High (n=
117)
p-
value
PICS, % ± SD 90 ± 73 87 ± 76 87 ± 74 0.834
Anxiety, % ± SD 31 ± 26 25 ± 23 34 ± 29 0.578
Depression, % ± SD 20 ± 17 21 ± 19 19 ± 16 0.816
Cognitive dysfunction, %
± SD
64 ± 54 58 ± 54 64 ± 57 0.837
Mobility, % ± SD 48 ± 40 44 ± 40 40 ± 35 0.641
Strength, % ± SD 9 ± 7 7 ± 6 4 ± 3 0.408
Nutrition, % ± SD 21 ± 17 8 ± 7 7 ± 5 0.007
Critical Care 2020, 24(Suppl 1):87 Page 163 of 213Table 1 (abstract P396). Patients expressing problems within each
domain of EQ-5D-5L and overall quality of life using EQ-VAS. Measured
at 1st clinic visit (baseline), 3 months and 12 months
EQ-5D-5L Domain Clinic baseline 3 months 12 months
Problems with mobility (%) 56 50 45
Problems with self-care (%) 40 33 36
Problems with usual activities (%) 80 61 55
Pain / discomfort (%) 76 72 64
Anxiety / depression (%) 64 39 45P395
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Introduction:
Despite improved outcomes of intensive care unit (ICU) patients,
sleep deprivation remains a major concern after ICU discharge.
Multifaceted causes make it difficult to treat and understand [1].
Not many studies have explored sleep deprivation beyond ICU.
This is evidenced by findings from a recent systematic review [2]
which included 8 studies with only one study [3] reporting sleep
deprivation beyond ICU. The aim of this paper is to present find-
ings of sleep deprivation beyond ICU from a larger study that ex-
amined the experience of critical illness in ICU and beyond in
the context of daily sedation interruption.
Methods:
Hermeneutic phenomenology was used to conduct the study. 12
participants aged 18 years and above who fulfilled the enrolment
criteria were enrolled into the study. The cohort comprised 7
male and 5 female participants. In-depth face to face interviews
at two weeks after discharge were conducted and repeated at six
to eleven months. Interviews were audio taped, transcribed and
thematically analysed. Significant statements were highlighted
and categorized for emergent themes.
Results:
Six participants continued to experience sleep deprivation up to
eleven months after ICU. Two cited dreams about ICU, three could
not explain why they continued to fail to sleep and one stated that
he continued hearing ICU alarms in the silence of the night.
Conclusions:
Sleep deprivation continues beyond ICU due to nightmares, de-
lusional memories and unexplained reasons. Further research is
needed to establish causes of sleep deprivation and explore
ways to promote sleep in critical illness survivors after ICU
discharge.
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Introduction:
Post intensive care syndrome (PICS) is well recognized following gen-
eral ICU care [1]. Intensive Care Syndrome:Promoting Independence
and Return to Employment (InS:PIRE) is a multidisciplinary complex
intervention designed to address PICS [2]. With a paucity of evidence
on PICS after cardiothoracic intensive care, we aim to evaluate PICS
and the feasibility of the InS:PIRE intervention in this population.
Methods:
Those attending the clinic received 5 weeks of intervention including
individual appointments with ICM nurse, physician, pharmacist, and
physiotherapist. A café area facilitated peer support alongside psych-
ology group sessions. Primary outcome was quality of life measured
by EQ-5D-5L. Further surveys included: pain, mental health, and self-
efficacy. Questionnaires were taken at baseline, 3 and 12 months.
Results:
Over 5 cohorts, 27 patients attended, 67% male, median age 66 years
(IQR 61–75), median APACHE 2 score of 17 (IQR 14-18.5), and median
ICU length of stay was 13 days (IQR 9-21). A total of 14 (53%) pa-
tients completed surveys at one year. Scheduled admissions repre-
sented 56% of those attending. Mean EuroQol EQ-VAS score was 70/
100 (SD +/- 18) at baseline increasing to 78/100 (SD +/- 16) by 1 year
(Table 1). Those with problems in at least one domain of EQ-5D-5L
fell from 92% at baseline to 73% at 1-year with the breakdown
shown in table 1. Severe problems were seen in 22% falling to 18%
at 1 year. HADS demonstrated an anxiety or depression rate of 44%.
Brief pain inventory identified 14 patients (52%) with ongoing
chronic pain. Mean self-efficacy was 32/40 (SD +/-6) at baseline
and 34/40 (SD +/-5) at 1 year.
Conclusions:
Cardiothoracic intensive care patients have ongoing and persistent
features of PICS with significant effects on health-related quality of
life. Further, the InS:PIRE multi-professional complex intervention is
feasible within this specialist group.
References:
1. Needham DM et al. Crit Care Med 40:502-9, 2012
2. McPeake J et al. PloS one. 12:e0188028, 2017Mean EQ-VAS score (0-100) 70 78 78
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Introduction:
Frailty is being increasingly seen as an independent syndrome. Frail
patients now account for an increasing proportion of hospital and
critical care admissions [1]. We aimed to compare frailty and mortal-
ity in our intensive care unit.
Methods:
Clinical Frailty Score (CFS) was incorporated within the electronic
health record (EHR) 2019. We performed this retrospective analysis
on the data collected between Jan’19 and Oct’19. The predictor and
outcome for this study were frailty and hospital mortality respect-
ively. All demographic data, acute physiology score, critical care and
hospital outcome data were automatically collected in the EHR and
recorded. We used a cut off of CFS>3 and above to define non-frail
and frail respectively. Chi-squared test, simple and multiple logistic
regression were used. Adjustment was done for ICNARC score and
age.
Results:
Total number of patients was 848, of which 140 (16.5%) died in hos-
pital. Within the patients<65 years (n=392), 79 (20%) were recorded
as frail or vulnerable. The number of elective and emergency admis-
sion were 292(34%) and 556(66%) respectively. In the frail and non-
frail, mortality rates were 30% and 9.5% (p<0.001) respectively, with
odds ratio of 4.14 (95% CI 2.8, 6; p<0.001) (Table 1). For emergency
patients, mortality in the frail and non-frail were 36.3% and 16.5% re-
spectively (p<0.001), with odds ratio 2.9 (95% CI 1.9, 4.3; p<0.001)
but after adjustment, it was not significant [OR 1.64 (95% CI 0.97,
1.77); p=0.06]. For patients, who were discharged from critical care,
mortality in the frail and non-frail were 11.8% and 1.2% respectively
(p<0.001) with odds ratio 11.8 (95% CI 4.6, 27.9; p<0.001) and ad-
justed OR 4.19 (95% CI 4.16, 11.1; p=0.06).
Conclusions:
Frailty is a risk factor for hospital mortality for critical care survivors,
independent of age. It is possible that enhanced targeted resource
allocation and appropriate placement for these patients could alter
adverse outcome.
References:
1) Flatten H et al. Intensive Care Med 43:1820-1828, 2017Table 1 (abstract P397). Mortality rate in frail versus non frail patient
population with unadjusted and adjusted odds ratio (OR)
Mortality rate
in frail
Mortality rate in
non-frail
Unadjusted OR Adjusted OR
All patients 30.2% 9.5% 4.14 (2.84, 6.05)
P<0.001
2.25 (1.36,3.71)
P<0.001
Emergency
patients
36.3% 16.5% 2.9 (1.95,4.31)
P<0.001
1.64 (0.97, 2.77)
P=0.06
Critical care 11.8% 1.2% 11.4 (4.6, 27.9) 4.19 (1.6, 11.1)
Fig. 1 (abstract P398). Age vs CFS emergency critical care admissionsP398
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survivors P<0.001 P=0.004Introduction:
Age is a well-known risk factor for Critical Care (CC) outcome and is
incorporated into many prognostic tools; however, this has been crit-
icized for assumption of normal physiology for young at baseline. In
recent years, frailty in CC prognostication has been of interest, with
meta-analysis correlating worsening outcomes with increasing frailty
[1]. In this study, we compared the effect of frailty versus age for de-
termining hospital survival for critically ill patients.
Methods:
This study was conducted in a UK District General Hospital, with 19
CC beds, where the Rockwood Clinical Frailty Score (CFS) is collected
on all adult admissions. Retrospective analysis of data, adjusted for
ICNARC score was performed on CC emergency admissions using
STATA 14, combining CFS, patient demographics and outcome data
from our electronic records. Logistic regression was used for mortal-
ity prediction. We defined non-frail as CFS<4. An age cut-off of 70
years was used for the age adjusted model, as remaining life expect-
ancy (RLE) at age 70 years has recently been shown to be equal to
RLE at age 65 years before [2].
Results:
Total number of patients was 556 (male- 58%) of which 140 (16.5%)
died in hospital. Importantly, in the patients <70 years (n=529),
137(48%) had CFS<4. The number of elective and emergency admis-
sion were 292(34%) and 556(66%) respectively. The risk for mortality
(OR) in the adjusted model with age and CFS cut off were 2.65 (1.61,
4.35) and 2.35 (1.44, 2.83) respectively. Both of these mortality pre-
diction models, one incorporating age cut-off 70 and the other based
on CFS, show equal performance of discrimination (AUROC 0.88) (Fig-
ure 1).
Conclusions:
Our data supports an association between increasing CFS and mor-
tality for the CC population independent of age. Frailty should be in-
corporated in clinical decision making in addition to utilisation of
arbitrary cut offs of age.
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Introduction:
ICU survivors are discharged from hospital with varying degrees of
frailty. The impact of ICU length of stay on the development of post-
ICU Syndrome symptoms is still controversial. Through a follow-up
Fig. 1 (abstract P400). Association of white blood cell count with
predicted mortality
Critical Care 2020, 24(Suppl 1):87 Page 165 of 213study after hospital discharge [1], we assessed the impact of critical
care on the psychological symptoms, functional outcomes and qual-
ity of life of patients
Methods:
We conducted a prospective cohort in 16 Brazilian hospitals includ-
ing 1616 survivors of an ICU stay > 72h. We compared chronic critic-
ally ill patients (ICU stay> 10 days) and the other patients. We
performed psychological and functional presential assessment in pa-
tients within 48 hours of ICU discharge and by telephone at 3 and 6
months.
Results:
The prevalence of chronic critically ill patients was 26%. Regarding
outcomes, chronic critically ill patients had a higher incidence of de-
pressive symptoms than other patients in the immediate post-ICU
discharge (p = 0.004), as well as a higher incidence of muscle weak-
ness (p <0.001). However, in subsequent evaluations, we found no
difference between groups regarding psychological symptoms - de-
pression, anxiety and post-traumatic stress. Higher functional de-
pendence was observed in critically ill patients, but without
difference in the quality of life score, both in the physical (p = 0.87)
and mental (p = 0.84) domains.
Conclusions:
Chronic critically ill patients, when compared to patients with stay>
72h, have a higher incidence of depressive symptoms at ICU dis-
charge. This difference disappears in the follow up. Chronic critically
ill patients present higher levels of functional dependence but with-
out repercussions on quality of life scores.
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Introduction:
Activation of the inflammatory response after cardiac arrest (CA) is a well-
documented phenomenon that may lead to multi-organ failure and death.
We hypothesized that white blood cell count (WBC), one marker of inflam-
mation, is associated with one-year mortality in ICU treated CA patients.
Methods:
We used a nationwide registry with data from five academic ICUs to
identify adult CA patients treated between January 1st 2003 and De-
cember 31st 2013. We evaluated the association between the most
abnormal WBC within 24 hours of hospital admission and one-year
mortality. We accounted for baseline risk of death using multivariable
logistic regression (adjusted for age, gender and 24h sequential
organ failure assessment [SOFA] score).
Results:
A total of 5,543 patients were included in the analysis. Of those pa-
tients 2,387 (43%) were alive one year after CA. We plotted WBC
against baseline risk of death and through graphic examination of a
locally weighted scatterplot smoothing (lowess) curve found the low-
est risk of death to be associated with a WBC of 12 (E9/l) (Figure 1).
We used this value as a cut-off point and ran separate multivariable
regression analyses, accounting for baseline risk, for patients with a
WBC over or under 12. For those with a WBC under 12, an increasing
WBC was associated with a reduced risk of death (OR 0.969, 95%
confidence interval [CI] 0.940–0.999). For those with a WBC over 12,
an increasing WBC was associated with an increased risk of death
(OR 1.018, 95% CI 1.004–1.034).Conclusions:
A WBC deviating from 12 E9/l is associated with a small but statisti-
cally significant increase in probability of death in CA patients. Mor-
tality increases with both high and low WBCs. The lowest mortality
was observed at WBC 12 which is higher than healthy population ref-
erence value (WBC 3.4 -8.2), suggesting that moderate leukocytosis
after CA may not be harmful.P401
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Introduction:
Dysphagia is common and independently predicts death in ICU pa-
tients. Risk factors for dysphagia are largely unknown with sparse
data available only from mostly small cohorts without systematic
dysphagia screening. We investigated risk factors for dysphagia in
ICU patients post invasive mechanical ventilation.
Methods:
Post-hoc analysis of data from a large monocentric prospective ob-
servational study (“Dysphagia in mechanically ventilated ICU patients,
DYnAMICS” [1]) using comprehensive statistical models to identify
potential risk factors for dysphagia in 933 primary ICU admissions. In
DYnAMICS, patients were systematically screened for dysphagia at
the bedside within 3 hours from extubation using the two-step Bern-
ese ICU Dysphagia Algorithm. Screening-positivity was followed
within 24 hours by a confirmatory exam, identifying 116 ICU patients
suffering from dysphagia.
Results:
After adjustment for typical confounders, baseline neurological dis-
ease (OR 4.45, 95%-CI: 2.74-7.24, p<0.01), emergency admission (OR
2.04, 95%-CI: 1.15-3.59, p<0.01), days on mechanical ventilation (OR
1.19, 95%-CI: 1.06-1.34, p<0.01), days on renal replacement therapy
(OR 1.1, 95%-CI: 1-1.23, p=0.03), and disease severity (APACHE II score
within first 24 hours; OR 1.03, 95%-CI: 0.99-1.07, p<0.01) remained in-
dependent risk factors for dysphagia post mechanical ventilation
(Figure 1). Increased body mass index reduced the risk for dysphagia
(6% per step increase, OR 0.94, 95%-CI: 0.9-0.99, p=0.03).
Conclusions:
In ICU patients, baseline neurological disease, emergency admission
and duration of invasive mechanical ventilation appeared as promin-
ent independent risk factors for dysphagia. Although screening for
dysphagia should be performed in all ICU patients, a risk-based
Critical Care 2020, 24(Suppl 1):87 Page 166 of 213screening approach might be implemented whenever screening of
the total ICU population is not deemed feasible.
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1. Schefold JC et al. Crit Care Med 45:2061-2069, 2017Table 1 (abstract P402). Results. CKD1 : Chronic kidney disease stage 3
and more, CAD : Coronary arterial disease, CI : Confidence limits
Variable Represcribed
N=40
Not represcribed
N=40
Odds ratio (95
% CI)
p-
value
Age, median (IQR) 72 (12.5) 75 (12.5) 1.04 (0.99-1.10) 0.10
CKD, N (%) 7 (17.5) 13 (32.5) 2.15 (0.78-5.92) 0.14
CAD, N (%) 10 (25.0) 17 (42.5) 2.22 (0.86-5.74) 0.10
SOFA score, median
(IQR)
3 (3.0) 5 (3.0) 1.20 (1.00-1.43) 0.045
APACHE II score,
median (IQR)
10 (13.0) 16.5 (11.0) 1.04 (0.98-1.11) 0.17
Vasopressor, N (%) 10 (25.0) 22 (55.0) 3.67 (1.42-9.47) 0.007
Fig. 1 (abstract P401). PCA of the correlated cluster of variables
days on RRT, days in hospital, cumulative midazolam dose, days on
ICU, days on gastric tube, days on invasive mechanical ventilation,
cumulative midazolam dose and APACHE II score. PCs 1 to 4 (A-C)
are shown on horizontal and vertical axes. Based on PC 1 to 3
(explaining 70.25% of the variance), three groups of swappable
variables were identified: (1) days on RRT, days in hospital and
cumulative midazolam dose, (2) days in ICU, days on gastric tube,
days on invasive mechanical ventilation and cumulative propofol
dose and (3) APACHE II score. The first member of each group was
selected as representative variableP402
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Introduction:
Admission and transitioning between services creates break points in
communication and can lead to unintentional medication discrepan-
cies during hospital stay [1]. Cardiovascular medications may be dis-
continued on ICU admission. Whether they are appropriately re-
initiated after the acute illness and on hospital discharge is unclear.
Methods:
We performed a retrospective chart review study in a tertiary ICU
from April 2016 to April 2017. Our medications of interest were ARBs
and ACEIs. We collected baseline characteristics, APACHE II and SOFA
scores on admission and whether patients were on chronic cardio-
vascular medications before hospitalization. Our outcome of interest
was the re-initiation of the same class of cardiovascular medication at
hospital discharge.
Results:
Data from the first 199 ICU survivors were analyzed. Median age was
68 (interquatile range (IQR)=18) years and 42.2% were female. The
APACHE II and SOFA scores on admission were 14 (IQR=11) and 4
(IQR=4) respectively. 99 (49.8%) of patients were mechanically venti-
lated and 77 (38.7%) needed vasopressor support during their ICUstay. There was a total of 80 patients on either ACEIs or ARBs before
hospitalization. Among them, 40 patients (50%) was re-prescribed an
ACEIs or ARBs at discharge and none of them stayed on renal re-
placement therapy at discharge. Univariate logistic regression
showed that SOFA score (odds ratio (OR)=1.20 [1.004-1.425], p=
0.045) and the need of vasopressor support (OR=3.66 [1.419-9.467],
p=0.0073) were associated with ACEIs and ARBS not being re-
initiated (Table 1).
Conclusions:
A significant proportion of ACEs and ARBs are not re-initiated at dis-
charge. Future studies need to address this discrepancy.
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Introduction:
During critical illness, chronic therapies are often withheld and subse-
quently not restarted, and ICU-specific treatments can be inappropri-
ately continued once discharged. Critically ill patients also experience
many transitions of care, which may also cause issues with on-going
medicine management. Additionally, patients are often prescribed
new medications, which they may not understand how to take effect-
ively, or which may cause adverse events. We aimed to determine if
we could predict Medication-Related Problems (MRPs), using demo-
graphic and in-ICU clinical data.
Methods:
183 patients enrolled in a post-intensive care programme between
September 2016 and June 2018. Intensive Care Syndrome: Promoting
Independence and Return to Employment (InS:PIRE), is a 5-week mul-
ticentre, multidisciplinary rehabilitation programme for ICU survivors.
MRPs were identified by a specialist ICU pharmacist during this
programme and classified by their significance on a scale of one to
four. Logistic regression was used to determine if demographic fac-
tors were associated with the occurrence of a clinically significant
MRP - a significance score of two or above (Figure 1).
Results:
The adjusted model included age, ICU LOS, hospital LOS, APACHE
II, number of days of renal replacement therapy, number of days of
ventilation, the number of medications prescribed at ICU discharge,
and the WHO analgesia classification at InS:PIRE. There were increased
odds of having a clinically significant MRP for hospital LOS (OR
Critical Care 2020, 24(Suppl 1):87 Page 167 of 2131.03 per day, 95% CI: 1.01-1.05, p=0.02), number of medications at
ICU discharge (OR 1.15 per medication, 95% CI: 1.04-1.28, p=0.01),
and WHO Step 2 analgesia at the InS:PIRE clinic (OR 5.20 vs WHO
level 0, 95% CI: 2.07-13.20, p=0.001).
Conclusions:
Length of days in hospital, the number of medications at ICU dis-
charge, and WHO step 2 analgesia prescription are all associated with
increased odds of developing an MRP. Patients with long stays and
complex polypharmacy should be reviewed in the post-ICU recovery
period.Fig. 1 (abstract P404). BNF category of MRPs
Fig. 1 (abstract P403). Significance scale of MRPsP404
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Introduction:
During critical illness, chronic therapies are often withheld and subse-
quently not restarted, and ICU-specific treatments can be inappropri-
ately continued once discharged. Critically ill patients are also
experience higher numbers of transitions of care, which may also
cause issues with on-going medicine management. Additionally, pa-
tients are often prescribed new medications which they may not
understand how to take effectively, or which may cause adverse
events. We aimed to categorise the nature of the Medication Related
Problems (MRPs) found in this population.
Methods:
183 patients enrolled in a post-intensive care programme between
September 2016 and June 2018. Intensive Care Syndrome: Promoting
Independence and Return to Employment (InS:PIRE), is a 5-week mul-
ticentre, multidisciplinary rehabilitation programme for ICU survivors
and their caregivers. MRPs were identified by a specialist ICU
pharmacist during this programme. This MRP was then categorized
by type and by British National Formulary (BNF) category.
Results:
62·8% (n=115) of patients required at least one pharmacy interven-
tion. The median number of interventions required per patient was
one (IQR 0-2); the maximum number was six. 198 MRPs were re-
corded in this cohort. The most common intervention was clarify-
ing duration of treatment (n=44), followed by education (n=33), and
correcting drug omissions (n=27). The BNF drug class most fre-
quently associated with MRPs was neurological (n=65), which com-
prises analgesics (n=45) and psychiatric medications (n=20) (Figure
1). This was followed by cardiovascular medications (n=40), gastro-
intestinal medications (n=34), nutritional medications (n=25), and
others (n=34).
Conclusions:
Many ICU survivors experience MRPs. The most common class of
MRP was neurological, reflecting the high incidence of chronic pain
and psychiatric illness in this populationP405
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Introduction:
Early mobilization of Intensive Care Unit (ICU) patients is effective in
accelerating ICU discharge. However data on mobilization practices
on ICU patients are inadequate. The aim of this study was to docu-
ment physiotherapy intervention practices on ICU Cardiac Surgery
patients at the Onassis Cardiac Surgery Center.
Methods:
For this study, of the 221 patients that were subjected to cardiothor-
acic surgery, 159 were assessed for the effects of early mobilization
on the duration of ICU hospitalization. Physiotherapy intervention
was recorded on the 1st, 3rd, 5th and 7th day of ICU admission.
Results:
Physiotherapy practice consisted of respiratory physiotherapy and
mobilization interventions such as active and passive limb
mobilization, sitting in bed and transferring from bed to chair. The
proportion of patients mobilized, was 18% (Ν=29/159) within 24
hours from ICU admission, 53% (Ν=46/87) in day 3, 54% (Ν=22/41) in
day 5 and 62% (N= 15/24) in day 7. The duration of stay in the ICU
was reduced in patients who were mobilized compared to bedrid-
den, (28 ± 37 vs 66 ± 92 hours, p = 0.001).
Conclusions:
Early mobilization rates of patients undergoing cardiothoracic sur-
gery appear reduced in the ICU Cardiac Surgery compared to inter-
national literature. Physiotherapy interventions practices are
associated with decreased ICU length of stay.P406
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Introduction:
The purpose of our retrospective study is to compare 2 groups (pa-
tients with amyotrophic lateral sclerosis - ALS- or neurological dis-
ease and patients non neurological disease) of tracheoventilated
patients in a considered period to highlight differences in ICU
Fig. 1 (abstract P408). Run chart showing time delay in rewriting
ICU drug chart in patients being discharged from ICU
Critical Care 2020, 24(Suppl 1):87 Page 168 of 213recovery for VAP [1] and mortality, due to VAP or other causes - ex.
acute renal failure or cardiac diseases.
Methods:
24 tracheostomized adult patients, cuffed cannulae, 24 hours of
home ventilation, cannula change every 60 days at home, in the
period 2015-2019, classified in 2 groups (group A: patients with ALS
or neurological diseases - 62.5% - and group B: patients without
neurological diseases ex. pulmonary diseases - 37.5%). We consider
VAP with ICU recovery and mortality due to VAP or other causes in
the 2 groups. Clinical, radiological and microbiological criteria have
been used for diagnosis of VAP. The results is expressed as percent-
age and as average and standard deviation.
Results:
VAP with ICU recovery involved 50% (12/24) of the patients [average
1.83 and standard deviation 0.79] (66% group A vs 22% group B).
The deaths for VAP 4/12 (33% - 26% group A vs 0% group B). Mortal-
ity for other causes 5/24 (20.5% - 13% group A vs 33% group B).
Conclusions:
Comparing the 2 groups, VAP with ICU recovery and mortality for
VAP in ICU are more frequent in group of neurological patients; mor-
tality for other causes is higher in the group of non neurological
patients.
References:
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P407
Prognostic factors of heterotopic ossification in critically ill
patients
AG Vassiliou1, I Dimopoulou2, E Jahaj2, Z Mastora2, SE Orfanos2, A
Kotanidou2
1National & Kapodistrian University of Athens, 1st Department of Critical
Care Medicine & Pulmonary Services, GP Livanos and M Simou
Laboratories, Athens, Greece; 2National & Kapodistrian University of
Athens, 1st Department of Critical Care Medicine & Pulmonary Services,
Athens, Greece
Critical Care 2020, 24(Suppl 1):P407
Introduction:
Heterotopic ossification (HO) is the formation of bone in soft tissues
and constitutes a potential complication of patients hospitalized in
the ICU. The exact pathogenetic mechanisms of HO are unknown.
Bone morphogenic proteins (BMPs) induce bone formation, while
signaling through the receptor activator of NF-κB (RANK) and its lig-
and (RANKL) regulates osteoclast formation, activation and survival in
normal bone modeling and remodeling. Osteoprotegerin (OPG) pro-
tects bone from excessive bone loss by preventing RANKL from bind-
ing to RANK. In the present study we investigated these molecules
as possible biomarkers of HO development in ICU patients.
Methods:
We measured the levels of BMP-2, RANKL and OPG on ICU admission,
and thereafter on days 7 and 30 in the sera of 28 critically ill patients
using ELISA.
Results:
Nine of the 28 patients developed HO in the ICU or during the 30-
day follow-up period. Our results showed that on admission to the
ICU, the patients who developed HO had significantly lower BMP-2
levels compared to patients who didn’t [566.7 (216.7-883.3) pg/ml vs.
1300 (566.7-2817) pg/ml, respectively, p= 0.037]. RANKL levels were
also decreased in the HO patients on admission [1.495 (0.285-2.465)
ng/ml vs. 2.465 (1.535-6.67) ng/ml, p= 0.048], while OPG levels were
similar in both groups. In the HO patients, on day 7, the levels of
BMP-2 were slightly elevated, whereas on day 30 they tended to in-
crease (p= 0.064). The patients who did not develop HO had stably
elevated levels during the 30 days. A small elevation was noted inRANKL levels in the HO patients, while OPG levels remained un-
altered at all time points, for both groups.
Conclusions:
In our cohort of critically ill patients, those who will develop hetero-
tropic ossification have significantly decreased levels of BMP-2 and
RANKL on admission, suggesting that these molecules may be used
as prognostic markers to identify patients who will develop this de-
bilitating condition.
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Introduction:
The transfer of patients from the intensive care unit (ICU) to the gen-
eral wards is a challenging transition of care. This project focused on
the handover of patients between ICU and the general wards in a
district general hospital where there was no formal handover system
in place. A baseline survey found 100% of foundation year 1 (FY1)
doctors felt medications were unclear when rewriting ICU drug
charts from the electronic notes. Junior doctors were often unaware
patients had been transferred. This resulted in significant delays in
drug charts being rewritten and missed or delayed medications. Our
aim was to reduce the median time delay in drug charts being re-
written by 50% in 4 months.
Methods:
Following discussion with ICU staff, ward staff and FY1 doctors, a for-
mal standardized handover system was introduced. This involved a
verbal handover to the appropriate FY1 by an ICU doctor and the pa-
tient drug chart to be rewritten in ICU at the time of handover. The
next change was to display posters on the wards to alert staff that
the medical team are to be contacted when a patient comes to the
ward from ICU and to ensure the drug chart is completed.
Results:
The baseline data showed a median time delay of 4 hours, with one
patient waiting 14 hours for a drug chart. Following the interventions
the median time delay has decreased to 0 hours within 4 months as
demonstrated in Figure 1. The changes have received positive feed-
back from ICU staff, ward staff and FY1 doctors.
Conclusions:
The aim of reducing the time delay by 50% has been achieved with
the median time delay now 0 hours. This has improved patient safety
by significantly reduced delays in medications and through the intro-
duction of a standardized handover. This has also provided an op-
portunity for junior doctors on the wards to seek clarification
regarding medications and the clinical management plan for the pa-
tient. This has established a communication channel between ICU
and the wards making patient care safer and more effective.
Table 1 (abstract P410). Characteristics and clinical outcomes related
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Introduction:
Telemonitoring outside the ICU is scarce. But with innovative wear-
ables measuring respiratory and heart rate wirelessly, culture on
intrahospital telemonitoring should definitely change. However, cul-
ture has been known to be one of the most crucial success factors in
innovation, especially in health care. Human design thinking is a
promising tool in health care innovation but rarely used in a multi-
disciplinary team to initiate an innovation culture and stimulate sus-
tainable collaboration. The aim of this study was to initiate a pilot
project with a multidisciplinary team to start using wearables for
Early Warning Score (EWS) on a clinical ward.
Methods:
Human Design Thinking was used to write a value proposition on
wearables in clinically admitted neutropenic hematologic patients in
an academic center. A multidisciplinary team was performed to cover
all disciplines involved in the technical, clinical and administrative
parts of the project. A vendor was chosen based on its product spec-
ifications in relation to the present hospital monitoring infrastructure.
In design thinking sessions, critical appraisal of multiple telemonitor-
ing factors was performed by sub teams and a Canvas projectplan
was constructed.
Results:
The project team was formed of registered nurses, physicians, IT-
specialists, Electronic Health Record consultants; a critical care phys-
ician was appointed as project leader. The main critical factors were:
 unseamlessly transmitting of both heart and respiratory rates
including appropriate movements filtering to the nurse's
smartphones
 direct uploading into electronic health record with automated
EWS calculation
 nurse driven protocol on EWS follow up.
Philips Healthcare with their IntelliVue Guardian wearable biosensor
was the chosen vendor (Figure 1).
Conclusions:
Design thinking in a multidisciplinary health care team could posi-
tively influence the innovation culture. Scientific evaluation of this
wearable will focus on both nurse's acceptance and data storage and
is expected in the summer of 2020.Fig. 1 (abstract P409). Wearable biosensor
to type of discharge
Discharge to home Discharge to ward P
Age 66.23±13.93 66.76±13.74 0.398
Gender 42.90% F / 57.10% M 37.60% / F 62.40% M 0.044
SAPS3 score 40.75±9.99 43.42±12.64 0.000
Mechanical ventilation 2.90% 18.90% 0.000
Vasopressors 13.90% 32.80% 0.000
Blood transfusion 1.90% 4.10% 0.032
ICU lengh of stay 2.59±2.64 3.30±3.99 0.000P410
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Introduction:
The aim is to determine the epidemiological profile and clinical out-
comes of patients receiving discharges directly to home (DDH) in a
coronary intensive care unit (CICU). There is an increasing proportion
of DDH from intensive care units. Secure DDH can improve health
system, resource utilization, and costs.
Methods:
We evaluated the characteristics and clinical outcomes of 3118 pa-
tients admitted to the CICU between 2014 and 2019. The sample
was divided into two groups: DDH group=373; discharge after ward
(DAW) group=2745. The analysis was performed by SPSS version 22.0
software, significance level of p <0.05. Data normality was assessed
by the Kolmogorov-Smirnov test. For the comparison between con-
tinuous variables the Wilcoxon test was used and for the categorical
variables the chi-square test was used.
Results:
Discharge directly to home increased from 49 (1.57% of all survivors)
patients in 2014 to 82 (2.82%) patients in 2019. Regarding the
baseline characteristics of DDH group, it was found mean age
66.23±13.93, male predominance 57.10%, main hospitalization
diagnoses: arrhythmias 24.10%, stent implantation 24.90%, un-
stable angina 13.40%. Regarding on clinical outcomes: ICU
length of stay (DDH=2.59±2.64; DAW: 3.30±3.99; P=0.000), sever-
ity by SAPS 3 points (DDH: 40.75±9.99; DAW: 43.42±12.64; P=
0.000), readmission rate (DDH: 6.20%; DAW: 9.30%; P=0.043), as
well as the need for invasive mechanical ventilation (DDH:
2.90%; DAW: 18.90%; P=0.000), use of vassopressors (DDH:
13,90%; DAW: 32.80%; P=0.000) and blood transfusion (DDH:
1.90%; DAW: 4.10%; P=0.032) were statistically smaller in DDH
group (Table1).
Conclusions:
Severity, readmission and lengh of stay were lower in patients re-
ceiving discharges directly to home. It seems like a safe way
to discharge low-risk short stay patients. It seems to save re-
sources and reduce costs, as well as the need for hospital
beds. However, futher estudies are needed to actualy evaluate
this safety.
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Introduction:
Critical Care Response Teams (CCRTs) were designed to quickly as-
sess and transfer, rapidly deteriorating ward patients to the intensive
care unit. The ultimate goal of a CCRT is to prevent cardiopulmonary
arrest, stabilize patients’ condition and help in optimizing the care
provided by the primary team in general wards. Septic patients man-
aged by CCRT are most likely to be initiated on one or more antimi-
crobials, frequently on an empiric basis. The objective of this study
was to compare the quantity and quality of antimicrobial use among
CCRT patients during three identified stages of their management;
before CCRT activation, during and on day four after CCRT activation
[1].
Methods:
Two hospitals in Riyadh, Saudi Arabia were utilized for this study. Ter-
tiary care hospitals serve over 750,000. Include 1300-beds, 15 differ-
ent intensive care units, and 50-inpatient wards. All patients above
15 years and managed by the CCRT during the study period were eli-
gible to be included in the study. Case-control design was used to
compare septic (cases) and non-septic (controls) CCRT patients, re-
cruited prospectively for five months (January to May 2018).
Results:
A total of 315 CCRT patients were included: 157 with sepsis (cases)
and 158 without sepsis (controls). Average age was 61.1 ± 20.4 years
and 54.6% of the patients were males. Among the 157 septic pa-
tients, 97 (61.8%) had a defined septic focus with pneumonia the
main diagnosis (33.6%). 60 (38.2%) had no defined septic focus. The
most frequent triggers for CCRT activation were changes in respira-
tory rates (29.5%). An antimicrobial was used during CCRT activation
in 96.2% of cases and 65.2% of controls (p < 0.001). Meropenem
(51.4%), vancomycin (41.3%), and piperacillin/tazobactam (28.6%)
were the most frequently used antimicrobials. More cases were likely
to be admitted to ICU than controls (43.9% versus 28.5%, p=0.004).
There were no differences in the development of antimicrobial ad-
verse events (31.8% versus 27.2%, p = 0.270) or in mortality (4.5%
versus 1.3%, p = 0.104) between cases and controls.
Conclusions:
The fact of no de-escalation of antimicrobials were noticed in major-
ity of CCRT patients; this led to the importance of establishing an
antimicrobial stewardship hospital wide program.
References :
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Introduction:
Bacterial resistance is an important issue in Intensive Care Units.
Screening patients admitted into ICU for multidrug-resistant bacteria
(MDR) nasal and fecal carriage, has become a rule in Romania. Our
objective was to weekly monitorize colonization with MDR bacteriaand the persistance of carriage of such pathogens, among patients
admitted to our hospital ICU and also, to determine the incidence for
nosocomial infections associated with this colonizations,considering
that colonization precedes infection.
Methods:
Prospective observational study:from 01/10/2017 to 15/08/2018 - we
have included all adult patients admitted directly to ICU (first admit-
tance only) or with previous general wards admittance for less then
48 hours. We performed nasal and rectal swap screening for MDR
bacteria: Meticilin Resistant Staphilococcus Aureus (MRSA), ESBL pro-
ducing Enterobacteriaceae (ESBL-EN), Carbapenemases Producing
Gram negative Bacteria (CBP-GNB), Vancomycin resistant Entero-
coccus (VRE), during hospitalisation, on day 0,7 and 14.
Results:
We have included 75 patients, 34 women, average age 62,9 yrs with
average length of hospitalisation of 15 days. Upon admission: 35 pa-
tients were colonized with MDR bacteria, in day 7- 65 colonized pa-
tients and 39 in day 14.Upon admission we had 5 MRSA, 25 ESBL, 6
CBP and 18 VRE strains. 13 patients had more then one strain
colonization.
Conclusions:
MDR bacterial colonization is frequent in patients admitted to ICU.
Colonization with MDR bacteria during hospitalisation in ICU in-
creased with the length of stay. Colonization could represent a risk
factor for increased rates of infection, especially with CBP-GNB and
VRE. Active surveillance program for indentification of MDR bacteria
colonized patients is necessary and useful.P413
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Introduction:
Sepsis due to Candida is an uncommon but a significant cause of death
in burns patients. Candida spp. represents the main cause of fungal
colonization in burned patients. The incidence of invasive candidiasis
occurs between 2 and 21% of burned patients, with an attributable
mortality between 30-90% and the incidence of candidaemia is around
3-5%. The aim was analyze the incidence, mortality and risk factors as-
sociated with the development of candidaemia in a population of
burned patients.
Methods:
A retrospective-observational study was conducted (2012-2019)
about all patients admitted to our Critical Care Burn Unit and had
any microbiological isolation by any Candida species. We collected:
demographic and epidemiological data, severity scores, characteris-
tics of burns, risk factors, organic supports, days of hospital stay and
mortality.
Results:
588 burned patients were admitted. 8 candidaemia were diagnosed: 5
C. albicans, 1 C. parapsilosis, 1 C. tropicalis, 1 C. glabrata. 5 patients were
colonized by yeasts in their burns. The candidaemia were treated em-
pirically with echinocandins. 84% of the patients the mechanism of the
burn was the flame. The medians were: age: 47 years; 6 men; TBSA:
42%; depth, 32%; ABSI: 8, APACHE-II: 18. The average hospital stay in
the ICU was 45 ± 9 days. All patients on mechanical ventilation at the
time of the diagnosis of candidaemia, and all of them also required nor-
epinephrine for septic shock. All had a central venous catheter, urinary
catheter, parenteral nutrition and broad-spectrum antibiotic therapy.
3 patients (38%) died, both with candidaemia due to C. albicans.
Conclusions:
Although the incidence of candidaemia in our population is very low,
almost half of the patients who develop it die during admission for
refractary septic shock. TBSA > 30%, multiple colonization by Can-
dida, parenteral nutrition, broad spectrum antibiotic therapy, central
venous catheter and urinary catheterization continue to be the main
risk factors for opportunistic fungal infections.
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Introduction:
Influenza is an acute viral illness with a significant financial burden.
Point of care testing for influenza is available and has demonstrated
accuracy [1,2], the current gap in knowledge is the question around
the opportunity cost of influenza testing. If POCT is financially a less
costly test this could free up scarce resource.
Methods:
The study adopts a cost minimisation approach. The point of care
test is the Roche Cobas® Liat® machine which can detect flu A/B and
is compared with the West of Scotland Specialist Virology centre’s
established in house multiplex real time PCR assay.The model was
developed using Microsoft Excel and has 2 arms comparing analysis
of the above mentioned tests.
Results:
The model estimates that the total cost of POCT per patient tested is
£3926.33 compared with £4053.92 for lab testing (Figure 1). This is a
saving of £127.60 per patient when POCT is used. The result swings
in favour of the lab test when POCT specificity falls to 95.72%. If the
lab could provide the result of influenza testing within 12 hours the
result would swing in favour of lab testing. Zanamivir which will po-
tentially be used increasingly in the intensive care setting can more
than double the difference between the 2 tests in favour of POCT.
Conclusions:
This research suggests that POCT offers potential cost savings in the
ICU setting. This is the case as long as POCT specificity is higher than
a threshold of 97.52% and the lab take longer that 12 hours to return
the result. The sensitivity analysis should allow for external validity
given the usual variations in ICU practice.
References:
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2. Merckx J et al. Ann Intern Med 167:394-409, 2017Fig. 1 (abstract P414). Sensitivity analysis of the cost savings
associated with POCT vs. formal lab testing. This table highlights
what factors have the largest impact on cost between these
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Introduction:
The aim of this study was to compare factors associated with the ICU
mortality for VAP due to multidrug-resistant (MDR) Klebsiella spp. in
case of monobacterial (MO) vs polibacterial (PO) origin.
Methods:
Retrospective data analysis of patients treated in ICU with MDR Kleb-
siella spp. strains as pathogens of VAP during three year period was
carried out.
Results:
Data of 71 patients were evaluated. MO vs PO of MDR Klebsiella
spp. VAP cases was found to be 35 (49.3 %) vs 36 (50.7%), p =
0.906. The ICU mortality was 9/35 (25.7%) in MO, and 17/36 (47.2%)
in PO one, p = 0.060. Statistical significant differences of survivors vs
non-survivors in MO and PO VAP due to MDR Klebsiella spp. were
found in medians of neutrophilosis 78.1% (IQR 72.4 – 82.2) vs 84.2%
(IQR 79.7 – 93.3), p = 0.011 and 83.1% (IQR 80.0 – 86.2) vs 87.9% (IQR
83.0 – 89.3), p = 0.029; in proportions of septic shock on diagnosis
day 9/26 (34.6%) vs 8/9 (88.9%), p = 0.005 and 1/19 (5.3%) vs 6/
17 (35.3%), p = 0.023, renal failure 12/26 (46.2%) vs 8/9 (88.9%), p =
0.026 and 8/19 (42.1%) vs 13/17 (76.5%), p = 0.037. Differences were
found in proportions of severe hypoxaemia 1/26 (3.8%) vs 3/9
(33.3%), p = 0.044 only in MO VAP, and RRT 2/19 (10.5%) vs 7/
17 (41.2%), p = 0.034, also cardiovascular disease 9/19 (47.4%) vs 16/
17 (94.1%), p = 0.002 only in PO one.
Conclusions:
The ICU mortality was almost twice higher in polybacterial than
monobacterial origin of VAP due to MDR Klebsiella spp. Septic shock,
renal failure and neutrophilosis were found to be associated with the
ICU mortality in both mono/polybacterial origin; severity of hypox-
aemia in case of monobacterial, but comorbidities in polybacterial
onset.
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Introduction:
The aim of the study was to evaluate the antibacterial resistance of
multidrug-resistant (MDR) Klebsiella spp. isolates as pathogens of ven-
tilator-associated pneumonia (VAP) and to determinate predictors of
ICU mortality.
Methods:
Retrospective data analysis of patients (pt) treated in ICU with MDR
Klebsiella spp. strains as pathogens of VAP during three years period
was carried out.
Results:
Data of 71 pt were evaluated. All tested strains of MDR Klebsiella spp. were
resistant to ampicillin, piperacillin, cefuroxime. Resistance to amoxicillin/cla-
vulanate was 35/36 (97.2%), ampicillin/sulbactam and cefotaxime 70/71
(98.6%), piperacillin/tazobactam 43/71 (60.6%), meropenem and imipenem
0/71 (0%), ertapenem 2/30 (6.7%), amikacin 4/59 (6.8%), gentamicin 40/71
(56.3%), ciprofloxacin 51/68 (75.0%), cefoperazon/sulbactam14/45
Critical Care 2020, 24(Suppl 1):87 Page 172 of 213(31.1%).The ICUmortality was 26/71 (36.6%). Statistical significant differences
of survivors vs non-survivors were found in median of neutrophilosis on
diagnosis day 80.9% (IQR 72.6 -83.6) vs 87.5% (IQR 81.4 -9.7), p < 0.001,and
between proportions of septic shock on diagnosis day10 (22.2 %) vs 14
(53.8%), p = 0.007, renal failure 20 (44.4%) vs 21 (80.8%), p = 0.003, renal re-
placement therapy (RRT) 4 (8.9%) vs 10 (38.5%), p = 0.003, Charlson Comor-
bidity Index ≥ 5 – 15 (33% ) vs 15 (57.7%), p = 0.045, cardiovascular 28
(62.2%) vs 25 (96.2%), p = 0.002, kidney 4 (8.9%) vs 9 (34.6%), p = 0.007
and autoimmune 0 (0%) vs 5 (19.2%), p = 0.005 disease. Odds ratio (OR) for
ICU mortality for RRT was OR 4.64 (95% CI 1.16-18.62), for septic shock OR
4.01 (95% CI 1.17 -13.67), and for neutrophilosis OR 1.16 (95% CI 1.05 -1.28).
Conclusions:
VAP due to MDR Klebsiella spp. was associated with the high rate of
antibacterial resistance to aminopenicillins, 3rd generation of cepha-
losporins, fluoroquinalons, aminoglycosides, but carbapenems. The
ICU mortality was 36.6%. The RRT, septic shock and neutrophilosis on
diagnosis were predictorsfor ICU mortality in patients with VAP due
to MDR Klebsiella spp.
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Introduction:
It has been known about possibility of microorganisms to create spe-
cific multi-layered structures called biofilms. Non-cellular deoxyribo-
nucleic acid actively participates in regulation of properties of
biofilms. Thus, in biofilms transfer of genetic information including
genes responsible for sensitivity to antibacterial drugs occurs much
more often than in single-living bacterial cells. However, despite the
involvement of extracellular deoxyribonucleic acid in adhesive pro-
cesses and intercellular interactions, its role has not been fully
understood.
Methods:
238 isolates isolated from sputum and pharynx of 175 patients dur-
ing 2016-2019 were studied. Patients were divided into two groups:
the 1st group of 139 people (79,4%) had severe respiratory infec-
tions, the 2nd of 36 people (20,6%) - respiratory infections of moder-
ate severity.
Results:
A method was developed for determining percentage of deoxyribo-
nucleic acid in microbial community using 4'6-diamidino-2-phenylin-
dole dihydrochloride. Average age of the 1st group was higher than
the second (p<0.05). Pseudomonas aeruginosa had the largest mass
of biofilm and percentage of deoxyribonucleic acid in group 1, 48,25
[30.5-70.1] mcg/ml and 5.21 [2.17-7.67] %, p = 0.04. A strong relation-
ship was found between percentage of deoxyribonucleic acid in
Pseudomonas aeruginosa and severity of disease, r = 0.73, p<0.05.
The incidence of adverse outcomes in isolating antibiotic resistant
isolates was higher than in antibiotic sensitive (p<0.05). Analysis ofresults made it possible to propose fatal outcome when mass of mi-
crobial biofilm is > 47.5 mcg/well and percentage of deoxyribo-
nucleic acid is >2.33% (p<0.01).
Conclusions:
Pathogens with high biofilm weight and percent of deoxyribonucleic
acid cause disease progression and death.P418
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Introduction:
Implementation of rapid molecular blood culture diagnostics in the
clinical management of sepsis is essential in providing fast pathogen
identification and resistance gene testing.The Genmark ePlex blood
culture panels offer a broad antimicrobial spectrum with minimal
hands-on time and around 1.5h time to result. By implementing
ePlex analysis when the department of clinical microbiology is
closed, the test can be optimally used in terms of clinical impact and
costs.
Methods:
Prospective ePlex testing on consecutive non-duplicate positive
blood cultures, primarily from the emergency room, incubated at a
satellite incubator at the 24h/7day open department of Clinical
Chemistry. The routine bio-medical analysts performed the analyses.
The result, except findings of CoNS, was made available to the at-
tending physician. Cultures were transferred to the Department of
Clinical Microbiology for conventional diagnostics the next day. The
ePlex results were compared to conventional diagnostics for patho-
gen identification and time to result. The clinical impact was assessed
by investigation of the patients´medical records.
Results:
Forty-four cultures were analyzed with ePlex (Figure 1). Complete
agreement with conventional diagnostics was observed in 38/44
cases. No false-positive results were observed, yielding a sensitivity
and specificity of 90% and 100% respectively for target pathogens.
Time to result was, on average, 10.4 h faster with ePlex compared to
conventional diagnostics. Antimicrobial therapy could have been op-
timized in 5 patients based on the ePlex result, but treatment was
only changed in one case (E.coli CTX-M+) receiving meropenem 8.5
h before the antibiogram was available.
Conclusions:
The ePlex blood culture panels provide high accuracy and signifi-
cantly faster results. The current implementation offers substantial
potential value at a minimal cost, and is a feasible approach to 24-h/
7 days blood culture diagnostics in many hospital settings. However,
efforts to increase adherence are needed.
Fig. 1 (abstract P419). Clustered bar count of dominant
microorganisms causing ICU infections according to patient’s
Fig. 1 (abstract P418). Result of consecutive positive blood cultures
analyzed with ePlex
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Introduction:
Nosocomial infections caused by Klebsiella pneumoniae, Acinetobacter
baumannii and other gram-negative organisms have emerged as a
major health problem globallyespecially in intensive care units (ICU).
Continued surveillance and finding a suitable drug is of central prior-
ity. This study examines Klebsiella pneumoniae and other nosocomial
infections in the intensive care unit of Aseer Central Hospital, deter-
mines their antibiogram, and evaluates predictors of mortality.
Methods:
The present investigation was a retrospective cross-sectional study
based on data collected from patients in the intensive care unit (ICU)
of Aseer Central Hospital, Saudi Arabia (2018-2019). Demographic,
microbiologic, antimicrobial treatment and outcomes were collected
from 150 patients with bacteremia, pneumonia, and other infections.A total of 150 patients were included (2018, n= 68; 2019, n= 82).
Identification of isolates and in vitro susceptibilities were done by
Vitek 2 system. Collected data were analyzed by descriptive statistics
and regression models.
Results:
One hundred and fifty patients were included in our study (51 fe-
males and 99 males). The clinical specimens were mainly derived
from respiratory (60.0%), followed by blood (16.7%), urine (11.3%),
wound and skin swab (4.7%), CSF (2.7%), pus, discharge and swab
(2.7%), and abdominal fluid and aspirate ((2.7%). Mortality was 36.0%
(54/150*100); Klebsiella pneumoniae was responsible for 27 case (27/
54*100 = 50%). Acinetobacterspp. (35.2%) and Pseudomonas aerugi-
nosa (9.3%) infections while the remaining organisms accounted for
5.6%. The overall in vitroresistance was 49.5% and shown an increase
in 2019 (p <0.01) (fig 1).
Conclusions:
Half of the ICU mortalities were caused by K. pneumoniae . The fre-
quency of K. pneumoniae and its resistance to antimicrobials was
high and obviously rising as for other gram-negative bacteria. Our re-
sults suggest that attention should be paid to strengthen measures
for better infection control measures.P420
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Introduction:
Data on the outcomes of HIV infected intensive care unit (ICU) pa-
tients in developing countries is limited. There are more people living
with HIV in South Africa than any other country in the world. This
study aimed to describe the patterns of presentation as well as de-
termine factors that influences mortality in HIV infected patients at
an ICU facility in Johannesburg.
Methods:
Consecutive medical records of 204 HIV infected individuals admitted
to the Charlotte Maxeke Johannesburg Academic Hospital adult ICU
during 2017 were reviewed. Data was described and subjected to
univariate and multivariate analysis.
Results:
Of the 903 total admissions during the period analysed, 204
(22.6%) were HIV infected. Ninety-five (46.6%) patients were
Critical Care 2020, 24(Suppl 1):87 Page 174 of 213admitted for sepsis related illnesses, 69 (33.8%) for post-operative
care and 40 (19.6%) for non-sepsis related illnesses. HIV infected
patients had a median length of ICU stay of 5 (2-9) days and ICU
mortality of 33.3% (n=68). On multivariate analysis of significant
parameters identified from the univariate analysis, requirement
for inotropes/vasopressors (p=0.009), mechanical ventilation (p=
0.037) and a non-sepsis related diagnosis (p=0.030) were associ-
ated with an increase in ICU mortality. The Risk Adjusted Mortal-
ity Ratio (RAMR – observed ICU mortality rate/ APAHCE II
predicted ICU mortality rate) was 0.51, which indicates that the
APACHE II score overestimated ICU mortality in HIV infected pa-
tients by approximately two-fold.
Conclusions:
Inotrope/vasopressor administration, mechanical ventilation and a
non-sepsis related diagnosis is significantly associated with mortality
in HIV infected patients in the ICU. The APACHE II score overesti-
mates mortality in HIV infected ICU patients.P421
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Introduction:
The rapid increase of extended spectrum β-lactamases (ESBL)-pro-
ducing pathogens worldwide makes it difficult to choose appro-
priate antibiotics in patients with Gram-negative bacterial
infection. Cica-beta reagent (KANTO CHEMICAL, Tokyo, Japan) is a
chromogenic test to detect beta-lactamases such as ESBL from
bacterial colonies. The purpose of the study was to reveal
whether Cica-beta reagent could detect ESBL-producing patho-
gens directly from urine rather than bacterial colonies to make a
rapid bedside diagnosis of the antibiotic susceptibility of Gram-
negative pathogens.
Methods:
We conducted a prospective observational study from July 2019
to October 2019. Patients were eligible if they were performed
urinary culture tests and Gram negative pathogens were detected
at least 1+ from their urine samples. The urine sample was cen-
trifugated at 200 x g for 5min. The supernatant of sample was
re-centrifugated at 1500 x g for 5min and the pellet was mixed
with Cica-beta reagent. The test was considered positive when
the enzymatic reaction turned from yellow to red or orange. The
reference standard was the result of urine culture and the anti-
biotic susceptibility test according to Clinical and Laboratory Stan-
dards Institute.
Results:
We included 331 urine samples during the study period. One
hundred ninety eight patients diagnosed UTI among them. ESBL
producing Enterobacteriaceae was isolated from 73 samples. Cica-
beta reagent showed sensitivity of 79.5% and specificity of 99.2%
in patients with Gram-negative bacteriuria. Sensitivity and specifi-
city were improved 89.7% and 100%, respectively when it was
performed in patients with UTI.
Conclusions:
Cica-beta reagent would be an efficient test for the detection of ESBL
producing pathogens in urine. Because it could provide immediate
information about ESBL, it might be a point-of-care test to predict
causative pathogens and guide appropriate antibiotics in patients
with UTI.P422
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Introduction:
The increasing emergence and spread of drug-resistant pathogens
all over the world has become catastrophic world health problems.
In fact, we experienced an uncontrollable outbreak of multidrug-
resistant pathogens and ICU closure for 3 weeks in January 2013.
Based on the experience, we built an infection control bundle includ-
ing contact precautions for every patient in the ICU, carrying per-
sonal alcohol-based hand rubs, cohorting patients who acquired
drug-resistant pathogens, active surveillance cultures once a week,
and enhanced environmental disinfection in January 2013. The pur-
pose of this study is to evaluate the effectiveness of the systemic in-
fection control bundle approach against acquisition of drug-resistant
pathogens.
Methods:
This was a retrospective historical control study conducted from April
2008 to March 2019 in 18-bed ICU of a tertiary care hospital in Japan.
Every patient admitted to the ICU during the study period was eli-
gible. Patients were divided into 2 groups: Conventional (from April
2008 to December 2012) or Intervention (from January 2013 to
March 2019).The primary outcome was the number of hospital-
acquired MRSA. We defined hospital-acquisition as the isolation of
MRSA after 48 hours of hospitalisation.
Results:
A total of 13,047 patients were included during the study period.
There were 5,128 patients in the control group (39.3%) from 2008 to
2012 and 7,919 patients in the intervention group (61.7%) from 2013
to 2019. The hospital-acquisition of MRSA was observed 284 patients
(5.5%) in the control group and 150 patients (1.9%) in the interven-
tion group. The interrupted time-series analysis suggested that the
intervention was significantly associated with reduced hospital-
acquisition of MRSA [risk ratio, 0.342(95% confidence interval, 0.282-
0.416);< 0.01] (Fig.1).
Conclusions:
The Bundle approach could be an effective strategy to prevent
hospital-acquisition of drug-resistant pathogens in ICUs.Fig. 1 (abstract P422). Predicted trend of hospital-acquired MRSA
by interrupted time-series analysis
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Introduction:
In the ASPECT-NP trial, C/T was noninferior to MEM for the treatment
of HABP/VABP. We evaluated outcomes from that study in the sub-
group of pts failing current antibacterial therapy for HABP/VABP at
enrollment.
Methods:
ASPECT-NP was a randomized, controlled, double-blind, phase 3 trial
in which mechanically ventilated pts with HABP/VABP received 3 g
C/T or 1 g MEM every 8 h for 8-14 days. Pts with >24 h of active
gram-negative antibacterial therapy within 72 h prior to first dose of
study therapy were excluded, except those pts failing current treat-
ment (i.e. signs/symptoms of the current HABP/VABP were persist-
ing/worsening despite ≥48h of antibiotic treatment). Primary and key
secondary endpoints, respectively, were 28-day all-cause mortality
(ACM) and clinical response at test of cure (TOC; 7-14 days after end
of therapy) in the intent to treat (ITT) population. Pts failing current
antibacterial therapy for HABP/VABP were prospectively categorized
as a clinically relevant subgroup.
Results:
At baseline, failing current therapy for HABP/VABP was reported in
53/362 (15%) C/T and 40/364 (11%) MEM ITT pts, mostly piperacillin/
tazobactam (34%), 3rd/4th-generation cephalosporins (31%), fluoro-
quinolones (29%), and aminoglycosides (12%). Baseline demographic
and clinical characteristics in this subgroup, including prior therapy
regimen, were generally similar between treatment arms. There were
greater proportions of patients with ESBL+ Enterobacterales (30%)
and Pseudomonas aeruginosa (25%) in the C/T arm than the MEM
arm (20% and 13%, respectively). Lower 28-day ACM was seen with
C/T than MEM, as evidenced by 95% confidence intervals for treat-
ment differences that excluded zero (Figure 1); statistical significance
cannot be assumed because subgroup analyses in this study were
not corrected for multiplicity.
Conclusions:
C/T was an effective treatment for HABP/VABP pts who had failed ini-
tial therapy.Fig. 1 (abstract P423). Efficacy outcomes in patients who were
failing current therapy for HABP/VABP at baselineP424
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Introduction:
Catheter-related blood stream infection (CRBSI) is common serious
infections and associated with increased mortality in intensive care
units (ICU). One of the most important strategy to prevent CRBSI is
to minimize the duration of central venous catheterization. We built
a medical team consisting of doctors, nurses and pharmacists in ICU
to discuss whether patients needed central venous catheter (CVC) in
terms of monitoring hemodynamics and administering drugs, and
recommend catheter removal to attending physicians every day in
April 2019. The purpose of this study is to evaluate whether our
team-based approach could shorten the total duration of
catheterization and reduce CRBSI.
Methods:
This was a retrospective historical control study conducted from April
2018 to October 2019 in the ICU of a tertiary care hospital in Japan.
Every patient admitted to the ICU during the study period was eli-
gible if they were inserted CVC. Patients were divided into 2 groups:
Conventional (from April 2018 to March 2019) or Intervention (from
April 2019 to October 2019). We set the primary endpoint as onset
of CRBSI. The secondary endpoints included the duration of central
venous catheterization, the length of ICU stay and hospital mortality.
CRBSI was defined as bloodstream infection in patients with CVC, not
related to another site.
Results:
We included 428 patients: 259 in the Conventional group and 169 in
the Intervention group. The reduced, though nonsignificant, ten-
dency of CRBSI was observed in the Intervention group [hazard ratio,
0.341(95% confidence interval, 0.074-1.557; p = 0.213)]. The Interven-
tion group was significantly associated with reduced duration of cen-
tral venous catheterization (5 days vs 7 days; p < 0.01). No difference
was observed in the length of ICU stay and in-hospital mortality be-
tween groups.
Conclusions:
The team-based approach to assess CVC necessity could shorten the
duration of central venous catheterization and might reduce CRBSI.P425
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Introduction:
Empiric antibiotic therapy decisions are based upon a combined pre-
diction of infecting pathogen and local antibiotic susceptibility,
adapted to patients’ characteristics. The objective of this study was
to describe the pathogen predominance and to evaluate the prob-
ability of covering the most common Gram-negative pathogens in
ICU patients with respiratory infections.
Methods:
Data were collected from multiple US and European hospitals as part
of the SMART Surveillance Program (2018). MIC (mg/L) testing was
performed by broth microdilution, with susceptibility defined as fol-
lows for P. aeruginosa & Enterobacterales: ceftolozane/tazobactam
Critical Care 2020, 24(Suppl 1):87 Page 176 of 213MIC ≤4 & ≤2; piperacillin/tazobactam MIC ≤16 & ≤8; meropenem MIC
≤2 & ≤1; ceftazidime MIC ≤8 & ≤8, respectively.
Results:
78 hospitals from 24 countries provided 3384 Gram-negative respira-
tory isolates from patients located in an ICU in the US (22%), Eastern
Europe (40%) and Western Europe (38%) in 2018. The 4 most com-
mon pathogens isolated were P. aeruginosa (26%), K. pneumoniae
(15%), E. coli (13%), and A. baumannii (10%). Among Enterobacter-
ales, 30% (588/1955) were ESBL positive. Figure 1 provides the prob-
ability of covering the most common respiratory Gram-negative
pathogens from ICU patients. Co-resistance between commonly pre-
scribed first line β-lactam antibiotics is common: when non-
susceptibility (NS) of one agent was present, susceptibility to other β-
lactams was generally <35%. Ceftolozane/tazobactam provided the
most reliable in vitro activity in both empiric and adjustment pre-
scribing scenarios compared to other β-lactam antibiotics.
Conclusions:
Ceftolozane/tazobactam ensured a wide coverage of the most com-
mon Gram-negative respiratory pathogens demonstrating high sus-
ceptibility levels and provided the most reliable in vitro activity in
both empiric and adjustment antibiotic prescribing scenarios. Further
studies are needed to define the clinical benefits that may translate
from these findings.Fig. 1 (abstract P425). Probability of covering the most common
respiratory Gram-negative pathogens from ICU patientsP426
Evaluation of compliance of ICU staff for VAP prevention strategies
on the outcome of patients
A Kaur
Fortis Hospital, Critical Care, Mohali, India
Critical Care 2020, 24(Suppl 1):P426
Introduction:
Ventilator-associated pneumonia is the most common nosocomial in-
fection diagnosed in adult critical care units. It is associated with pro-
longed duration of mechanical ventilation, increased ICU stay and
increased mortality. It continues to be a major challenge to the crit-
ical care physicians despite advances in diagnostic and treatment
modalities. The primary objective of the study was to determine the
compliance of ICU staff towards VAP prevention bundle and second-
ary objective was to determine the incidence, risk factors and out-
come of VAP patients.
Methods:
Single center, prospective, observational study carried out from Feb-
ruary 2017 to July 2018. Patients mechanically ventilated for more
than 48 hours and satisfying the inclusion and exclusion criteria were
enrolled in the study. VAP was diagnosed using the CDC criteria and
clinical pulmonary infection score. VAP preventive strategies were
employed and compliance of ICU staff was assessed.
Results:
A total of 1617 patients were admitted to ICU over the set time
period and out of them 483 patients were ventilated for more than
48 hours. Among them only 166 patients fulfilled the inclusion and
exclusion criteria and were enrolled in the present study. Excellent
compliance was observed in head end elevation, sedation vacation,stress ulcer prophylaxis, and heat moist exchanger filter use, good
compliance in oral care and hand hygiene and moderate to poor
compliance in subglottic suctioning. The incidence of VAP was 24.7%
with a VAP rate of 30.87/1000 ventilator days. There was a significant
correlation between primary diagnosis, hemodialysis, massive blood
transfusion and development of VAP (p<0.05)). Mean duration of
ventilation (p<0.001) and mortality (p<0.05) were highly significant in
VAP patients.
Conclusions:
Improvement in compliance towards VAP bundle and reduction of
risk factors can help decrease incidence of VAP and related morbidity
and mortality.
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Introduction:
Preventive strategies are effective in reducing ventilation-associated
pneumonia (VAP) in adults [1, 2]. In paediatric population there are
no data about VAP prevention, so we introduced a new bundle
(VAP-p) based on the available evidence for adults.
Methods:
This was designed as a before-after study. We enrolled all patients
admitted to 8-bed medical-surgical paediatric ICU at Gemelli Hospital
in Rome, requiring mechanical ventilation for at least 48 hours. Pa-
tients with pre-existing tracheostomy were excluded. VAP-p has been
introduced since 2018 in order to improve quality of assistance. Our
bundle consisted in twice a day oral hygiene with chlorhexidine
swab, daily check of oral bacterial colonization and aspiration pre-
vention. Comparison was made with an historical group including
patients admitted before VAP-p introduction (since 2016 to 2017). All
data about demographics, antimicrobial therapy, ICU stay and treat-
ments, were collected.
Results:
162 patients were included (82 after and 80 before VAP-p introduc-
tion). 5(6%) events of VAP were recorded in VAP-p group compared
to 16 (20%, p=0.01) VAP-p group had less VAP per days of mechan-
ical ventilation (1/100 compared to 3.3/100 p=0.01). Multivariate ana-
lysis yielded an OR of 0.23 (95%CI 0.07-0.81) for VAP incidence after
bundle introduction. Mortality rate was slightly reduced in VAP-p
group (2.4%vs 6.2% p=ns). Patients who developed VAP required
more days on mechanical ventilation and had higher mortality rate
(12 vs 5 days p<0.001 and 14%vs 3% p=0.047, respectively).
Conclusions:
Our VAP-p seems effective in reducing VAP incidence in critically ill
paediatric population.
References:
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The aim of the present study is to describe the demographic, clinical,
microbiological aspects and the outcome of patients with intensive
care unit-related (ICU-related) bacteremia. Moreover, we aimed to
study the patient outcome in association with colistin susceptibility.
Methods:
Retrospective, single-center study in a 16-bed ICU for 12 months,
from 1/10/2018 to 30/9/2019. ICU-related bacteremia was defined as
bacteremia in patients with ICU stay >48 hours or ICU readmission
(first admission ≥ 1 month before). Only the first episode of
bacteremia was considered. The primary outcome was 28-day mor-
tality. Data regarding clinical, demographic and outcome characteris-
tics were retrieved from the patient files. The hospital’s ethics
committee approved the present protocol. Moreover, the patients
with bacteremia due to colistin-resistant pathogens were compared
with the patients affected by colistin sensitive microbes.
Results:
Forty episodes of Gram-negative ICU bacteremia were collected dur-
ing the aforementioned period in 40 patients (61.5% male) with a
mean age and APACHE II of 60.6±16.8 years and 18±8.1, respectively.
The event had taken place at an average of 13.7 days. The respon-
sible isolates were resistant to carbapenems in 82.5% of the epi-
sodes. The majority of the events were due to a single isolate
(85%). Acinetobacter baumannii and Klebsiella pneumoniae presented
the majority of the implicated microbes (35% and 37.5%, respect-
ively). The crude 28-day mortality was 30%. Finally, we could not de-
tect any difference in mortality between the colistin sensitive and
the colistin-resistant pathogens (Figure 1).
Conclusions:
The present study denotes that, in a setting of extremely drug-
resistant pathogens with limited treatment options, Gram-negative
bacteremia in the ICU is associated with increased mortality.
Image 1 :Fig. 1 (abstract P429). Kaplan-Meier survival curve (Black solid and
blue dashed line present patients with colistin sensitive and colistin
resistant pathogens, respectively)P430
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Introduction:
We study the population structure and resistome of MDR Enterobac-
terales and Pseudomonas aeruginosa isolates, C/T-susceptible or -re-
sistant, recovered from low respiratory, intraabdominal and urinary
tract infections of ICU patients of 11 Portuguese Hospitals (STEP
study, 2016-2017).
Methods:
MICs were determined (ISO-broth microdilution, EUCAST) and 30
Escherichia coli, 79 Klebsiella spp. and 42 P. aeruginosa isolates were
selected for Whole Genome Sequencing (Illumina-NovaSeq 6000,
OGC, UK). Assembly (SPAdes), annotation (Prokka) and in silico MLST
were performed. Resistance genes were identified (Abricate). E. coli
phylogroup (ClermonTyping), serotypes (SerotypeFinder) and fimH-
types (FimTyper) were determined. Klebsiella spp. capsule (K) and LPS
(O) serotype were predicted (Kleborate). P. aeruginosa O-specific anti-
gen was identified (Blastn).
Results:
In E. coli, two VIM-2 producers were found (ST131-B2-H30-O25:H4-
CTX-M-15 and ST88-C-H39-O22:H4) (C/T-MIC=0.5/4-1/4 mg/L). A KPC-
3-ST5463-cladeV-H160-O164:H56 (16/4 mg/L) was also detected. The
most frequent ESBL-E. coli clone was ST131-B2-H30-O25:H4 (n=14)
(0.25/4-1/4 mg/L), related to CTX-M-15 (10/14) or CTX-M-27 (4/14).
Ninety-five percent of carbapenemase-Klebsiella isolates (n=21) were
C/T resistant (2/4->64/4 mg/L). KPC-3-ST13-KL3-O1v2 (n=5), KPC-3-
ST5-KL112-O1v1 (n=2), KPC-3-ST231-KL51-O1v2 (n=2), OXA-181-ST17-
KL25-O5 (n=2) and OXA-48-ST215-KL16-O1v1 (n=2) were the most
frequent clones. A high diversity was found in ESBL (n=41) and non-
ESBL (n=17) strains (0.5/4->64/4 mg/L). In P. aeruginosa, the most fre-
quent clone was GES-13-ST235-O11 (n=13) (32/4->64/4 mg/L). VIM-2
was found in ST244-O5 and ST179-O6 (>64/4 mg/L) and KPC-3 in
ST499-O1 and ST253-O12 (1/4 mg/L). A high clonal diversity was
found in non-carbapenemase producers (0.5/4-4/4 mg/L).
Conclusions:
Carbapenemase genes are not always associated with C/T resistance
in Enterobacterales and P. aeruginosa, but other mechanisms might
be involved.
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Fig. 1 (abstract P432). Patient PK/PD measurements
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Clostridium difficile infection (CDI) is the main cause of hospital ac-
quired diarrhoea [1]. The aim of this study was to compare character-
istics of CDI during yr 2011 and 2015.
Methods:
A retrospective observational study was carried out in Lithuanian
University of Health Sciences hospital - the largest teaching facility of
tertiary care in country. According to Department of infection control
records, patients (pt) with (w.) diarrhoea and the first positive stool
test for C.difficile toxin A/B were included. Age, Charlson Comorbidity
Index (CCI) score, profile of hospital department (medical (MD), surgi-
cal or ICU) where CDI was diagnosed, type of CDI (healthcare-associ-
ated (HA), hospital or community-acquired) and rate of risk factors
(RF) have been estimated in both 2011 and 2015. IBM SPSS 23.0;
Pearson’s Chi-square, Fisher’s exact tests were used for statistics. P <
0.05 was statistically significant.
Results:
In total 7 pt from 2011, 72 from 2015 were enrolled. In 2011 n=4
(57%) pt were ≥65 yr old, in 2015 - n=45 (63%), (p=0.045). In 2011
CCI>5 was estimated in n=6 (86%) pt in comparison of n=46 (64%)
in 2015, (p=0.025). In 2011 n=0 (0%) of CDI cases were HA, in 2015 –
n=12 (17%), (p=0.01). In 2011 n=5 (71%) of CDI were diagnosed in
MD in comparison of n=60 (83%) in 2015, (p=0.01). In 2011 12 weeks
prior to CDI n=5 (71%) pt have been admitted to hospitals, n=7
(100%) have been treated w. antibiotics, n=4 (50%) - w. PPIs, n=5
(36%) - w. H2 antagonists, n=3 (43%) - w. immunosupressants in
comparison of n=51 (71%), n=69 (96%), n=36 (57%), n=26 (71%) and
n=21 (29%) in 2015, respectively, (p>0.05).
Conclusions:
Overall rate of CDI cases among in-hospital patients increased ten-
fold by yr 2011 and 2015. In 2015, more elderly patients had CDI and
severe comorbidities were less frequent in comparison with 2011. In
2015, more cases of CDI were hospital-acquired and have occured in
medical departments. Rate of risk factors of CDI remained
unchanged.
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Introduction:
Ceftolozane/Tazobactam (C/T) is a new antibiotic against MDR Gram-
negative bacteria infections, whose target population are the critic-
ally ill patients. Even though 2/1 g dose safety administered as a 3-
hour-infusion has been already assessed, these patients can be under
renal replacement therapy (RRT) and suffer changes in their volume
of distribution (Vd) that may affect antibiotic concentrations.
Methods:
The objective was to determine concentration reached by 3g C/T (3-
hour infusion) in septic patients on RRT (CVVHDF) and interdose be-
havior. We have used RRT machine PRISMAFLEX with Oxyris filter
and M100. HPLC-UV method was used for simultaneous quantifica-
tion of C/T. Study population consisted of three obese critically ill pa-
tients with sepsis, on CVVHDF while receiving 3g C/T every 8 hours.
Samples were taken of prefilter, post filter blood and effluent, 30 min
before infusion and 1, 2 and 4 hours after the end of it.
Results:
We found great interpatient variability with the lowest C-
concentration values in the patient with more hemodynamic instabil-
ity using Oxyris filter. Even though Cmax was less than reported inhealthy subjects, we found similar values of AUC and t ½ in compari-
son with healthy population studies. Cmax of T was also compro-
mised in comparison with values reported in healthy subjects, but
with higher AUC and t ½. CVVHDF contributes to C/T clearance.
M100 filter showed the least clearance and higher values of AUC and
t ½. Extraction rate was similar in all patients and filters (Figure 1).
Conclusions:
Cmax achieved may be impaired because of the varying Vd caused by
obesity and RRT, but not affecting the antibiotic characteristics and be-
haviour. We conclude that because of the variety of clinical conditions,
C-concentration is compromised particularly in hemodynamically un-
stable patients. However, the small sample doesn´t let us extrapolate
these results. The extended infusion seems to be adequate to achieve
the interdose antibiotic concentration.P433
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Introduction:
The use of biomarkers in sepsis is useful for early diagnosis and prog-
nosis. The desired marker should be sensitive, specific, fast and ac-
curate. Procalcitonin (PCT) measurement is approved by the FDA
even its efficacy is still under question. The determination of alfator-
quetenovirus (TTV) could be a useful marker [1].
Methods:
We analyzed 55 samples from 23 patients admitted to ICU with clin-
ical suspicion of sepsis. Analytical data of C-reactive protein (CRP),
neutrophils and procalcitonin were collected. The SOFA and APACHE
II scales were calculated and patients stratified according to these
values in good and poor prognosis. TTV quantitative determination
was carried by using a quantitative CRP2. We calculated area under
the curve (AUC) of TTV plasma levels as a function of time. The statis-
tical analysis involved U-Mann-Whitney and Spearman test, using
Chi2 for qualitative variables.
Results:
Results showed a not significant (NS) inverse relationship between
the TTV AUC and the patient proinflammatory level. A tendency (NS)
was found between poor prognosis and the PCT median values and
CRP being higher in the poor prognosis.group. A trend showed lower
TTV DNA count related to worse prognosis. An inverse relationship
was found between PCT and CRP values and the TTV copies /ml
plasma, NS correlation in the case of PCT. There was a clear trend be-
tween the neutrophils´ expansion and the regression line slope, ob-
tained between TTV loads in the first two study steps.
Critical Care 2020, 24(Suppl 1):87 Page 179 of 213These results indicate a possible relationship between TTV DNA
count and immunological alteration.
Conclusions:
The TTV quantitative determination could be useful as a proinflam-
matory marker in sepsis, with some benefits: low cost, easy determin-
ation and good correlation with immune system functionalit. It will
be necessary to perform a larger study to check our hypothesis and
to establish a TTV level threshold that may allow to anticípate the
disease prognosis.
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Introduction:
Acute kidney injury (AKI) is a serious complication in sepsis and asso-
ciated with high morbidity and mortality. The combination antimicro-
bial regimens with vancomycin (VCM) and broad-spectrum beta-
lactams (BSBL), such as piperacillin tazobactam and cefepime, have
been identified as potentially nephrotoxic combinations, but existing
studies have not provided sufficient evidence. The aim of this study
was to evaluate detailed association between the combination anti-
microbial therapy and the risk of AKI in septic patients.
Methods:
This investigation was a post hoc analysis of 2 prospective nation-
wide cohorts enrolling consecutive adult patients with sepsis in in-
tensive care units in Japan. In this study, progression of AKI was
defined as one or more elevation of renal sub-score in Sequential
Organ Failure Assessment score from day 1 to day 4. We regarded
anti-pseudomonal penicillins, fourth generation cephalosporines, and
carbapenems as BSBL. Multivariable logistic regression analysis in-
cluding a two-way interaction term (VCM x BSBL) was performed to
assess the add-on effects of each antimicrobial agent on the progres-
sion of AKI.
Results:
The final study cohort comprised 1837 patients with sepsis. Among
them, 45 received VCM without BSBL, 1055 received BSBL without
VCM, 249 received both VCM and BSBL, and 488 received other type
of antimicrobials. The administration of VCM was associated with an
increased risk of AKI in patients with BSBL [odds ratio (OR), 1.57
(0.96-2.57); p=0.072]. However, the tendency was not evident in pa-
tients without BSBL [OR, 0.23 (0.03-1.56); p=0.133]. The interaction ef-
fect on the progression of AKI between VCM and BSBL were
statistically significant (p for interaction=0.038).
Conclusions:
The regression model including two-way interaction term suggested
that the combination of VCM and BSBL might synergistically increase
the risk of AKI in patients with sepsis.
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Introduction:
Increasing resistance to carbapenems due to carbapenemase produc-
tion – one of main actual problems of antibacterial resistance in burnICU. Production of several types of carbapenemases (KPC, NDM and
OXA-48) is common in K. pneumoniae strains. Carbapemenase pro-
duction is a marker of extreme antibacterial resistance. The aim of
our study was to investigate the epidemiology of nosocomial infec-
tions caused by producing KPC, NDM and OXA-48 K. pneumonia
strains in burn ICU.
Methods:
Total of 26 patients with nosocomial infections caused by 26 carba-
penem resistance strains of K. pneumoniae were included in the
study, from whom 3 had lower respiratory tract infection, 23 had skin
and skin structure infection. Initial identification of isolates was per-
formed in laboratory by automatic microbiological analyzer. For all of
K. pneumoniae isolates presence of blaNDM, blaOXA-48 and blaKPC –
genes were examined by PCR method.
Results:
Baseline characteristics of patients: Me (IQR) of age – 50 (39; 64)
years, Me (IQR) of TBSA – 40 (29; 52) percent, Me (IQR) of ICU LOS –
30 (21; 35) days. Inhalation injury was diagnosed in 10 (38.4%) pa-
tients. Total of 11 patients died, mortality rate was 42.3%. All patients
were diagnosed with nosocomial infection caused by K. pneumoniae.
From 26 K. pneumonia strains 1 (3.8%) were found to be producing
KPC, 3 (11.5%) – producing NDM and 20 (76.9%) –producing OXA48.
Only 5 (19.2%) carbapenem resistance K. pneumoniae isolates were
not producing carbapenemases. From 20 patients infected by OXA48
producing K. pneumoniae 20 patients died, mortality rate was 40%.
From 23 patients infected by OXA48 or NDM producing K. pneumo-
niae 10 patients died, mortality rate was 43.5%. From 5 patients in-
fected by non-carbapenemase producing K. pneumonia no one died.
Conclusions:
Carbapenemase producing strains are widely spread among carba-
penem resistance strains of K. pneumoniae in burn ICU. Mortality of
patients infected by producing OXA48 or NDM K. pneumoniae strains
reaches 43.5%.
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Introduction:
The rationale for blood purification as adjunctive therapy during sep-
sis involved the capacity in removing endogenous and exogenous
toxins, but currently no recommendations exists [1]. A critical point
may be the potential interaction with antimicrobial therapy, which
remains the mainstay of sepsis treatment. The aim of our study was
to investigate the vancomycin (VAN) removal during blood purifica-
tion using an in vitro model of hemoperfusion (HP) with HA330 cart-
ridge (Jafron, Zhuhai City, China), most widely used in China and
actually available in Europe.
Methods:
This is an experimental study. Three independent experiments were
performed: we injected 250 mg of VAN in 500ml of whole blood
from healthy donors (experiment 1 and 2) or in 500ml of balanced
solution (experiment 3) in order to assess membrane saturation. A
closed-circuit (blood flow of 250ml/min) simulating HP ran using
HA330. Samples were collected from arterial line at 0, 5, 10, 15, 30,
45, 60, 90, 120 minutes; VAN plasma concentrations were measured
and removal was evaluated using mass balance analysis. Differences
in mass removal was assessed using Kruskal-Wallis test.
Results:
Figure 1 shows VAN mass at each timepoints. We observed no differ-
ence between in blood and in balanced solution experiments (p-
Critical Care 2020, 24(Suppl 1):87 Page 180 of 213value>0.05), suggesting that the adsorptive mechanism wasn't pri-
marily mediated by plasma protein. HA330 was saturated after ad-
sorption of a total of 280.28±12.33 mg of VAN. The adsorptive
kinetics showed an exponential reduction of VAN mass that reached
a plateau after 30 minutes of circulation.
Conclusions:
In our study, simulating in vivo conditions of HP using HA330 during
sepsis, a rapid and clinically relevant removal of VAN has been
shown. After 2 hours of HP, we suggest to assess VAN plasma con-
centration and a loading dose of VAN should be considered. How-
ever, not knowing the potential interactions with other drugs, further
in vivo studies are warranted to confirm these findings.
References:
1. Rhodes A et al. Crit Care Med 45:486-552. 2017Fig. 1 (abstract 436). Vancomycin mass removal over 120 minutes
of hemoperfusion using HA330. Bars refer to vancomycin mass (mg):
blue (experiment 1) and red (experiment2) bars using blood while
green (experiment 3) bar using balanced solution. Yellow dashes are
mean mass values of the three experiments (with standard
deviations) and yellow line represents the reduction curve over time
Table 1 (abstract P438). Results. * p-value versus non-ESKAPE
Subgroup Mechanical
ventilation, days*
AMT, days* ICU LOS,
days*
Hospital LOS,
days*
non-ESKAPE 5 (0-15) 11.5 (7-20) 12 (5-22) 30 (17-55)
ESKAPE 7.5 (2-24) р=0.002 12 (8-21)
р=0.162
15 (7-28.5)
р=0.019
32 (20-57) р=
0.247
CPR
Kl.pneumoniae
7.5 (2-26) р=0.043 12 (9-28)
р=0.286
15 (8-27) р=
0.169
31 (21.5-58)
р=0.481
MDR
Ps.aeruginosa
11 (6-27) р=0.023 14 (8-21)
р=0.279
18 (8-30) р=
0.099
32.5 (15-49)
р=0.717
Candida spp. 12.5 (2-41) р=0.023 - 19.5 (9-41)
р=0.03
44.5 (18-75)
р=0.263P437
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Introduction:
The aim of this study is to determine if routine BBV testing in the
ICU contributes to the discovery of undiagnosed BBV infections. ICU
patients may require renal replacement therapy (RRT). Sharing RRT
equipment carries a risk of BBV transmission, which mainly relates to
Hepatitis B (HBV), Hepatitis C (HCV) and HIV. Since 2012, all Glasgow
Royal Infirmary ICU patients undergo routine BBV screening, with RRT
machines allocated for patients with specific BBV statuses. Routine
BBV testing is beneficial to both the individual and society. HCV is a
pertinent health issue in Scotland. The Scottish government aims to
eliminate HCV by 2030 and is researching innovative and cost-
effective methods to identify undiagnosed infections.
Methods:
This single-centre retrospective observational study examined pro-
spectively collected clinical data from 1069 ICU admissions. Propor-
tions were compared using a two-proportion z-test and a logistic
regression model was carried out to determine if deprivation quintile
was independently associated with the seroprevalence of BBVs.
Results:
The BBV seroprevalence in the cohort studied: 0.45% (HBV), 11.7%
(HCV), 0.91% (HIV). The seroprevalence of HBV in the cohort studied
was similar to that of Scotland (p=0.11), but the seroprevalence of
HCV (p<0.001) and HIV (p=0.01) were statistically significantly higher
than that of Scotland. Due to the small number of reactive testresults for HBV and HIV, the relationship between deprivation and
BBV seroprevalence was explored for HCV only. The only independ-
ent variable associated with a reactive anti-HCV test result was
“current or previous illicit drug use” (adjusted odds ratio of 40.2; 95%
confidence interval of 21.1-76.4; p<0.001).
Conclusions:
This study shows that routine BBV testing in the ICU is useful in dis-
covering new BBV infections. This is the first observational study fo-
cusing on the value of routine BBV testing in an ICU setting to our
knowledge.P438
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Introduction:
It was shown that bacteremia in ICU patient with infection of differ-
ent localization becomes an independent risk factor for adverse out-
come, but it remains unclear how clinical outcome of bacteremia
depends on causative pathogen and its features. The aim of the
study was to compare mortality rate and clinical outcomes of ICU pa-
tients with bacteremia complicated infections according to pathogen
and its properties.
Methods:
We conducted a retrospective cohort study from January 2011 to De-
cember 2017 in four general ICUs of a multidisciplinary hospital.
7560 patients were screened, 374 patients with infection complicated
by bacteremia were included in the study. The average age was 61±
14.5 years, male 63.1%, APACHE2 score 16 (11-21), SOFA 5 (2-7). Ac-
cording to the causative agent the cohort was divided into sub-
groups: ESKAPE (136 patients), MDR Pseudomonas aeruginosa (18
patients), CPR Klebsiella pneumoniae (32 patients), Candida spp.
(21 patients). The comparison subgroup consisted of 217 patients
with bacteremia caused by non-ESCAPE pathogens. We evaluated
the days of mechanical ventilation, duration of antibiotic therapy
(AMT), ICU length of stay (LOS), hospital LOS and mortality (Table 1).
Results:
Mortality in patients with bacteremia caused by non-ESKAPE patho-
gens was 23.5%, Candida spp. – 42.9% (p=0.052), in MDR Ps.aerugi-
nosa subgroup – 44.4% (p=0.084), ESKAPE – 50.7% (p<0.0001), CPR
Kl.pneumoniae – 68.75% (p<0.0001).
Conclusions:
Bacteremia caused by CPR Klebsiella pneumoniae or all ESKAPE
group pathogens, as well as candidemia, caused by Candida spp. sig-
nificantly worsens the clinical outcomes and increases mortality of
ICU patients.
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Introduction:
It is commonly accepted that larger blood culture (BC) volumes (BCV)
increase the yield of true positive cultures, and optimally 20 cc of
blood should be obtained per set (2 bottles). Only scarce data exists
on the matter of optimal BCV. It is unknown what is the minimal vol-
ume that is acceptable for BC. The objective of this study was to de-
termine the association between BCV and the rate of positive BC.
Methods:
Blood taken for cultures in BD BACTEC Plus Aerobic/F negative bot-
tles was collected from ICUs and acute care floors at 8 hospitals at
the DMC over 6 months. Blood volume was estimated automatically
from blood background signal data in the BD BACTEC FX instrument.
Cultures were analyzed for each bottle. Data was summarized for
every month as the average volume and number of cultures taken
and rate of positive BC for every unit. Units were classified according
to unit type (ICU, Medicine, Surgery, Mixed, Emergency Department
(ED), Organ/BMT or "other" which did not fit the previous categories)
and analyzed as a group.
Results:
A total of 23795 cultures were taken in 84 units. There is a positive
association between BV and positive BC rate for ED and “other” units
(IRR=1.27, p=0.006 for the ED, IRR=5.00, p<0.001 for “other” unit). All
other units had no association between BV and positive BC rate (Fig-
ure 1). Secondary analysis, excluding Pediatric units, gave very similar
results. When comparing BV between unit types, the ED and “other”
unit had significantly lower BV (2.4 ml in the ED and 3.5 ml in “other”
unit compared to 4.9 ml in the ICU, 4.7 ml in surgery, 4.2 ml in mixed
and 7.7 ml in BMT).
Conclusions:
The correlation between BV and positive BC rate is probably limited
to units taking very low BV for cultures. Units taking volumes above
4 ml show no improvement in positive BC rate when higher volumes
are taken. Better prospective studies should be done to further es-
tablish the minimal BCV needed and spare unnecessary blood loss to
hospitalized patients without compromising BC yield.Fig. 1 (abstract P439). Correlation of blood culture positivity rate
with blood culture volume by unit typeP440
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Introduction:
In septic patients, the early use of appropriate empiric antibiotic ther-
apy reduces morbidity and mortality. De-escalation refers to narrowing
the broad-spectrum antibiotics once the pathogen and sensitivities are
known. T2 Magnetic Resonance (T2MR) is a novel method of detecting
ESKAPE pathogens. We aim at investigating if using T2MR technology
can expedite de-escalation of broad spectrum antibiotics.
Methods:
This is a prospective observational study conducted in our 35-bed
university ICU. Inclusion criteria were critically ill patients age>18 y.o.,
with newly diagnosed sepsis and clinical suspicion of ESKAPE blood-
stream infection. A sample for T2MR and a blood culture (BC) sample
were collected simultaneously from the patients enrolled. The T2MR
Bacteria panel test was run according to the manufacturer’s guide-
lines and the BCs were processed according to the hospital standard
procedures. We recorded clinical data and administered antibiotics.
Results:
26 patients were included in the study. Mean time to culture positiv-
ity was 84 hours while mean time to T2MR result was 3.5 hours. In
20 patients the results of T2MR were in concordance with the BCs. In
the remaining 6 cases, the BCs were negative while the T2 MR de-
tected one or more ESKAPE pathogens. There were no false negative
results. De-escalation in at least one drug was applied to 8 patients
(30.8%). No escalation was applied to 15 patients (57.7%) and anti-
biotic escalation in 3 (11.5%).
Conclusions:
T2MR provides a quicker detection time that could shorten the time
to targeted therapy. In our population this corresponded to early
(within 6-12h) antibiotic de-escalation in approximately 1/3 of the in-
cluded patients.
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Introduction:
The increasing antibiotic resistance in microorganisms urged interven-
tions such as the antibiotic stewardship programs in ICU focused on re-
ducing the inappropriate use of antibiotics by improving the antibiotic
selection, the dosage, administration route and length as well as im-
proving clinical outcomes and reducing antibiotic resistance.
Methods:
Retrospective study where antibiotic consumption was analysed and
measured in days of therapy (DOTs) between 2015 and 2018 in a
medical-surgical ICU of a university hospital where a multimodal edu-
cational program was established. Specific training in infectious dis-
eases in critically ill patients, periodic clinical and formative sessions
Table 1 (abstract P442). Comparison of primary efficacy endpoint and
safety parameters between overall trial population and Indian subset of
patients
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designated.
Results:
4128 patients were admitted to ICU. There was a reduction of 20,5%
in DOTs (Figure 1), reduction in antimicrobial resistance rates (14,36
in 2015, 7,4 in 2018 [days of resistant microorganism/1000 patient-
days]) without an impact in ICU global mortality (19,7% in 2015,
19,4% in 2018). The resistant bacteria registered were Acinetobacter
baumannii, S. aureus MR, BLEE and carbapenemase-producing En-
terobacteriaceae, Pseudomonas aeruginosa MR and Clostridium diffi-
cile. The safe in antimicrobial consumption was 391500€ (70%
reduction). The ICU stay decreased from 8,2 days (2015) to 6,9 (2018),
with no variation in mean APACHE II (17,8). The bigger decrease in
antibiotic consumption was in Colistin related to the reduction in re-
sistance bacteria, in special Acinetobacter baumannii, in linezolid and
in piperacilin/tazobactam, even more remarkable in 2018 due to
shortage of supplies which meant an increase in meropenem.
Conclusions:
The application of an antibiotic stewardship program in ICU suc-
ceeded in reducing antibiotic consumption, antibiotic resistance and
costs without an impact in clinical outcomes like mortality or ICU
stay.Fig. 1 (abstract P441). Antibiotic consumption and general
epidemiology in ICU
Parameters Overall
Population
(n=258)
Overall
Population
(n=258)
Indian
Subset (n=
12)
Indian
Subset (n=
17)
All- cause mortality
(Day 42)
48 (19) 52 (20) 5 (41.6) 5 (29.4)
Adjusted Treatment
Difference
-1% 12.2%
TEAE leading to
treatment
discontinuation
37 (14) 59 (23) 2 (16.7) 4 (23.5)
Ocular toxicity 39 (15) 69 (27) 0 2 (11.8)
Skin and
Subcutaneous Tissue
disorder
86 (33) 110 (42) 1 (8.3) 1 (5.9)
Hepatobiliary disorder 23 (9) 42 (16) 0 1 (5.9)P442
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Introduction:
The SECURE trial was designed to compare the safety and efficacy of
Isavuconazole (A) versus Voriconazole (V) for primary treatment of in-
vasive mould disease caused by Aspergillus and other filamentous
fungi. The present analysis is aimed at comparing the Indian subset
of patients with that of the overall trial population and to ascertain
any similarity or difference in the primary efficacy endpoint and
safety/tolerability in these two groups.
Methods:
In SECURE trial, 258 patients in one group received (I) & another 258
patients received (V). The Indian subset had 29 patients. We have
done a qualitative analysis as the sample size of the Indian subset
was small. Non-inferiority of (I) to (V) in terms of all cause mortality
from first dose to day 42 was assessed in overall patients. The treat-
ment difference between (I) and (V) group in the Indian subset of pa-
tients was analyzed. Proportion of patients who had to discontinue
treatment due to TEAEs was analyzed.Results:
The all-cause mortality in the overall trial population met non-
inferiority margin (Table 1). In the Indian subset, it was higher for (I)
than (V). There was a lower incidence of ocular, hepatobiliary, skin &
subcutaneous tissue disorders in the (I) treated patients (see Table 1).
In Indian subset, the above adverse events were less in the (I) group,
but statistical inference could not be done due to small sample size.
However, similar trend of less number of patients discontinuing ther-
apy due to TEAEs in the (I) treated patients was seen in the overall
patients & the Indian subset.
Conclusions:
The all-cause mortality in the Indian subset was higher in the (I) pa-
tients. A trend similar to the overall population regarding safety pa-
rameters favoring (I) was seen in the Indian patients. Considering the
significantly higher prevalence of IA in India, suitably powered study
design is necessary to draw definitive conclusions on the non-inferior
efficacy & better safety & tolerability of (I) over (V) in patients of IA.P443
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Introduction:
Ventilator-associated pneumonia (VAP) is one of the most frequent
healthcare-associated infections, correlated with increased mortali-
ty,extended hospital stay and prolonged mechanical ventilation. Con-
sidering the latest outbreak of multiresistant A. baumannii infections
in the critically ill patients with VAP, there is a growing concern re-
garding challenges of the antibiotherapy in these patients. Although
ceftazidim-avibactam is considered to have limited effects on A. bau-
mannii, it is reported to have a synergic activity in combination with
other antibiotics.
Methods:
We performed a retrospective, observational study which included 24
ICU patients diagnosed with VAP(CPIS > 6). OXA 23 A. baumannii was
isolated from the tracheal secretions using a rapid molecular diagnostic
platform(Unyvero A50 System). Patients were divided in two groups ac-
cording to the antibiotherapy:group A Meropenem + Colistin and
group B Meropenem + Colistin + Ceftazidim-avibactam.Statistical ana-
lysis was performed using GraphPad6 applying T-test and Kaplan-Meier
curves, having the in-hospital mortality as primary outcome and days
of mechanical ventilation and hospital stay as secondary outcomes.
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Mean age(y.o) in group A was 46 and 52 in group B and in both
groups mean Charlson comorbidity index was 3 points. Survival per-
cent was higher in the group treated with Ceftazidim-avibactam (67
% vs 57 %, p = 0.08)-(Fig. 1). Length of stay was significantly de-
creased in group B (26.5 days vs 43 days in group A, p = 0.046).
Number of days under mechanical ventilation was also decreased in
the ceftazidim-avibactam group (19 vs 22) but the data was not sta-
tistically significant.
Conclusions:
In light of the important thread of multiresistant A. baumannii and
the lack of therapeutic measures, the synergistic activity of
Ceftazidim-avibactam use in combination with other antibiotics may
be a promising approach to lower the mortality and hospitalization
in critically ill patients diagnosed with VAP.Fig. 1 (abstract P443). Survival proportions : Survival of two groups.
Blue - Group A, Red - Group BP444
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Introduction:
Infections caused by Multi Resistant Bacteria are a major health prob-
lem, especially in ICUs, and it may be associated with high mortality
rates. Colonization precedes infection in most instances; therefore it
may be a marker of a poor outcome. We tried to determine the im-
pact of colonization on mortality at 28 and 90 days in a population
of patients admitted to one medical and one surgical ICU in the
same institution.
Methods:
Medical records review over three years 2016-2018 of all patients ad-
mitted to one surgical et one medical ICU at Hotel Dieu de FranceHospital staying more than 24h. Colonization to resistant bacteria
was defined as MRSA, ESBL, MDR, and VRE. All patient received a
nasal and rectal screen on ICU admission, in intubated patients tra-
cheal aspirate was considered as colonization in the absence of clin-
ical respiratory tract infection. Demographics, APACHE, SOFA,
immunosupression, Charleston comorbidity index, length of stay,
mechanical ventilation, hospitalization and antibiotic use in the previ-
ous 3 month were collected. Mortality at 28 and 90 days was
assessed through medical records or phone call. Pearson Chi-Square
was calculated for the association of colonization and mortality at 28
and 90 days, and subsequently odd ratio was estimated.
Results:
1337 patients fulfilled our study criteria. 413 0r 53.3% were colonized,
28 patients or 2.8% of the population had MRSA on nasal screen.
Rectal swab identified 44.5 % of ESBL, 3% of MDR and 4.8% of VRE.
Mortality at 28 and 90 days were 19% and 30% respectively. No sig-
nificant difference was found between either nasal or rectal or any
colonization and mortality at 28 and 90 days. Odd ratio for 28 days
mortality in colonized patient was calculated to 0.98 (CI:0.74-1.29)
and for 90 days mortality 1.09 (CI:0.85-1.39).
Conclusions:
In this study we concluded that colonization with resistant bacteria is
not a risk factor for mortality at 28 and 90 days.
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Introduction:
Critically unwell patients have been observed to respond unpredict-
ably to traditional intermittent dosing (ID) schedules of vancomycin,
likely due to the complex physiological derangements caused by crit-
ical illness. Continuous infusion (CI) of vancomycin has been sug-
gested to overcome such problems by allowing more regular
therapeutic drug monitoring and subsequent effective dose titration
[1].
Methods:
This study conducted at a tertiary intensive care unit, reports our ex-
perience following implementation of a continuous vancomycin
infusion protocol. Prospective data was collected over two consecua-
tive periods of three months, initially capturing plasma levels for ID
(target level of 15-20mg/L) followed by reviewing plasma concentra-
tion levels in a CI protocol (target level of 20-25 mg/L). Patients
recieving renal replacement therapy were excluded.
Results:
A total of 22 intermittent vancomycin prescriptions were adminis-
tered and dosing levels observed. In the three month CI period, 26
patients received CI vancomycin and levels subsequently checked.
The CI protocol resulted in increased blood sampling (107 samples in
CI group vs. 73 samples in ID cohort). Two non serious incidents
were reported in the CI cohort relating to preparation of vancomycin.
Both groups had a comparable median time to therapeutic range (48
hours). However, CI vancomycin group had a greater proportion of
first samples outside the desired therapeutic range (70%vs 36%) (Fig-
ure 1). As the therapy continued, CI vancomycin demonstrated a
greater propensity towards consistent therapeutic levels than that
observed with ID. 83% of patients on a CI regime achieve the desired
target levels compared to 77% in the ID cohort
Critical Care 2020, 24(Suppl 1):87 Page 184 of 213Conclusions:
Continuous infusion vancomycin protocol is a safe, acceptable and
effective alternative to intermittent dosing of vancomycin in critical
care.
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Fig. 1 (abstract P445). Scatter plot of vancomycin plasma levels
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Introduction:
Biofire® Filmarray® multiplex PCR pneumonia panel (BFPCR) can
shorten microbial detection time.
Methods:
Six months comparison of time to microbial diagnosis and treatment
changes in pneumonia cases, between in-house bronchoalveolar lav-
age (BAL) stains and cultures and BFPCR done by remote laboratories
[Dr. Dangs Lab, New Delhi (Lab 1) and SRL Mumbai (Lab 2)].
Results:
Thirty-four BAL samples obtained from 32 patients were sent for
stains, culture and BFPCR. The mean time to results was less for
BFPCR (12.9±14.5 hrs) (3.3±1.1 hrs for Lab 1 and 30.8±9.6 hrs for Lab
2) in comparison to culture (48±5 hrs) (p<0.01). Lab 1 time was less
than reporting time of stains (4.0±1.8 hrs; p=0.04). BFPCR was posi-
tive in 31(91.2%) samples and reported higher (p<0.01) yield of mi-
crobes (77 vs 25) and bacterial resistances (61 vs. 10) than cultures
(Fig. 1). It was positive for single or multiple microbes in 9(26.5%)
and 22(64.7%) samples respectively. Single or multiple resistance
genes were detected in 5(25%) and 20(80%) samples respect-
ively. BFPCR was positive only for bacteria in 13(38.2%), virus
in 2(5.9%) and for both in 16(47.1%) cases. Influenza A was found
in 10(29.4%) cases. The most common organisms in community and
hospital acquired pneumonia were Streptococcus pneumoniae (4/12)
and A. baumannii (10/22) respectively. Bacterial cultures were con-
cordant with BFPCR in 11/11 (100%) of positive cases. Decisions to
change antibiotics could be taken earlier based on BFPCR (p< 0.001)
than if were based solely on cultures – both in culture positive (9.7±
14.3 vs 50.03±6.0 hrs) and negative cases (14.7±14.9 vs 48.0+4.3 hrs)where antibiotics would have remained unchanged. Based on BFPCR
antibiotics were escalated in 17(50%) patients and teicoplanin (11/
19) was most often stopped.
Conclusions:
BAL BFPCR were obtained significantly earlier, identified more organ-
isms and bacterial resistance than culture reports and lead to more
frequent and earlier antibiotic changes.P447
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Introduction:
Severe community-acquired pneumonia (SCAP) is a frequent cause of
hospitalization and mortality. Ceftaroline is efficacious for treatment
of CAP (PORT risk class III or IV). Most severe patients were excluded
from the clinical trials, so the efficacy of ceftaroline in these kind of
patients is unknown
Methods:
This is a health record-based retrospective before-after study in a ter-
tiary care hospital. All SCAP patients admitted in ICU between No-
vember 2017 and February 2019 receiving ceftaroline were included.
Control group included patients with same inclusion criteria but re-
ceiving ceftriaxone. Propensity scores to adjust for potential baseline
differences between groups were performed. Levofloxacin or azy-
thromicin were administered in both groups. Primary outcome was
the change in SOFA score over the first 96h and secondary were
days of mechanical ventilation, respiratory failure at 96h, need of res-
cue antibiotics, length of stay and mortality
Results:
There were 28 patients in ceftaroline group and 43 in ceftriaxone
group. Baseline characteristics were similar except from more intu-
bated patients in ceftaroline group (Figure 1). There were less re-
spiratory failure at 96h in patients with ceftaroline treatment
(-73.3% vs. -51.6%; p 0,015), but no differences in other organ fail-
ures, mortality, days of mechanical ventilation or LOS. There were
more need of rescue antibiotics in ceftriaxone group (7.1% vs .46.5%;
p 0,001). We found more Streptococcus pneumoniae isolation in cef-
taroline group (18 (64.2%) vs 11 (25.5%); p = 0.001); more empiric
use of oseltamir (16 (57.1%) vs 11 (25.5%); p = 0.012), but no more
influenzae infections (11 (39.2%) vs 8 (18.6%); p = 0.101). S. aur-
eus was detected in 1 patient in ceftaroline group and in 5 in ceftri-
axone group.
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Ceftaroline is an efficacious treatment in patients with severe CAP,
admitted in ICU. It relates to earlier resolution of respiratory failure
and less rescue antibiotics. We need an adequately pragmatic trial to
confirm our findingsFig. 1 (abstract P447). Baseline characteristics of ceftaroline and
ceftriaxone groupsP448
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Introduction:
Scrub typhus is caused by Orientia tsutsugamushi [1,2,3,4,5]. Its
preads by bite of larval stageof thromboculid mites or chigger [1].
Clinical features may include fever, headache, myalgia, lymphaden-
opathy, eschar, skinrash. It may also cause pneumonia, renal failure,
shock, meningoencephalitis, multiple organ failure[1,2]. Our study
aims to discuss the incidence of organ dysfunction in a comprehen-
sive way taking the overall population of patients with identified
scrub typhus infection. There is lack of data in eastern India regard-
ing the incidence and risk factors of developing multiorgan dysfunc-
tion syndrome (MODS) in scrub typhus.
Methods:
In this retrospective study we studied the incidence of various organ
involvement and the risk factors associated with the development of
MODS in scrub typhus. We collected data from December 2016 toNovember 2019 in tertiary care hospital at Kolkata. We have included
all patients who are having fever, scrub typhus IgM antibody positive,
age more than 14 years. SOFA score was used in evaluating patients
with MODS. Exclusion criteria involves patient who are having co-
infectional ong with scrub typhus.
Results:
In a cohort (n=114), patients with multiorgan dysfunction syndrome
was seen in 27 patients (23.68%), the mean age in group of patients
with MODS was 50.0+/-14.96 years (mean+/-SD). In group of patients
with MODS, fever duration in days was of 11+/-3.58 days (mean+/-
SD), interval from treatment to defervescenc in days was 5.11+/-2.39
days (mean +/-SD). Among patients with MODS, hematologic in-
volvement was seen in 7 patients (25.92%), hepatic involvement was
seen in 19 patients (70.37%), renal involvement was seen in 17 pa-
tients (62.96%), neurologic involvement was seen in 24 patients
(88%), respiratory involvement was seen in 14 patients (51.85%), car-
diovascular was seen in 8 patients (29.63%), ICU shifting was neces-
sary in 20 patients (74.07%), mechanical intubation was needed in 14
patients (51.85%) in multiorgan dysfunction syndrome patients. Hos-
pital mortality in patients with MODS was 3 patients (11.11%). No
mortality was seen in patients without MODS. Other parameters were
evaluated among patients with MODS. They include eschar in 1 pa-
tient (3.7%), seizure in 7 patients (25.93%), hepatoslenomegaly in 26
patients (96.3%), leucopenia in 3 patients (11.11%), leucocytosis in 13
patients (48.14%), thromnbocytopenia in 7 patients (25.92%),de-
creased hemoglobin in 22 patients (81.48%), transaminitis in 19 pa-
tients (70.37%). The risk factors associated with the development of
MODS are platelet counts, bilirubin, transaminitis, Glasgow coma
scale, time interval from treatment to defervescence, hemoglobin,
total leucocyte count and fever duration.
Conclusions:
Scrub typhus is an important cause of acute febrile illness in this part
of the country and is frequently associated with organ dysfunction.
However, the overall mortality is low which is similar to other studies
done before [2].
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Introduction:
Acute respiratory failure (ARF) due to pulmonary infections is a usual
cause of intensive care unit (ICU) admission. Immigration patterns
and iatrogenic immune-suppression have made tuberculosis (TB) a
common disease in Western Europe. Severe TB requiring ICU care is
rare. Nevertheless, mortality associated with active TB and ARF is
poor [1].
Methods:
Adult patients with TB admitted to ICU from 2014-2018 were identified
retrospectively. Diagnosis was based on: positive cultures of sputum,
bronchial aspirates or bronchioalveolar lavage fluid. Demographic char-
acteristics, reasons for admission, HIV status, anti-TB treatment and
mortality were recorded.
Results:
Total of 25 patients with TB were admitted to ICU. Mean APACHE II
score was 20,2±6,9. Sixteen were male. Mean age 49,1±14,7 years.
Eight (32%) were HIV-positive, 3 (12%) diabetes mellitus type 2, 3
(12%) chronic liver disease. Six (24%) had other causes of immune-
suppression. Main causes for ICU admission were ARF due to non-
Critical Care 2020, 24(Suppl 1):87 Page 186 of 213Mycobacterium tuberculosis pathogens in 64%, acute liver failure in
12%, septic shock due to non-respiratory cause in 8%. Overall,
52% were on anti-TB treatment at time of admission. TB involved the
lung parenchyma in all patients. Pleural involvement was present in
12% and lymph node in 20%. Extrapulmonary sites were present in
28%: urogenital, gastrointestinal, bone marrow. Pathogens identified
in over-infections: 16% gram positive coccus, 20% gram negative ba-
cilli, 16% fungal, 4% MDR-pathogen. One patient HIV-positive suffered
ARF due to Pneumocystis jiroveci. Overall, 64% died during ICU stay.
Conclusions:
Besides its latent evolution, mortality of TB patients admitted to ICU
is extremely high. ARF due to over-infection seems to be the main
cause for ICU admission and mortality. Better preventive approach of
these patients may improve their outcome.
References:
1. Erbes R et al. Eur Resp J 27:1223-1228, 2006P450
Critical care management of fulminant East African sleeping
sickness
D Hall1, J Harrington1, J Eapen2, S Chanda3
1Royal Infirmary of Edinburgh, Edinburgh, United Kingdom; 2NYU
Langone Medical Center, Division of Infectious Disease, New York,
United States; 3University Teaching Hospital, Lusaka, Zambia
Critical Care 2020, 24(Suppl 1):P450
Introduction:
Human African Trypanosomiasis (HAT) is rarely encountered by crit-
ical care clinicians, but is an important differential for fever in the
returning tropical traveler. Late disease is characterized by seizures,
fever and multi-organ failure [1, 2]. We present an anonymized case
presenting from an endemic area in Zambia referred for tertiary crit-
ical care management. The patient was too obtunded to give in-
formed consent and his relatives could not be contacted despite
extensive efforts.
Methods:
A middle-aged man with no past medical history from rural Zambia
presented to a local clinical officer post with fever and arthralgia. He
was treated twice with anti-malarial medication without resolution of
symptoms. Two months later he was admitted febrile and obtunded
to a local hospital with worsening confusion. He was transferred 8
hours by ambulance to our facility in Lusaka, which is the only public
tertiary critical care unit in Zambia
Results:
GCS on arrival was E3M4V2 without localizing neurology. Micro-
biology investigations were negative, including for toxoplasma,
cryptococcus, HIV or malaria. The patient suffered a generalized
seizure followed by a sustained GCS of 3 and was admitted to
the ICU for invasive ventilation and seizure control. Peripheral
blood smears demonstrated trypanosomes consistent with HAT
secondary to Trypanosoma brucei rhodesiense. He was commenced
on melarsoprol but rapidly deteriorated, with signs of
melarsoprol-induced arsenic encephalopathy and subsequent ton-
sillar herniation. His death was confirmed by neurological criteria.
Conclusions:
ICU management of fulminant HAT involves supportive neurocritical
care plus melarsoprol, a toxic arsenic compound with common side
effects of hepatotoxicity and dysrhythmia. Arsenic encephalopathy
occurs in 10% of late HAT, with a fatality rate of 70% [1]. Early diag-
nosis is associated with a 95% survival rate in developed world trav-
elers repatriated from endemic areas [2].
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Introduction:
The aim of the study was to investigate into effectiveness of lithium
chloride (LiCl) as agent that prevents damage to the monolayer of
endothelial cells under the action of serum from multiple trauma pa-
tients with septic shock.
Methods:
Serum from 5 pts with septic shock (Sepsis-3) and 5 healthy donors
was withdrawn. Monolayer of Ea.hy926 endothelial cells were incu-
bated for 3 hrs at 37 ° C with healthy person’s serum and with septic
patient’s serum without LiCl and with it at concentrations of 0.01
mmol, 0.1 mmol, 1 mmol, 10 mmol. LiCl was added 1 hour before
the change of serum. After incubation cells were washed and fixed
with 2% paraform solution and permeabilized with 1% Triton X-100
solution. Fixed cells were stained with primary antibodies to VE-
cadherin and then incubated with secondary antibodies conjugated
with Oregon Green 488 fluorescent dye as well as with phalloid red
and Hoechst dye 33342. Images were processed by fluorescence
microscope and ImageJ 1.44p and MetaVue 4.6 programs. Western
blotting was used to detect antibodies to VE-cadherin, claudin and
GSK-3beta. Statistics included Mann-Whitney test and chi-square test.
Results:
Incubation of a monolayer of endothelial cells with 5% serum of sep-
tic shock patients led to loss of VE-cadherin contacts and decrease of
claudine. Preincubation with LiCl 0.01 mmol did not prevent dis-
mantling of claudine, actin, VE-cadherins; 0.1 mmol LiCl prevented it
(p>0.05), but at higher concentrations (1 mmol, 10 mmol) almost
completely protected endothelial monolayer from destruction of
intercellular contacts (p<0.05). Serum had almost no effect on the
phospho-GSK-3β level after 5 min, 15 min, 30 min and 1 hr, but
caused a significant (60%) decrease in its level after 2 and 4 hrs. LiCl
(1 mmol) caused a significant increase in phospho-GSK-3β already 15
mins and up to 4 hrs after exposure.
Conclusions:
LiCl prevents septic damage to the monolayer of endothelial cells
in vitro in a GSK-3beta mediated way.
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Introduction:
The autonomic nervous system (ANS) controls both heart rate and
vascular tone, which are known to be impaired during septic shock
(SS) . Acute inflammation is presumed to increase arterial stiffness of
large arteries in experimental studies [1]. The objectives of this work
are to verify if standard SS resuscitation modulate mechanical vascu-
lar properties and to verify if alterations in these vascular properties
and ANS activity are correlated.
Methods:
A protocol of fecal peritonitis septic shock and standard resuscitation
(fluids and noradrenaline) was applied on 6 pigs. The arterial blood
Fig. 1 (abstract P454). Time course of total concentration of LPS
(A) and active to total concentration ratio (B) after intra-peritoneal
injection in wild-type and PLTP knocked-out mice. Results are
represented as mean and standard error of the mean * Significantly
different LPS: Lipopolysaccharide; PLTP: Phospholipid transfer
protein; PLTP-KO: PLTP knocked-out mice
Critical Care 2020, 24(Suppl 1):87 Page 187 of 213pressure waveform was recorded in the central aorta and in the fem-
oral and radial arteries. The characteristic arterial time constant
tau was computed at the three arterial sites, based on the two-
element Windkessel model [2]. The total arterial compliance (AC) and
the total peripheral resistance (TPR) were also estimated. Baroreflex
sensitivity (BRS), low frequency (LF, 0.04-0.15 Hz) spectral power of
diastolic blood pressure, and indices of heart rate variability (HRV)
were computed to assess ANS functionality.
Results:
Septic shock induced a severe vascular disarray, decoupling the usual
pressure wave propagation from central to peripheral sites, as shown
by the inversion of pulse pressure (PP) amplification, with a higher
PP in the central aorta than in the peripheral arteries during shock.
The time constant tau together with AC and TPR were independ-
ently decreased. A decrease in BRS, LF power, and HRV describe an
ANS dysfunction. After the administration of fluids and noradrenaline,
both vascular and autonomic dysfunction persisted and these were
found to be significantly correlated.
Conclusions:
Measures of mechanical vascular function and ANS activity could represent
an useful end-point to guide further clinical investigations and refine our
understanding of SS mechanisms, especially under medical treatment.
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Introduction:
Adequate animal models are clearly needed for the development of truly
effective clinical strategies for the treatment of sepsis. The recently accepted
recommendations (Minimum Quality Threshold in Pre-Clinical Sepsis Stud-
ies - MQTiPSS, Osuchowski et al. Shock 2018) are defining several aspects
of rodent sepsis models, but the microbiological background received rela-
tively less attention. In this line our aim was to explore the significance of
microbial profile in the outcome of peritonitis-induced sepsis models.
Methods:
Fecal peritonitis was induced in Sprague-Dawley rats (n=22, with
1.22×106 – 5.9×106 CFU ip) and Vietnamese minipigs (n=18. with
3.8×107-6.2×109 CFU). Invasive hemodynamic monitoring and blood
gas analyses were performed on anesthetized animals between 18-
24h of sepsis. The respiratory, cardiovascular, renal, hepatic and
metabolic dysfunctions were evaluated with the species-specific Se-
quential Organ Failure Assessment (ssSOFA) score, the microbial pro-
file was determined with selective media and MALDI-TOF MS in the
initial inoculum and in the abdominal fluid taken 20h after sepsis
induction.
Results:
Strong correlation was found between the initial dose of the inocu-
lum (CFU) and the ssSOFA scores for organ dysfunction (rats: r =
0.656, P=0.0186; pigs: r=0.570, P = 0.0391). Similar to the human
microbiota Protebacteria (rat: 53%; pig: 27%) and Firmicutes (rat:
40%; pig: 55%) were the predominant phyla in the induction inocu-
lum in both model.
Conclusions:
Taxonomical similarity was present in both peritonitis model with hu-
man microbiota and the severity of organ dysfunction was associated
with the initial bacterial concentration in both species. These findings
can advance the process of refining the animal models to follow the
latest guidelines.
Grant supports: NKFIH K116689, GINOP-2.3.2-15-2016-00034; EFOP-
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Introduction:
Lipopolysaccharide (LPS), is a component of gram-negative bacteria
known for its activation of the host immune system. The phospho-
lipid transfer protein (PLTP) has previously been shown to promote
the binding of LPS to lipoproteins, to limit inflammation and to lower
mortality following injections of LPS or bacterial infection. The aim of
the present study was to investigate the role of PLTP and lipopro-
teins in the detoxification of LPS from the peritoneal cavity.
Methods:
Injection of LPS intra-peritoneally (IP) (1mg/kg) to wild type (WT) and PLTP
knocked-out mice (PLTP-KO) (n = 9 per group). Mass concentration and ac-
tivity of LPS were quantitated by LCMSMS analysis of 3-hydroxymyristate
and LAL bioassay, respectively. Lipoprotein fractions in plasma were sepa-
rated by ultracentrifugation (n=10 vs n =12).
Results:
Following intra-peritoneal injection, clearance of intra-abdominal LPS was
faster and plasma neutralization was more efficient in WT than in PLTP-KO
mice (Figure 1). Indeed, LPS found in plasma of WT mice was proportionally
less active, sustaining a higher capacity for WT mice to neutralize LPS (Fig-
ure 1B). Quantitative dosage of LPS in portal blood, 15 minutes after IP in-
jection, revealed that plasma LPS associates rapidly with the lipoprotein
fraction (HDL plus LDL), and in higher proportions as compared to PLTP-KO
mice (66 [62-72] % vs 50 [41-54] %, respectively; p < 0.01). In line with previ-
ous studies, these observations now indicate that, LPS readily associates
with lipoproteins in a neutralizing process PLTP mediated. Finally, even with
a heavy LPS load (25 mg/kg), the bulk of LPS was still found in the lipopro-
tein fraction (80 [80-90] %), suggesting that lipoproteins plus PLTP in WT
mice have a high capacity to detoxify intraperitoneal LPS.
Conclusions:
In a model of peritonitis, lipoproteins and PLTP were found to consti-
tute key playors for peritoneal clearance and neutralization of LPS. It
emerges as a key pathway for the resolution of the inflammatory re-
sponse in peritonitis.
Table 1 (abstract P456). eSNPs associated with pneumonia in the
Global Biobank Engine
eSNP, allele Gene (up (↑)/down
(↓) regulation for
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(GTEx or
eQTL blood)
P-value
(GTEx /
eQTL
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pneumonia in
GBE (P-value)
rs11692150-
C
TNFAIP6(↓) GTEx/eQTL
blood
3.0E-7 /
6.70E-17
rs11692150-C
(0.00272)
rs9923575-T HP(↓) GTEx/eQTL
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8.3E-5 /
7.14E-71
rs9923575-T
(0.00244)
rs581623-C FCAR(↓) GTEx/eQTL
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8.5E-6 /
2.87E-5
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(0.00461)
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C
PGLYRP1(↓) eQTL blood 1.89E-5 rs8111613-C
(0.00342)
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Introduction:
Autotaxin (ATX, Enpp2) is a secreted enzyme present in biological
fluids that catalyses the production of lysophosphatidic acid (LPA).
LPA is a bioactive phospholipid evoking various cellular responses in
most cell types. Upregulated ATX levels have been reported in vari-
ous chronic inflammatory diseases. Given the established role of LPA
in the inflammatory response, we investigated a possible role for the
ATX/LPA axis in LPS-induced endotoxemia.
Methods:
LPS was injected intraperitoneally (20 mg/kg) in mice producing 50%
ATX levels (ATXdf/+, heterozygous null mutant mice), in mice produ-
cing 20-30% reduced ATX levels upon inducible inactivation
(R26CreERT2/Enpp2n/n mice) and in mice expressing 150-200% in-
creased ATX levels (Enpp2-Tg mice). Kaplan-Meier survival analysis
was performed. ATX activity was measured using the TOOS activity
assay.
Results:
ATXdf/+ mice that produce almost 50% reduced serum ATX levels
show increased survival compared to their littermate controls. For
the inducible inactivation of ATX, Enpp2n/n targeted mice were
crossed with the R26Cre-ERT2 mice and tamoxifen induction enabled
temporal control of floxed gene expression. R26CreERT2/Enpp2n/n
mice were more protected against LPS-induced endotoxemia com-
pared to control mice. Enpp2-Tg mice overexpressing autotaxin and
showing a 2-fold increase in plasma levels do not display improved
survival rates compared to control group.
Conclusions:
ATX participates in systemic inflammation, as reduced ATX levels in
circulation decrease lethality of mice from caused by LPS. The excess
amount of circulating ATX does not exacerbate the systemic inflam-
matory response to LPS.
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Introduction:
Pneumonia (Pn) is a prevalent and severe infectious lung disease.
Host genetics plays an essential role in the pathogenesis of infectious
diseases including Pn [1]. The aim of the study was to analyze the
variability of genes associated with neutrophil activation in
pneumonia.
Methods:
To identify differential expressed genes (DEGs) in community-
acquired (CAP) and hospital-acquired pneumonia (HAP) dataset
«Genome-wide blood transcriptional profiling in critically ill patients -
MARS consortium» (GSE65682) from Gene Expression Omnibus was
analyzed (logFC≥2.0, FDR-corrected P-value<0.05). DEGs associated
with neutrophil activation were selected according to gene ontologyGO:0042119 («neutrophil activation»). With the use of GTEx Portal
and Blood eQTL browser, we searched for eSNPs (expression single
nucleotide polymorphisms) in whole blood for neutrophil activation
genes differentially expressed in CAP/HAP. These eSNPs were further
analyzed for their association with Pn via the Global Biobank Engine
(GBE).
Results:
A total of 46 DEGs from GSE65682 correspond to GO:0042119 genes
(43 up- and 3 down-regulated) of which 39 genes were common to
CAP and HAP. Functional enrichment of 46 DEGs based on DisGeNET
detected top-5 diseases associated with these genes (FDR-corrected
P-value<0.05): Myeloid Leukemia, chronic; Sepsis; Asthma; Lung dis-
eases; Allergic asthma. For these 46 genes 1366 eSNPs common to
GTEx Portal and Blood eQTL browser were identified. More than half
of all variants were located on the second chromosome and influ-
enced the expression of TNFAIP6 and IL18RAP genes. Among all
eSNPs we identified variants associated with Pn in the GBE (Table 1).
Conclusions:
We identified genes related to neutrophil activation, genetic variabil-
ity of which was associated with pneumonia.
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Introduction:
The role of hydrogen sulfide (H2S) in the pathogenesis of severe bac-
terial infections is unclear. We investigated the role of host-produced
H2S through cystathionine-γ-lyase (Cse) in an animal infection model
of multi-drug resistant (MDR) Pseudomonas (P.) aeruginosa.
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Sepsis was induced in wild-type C57Bl6 mice (n=41) and Cse knockout mice
(n=41) by i.p. injection of 108 cfu/mice MDR P. aeruginosa. Similar experi-
ments were repeated after cyclophosphamide induced neutropenia. Sur-
vival was recorded for 7 days. Mice were sacrificed for determination of
bacterial load and myeloperoxidase (MPO) activity as a surrogate marker of
myeloid cell recruitment. Cytokines were measured in serum by Legen-
dplex inflammatory panel. Total leukocytes from mice spleens, with or with-
out pretreatment with the H2S donor GYY3147, were incubated with 1 x
104 cfu/mL MDR P. aeruginosa. Bacterial clearance was recorded.
Results:
We observed a significant decrease in survival of Cse-/- mice as compared
to Cse+/+ mice (12% vs. 47%; p: 0.025). This survival advantage was elimi-
nated in neutropenic mice (17% for both groups, p: 0.873). Cse-/- mice had
increased pathogen load in the liver (6.57 ± 0.13 vs 5.26 ± 0.50, p: 0.029)
and lung (6.70 ± 0.17 vs 5.29 ± 0.55, p: 0.035). MPO activity was lower
in Cse-/- mice in the liver (634 ± 71 vs 1029± 179, p: 0.048) and lung (7627 ±
585 vs 11121 ± 1468, p: 0.34). Cse+/+ mice had increased serum levels of IL-
23 (121.13 ± 33.68 vs 31.41 ± 7.02 of Cse-/-, p: 0.001); MCP-1 (4769.91 ±
908.83 vs 1940.37 ± 1062.65, p: 0.026) and GM-CSF (22.91 ± 4.66 vs 8.11 ±
1.92, p: 0.004). Phagocytic activity of leukocytes from Cse-/- mice was reduced
compared to Cse+/+ mice. This deficit was eliminated after GYY4137 pretreat-
ment (Fig. 1).
Conclusions:
Deficiency of host- derived H2S leads to increased susceptibility to MDR P.
aeruginosa infection due to an inefficient neutrophil chemotaxis and neu-
trophil mediated phagocytosis.
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drug resistant Pseudomonas aeruginosa by total leukocytes in vitroIntroduction:
Neuroinflammation often develops in sepsis along with increasing
permeability of the blood-brain barrier (BBB), which leads to sep-
tic encephalopathy [1]. The barrier is formed by tight junction
structures between the cerebral endothelial cells [2]. We investi-
gated the expression of tight junction proteins related to endo-
thelial permeability in brain autopsy specimens in critically ill
patients deceased with sepsis, and analyzed the relationship of
BBB damage and measures systemic inflammation and systemic
organ dysfunction.
Methods:
Case series included all adult patients deceased with sepsis in
the years 2007- 2015 with brain specimens taken at autopsy
available. Specimens were categorized according to anatomical
location (cerebrum, hippocampus, cerebellum). The immunohisto-
chemical stainings were performed for occludin, ZO-1 and clau-
din. Patients were categorized as having BBB damage if there
was no expression of occludin in the endothelium of cerebral
microvessels.
Results:
38% (18/47) developed multiple organ failure before death.
74.5% (35/47) had septic shock. The deceased with BBB damage
had higher SOFA maximum scores (16 vs.14, p=0.04), and had
more often procalcitonin levels above 10 (56 % vs.28 %, p=
0.045). BBB damage in cerebellum was more common in cases
with c reactive protein above 100 mg/L as compared with CRP
less than 100 (69% vs. 31 %, p=0.025). Absence of ZO-1 expres-
sion in cerebral meningeal samples associated with BBB damage
(17 % vs. 0 %, p=0.046). Positive blood cultures (n = 22) were as-
sociated to absence of ZO-1 expression in cerebellar glial cells
(92 % vs. 44 %, p=0.018).
Conclusions:
In fatal sepsis, damaged BBB defined as loss of cerebral endothelial
expression of occludin (Figure 1) is related with severe organ dys-
function and systemic inflammation. Loss of ZO-1 in endothelial cells
associates with BBB damage, and sepsis contributes to ZO-1 loss in
cerebellar glial cells.References:
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Introduction:
Oxylipins are oxidative breakdown products of cell membrane fatty
acids. Animal models have demonstrated that various vasoactive oxy-
lipin pathways may be implicated in septic shock pathophysiology
but these have been poorly studied in humans.
Methods:
Oxylipin profiling was performed on serum samples collected on en-
rolment to the VANISH (Vasopressin vs. Norepinephrine as Initial
Therapy in Septic Shock) trial. Samples were analysed with liquid
chromatography-mass spectrometry. Patients were followed up until
28 days.
Results:
Samples were collected from 154 of 409 (37.7%) patients on inclusion to
the trial and 39 (25.3%) had died by 28 days. Non-survivors were found to
have higher levels of a number of oxylipins including: 14,15-dihydroxyeico-
satrienoic acid (DHET) (p<0.01), 11,12-DHET (p=0.03), 15(S)-hydroxyeicosate-
traenoic acid (p=0.02), 14-hydroxyoctadeca-pentaenoic acid (p=0.04) but
lower levels of the precursor eicosapentaenoic acid (p=0.012). When cor-
rected for multiple comparisons with the Benjamini-Hochberg test, only
14,15-DHET remained significant (p=0.025). Although there was a difference
in median 14,15-DHET levels between survivors and non-survivors, many
values were below the level of detection (n=84/154 (54.5%)). As such, we
also analysed 14-15-DHET as a binary variable (Figure 1). Patients with de-
tectable 14,15-DHET were more likely to die (HR 2.4 [95% CI 1.2-4.6], p<
0.01) and have a higher median lactate (p =0.01) and total SOFA score (p<
0.01) than those patients where baseline 14,15-DHET was undetectable.
Conclusions:
Our study suggests the oxylipin 14,15-DHET may be associated with
septic shock severity and 28-day mortality. These results are consist-
ent with the known vasodilatory actions of this class of oxylipin.
More work is needed to confirm its exact role in septic shock and
whether this pathway is amenable to therapeutic intervention.Fig. 1 (abstract P459). Survival curve for patients with vs without
detectable levels of the oxylipin 14,15-DHET. Followed up until
28 daysP460
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Introduction:
Activation of neutrophils is a mandatory stage and a sensitive marker
of systemic inflammatory conditions that can lead to the develop-
ment of multiorgan failure. The aim of the study was to investigate
into the antiinflammatory effects of lithium chloride on human neu-
trophils in vitro.
Methods:
Study was carried out on neutrophils isolated from the blood of 5
healthy donors. 50% of neutrophils were activated by 100 mkM
fMLP, 50% - by 100 ng/ml lipopolysaccharide (LPS); then their activity
was evaluated by fluorescent antibodies to CD11b and CD66b de-
granulation markers. Intact and activated neutrophils were treated
with a solution of lithium chloride (9 mmol). Immunoblotting was
used to assess GSK3b activity in neutrophils. Mann-Whitney criterion
and p<0.05 were used for statistics.
Results:
Lithium chloride 9 mmol decreased the level of expression of CD11b
on intact neutrophils by 16% (p=0.07), CD66b by 15% (p=0.07). fMLP
increased CD11b expression on neutrophils by 2.6 times (p=0.0007),
CD66b by 2.5 times (p=0, 0022). Addition of lithium chloride solution
to fMLP activated neutrophils reduced the expression of CD11b (p=
0.0317) and CD66b (p=0.0079). LPS increased CD11b and CD 66b ex-
pression by 2.1 times (p=0.0007, p=0.0022, respectively); addition of
lithium chloride reduced the expression of CD11b (p=0,0317) and
CD66b (p=0.0079) on neutrophils. fMLP led to a dephosphorylation
of GSK-3b by 47% (p<0.05), lithium chloride increased its phosphoryl-
ation by 387% (p <0.05). Adding lithium chloride to activated fMLP
neutrophils restored the level of GSK-3b phosphorylation by 277%
compared to controls (p<0.05).
Conclusions:
Lithium chloride modulates the inflammatory activation of neutro-
phils by bacterial components through the phosphorylation of
GSK3b in neutrophils.
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Introduction:
Sepsis, a leading cause of mortality among critically-ill patients in the
ICU, recently recognized by the WHO as a global health burden. Pa-
tients that suffer from sepsis exhibit an early hyper-inflammatory im-
mune response which can lead to organ failure and death. In our
study, we assessed the immune modulations in the human in vivo
endotoxemia model and compared it to ex vivo lipopolysaccharides
(LPS) stimulation using 38 transcriptomic markers.
Methods:
Eight healthy volunteers were challenged with intravenous LPS
in vivo. In parallel, blood from another 8 volunteers was challenged
with LPS ex vivo. Blood was collected before and after 4 hours of LPS
challenge and tested with the Immune Profiling Panel (IPP) prototype
using the FilmArray® system.
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The use of IPP showed that markers from the innate immunity domi-
nated the response to LPS in vivo, mainly markers related to mono-
cytes and neutrophils. Comparing the two models, in vivo and
ex vivo, revealed that most of the markers were modulated in a simi-
lar pattern (68%). Some cytokine markers such as TNF, IFN-γ and IL-
1β were under-expressed ex vivo compared to in vivo. T-cell markers
were either unchanged or up-modulated ex vivo, compared to a
down-modulation in vivo. Interestingly, markers related to neutro-
phils were expressed in opposite directions, which might be due to
the presence of cell recruitment and feedback loops in vivo.
Conclusions:
The majority of IPP markers showed similar patterns of expression
post-LPS challenge in both models, except for several markers re-
lated to neutrophils and T-cells. The IPP tool was able to capture the
early immune response in the human in vivo endotoxemia model,
which is a translational model mimicking immune host response in
septic patients.P462
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Introduction:
Serum levels of tyrosine kinase receptor Mer and its ligand Gas6 pre-
dict mortality in septic patients in the intensive care unit. However,
whether their early measurement at emergency department (ED)
presentation also predicts mortality and organ failure still needs to
be clarified.
Methods:
In this multicentre observational study, septic patients admitted to 5
Italian EDs were included [1]. At ED presentation blood samples were
taken for routine biochemical analyses and serum Mer and Gas6 meas-
urement. Urinalyses, blood gas analyses and chest X-ray were routinely
performed. Mortality at 7 and 30 days, as well as the presence of organ
damage such as acute kidney injury (AKI), thrombocytopenia, PT-INR
derangement and sepsis-induced coagulopathy (SIC) were evaluated
according to baseline levels of Mer and Gas6.
Results:
890 septic patients were enrolled between March 2013 and March
2015. 7 and 30-day mortality were 9.7% and 19.9%, respectively. Mer
and Gas6 baseline levels were 31.1[23.2–43.5]ng/mL and 8.3[4.0–
14.4]ng/mL each, and no difference was observed between survivors
and non-survivors, at both 7 and 30 days (p>0.05). AKI patients showed
higher Mer and Gas6 levels compared to the non-AKI ones (9.8[4.1–
17.8] vs. 7.9[3.8–12.9]ng/mL and 34.8[26.4–47.5] vs. 29.8[22.1–41.6]ng/
mL, respectively; p<0.01). However, at the multivariate analysis neither
Mer nor Gas6 were confirmed as AKI predictors. On the contrary, both
Mer and Gas6 independently predicted thrombocytopenia in septic pa-
tients (OR 1.01[1.00-1.02] and 1.04[1.02-1.06], respectively). Moreover,
Mer emerged as an independent factor for developing both PT-INR de-
rangement (OR 1.03[1.00-1.06]) and SIC (OR 1.05[1.02-1.07]) (p<0.001).
Conclusions:
In conclusion, neither Mer nor Gas6 are early predictors of mortality
in septic patients at ED presentation. However, Mer independently
predicted the development of SIC, thrombocytopenia and PT-INR de-
rangement in this population.
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Introduction:
Endothelial hyperpermeability would play a major role in septic
shock related organ failure. The aim of this study is to clarify the rela-
tionship between glycocalyx shedding and respiratory failure, SOFA
score, plasma angiopoietin (Ang)-2 level and patient survival.
Methods:
Plasma samples were collected from 30 septic shock patients from
admission to ICU discharge and 10 healthy volunteers. Plasma synde-
can (Syn)-1 and Ang-2 were measured and clinical data was also col-
lected. Septic shock patients were classified into 3 groups according
to the time-course change of Syn-1 levels. Excess Syn-1 (>400 ng/ml)
during 0 to 3 days and remaining high following 4 to 7 days were
assigned to Group I. Excess Ang-2 during 0 to 3 days and decreased
following 4 to 7 days were assigned to Group II. Moderate increase
(<400 ng/ml) during 0 to 7 days were assigned to Group III.
Results:
Plasma Syn-1 levels are positively associated with increased Ang-2
levels (r2=0.41, P= 0.005), suggesting that Ang-2 is involved in endo-
thelial hyperpermeability. Fluid balance and ventilator-free days
(VFD) are significantly increased in Group I as compared with Group
III. SOFA score, Apache II and patient outcome does not show any
differences between Groups I, II, and III.
Conclusions:
The positive correlation between glycocalyx shedding and fluid bal-
ance indicates plasma Syn-1 may be a valuable marker for endothe-
lial hyperpermeability. The negative correlation between glycocalyx
shedding and VFD indicates plasma Syn-1 may be a valuable marker
for respiratory failure. The plasma level of Syn-1 for prognosis and
organ failure excluding ARDS in patients with septic shock requires
further investigation.P464
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Introduction:
Serum procalcitonin (PCT) is a promising biomarker for differentiat-
ing bacterial infections from other inflammatory states. Moreover, in-
cluding serial PCT measurements in the management of acute
respiratory infection reduces the duration of antibiotic therapy without
increasing the mortality. However, limited real-world information is
available regarding the use of PCT in intensive care units (ICUs).
Methods:
We extracted and analysed data from January 1 to December 31,
2018 from all the orders and results of PCT measurements in the
ICU (26 beds) at Hiroshima University Hospital.
Results:
A total of 1,252 PCT measurements from 409 ICU patients were in-
cluded. In 170 patients, PCT was tested ≥3 times during a single ICU
stay. Serial PCT measurements showed a fade-out pattern (76 [45%]
patients), a second day-peaked decrease pattern (35 [21%] patients),
and a series of negative patterns (30 [18%] patients). Compared to
patients who demonstrated the fade-out pattern, those who
Critical Care 2020, 24(Suppl 1):87 Page 192 of 213demonstrated the second day-peaked decrease pattern had higher
mortality rates (3% vs. 20%, p < 0.01).
Conclusions:
Approximately one-third patients in the ICU who had decreasing ser-
ial PCT values demonstrated the second day-peaked decrease pat-
tern. Since this group of patients had poorer survival, further
studies are needed to clarify the association between a late rise in
PCT levels and delayed therapeutic intervention.P465
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Introduction:
Sepsis diagnostics during the pre-clinical stage remains a most com-
plex issue. Research objective: increasing the efficiency of sepsis
diagnostics.
Methods:
The research was performed on 200 full-term newborns; no clinical
signs of bacterial infection were diagnosed. On the 1, 5, 20 days the
plasmà concentration of IL-1ß, IL-6, IL-8, TNF-α, G-CSF, sFas, FGF, NO
was determined by capture ELISA; CD3CD19, CD3CD4, CD3CD8,
CD69, CD71, CD95, HLA-DR, CD34, CD14, CD3CD56, lymphocytes in
apoptosis - immunophenotype analysis. By applying the statistical
cluster population analysis of the immunological criteria under study
we have evaluated the feasibility of sepsis diagnostics at the admis-
sion to the intensive therapy unit. The diagnostic rule for sepsis has
been formulated By applying the "decision tree" approach to the "R"
statistic medium.
Results:
The cluster analysis confirms the presence of two clusters (presence
of absence of sepsis: these two components explain the 60.81% of
the point variability). The diagnostic rule for the early diagnostics of
sepsis is as follows: disease develops providing during the first 48
hours CD95≥16.8%, NO≤9.6 mkmol/l or CD95≤16.8%, CD34≤0.2%,
CD69≥4.12% or CD95≤16.8%, CD34≤0.2%, CD69≤4.12% and lympho-
cytes AnnexinV-FITC+PI-≥12.3%. 45 newborns featured the confirmed
sepsis development. The accuracy of this diagnostics amounts to
95.41%; sensitivity to 97.06%; specificity to 94.67%; diagnostic false
positive share to 5.33%; diagnostic false positive share to 2.94%; posi-
tive result accuracy to 89.19%; negative result accuracy to 98.61%.
Conclusions:
The aggregate determination of CD95, CD69, AnnexinV-FITC+ PI-,
CD34 and the plasma concentration of NO enables the pre-clinical
diagnostics of sepsis development.
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Pancreatic stone protein (PSP) has shown promise as a biomarker of
infection however, its diagnostic potential has not been systematic-
ally evaluated. We performed a systematic review and meta-analysis
of available data on PSP to evaluate its value for detecting infection
in adults and determining a plasma or serum threshold value.
Methods:
The PubMed and Cochrane Library database were searched for stud-
ies on PSP in adult patients and their raw data were analyzed to esti-
mate the best PSP cut-off value that could detect infected patients
using the Youden’s index. The cut-off sensitivity, specificity, positive
predictive value (PPV) and negative predictive value (NPV) were com-
puted and compared to those for procalcitonin (PCT) and C-reactive
protein (CRP). Finally, we explored the potential value of a model
combining all three biomarkers to detect infection.
Results:
From a total of 44 potentially eligible published studies, 5 containing
631 patients were included in quantitative analysis. Among them,
370 patients suffered from a clinically confirmed infection. The me-
dian [IQR ] PSP values of infected versus uninfected patients
were 81.8 [31.19, 237.75] versus 19.2 [12.66, 33.4] ng/ml respectively,
compared to 150 [83.75, 229.32] versus 64 [18.1, 124] mg/l for CRP
and 0.9 [0.3, 4.4] versus 0.3 [0.07, 0.5] ng/ml for PCT. When the PSP
cut-off value was fixed to 44.2ng/ml for infection versus non-
infection, the ROC AUC for PSP reached 0.81 (0.78, 0.84) with a sensi-
tivity 0.66 (0.62, 0.71), specificity 0.83 (0.79, 0.88) PPV 0.85 (0.81, 0.89)
and NPV 0.64 (0.58, 0.69). Using a joint model including PSP and
CRP, the ROC AUC reaches 0.90 (0.87, 0.92) with respective higher
sensitivity 0.82 (0.78, 0.86) and specificity 0.85 (0.79, 0.90) for discrim-
inating infection from non-infection.
Conclusions:
In adult patients, a PSP threshold of 44.2ng/ml identifies patients
with infection. The combination of PSP with CRP increased further its
ability to discriminate between infection and non-infection.
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Introduction:
Neutrophil CD64 is evolving as a prognostic biomarker. The primary
objective was to correlate serial levels of CD64, PCT (Procalcitonin)
and CRP (C-reactive protein) with mortality during ICU stay.
Methods:
It is a prospective observational study carried out after Institutional
Ethics Committee approval in a 20 bedded mixed ICU from Decem-
ber 2017 onwards. Adult patients of >18 years with diagnosis of sep-
sis or septic shock (as per sepsis 3 criteria) at admission were
included. Demographic and clinical parameters were noted at admis-
sion. Biomarker levels were measured serially at admission, on day 4
and day 8 of ICU stay along with clinical and laboratory parameters.
Appropriate statistical tests were used using SPSS 23. CD 64 was
expressed as % age of neutrophils expressing positivity.
Results:
Sixty patients were analyzed. All parameters were compared be-
tween survivors and non survivors. Demographics were comparable.
Most common source of sepsis was lungs and majority were admit-
ted due to medical reason. Non-survivors had significantly increased
number of days with septic shock. At day 8 median values of all the
biomarkers and the SOFA score were significantly higher in the non-
survivor group (p<0.05). There was a decreasing trend of all 3 bio-
markers and SOFA score amongst survivors. On multivariate logistic
regression analysis, increased CD64 and CRP levels between baseline
and day 8, increased days with septic shock and increased SOFA
Fig. 1 (abstract P469). Impact of 24h lactate and bio-ADM values in
patients with elevated lactate level at admission. The green curve in
the left KM-plot illustrates data from 75 patients with 5 events; the
red curve 70 patients with 18 events. The green curve in the right
KM-plot illustrates data from 28 patients with 4 events; the red curve
96 patients with 48 events. Of note, differences in numbers between
admission (n=328) and 24h (n=269) is related to initial mortality
Critical Care 2020, 24(Suppl 1):87 Page 193 of 213score at baseline were significant (p<0.05) predictors of mortality.
Highest area under the ROC curve was obtained for number of days
with septic shock (0.857) followed by increased CD64 between base-
line and day 8 (0.798). Though serial PCT levels significantly increased
amongst non-survivors, it did not predict mortality.
Conclusions:
Serial level of biomarkers in ICU patients may predict mortality. Lar-
ger trials are needed to confirm the results.
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Introduction:
TREM-1 is an innate immune receptor which activation promotes the
development of exacerbated inflammatory response in septic shock.
Plasma levels of soluble TREM-1, a marker of TREM-1 pathway activa-
tion, are correlated with patients’ outcome. The role of TREM-1 in the
development of immunosuppression in septic shock patients has never
been assessed. So far, decreased monocyte HLA-DR expression (mHLA-
DR) is the most studied marker of immune alterations in septic shock.
Methods:
Plasma sTREM-1 levels were retrospectively measured at Day 1-2, 3-4
and 6-8 in 116 septic shock patients from the IMMUNOSEPSIS cohort
(NCT02803346), included between 01/2016 and 12/2018, using a vali-
dated ELISA method. The associations between sTREM-1, mHLA-DR,
28-day survival status, and occurrence of ICU-acquired nosocomial in-
fection (NI) were assessed.
Results:
Neither sTREM-1 nor mHLA-DR levels at D1/2 were associated with
the occurrence of ICU-acquired NI. However, 28-day mortality was
significantly higher in patients with D1-2 sTREM-1 value superior to
the median (39.6% vs 11.3%, p=0.0103; median=539 pg/mL). A sig-
nificant inverse correlation was found between mHLA-DR at D6-8
and sTREM-1 at D1-2 (Sp -0.378, p<0.0001) and at D6-8 (Sp -0.382,
p<0.0001). At D6-8, when stratifying patients based on sTREM-1
(400pg/mL) and mHLA-DR (5000 AB/C), patients combining elevated
sTREM-1 and low mHLA-DR presented with significantly higher 28-
day mortality (47.6% vs 8.7%, p = 0.0003, Chi-squared test) and NI in-
cidence (31.8 vs 12%, p=0.044) compared with patients with low
sTREM-1 / high mHLA-DR.
Conclusions:
This study shows for the first time that TREM-1 pathway activation is
associated with septic shock-induced immunosuppression, as shown
by an inverse correlation between sTREM-1 at baseline and mHLA-DR
expression at D6-8. Persisting high sTREM-1 values and low mHLA-DR
expression in septic shock patients are significantly associated with
higher rate of ICU-acquired infection and mortality.
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Introduction:
Sepsis mortality remains high [1]. The Surviving Sepsis Campaign
(SSC) recommends to guide resuscitation on normalization of lactatelevels [2], however this is debated [3]. We have shown that plasma
levels of bio-adrenomedullin (bio-ADM) were associated with patient
outcome during sepsis [4]. We therefore aimed to evaluate the
added value of bio-ADM to lactate measurement in the AdrenOSS
cohort.
Methods:
This is a post-hoc analysis of the Adrenomedullin and Outcome in
Severe Sepsis and Septic Shock (AdrenOSS) cohort study. The Adre-
nOSS study is a prospective observational study conducted in
twenty-four centers and included 583 septic patients [4]. We studied
the relationship between the association of initial evolution of lactate
plasma levels and bio-ADM level at 24h and outcome in patients for
whom both markers were available at admission and one day later
(“24h”). Bio-ADM levels below 70 pg/mL were considered as low, and
high if greater than 70 pg/mL [4].
Results:
In patients with high lactate levels (>2 mmol/L) at admission (n=328),
lactate normalization (<2 mmol/L) at 24h was associated with better
outcome than in patients with persistently high lactate at 24h (28-
day mortality 15.9% vs 41.9% respectively, HR 3.3 [2.0-5.3], p<0.001)
(Figure 1). Among patients with decreasing lactate, high and low bio-
ADM levels at 24h identified patients with different outcomes (28-
day mortality 7% vs 26% for low vs high bio-ADM respectively, HR
4.4 [1.6-11.7], p<0.005). High and low bio-ADM levels at 24h also dif-
ferentiated outcome of patients with persistently elevated lactate
(HR 4.5 [1.6-12.3], p<0.005). In patients with low initial lactate, neither
lactate or bio-ADM had no added prognostic.
Conclusions:
Our data suggest that measurement of bio-ADM in addition to lac-
tate may help physicians to refine risk stratification and therefore to
guide resuscitation during sepsis.
References:
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Introduction:
The inflammatory response in sepsis can lead to a spectrum of co-
agulation system defects [1]. Sepsis and severe sepsis is associated
with a hypercoagulable state where the clot microstructure is known
to be a tight and highly elastic clot, which is potentially resistant to
fibrinolysis (Figure 1). Conversely, septic shock is associated with a
hypocoagulable state where the clot microstructure is loose and
structurally weak. The study aim to investigate the effect of fluid re-
suscitation and replacement in clot microstructure over 24 hours.
Methods:
100 patients (50 sepsis, 20 severe sepsis and 30 septic shock) were
included in the study. All these patients received standard fluid re-
placement therapy with crystalloids. Blood samples were collected at
0 hours, 4 hours and 24 hours. Clot microstructure, standard markers
of coagulation and inflammatory markers were measured.
Results:
In sepsis group following fluid administration, the df reduced initially
and then remained stable (1.78- 0 hours, 1.74- 4 hours, 1.73- 24
hours, normal df range 1.73 ± 0.04). In severe sepsis group, the df re-
duced initially, then increased (1.80- 0 hours, 1.71- 4 hours, 1.76- 24
hours) and in septic shock, the df was very low to start with and
there were only slight increase with fluid administration (1.66- 0
hours, 1.68- 4 hours, 1.67- 24 hours).
Conclusions:
The hypercoagulable state and clot quality in both sepsis and severe
sepsis group improved with fluid resuscitation, however despite an
early improvement in clot quality, ongoing fluid resuscitation re-
sulted in markedly reduced functional clot with very low clot
strength and functionality. This study demonstrates that df as a
marker of clot quality and function may have potential in fluid and
component replacement in critical illness and injury.
References:
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Introduction:
Adrenomedullin (AM) is a peptide synthesized in vascular endothelial
cells and cleared by the lungs. The use of AM as an inflammatory
biomarker and his predictive value has been studied in critically ill
patients, but not yet in veno-venous extracorporeal membrane oxy-
genation (ECMO). The purpose of this study was to describe the plas-
matic levels of AM in patients supported with ECMO for acute
respiratory failure
Methods:
AM (normal values <0.55 nmol/L) was measured at 5 time points:
immediately before (T0), 24-h (T1) and 72-h after (T3) ECMO
initiation and immediately before (T4) and 72-h (T5) after ECMO
removal, in consecutive patients with severe respiratory failure
supported with ECMO enrolled in the GATRA study
(NCT03208270) at Fondazione IRCCS Ca’ Granda – Policlinico of
Milan. Data are reported as median (25th - 75th percentile). Statis-
tical analysis was performed using logistic and random effects re-
gression models (to account for repeated measurements within
individuals)
Results:
A total of 131 measurements were taken in 32 consecutive pa-
tients. AM (nmol/L) decreased along the course of ECMO: T0=2.0
(1.5-6.4), T2=2.0 (1.5-6.4), T3=1.6 (1.1-3.1), T4=1.3 (0.8-2.0), T5=0.9
(0.6-2.1) (mean diff.= -0.65, 95%: CI -0.96, -0.35). AM was lower in
patients with viral compared to bacterial ARDS (mean diff.= -2.7,
95%CI -5.2, -0.2) (Figure 1). AM was higher in more severe pa-
tients (SOFA>= 10, N=14) compared to less severe patients (sofa<
10, N=18): 5.7±4.8 vs 1.4±0.8 nmol/L, respectively p<0.001. Basal
values of AM could not predict mortality at 28 days (OR=0.8,
95%CI: 0.5-1.2) after conditioning for SOFA score and respiratory
failure etiology
Conclusions:
AM plasmatic values seem to be higher in more severe patients
and in patients with bacterial ARDS. AM decreased along the
ECMO course but could not predict mortality in our group of
patientsFig. 1 (abstract P471). Plasmatic adrenomedullin during ECMO
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Introduction:
We characterized the association of C-reactive protein (CRP) with
extracellular vesicles (EVs) in plasma from sepsis patients and
assessed a commercial CRP adsorbent (Pentrasorb, Pentracor, Hen-
nigsdorf, Germany) to deplete free and EV-associated CRP. In
addition, we characterized the potential pro-inflammatory effects of
EV-bound CRP on monocytes and endothelial cells.
Methods:
The association of EVs with CRP was characterized by flow cytometry
and Western Blotting. Plasma CRP levels were quantified using ELISA.
To deplete CRP, plasma was incubated with Pentrasorb (10 vol%) for
60 min. Monocytes and human umbilical vein endothelial cells
(HUVECs) were stimulated with isolated EVs (20,000 g, 30 min).
Monocyte IL-8 secretion was quantified by ELISA; the activation of
HUVECs was assessed by their expression of ICAM-1 and E-selectin
using confocal microscopy.
Results:
Septic plasma (n=30) contained 227.0±88.6 mg/L CRP vs. 0.7±0.4 mg/
L for healthy controls (n=5). Both, total EVs and CRP+ EVs were sig-
nificantly elevated in septic plasma as compared to healthy controls
(14,732±14,657 EVs/μL with 45.9±17.2% CRP+ EVs vs. 3,741±2,328
EVs/μL with 0.2±0.2% CRP+ EVs). Incubation of septic plasma with
Pentrasorb resulted in depletion of free CRP (247.2±72.6 mg/L before
vs. 1.8±0.7 mg/L after adsorption) as well as in a significant reduction
in CRP+ EVs (15,053±3,992 EVs/μL with 61.0±5.0% CRP+ EVs before
vs. 6,097±1,973 EVs/μL with 1.8±1.3% CRP+ EVs after adsorption; n=
3). Septic EVs induced a significant release of IL-8 in monocytes as
compared to EVs from healthy donors (3,409.0±3,545 pg/mL, n=7 vs.
1,333.0±202.9 pg/mL, n=4). EVs from CRP- depleted septic plasma in-
duced significantly lower IL-8 levels. HUVEC ICAM-1 or E-selectin ex-
pression, however, did not increase upon stimulation with septic EVs.
Conclusions:
Treatment of septic plasma with Pentrasorb efficiently removes free
CRP and detaches CRP from the EV surface, resulting in reduced pro-
inflammatory effects.
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Introduction:
Circulating monocytes comprise classical (CM, CD14++CD16-), inter-
mediate (IM, CD14++CD16+), and non-classical (NCM, CD14+CD16++)
subsets. Changes in subset distribution, specifically a shift towards
proinflammatory CD16+ monocytes, have been described in various
pathologies including sepsis. We analyzed the distribution of mono-
cyte subsets following monocyte isolation from whole blood and the
potential influence of platelets and platelet-derived extracellular vesi-
cles (EVs) on monocyte subset distribution.
Methods:
Monocyte subsets were characterized by flow cytometry after mono-
cyte isolation by density gradient centrifugation and negative deple-
tion of non-monocytes using two different monocyte isolation
protocols (both from Miltenyi Biotec). The association of monocyteswith platelets (CD41+) and platelet-derived EVs (CD41+lactadherin+)
was assessed by flow cytometry.
Results:
Monocyte subset distribution was comparable for both isolation pro-
tocols (87.5±4.9% vs. 83.7±3.3% CM, 4.8±2.2% vs. 5.4±2.8% IM, 7.7±
5.8% vs. 10.9±5.0% NCM for protocol I vs. protocol II; n=4) and did
not differ from the distribution in whole blood. Isolated monocytes
contained residual platelets and platelet-derived EVs. Overnight stor-
age of isolated monocytes, but not of whole blood, led to a signifi-
cant increase in IM (86.4±6.2% vs. 50.5±11.8% CM, 5.4±2.6% vs. 47.1±
13.4% IM, and 8.2±4.2% vs. 2.4±2.0% NCM at 0h vs. 15h). Flow cy-
tometry confirmed the association of monocytes with platelets and
platelet-derived EVs as well as the uptake of EVs by monocytes.
Conclusions:
Storage of isolated monocytes induces a shift towards CD16 express-
ing proinflammatory monocytes, which seems to be mediated by re-
sidual platelets and platelet-derived EVs. It remains to be clarified
whether EVs released from activated platelets can also trigger a shift
towards proinflammatory, intermediate monocytes in vivo.
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Introduction:
Early recognition of bacterial infection and sepsis is a key step for ini-
tiation of antibiotic treatment. Calprotectin is released by neutrophils
upon their activation and may thus act as a biomarker of inflamma-
tion. This study sought to characterize the kinetics of calprotectin
and compare them to established biomarkers following intravenous
endotoxin challenge.
Methods:
Healthy male volunteers (n=10, mean age 26 years) were adminis-
tered a bolus injection of 2ng/kg endotoxin (CCRE, E.coli O:113 EC-6).
Blood was collected at baseline, 1, 1.5, 2, 4, 6, 8, 24, 48, 72hours and
7 days post injection. Plasma calprotectin was analyzed with a par-
ticle enhanced turbidimetric immunoassay (PETIA, Gentian Diagnos-
tics). CRP was analyzed via The Doctors Laboratory, London.
Procalcitonin was determined via ELISA (Abcam). Ethical approval
was provided by UCL Research Ethics Committee (5060/001). Paired
parametric analyses were performed and data displayed as mean +/-
95% CI.
Results:
Plasma calprotectin concentration began to increase 1.5hours after
endotoxin administration, was significantly higher than baseline by 2
hours (356.7ng/mL vs. 737ng/mL, p <0.01), peaked at 4 hours (mean
1373ng/mL, Figure 1) and normalized by 24 hrs. Calprotectin peaked
earlier than comparator soluble mediators (procalcitonin 8hrs, CRP,
24hrs) and exhibited 100% sensitivity; all participants demonstrating
a minimum 2-fold increase from baseline (mean 3.84x). Calprotectin
displayed greater baseline variability (SD 147.9ng/mL) than either
CRP or procalcitonin.
Conclusions:
Our results indicate the potential of plasma calprotectin as a bio-
marker for bacterial infection. It increases earlier and peaks more rap-
idly than standard biomarkers. Whilst higher baseline variability was
observed, all participants exhibited a significant increase from base-
line to peak concentration. Plasma calprotectin warrants further in-
vestigation as a tool to permit rapid diagnosis and treatment of
infection.
Fig. 1 (abstract P474). Results
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Introduction:
This study analyses the prognostic ability of white blood cell count
(WBC), neutrophil:lymphocyte ratio (NLR) and C-reactive protein(CRP). Hypo- and hyperimmune responses have been associated with
increased mortality from septic shock [1].
Methods:
Patients with septic shock (Sepsis 3.0) admitted to Queen Elizabeth
Hospital Birmingham, between December 2017 and July 2019 were
included. The primary outcome was 90-day mortality. Data was
tested for normality and presented as median (IQR) and analysed
using a Mann Whitney U test. Categorical data was presented as %
and analysed using a chi-squared test. A p value of < 0.05 was used
to determine significance. A multivariate binary logistic regression
analysis was conducted using age, APACHE II, charlson comorbidity
index, performance status, and initial lactate as covariates. A Hosmer
Lemeshow test of >0.05 indicated good fit.
Results:
474 patients were admitted with septic shock. The majority (61%) were
male, with a median age of 64 (55-75) and a 90-day mortality of
37%. On day 1, WBC was lower in patients who died compared to pa-
tients who survived (9 [7-15] vs. 13 [9-21]; p = 0.005). NLR (8 [3-16] vs.
16 [5-33]; p = 0.001) and CRP (99 [31-177] vs. 170 [91-266]; p <0.0001)
were also lower in patients who died compared to survivors. A low
WBC on day 1 (<4) was associated with an increased mortality com-
pared to WBC ≥ 4 (45% vs. 35%; p = 0.01). Multivariate logistic regres-
sion analysis identified that day 1 WBC (OR 0.965 [0.925-1.07]; p = 0.1),
NLR (OR 0.99 [0.97-1.01]; p = 0.69) and CRP (OR 0.97 [0.95-1.02]; p =
0.93) were not independently associated with mortality.
Conclusions:
Patients who died of septic shock had a lower WBC, NLR and CRP re-
sponse early on compared to survivors. This may represent early
immunoparesis that allows infection to propagate unchecked. How-
ever, this was not independently associated with mortality when con-
founding factors were accounted for.
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Introduction:
A specific metabolite of mitochondria – itaconic acid is formed upon pro-
inflammatory activation. The attempts of various researches to find the itaco-
nic acid in peripherical blood of patients with sepsis were unsuccessful [1].
Some phenylcarboxylic acids (PhCAs) are known to be microbial metabolites
and sepsis biomarkers; they also affect the mitochondrial functions [2].
Methods:
Concentrations of PhCAs (phenyllactic, p-hydroxyphenylacetic, p-
hydroxyphenyllactic acids) and mitochondrial metabolites (succinic,
itaconic acids) in 48 serum samples from 8 patients on the 1st day of
diagnosis of sepsis and 35 serum samples from 22 patients with late
stages of sepsis (SEPSIS-3) were measured by gas chromatography–
mass spectrometry; control group – 20 donors.
Results:
Itaconic acid was found in low concentrations (0.5–2.3 μM) only at
early stage of sepsis. The multiple increase in levels of PhCAs and
mitochondrial metabolites were detected in patients with late stage
of sepsis in comparison with early stage and donors, p<0.001. In-
creased succinic acid (up to 100–1000 μM) concentration is the result
of succinate dehydrogenase inhibition by microbial metabolism inter-
mediates (PhCAs), which was confirmed by in vitro experiments in
isolated mitochondria (Fig.1).
Conclusions:
Itaconic acid may be a promising marker in early stage of sepsis,
which needs to be proved.
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Fig. 1 (abstract P476). The mitochondrial and microbial metabolites
contributing to an increase in the level of succinic acid in the blood of
septic patientsP477
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Introduction:
Prediction of severe events in clinical sepsis is challenging. For such
prediction we aimed to compare the novel biomarker calprotectin in
plasma, with routine biomarkers.
Methods:
In a prospective study, blood samples were collected from consecu-
tive patients who triggered the sepsis alert in the emergency depart-
ment in our hospital. C-reactive protein (CRP), procalcitonin,
neutrophils, and lymphocytes were analysed according to routine
practice. P-calprotectin was analysed using a specific particle en-
hanced turbidimetric assay (Gentian Diagnostics AS). The composite
endpoint, which was termed severe event, was defined as death or
admission to the intensive care unit (ICU)/high dependency unit
(HDU) within 48 hours from arrival.
Results:
The study included 367 patients with written informed consent, of
whom 335 were considered to have infection (defined as obtained
blood culture and subsequent antibiotic therapy for at least 4 days
or until discharge or death), and 32 had no infection. Seventy-four
patients (22%) with infection developed a severe event. Mean p-
calprotectin was 2.99 mg/L (standard deviation (SD) 2.10) among pa-
tients with infection and 2.35 mg/L (SD 2.64) among patients without
infection (p=0.02). In patients with infection mean p-calprotectin was
3.81 mg/L (SD 3.18) among those with and 2.75 mg/L (SD 2.50)
among those without a severe event (p=0.006). Analysis of area
under the receiver-operating characteristic (ROC) curve for prediction
of severe events showed superiority for p-calprotectin compared
with procalcitonin and neutrophil-lymphocyte-ratio, both regarding
all sepsis alert cases and regarding the patients with infection (p<0.05 for all comparisons), Fig 1. In addition, there was a trend toward
superior performance compared to CRP (p=0.10 and 0.15).
Conclusions:
In sepsis alert patients, p-calprotectin was elevated in those who sub-
sequently developed severe events. P-calprotectin was superior to
traditional biomarkers for prediction of severe events.P478
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Introduction:
Rapid diagnosis of acute infections and sepsis is critical in Emergency
Departments (EDs). Current tests have slow turnaround times, low
sensitivities, and/or signals from contaminant or commensal organ-
isms. Empirical antimicrobial treatment may result in severe adverse
events and contributes to antimicrobial resistance. Diagnostics to dis-
tinguish bacterial from viral infections and noninfectious etiologies
support clinicians in efforts toward antimicrobial stewardship.
Methods:
In a prospective, non-interventional study in the EDs of 6 sites in
Greece (PROMPT study NCT03295825), we evaluated HostDx Sepsis, a
host response test for suspected acute infections and suspected sep-
sis. HostDx Sepsis measures 29 human mRNA targets and employs
advanced machine learning to differentiate patients with bacterial
and viral infections, and noninfectious etiologies. Adult patients pre-
senting with suspected acute infection and at least one vital sign
change were enrolled. Whole blood RNA was quantified using Nano-
String nCounter. Predicted probabilities of bacterial and viral infec-
tion were calculated (BVN-1 algorithm). Patients were adjudicated in
a retrospective chart review by 3 independent infectious disease spe-
cialists blinded to HostDx Sepsis results.
Results:
Among 396 patients adjudicated as bacterial (56), viral (45), nonin-
fected (1), or indeterminate (294) the Area Under the Receiver Oper-
ating Characteristics (AUROC) of HostDx Sepsis for predicting
bacterial vs. viral/non-infected patients was 0.92, and AUROC for viral
vs. bacterial/non-infected patients was 0.87 (Fig.1).
Conclusions:
Our results indicate that HostDx Sepsis distinguishes bacterial from
viral infections and other etiologies with high accuracy. HostDx Sep-
sis is currently developed as a rapid point-of-care device with a
turnaround-time of less than 30 minutes. HostDx Sepsis may there-
fore assist ED doctors in making appropriate treatment decisions
earlier, towards the ultimate goal of antimicrobial stewardship.
Fig. 1 (abstract P478). HostDx Sepsis scores for (A) bacterial and (B)
viral infection for patients with bacterial, viral, and non-infected
status as determined by consensus physician adjudication
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Introduction:
We studied the diagnostic value of a leukocyte deformability assay
that rapidly quantifies the immune activation signatures of sepsis in
an undifferentiated population of adults presenting to the ED. ED cli-
nicians must balance the benefits of early intervention against the
risks of indiscriminate use of resource-intensive interventions. There
are no currently available rapid diagnostics with acceptable perform-
ance to achieve this balance.
Methods:
We prospectively enrolled adult patients within 5 hours of presentation
with signs of suspicion of infection in two EDs in the USA. EDTA-antic-
oagulated blood was drawn and analyzed using deformability cytome-
try [1]. Procalcitonin (PCT) levels were also measured. Patients were
retrospectively adjudicated for Sepsis-3 by physician committee using
the entire medical record. Diagnostic performance characteristics and
receiver operating curves were used to examine the diagnostic per-
formance of the assay as well as PCT.
Results:
Of the 190 patients enrolled, 17.4% were adjudicated as septic. The
leukocyte deformability assay demonstrated 91% sensitivity, 68%
specificity, and 97% Negative Predictive Value for a single cutoff. The
AUC was 0.86 (Figure 1). PCT with a cutoff of 0.5 ng/mL had 55%
sensitivity, 87% specificity, and 90% Negative Predictive Value. The
AUC for PCT (as continuous variable) was 0.8.
Conclusions:
The leukocyte deformability assay of immune activation signatures
demonstrated superior diagnostic performance for sepsis when com-
pared to PCT. The assay’s diagnostic performance and rapid turn-
around time of 5 minutes may positively impact patient outcomes
while minimizing indiscriminate use of valuable resources in the ED.
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Introduction:
It is already known in literature that high levels of midregional proadre-
nomedullin (MRproADM) are related with organ disfunction in infec-
tions despite of source and pathogens [1]. Similarly, microcirculatory
impairment has been reported in sepsis. We examine the correlation
between microcirculatory disfunction and MRproADM as a sign of early
organ failure.
Methods:
We included 20 consecutive adult patients with suspected infection,
sepsis or septic shock admitted to our Intensive Care Unit (ICU) as
first hospital admission with an expected ICU stay of > 24hours.
MRproADM was measured daily during the first five consecutive days
and sublingual microcirculation was assessed with Incident Dark Field
(IDF) technology at T1, T2, and T5. We collected information on SAPS
II, APACHE scores, and SOFA score for each timepoint.
Results:
Ten patients had septic shock, 5 sepsis and 5 infection. Three pa-
tients died during ICU stay. A MRproADM clearance of 20% or more
between T1 and T2 was found associated with the improvement of
MFI (Mann-Whitney U test, median increase 12.35% versus 2.23%, p=
0.005) (Figure 1). A MRproADM >1.42 nmol/l at the ICU admission
was associated with a worse SOFA score at all the timepoint. More-
over, MRproADM levels at admission was found significantly related
with ICU mortality (AUC 0.941 [0.819-1]; p=0.017). MRproADM shown
no relation with absolute value of MFI.
Conclusions:
The study shows a good correlation between the clearance of the
biomarker and the improvement in MFI. Moreover, our results sup-
port previous findings on the prognostic value of MRproADM in
terms of SOFA and ICU-mortality.
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Fig. 1 (abstract P480). A): Percentage of variation for MFI of small
vessels in the first 24 hours of evaluation, in the 2 groups of patients
(clearance of MR-proADM inferior-to-equal or higher than 20%). P=
0.005 B): ROC curves - SOFA score day1-to-day5 in patients with MR-
proADM >1.42 nmol/l at admission in ICU. SOFA-D1: AUC 0.933
[0.807-1], p=0.009; SOFA-D2: AUC 0.975 [0.911-1], p=0.004; SOFA-D3:
AUC 0.8 [0.601-0.99], p=0.072; SOFA-D4: AUC 0.875 [0.718-1], p=0.024;
SOFA-D5: AUC 0.875 [0.716-1], p=0.024. SOFA score = Sequential Organ
Failure Assessment score
Table 1 (abstract P482). Numbers of datasets and comparisons, and
patient types used in the analysis
# Datasets /
Comparisons
# Case /
Controls
Patients Location Mean
AUC
13 / 35 1640 / 987 Adults ICU, Ward,
ED
0.88
2 / 4 177 / 513 Adults / Pediatric Ward 0.85
7 / 16 417 / 589 Pediatric /
Neonates
ICU, Ward,
ED
0.87
Totals
22 / 55 2234 / 2089 0.87
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Introduction:
The purpose of this study was to clinically validate a new, rapid ver-
sion of the SeptiCyte™ assay on a near-patient testing platform (Bio-
cartis Idylla™). SeptiCyte™ LAB is the first-in-class sepsis diagnostic to
gain FDA-clearance but has a complex workflow and a turnaround
time (TaT) of ~ 6 hours. The assay in Idylla™ cartridge format is called
SeptiCyte™ RAPID.
Methods:
SeptiCyte™ LAB was translated to the Biocartis Idylla™ near-patient
testing platform and analytically validated. For this study, 0.9mL of
peripheral blood PAXgeneTM solution from previously collected pa-
tient samples was pipetted directly into the cartridge and inserted
into the Idylla™ reader. Patients were part of an independent cohort
(N=200) from Intensive Care Units located in the USA and Europe.
SeptiCyte™ RAPID results were reported as a SeptiScore™ between 0
and 10 with higher scores representing higher probability of sepsis.
Assay performance determined included technician hands-on-time
(HoT), assay TaT, failure rates, and Area Under ROC Curve based on
comparison to retrospective physician diagnosis.
Results:
Average HoT was 2 minutes, and average TaT was 65 minutes. Clin-
ical samples could be processed immediately with SeptiCyte™ RAPID
and did not require 2 hour pre-incubation of PAXgene blood, greatly
improving TaT. Correlation of SeptiScore™ values between LAB and
RAPID, based upon a subset of samples run on both platforms, was
very high (R2>0.97). Estimated ROC AUC performance for discriminat-
ing sepsis from non-infectious systemic inflammation (NISI/SIRS) was
similar to that previously reported for SeptiCyte™ LAB.
Conclusions:
This is the first demonstration of a validated, fully-integrated, rapid, re-
producible, near-patient, immune-response sepsis diagnostic, providingactionable results ~ 1 hr, to differentiate sepsis from non-infectious sys-
temic inflammation / SIRS.P482
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Introduction:
The purpose of the study was to demonstrate sepsis diagnostic per-
formance of the biomarkers of SeptiCyte™ in subjects other than crit-
ically ill adults, and in hospital locations other than ICU. SeptiCyte™
LAB was the first immune-response sepsis diagnostic assay to gain
FDA-clearance (K163260) and, as part of gaining this clearance, clin-
ical validation was performed on adult patients admitted to intensive
care (ICU) only [1]. We therefore performed an in silico analysis across
a broad range of patients using the SeptiCyte™ host immune re-
sponse biomarkers and algorithm.
Methods:
Peripheral blood gene expression data, including public and pri-
vate datasets, were chosen based on quality, annotation, and
clinical context for the intended use of SeptiCyte™. Multiple com-
parisons were performed within datasets to better understand
the diagnostic performance in certain cohorts including healthy
subjects. Diagnostic performance was determined using Area
Under Curve (AUC).
Results:
Table 1 shows some characteristics of the selected datasets and
patients, including number of datasets (N=22) and comparisons
(N=55), number of cases (N=2234) and controls (N=2089) used in
comparisons, patient category and hospital location. SeptiCyte™
AUCs for the three groups of adults, adult / pediatric and
pediatric / neonates were 0.88, 0.85, and 0.87 respectively, which
is similar to that previously reported (0.82 – 0.89) [1].
Conclusions:
These results suggest that the SeptiCyte™ signature has diagnostic
utility beyond adults suspected of sepsis and admitted to ICU. This
signature has now been translated to the near-patient testing plat-
form Biocartis Idylla™ (as SeptiCyte™ RAPID) which promises rapid
(~1 hour) diagnosis of sepsis in a broad patient population following
further validation.
References:
1 Miller III RR et al. Am J Rrespir Crit Care Med 198: 903–913, 2018.
Critical Care 2020, 24(Suppl 1):87 Page 200 of 213P483
Open heart surgery interferes with vascular protective
sphingosine-1-phosphate
G Greiwe1, M Winkler2
1University Medical Center Hamburg-Eppendorf, Department of
Anesthesiology, Hamburg, Germany; 2University Medicine Göttingen,
Department of Anesthesiology and Intensive Care Medicine, Göttingen,
Germany
Critical Care 2020, 24(Suppl 1):P483
Introduction:
Especially extracorporeal cardio pulmonary bypass (CPB) is known to
induce severe inflammation. Postoperative inflammation is associated
with a sepsis like syndrome including endothelial barrier disruption,
volume depletion and hypotension. Sphingosine-1-phosphate (S1P)
is a signaling lipid regulating permeability and vascular tone. In sep-
tic humans decreased serum-S1P levels could be identified as marker
for sepsis severity. We addressed three main issues: (1) Are serum-
S1P levels affected by cardiac surgery? (2) Are potential alterations of
serum-S1P levels related to changes of acute-phase proteins, S1P
sources or carrier? (3) Is the invasiveness of the surgery a factor that
may influence serum-S1P levels?
Methods:
46 elective major cardiac surgery patients were prospectively en-
rolled in this study. Serum samples were drawn pre-, post- procedure
and on day 1 and day 4 after surgery. We analyzed S1Pand its poten-
tial sources: Red blood cells (RBC) and platelets. We further quanti-
fied levels of other inflammatory markers and documented other
clinical parameters.
Results:
Median serum-S1P levels in all patients before the procedure were
0.77 (IQR 0.61-0.99) nmol/ml. Serum-S1P levels decrease after sur-
gery, whereas all other inflammatory markers increase. Serum-S1P
levels dropped by 58% in the on-pump and 31% in the off-pump
group. Changes of serum-S1P levels are associated with S1P sources
and carriers: albumin, HDL and vWF:AG activity. Patients with a full
recovery of their serum-S1P levels after surgery compared to their in-
dividual baseline presented with a lower SOFA score (P>0.05) and
shorter ICU stay (P<0.05).
Conclusions:
Serum-S1P levels are disrupted by open heart surgery and levels
might be negatively affected by endothelial injury or loss of S1P
sources. Low serum-S1P levels may contribute to prolonged ICU stay
and worse clinical status. Future studies may investigate the benefi-
cial effects of S1P administration during cardiac surgery.P484
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Introduction:
The aim of study is to measure and correlate the expression of
nCD64, mHLA-DR, PCT (procalcitonin) and qCRP (quantitative C-
reactive protein) to predict development of sepsis and its outcome.
Methods:
In this tertiary centre based longitudinal cohort study, a total 110 pa-
tients were enrolled in whom sepsis was suspected on the basis of
clinical diagnosis and supported by lab investigations. They weredivided into two groups sepsis/case and non-sepsis/control. Disease
severity in ICU was assessed by Sequential organ failure score (SOFA).
Blood samples for routine lab investigations and biomarkers were
taken at the time of admission in ICU before administration of first
dose of antibiotics at time D0/D1. Assessment of biomarkers was
done simultaneously with TLC at D0/D1, D3 and during follow up of
patients till their final outcome.
Results:
There was no significant (p>0.05) mean change in PCT, qCRP, SOFA,
nCD64, mHLA-DR from Day 1 to Day 3, however, mean change was
higher among cases than controls.On comparison of mHLA-DR be-
tween the groups across time periods, mHLA-DR was significantly
(p=0.0001) lower among septic patients than controls at both Day 1
and Day 3. All biomarker correctly predicted cases among different
percentage of patients with different sensitivity and specificity. There
was no significant (p>0.05) association of mortality with the study
biomarkers except for PCT.
Conclusions:
In our study, diagnostic value of PCT in differentiating sepsis from
non-sepsis was similar to nCD64 among all biomarkers studied. No
advantage of nCD64 or mHLA-DR was found over PCT in diagnosis
and correlation with disease progression and mortality.P485
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Introduction:
AQP4 is a water channel protein contributing to astrocyte and im-
mune cells migration, blood-brain barrier maintenance and cell sur-
vival [1-2]. AQP4 genetic variants represent biomarkers associating
with outcome after traumatic brain injury and intracerebral
hemorrhage [3-4]. Linking AQP4 genetic polymorphism to the course
of sepsis has not been studied.
Methods:
Study cohort included 124 ICU patients diagnosed according to
SEPSIS-3 consensus. AQP4 rs11661256 polymorphism was studied by
analyzing PCR products in a 2% agarose gel using an AQP4 specific
polynucleotide tetraprimer set. Data were analyzed by log rank test
(MedCalc 18.11.3), and odds ratios/hazard ratios were computed.
Statistical significance was determined by Fisher test (FT) or Mann-
Whitney test.
Results:
23 of 124 sepsis patients had the minor mutation A for SNP
rs11661256 located within the regulatory 3’ region of the AQP4
gene. Septic shock occurred more frequently in homozygotic carriers
of AQP4 C allele vs. patients with AA or CA genotype: OR=3.75
(95%CI: 1.47-9.56), P=0.006 (FT). Lethality in septic shock patients, n=
85, significantly increased compared to sepsis patients with no shock,
n=39 (82% vs. 20%, P=0.001, FT). Maximum SOFA values were signifi-
cantly lower in patients with minor allele A compared to CC carriers
of (9.6 vs. 12.0, respectively, P=0.008). In post-surgery group of pa-
tients, carriers of AC or AA genotypes had significantly increased sur-
vival compared to patients with CC genotypes: Chi-square=5.804;
HR=0.455 (95%CI: 0.24 -0.863) for lethality; P=0.016 (Figure 1).
Conclusions:
Association of minor allele A of AQP4 SNP rs11661256 with survival
in sepsis patients seems secondary to linking the SNP to decreased
development of multiorgan failure and septic shock that contribute
to mortality.
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Introduction:
Sepsis is an everyday challenge for the intensivist and biomarkers are
useful tools for identification and treatment of this syndrome. We
sought to validate presepsin as a biomarker of sepsis in comparison
to PCT(procalcitonin) and Interleukins (IL-6,IL-8).
Methods:
We enrolled 25 patients,18 men and 7 women average age 58 (39.5-74)
years old, APACHE II 16 (13.5-20.5), SAPS II 48(40.5-58.5), SOFA 8 (6.5-9). 11
patients were septic on admission (according to Surviving Sepsis Campaign:
International guidelines for Management of Sepsis and Septic Shock: 2016),
9 had a septic episode during their hospitalization in the ICU while 5 pa-
tients never endured sepsis. We measured presepsin, procalcitonin, IL-6, IL-
8 during sepsis and on remission.
Results:
All septic patients had increased values of presepsin, PCT, IL-6 and IL-
8 during sepsis with a cutoff value for presepsin 800pg/ml, while the
values of these biomarkers were significantly decreased duringremission or in comparison to non-septic patients(presepsin p =
0.002, PCT p≤ 0.001, IL-6 p≤ 0.001, IL-8 p= 0.004. All patients who
were not septic survived while among septic patients 8 died (40%
mortality). Presepsin correlated significantly with PCT, IL-6 and IL-8
(p<0.05).
Conclusions:
Presepsin is a valid biomarker of sepsis and correlates significantly
with all the other values of PCT, IL-6 and IL-8.P487
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Introduction:
Clinical sepsis phenotypes are proposed at hospital presentation.
These phenotypes, biomarker profiles, and outcomes are not yet
reproduced in prospective data. Even less is known about the bio-
logic mechanism the drives these distinct groups. Thus, we sought to
validate clinical phenotypes and to determine markers of innate im-
munity, coagulation, tolerance and tissue damage in a prospective
cohort.
Methods:
We prospectively studied patients with Sepsis-3 criteria within 6
hours of presentation at 12 hospitals in Pennsylvania (2018-2019)
using automated electronic alerts. Using 29 clinical variables, we pre-
dicted phenotypes (α, β, γ, δ) for each patient using Euclidean dis-
tance anchored to published SENECA phenotype centroids.
Discarded blood was analyzed in a subset (n=160) for markers of in-
nate immunity (e.g. IL-6, IL-10), coagulation (e.g antithrombin III, e-
selectin), tolerance (e.g. HO-1, IGFBP7), and tissue damage (e.g.
serum lactate, bicarbonate)
Results:
Among 549 patients, α-type was present in 146 (27%), β-type in
140 (25%), γ-type in 168 (31%) and δ-type in 95 (17%, Figure 1a).
On average, β-type was older and more comorbid (mean 73, SD
9 yrs; mean Elixhauser 4.6, SD 2.2) with renal dysfunction (median
creatinine 1.8 [IQR 1.1 – 2.9] mg/dL, p<0.01 all). The δ-type had
more acidosis (mean HCO3- 20.1, SD 4.7 mEq/L), higher serum
lactate (median 1.8 [IQR 1.0-3.5] mmol/L, p <0.01 both) and in-
patient mortality (13%, Figure 1b). The γ- and δ-type had greater
markers of innate immunity and abnormal coagulation (e.g IL-6,
ICAM p<0.01 both), while markers of increased tissue damage
(lactate) and poor tolerance (HO-1) were present in δ-type, com-
pared to α-type (Figure 1c).
Conclusions:
The distribution and characteristics of clinical sepsis phenotypes were
reproduced in a prospective validation cohort. Similar to the SENECA
study, distinct biomarker profiles of tissue damage, innate immunity
and poor tolerance were present for the δ-type.
Fig. 1 (abstract P488). CRP kinetics in cytoreductive surgery
Fig. 1 (abstract P487). (A) Phenotype distribution (green: α-type,
purple: β-type, red: γ-type, blue: δ-type) (B) Chord plot with ribbons
connecting individual phenotype to an organ system if the group
mean is greater or lesser than the overall mean for the entire cohort.
(C) Heatmap showing the log of the fold change of the median
biomarker value (column) per patient (row) for various markers of
the septic host response grouped by those reflecting tissue damage,
innate immunity and tolerance by phenotype. Red represents
greater median biomarker value for that phenotype compared to
the median of the entire study, while green represents lower values
of the biomarker compared to the median of the entire study. White
cells are those in which the biomarker was not measured
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Introduction:
The effect that neoadjuvant chemotherapy and hyperthermic intra-
peritoneal chemotherapy (HIPEC) may have in the postoperative kin-
etics of biomarkers remains unknow. Some studies demonstrate that
neoadjuvant chemotherapy and HIPEC do not invalidate the use of
inflammatory markers in postoperative patient monitoring, but none
have compared biomarkers kinetics between patients who under-
went HIPEC or only cytoreduction surgery. Our main purpose was to
identify a difference pattern in C-reactive protein (CRP).
Methods:
We conducted a single-center observational study from January 2015
to November 2019, including all patients who underwent cytoreduc-
tive surgery with or without HIPEC. CRP was measured daily until
seven post-operative day. We compared patients with and without
HIPEC.
Results:
A total of 19 patients were included, 15 were female. Mean age was
63 yrs (44-76). No clinical and demographical differences were ob-
served between groups. No documented infection was found. After
surgery CRP increased markedly in both groups. CRP time-course
from the day of surgery onwards was significantly different in HIPEC
patients (9.78 ± 3.95 mg/dL vs 14.80 ± 5.63 mg/dL; p=0.035). Multiple
comparisons between HIPEC and non HIPEC patients were performed
and CRP concentration was significantly different on the 5th and 7th
POD (Figure 1). No differences were found in other biomarkers (leu-
cocytes and platelets) neither in body temperature.Conclusions:
After a major elective surgical insult CRP levels markedly increase in-
dependently of HIPEC. Serum CRP time-course showed a higher pat-
tern in HIPEC patients despite no infection detected.P489
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Introduction:
Sepsis associated coagulopathy (SAC) is commonly seen in patients
which leads to dysfunctional hemostasis in which uncontrolled prote-
ase generation results in the consumption of clotting factors. The
purpose of this study is to determine the thrombin generation po-
tential of baseline blood samples obtained from SAC patients and
demonstrate their relevance to thrombin generation markers.
Methods:
Baseline citrated blood samples were prospectively collected from 49
patients with SAC at the University of Utah clinic. Citrated normal
controls (n=50) were obtained from George King Biomedical (Over-
land Park, KS). Thrombin generation studies were carried out using a
flourogenic substrate method. TAT and F1.2 were measured using
ELISA methods (Seimens, Indianapolis, IN). Functional antithrombin
levels were measured using a chromogenic substrate method.
Results:
The peak thrombin levels and AUC levels were lower in the SAC pa-
tients in comparison to higher levels observed in the normal plasma
(Table 1). The SAC group showed much longer lag time in compari-
son to the normal group. Wide variations in the results were ob-
served in these parameters in the SAC group. The F1.2 and TAT
levels in the SAC group were much higher in comparison to the nor-
mal. The functional antithrombin levels were decreased in the SAC
group.
Conclusions:
These results validate that thrombin generation markers such as F1.2
and TAT are elevated in patients with SAC. However, thrombin gen-
eration parameters are significantly decreased in this group in com-
parison to normal. This may be due to the consumption of
prothrombin due to the activation of the coagulation system. Thus,
persistent thrombin generation with simultaneous consumption of
clotting factors such as prothrombin contributes to the consumption
coagulopathy observed in sepsis patients.
Fig. 1 (abstract P490). PCT values in patients with positive blood
cultures and patients with negative blood cultures
Table 1 (abstract P489). Comparison of thrombin generation
parameters and markers in normal and SAC plasma samples
Parameters/Markers Normal Plasma (n=50) SAC Samples (n=49)
Peak Thrombin (nM) 160 ± 10.78 82 ± 40
Lag Time (min) 2.7 ± 0.20 4.1 ± 2.05
Area Under Curve (nM*min) 700 ± 17.76 561 ± 283
F1.2 (pmol) 570.0 ± 48 210 ± 25
TAT (ng/ml) 27.9 ± 5.1 2.8 ± 0.8
AT (%) 100 ± 20 64.0 ± 11
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Introduction:
Procalcitonin (PCT) is used in the ICU as an inflammatory marker to
monitor bacterial infections and guide antibiotic therapy. Whether
PCT can predict bacteremia and therefore could prevent expenses at-
tached to bloodcultures is unknown . We investigated whether PCT
can predict the outcome of blood cultures in the ICU and reduce
expences.
Methods:
A single centre observational cohort study was performed in a Dutch
community teaching hospital . Adult patients who were staying in
the ICU and were suspected of bacteremia were included. Simultan-
eously with drawing of blood cultures, samples for PCT measurement
were obtained. Expenses for PCT measurement and bloodcultures
were calculated.
Results:
In the study period of one year, a total of 120 patients were in-
cluded. Three patients were excluded because of incomplete
data. Out of the 117 included patients, ten patients had positive
blood cultures. There was a significant difference in PCT levels
between patients who had positive bloodcultures versus pa-
tients with negative bloodcultures (8.01 ng/ml vs 0.71 ng/ml)
(Figure 1). The negative predictive value for negative blood cul-
tures is 97% when PCT is below 2ng/ml, There was no differ-
ence in CRP levels between the two groups (148 mg/l vs 179
mg/l, p= 0.83).A set of negative blood cultures in our centre
costs 35 euros. Positive blood cultures however costs signifi-
cantly more depending on the micro-organisms found. PCT only
costs 8.50 euros per measurement. So when blood cultures are
omitted when the PCT level is below 2ng/ml, a cost reduction
of 38% can be achieved.
Conclusions:
A PCT value below 2 ng/ml is a good predictor of a negative blood
cultures in ICU patients suspected of bacteremia. PCT guided blood-
culture management in these patients could lead to a significant cost
reductionP491
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Introduction:
Level of cfDNA in plasma is a promising prognostic candidate bio-
marker in critical illness [1]. Oxidized cfDNA (ocfDNA) have not been
studied as a biomarker although its functional role in cellular stress
have attracted attention of researches [2]. The goal of our study was
to assess the early prognostic value of plasma cfDNA/ocfDNA for sep-
sis in a NICU setting.
Methods:
The cohort included 115 NICU patients diagnosed with stroke, intrace-
rebral hemorrhage (ICH), anoxia, encephalopathy. cfDNA was isolated
from day 1 plasma and stained with PicoGreen. Oxidized DNA was de-
termined using DNA immunoblotting with anti-8-oxo-desoxiguanosine
antibodies. Genotyping of allelic variants of the TLR9 rs352162 gene
was performed using a PCR and designed allele-specific tetraprimers
followed by electrophoretic separation of the products Statistics was
performed by the Fisher test and Mann-Whitney test.
Results:
Sepsis was diagnosed by SEPSIS-3 criteria in 35 patients (30.4%).
Average NISU staying was 8,8±11,1 days. Circulating DNA plasma
levels on day 1 predicted the future sepsis development (Figure 1):
OR for cfDNA was 7.54 (95%CI: 3.03-18.76), P<0.001; OR for ocfDNA
was 5.57 (95%CI: 1.64-18.97), P=0.008. Power of both performed tests
with alpha=0.05: 1.0. Log rank test demonstrated better predictive
value of cfDNA vs. ocfDNA (Figure). Concentrations of cfDNA, but not
ocfDNA, on day 1 significantly positively correlated with maximum
SOFA values during hospitalization, day 3 and pre-outcome leukocyte
count and neutrophil-to-lymphocyte ratios in a limited cohort of
NISU patients with TLR9 rs352162 CC genotype and not in other pa-
tients with genotype TLR9 CT+TT.
Conclusions:
Increased level of plasma cfDNA better then ocfDNA predicts sepsis
development in NISU. Further studies are warranted to clarify the
Critical Care 2020, 24(Suppl 1):87 Page 204 of 213possible utility of TLR9 rs352162 polymorphism determining for sep-
sis risk stratification early on NISU admittance.
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HBP versus qSOFA score
Fig. 1 (abstract P491). Circulating DNA not oxiDNA predicts
sepsis developmentP492
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Introduction:
Heparin binding protein (HBP) is released from activated neutrophils
upon stimulation of b2 integrins. This pro-inflammatory effect gener-
ates the hypothesis that it can be a sepsis biomarker for patients ad-
mitted at the emergency department (ED)
Methods:
The PROMPT study (ClinicalTrials.gov NCT03295825) took place at the
ED of six Greek hospitals. Participants were admitted with suspected
acute infection and at least one vital sign change. HBP was measured
by an enzyme immunosorbent assay in plasma. Sepsis was diag-
nosed by the Sepsis-3 criteria. The primary study endpoint was the
sensitivity for the diagnosis of sepsis. Outcome prediction was the
secondary endpoint.
Results:
A total of 371 patients were enrolled; 166 had sepsis. The most com-
mon infections among patients without and with sepsis were upper
respiratory tract infections in 30.2% and 1.2%; community-acquired
pneumonia in 6.8% and 28.3%; and acute pyelonephritis in 9.3% and
28.3%. Median HBP was 24.0 and 32.7 ng/ml respectively (p: 0.027).
Following analysis of the area under the curve (AUC) it was found
that the best discriminatory cut-off for sepsis was 19.8ng/ml. The
comparative diagnostic performance of HBP versus qSOFA score is
shown in Figure 1. The odds ratio for sepsis with HBP above 19.80
ng/ml was 2.07 (p: 0.001). At the same cut-off point the sensitivity,
specificity, positive predictive value (PPV) and negative predictive
value (NPV) for the prediction of early death after 72 hours was
100%, 35.7%, 4.1% and 100% respectively.Conclusions:
HBP is more sensitive but less specific than qSOFA for the diagnosis
of sepsis in the ED. The rule-out prediction of early death seems the
great merit.P493
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Introduction:
Rhythmicity and complexity of several circadian biomarkers, such as
melatonin, cortisol and temperature have been found to be modified
by critical illness.
Methods:
We examined the potential alterations of core body temperature (CBT)
fluctuations and complexity in three groups (N=21): patients with septic
shock upon ICU admission (Group A, N=10), patients who developed
septic shock at ICU hospitalization (Group B, N= 6) and controls (Group
C, N=5). The hourly, average CBT was computed for 24 h upon ICU ad-
mission and discharge in Groups A and C, as well as during septic
shock onset in Group B. Cosinor analysis of CBT curves was performed
leading to the estimation of mesor (mean value), amplitude (the differ-
ence between peak and mean values) and acrophase (phase shift of
maximum values in hours). Complexity of CBT signals was evaluated
with Recurrence Quantification Analysis (RQA).
Results:
No significant alterations in any circadian feature within groups were
found, except for amplitude. Controls exhibited increased entry CBT
amplitude (0.45 ± 0.19) compared to Groups A (0.28 ± 0.18, p < 0.05)
and B (0.32 ± 0.13, p < 0.05). Higher entry CBT amplitude in Groups
B and C was related with lower SAPS II (r = -0.72 and -0.84, p <
0.003) and APACHE II scores (r = -0.70 and -0.6, p < 0.003) respect-
ively, reduced ICU and hospital stay in Group B (r = -0.62 and -0.64, p
< 0.003) and entry SOFA score in Group C (r = -0.82, p < 0.003). Re-
covery CBT time series appeared more periodic in relation with ICU
entry, for all groups. A more random CBT signals pattern upon
Critical Care 2020, 24(Suppl 1):87 Page 205 of 213admission was related with higher severity of illness and extension of
ICU stay for all groups.
Conclusions:
Reduced CBT fluctuations upon ICU admission was found to more se-
verely ill patients with worse clinical outcomes, while the more peri-
odic CBT patterns were correlated with high CBT rhythmicity and
better outcome.Fig. 1 (abstract P494). a Age-adjuste cumulative incidence of BSI
among men and women. Fig 1b Age-adjusted cumulative mortality
in BSI patients, among men and womenP494
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Introduction:
The impact of sex on sepsis incidence and mortality have been eluci-
dated in previous studies, and sex is increasingly recognized as one
key factor in sepsis [1]. Some studies indicate that women have bet-
ter immunologic responses to infections [2]. Later investigations as-
sume this advantage is linked to immune modulating genes located
on the X-chromosome [3]. The purpose of this study is to reveal sex
differences in incidence of and mortality of sepsis in a large
population-based cohort.
Methods:
64049 adult participants in the HUNT2 study (1995-97) were followed
from inclusion through end of 2011. Incident bloodstream infections
(BSI) from all local and regional hospitals in Nord-Trøndelag county
were identified through linkage with the Mid-Norway Sepsis Register,
which includes prospectively registered information on BSI used as a
specific indicator of sepsis. We estimated age-adjusted cumulative in-
cidence of first-time BSI and compared the risk of a first-time BSI and
BSI mortality in men and women using age-adjusted Cox propor-
tional hazard regression.
Results:
During a median follow-up of 14.8 years 1840 individuals experi-
enced at least one episode of BSI, and 396 died within 30 days after
a BSI. Cumulative incidence and cumulative mortality curves are
shown in Fig. 1a and 1b. BSI risk was higher among men (HR 1.39
95%CI 1.26–1.52), also BSI mortality was higher among men (HR 1.79
95%CI 1.46-2.19). In analyses of the most common bacteria, men
showed higher risk of BSI caused by S. aureus (HR 2.09 95%CI 1.58-
2.75) and S. pneumoniae (HR 1.36 95%CI 1.05-1.76), while E. coli did
not show sex differences (HR 0.97 95%CI 0.83-1.13).
Conclusions:
Male sex is associated with increased risk of BSI and BSI mortality
caused by Gram-positive bacteria. Sepsis is a global burden, and it us
of urgent importance to reveal the aetiology of this sex disparity in
sepsis.
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Introduction:
The proportion of hospital-acquired infections (HAI) among sepsis pa-
tients is unknown in Germany. Systematic differences in HAI foci be-
tween sepsis patients with and without ICU treatment are
insufficiently described.
Methods:
Retrospective cohort study based on nationwide health claims data
of the German statutory health insurance AOK. Incident inpatient
sepsis cases were identified in 2013/2014 among insured persons
>15y without preceding sepsis in 24 months prior to index
hospitalization. Sepsis was defined according to explicit sepsis ICD-
10-codes (incl. severe sepsis/septic shock). HAI were defined based
on specific ICD-10-codes for surgical site infection, catheter-
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infections, nosocomial pneumonia, central-line associated blood-
stream infection (CLABSI) and other nosocomial infections. ICU treat-
ment was identified by OPS-codes for intensive care complex
treatment.
Results:
Among 23.011.601 individuals, 159.691 received inpatient treatment
for sepsis. 41% had severe sepsis. 21% of sepsis and 28% of severe
sepsis patients had an explicitly coded HAI. The proportion of HAI
was higher in patients that received ICU-treatment than in patients
without ICU-treatment (35% in ICU/14% in Non-ICU sepsis, 37% in
ICU/17% in Non-ICU severe sepsis patients). Tab. 1 shows the foci of
explicitly coded HAI. Nosocomial pneumonia was the most common
HAI in all patient groups. CLABSI occurred more frequently in ICU-
treated patients; 21% were affected. CAUTI and C. diff infections were
more common among Non-ICU-treated sepsis patients. More than
one quarter of Non-ICU-treated sepsis patients had a C. diff infection.
Conclusions:
HAI are common causes of sepsis and pose a significant healthcare
burden. The proportion of patients affected and the distribution of
foci differ between Non-ICU- and ICU-treated sepsis patients with im-
portant implications for sepsis management within hospitals.Table 1 (abstract P496). Sepsis managements and outcomes
Sepsis managements and outcomes Pre-protocol n=
141
Post-protocol n=
141
P
Initial Laboratory measurement n(%) 138(97.9) 140(99.3) 0.32
Initial lactate measurement n(%) 46(32.6) 90(63.8) 0.00
Blood culture taking before
antibioticsn(%)
137(97.2) 140(99.3) 0.18
Time to antibiotics less than 1
hour(%)
53(37.6) 80(56.7) 0.00
Fluid management n(%) 22(15.6) 51(36.2) 0.00
ICU Length of stay,days, median
(IQR)
10.0 (5.0 – 20.5) 8.0 (3.0 – 16.5) 0.01
In-hospital mortality, n(%) 51(36.2) 44(31.2) 0.39
Table 1 (abstract P495). Foci of explicitly coded HAI in sepsis patients
ICU-treated
Sepsis (n=
54,319)
Non-ICU-
treated Sepsis
(n=105,372)
ICU-treated
Severe Sepsis
(n=34,999)
Non-ICU-treated
Severe Sepsis
(n=29,993)
Explicitly
coded HAI, n,
Among them:
19,091 14,312 12,897 5,206
Nosocomial
pneumonia, n,
%
10,300
(54%)
4,758 (33%) 7,380 (57%) 2,091 (40%)
Surgical site
infection, n, %
1,934 (10%) 1,862 (13%) 1,177 (9%) 533 (10%)
CLABSI, n, % 3,960 (21%) 2,033 (14%) 2,565 (20%) 613 (12%)
CAUTI, n, % 1,124 (6%) 1,416 (10%) 824 (6.4%) 545 (10%)
Clostridium
difficile
infection, n, %
3,107 (16%) 3,851 (27%) 2,107 (16%) 1,450 (28%)
Other
nosocomial
3,825 (20%) 1,904 (13%) 2,478 (19%) 638 (12%)infections, n, %P496
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Introduction:
Sepsis is now early identified and managed during triage in the
emergency department. However, there is less focus on the effect of
patients’ management at the ward level. We aim to evaluate the im-
pact of the implementation of the sepsis protocol on clinical out-
comes in in-patients with new-onset sepsis.
Methods:
We conducted a prospective observational cohort study among adult
medical patients admitted to the general wards in a universityhospital. A 25-month pre-protocol period (August 2016 to August
2018) was assigned to a control group, and a 14- month protocol
period (September 2018 to October 2019) was allocated to a proto-
col group. An in-patient sepsis protocol comprised nurse-initiated
sepsis protocol by Ramathibodi early warning score (REWS)≥ 2 plus
suspected infection, prompt antibiotic, lactate measurement, and
fluid resuscitation was implemented.
Results:
282 patients were evaluated (141 pre-implementation, 141 post-
implementation). 95.7% of sepsis patients have REWS ≥2. More pa-
tients in protocol period had lactate measured [90 pts (63.8%) vs. 46
pts (32.6%), P=0.00] and fluid management [51 pts (36.2%) vs.22 pts
(15.6%), P=0.00]. More patients in protocol period received antibiotics
within 1 hr of presentation compared with pre-protocol period [80
pts (56.7%) vs.53 pts (37.6%), P=0.00]. The length of ICU stay was
shorter in sepsis patients in the protocol period [8 days (3, 16.5)
vs.10 days (5, 20.5), P<0.05]. There was no difference for in-hospital
mortality between both groups (Table 1).
Conclusions:
The implementation of in-hospital sepsis protocol was associated
with significant improvement in patients’ outcomes, namely lactate
measurement, starting antibiotic within 1 hr, fluid management, and
the shorter length of ICU stay.P497
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Introduction:
Routine nursing procedures (NP) can interfere with blood pressure
and cardiac output and may therefore alter cerebral hemodynamics
in critical illness. This may be risk factor of sepsis-associated
encephalopathy.
Methods:
20 sedated and mechanically ventilated pigs were randomized to
fecal peritonitis or controls (n=10, each). After 8 hours of untreated
peritonitis, the animals were resuscitated for 76 hours (resuscitation
period). NP [assessment of sedation (AS), tracheal suctioning (TS),
change in body position (CP), lung recruitment maneuver (RM)] were
performed at baseline and 8h, 32h, 56h and 72h after start of RP. Sys-
temic and cerebral hemodynamics and O2 saturations were recorded
continuously.
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After sepsis induction, mean arterial pressure (MAP) decreased by 15
(7-22) mmHg, cardiac output by 1.3 (0.7-2.2) L/min and arterial lac-
tate increased by 0.2 (0.1-0.5) mmol/L. Intracranial pressure (ICP) was
not affected. In controls, NP decreased MAP (max. 23±11mmHg) and
increased ICP (max. 3.0±1.4mmHg). Cerebral perfusion pressure (CPP,
max. 26±11mmHg) and carotid arterial flow decreased (max. 79±
27ml/min). Thus, cerebral O2 delivery (DO2, max. 0.58±0.33ml/min/
kg) and superior sagittal sinus O2 saturation (SssO2, max. 20±15%)
decreased markedly, despite maintained arterial O2 saturation (all p<
0.05). The alterations recovered within 1 min after end of NP. The ef-
fects of NP on CPP, DO2 and SssO2 were attenuated during the resus-
citation period. NP with most impact on SssO2 were TS, CP and RM.
In septic animals, NP led to similar changes as in controls. Higher
SssO2 values in sepsis – both before and after NP - were the result of
numerically higher cerebral DO2 and lower O2 consumption (VO2).
Conclusions:
NP impaired cerebral O2 transport similarly in control and in septic
animals, but the changes were short lasting and attenuated during
the course of treatment. In septic animals, cerebral VO2 was numeric-
ally lower than in controls, despite numerically higher DO2.P498
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Introduction:
Elevated renin is associated with an increased risk of death in pa-
tients with vasodilatory shock (VS). Recent data show that patients
with VS and elevated renin levels have improved survival when
treated with angiotensin II (Ang II) + standard care (SC) vs placebo +
SC. Patients with acute respiratory distress syndrome (ARDS) can de-
velop angiotensin-converting enzyme (ACE) defects that can lead to
elevated renin levels and insufficient endogenous Ang II production.
We hypothesized that patients with severe ARDS and elevated renin
shock would have improved survival when treated with Ang II + SC
vs placebo + SC.
Methods:
In the randomized, placebo-controlled, double-blind ATHOS-3 study,
321 patients with severe VS receiving >0.2 μg/kg/min of norepineph-
rine or the equivalent were randomized to intravenous Ang II (n=
163) or placebo (n=158). In a post hoc analysis, we assessed the sub-
set of patients with elevated renin (defined as a renin level greater
than the median value of the overall ATHOS-3 population) and ARDS
(defined by a PaO2/FiO2 ratio <300) at the time of randomization.
Survival to 28 days was compared between the Ang II group (n=41)
and the placebo group (n=61).
Results:
In patients with elevated renin and ARDS, baseline age, Acute Physi-
ology and Chronic Health Evaluation II score, and blood pressure
were similar in the Ang II and placebo groups. The median serum
renin level was 459.5 pg/ml (IQR: 285.8-1036.0) compared to the nor-
mal range for serum renin: 5-58 pg/ml. A significantly higher propor-
tion of patients receiving Ang II survived to day 28 compared to
those in the placebo group (51% vs 31%; p=0.01).
Conclusions:
Elevated renin identified patients with VS and ARDS who were most
likely to gain a survival benefit from Ang II. Elevated renin is likely
caused by an ACE defect and may describe an important subset of
patients with a biotype that responds well to Ang II therapy.P499
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Introduction:
Elevated renin levels have been shown to be associated with an in-
creased risk of death and more severe acute kidney injury (AKI) in pa-
tients with vasodilatory shock (VS). Recent data show that patients
with VS and elevated renin levels have improved survival when
treated with angiotensin II (Ang II) + standard care (SC) vs placebo
(PBO) + SC. We hypothesized that VS patients with severe AKI and el-
evated renin levels would have improved survival and enhanced
renal recovery with Ang II treatment.
Methods:
In the randomized, PBO-controlled, double-blind ATHOS-3 study, 321
patients with severe VS received >0.2 μg/kg/min of norepinephrine
or the equivalent and were randomized to intravenous Ang II + SC
(n=163) or PBO + SC (n=158). In a post hoc analysis, we assessed the
subset of patients with elevated renin (defined as a renin level
greater than the median value of the overall ATHOS-3 population)
and severe AKI (defined as those with AKI requiring renal replace-
ment therapy [RRT] at baseline). Survival and renal recovery were
assessed in patients treated with Ang II + SC (n=45) and PBO + SC
(n=60).
Results:
In patients with elevated renin and severe AKI, baseline age, Acute
Physiology and Chronic Health Evaluation II score, and blood pres-
sure were similar between Ang II + SC vs PBO + SC. The median
baseline serum renin level in the whole group was 352.5 pg/ml (IQR:
115.9-785.4; normal range for serum renin: 5-58 pg/ml). A signifi-
cantly higher proportion of patients receiving Ang II + SC vs PBO +
SC survived to day 28 (43% vs 22%, respectively; p=0.03). Ang II re-
cipients also had a higher rate of discontinuation from RRT by day 7
(43% vs 12%; p=0.04).
Conclusions:
In this study, elevated-renin shock patients with AKI treated with Ang
II + SC gained a survival benefit and earlier discontinuation from RRT
compared to those receiving PBO + SC. Elevated renin is likely
caused by an angiotensin-converting enzyme defect and may iden-
tify those patients with a biotype that responds well to Ang II
therapy.
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Introduction:
Most clinical trials conclude the ineffective use of anticoagulation for
sepsis-induced coagulopathy [1]. However, post hoc analyses of ran-
domized control trials report positive results [2], suggesting anticoa-
gulation is effective in specific populations exhibiting coagulopathy.
Further, anticoagulants should be administered in the early phase
[3]; however, methods for precisely predicting the progression of
Critical Care 2020, 24(Suppl 1):87 Page 208 of 213sepsis-induced coagulopathy are not established. This study aimed
to create and evaluate a prediction model of coagulopathy progres-
sion using machine-learning techniques.
Methods:
We performed a subgroup analysis of data from a retrospective co-
hort study involving adult septic patients in 40 Japanese institutions
from January 2011 to December 2013 and used the Japanese Associ-
ation for Acute Medicine disseminated intravascular coagulation
(DIC) score as a DIC severity index test. The predictive ability of ΔDIC
([DIC score on Day 3] – [DIC score on Day 1]) was evaluated using
various statistical methods. Using variables available at the outset,
we compared the predictive ability of Random Forest (RF) and Sup-
port Vector Machine (SVM) with that of multiple linear regression
analysis.
Results:
A total of 1110 adults with sepsis were included in the analysis. The
Root Mean Square Error in ΔDIC score for the multiple linear regres-
sion analysis model was 2.1168 compared with values of 1.6508 and
1.9394 for RF and SVM, respectively. Thus, the RF method predicted
the progression of sepsis-induced coagulopathy more accurately
than multiple linear regression analysis.
Conclusions:
RF, a machine-learning technique, was superior to multiple linear re-
gression analysis in predicting the progression of sepsis-induced co-
agulopathy. This prediction model might enable us to use
anticoagulation in an early phase.
References:
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Introduction:
This study examined the efficacy and safety of landiolol, an ultra-
short-acting β1-blocker, for treating sepsis-related tachyarrhythmia,
according to patient background characteristics.
Methods:
The J-Land 3S study (JapicCTI-173767) was conducted in patients
with sepsis, diagnosed according to the Sepsis-3 criteria, and tachyar-
rhythmia (atrial fibrillation, atrial flutter, or sinus tachyarrhythmia).
The patients had a mean heart rate of ≥100 beats/min and required
catecholamine administration to maintain a mean blood pressure of
≥65 mmHg. The efficacy endpoint was the percentage of patients
whose heart rate could be controlled within 60–94 beats/min at 24 h
of registration. The safety endpoint was the incidence of adverse
events within 168 h of registration. Subgroup analyses of efficacy
and safety were performed after stratifying the patients according to
various patient background characteristics.Results:
A total of 151 patients were randomized, 76 to landiolol and 75 to the con-
trol group. The efficacy endpoint, percentage of patients with a heart rate
of 60–94 beats/min at 24 h of registration, was significantly higher in the
landiolol group (54.7% vs 33.3%; Mantel–Haenszel test: p = 0.0031). The in-
cidence of adverse events was 63.6% and 59.5% in the landiolol and con-
trol groups, respectively, and there was no difference between the two
groups. Most adverse events were related to sepsis or septic shock. The
subgroup analyses showed that no patient background characteristic clearly
affected the efficacy and safety of landiolol.
Conclusions:
Landiolol is a well tolerated and effective therapeutic agent for con-
trolling heart rate in patients with sepsis-related tachyarrhythmias; its
safety and efficacy were not affected by the patient background
characteristics investigated.
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Introduction:
Near-infrared Spectroscopy (NIRS) was proposed as a concept in the
end of 20th century. This method offers noninvasive monitoring of
oxy- and deoxyhemoglobin in tissues.NIRS could be measured on the
thenar or forehead within few santimeters of the skin. It was first ap-
plied as a monitoring in cardiovascular surgery.
Patients with sepsis have changes in the microcirculation which are
important target for therapy. Invasive monitoring of oxygen delivery
and consumption has been used in patients with sepsis but as every
invasive technique such a monitoring hides risks. NIRS offers a nonin-
vasive method for tissue oxygenation monitoring (StO2) and could
be useful in patients with sepsis and septic shock. The aim of the
study is to compare noninvasive tissue oxygenation monitoring with
hemodinamic monitoring and lactate values in patients with sepsis
Methods:
The study includes 19 critically ill patients in ICU of UMHAT Alexan-
drovska, Sofia. 10 of the patients fullfil the criteria for septic state.
The other 9 patients do not have sepsis. In both group of patients
are measured tissue oxygenation with INVIOS monitor, mean arterial
pressure, oxygen saturation in mixed venous blood and lactate
values during 72 h after ICU admission.
Results:
Patients with sepsis are reported with significantly lower values of tissue oxy-
genation, compared to patients without sepsis. The values of tissue oxygen-
ation correlate well with the mixed venous blood oxygenation, mean arterial
pressure and lactate values but not significantly with APACHE scores.
Conclusions:
NIRS when used for tissue oxygenation monitoring correlates well
with the hemodinamic monitoring and lacate values in patients with
sepsis and could be used as an noninvasive monitoring for guiding
teurapeutic strategies. Tissue oxygenation monitoring has no linear
correlation with the severity of illness in patients with sepsis and
could not be reccomended as a guidance in the early ressuscitating
stage of sepsis. Further investiganions in these field are needed.
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Introduction:
Digitization of health data enables development of virtual care pro-
viders. In early sepsis care, development of such technologies,
Critical Care 2020, 24(Suppl 1):87 Page 209 of 213through reinforcement learning and other strategies, first requires un-
derstanding the sequence of vital sign or laboratory measurements
and treatments. Thus, we explored patterns of data availability and
intravenous (IV) fluid/vasopressor administration in a sepsis cohort.
Methods:
We analyzed a retrospective cohort of electronic health records from
adult sepsis patients at 12 UPMC hospitals from 2010 to 2014. We
defined Sepsis-3 by i.) suspected infection (e.g., administration of an-
tibiotics or body fluid culture) & ii.) organ dysfunction (e.g., 2 or more
SOFA points) in the first 6 hours of care. Data were organized by
hour and included vital signs, lab values, and treatments (e.g., total
hourly IV fluids (mL) and norepinephrine equivalent dose). For each
hour we describe, i.) available data elements, ii.) presence of Sepsis-3,
and iii.) treatment patterns.
Results:
We studied 71,272 sepsis patients (median age 68, [IQR, 56-81] years;
34,384 [48% male]. During Hour 1, vital signs were measured in 70%
(n=49,890), lab values (e.g. complete blood count) in 51% (n= 36,348),
fluid culture in 46% (n=32,785) and serum lactate in 10% (n=
7,172, Fig1A). By Hour 6, most patients had vital signs (99%; n=70,559),
basic labs (88%; n=62,719), fluid cultures (94%, n= 66,995), while serum
lactate was completed in 24% (n=17,818). These data contributed to
Sepsis-3 criteria in Hour 1 in 78% (n=55,592) and 100% by hour 5
(Fig1B). Amidst this changing background, IV fluids were given in 17%
(mean volume, 166 mL [SD, 411]) and vasopressors in 1% (n=712) in
Hour 1. By Hour 6, all received fluids, (mean volume, 1170 mL [SD,
979]), and 80% (n=57,018) received a vasopressor (Fig1C).
Conclusions:
Early sepsis care patterns are variable. IV fluids were given during
early hours, when uncertainty about sepsis was greatest, while vaso-
pressors were administered after Sepsis-3 elements were present.Fig. 1 (abstract P503). (A) Heatmap of available data elements per
hour. X-axis represents hour after hospital arrival; y-axis represents
physiologic or laboratory variable. Dark blue corresponds to no
missing variables; white corresponds to 100% missing. (B) Time-to-
event plot of Sepsis-3 elements, overlaid on cumulative proportion
of patients with Sepsis-3. X-axis is hour after hospital arrival. (C)
Patterns of IV fluid and vasopressor prescriptions per hour. X-axis
represents hour after hospital arrival. Left y-axis corresponds with
line graph and purple bars, which represent the cumulative density
of sepsis patients and proportion of patients receiving vasopressors,
respectively. Right y-axis corresponds with blue bars and represents
mean IV fluid volume administered per hour; error bars represent
standard deviationP504
Effects of abdominal negative pressure treatment on splanchnic
hemodynamics and liver and kidney function in a porcine fecal
peritonitis model
SL Liu1, BS Schnüriger2, DC Casoni3, AK Kohler2, SJ Jakob1
1Inselspital, Department of Intensive Care Medicine, Bern, Switzerland;
2Inselspital, Department of Visceral Surgery and Medicine, Bern,
Switzerland; 3Department for Biomedical Research, Experimental Surgery
Facility, Department for Biomedical Research, Bern, Switzerland
Critical Care 2020, 24(Suppl 1):P504Introduction:
The effects of abdominal negative pressure treatment (NPT) on
splanchnic hemodynamics after abdominal surgery for sepsis are not
well known.
Methods:
Twenty mechanically ventilated pigs underwent surgery for splanch-
nic hemodynamic monitoring under general anesthesia, followed by
analgo-sedation and randomization to fecal peritonitis or controls
with/without NPT (ABThera, KCI, US) (n=5/group). After 8 hours of un-
treated peritonitis, animals were resuscitated w/wo NPT for 76 hours
(resuscitation period, RP). Splanchnic hemodynamics and laboratory
parameters were measured at baseline (BL, start of RP), and 24h, 48h
and 72h after start of RP. Two/three-way RM-ANOVA or mixed-effects
analysis, and Student t tests were performed.
Results:
NPT in controls had no effect. After sepsis induction, mean arterial
pressure (MAP) decreased by 15 (7-22) mmHg, cardiac output (CO)
by 1.3 (0.7-2.2) L/min, and arterial lactate increased by 0.2 (0.1-0.5)
mmol/L. Sepsis and resuscitation was associated with increasing hep-
atic and renal arterial flows (p≤0.002, both), and increasing prothrom-
bin time [max. increase 1.4 (0.3-2.9) sec], aspartate aminotransferase
[max. increase 70 (49-79) IU] and creatinine [max. increase 72 (59-85)
μmol/L; all p≤0.005]. MAP, CO, or hepatic/renal hemodynamics and
functions were not affected by NPT. Nevertheless, NPT in sepsis re-
sulted in numerically less noradrenaline administration (0.3±0.3 ug/
min/kg in sepsis with NPT vs. 0.8±0.7 ug/min/kg without NPT, p=
0.310) and positive fluid balance (2.8±0.4 ml/h/kg with NPT vs. 3.1±
0.4 ml/h/kg without, p=0.241).
Conclusions:
In our experimental fecal peritonitis model, NPT did neither impair
splanchnic hemodynamics nor abdominal organ function. Whether
NPT helps to reduce noradrenaline and volume administration in ab-
dominal sepsis should be evaluated in further studies.
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Introduction:
Shock is the most common cause of death in the postsurgical ICU,
including septic shock and hypovolemic shock, reaching the 50–60%
mortality in septic shock. The inadequate response of the immune
system to the infection triggers a potent inflammatory cascade,
where the C-Reactive Protein (CRP) is an essential key in the amplifi-
cation and maintenance of this cascade. The gene encoding to CRP
is located on the proximal long arm of human chromosome 1 (1q32).
The GT polymorphism in the promoter sequence of CRP gene
(rs2794521) has been associated with invasive pneumococcal disease.
Thus, we analyze the relationship between rs2794521 polymorphism
and the risk of developing septic shock in postsurgical patients.
Methods:
An observational, retrospective and single-center study was con-
ducted on a sample of Caucasian patients undergoing major abdom-
inal surgery, of which one part developed septic shock and another
part developed systemic inflammatory response syndrome, who
were used as control. The rs2794521 polymorphism was analyzed by
Critical Care 2020, 24(Suppl 1):87 Page 210 of 213the Sequenom´s MassARRAY platform and a recessive inheritance
model was selected (CC vs TT/CT).
Results:
The possible association between the CC recessive form of the
rs279451 polymorphism and the septic shock risk was analyzed, dem-
onstrating a statistically significant relationship (p=0.02) between both
conditions. Among patients who developed septic shock, 79.2% pre-
sented a recessive inheritance pattern while 54.5% showed the CT/TT
genotype. On the other hand, those patients with the recessive form of
the rs279451 polymorphism were selected and a statistical analysis was
performed comparing those patients who developed septic shock from
those who did not develop it, obtaining a statistically significant rela-
tionship (p=0.036) between the presence of the recessive form of poly-
morphism and the likelihood of developing septic shock.
Conclusions:
The recessive form of rs279451 polymorphism is a risk factor for sep-
tic shock in post-operative patients of major abdominal surgery.P506
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Introduction:
Sepsis remains one of the major causes of morbidity with mortal-
ity rates as high as 50 % worldwide, representing significant clinical
challenge to confront highly intangible therapeutic needs. RNA-
based structures are emerging as versatile tools encompassing a var-
iety of functions capable to bypass the current protein- and cell-
based therapies. RNA aptamers act as disease-associated protein an-
tagonists. Here, the effects of an aptamer, Apta-1, were evaluated in
animal models that mimic systemic inflammation in humans.
Methods:
High dose of LPS endotoxin was used to induce systemic inflammation in
mice and in non-human primate animal models. Apta-1 was administered
intravenously in two doses post LPS infection. Animals were monitored and
blood samples collected up to 72 hours after Apta-1 administration.
Healthy- and LPS-only treated animals served as control groups. Complex
analyses of clinical parameters, hematology, serum biochemistry, inflamma-
tion and tissue damage markers were performed.
Results:
Apta-1 increased survival of endotoxin challenged animals up to 80%
in a dose-dependent manner and exerted profound effects on well-
being and recovery of healthy eating habits. Administration of Apta-
1 led to delayed coagulation and enhanced fibrinolysis; maintained
the complement cascade activated while preventing it from further
amplification. Expression of pro-inflammatory cytokines was reduced
while anti-inflammatory increased. Endogenous pro-inflammatory
molecules (DAMPs), secreted from injured cells, were preserved at
healthy level in animals treated with Apta-1.
Conclusions:
Systemic inflammation and sepsis lead to severe dysregulation of
several arms/axis of innate immune response. Our studies showed
that Apta-1 affects various components of this system and re-
stores the organism’s control over its dysregulated immune re-
sponse. Thus, Apta-1 might be a promising potential therapeutic
candidate to treat life-threatening conditions such sepsis.
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Surgical septic shock is associated with high morbidity & mortality espe-
cially when associated with organ dysfunction. The aim of this study was to
study the incidence & predictors of organ failure & mortality in surgical sep-
tic shock on admission to the SICU after surgical source control
Methods:
This prospective observational study was done in 220 (age≥18 yrs)
septic shock pts on admission to the SICU after surgical source con-
trol between Oct 2014-Sep 2019. Pts with preadmission ARDS, ESRD,
stroke&delirium were excluded. Study data included: pts demo-
graphic, comorbidities, ASA class, source of infection, time of first
antibiotic, shock reversal & source control, used of NE or other vaso-
pressor/inotrope,steroid,intraop resuscitation & complications. First
72 hr data included admission& average Hb, serum albumin& lactate;
fluid/blood replacement & balanced; organ failure as stroke, deliriu-
m,ARDS & AKI (KEDIGO criteria), 7days& 28days mortality.
Results:
Among the study pts (age 67.9±14.5 yrs), 82% was ASA III, admission SOFA
score 2.9 ±2.1, 82% were cancer. 66% had intraabdominal infection, 38%,
6%, 3%,14 & 22%had AKI, ARDS,delirium,7 & 28 days mortality subse-
quently. Eight patients develped cardiac arrest during anesthesia induction.
From multivariate analysis showed age >75 yrs, smoker, GFR<40 ml/min, in-
adequate preop/intraop fluid resuscitation & overused NE/inotrop, admitted
Hb<9gm% & serum albumin<3mg/dL were significant predictor of AKI. Pts
with 7 days mortality had higher incidence of low EF (<40%)/heart failure,
longer (>6hr) time to start & inadequate source control, inadequate pre/
intraop resuscitation & overused NE/inotrop, higher SOFA score, antibiotic
resistance, later start RRT. Blood purification were used in 4 pts with good
outcome.
Conclusions:
Pre/intraoperative resuscitation, faster & adequate source control
were key component in surgical septic shock
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Introduction:
Several preclinical studies demonstrated beneficial effects for me-
thane (CH4) administration in various inflammatory conditions. Our
aim was to investigate the consequences of post-treatment with in-
haled CH4 in a clinically relevant intra-abdominal sepsis model.
Methods:
Anesthetized minipigs were subjected to fecal peritonitis (0.6 g/kg, 5-
9x106 CFU i.p.; n=22) or sham-operation (sterile saline i.p; n=5). Inva-
sive hemodynamic monitoring with blood gas analyses was started
between 16-24 hours, organ dysfunction parameters (PaO2/FiO2 ratio;
mean arterial pressure; lactate, bilirubin, creatinine; urine output and
platelet counts) were determined according to a modified porcine-
specific Sequential Organ Failure Assessment (ps-SOFA) score system,
the perfusion rate (PR) of sublingual microcirculation was measured
by incident dark field illumination imaging. The animals were divided
into non-treated septic or septic shock groups (n=6-6) and CH4-
treated septic or septic shock (n=5-5) subgroups, CH4 inhalation
started from the 18th hr (2.2% CH4 in normoxic air; 500 mL/min).
Results:
Despite the standardized induction, heterogeneous severity of organ dam-
age was evolved. In septic and septic shock groups the median values of
ps-SOFA score reached 5 (4.75-5.65) and 13 (11.75-14), respectively. Septic
shock was characterized by significant elevations of creatinine and bilirubin
levels, while the platelet count decreased (from 332 to 76 *109/L). Inhalation
of CH4 increased the sublingual PR by 22% in the septic group, the creatin-
ine and bilirubin levels were decreased by 28% and 80%, respectively. CH4
post-treatment significantly decreased the ps-SOFA score (to 1; 0.5-2.75)
and resulted in lower values in septic shock group (to 10; 9.5-12.4).
Conclusions:
Methane post-treatment effectively influences sepsis-related end
organ dysfunction. Up to a severity threshold it may be a promising
additional organ protective tool.
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EFOP-3.6.2-16-2017-00006Fig. 1 (abstract P509). Relationship between vasopressor exposure
and limb or digit threat following vasopressor-dependent sepsis.
Panel A demonstrates the estimated contribution of daily
vasopressor intensity prior to surgical evaluation for limb or digit
threat, with mortality as a competing risk. Panel B and C explore the
relationship between threat and both cumulative vasopressor
exposure and the pattern of exposure following sepsis onset. (B) The
maximum cumulative vasopressor exposure was associated with the
highest risk of limb or digit threat (SHR 17.5) when compared to
reference exposure pattern (SHR 1.0, reference). (C) Increasing (SHR
1.2) and peak (SHR 1.2) patterns of cumulative exposure were
associate with an increased SH of limb threat, while a decreasing
pattern was associated with a lower risk (SHR 0.8) when compared
to constant intensity (SHR 1.0, reference). Abbreviations: SHR: Sub-
distribution hazard ratioP509
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Introduction:
Vasoactive medications are commonly used in sepsis treatment but
may correlate with peripheral ischemia and the well-publicized com-
plication of limb and digit loss. Yet, the association between limb
and digit threat and the intensity, duration, and pattern of vasopres-
sor exposure are unknown.
Methods:
We studied adults (2010-2014) at 12 hospitals in an integrated
health system who met criteria for Sepsis-3. We identified the
time to clinically apparent limb or digit threat using clinical adju-
dication among those with vasopressor-dependent sepsis (i.e. >1
hour of vasopressors at sepsis onset) who had a surgical evalu-
ation within 28-days of sepsis onset. We defined daily vasopres-
sor intensity as 0 to 4 vasopressors administered. Then, we
created a time-dependent model for threat with mortality as a
competing risk with a weight function to estimates the varying
contribution of vasopressors over time. We determined the sub-
distribution hazard (SH) ratio of threat for various patterns of
vasopressor exposure and intensity, adjusted for age, baseline risk
factors, and sequential organ failure assessment (SOFA) score at
sepsis onset.
Results:
Of 110,621 adults with sepsis, 13,147 (12%) were vasopressor-
dependent (age, 66 [IQR, 56-77]; 7,040 [54%] males; max SOFA score,
8 [SD 5]). Of these, 3,664 (28%) died and 117 (0.9%) had evaluations
for limb or digit threat 4 [IQR, 1-8] days after sepsis onset. The
model-based weight function showed the contribution of vasopres-
sors to threat was stable over time (Fig 1A). Overall, a 1 unit increase
in cumulative vasopressor exposure was associated with risk of threat
(SH ratio, 2.60 [95%CI, 1.60-4.23], p<.001). For various patterns of
vasopressor exposure, greater intensity associated with increased risk
of threat (Fig 1B). Compared to constant exposure, an increasing and
peak pattern associated with the greatest SH (Fig 1C).
Conclusions:
Cumulative vasopressor exposure was associated with an increased
risk-adjusted hazard of limb or digit threat following sepsis.
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Introduction:
Sepsis is a common life-threatening condition in critically ill patients
[1]. Public awareness is important for early recognition of sepsis and
improvement of outcomes [2]. We aimed to evaluate sepsis aware-
ness among different groups of people.
Methods:
Prospective paper-based surveys were issued between 1st July and 1st
August 2019 to patients, the relatives of the patiens, hospital staff and
general public who gave consent to participate in the study. The ques-
tionnaire included ten questions about demographic informations, oc-
cupational informations of hospital stuff and sepsis awareness.
Results:
A total of 588 participated in the survey. Of these participants, 87
(14.3%) were patients, 50 (8.5%) were relatives of patients, 134 (22.8%)
were physicians, 125 (21.3%) were medical students, 49 (8.3%) were
nurses, 51 (8.7%) were other hospital stuff and 92 (%15.6) were other
people. Of these participants, 425 (72.3%) had heard of the word “sep-
sis”. 206 (35.0%) responded correctly regarding the definition of sepsis.
325 (55.3%) of the participants heard the word “sepsis” during their
education, but only 53 (9%) heard it through the media. In the groups
of high school graduates, university graduates and postgraduates, the
rate of hearing the word sepsis and correctly identifying sepsis is sig-
nificantly higher than the primary school graduates or illiterate groups.
(p<0.05). Physicians, nurses and medical students were heard of the
word “sepsis” significantly more than other groups (p<0.005). Physi-
cians and medical students responded more accurately to the defin-
ition of sepsis than other groups (p<0.05).
Conclusions:
Public awareness of sepsis is limited compared to healthcare workers.
Increasing public knowledge of sepsis through education and
through media may contribute to raising public awareness and im-
proving outcomes.
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2. Rubulotta FM et al. Crit Care Med 37:167-170, 2009Fig. 1 (abstract P511). Panel A: variations of acetaminophen plasmatic
levels after 30 minutes (t1) and 2 hours (t2) after administration of an iv dose
of 1g of paracetamol in WT patients and patients carrying mutation; Panel B:
body temperature variations in WT patients and patients carrying mutationsP511
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Critical Care 2020, 24(Suppl 1):P511Introduction:
UDP-glucuronidation and oxido-reduction are the main pathways in-
volved in the hepatic metabolism of acetaminophen. Polymorphisms
rs8330 C>G for Uridine diphosphate-glucuronosyltransferase 1A1
(UGT1A1p) and rs776746 G>A for Cytochrome 3A5 (CYP3A5p) oxido-
reductase [1] might potentially affect the efficacy of paracetamol in
controlling fever and increase the toxic effects.
Methods:
Prospective observational study in 50 febrile (body temperature ≥ 38
°C) patients with sepsis/septic shock. Blood samples were collected
before i.v. administration of 1 g standard dose of paracetamol (t0), at
30 minutes (t1) and 2 hours (t2) after the infusion, to measure drug
plasma levels. An analysis of polymorphisms was conducted.
Results:
The prevalence of the polymorphisms was 36% for UGT1A1p and 8%
for CYP3A5p. Peak plasmatic levels in patients with CYP3A5p were
higher than wild type(WT) and UGT1A1p at t1(17.6[16.2-21.7] vs
11.4[9.1-14.3] and 10.5[9.3-13.1]mcg/ml; p=0.03 and 0.02 respect-
ively). No significant differences were founded on t2 (Fig.1A). Not-
ably, the three groups received a comparable pro kg dose of
acetaminophen. No difference was found between groups in term of
toxic effects. Patients carrying the CYP3A5p showed a more pro-
nounced effect on body temperature in respect of WT and UGT1A1p
with a delta t° of -0.85[-1.65—0.02] vs -0.4[-0.8—0.05] and
-0.45[0.65—0.1]°C respectively, but it does not reach statistical signifi-
cance (Fig.1B). Only 50% of the patients reach a temperature <38°C
at t2 and only 20% <37.5°C.
Conclusions:
Polymorphisms in enzymes involved in the metabolism of acet-
aminophen are relatively common. CYP3A5p seems to lead to higher
peak plasmatic concentration and a slightly increased efficacy in
fever control. These data could serve as basis for further research on
pharmacokinetics of acetaminophen in critically ill patients with well-
known increased volume of distribution that could affect clinical
efficacy.
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Fig. 1 (abstract P512). (A) Heap Map showing phenotype assignments
at 6-hr intervals for first 24hrs after presentation. (B) Bar graph showing
proportion of encounters transitioning from phenotype at presentation
within 24hrs, by arrival phenotype assignment and probability of
membership. (C) tSNE plots for α-type, ß-type, y-type, and ∂-type, with core
(dark), marginal (light), and non-members (grey) in plots on the left and
core, marginal, non members, and transitioning members (black) on
the right
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Introduction:
Sepsis is common, deadly, and heterogeneous. Prior work pro-
posed clinical phenotypes of sepsis at presentation. However, lit-
tle is known about how those phenotypes change over time. We
explored trajectories of clinical sepsis phenotypes for 24hrs after
presentation and contribution of phenotype cohesiveness to sub-
sequent transitions.
Methods:
We analyzed a retrospective cohort of adult patients meeting
Sepsis-3 criteria within 6hrs of presentation using electronic
health data from 12 hospitals in a large health system in Pennsyl-
vania. We predicted clinical phenotypes at 6-hr intervals over
24hrs using Euclidean distance anchored to previously published
cluster centroids (α,ß,y,∂). We determined phenotype cohesiveness
using probability of assignment at presentation, defining core
members as ≥90% and marginal as <90% probability. We deter-
mined how members transitioned to other phenotypes over
24hrs using t-distributed stochastic neighbor embedding (tSNE)
plots and determined the odds (95%CI) of transition.
Results:
We studied 37,198 adult sepsis encounters (median age 69, [IQR
57-81]; 51% male, median SOFA at arrival 3, [IQR 2-4]) hospital-
ized for at least 24hrs. At presentation, encounters were 28% α-
type, 30% ß-type, 28% y-type, and 14% ∂-type. Phenotype was
unchanged over 24hrs among 68% of encounters. Transitions
were most common for ∂-type (20% core, 57% marginal) and
least common for α-type (11% core, 39% marginal, Figure 1A).
Core members were less likely to transition than marginal mem-
bers for all phenotypes (p<0.01, Figure 1B,1C) The odds of ever
transitioning from presenting phenotype increased significantly
for marginal members vs. core for all phenotypes (α: OR 5.3,95%CI 4.7-6.0; ß: OR 2.9, 95%CI 2.6-3.2; y: OR 3.6 95%CI 3.2-3.9, ∂:
OR 5.2, 95%CI 4.6-5.9, p<0.01 for all).
Conclusions:
More than half of patients had stable clinical sepsis phenotypes for 24hrs
after presentation. Transitions to other phenotypes were significantly more
common among marginal members and those in the ∂-type.Publisher’s Note
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